Metadata_Plate,Metadata_Well,Metadata_broad_sample,Metadata_moa
24280,a01,BRD-K78364995-236-03-5,bacterial cell wall synthesis inhibitor
24280,a03,BRD-K78485176-001-02-9,angiotensin receptor antagonist
24280,a05,BRD-K78599730-001-02-6,farnesyltransferase inhibitor|NFkB pathway inhibitor|ras farnesyltransferase inhibitor
24280,a07,BRD-K78633253-001-01-2,ARF inhibitor
24280,a08,BRD-K78637815-001-01-4,cannabinoid receptor antagonist
24280,a09,BRD-K78643075-001-03-3,dopamine receptor antagonist
24280,a10,BRD-K78692225-001-11-2,dihydroorotate dehydrogenase inhibitor|PDGFR tyrosine kinase receptor inhibitor
24280,a11,BRD-K78815826-001-04-7,cyclooxygenase inhibitor
24280,a12,BRD-K78838262-001-02-4,hypolipidemic
24280,a16,BRD-K78959463-001-02-5,calcium channel activator
24280,a18,BRD-K79092138-001-04-5,POXB inhibitor|bacterial DNA inhibitor
24280,a19,BRD-K79116891-003-03-7,sodium channel blocker
24280,a20,BRD-K79124250-001-03-0,radiopaque medium
24280,a21,BRD-K79131256-001-03-9,tubulin polymerization inhibitor
24280,a22,BRD-K79145749-001-01-8,norepinephrine reputake inhibitor
24280,a24,BRD-K79366068-236-01-5,NTPDase inhibitor
24280,b01,BRD-K79425933-001-03-6,dopamine receptor antagonist
24280,b02,BRD-K79437791-001-02-4,Inhibitor of methylation of endogenous isoprenylated proteins
24280,b03,BRD-K79501723-003-03-4,histamine receptor modulator
24280,b04,BRD-K79684402-300-01-0,dopamine receptor partial agonist
24280,b05,BRD-K79711234-001-04-3,bacterial 50S ribosomal subunit inhibitor
24280,b06,BRD-K79759585-001-02-1,phosphodiesterase inhibitor
24280,b07,BRD-K79930101-300-01-1,EGFR inhibitor|epidermal growth factor receptor (EGFR) inhibitor|ErbB2 tyrosine kinase inhibitor|receptor tyrosine protein kinase inhibitor
24280,b09,BRD-K80315159-051-01-2,histamine receptor antagonist
24280,b12,BRD-K80334323-001-03-5,progestogen hormone
24280,b15,BRD-K80353807-001-03-0,vasodilator
24280,b16,BRD-K80396088-001-03-9,Sulfonylurea
24280,b17,BRD-K80451230-051-01-8,acetylcholine receptor antagonist
24280,b19,BRD-K80639402-003-01-1,serotonin receptor antagonist
24280,b20,BRD-K80725821-300-01-1,serotonin receptor antagonist
24280,b21,BRD-K80738081-001-06-2,cytochrome P450 inhibitor|SIRT activator
24280,b22,BRD-K80778372-001-01-7,GABA benzodiazepine site receptor inverse agonist
24280,b24,BRD-K80946661-001-02-8,p53 activator
24280,c01,BRD-K80970344-201-02-9,NFkB pathway inhibitor
24280,c02,BRD-K81029756-001-02-8,L-type calcium channel blocker|calcium channel antagonist|calcium channel blocker
24280,c04,BRD-K81209159-001-02-9,Acetylcholinesterase inhibitor
24280,c05,BRD-K81209512-001-01-3,EGFR inhibitor|epidermal growth factor receptor (EGFR) inhibitor|tyrosine kinase inhibitor
24280,c06,BRD-K81225797-001-01-5,adenosine receptor antagonist
24280,c07,BRD-K81272440-001-02-6,calcium channel blocker
24280,c09,BRD-K81376179-001-01-4,FLT3 inhibitor
24280,c14,BRD-K81709173-001-03-8,glucocorticoid receptor agonist
24280,c17,BRD-K81729199-001-01-0,acetylcholine receptor antagonist
24280,c20,BRD-K81839095-001-02-0,Estrogen receptor agonist
24280,c21,BRD-K81876028-300-01-2,Serotonin receptor agonist
24280,c23,BRD-K82103381-003-03-7,vasodilator
24280,d03,BRD-K82255054-001-04-3,GABA receptor agonist
24280,d04,BRD-K82484965-003-02-7,dopamine receptor agonist
24280,d05,BRD-K82561139-001-01-9,casein kinase inhibitor
24280,d06,BRD-K82562631-236-02-0,Cyclooxygenase inhibitor
24280,d07,BRD-K82577285-001-01-7,Dopamine receptor agonist
24280,d08,BRD-K82731415-001-04-7,CDK inhibitor
24280,d09,BRD-K82795137-001-02-3,Histamine receptor antagonist
24280,d10,BRD-K82823076-001-01-8,GABA benzodiazepine site receptor inverse agonist
24280,d13,BRD-K82846253-001-03-0,Insulin secretagogue
24280,d14,BRD-K82865713-001-02-6,cAMP inhibitor
24280,d17,BRD-K83023055-001-01-9,Melatonin receptor agonist
24280,d19,BRD-K83063356-003-01-7,CC chemokine receptor antagonist|CCR antagonist
24280,d23,BRD-K83302049-001-01-6,Histamine receptor antagonist
24280,d24,BRD-K83322645-103-01-6,sigma receptor antagonist|sigma receptor ligand
24280,e04,BRD-K83459933-001-02-1,angiogenesis inhibitor
24280,e05,BRD-K83508485-001-01-9,tachykinin antagonist
24280,e06,BRD-K83597974-003-05-7,Monoamine oxidase inhibitor
24280,e07,BRD-K83637872-001-01-7,Smoothened receptor antagonist
24280,e08,BRD-K84175871-003-02-2,Adrenergic receptor agonist
24280,e12,BRD-K84266862-001-01-6,phosphodiesterase inhibitor
24280,e13,BRD-K84421793-001-01-1,dopamine receptor agonist
24280,e14,BRD-K84595254-001-03-0,ATPase inhibitor
24280,e15,BRD-K84663978-001-02-3,phosphodiesterase inhibitor|platelet aggregation inhibitor|potassium channel blocker
24280,e16,BRD-K84709232-001-02-6,lipoxygenase inhibitor|HIV integrase inhibitor|NFkB pathway inhibitor|nitric oxide production inhibitor|PPAR receptor modulator|tumor necrosis factor production inhibitor
24280,e20,BRD-K85090592-003-08-7,Acetylcholine receptor agonist
24280,e22,BRD-K85119730-001-06-5,ATP channel blocker
24280,e23,BRD-K85242180-001-01-1,"indoleamine 2,3-dioxygenase inhibitor"
24280,e24,BRD-K85266041-304-01-7,glutamate receptor antagonist
24280,f04,BRD-K85383046-001-02-5,chloride channel blocker
24280,f06,BRD-K85871428-001-01-9,p38 MAPK inhibitor
24280,f11,BRD-K85883481-001-02-6,glucocorticoid receptor agonist
24280,f12,BRD-K86204871-001-02-2,sterol demethylase inhibitor
24280,f13,BRD-K86301799-001-14-0,phosphodiesterase inhibitor
24280,f14,BRD-K86434416-001-02-7,Monoamine oxidase inhibitor
24280,f15,BRD-K84663978-001-03-1,phosphodiesterase inhibitor|platelet aggregation inhibitor|potassium channel blocker
24280,f16,BRD-K86509404-001-02-0,CDK inhibitor
24280,f19,BRD-K86600316-003-01-2,Adrenergic receptor antagonist
24280,f20,BRD-K86727142-001-06-6,HCV inhibitor|XIAP inhibitor
24280,f21,BRD-K86873305-236-03-0,Bacterial cell wall synthesis inhibitor
24280,f22,BRD-K86882815-001-01-6,dopamine receptor agonist|prolactin inhibitor|prolactin secretion inhibitor
24280,f23,BRD-K86958018-001-01-9,TRPV agonist
24280,f24,BRD-K87048468-003-01-9,Serotonin receptor antagonist
24280,g01,BRD-K87049188-001-03-6,chelating agent|dopamine beta hydroxylase inhibitor
24280,g08,BRD-K87510569-001-01-0,CC chemokine receptor antagonist
24280,g09,BRD-K87696786-003-01-0,glutamate receptor antagonist
24280,g14,BRD-K87990216-001-03-7,Glucocorticoid receptor agonist
24280,g15,BRD-K87991767-001-02-0,carbonic anhydrase inhibitor|cyclooxygenase inhibitor
24280,g16,BRD-K88090157-050-03-3,antihistamine
24280,g21,BRD-K88282786-066-04-9,cannabinoid receptor agonist
24280,g22,BRD-K88358234-003-01-4,serotonin receptor agonist|nerve growth factor agonist|neurotrophic factor enhancer
24280,g23,BRD-K88366685-300-03-7,3-ketoacyl CoA thiolase inhibitor
24280,g24,BRD-K88405679-003-01-5,antihistamine
24280,h01,BRD-K88429204-001-04-7,dihydrofolate reductase inhibitor
24280,h02,BRD-K88544581-001-01-2,ACAT inhibitor
24280,h05,BRD-K88568253-065-02-1,monoamine oxidase inhibitor
24280,h06,BRD-K88611939-001-01-8,Glutamate receptor agonist
24280,h08,BRD-K88677950-001-01-3,MAP kinase inhibitor|MEK inhibitor
24280,h10,BRD-K88741031-001-01-0,EGFR inhibitor|tyrosine kinase inhibitor
24280,h11,BRD-K88743730-001-01-0,serotonin receptor partial agonist
24280,h12,BRD-K88759641-003-01-0,Angiotensin receptor antagonist
24280,h13,BRD-K88789588-001-03-2,aromatase inhibitor
24280,h14,BRD-K88809146-003-02-1,monoamine oxidase inhibitor
24280,h15,BRD-K88849294-001-02-1,Tyrosine phosphatase inhibitor
24280,h16,BRD-K88871508-001-01-9,Dopamine receptor agonist
24280,h18,BRD-K89046952-001-03-4,bacterial cell wall synthesis inhibitor
24280,h21,BRD-K89055274-048-03-7,muscle relaxant
24280,h22,BRD-K89085489-001-02-6,apoptosis stimulant|retinoid receptor agonist
24280,h23,BRD-K89125793-001-05-4,antiprotozoal agent
24280,h24,BRD-K89152108-001-03-3,thyroid hormone stimulant
24280,i01,BRD-K89210380-001-03-8,vitamin B
24280,i04,BRD-K89272762-001-04-4,chloride channel blocker
24280,i07,BRD-K89274813-001-01-5,acetylcholine release enhancer
24280,i08,BRD-K89375097-300-04-7,Acetylcholine receptor antagonist
24280,i09,BRD-K89402695-001-01-5,Thromboxane receptor antagonist
24280,i13,BRD-K89732114-001-02-6,dopamine receptor antagonist
24280,i14,BRD-K89923877-003-02-4,acetylcholine receptor antagonist
24280,i15,BRD-K89930444-001-01-9,tyrosine kinase inhibitor
24280,i16,BRD-K89997465-001-02-0,dopamine receptor antagonist
24280,i17,BRD-K90027355-001-03-4,mineralocorticoid receptor antagonist
24280,i23,BRD-K90259198-003-04-8,calmodulin antagonist|potassium channel blocker|squalene monooxygenase channel blocker
24280,i24,BRD-K90333595-001-02-8,adrenergic receptor antagonist
24280,j01,BRD-K90524085-001-05-2,phosphodiesterase inhibitor|platelet aggregation inhibitor
24280,j04,BRD-K90574421-001-01-9,Serotonin receptor agonist
24280,j08,BRD-K90789829-003-03-3,Adrenergic inhibitor
24280,j09,BRD-K90976994-001-02-1,Bile acid
24280,j10,BRD-K91243525-001-01-5,Neurotensin receptor antagonist
24280,j11,BRD-K91263825-001-02-8,tricyclic antidepressant
24280,j13,BRD-K91315211-334-02-3,Histamine receptor agonist
24280,j15,BRD-K91336023-001-01-4,Dopamine receptor agonist
24280,j16,BRD-K91370081-001-04-6,DNA synthesis inhibitor
24280,j19,BRD-K91904471-001-01-6,p38 MAPK inhibitor
24280,j20,BRD-K92000912-001-06-8,cannabinoid receptor antagonist
24280,j24,BRD-K92015269-001-01-6,dopamine uptake inhibitor
24280,k02,BRD-K92049597-001-04-2,sodium channel blocker
24280,k04,BRD-K92093830-003-05-0,topoisomerase inhibitor
24280,k05,BRD-K92138166-001-01-0,other antibiotic
24280,k09,BRD-K92492521-001-01-1,Leukotriene receptor antagonist
24280,k12,BRD-K92678294-001-01-0,Isoflavone
24280,k14,BRD-K92726801-003-02-7,Haemostatic agent
24280,k17,BRD-K92731339-227-02-3,ACE inhibitor
24280,k18,BRD-K92758126-001-06-3,NFkB pathway inhibitor
24280,k19,BRD-K92778217-001-04-6,Cyclooxygenase inhibitor
24280,k20,BRD-K92830582-003-04-8,adrenergic receptor antagonist
24280,k22,BRD-K92984783-003-02-4,Serotonin receptor antagonist
24280,l01,BRD-K93080877-001-02-1,tripeptidyl peptidase inhibitor
24280,l02,BRD-K93176058-001-01-0,retinoid receptor agonist
24280,l03,BRD-K93188295-300-01-4,adrenergic receptor antagonist
24280,l05,BRD-K93258693-001-02-5,PPAR receptor antagonist
24280,l06,BRD-K93280214-004-02-3,GABA receptor antagonist
24280,l09,BRD-K93325701-001-03-0,SRC inhibitor
24280,l10,BRD-K93332168-001-03-2,Monoamine oxidase inhibitor
24280,l11,BRD-K93441486-067-03-7,Acetylcholine receptor antagonist
24280,l12,BRD-K93460210-001-01-3,Serotonin receptor antagonist
24280,l13,BRD-K93461745-001-01-5,Serotonin receptor agonist
24280,l14,BRD-K93480852-001-02-2,calcium/calmodulin dependent protein kinase inhibitor
24280,l19,BRD-K93568044-001-03-1,glucocorticoid receptor agonist
24280,l20,BRD-K93658967-001-01-7,CDK inhibitor|CFTR channel activator|glycogen synthase kinase inhibitor|JNK inhibitor
24280,l21,BRD-K93754473-001-02-9,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)
24280,l22,BRD-K94144010-001-05-5,nicotine metabolite
24280,m04,BRD-K94270326-004-01-0,dopamine receptor antagonist
24280,m06,BRD-K94379058-001-03-5,cannabinoid receptor inverse agonist
24280,m07,BRD-K94441233-001-03-1,HMGCR inhibitor
24280,m08,BRD-K94512704-001-01-3,dopamine receptor antagonist
24280,m12,BRD-K94689771-001-02-5,CYP1B1 inhibitor
24280,m17,BRD-K94832621-001-01-5,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)
24280,m19,BRD-K94841585-001-02-8,laxative|free radical generator
24280,m21,BRD-K94887716-001-01-5,Serotonin receptor agonist
24280,m22,BRD-K94920105-001-01-3,PARP inhibitor
24280,m24,BRD-K95202259-001-01-9,p38 MAPK inhibitor
24280,n01,BRD-K95237249-001-04-2,Uricosuric blocker
24280,n02,BRD-K95309561-001-04-9,estrogen receptor agonist
24280,n04,BRD-K95435023-001-01-0,c-Met inhibitor|hepatocyte growth factor receptor inhibitor
24280,n07,BRD-K95603879-001-03-4,ATPase inhibitor
24280,n08,BRD-K95609758-001-01-1,potassium channel activator
24280,n11,BRD-K95655893-001-01-0,VEGFR kinase inhibitor
24280,n12,BRD-K95676198-001-02-6,JAK inhibitor
24280,n15,BRD-K95739795-001-01-1,Vesicular monoamine transporter inhibitor
24280,n16,BRD-K95763993-001-03-7,PDGFR receptor inhibitor
24280,n17,BRD-K95785537-001-04-1,src inhibitor
24280,n20,BRD-K95851186-001-02-9,GABA receptor modulator
24280,n21,BRD-K95899059-003-01-0,Serotonin receptor agonist
24280,n22,BRD-K95992530-001-02-4,integrin antagonist
24280,n23,BRD-K96119599-001-04-7,Melanin inhibitor
24280,n24,BRD-K96144918-001-02-3,KPL-1 tumor suppressor
24280,o04,BRD-K96263742-001-02-3,PPAR receptor agonist
24280,o05,BRD-K96271548-001-02-2,antioxidant
24280,o07,BRD-K96402602-001-01-8,PPMTase inhibitor
24280,o08,BRD-K96527333-001-03-4,GABA receptor modulator
24280,o10,BRD-K96670504-001-01-9,Glucokinase inhibitor
24280,o13,BRD-K96720755-001-01-8,Vasopressin receptor antagonist
24280,o14,BRD-K96799727-001-01-7,HSP inhibitor
24280,o15,BRD-K96809896-001-01-9,p38 MAPK inhibitor
24280,o16,BRD-K96862998-001-03-1,TGF beta receptor inhibitor
24280,o17,BRD-K97061094-001-03-2,Histamine receptor antagonist
24280,o18,BRD-K97118047-001-01-2,Casein kinase inhibitor
24280,o19,BRD-K97158071-001-04-1,Dopamine receptor antagonist
24280,o20,BRD-K97181089-001-02-7,sodium channel blocker
24280,o22,BRD-K97330509-001-01-4,src inhibitor
24280,o23,BRD-K97354755-001-01-5,src inhibitor
24280,o24,BRD-K97365803-001-01-3,PI3K inhibitor
24280,p01,BRD-K97399794-001-07-0,polar auxin transport inhibitor
24280,p02,BRD-K97440753-066-03-3,adrenergic receptor antagonist|prolactin inhibitor
24280,p04,BRD-K97509413-001-01-8,AGE inhibitor|estrogen receptor agonist|estrogen receptor ligand
24280,p05,BRD-K97521363-001-03-9,glycolysis inhibitor
24280,p06,BRD-K97530723-001-04-3,melatonin receptor agonist|nitric oxide synthase inhibitor
24280,p07,BRD-K97564742-103-01-9,histamine receptor antagonist
24280,p10,BRD-K97688263-001-02-9,sodium channel blocker
24280,p13,BRD-K97746869-001-04-9,ATP channel blocker
24280,p14,BRD-K97752965-001-01-6,ATP channel activator|nitric oxide donor|potassium channel agonist
24280,p15,BRD-K97799481-002-03-6,Adenosine receptor antagonist
24280,p16,BRD-K97810537-001-03-7,glucocorticoid receptor agonist
24280,p17,BRD-K98039984-001-03-0,glucocorticoid receptor agonist
24280,p18,BRD-K98143437-001-01-7,p38 MAPK inhibitor|interleukin inhibitor|tumor necrosis factor production inhibitor
24280,p20,BRD-K98157055-001-04-2,glutamate receptor antagonist
24280,p21,BRD-K98174813-001-05-7,bacterial 30S ribosomal subunit inhibitor
24280,p23,BRD-K98297262-001-01-1,"1,3-beta-glucan synthase inhibitor"
24280,p24,BRD-K98521173-001-03-8,mineralocorticoid receptor agonist
24304,a01,BRD-A44966919-001-03-1,acetylcholine receptor antagonist
24304,a02,BRD-A45140972-060-02-4,bacterial 50S ribosomal subunit inhibitor
24304,a03,BRD-A45499626-001-01-0,Glutamate receptor antagonist
24304,a04,BRD-A45543382-001-02-7,radiopaque medium
24304,a05,BRD-A46066006-004-04-4,muscarinic antagonist
24304,a10,BRD-A47144777-001-02-5,HSP90 inhibitor
24304,a11,BRD-A47494775-003-03-0,Adrenergic receptor agonist
24304,a12,BRD-A47513740-001-02-5,protein phosphatase inhibitor
24304,a15,BRD-A47598013-004-02-0,selective serotonin reuptake inhibitor (SSRI)
24304,a17,BRD-A48257147-001-01-9,glutamate receptor agonist
24304,a18,BRD-A48300215-001-01-4,sodium channel blocker
24304,a21,BRD-A48809242-001-02-9,adenosine receptor agonist
24304,a23,BRD-A49046702-001-01-2,GABA uptake inhibitor
24304,a24,BRD-A49172652-001-13-1,ATPase inhibitor
24304,b01,BRD-A49225603-045-02-7,histamine receptor agonist
24304,b02,BRD-A49358627-001-03-9,PPAR receptor agonist
24304,b03,BRD-A49370193-051-01-7,serotonin receptor agonist
24304,b05,BRD-A49680073-001-01-9,JAK inhibitor|Lipocortin synthesis stimulant|STAT inhibitor
24304,b06,BRD-A49734948-001-03-3,Plant alkaloid
24304,b07,BRD-A49906757-004-03-1,Acetylcholine receptor antagonist
24304,b09,BRD-A50157456-065-02-4,adrenergic receptor agonist
24304,b10,BRD-A50311610-300-04-7,CAR agonist
24304,b11,BRD-A50675702-001-03-0,chloride channel blocker|GABA gated chloride channel blocker
24304,b12,BRD-A50684349-001-01-5,dopamine receptor agonist
24304,b15,BRD-A50737080-001-01-4,ATR kinase inhibitor
24304,b16,BRD-A50764878-001-01-4,serotonin receptor antagonist
24304,b19,BRD-A51410489-001-01-4,adrenergic receptor antagonist
24304,b21,BRD-A51714012-001-02-3,Adrenergic inhibitor
24304,b22,BRD-A51820102-008-04-0,Bacterial cell wall synthesis inhibitor
24304,b23,BRD-A51829654-001-01-4,Serotonin receptor antagonist
24304,c01,BRD-A52588987-004-04-1,Dopamine receptor antagonist
24304,c02,BRD-A52660433-066-01-3,Monoamine oxidase inhibitor
24304,c04,BRD-A52922642-001-02-9,L-type calcium channel blocker
24304,c05,BRD-A53077924-236-01-4,Selective serotonin reuptake enhancer (SSRE)
24304,c07,BRD-A53416814-001-01-5,nitric oxide production inhibitor|phosphoenolpyruvate carboxylase activator|serine/threonine protein phosphatase activator
24304,c09,BRD-A53576514-003-03-1,Acetylcholine receptor antagonist
24304,c10,BRD-A53952395-003-04-6,local anesthetic
24304,c13,BRD-A54029483-001-01-5,endothelin receptor antagonist
24304,c14,BRD-A54236247-003-02-7,Adrenergic receptor agonist
24304,c17,BRD-A54490543-066-04-4,monoamine oxidase inhibitor
24304,c18,BRD-A54845972-066-01-5,serotonin receptor agonist|adrenergic receptor partial agonist|dopamine receptor agonist
24304,c19,BRD-A54927599-001-07-8,P-selectin inhibitor
24304,c22,BRD-A55272860-001-03-9,dopamine receptor antagonist
24304,c23,BRD-A55369275-001-01-6,GABA receptor antagonist
24304,c24,BRD-A55393291-001-02-4,Androgen receptor agonist
24304,d01,BRD-A55424491-001-04-1,dihydrofolate reductase inhibitor
24304,d04,BRD-A55756846-001-05-5,PKA inhibitor
24304,d05,BRD-A55913614-316-04-7,antimalarial agent|DNA inhibitor
24304,d07,BRD-A56020723-001-02-0,cathepsin inhibitor|antiamyloidogenic agent
24304,d08,BRD-A56675431-001-04-0,Thiazide diuretic
24304,d13,BRD-A56987319-001-03-8,Adenylyl cyclase inhibitor
24304,d14,BRD-A57133233-003-03-7,histamine receptor antagonist
24304,d17,BRD-A57382968-001-06-8,Cyclooxygenase inhibitor
24304,d20,BRD-A58048407-001-06-3,Calcium channel blocker
24304,d24,BRD-A59215453-003-03-3,Acetylcholine receptor antagonist
24304,e03,BRD-A59303141-001-03-9,Thiazide diuretic
24304,e06,BRD-A60197193-001-05-4,Dopamine receptor antagonist
24304,e12,BRD-A61154809-001-03-5,ATP channel blocker|insulin secretagogue
24304,e14,BRD-A61392169-001-01-9,glutamate receptor antagonist
24304,e15,BRD-A61470182-001-02-4,macrophage activator
24304,e16,BRD-A61793559-001-04-0,Carbonic anhydrase inhibitor
24304,e19,BRD-A61856038-001-01-2,Lipoxygenase inhibitor
24304,e22,BRD-A62021152-003-01-8,serotonin receptor agonist
24304,e23,BRD-A62057054-001-01-5,Serotonin receptor antagonist
24304,f04,BRD-A62428732-096-02-6,antihistamine
24304,f05,BRD-A62505706-001-02-3,DNA directed DNA polymerase inhibitor
24304,f06,BRD-A62525898-001-02-9,Glucocorticoid receptor agonist
24304,f08,BRD-A63346720-300-01-1,sigma receptor antagonist|dopamine reuptake inhibitor
24304,f11,BRD-A63546914-003-01-2,Glutamate receptor antagonist
24304,f12,BRD-A63667919-103-01-9,dopamine receptor antagonist|partial serotonin receptor agonist
24304,f14,BRD-A63836183-362-01-1,angiotensin receptor antagonist
24304,f15,BRD-A63894585-001-03-4,glucocorticoid receptor agonist
24304,f16,BRD-A64092382-003-03-5,Sodium channel blocker
24304,f19,BRD-A64125466-236-02-0,choleretic agent
24304,f20,BRD-A64227845-004-02-8,Dopamine receptor agonist
24304,f21,BRD-A64228451-001-03-5,BTK inhibitor
24304,f23,BRD-A64485570-001-02-9,DNA directed DNA polymerase inhibitor|thymidylate synthase inhibitor
24304,g02,BRD-A64933752-001-01-0,adenosine receptor agonist
24304,g06,BRD-A64977602-001-01-9,Adrenergic receptor antagonist
24304,g07,BRD-A65013509-003-03-8,Acetylcholine receptor antagonist
24304,g08,BRD-A65051990-001-03-8,vitamin K antagonist
24304,g09,BRD-A65076780-001-01-3,adrenergic receptor antagonist|prolactin inhibitor
24304,g10,BRD-A65145453-001-02-0,glutamate receptor agonist
24304,g11,BRD-A65280694-003-03-8,Dopamine receptor antagonist
24304,g12,BRD-A65440446-001-02-5,Adrenergic receptor agonist
24304,g13,BRD-A65597028-003-02-4,Adrenergic receptor antagonist
24304,g14,BRD-A65615053-003-01-4,Serotonin receptor antagonist
24304,g15,BRD-A65671304-001-02-6,angiotensin receptor antagonist
24304,g17,BRD-A66025870-237-05-1,bacterial cell wall synthesis inhibitor
24304,g18,BRD-A66199457-001-02-2,antineoplastic
24304,g22,BRD-A66435872-313-01-8,Histamine receptor agonist
24304,g23,BRD-A66563878-003-01-8,Adrenergic receptor agonist
24304,h01,BRD-A66927094-001-01-7,Dopamine receptor antagonist
24304,h07,BRD-A67552019-001-02-2,ATPase inhibitor
24304,h09,BRD-A67862938-034-04-0,Adrenergic receptor antagonist
24304,h10,BRD-A68281735-001-02-0,Leukotriene receptor antagonist
24304,h12,BRD-A68723818-050-04-4,Histamine receptor antagonist
24304,h13,BRD-A68888262-003-02-9,histamine receptor antagonist
24304,h14,BRD-A68929948-001-01-9,antiamyloidogenic agent|gamma secretase inhibitor
24304,h15,BRD-A69636825-003-02-1,Calcium channel blocker
24304,h17,BRD-A69777949-001-04-4,topoisomerase inhibitor
24304,h18,BRD-A69786436-003-02-5,acetylcholine receptor antagonist
24304,h23,BRD-A70083328-001-02-9,Acetylcholinesterase inhibitor
24304,h24,BRD-A70268693-103-01-9,Acetylcholine receptor agonist
24304,i01,BRD-A70407468-001-01-2,adenosine receptor antagonist
24304,i02,BRD-A70514680-003-03-9,Local anesthetic
24304,i03,BRD-A70649075-008-04-3,sterol demethylase inhibitor
24304,i08,BRD-A71157293-003-03-5,Vitamin B
24304,i09,BRD-A71203467-001-01-5,Dopamine receptor antagonist
24304,i10,BRD-A71774530-001-01-8,chitin inhibitor
24304,i12,BRD-A71816415-236-02-7,HMGCR inhibitor
24304,i13,BRD-A72066420-001-01-1,PPAR receptor antagonist
24304,i14,BRD-A72483914-001-01-1,Serotonin receptor antagonist
24304,i15,BRD-A72596465-001-01-3,PPAR receptor antagonist
24304,i16,BRD-A72703248-001-02-7,calcium channel blocker|cytochrome P450 inhibitor
24304,i17,BRD-A72711497-236-02-0,bacterial permeability inducer
24304,i18,BRD-A72988804-001-03-8,Cyclooxygenase inhibitor
24304,i19,BRD-A73368467-003-02-8,Histamine receptor antagonist
24304,i23,BRD-A73859745-236-01-8,Apoptosis stimulant
24304,j02,BRD-A74667430-001-04-6,Cyclooxygenase inhibitor
24304,j03,BRD-A74904029-001-04-0,Casein kinase inhibitor
24304,j07,BRD-A74980173-001-02-8,Bacterial DNA gyrase inhibitor
24304,j09,BRD-A75478957-001-01-6,collagenase inhibitor|metalloproteinase inhibitor|stromelysin inhibitor
24304,j10,BRD-A75552914-001-04-4,Cyclooxygenase inhibitor
24304,j12,BRD-A75769826-003-01-3,opioid receptor antagonist
24304,j13,BRD-A75817871-001-02-6,ATPase inhibitor
24304,j14,BRD-A75850590-003-04-9,bacterial DNA gyrase inhibitor
24304,j16,BRD-A76093993-001-01-8,Potassium channel activator
24304,j24,BRD-A77291778-003-04-8,acetylcholine receptor antagonist
24304,k01,BRD-A77299732-001-01-6,Eukaryotic translation initiation factor inhibitor
24304,k02,BRD-A77349281-001-02-2,heparanase inhibitor|tyrosine phosphatase inhibitor
24304,k06,BRD-A78295502-337-03-5,anti-arrhythmia agent
24304,k10,BRD-A78377521-001-02-2,Kinesin-like spindle protein inhibitor
24304,k11,BRD-A78877355-003-03-6,Cyclooxygenase inhibitor
24304,k12,BRD-A78942461-003-01-3,Adrenergic receptor antagonist
24304,k13,BRD-A79226577-003-01-1,serotonin receptor antagonist|polarization inhibitor|sodium channel blocker
24304,k17,BRD-A79672927-001-04-1,Acetylcholine receptor antagonist
24304,k18,BRD-A79981887-003-04-0,adrenergic receptor agonist
24304,k19,BRD-A80017228-001-04-2,Sodium/potassium/chloride transporter inhibitor
24304,k21,BRD-A80213327-305-01-8,Ras GTPase inhibitor
24304,k22,BRD-A80594172-001-02-0,glucocorticoid receptor agonist
24304,l01,BRD-A80641450-001-01-4,Endothelin receptor antagonist
24304,l05,BRD-A81177136-001-03-6,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist
24304,l10,BRD-A81615860-001-02-9,tryptophan hydroxylase inhibitor
24304,l11,BRD-A81795050-003-01-7,oxidosqualene cyclase inhibitor
24304,l12,BRD-A81866333-003-01-5,Adenosine receptor agonist
24304,l13,BRD-A82238138-001-01-7,glucocorticoid receptor agonist
24304,l17,BRD-A82371568-001-01-5,ribonucleoside reductase inhibitor|DNA polymerase inhibitor|DNA repair enzyme inhibitor|DNA synthesis inhibitor|ribonucleotide reductase inhibitor
24304,l19,BRD-A82590476-001-01-1,tachykinin antagonist
24304,l20,BRD-A82656074-003-01-2,opioid receptor antagonist
24304,l22,BRD-A83326220-001-02-6,Nitric oxide production inhibitor
24304,m02,BRD-A83431637-001-01-3,Cytochrome P450 inhibitor
24304,m04,BRD-A83695761-001-01-1,Potassium channel blocker
24304,m05,BRD-A83855350-003-01-4,Opioid receptor antagonist
24304,m07,BRD-A83937277-001-03-0,Hydantoin antiepileptic
24304,m08,BRD-A84174393-001-02-0,Cyclooxygenase inhibitor
24304,m11,BRD-A84174873-001-06-0,benzodiazepine receptor agonist
24304,m12,BRD-A84389091-001-01-1,GABA receptor inverse agonist
24304,m15,BRD-A84389633-001-01-6,serotonin receptor antagonist
24304,m19,BRD-A85137183-001-01-2,bacterial cell wall synthesis inhibitor
24304,m21,BRD-A85234536-001-04-5,Adenosine receptor agonist
24304,m22,BRD-A85280935-003-01-7,Dopamine receptor agonist
24304,m23,BRD-A85472596-001-01-4,Prostanoid receptor antagonist
24304,m24,BRD-A85587465-001-01-7,Serotonin receptor antagonist
24304,n01,BRD-A86044036-001-04-2,cyclooxygenase inhibitor
24304,n06,BRD-A87479750-001-01-9,Cyclooxygenase inhibitor
24304,n08,BRD-A87719232-001-02-4,Cyclooxygenase inhibitor
24304,n11,BRD-A88254928-001-04-6,adrenergic receptor agonist
24304,n12,BRD-A88282067-001-02-2,Antiarrhythmic
24304,n15,BRD-A88548664-001-01-5,dopamine receptor agonist
24304,n18,BRD-A89434049-001-02-1,ATPase inhibitor
24304,n19,BRD-A89585551-003-03-4,adenosine receptor antagonist|hemoglobin antagonist
24304,n20,BRD-A89672324-001-02-2,GABA receptor antagonist
24304,n22,BRD-A89947015-001-01-4,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor
24304,n24,BRD-A90311807-236-01-4,Dehydropeptidase inhibitor
24304,o01,BRD-A90462498-003-02-1,antineoplastic
24304,o02,BRD-A90490067-001-01-9,estrogen receptor antagonist|DNA directed DNA polymerase inhibitor|soluble epoxide hydrolase inhibitor
24304,o03,BRD-A90515964-001-05-8,expectorant
24304,o04,BRD-A90799790-001-04-1,calcium channel blocker
24304,o06,BRD-A91008255-001-02-8,calcium channel blocker
24304,o08,BRD-A91699651-316-04-2,Antimalarial
24304,o09,BRD-A91866971-001-02-2,Thromboxane receptor antagonist
24304,o13,BRD-A92161634-001-02-6,Acetylcholine receptor antagonist
24304,o14,BRD-A92585442-237-01-0,Cytochrome P450 inhibitor
24304,o15,BRD-A92670106-003-03-9,Sodium channel blocker
24304,o16,BRD-A92826379-009-02-6,Sodium channel blocker
24304,o18,BRD-A93000692-001-03-2,PPAR receptor agonist
24304,o19,BRD-A93206962-001-01-2,adrenergic receptor agonist|adrenergic receptor partial agonist
24304,o20,BRD-A93255169-001-06-9,TNF production inhibitor
24304,o24,BRD-A93477898-001-01-8,caspase activator
24304,p01,BRD-A93659613-051-03-6,Opioid receptor agonist
24304,p02,BRD-A93739713-065-02-7,muscarinic antagonist
24304,p05,BRD-A94413429-003-01-6,neuropeptide receptor antagonist
24304,p06,BRD-A94543220-001-02-3,Sterol demethylase inhibitor
24304,p07,BRD-A94624445-236-02-2,adenosine receptor agonist|cAMP stimulant
24304,p08,BRD-A94669766-001-02-6,Aromatase inhibitor
24304,p10,BRD-A94709349-001-02-6,Muscle relaxant
24304,p13,BRD-A95096829-300-01-4,dopamine receptor antagonist
24304,p14,BRD-A95207036-001-02-8,androgen receptor antagonist
24304,p15,BRD-A95445494-001-02-9,interleukin synthesis inhibitor|sodium/glucose cotransporter inhibitor
24304,p16,BRD-A95513702-001-02-2,aromatase inhibitor
24304,p17,BRD-A95696066-003-06-2,Norepinephrine reuptake inhibitor
24304,p18,BRD-A95869247-001-03-8,thiazide diuretic
24304,p19,BRD-A95939040-008-03-3,sterol demethylase inhibitor
24304,p20,BRD-A96456596-001-01-4,Leukotriene receptor antagonist
24304,p21,BRD-A96485169-001-02-8,Aldose reductase inhibitor
24304,p23,BRD-A96882008-001-01-3,Tachykinin antagonist
24304,p24,BRD-A96897502-001-02-0,lipid peroxidase inhibitor
24312,a01,BRD-K40782193-003-01-1,sodium channel blocker
24312,a02,BRD-K40887525-001-02-9,serotonin receptor antagonist
24312,a03,BRD-K40901640-001-01-0,serotonin receptor antagonist
24312,a04,BRD-K40905133-001-02-3,sodium channel blocker
24312,a05,BRD-K40965114-001-01-2,Adrenergic receptor antagonist
24312,a06,BRD-K40990712-001-02-4,gonadotropin releasing factor hormone receptor antagonist|sodium/hydrogen antiport inhibitor|sodium/hydrogen exchanger inhibitor|urokinase inhibitor
24312,a07,BRD-K41143549-003-01-6,glutamate receptor antagonist
24312,a08,BRD-K41337261-001-01-4,Src and Abl inhibitor|vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor
24312,a09,BRD-K41406082-001-04-8,PABA antagonist
24312,a11,BRD-K41445866-001-03-0,Chloride channel agonist
24312,a12,BRD-K41524689-001-05-2,cyclooxygenase inhibitor
24312,a15,BRD-K41564320-001-01-2,tyrosine kinase inhibitor
24312,a16,BRD-K41567364-001-01-2,orexin receptor antagonist
24312,a19,BRD-K41707108-001-02-3,Phosphoenolpyruvate carboxylase activator
24312,a20,BRD-K41713976-001-02-0,potassium channel blocker
24312,a23,BRD-K41868777-003-02-9,calmodulin antagonist
24312,b01,BRD-K41876534-001-02-0,carbonic anhydrase inhibitor
24312,b02,BRD-K41996876-001-05-5,EGFR inhibitor
24312,b03,BRD-K42098891-003-03-1,tricyclic antidepressant
24312,b04,BRD-K42221274-001-01-4,GAT inhibitor
24312,b05,BRD-K42348709-003-04-0,adrenergic receptor agonist|serotonin receptor agonist
24312,b07,BRD-K42452249-001-01-7,p38 MAPK inhibitor
24312,b08,BRD-K42500029-001-01-9,"MAP kinase inhibitor|MAPK-interacting kinase inhibitor,"
24312,b10,BRD-K42635745-001-02-4,adrenergic receptor antagonist
24312,b12,BRD-K42679050-001-01-3,potassium channel activator|potassium channel agonist
24312,b16,BRD-K42748308-300-01-2,acetylcholine release enhancer|potassium channel blocker|voltage-gated potassium channel blocker
24312,b18,BRD-K43068349-001-01-9,TRPV antagonist
24312,b19,BRD-K43149758-001-04-5,Androgen receptor agonist
24312,b21,BRD-K43245338-001-02-4,calpain inhibitor|cathepsin inhibitor
24312,b22,BRD-K43290182-001-01-9,Serotonin receptor antagonist
24312,b23,BRD-K43330982-001-01-5,lysophospholipid receptor antagonist
24312,b24,BRD-K43389675-003-02-7,RNA synthesis inhibitor|topoisomerase inhibitor
24312,c01,BRD-K43405658-001-01-8,protein tyrosine kinase inhibitor
24312,c02,BRD-K43457670-001-04-7,carbonic anhydrase inhibitor
24312,c03,BRD-K43468059-001-02-9,Mycotoxin
24312,c05,BRD-K43736954-001-03-3,glucocorticoid receptor agonist
24312,c06,BRD-K43744935-048-01-6,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)|estrogen receptor agonist|estrogen receptor modulator|PKC inhibitor
24312,c07,BRD-K43796186-001-01-1,EGFR inhibitor
24312,c08,BRD-K43860855-065-03-6,antineoplastic agent
24312,c09,BRD-K44067360-001-06-3,chloride channel blocker
24312,c10,BRD-K44084986-001-03-9,rho associated kinase inhibitor
24312,c18,BRD-K44849676-001-03-0,TRPV agonist
24312,c19,BRD-K44876623-001-01-1,Benzodiazepine receptor agonist
24312,c20,BRD-K44899736-003-02-1,Monoamine oxidase inhibitor
24312,c22,BRD-K45033733-001-02-3,DNA polymerase inhibitor
24312,c24,BRD-K45068323-003-01-3,Calmodulin antagonist
24312,d02,BRD-K45117373-001-01-1,potassium channel activator|potassium channel agonist
24312,d03,BRD-K45158365-001-02-3,angiotensin receptor antagonist
24312,d04,BRD-K45296539-003-01-0,Adrenergic receptor agonist
24312,d05,BRD-K45330754-001-04-3,estrogen receptor agonist
24312,d06,BRD-K45401373-001-05-0,Apoptosis stimulant
24312,d07,BRD-K45435259-001-01-6,Dopamine receptor antagonist
24312,d09,BRD-K45479396-001-01-8,Serotonin receptor agonist
24312,d13,BRD-K45542189-048-04-9,Lipoxygenase inhibitor
24312,d14,BRD-K45662124-001-01-8,dopamine receptor ligand
24312,d17,BRD-K45861246-001-04-3,Dopamine receptor antagonist
24312,d19,BRD-K46018455-001-06-0,PPAR receptor agonist
24312,d20,BRD-K46137903-001-03-3,phospholipase activator
24312,d21,BRD-K46142322-003-01-6,serotonin receptor partial agonist
24312,d22,BRD-K46211610-003-05-1,Adrenergic receptor antagonist
24312,d23,BRD-K46317332-003-04-6,Nitric oxide synthase inhibitor
24312,d24,BRD-K46384212-001-01-1,phospholipase activator
24312,e03,BRD-K46424862-001-04-2,Monoamine oxidase inhibitor
24312,e04,BRD-K46435977-003-01-2,DNA polymerase inhibitor
24312,e05,BRD-K46441700-001-01-8,serotonin receptor antagonist
24312,e06,BRD-K46469693-001-01-8,adenosine receptor antagonist
24312,e08,BRD-K46556543-237-03-0,Mineralocorticoid receptor antagonist
24312,e13,BRD-K46766488-003-01-2,Serotonin receptor agonist
24312,e14,BRD-K46862739-001-03-6,cytochrome P450 inhibitor
24312,e15,BRD-K46937689-001-05-1,Cyclooxygenase inhibitor
24312,e16,BRD-K47105409-001-05-3,JAK inhibitor
24312,e20,BRD-K47150025-001-01-2,PDGFR alpha and c-Kit inhibitor|vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor|VEGFR inhibitor
24312,e21,BRD-K47192521-001-02-1,Platelet aggregation inhibitor
24312,e22,BRD-K47207162-312-02-2,Serotonin reuptake inhibitor
24312,e23,BRD-K47278471-003-04-0,Histamine receptor antagonist
24312,e24,BRD-K47323024-003-04-6,Histamine receptor antagonist
24312,f03,BRD-K47328134-001-02-0,heparin activation inhibitor
24312,f07,BRD-K47598052-001-04-2,src inhibitor
24312,f08,BRD-K47608922-001-02-1,chelating agent
24312,f11,BRD-K47631482-003-02-1,Mucolytic agent
24312,f12,BRD-K47635719-001-03-9,glucocorticoid receptor agonist
24312,f13,BRD-K47639036-003-03-3,Acetylcholine receptor antagonist
24312,f14,BRD-K47659338-003-01-0,serotonin receptor agonist
24312,f15,BRD-K47693913-001-02-4,Furoquinoline alkaloid
24312,f16,BRD-K47717570-304-01-5,Glutamate receptor antagonist
24312,f21,BRD-K47869605-001-04-9,microtubule inhibitor|tubulin polymerization inhibitor
24312,f23,BRD-K47936004-001-01-9,dopamine receptor agonist
24312,f24,BRD-K47943470-001-02-8,EGFR inhibitor
24312,g05,BRD-K48168960-001-05-1,Thyroid peroxidase inhibitor
24312,g07,BRD-K48300629-001-03-8,Sodium channel blocker
24312,g11,BRD-K48692744-001-01-2,PARP inhibitor
24312,g12,BRD-K48722258-300-04-5,adenosine reuptake inhibitor
24312,g13,BRD-K48735772-001-01-4,EGFR inhibitor|epidermal growth factor receptor (EGFR) inhibitor
24312,g15,BRD-K49027941-237-01-1,Adenosine receptor antagonist
24312,g16,BRD-K49049886-001-03-8,adenosine receptor antagonist
24312,g17,BRD-K49111258-001-02-8,Adrenergic receptor antagonist
24312,g23,BRD-K49294207-300-01-2,EGFR inhibitor
24312,g24,BRD-K49448285-001-01-3,CDK inhibitor
24312,h01,BRD-K49481516-004-03-5,Acetylcholinesterase inhibitor
24312,h02,BRD-K49519092-303-01-4,Histamine receptor agonist
24312,h05,BRD-K49577446-001-03-1,cytochrome P450 inhibitor
24312,h06,BRD-K49657628-001-02-3,EGFR inhibitor|tyrosine kinase inhibitor
24312,h07,BRD-K49671696-001-02-1,Serotonin receptor antagonist
24312,h11,BRD-K49890030-236-01-6,Glutamate receptor antagonist
24312,h12,BRD-K49945136-001-03-5,Serotonin receptor antagonist
24312,h13,BRD-K50018155-003-01-3,Serotonin receptor partial agonist
24312,h15,BRD-K50135270-001-01-9,dopamine uptake inhibitor
24312,h17,BRD-K50214219-001-02-4,PARP inhibitor
24312,h21,BRD-K50325075-001-01-3,potassium channel blocker|slow afterhyperpolarization channel blocker
24312,h22,BRD-K50388907-001-04-9,PPAR receptor agonist
24312,h23,BRD-K50398167-236-02-9,Cyclooxygenase inhibitor
24312,i01,BRD-K50417881-003-05-9,Dopamine receptor antagonist
24312,i02,BRD-K50422030-001-01-2,GABA receptor antagonist
24312,i03,BRD-K50464341-001-02-6,calmodulin antagonist
24312,i04,BRD-K50495309-001-01-2,src inhibitor
24312,i07,BRD-K50660797-001-02-8,Bacterial DNA gyrase inhibitor
24312,i08,BRD-K50836978-001-01-7,CDK inhibitor
24312,i09,BRD-K50841342-001-01-6,caspase activator
24312,i10,BRD-K50859149-001-04-7,bacterial antifolate
24312,i11,BRD-K50891186-001-01-0,dopamine receptor antagonist
24312,i14,BRD-K51276371-001-01-8,CDK inhibitor|CFTR channel activator|glycogen synthase kinase inhibitor|JNK inhibitor
24312,i15,BRD-K51318897-001-04-7,tubulin polymerization inhibitor
24312,i17,BRD-K51465424-003-03-6,adrenergic receptor agonist
24312,i18,BRD-K51476772-001-01-9,tyrosine kinase inhibitor
24312,i19,BRD-K51541829-001-01-3,Ionotropic glutamate receptor antagonist
24312,i23,BRD-K51575138-001-01-7,IKK inhibitor
24312,i24,BRD-K51671335-001-01-5,Dopamine receptor antagonist
24312,j01,BRD-K51751936-001-03-4,benzodiazepine receptor agonist
24312,j03,BRD-K51918615-303-01-1,histamine receptor antagonist|histamine receptor inhibitor|ionotropic glutamate receptor antagonist
24312,j07,BRD-K52020312-001-04-5,DNA inhibitor
24312,j08,BRD-K52075040-001-02-2,fatty acid synthase inhibitor
24312,j10,BRD-K52219182-001-01-6,Phosphodiesterase inhibitor
24312,j11,BRD-K52313696-001-01-6,HDAC inhibitor
24312,j13,BRD-K52394958-001-01-9,tachykinin antagonist
24312,j14,BRD-K52397688-001-01-9,dopamine receptor antagonist|FAAH inhibitor|serotonin receptor antagonist
24312,j15,BRD-K52459643-001-10-2,Prostanoid receptor agonist
24312,j16,BRD-K52512893-001-03-0,Prostanoid receptor antagonist
24312,j18,BRD-K52662033-001-02-6,histamine receptor agonist
24312,j19,BRD-K52721684-001-02-2,potassium channel activator
24312,j20,BRD-K52850071-001-01-2,JAK inhibitor
24312,j23,BRD-K52930707-001-04-8,ACE inhibitor
24312,k01,BRD-K52989797-001-01-1,serotonin transporter (SERT) inhibitor
24312,k03,BRD-K53123955-001-03-0,Phosphofructokinase inhibitor
24312,k05,BRD-K53263234-001-02-9,constitutive androstane receptor (CAR) agonist
24312,k06,BRD-K53318339-001-04-1,Phosphodiesterase inhibitor
24312,k09,BRD-K53523901-001-01-0,adiponectin receptor agonist|AP inhibitor|aryl hydrocarbon receptor antagonist|HIV integrase inhibitor|MEK inhibitor|NFkB pathway inhibitor|topoisomerase inhibitor
24312,k11,BRD-K53545112-304-01-6,Glutamate receptor antagonist
24312,k13,BRD-K53737926-003-04-7,Norepinephrine inhibitor
24312,k14,BRD-K53857191-001-04-5,Dopamine receptor antagonist
24312,k17,BRD-K53878242-001-02-4,phosphodiesterase inhibitor
24312,k19,BRD-K53979406-003-01-0,glycine transporter inhibitor|GlyT-1 inhibitor
24312,k20,BRD-K54094468-001-01-6,dopamine receptor antagonist
24312,k21,BRD-K54095730-001-01-5,p38 MAPK inhibitor
24312,k22,BRD-K54142781-001-02-1,Adrenergic receptor agonist
24312,l01,BRD-K54210043-001-02-0,calcium channel activator|large conductance potassium channel activator
24312,l02,BRD-K54233340-300-01-0,AMPK inhibitor|DNA damaging|TGF beta receptor inhibitor
24312,l03,BRD-K54330070-001-05-5,p38 MAPK inhibitor
24312,l04,BRD-K54411430-001-02-5,cAMP inhibitor
24312,l06,BRD-K54529596-001-04-0,ACE inhibitor
24312,l10,BRD-K54665485-001-01-2,Diacylglycerol kinase inhibitor
24312,l11,BRD-K54704028-001-01-3,glutamate receptor antagonist
24312,l12,BRD-K54708045-001-01-3,PPAR receptor agonist
24312,l13,BRD-K54759182-003-02-3,Norepinephrine reuptake inhibitor
24312,l14,BRD-K54771420-001-03-2,Cholesterol inhibitor
24312,l17,BRD-K54790157-001-03-1,DNA synthesis inhibitor
24312,l19,BRD-K55034111-066-02-3,bacterial DNA gyrase inhibitor
24312,l21,BRD-K55191674-236-03-7,Penicillin binding protein inhibitor
24312,m01,BRD-K55344148-003-01-8,Imidazoline receptor ligand
24312,m02,BRD-K55424922-001-01-4,Serotonin receptor agonist
24312,m03,BRD-K55430733-003-01-6,Serotonin receptor agonist
24312,m04,BRD-K55454768-001-01-8,voltage-independent calcium influx blocker
24312,m05,BRD-K55468218-001-04-8,dopamine receptor antagonist
24312,m06,BRD-K55529781-236-02-0,thromboxane synthase inhibitor
24312,m07,BRD-K55567017-001-02-4,alcohol dehydrogenase inhibitor
24312,m08,BRD-K55677650-003-01-1,ionotropic glutamate receptor antagonist
24312,m11,BRD-K55748775-001-01-4,ATPase inhibitor|potassium-competitive acid antagonist
24312,m16,BRD-K55930204-001-02-7,Hydantoin antiepileptic
24312,m17,BRD-K56047318-001-02-2,Triacylglycerol lipase inhibitor
24312,m18,BRD-K56064827-001-04-7,PKC inhibitor
24312,m20,BRD-K56115039-003-01-3,Imidazoline receptor ligand
24312,m22,BRD-K56403959-300-01-9,CC chemokine receptor ligand
24312,m23,BRD-K56429665-001-03-9,vitamin D receptor agonist
24312,m24,BRD-K56509348-003-01-3,Endothelin receptor antagonist
24312,n02,BRD-K56558538-003-02-8,Sodium channel blocker
24312,n03,BRD-K56596464-004-02-4,Sodium channel blocker
24312,n04,BRD-K56699285-001-03-7,dopamine receptor agonist|serotonin receptor antagonist
24312,n08,BRD-K57033106-048-02-8,Histamine receptor antagonist
24312,n11,BRD-K57179821-001-04-8,Antipruritic
24312,n12,BRD-K57222227-001-06-1,cyclooxygenase inhibitor
24312,n16,BRD-K57304726-003-03-6,Sigma receptor agonist
24312,n18,BRD-K57545991-050-03-3,angiotensin converting enzyme inhibitor
24312,n19,BRD-K57569181-001-04-4,Phosphodiesterase inhibitor
24312,n21,BRD-K57718010-001-06-9,GABA receptor antagonist
24312,n22,BRD-K57886322-001-03-4,glucocorticoid receptor agonist
24312,n23,BRD-K57926513-001-02-9,PDGFR receptor inhibitor
24312,o01,BRD-K58220566-001-02-2,PKC inhibitor|sodium channel blocker|calcium channel blocker
24312,o02,BRD-K58265391-001-03-6,diuretic
24312,o03,BRD-K58299615-001-02-7,amyloid precursor protein inhibitor|beta amyloid aggregation inhibitor
24312,o05,BRD-K58466253-003-04-1,serotonin release inhibitor
24312,o06,BRD-K58685305-001-02-2,11-beta hydroxysteroid dehydrogenase inhibitor
24312,o08,BRD-K58930050-001-01-1,glutamate receptor antagonist
24312,o09,BRD-K58938839-001-03-8,smoothened receptor antagonist|hedgehog pathway inhibitor
24312,o10,BRD-K59037100-001-04-8,lipase inhibitor
24312,o13,BRD-K59058766-003-03-7,dopamine receptor antagonist
24312,o15,BRD-K59184148-001-04-2,glycogen synthase kinase inhibitor
24312,o18,BRD-K59273480-001-01-5,adenosine reuptake inhibitor|phosphodiesterase inhibitor
24312,o20,BRD-K59332007-300-01-9,acetylcholine release enhancer|acetylcholine release stimulant|neurotransmitter agonist|voltage-gated potassium channel blocker
24312,o22,BRD-K59419204-001-01-9,cannabinoid receptor antagonist|cannabinoid receptor inhibitor
24312,o23,BRD-K59469039-001-04-9,Angiogenesis inhibitor
24312,o24,BRD-K59522102-001-04-7,monoamine oxidase inhibitor
24312,p01,BRD-K59574735-001-02-7,leukotriene synthesis inhibitor
24312,p02,BRD-K59637651-001-01-4,protein synthesis inhibitor|botulin neurotoxin inhibitor|mur synthetase inhibitor
24312,p03,BRD-K59650319-003-01-7,glutamate receptor antagonist
24312,p04,BRD-K59753853-001-01-5,glutamate receptor antagonist
24312,p06,BRD-K59851896-001-02-4,GABA release inhibitor
24312,p07,BRD-K59983611-001-05-2,bacterial antifolate
24312,p09,BRD-K60060639-005-01-4,antiarrhythmic medication
24312,p10,BRD-K60174629-001-02-2,prolyl endopeptidase inhibitor
24312,p13,BRD-K60184833-001-02-3,tyrosine kinase inhibitor
24312,p14,BRD-K60230970-001-04-3,proteasome inhibitor
24312,p15,BRD-K60274257-001-01-1,tyrosine phosphatase inhibitor
24312,p17,BRD-K60298136-001-01-7,aryl hydrocarbon receptor agonist|aryl hydrocarbon receptor ligand
24312,p18,BRD-K60476892-001-02-1,activator of soluble guanylyl cyclase|guanylate cyclase activator|hypoxia inducible factor inhibitor
24312,p19,BRD-K60511616-236-01-4,HMGCR inhibitor
24312,p20,BRD-K60640630-001-03-7,glucocorticoid receptor agonist
24312,p22,BRD-K60923938-001-02-8,sodium channel activator
24312,p23,BRD-K60932973-001-01-7,dopamine receptor agonist
24312,p24,BRD-K61097567-001-03-6,tachykinin antagonist
24279,a01,BRD-K78364995-236-03-5,bacterial cell wall synthesis inhibitor
24279,a03,BRD-K78485176-001-02-9,angiotensin receptor antagonist
24279,a05,BRD-K78599730-001-02-6,farnesyltransferase inhibitor|NFkB pathway inhibitor|ras farnesyltransferase inhibitor
24279,a07,BRD-K78633253-001-01-2,ARF inhibitor
24279,a08,BRD-K78637815-001-01-4,cannabinoid receptor antagonist
24279,a09,BRD-K78643075-001-03-3,dopamine receptor antagonist
24279,a10,BRD-K78692225-001-11-2,dihydroorotate dehydrogenase inhibitor|PDGFR tyrosine kinase receptor inhibitor
24279,a11,BRD-K78815826-001-04-7,cyclooxygenase inhibitor
24279,a12,BRD-K78838262-001-02-4,hypolipidemic
24279,a16,BRD-K78959463-001-02-5,calcium channel activator
24279,a18,BRD-K79092138-001-04-5,POXB inhibitor|bacterial DNA inhibitor
24279,a19,BRD-K79116891-003-03-7,sodium channel blocker
24279,a20,BRD-K79124250-001-03-0,radiopaque medium
24279,a21,BRD-K79131256-001-03-9,tubulin polymerization inhibitor
24279,a22,BRD-K79145749-001-01-8,norepinephrine reputake inhibitor
24279,a24,BRD-K79366068-236-01-5,NTPDase inhibitor
24279,b01,BRD-K79425933-001-03-6,dopamine receptor antagonist
24279,b02,BRD-K79437791-001-02-4,Inhibitor of methylation of endogenous isoprenylated proteins
24279,b03,BRD-K79501723-003-03-4,histamine receptor modulator
24279,b04,BRD-K79684402-300-01-0,dopamine receptor partial agonist
24279,b05,BRD-K79711234-001-04-3,bacterial 50S ribosomal subunit inhibitor
24279,b06,BRD-K79759585-001-02-1,phosphodiesterase inhibitor
24279,b07,BRD-K79930101-300-01-1,EGFR inhibitor|epidermal growth factor receptor (EGFR) inhibitor|ErbB2 tyrosine kinase inhibitor|receptor tyrosine protein kinase inhibitor
24279,b09,BRD-K80315159-051-01-2,histamine receptor antagonist
24279,b12,BRD-K80334323-001-03-5,progestogen hormone
24279,b15,BRD-K80353807-001-03-0,vasodilator
24279,b16,BRD-K80396088-001-03-9,Sulfonylurea
24279,b17,BRD-K80451230-051-01-8,acetylcholine receptor antagonist
24279,b19,BRD-K80639402-003-01-1,serotonin receptor antagonist
24279,b20,BRD-K80725821-300-01-1,serotonin receptor antagonist
24279,b21,BRD-K80738081-001-06-2,cytochrome P450 inhibitor|SIRT activator
24279,b22,BRD-K80778372-001-01-7,GABA benzodiazepine site receptor inverse agonist
24279,b24,BRD-K80946661-001-02-8,p53 activator
24279,c01,BRD-K80970344-201-02-9,NFkB pathway inhibitor
24279,c02,BRD-K81029756-001-02-8,L-type calcium channel blocker|calcium channel antagonist|calcium channel blocker
24279,c04,BRD-K81209159-001-02-9,Acetylcholinesterase inhibitor
24279,c05,BRD-K81209512-001-01-3,EGFR inhibitor|epidermal growth factor receptor (EGFR) inhibitor|tyrosine kinase inhibitor
24279,c06,BRD-K81225797-001-01-5,adenosine receptor antagonist
24279,c07,BRD-K81272440-001-02-6,calcium channel blocker
24279,c09,BRD-K81376179-001-01-4,FLT3 inhibitor
24279,c14,BRD-K81709173-001-03-8,glucocorticoid receptor agonist
24279,c17,BRD-K81729199-001-01-0,acetylcholine receptor antagonist
24279,c20,BRD-K81839095-001-02-0,Estrogen receptor agonist
24279,c21,BRD-K81876028-300-01-2,Serotonin receptor agonist
24279,c23,BRD-K82103381-003-03-7,vasodilator
24279,d03,BRD-K82255054-001-04-3,GABA receptor agonist
24279,d04,BRD-K82484965-003-02-7,dopamine receptor agonist
24279,d05,BRD-K82561139-001-01-9,casein kinase inhibitor
24279,d06,BRD-K82562631-236-02-0,Cyclooxygenase inhibitor
24279,d07,BRD-K82577285-001-01-7,Dopamine receptor agonist
24279,d08,BRD-K82731415-001-04-7,CDK inhibitor
24279,d09,BRD-K82795137-001-02-3,Histamine receptor antagonist
24279,d10,BRD-K82823076-001-01-8,GABA benzodiazepine site receptor inverse agonist
24279,d13,BRD-K82846253-001-03-0,Insulin secretagogue
24279,d14,BRD-K82865713-001-02-6,cAMP inhibitor
24279,d17,BRD-K83023055-001-01-9,Melatonin receptor agonist
24279,d19,BRD-K83063356-003-01-7,CC chemokine receptor antagonist|CCR antagonist
24279,d23,BRD-K83302049-001-01-6,Histamine receptor antagonist
24279,d24,BRD-K83322645-103-01-6,sigma receptor antagonist|sigma receptor ligand
24279,e04,BRD-K83459933-001-02-1,angiogenesis inhibitor
24279,e05,BRD-K83508485-001-01-9,tachykinin antagonist
24279,e06,BRD-K83597974-003-05-7,Monoamine oxidase inhibitor
24279,e07,BRD-K83637872-001-01-7,Smoothened receptor antagonist
24279,e08,BRD-K84175871-003-02-2,Adrenergic receptor agonist
24279,e12,BRD-K84266862-001-01-6,phosphodiesterase inhibitor
24279,e13,BRD-K84421793-001-01-1,dopamine receptor agonist
24279,e14,BRD-K84595254-001-03-0,ATPase inhibitor
24279,e15,BRD-K84663978-001-02-3,phosphodiesterase inhibitor|platelet aggregation inhibitor|potassium channel blocker
24279,e16,BRD-K84709232-001-02-6,lipoxygenase inhibitor|HIV integrase inhibitor|NFkB pathway inhibitor|nitric oxide production inhibitor|PPAR receptor modulator|tumor necrosis factor production inhibitor
24279,e19,BRD-K85015012-003-01-1,GABA uptake inhibitor|GAT inhibitor
24279,e20,BRD-K85090592-003-08-7,Acetylcholine receptor agonist
24279,e22,BRD-K85119730-001-06-5,ATP channel blocker
24279,e23,BRD-K85242180-001-01-1,"indoleamine 2,3-dioxygenase inhibitor"
24279,e24,BRD-K85266041-304-01-7,glutamate receptor antagonist
24279,f04,BRD-K85383046-001-02-5,chloride channel blocker
24279,f06,BRD-K85871428-001-01-9,p38 MAPK inhibitor
24279,f11,BRD-K85883481-001-02-6,glucocorticoid receptor agonist
24279,f12,BRD-K86204871-001-02-2,sterol demethylase inhibitor
24279,f13,BRD-K86301799-001-14-0,phosphodiesterase inhibitor
24279,f14,BRD-K86434416-001-02-7,Monoamine oxidase inhibitor
24279,f15,BRD-K84663978-001-03-1,phosphodiesterase inhibitor|platelet aggregation inhibitor|potassium channel blocker
24279,f16,BRD-K86509404-001-02-0,CDK inhibitor
24279,f19,BRD-K86600316-003-01-2,Adrenergic receptor antagonist
24279,f20,BRD-K86727142-001-06-6,HCV inhibitor|XIAP inhibitor
24279,f21,BRD-K86873305-236-03-0,Bacterial cell wall synthesis inhibitor
24279,f22,BRD-K86882815-001-01-6,dopamine receptor agonist|prolactin inhibitor|prolactin secretion inhibitor
24279,f23,BRD-K86958018-001-01-9,TRPV agonist
24279,f24,BRD-K87048468-003-01-9,Serotonin receptor antagonist
24279,g01,BRD-K87049188-001-03-6,chelating agent|dopamine beta hydroxylase inhibitor
24279,g08,BRD-K87510569-001-01-0,CC chemokine receptor antagonist
24279,g09,BRD-K87696786-003-01-0,glutamate receptor antagonist
24279,g14,BRD-K87990216-001-03-7,Glucocorticoid receptor agonist
24279,g15,BRD-K87991767-001-02-0,carbonic anhydrase inhibitor|cyclooxygenase inhibitor
24279,g16,BRD-K88090157-050-03-3,antihistamine
24279,g21,BRD-K88282786-066-04-9,cannabinoid receptor agonist
24279,g22,BRD-K88358234-003-01-4,serotonin receptor agonist|nerve growth factor agonist|neurotrophic factor enhancer
24279,g23,BRD-K88366685-300-03-7,3-ketoacyl CoA thiolase inhibitor
24279,g24,BRD-K88405679-003-01-5,antihistamine
24279,h01,BRD-K88429204-001-04-7,dihydrofolate reductase inhibitor
24279,h02,BRD-K88544581-001-01-2,ACAT inhibitor
24279,h05,BRD-K88568253-065-02-1,monoamine oxidase inhibitor
24279,h06,BRD-K88611939-001-01-8,Glutamate receptor agonist
24279,h08,BRD-K88677950-001-01-3,MAP kinase inhibitor|MEK inhibitor
24279,h10,BRD-K88741031-001-01-0,EGFR inhibitor|tyrosine kinase inhibitor
24279,h11,BRD-K88743730-001-01-0,serotonin receptor partial agonist
24279,h12,BRD-K88759641-003-01-0,Angiotensin receptor antagonist
24279,h13,BRD-K88789588-001-03-2,aromatase inhibitor
24279,h14,BRD-K88809146-003-02-1,monoamine oxidase inhibitor
24279,h15,BRD-K88849294-001-02-1,Tyrosine phosphatase inhibitor
24279,h16,BRD-K88871508-001-01-9,Dopamine receptor agonist
24279,h18,BRD-K89046952-001-03-4,bacterial cell wall synthesis inhibitor
24279,h21,BRD-K89055274-048-03-7,muscle relaxant
24279,h22,BRD-K89085489-001-02-6,apoptosis stimulant|retinoid receptor agonist
24279,h23,BRD-K89125793-001-05-4,antiprotozoal agent
24279,h24,BRD-K89152108-001-03-3,thyroid hormone stimulant
24279,i01,BRD-K89210380-001-03-8,vitamin B
24279,i04,BRD-K89272762-001-04-4,chloride channel blocker
24279,i07,BRD-K89274813-001-01-5,acetylcholine release enhancer
24279,i08,BRD-K89375097-300-04-7,Acetylcholine receptor antagonist
24279,i09,BRD-K89402695-001-01-5,Thromboxane receptor antagonist
24279,i13,BRD-K89732114-001-02-6,dopamine receptor antagonist
24279,i14,BRD-K89923877-003-02-4,acetylcholine receptor antagonist
24279,i15,BRD-K89930444-001-01-9,tyrosine kinase inhibitor
24279,i16,BRD-K89997465-001-02-0,dopamine receptor antagonist
24279,i17,BRD-K90027355-001-03-4,mineralocorticoid receptor antagonist
24279,i23,BRD-K90259198-003-04-8,calmodulin antagonist|potassium channel blocker|squalene monooxygenase channel blocker
24279,i24,BRD-K90333595-001-02-8,adrenergic receptor antagonist
24279,j01,BRD-K90524085-001-05-2,phosphodiesterase inhibitor|platelet aggregation inhibitor
24279,j04,BRD-K90574421-001-01-9,Serotonin receptor agonist
24279,j08,BRD-K90789829-003-03-3,Adrenergic inhibitor
24279,j09,BRD-K90976994-001-02-1,Bile acid
24279,j10,BRD-K91243525-001-01-5,Neurotensin receptor antagonist
24279,j11,BRD-K91263825-001-02-8,tricyclic antidepressant
24279,j13,BRD-K91315211-334-02-3,Histamine receptor agonist
24279,j15,BRD-K91336023-001-01-4,Dopamine receptor agonist
24279,j16,BRD-K91370081-001-04-6,DNA synthesis inhibitor
24279,j19,BRD-K91904471-001-01-6,p38 MAPK inhibitor
24279,j20,BRD-K92000912-001-06-8,cannabinoid receptor antagonist
24279,j24,BRD-K92015269-001-01-6,dopamine uptake inhibitor
24279,k02,BRD-K92049597-001-04-2,sodium channel blocker
24279,k04,BRD-K92093830-003-05-0,topoisomerase inhibitor
24279,k05,BRD-K92138166-001-01-0,other antibiotic
24279,k09,BRD-K92492521-001-01-1,Leukotriene receptor antagonist
24279,k12,BRD-K92678294-001-01-0,Isoflavone
24279,k14,BRD-K92726801-003-02-7,Haemostatic agent
24279,k17,BRD-K92731339-227-02-3,ACE inhibitor
24279,k18,BRD-K92758126-001-06-3,NFkB pathway inhibitor
24279,k19,BRD-K92778217-001-04-6,Cyclooxygenase inhibitor
24279,k20,BRD-K92830582-003-04-8,adrenergic receptor antagonist
24279,k22,BRD-K92984783-003-02-4,Serotonin receptor antagonist
24279,l01,BRD-K93080877-001-02-1,tripeptidyl peptidase inhibitor
24279,l02,BRD-K93176058-001-01-0,retinoid receptor agonist
24279,l03,BRD-K93188295-300-01-4,adrenergic receptor antagonist
24279,l05,BRD-K93258693-001-02-5,PPAR receptor antagonist
24279,l06,BRD-K93280214-004-02-3,GABA receptor antagonist
24279,l09,BRD-K93325701-001-03-0,SRC inhibitor
24279,l10,BRD-K93332168-001-03-2,Monoamine oxidase inhibitor
24279,l11,BRD-K93441486-067-03-7,Acetylcholine receptor antagonist
24279,l12,BRD-K93460210-001-01-3,Serotonin receptor antagonist
24279,l13,BRD-K93461745-001-01-5,Serotonin receptor agonist
24279,l14,BRD-K93480852-001-02-2,calcium/calmodulin dependent protein kinase inhibitor
24279,l19,BRD-K93568044-001-03-1,glucocorticoid receptor agonist
24279,l20,BRD-K93658967-001-01-7,CDK inhibitor|CFTR channel activator|glycogen synthase kinase inhibitor|JNK inhibitor
24279,l21,BRD-K93754473-001-02-9,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)
24279,l22,BRD-K94144010-001-05-5,nicotine metabolite
24279,m04,BRD-K94270326-004-01-0,dopamine receptor antagonist
24279,m06,BRD-K94379058-001-03-5,cannabinoid receptor inverse agonist
24279,m07,BRD-K94441233-001-03-1,HMGCR inhibitor
24279,m08,BRD-K94512704-001-01-3,dopamine receptor antagonist
24279,m12,BRD-K94689771-001-02-5,CYP1B1 inhibitor
24279,m17,BRD-K94832621-001-01-5,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)
24279,m19,BRD-K94841585-001-02-8,laxative|free radical generator
24279,m21,BRD-K94887716-001-01-5,Serotonin receptor agonist
24279,m22,BRD-K94920105-001-01-3,PARP inhibitor
24279,m24,BRD-K95202259-001-01-9,p38 MAPK inhibitor
24279,n01,BRD-K95237249-001-04-2,Uricosuric blocker
24279,n02,BRD-K95309561-001-04-9,estrogen receptor agonist
24279,n04,BRD-K95435023-001-01-0,c-Met inhibitor|hepatocyte growth factor receptor inhibitor
24279,n07,BRD-K95603879-001-03-4,ATPase inhibitor
24279,n08,BRD-K95609758-001-01-1,potassium channel activator
24279,n11,BRD-K95655893-001-01-0,VEGFR kinase inhibitor
24279,n12,BRD-K95676198-001-02-6,JAK inhibitor
24279,n15,BRD-K95739795-001-01-1,Vesicular monoamine transporter inhibitor
24279,n16,BRD-K95763993-001-03-7,PDGFR receptor inhibitor
24279,n17,BRD-K95785537-001-04-1,src inhibitor
24279,n20,BRD-K95851186-001-02-9,GABA receptor modulator
24279,n21,BRD-K95899059-003-01-0,Serotonin receptor agonist
24279,n22,BRD-K95992530-001-02-4,integrin antagonist
24279,n23,BRD-K96119599-001-04-7,Melanin inhibitor
24279,n24,BRD-K96144918-001-02-3,KPL-1 tumor suppressor
24279,o04,BRD-K96263742-001-02-3,PPAR receptor agonist
24279,o05,BRD-K96271548-001-02-2,antioxidant
24279,o07,BRD-K96402602-001-01-8,PPMTase inhibitor
24279,o08,BRD-K96527333-001-03-4,GABA receptor modulator
24279,o10,BRD-K96670504-001-01-9,Glucokinase inhibitor
24279,o13,BRD-K96720755-001-01-8,Vasopressin receptor antagonist
24279,o14,BRD-K96799727-001-01-7,HSP inhibitor
24279,o15,BRD-K96809896-001-01-9,p38 MAPK inhibitor
24279,o16,BRD-K96862998-001-03-1,TGF beta receptor inhibitor
24279,o17,BRD-K97061094-001-03-2,Histamine receptor antagonist
24279,o18,BRD-K97118047-001-01-2,Casein kinase inhibitor
24279,o19,BRD-K97158071-001-04-1,Dopamine receptor antagonist
24279,o20,BRD-K97181089-001-02-7,sodium channel blocker
24279,o22,BRD-K97330509-001-01-4,src inhibitor
24279,o23,BRD-K97354755-001-01-5,src inhibitor
24279,o24,BRD-K97365803-001-01-3,PI3K inhibitor
24279,p01,BRD-K97399794-001-07-0,polar auxin transport inhibitor
24279,p02,BRD-K97440753-066-03-3,adrenergic receptor antagonist|prolactin inhibitor
24279,p04,BRD-K97509413-001-01-8,AGE inhibitor|estrogen receptor agonist|estrogen receptor ligand
24279,p05,BRD-K97521363-001-03-9,glycolysis inhibitor
24279,p06,BRD-K97530723-001-04-3,melatonin receptor agonist|nitric oxide synthase inhibitor
24279,p07,BRD-K97564742-103-01-9,histamine receptor antagonist
24279,p10,BRD-K97688263-001-02-9,sodium channel blocker
24279,p13,BRD-K97746869-001-04-9,ATP channel blocker
24279,p14,BRD-K97752965-001-01-6,ATP channel activator|nitric oxide donor|potassium channel agonist
24279,p15,BRD-K97799481-002-03-6,Adenosine receptor antagonist
24279,p16,BRD-K97810537-001-03-7,glucocorticoid receptor agonist
24279,p17,BRD-K98039984-001-03-0,glucocorticoid receptor agonist
24279,p18,BRD-K98143437-001-01-7,p38 MAPK inhibitor|interleukin inhibitor|tumor necrosis factor production inhibitor
24279,p20,BRD-K98157055-001-04-2,glutamate receptor antagonist
24279,p21,BRD-K98174813-001-05-7,bacterial 30S ribosomal subunit inhibitor
24279,p23,BRD-K98297262-001-01-1,"1,3-beta-glucan synthase inhibitor"
24279,p24,BRD-K98521173-001-03-8,mineralocorticoid receptor agonist
24321,a01,BRD-K90382497-001-01-6,PLK inhibitor
24321,a02,BRD-K92723993-066-02-9,PDGFR tyrosine kinase receptor inhibitor|Bcr-Abl kinase inhibitor|KIT inhibitor|Abl kinase inhibitor|apoptosis stimulant|breast cancer resistance protein inhibitor|colony stimulating factor receptor inhibitor
24321,a03,BRD-K07762753-001-03-6,CDK inhibitor|tyrosine kinase inhibitor
24321,a04,BRD-K09991945-001-02-0,glycogen synthase kinase inhibitor|PKC inhibitor|superoxide dismutase expression inhibitor
24321,a05,BRD-K37312348-001-05-1,CDK inhibitor|glycogen synthase kinase inhibitor
24321,a06,BRD-K46678324-001-03-7,rho associated kinase inhibitor
24321,a07,BRD-K67860401-001-02-3,glycogen synthase kinase inhibitor
24321,a08,BRD-K52620403-001-01-8,calcium/calmodulin dependent protein kinase inhibitor|calmodulin inhibitor
24321,a09,BRD-K68336408-001-03-4,EGFR inhibitor
24321,a10,BRD-K72703948-001-01-0,Aurora kinase inhibitor
24321,a11,BRD-K93201660-001-05-7,myosin light chain kinase inhibitor
24321,a15,BRD-A47633927-001-01-8,ICAM1 antagonist
24321,a16,BRD-A68039575-001-02-5,Aromatase inhibitor
24321,a17,BRD-A75455249-001-02-0,calcium channel modulator|mTOR inhibitor|sodium channel blocker
24321,a18,BRD-K01555864-001-02-8,antineoplastic
24321,a19,BRD-K09497549-001-03-6,calcium channel modulator|mTOR inhibitor|sodium channel blocker
24321,a20,BRD-K14536225-001-02-7,Glucosidase inhibitor
24321,a21,BRD-K15086322-103-01-0,histamine receptor antagonist|histamine receptor silent antagonist
24321,a23,BRD-K23623876-001-01-6,ultrasound contrast agent
24321,a24,BRD-K36377456-001-02-0,angiogenesis inhibitor
24321,b01,BRD-K36395411-003-01-4,serotonin receptor antagonist|serotonin receptor partial agonist
24321,b03,BRD-K41160163-001-01-9,Glutamate receptor antagonist
24321,b04,BRD-K42095107-001-02-3,estrogen receptor agonist
24321,b05,BRD-K43797669-001-02-3,tyrosine kinase inhibitor
24321,b06,BRD-K45988865-001-01-0,organosilicon compound used as an internal standard in NMR spectroscopy
24321,b07,BRD-K49061529-001-01-0,GABA benzodiazepine site receptor inverse agonist
24321,b09,BRD-K59331372-001-01-2,TRPV antagonist
24321,b11,BRD-K60690191-003-02-1,glutamate receptor antagonist
24321,b12,BRD-K61177364-003-01-1,CRF receptor antagonist
24321,b17,BRD-K61250553-001-02-9,opioid receptor agonist
24321,b18,BRD-K61269089-001-01-4,Protein kinase inhibitor
24321,b19,BRD-K61271364-001-02-4,GABA receptor antagonist
24321,b20,BRD-K61323504-001-02-4,CC chemokine receptor antagonist
24321,b22,BRD-K61496577-001-03-8,glucocorticoid receptor agonist
24321,b23,BRD-K61590534-001-01-4,EGFR inhibitor
24321,c01,BRD-K61737877-001-01-6,VEGFR inhibitor
24321,c03,BRD-K61951118-001-01-2,GABA benzodiazepine site receptor inverse agonist
24321,c04,BRD-K62008436-001-03-1,tubulin polymerization inhibitor
24321,c05,BRD-K62056274-001-01-9,Serotonin receptor agonist
24321,c07,BRD-K62206109-303-01-1,histamine receptor antagonist
24321,c08,BRD-K62221994-001-01-8,gonadotropin releasing factor hormone receptor antagonist
24321,c10,BRD-K62289640-003-01-9,Cannabinoid receptor agonist
24321,c13,BRD-K62310379-001-03-0,glucocorticoid receptor agonist
24321,c17,BRD-K62353524-001-01-8,estrogen receptor agonist
24321,c18,BRD-K62363391-001-04-1,bacterial antifolate
24321,c23,BRD-K62607865-001-03-0,bacterial cell wall synthesis inhibitor
24321,c24,BRD-K62609077-001-02-2,adrenergic receptor antagonist|GABA receptor antagonist|serotonin receptor antagonist
24321,d01,BRD-K62810658-001-05-6,MEK inhibitor
24321,d02,BRD-K62929068-001-01-7,Purinergic receptor activator
24321,d04,BRD-K62996583-001-03-8,calcium channel blocker
24321,d05,BRD-K63089472-001-02-7,Inhibitor of methyl esterification of farnesylated proteins
24321,d06,BRD-K63150726-001-01-3,cannabinoid receptor inverse agonist
24321,d07,BRD-K63151507-001-01-6,Lymphocyte inhibitor
24321,d08,BRD-K63165456-001-03-3,Adrenergic receptor agonist
24321,d09,BRD-K63430059-001-03-2,DNA synthesis inhibitor
24321,d10,BRD-K63504947-001-05-5,VEGFR inhibitor
24321,d13,BRD-K63516691-001-01-6,Phosphodiesterase inhibitor
24321,d14,BRD-K63533170-001-01-1,cannabinoid receptor antagonist|cannabinoid receptor inverse agonist
24321,d17,BRD-K63606607-001-01-8,ATPase inhibitor|chloride channel activator
24321,d18,BRD-K63630713-001-04-3,sodium/potassium/chloride transporter inhibitor
24321,d19,BRD-K63750851-001-03-3,dehydrogenase inhibitor|inositol monophosphatase inhibitor
24321,d21,BRD-K63784565-001-02-1,Topoisomerase inhibitor
24321,d22,BRD-K63792901-075-01-3,acetylcholine receptor agonist
24321,d23,BRD-K63828191-003-07-3,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)
24321,e03,BRD-K63874012-103-01-5,histamine receptor antagonist|histamine receptor inverse agonist
24321,e04,BRD-K63913457-001-02-7,vasodilator
24321,e06,BRD-K63945320-001-02-4,Phospholipase inhibitor
24321,e07,BRD-K63979671-001-03-6,Compound used in hepatobiliary scans of the liver
24321,e08,BRD-K64044582-001-02-8,ACAT inhibitor
24321,e11,BRD-K64157027-003-01-9,Adrenergic receptor agonist
24321,e14,BRD-K64245000-001-01-7,FXR agonist
24321,e16,BRD-K64341947-003-01-6,guanylate cyclase activator
24321,e20,BRD-K64402243-001-01-1,Caspase inhibitor
24321,e22,BRD-K64670467-001-01-2,glutamate receptor antagonist
24321,f03,BRD-K64755930-003-01-6,phosphodiesterase inhibitor
24321,f04,BRD-K64862097-001-03-9,glucocorticoid receptor agonist
24321,f06,BRD-K64994968-001-03-6,Progesterone receptor agonist
24321,f07,BRD-K65146499-001-04-8,Cyclooxygenase inhibitor
24321,f11,BRD-K65285700-001-01-5,cannabinoid receptor agonist
24321,f12,BRD-K65417056-003-03-6,Local anesthetic
24321,f13,BRD-K65503129-001-01-4,HSP inhibitor|HSP antagonist
24321,f15,BRD-K65639003-001-02-5,phosphodiesterase inhibitor
24321,f16,BRD-K65667145-001-04-1,cell division inducer
24321,f19,BRD-K65786282-001-02-6,GABA receptor modulator
24321,f20,BRD-K65814004-001-02-3,nitric oxide synthase inhibitor|aldehyde dehydrogenase inhibitor|cytochrome P450 inhibitor|NADPH oxidase inhibitor|xanthine oxidase inhibitor
24321,f23,BRD-K66093087-001-01-5,Benzodiazepine receptor agonist
24321,f24,BRD-K66206289-003-03-1,Acetylcholine receptor antagonist
24321,g02,BRD-K66353228-001-05-4,myorelaxant
24321,g05,BRD-K66404838-003-03-8,opioid receptor agonist|opioid receptor antagonist
24321,g08,BRD-K66707493-001-02-6,Coloring agent
24321,g09,BRD-K66715657-001-01-3,dopamine receptor antagonist
24321,g10,BRD-K66782112-001-01-2,Histamine receptor antagonist
24321,g11,BRD-K66874953-001-02-7,TP53 inhibitor
24321,g12,BRD-K66898851-001-03-7,apoptosis stimulant
24321,g13,BRD-K66944906-001-02-6,Carbonic anhydrase inhibitor
24321,g14,BRD-K67013324-001-01-5,melatonin receptor antagonist
24321,g16,BRD-K67017579-001-13-3,Phosphodiesterase inhibitor
24321,g17,BRD-K67043667-001-04-1,DNA synthesis inhibitor
24321,g18,BRD-K67080878-001-05-5,phosphodiesterase inhibitor
24321,g21,BRD-K67102207-236-01-0,HDAC inhibitor
24321,g23,BRD-K67261995-001-03-4,Contrast agent
24321,g24,BRD-K67277431-002-03-0,thromboxane receptor antagonist|thromboxane synthase inhibitor
24321,h01,BRD-K67298865-001-02-5,TGF beta receptor inhibitor
24321,h02,BRD-K67352070-364-01-5,Acetylcholine receptor agonist
24321,h05,BRD-K67439147-001-01-7,glutamate receptor antagonist
24321,h06,BRD-K67445247-001-01-3,Urease inhibitor
24321,h08,BRD-K67537649-001-01-1,insulin growth factor receptor inhibitor
24321,h12,BRD-K67680372-003-01-8,GAT inhibitor
24321,h13,BRD-K67783091-001-05-5,Dopamine receptor antagonist
24321,h14,BRD-K67831364-003-01-7,vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor|VEGFR inhibitor
24321,h17,BRD-K68095457-001-04-4,Cannabinoid receptor agonist
24321,h18,BRD-K68103045-001-01-1,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist
24321,h21,BRD-K68143200-001-04-2,CDC inhibitor
24321,h24,BRD-K68190965-001-01-4,Serotonin receptor agonist
24321,i01,BRD-K68246049-001-01-4,Retinoid receptor agonist
24321,i02,BRD-K68264559-001-07-6,Adrenergic receptor agonist
24321,i03,BRD-K68332390-001-03-3,aldose reductase inhibitor|reductase inhibitor
24321,i04,BRD-K68341547-003-01-6,calmodulin antagonist
24321,i07,BRD-K68392338-003-01-2,Benzodiazepine receptor antagonist
24321,i08,BRD-K68402494-001-04-7,myosin light chain kinase inhibitor
24321,i10,BRD-K68507560-003-04-8,acetylcholine receptor antagonist
24321,i12,BRD-K68552125-001-03-8,PKC activator|CD antagonist
24321,i13,BRD-K68553471-003-04-0,antihypertensive agent
24321,i14,BRD-K68558722-001-02-4,Cyclooxygenase inhibitor
24321,i15,BRD-K68620903-001-03-1,progesterone receptor agonist
24321,i17,BRD-K68873215-001-01-3,phosphodiesterase inhibitor
24321,i18,BRD-K69023402-001-02-5,ATPase inhibitor|calcium channel blocker|PKC activator
24321,i19,BRD-K69032158-001-02-2,Dipeptidyl peptidase inhibitor
24321,i20,BRD-K69195780-001-01-5,Serotonin receptor agonist
24321,i23,BRD-K69556541-001-02-6,Calcium channel blocker
24321,j01,BRD-K69763916-001-01-7,Glutamate receptor antagonist
24321,j02,BRD-K69837166-003-01-2,Nociceptin/orphanin FQ (NOP) receptor antagonist
24321,j03,BRD-K70241288-001-01-1,Growth hormone releasing peptide ligand agonist
24321,j04,BRD-K70246307-001-02-5,vitamin B2
24321,j07,BRD-K70281171-001-01-7,Dopamine receptor antagonist
24321,j08,BRD-K70330367-001-02-4,Glutamate receptor antagonist
24321,j10,BRD-K70487031-001-01-0,dopamine receptor antagonist
24321,j12,BRD-K70778732-003-04-4,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor
24321,j13,BRD-K70792160-003-01-2,AKT inhibitor
24321,j15,BRD-K70881766-001-02-3,Acetylcholinesterase inhibitor
24321,j16,BRD-K70914287-300-01-0,EGFR inhibitor|tyrosine kinase inhibitor
24321,j17,BRD-K70976396-236-04-7,Bacterial cell wall synthesis inhibitor
24321,j18,BRD-K71003802-001-02-9,Plant alkaloid
24321,j19,BRD-K13356952-001-11-1,carbonic anhydrase inhibitor
24321,k03,BRD-K71266197-236-01-9,NTPDase inhibitor
24321,k04,BRD-K71430621-303-01-5,histamine receptor antagonist|histamine receptor inverse agonist
24321,k06,BRD-K71499074-001-03-8,Carbonic anhydrase inhibitor
24321,k09,BRD-K71534238-001-03-5,Free fatty acid receptor agonist
24321,k11,BRD-K71726959-001-05-9,CDK inhibitor
24321,k12,BRD-K71731651-001-01-9,Acetylcholine receptor agonist
24321,k13,BRD-K71799778-001-02-2,CDK inhibitor
24321,k14,BRD-K71799949-001-04-2,Carboxamide antiepileptic
24321,k17,BRD-K71860425-001-01-1,CDK inhibitor
24321,k18,BRD-K72024482-001-01-3,adenosine receptor antagonist
24321,k19,BRD-K72034655-001-02-1,apoptosis inducer|antileukemic
24321,k22,BRD-K72222507-003-02-8,ACE inhibitor
24321,l04,BRD-K72676686-103-01-8,selective serotonin reuptake inhibitor (SSRI)|serotonin reuptake inhibitor|serotonin uptake inhibitor
24321,l05,BRD-K72726508-001-01-3,CDK inhibitor
24321,l06,BRD-K72783841-001-01-0,CDK inhibitor|epidermal growth factor receptor (EGFR) inhibitor|tyrosine kinase inhibitor|EGFR inhibitor
24321,l09,BRD-K72895815-001-01-4,leukocyte elastase inhibitor
24321,l10,BRD-K72903603-001-03-8,Reverse transcriptase inhibitor
24321,l13,BRD-K73109821-001-05-2,Potassium channel activator
24321,l18,BRD-K73196317-003-06-4,adrenergic receptor antagonist
24321,l21,BRD-K73290745-003-01-8,opioid receptor agonist
24321,l22,BRD-K73323637-003-03-4,adrenergic receptor antagonist
24321,m02,BRD-K73391359-003-03-7,Local anesthetic
24321,m05,BRD-K73397362-001-01-7,smoothened receptor agonist
24321,m06,BRD-K73589401-001-03-8,mineralocorticoid receptor agonist
24321,m12,BRD-K73789395-001-04-0,RAF inhibitor
24321,m15,BRD-K73991644-001-01-7,aldose reductase inhibitor|falcipain inhibitor
24321,m17,BRD-K74112339-001-02-7,Urease inhibitor
24321,m18,BRD-K74141488-003-03-9,Fungal squalene epoxidase inhibitor
24321,m20,BRD-K74195153-050-03-0,Phosphodiesterase inhibitor
24321,m21,BRD-K74212935-001-03-1,Dopamine agonist
24321,m23,BRD-K74305673-001-01-3,IKK inhibitor|NFkB pathway inhibitor|protein kinase inhibitor
24321,m24,BRD-K74430258-001-01-2,hepatotoxicant
24321,n02,BRD-K74765201-001-01-9,Leukotriene receptor antagonist
24321,n03,BRD-K74913225-001-03-3,Carbonic anhydrase inhibitor
24321,n05,BRD-K75089421-001-02-5,sodium channel blocker
24321,n06,BRD-K75181824-001-02-3,inhibitor of methyl esterification of geranylgeranylated proteins
24321,n11,BRD-K75478907-001-01-5,GABA receptor modulator|GABA receptor positive allosteric modulator
24321,n16,BRD-K75615183-001-01-7,Adrenergic receptor agonist
24321,n17,BRD-K75641298-001-01-5,Dopamine receptor antagonist
24321,n21,BRD-K75958195-001-01-7,serotonin receptor antagonist
24321,n24,BRD-K76064317-001-04-0,FLT3 inhibitor
24321,o01,BRD-K76133116-001-01-2,Membrane integrity inhibitor
24321,o03,BRD-K76274772-001-02-7,Ceramidase inhibitor
24321,o05,BRD-K76304753-003-04-7,local anesthetic
24321,o07,BRD-K76568384-001-01-4,estrogen receptor antagonist
24321,o08,BRD-K76587808-001-02-0,Antioxidant
24321,o09,BRD-K76617868-001-02-2,rho associated kinase inhibitor
24321,o10,BRD-K76634210-001-02-2,DNA directed DNA polymerase inhibitor
24321,o13,BRD-K76674262-001-01-7,apoptosis stimulant|protein synthesis inhibitor
24321,o15,BRD-K76723084-001-05-9,retinoid receptor agonist
24321,o16,BRD-K76775527-001-06-2,Cyclooxygenase inhibitor
24321,o17,BRD-K76805682-001-05-0,glycogen synthase kinase inhibitor
24321,o18,BRD-K76810206-001-05-7,adrenergic receptor antagonist
24321,o20,BRD-K76840893-003-01-7,adrenergic receptor antagonist
24321,o22,BRD-K76872913-001-02-8,Aromatic hydrocarbon derivative
24321,o23,BRD-K76927775-001-04-3,DNA inhibitor
24321,o24,BRD-K77133231-001-01-1,p38 MAPK inhibitor
24321,p01,BRD-K77171813-050-01-4,histamine receptor modulator
24321,p03,BRD-K77554836-001-03-3,glucocorticoid receptor agonist
24321,p07,BRD-K77641333-003-04-0,adrenergic receptor agonist
24321,p08,BRD-K77677632-003-01-8,serotonin receptor antagonist
24321,p09,BRD-K77695569-001-04-5,angiogenesis inhibitor
24321,p10,BRD-K77771411-003-03-2,imidazoline receptor agonist
24321,p13,BRD-K77793136-003-01-4,rho associated kinase inhibitor
24321,p15,BRD-K77925998-001-01-3,serotonin receptor agonist
24321,p16,BRD-K77947974-001-04-9,dopamine receptor antagonist
24321,p17,BRD-K77987382-001-05-8,acetylcholinesterase inhibitor|microtubule inhibitor|tubulin inhibitor
24321,p18,BRD-K78010432-001-04-1,diuretic
24321,p20,BRD-K78084463-003-01-0,calmodulin antagonist
24321,p21,BRD-K78113049-001-04-8,topoisomerase inhibitor
24321,p22,BRD-K78122587-300-01-9,T-type calcium channel blocker
24321,p23,BRD-K78280988-001-02-2,cannabinoid receptor agonist|potassium channel blocker|TRPV agonist
26232,a01,BRD-K78364995-236-03-5,bacterial cell wall synthesis inhibitor
26232,a03,BRD-K78485176-001-02-9,angiotensin receptor antagonist
26232,a05,BRD-K78599730-001-02-6,farnesyltransferase inhibitor|NFkB pathway inhibitor|ras farnesyltransferase inhibitor
26232,a07,BRD-K78633253-001-01-2,ARF inhibitor
26232,a08,BRD-K78637815-001-01-4,cannabinoid receptor antagonist
26232,a09,BRD-K78643075-001-03-3,dopamine receptor antagonist
26232,a10,BRD-K78692225-001-11-2,dihydroorotate dehydrogenase inhibitor|PDGFR tyrosine kinase receptor inhibitor
26232,a11,BRD-K78815826-001-04-7,cyclooxygenase inhibitor
26232,a12,BRD-K78838262-001-02-4,hypolipidemic
26232,a16,BRD-K78959463-001-02-5,calcium channel activator
26232,a18,BRD-K79092138-001-04-5,POXB inhibitor|bacterial DNA inhibitor
26232,a19,BRD-K79116891-003-03-7,sodium channel blocker
26232,a20,BRD-K79124250-001-03-0,radiopaque medium
26232,a21,BRD-K79131256-001-03-9,tubulin polymerization inhibitor
26232,a22,BRD-K79145749-001-01-8,norepinephrine reputake inhibitor
26232,a24,BRD-K79366068-236-01-5,NTPDase inhibitor
26232,b01,BRD-K79425933-001-03-6,dopamine receptor antagonist
26232,b02,BRD-K79437791-001-02-4,Inhibitor of methylation of endogenous isoprenylated proteins
26232,b03,BRD-K79501723-003-03-4,histamine receptor modulator
26232,b04,BRD-K79684402-300-01-0,dopamine receptor partial agonist
26232,b05,BRD-K79711234-001-04-3,bacterial 50S ribosomal subunit inhibitor
26232,b06,BRD-K79759585-001-02-1,phosphodiesterase inhibitor
26232,b07,BRD-K79930101-300-01-1,EGFR inhibitor|epidermal growth factor receptor (EGFR) inhibitor|ErbB2 tyrosine kinase inhibitor|receptor tyrosine protein kinase inhibitor
26232,b09,BRD-K80315159-051-01-2,histamine receptor antagonist
26232,b12,BRD-K80334323-001-03-5,progestogen hormone
26232,b15,BRD-K80353807-001-03-0,vasodilator
26232,b16,BRD-K80396088-001-03-9,Sulfonylurea
26232,b17,BRD-K80451230-051-01-8,acetylcholine receptor antagonist
26232,b19,BRD-K80639402-003-01-1,serotonin receptor antagonist
26232,b20,BRD-K80725821-300-01-1,serotonin receptor antagonist
26232,b21,BRD-K80738081-001-06-2,cytochrome P450 inhibitor|SIRT activator
26232,b22,BRD-K80778372-001-01-7,GABA benzodiazepine site receptor inverse agonist
26232,b24,BRD-K80946661-001-02-8,p53 activator
26232,c01,BRD-K80970344-201-02-9,NFkB pathway inhibitor
26232,c02,BRD-K81029756-001-02-8,L-type calcium channel blocker|calcium channel antagonist|calcium channel blocker
26232,c04,BRD-K81209159-001-02-9,Acetylcholinesterase inhibitor
26232,c05,BRD-K81209512-001-01-3,EGFR inhibitor|epidermal growth factor receptor (EGFR) inhibitor|tyrosine kinase inhibitor
26232,c06,BRD-K81225797-001-01-5,adenosine receptor antagonist
26232,c07,BRD-K81272440-001-02-6,calcium channel blocker
26232,c09,BRD-K81376179-001-01-4,FLT3 inhibitor
26232,c14,BRD-K81709173-001-03-8,glucocorticoid receptor agonist
26232,c17,BRD-K81729199-001-01-0,acetylcholine receptor antagonist
26232,c20,BRD-K81839095-001-02-0,Estrogen receptor agonist
26232,c21,BRD-K81876028-300-01-2,Serotonin receptor agonist
26232,c23,BRD-K82103381-003-03-7,vasodilator
26232,d03,BRD-K82255054-001-04-3,GABA receptor agonist
26232,d04,BRD-K82484965-003-02-7,dopamine receptor agonist
26232,d05,BRD-K82561139-001-01-9,casein kinase inhibitor
26232,d06,BRD-K82562631-236-02-0,Cyclooxygenase inhibitor
26232,d07,BRD-K82577285-001-01-7,Dopamine receptor agonist
26232,d08,BRD-K82731415-001-04-7,CDK inhibitor
26232,d09,BRD-K82795137-001-02-3,Histamine receptor antagonist
26232,d10,BRD-K82823076-001-01-8,GABA benzodiazepine site receptor inverse agonist
26232,d13,BRD-K82846253-001-03-0,Insulin secretagogue
26232,d14,BRD-K82865713-001-02-6,cAMP inhibitor
26232,d17,BRD-K83023055-001-01-9,Melatonin receptor agonist
26232,d19,BRD-K83063356-003-01-7,CC chemokine receptor antagonist|CCR antagonist
26232,d23,BRD-K83302049-001-01-6,Histamine receptor antagonist
26232,d24,BRD-K83322645-103-01-6,sigma receptor antagonist|sigma receptor ligand
26232,e04,BRD-K83459933-001-02-1,angiogenesis inhibitor
26232,e05,BRD-K83508485-001-01-9,tachykinin antagonist
26232,e06,BRD-K83597974-003-05-7,Monoamine oxidase inhibitor
26232,e07,BRD-K83637872-001-01-7,Smoothened receptor antagonist
26232,e08,BRD-K84175871-003-02-2,Adrenergic receptor agonist
26232,e12,BRD-K84266862-001-01-6,phosphodiesterase inhibitor
26232,e13,BRD-K84421793-001-01-1,dopamine receptor agonist
26232,e14,BRD-K84595254-001-03-0,ATPase inhibitor
26232,e15,BRD-K84663978-001-02-3,phosphodiesterase inhibitor|platelet aggregation inhibitor|potassium channel blocker
26232,e16,BRD-K84709232-001-02-6,lipoxygenase inhibitor|HIV integrase inhibitor|NFkB pathway inhibitor|nitric oxide production inhibitor|PPAR receptor modulator|tumor necrosis factor production inhibitor
26232,e19,BRD-K85015012-003-01-1,GABA uptake inhibitor|GAT inhibitor
26232,e20,BRD-K85090592-003-08-7,Acetylcholine receptor agonist
26232,e22,BRD-K85119730-001-06-5,ATP channel blocker
26232,e23,BRD-K85242180-001-01-1,"indoleamine 2,3-dioxygenase inhibitor"
26232,e24,BRD-K85266041-304-01-7,glutamate receptor antagonist
26232,f04,BRD-K85383046-001-02-5,chloride channel blocker
26232,f06,BRD-K85871428-001-01-9,p38 MAPK inhibitor
26232,f11,BRD-K85883481-001-02-6,glucocorticoid receptor agonist
26232,f12,BRD-K86204871-001-02-2,sterol demethylase inhibitor
26232,f13,BRD-K86301799-001-14-0,phosphodiesterase inhibitor
26232,f14,BRD-K86434416-001-02-7,Monoamine oxidase inhibitor
26232,f15,BRD-K84663978-001-03-1,phosphodiesterase inhibitor|platelet aggregation inhibitor|potassium channel blocker
26232,f16,BRD-K86509404-001-02-0,CDK inhibitor
26232,f19,BRD-K86600316-003-01-2,Adrenergic receptor antagonist
26232,f20,BRD-K86727142-001-06-6,HCV inhibitor|XIAP inhibitor
26232,f21,BRD-K86873305-236-03-0,Bacterial cell wall synthesis inhibitor
26232,f22,BRD-K86882815-001-01-6,dopamine receptor agonist|prolactin inhibitor|prolactin secretion inhibitor
26232,f23,BRD-K86958018-001-01-9,TRPV agonist
26232,f24,BRD-K87048468-003-01-9,Serotonin receptor antagonist
26232,g01,BRD-K87049188-001-03-6,chelating agent|dopamine beta hydroxylase inhibitor
26232,g08,BRD-K87510569-001-01-0,CC chemokine receptor antagonist
26232,g09,BRD-K87696786-003-01-0,glutamate receptor antagonist
26232,g14,BRD-K87990216-001-03-7,Glucocorticoid receptor agonist
26232,g15,BRD-K87991767-001-02-0,carbonic anhydrase inhibitor|cyclooxygenase inhibitor
26232,g16,BRD-K88090157-050-03-3,antihistamine
26232,g21,BRD-K88282786-066-04-9,cannabinoid receptor agonist
26232,g22,BRD-K88358234-003-01-4,serotonin receptor agonist|nerve growth factor agonist|neurotrophic factor enhancer
26232,g23,BRD-K88366685-300-03-7,3-ketoacyl CoA thiolase inhibitor
26232,g24,BRD-K88405679-003-01-5,antihistamine
26232,h01,BRD-K88429204-001-04-7,dihydrofolate reductase inhibitor
26232,h02,BRD-K88544581-001-01-2,ACAT inhibitor
26232,h05,BRD-K88568253-065-02-1,monoamine oxidase inhibitor
26232,h06,BRD-K88611939-001-01-8,Glutamate receptor agonist
26232,h08,BRD-K88677950-001-01-3,MAP kinase inhibitor|MEK inhibitor
26232,h10,BRD-K88741031-001-01-0,EGFR inhibitor|tyrosine kinase inhibitor
26232,h11,BRD-K88743730-001-01-0,serotonin receptor partial agonist
26232,h12,BRD-K88759641-003-01-0,Angiotensin receptor antagonist
26232,h13,BRD-K88789588-001-03-2,aromatase inhibitor
26232,h14,BRD-K88809146-003-02-1,monoamine oxidase inhibitor
26232,h15,BRD-K88849294-001-02-1,Tyrosine phosphatase inhibitor
26232,h16,BRD-K88871508-001-01-9,Dopamine receptor agonist
26232,h18,BRD-K89046952-001-03-4,bacterial cell wall synthesis inhibitor
26232,h21,BRD-K89055274-048-03-7,muscle relaxant
26232,h22,BRD-K89085489-001-02-6,apoptosis stimulant|retinoid receptor agonist
26232,h23,BRD-K89125793-001-05-4,antiprotozoal agent
26232,h24,BRD-K89152108-001-03-3,thyroid hormone stimulant
26232,i01,BRD-K89210380-001-03-8,vitamin B
26232,i04,BRD-K89272762-001-04-4,chloride channel blocker
26232,i07,BRD-K89274813-001-01-5,acetylcholine release enhancer
26232,i08,BRD-K89375097-300-04-7,Acetylcholine receptor antagonist
26232,i09,BRD-K89402695-001-01-5,Thromboxane receptor antagonist
26232,i13,BRD-K89732114-001-02-6,dopamine receptor antagonist
26232,i14,BRD-K89923877-003-02-4,acetylcholine receptor antagonist
26232,i15,BRD-K89930444-001-01-9,tyrosine kinase inhibitor
26232,i16,BRD-K89997465-001-02-0,dopamine receptor antagonist
26232,i17,BRD-K90027355-001-03-4,mineralocorticoid receptor antagonist
26232,i23,BRD-K90259198-003-04-8,calmodulin antagonist|potassium channel blocker|squalene monooxygenase channel blocker
26232,i24,BRD-K90333595-001-02-8,adrenergic receptor antagonist
26232,j01,BRD-K90524085-001-05-2,phosphodiesterase inhibitor|platelet aggregation inhibitor
26232,j04,BRD-K90574421-001-01-9,Serotonin receptor agonist
26232,j08,BRD-K90789829-003-03-3,Adrenergic inhibitor
26232,j09,BRD-K90976994-001-02-1,Bile acid
26232,j10,BRD-K91243525-001-01-5,Neurotensin receptor antagonist
26232,j11,BRD-K91263825-001-02-8,tricyclic antidepressant
26232,j13,BRD-K91315211-334-02-3,Histamine receptor agonist
26232,j15,BRD-K91336023-001-01-4,Dopamine receptor agonist
26232,j16,BRD-K91370081-001-04-6,DNA synthesis inhibitor
26232,j19,BRD-K91904471-001-01-6,p38 MAPK inhibitor
26232,j20,BRD-K92000912-001-06-8,cannabinoid receptor antagonist
26232,j24,BRD-K92015269-001-01-6,dopamine uptake inhibitor
26232,k02,BRD-K92049597-001-04-2,sodium channel blocker
26232,k04,BRD-K92093830-003-05-0,topoisomerase inhibitor
26232,k05,BRD-K92138166-001-01-0,other antibiotic
26232,k09,BRD-K92492521-001-01-1,Leukotriene receptor antagonist
26232,k12,BRD-K92678294-001-01-0,Isoflavone
26232,k14,BRD-K92726801-003-02-7,Haemostatic agent
26232,k17,BRD-K92731339-227-02-3,ACE inhibitor
26232,k18,BRD-K92758126-001-06-3,NFkB pathway inhibitor
26232,k19,BRD-K92778217-001-04-6,Cyclooxygenase inhibitor
26232,k20,BRD-K92830582-003-04-8,adrenergic receptor antagonist
26232,k22,BRD-K92984783-003-02-4,Serotonin receptor antagonist
26232,l01,BRD-K93080877-001-02-1,tripeptidyl peptidase inhibitor
26232,l02,BRD-K93176058-001-01-0,retinoid receptor agonist
26232,l03,BRD-K93188295-300-01-4,adrenergic receptor antagonist
26232,l05,BRD-K93258693-001-02-5,PPAR receptor antagonist
26232,l06,BRD-K93280214-004-02-3,GABA receptor antagonist
26232,l09,BRD-K93325701-001-03-0,SRC inhibitor
26232,l10,BRD-K93332168-001-03-2,Monoamine oxidase inhibitor
26232,l11,BRD-K93441486-067-03-7,Acetylcholine receptor antagonist
26232,l12,BRD-K93460210-001-01-3,Serotonin receptor antagonist
26232,l13,BRD-K93461745-001-01-5,Serotonin receptor agonist
26232,l14,BRD-K93480852-001-02-2,calcium/calmodulin dependent protein kinase inhibitor
26232,l19,BRD-K93568044-001-03-1,glucocorticoid receptor agonist
26232,l20,BRD-K93658967-001-01-7,CDK inhibitor|CFTR channel activator|glycogen synthase kinase inhibitor|JNK inhibitor
26232,l21,BRD-K93754473-001-02-9,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)
26232,l22,BRD-K94144010-001-05-5,nicotine metabolite
26232,m04,BRD-K94270326-004-01-0,dopamine receptor antagonist
26232,m06,BRD-K94379058-001-03-5,cannabinoid receptor inverse agonist
26232,m07,BRD-K94441233-001-03-1,HMGCR inhibitor
26232,m08,BRD-K94512704-001-01-3,dopamine receptor antagonist
26232,m12,BRD-K94689771-001-02-5,CYP1B1 inhibitor
26232,m17,BRD-K94832621-001-01-5,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)
26232,m19,BRD-K94841585-001-02-8,laxative|free radical generator
26232,m21,BRD-K94887716-001-01-5,Serotonin receptor agonist
26232,m22,BRD-K94920105-001-01-3,PARP inhibitor
26232,m24,BRD-K95202259-001-01-9,p38 MAPK inhibitor
26232,n01,BRD-K95237249-001-04-2,Uricosuric blocker
26232,n02,BRD-K95309561-001-04-9,estrogen receptor agonist
26232,n04,BRD-K95435023-001-01-0,c-Met inhibitor|hepatocyte growth factor receptor inhibitor
26232,n07,BRD-K95603879-001-03-4,ATPase inhibitor
26232,n08,BRD-K95609758-001-01-1,potassium channel activator
26232,n11,BRD-K95655893-001-01-0,VEGFR kinase inhibitor
26232,n12,BRD-K95676198-001-02-6,JAK inhibitor
26232,n15,BRD-K95739795-001-01-1,Vesicular monoamine transporter inhibitor
26232,n16,BRD-K95763993-001-03-7,PDGFR receptor inhibitor
26232,n17,BRD-K95785537-001-04-1,src inhibitor
26232,n20,BRD-K95851186-001-02-9,GABA receptor modulator
26232,n21,BRD-K95899059-003-01-0,Serotonin receptor agonist
26232,n22,BRD-K95992530-001-02-4,integrin antagonist
26232,n23,BRD-K96119599-001-04-7,Melanin inhibitor
26232,n24,BRD-K96144918-001-02-3,KPL-1 tumor suppressor
26232,o04,BRD-K96263742-001-02-3,PPAR receptor agonist
26232,o05,BRD-K96271548-001-02-2,antioxidant
26232,o07,BRD-K96402602-001-01-8,PPMTase inhibitor
26232,o08,BRD-K96527333-001-03-4,GABA receptor modulator
26232,o10,BRD-K96670504-001-01-9,Glucokinase inhibitor
26232,o13,BRD-K96720755-001-01-8,Vasopressin receptor antagonist
26232,o14,BRD-K96799727-001-01-7,HSP inhibitor
26232,o15,BRD-K96809896-001-01-9,p38 MAPK inhibitor
26232,o16,BRD-K96862998-001-03-1,TGF beta receptor inhibitor
26232,o17,BRD-K97061094-001-03-2,Histamine receptor antagonist
26232,o18,BRD-K97118047-001-01-2,Casein kinase inhibitor
26232,o19,BRD-K97158071-001-04-1,Dopamine receptor antagonist
26232,o20,BRD-K97181089-001-02-7,sodium channel blocker
26232,o22,BRD-K97330509-001-01-4,src inhibitor
26232,o23,BRD-K97354755-001-01-5,src inhibitor
26232,o24,BRD-K97365803-001-01-3,PI3K inhibitor
26232,p01,BRD-K97399794-001-07-0,polar auxin transport inhibitor
26232,p02,BRD-K97440753-066-03-3,adrenergic receptor antagonist|prolactin inhibitor
26232,p04,BRD-K97509413-001-01-8,AGE inhibitor|estrogen receptor agonist|estrogen receptor ligand
26232,p05,BRD-K97521363-001-03-9,glycolysis inhibitor
26232,p06,BRD-K97530723-001-04-3,melatonin receptor agonist|nitric oxide synthase inhibitor
26232,p07,BRD-K97564742-103-01-9,histamine receptor antagonist
26232,p10,BRD-K97688263-001-02-9,sodium channel blocker
26232,p13,BRD-K97746869-001-04-9,ATP channel blocker
26232,p14,BRD-K97752965-001-01-6,ATP channel activator|nitric oxide donor|potassium channel agonist
26232,p15,BRD-K97799481-002-03-6,Adenosine receptor antagonist
26232,p16,BRD-K97810537-001-03-7,glucocorticoid receptor agonist
26232,p17,BRD-K98039984-001-03-0,glucocorticoid receptor agonist
26232,p18,BRD-K98143437-001-01-7,p38 MAPK inhibitor|interleukin inhibitor|tumor necrosis factor production inhibitor
26232,p20,BRD-K98157055-001-04-2,glutamate receptor antagonist
26232,p21,BRD-K98174813-001-05-7,bacterial 30S ribosomal subunit inhibitor
26232,p23,BRD-K98297262-001-01-1,"1,3-beta-glucan synthase inhibitor"
26232,p24,BRD-K98521173-001-03-8,mineralocorticoid receptor agonist
24300,a01,BRD-A00100033-001-04-8,DNA inhibitor
24300,a02,BRD-A00267231-001-01-1,Adenosine receptor agonist
24300,a04,BRD-A00520476-001-03-3,Acetylcholine receptor antagonist
24300,a06,BRD-A00993607-003-04-8,Adrenergic receptor antagonist
24300,a07,BRD-A01078468-001-04-9,synthetic estrogen
24300,a08,BRD-A01295252-001-01-5,Dopamine receptor ligand
24300,a09,BRD-A01320529-001-05-9,adrenergic receptor agonist
24300,a11,BRD-A01593789-001-01-5,5 alpha reductase inhibitor
24300,a12,BRD-A01636364-003-04-5,sodium channel blocker
24300,a15,BRD-A01787639-003-08-6,adrenergic receptor antagonist
24300,a16,BRD-A02006392-001-06-5,calcium channel blocker
24300,a17,BRD-A02176148-001-02-2,Mitochondrial complex I inhibitor
24300,a19,BRD-A02710418-003-03-5,opioid receptor agonist
24300,a20,BRD-A02713983-001-02-0,growth factor receptor activator
24300,a21,BRD-A02759312-003-11-2,Adrenergic receptor antagonist
24300,a23,BRD-A03216249-003-02-9,Potassium channel blocker
24300,a24,BRD-A03359064-001-01-5,Adrenergic receptor antagonist
24300,b02,BRD-A03623303-045-02-0,Adrenergic receptor antagonist
24300,b03,BRD-A03816571-001-01-0,cannabinoid receptor agonist|CC chemokine receptor antagonist
24300,b09,BRD-A04322457-003-03-9,adrenergic receptor agonist
24300,b10,BRD-A04438777-001-01-4,dopamine receptor agonist
24300,b11,BRD-A04553218-050-03-0,histamine receptor antagonist
24300,b15,BRD-A04668240-001-01-5,GABA receptor antagonist
24300,b16,BRD-A04706586-236-01-7,Adenosine receptor agonist
24300,b18,BRD-A05186015-003-04-0,dopamine uptake inhibitor
24300,b24,BRD-A06352418-001-03-6,Histamine receptor antagonist
24300,c01,BRD-A06352508-001-02-9,CHK inhibitor
24300,c02,BRD-A06390036-001-02-0,Antiarrhythmic
24300,c03,BRD-A06726973-001-02-0,cGMP analog
24300,c04,BRD-A06935312-001-02-7,bacterial 30S ribosomal subunit inhibitor
24300,c06,BRD-A07207424-001-04-1,phosphodiesterase inhibitor
24300,c08,BRD-A07440155-003-04-9,Adrenergic receptor antagonist
24300,c09,BRD-A07780951-001-02-2,Adrenergic receptor agonist
24300,c10,BRD-A07824748-001-02-6,11-beta hydroxysteroid dehydrogenase inhibitor
24300,c14,BRD-A07875874-001-01-6,calcium channel blocker
24300,c17,BRD-A07932845-001-01-1,anti-HCVE2
24300,c18,BRD-A07952294-001-02-3,farnesyltransferase inhibitors
24300,c19,BRD-A08187463-001-03-8,enkephalinase inhibitor
24300,c22,BRD-A08709697-001-02-9,pyrrolizidine alkaloid
24300,c23,BRD-A08877921-001-02-2,Protein synthesis inhibitor
24300,c24,BRD-A09056319-003-03-6,Adrenergic receptor antagonist
24300,d01,BRD-A09062839-003-03-5,Local anesthetic
24300,d02,BRD-A09094913-001-02-3,acetylcholine receptor antagonist
24300,d03,BRD-A09161221-001-01-9,HSP inhibitor
24300,d04,BRD-A09349126-001-02-4,progesterone receptor agonist
24300,d05,BRD-A09467419-003-04-2,acetylcholine receptor antagonist
24300,d06,BRD-A09472452-001-02-8,Sodium channel blocker
24300,d07,BRD-A09533288-001-02-7,calcium channel blocker
24300,d08,BRD-A09539288-004-02-8,Acetylcholine receptor antagonist
24300,d09,BRD-A09828896-004-04-5,Dopamine receptor agonist
24300,d10,BRD-A09925278-003-03-1,Adrenergic receptor agonist
24300,d14,BRD-A10070317-003-05-1,adrenergic receptor antagonist
24300,d17,BRD-A10355991-003-01-8,Glutamate receptor antagonist
24300,d18,BRD-A10715913-001-02-0,Dopamine receptor antagonist
24300,d19,BRD-A10739734-003-01-5,adrenergic receptor antagonist
24300,d20,BRD-A10903566-003-02-8,Adrenergic receptor antagonist
24300,d21,BRD-A10969569-001-02-0,Plant alkaloid
24300,d22,BRD-A10977446-001-04-8,Adrenergic receptor antagonist
24300,e03,BRD-A11605036-001-03-2,GABA receptor antagonist
24300,e04,BRD-A11609859-303-01-2,opioid receptor agonist
24300,e05,BRD-A11678676-001-02-6,PI3K inhibitor
24300,e07,BRD-A11813248-001-02-8,Potassium channel blocker
24300,e08,BRD-A12016240-001-01-7,Serotonin receptor antagonist
24300,e14,BRD-A13188892-066-03-3,Adrenergic receptor antagonist
24300,e15,BRD-A13650332-236-03-9,Bacterial cell wall synthesis inhibitor
24300,e16,BRD-A13946108-001-03-1,Cyclooxygenase inhibitor
24300,e23,BRD-A14395271-001-01-5,Dopamine receptor antagonist
24300,e24,BRD-A14566392-004-03-5,acetylcholine receptor antagonist
24300,f03,BRD-A14574269-051-01-4,Acetylcholine receptor agonist
24300,f04,BRD-A15034104-002-03-6,interleukin inhibitor
24300,f05,BRD-A15070535-323-02-1,adenosine receptor agonist|cAMP stimulant
24300,f06,BRD-A15415227-003-01-1,PPAR receptor agonist
24300,f07,BRD-A15435692-003-01-5,sigma receptor antagonist|glutamate receptor antagonist|serotonin receptor agonist
24300,f11,BRD-A15530910-001-01-3,adrenergic receptor antagonist|serotonin receptor antagonist
24300,f14,BRD-A15914070-001-01-5,cytotoxic lipid peroxidation product
24300,f15,BRD-A16332958-001-02-4,Adrenergic receptor agonist
24300,f16,BRD-A16665823-008-03-3,Bacterial cell wall synthesis inhibitor
24300,f19,BRD-A16694057-001-02-7,PPAR receptor antagonist
24300,f21,BRD-A17065207-001-06-9,protein synthesis inhibitor
24300,f23,BRD-A17428743-001-01-1,Serotonin receptor agonist
24300,f24,BRD-A17453586-001-01-9,Serotonin receptor agonist
24300,g02,BRD-A17535965-001-02-2,Acetylcholine receptor antagonist
24300,g05,BRD-A17655518-001-02-0,Cyclooxygenase inhibitor
24300,g08,BRD-A18043272-001-03-2,succinimide antiepileptic
24300,g09,BRD-A18202423-001-01-6,Glutamate receptor antagonist
24300,g10,BRD-A18497530-001-04-6,adenosine kinase inhibitor|nucleoside transporter inhibitor
24300,g11,BRD-A18579359-001-03-1,Neural Wiskott-Aldrich syndrome protein inhibitor
24300,g12,BRD-A18696154-003-11-9,adrenergic receptor antagonist
24300,g13,BRD-A18763547-019-01-0,Cytochrome C release inhibitor
24300,g15,BRD-A19053259-003-03-3,Anthelmintic
24300,g17,BRD-A19195498-050-04-2,Norepinephrine reuptake inhibitor
24300,g18,BRD-A19736161-310-01-3,Serotonin receptor antagonist
24300,g23,BRD-A20239487-001-02-5,Adrenergic receptor antagonist
24300,h01,BRD-A20348246-001-04-2,GABA receptor modulator
24300,h06,BRD-A20968261-001-01-3,glutamate transporter inhibitor
24300,h08,BRD-A21723284-066-01-7,Opioid receptor antagonist
24300,h09,BRD-A21858158-001-04-5,Anthelmintic
24300,h14,BRD-A22305049-003-04-5,gluconeogenesis inhibitor
24300,h15,BRD-A22380646-001-01-5,ATPase inhibitor
24300,h16,BRD-A22684332-003-02-3,adrenergic receptor agonist
24300,h17,BRD-A22707317-001-02-5,GABA receptor modulator
24300,h21,BRD-A22769835-300-03-2,Antihistamine
24300,h22,BRD-A22783572-065-01-3,microtubule formation inhibitor|tubulin inhibitor|tubulin polymerisation inhibitor
24300,h23,BRD-A22844106-001-04-7,Cyclooxygenase inhibitor
24300,h24,BRD-A23034328-003-03-4,protein synthesis inhibitor
24300,i01,BRD-A23072235-050-04-5,Histamine receptor antagonist
24300,i02,BRD-A23226398-001-02-7,estrogen receptor agonist
24300,i03,BRD-A23683907-334-01-0,serotonin receptor antagonist
24300,i04,BRD-A23723433-001-01-2,tubulin inhibitor|microtubule stabilizing agent|microtubule stimulant|P glycoprotein inhibitor|taxane
24300,i08,BRD-A24122750-001-01-1,GABA receptor antagonist
24300,i09,BRD-A24191444-045-03-1,Adrenergic receptor antagonist
24300,i10,BRD-A24228527-001-04-2,Bacterial DNA gyrase inhibitor
24300,i13,BRD-A24514565-236-01-6,Vitamin K antagonist
24300,i15,BRD-A24587114-066-03-5,adrenergic receptor agonist
24300,i16,BRD-A24817035-001-04-7,central nervous system agent
24300,i17,BRD-A25234499-001-04-3,glucocorticoid receptor antagonist
24300,i20,BRD-A25775766-001-03-3,GABA receptor antagonist|TP53 activator
24300,i23,BRD-A26032986-050-01-3,Calmodulin antagonist
24300,i24,BRD-A26222320-001-02-6,protein synthesis inhibitor
24300,j01,BRD-A26334849-001-02-1,Antiarrhythmic
24300,j02,BRD-A26384407-001-04-6,Carbonic anhydrase inhibitor
24300,j03,BRD-A26711594-001-02-7,calcium channel blocker
24300,j07,BRD-A26845397-001-01-4,Adrenergic receptor antagonist
24300,j09,BRD-A27143604-001-01-2,Estrogen receptor agonist
24300,j14,BRD-A28318179-003-03-6,Nitric oxide synthase inhibitor
24300,j15,BRD-A28856712-003-04-7,adrenergic receptor agonist
24300,j18,BRD-A29260609-003-04-7,adrenergic receptor antagonist
24300,j19,BRD-A29289453-001-02-1,platelet activating factor receptor antagonist
24300,j20,BRD-A29322418-237-02-4,mineralocorticoid receptor antagonist
24300,k01,BRD-A29426959-050-04-1,Histamine receptor antagonist
24300,k02,BRD-A29437505-001-01-6,TLR agonist
24300,k04,BRD-A29644307-050-04-8,Dopamine uptake inhibitor
24300,k05,BRD-A29734509-011-02-9,Sodium channel blocker
24300,k10,BRD-A30590053-003-01-1,Acetylcholine release enhancer
24300,k11,BRD-A30655177-001-04-1,BTK inhibitor
24300,k13,BRD-A30717181-001-02-7,glucocorticoid receptor agonist
24300,k14,BRD-A30815329-001-03-0,Calcium channel blocker
24300,k17,BRD-A31007383-001-01-0,Adenosine receptor agonist
24300,k18,BRD-A31159102-001-01-9,Selective serotonin reuptake inhibitor (SSRI)
24300,k19,BRD-A31195449-004-01-9,Serotonin receptor agonist
24300,k20,BRD-A31521121-001-04-1,Muscle relaxant
24300,k21,BRD-A31575449-300-01-4,Adrenergic receptor antagonist
24300,l02,BRD-A31800922-003-04-6,acetylcholine receptor antagonist
24300,l05,BRD-A32164164-048-01-4,Acetylcholine receptor antagonist
24300,l06,BRD-A32505112-001-02-8,angiotensin converting enzyme inhibitor
24300,l09,BRD-A32673558-003-02-1,acetylcholine receptor agonist
24300,l10,BRD-A32949107-001-01-7,calcium channel blocker
24300,l12,BRD-A33168282-003-06-5,Adrenergic receptor antagonist
24300,l13,BRD-A33447119-001-02-5,Anthelmintic
24300,l14,BRD-A33711280-311-02-0,Acetylcholine receptor antagonist
24300,l19,BRD-A34255068-001-04-8,phosphodiesterase inhibitor
24300,l20,BRD-A34309505-001-08-5,benzodiazepine receptor agonist
24300,l22,BRD-A34706053-003-01-9,Adrenergic receptor agonist
24300,m01,BRD-A34751532-001-03-6,HSP inducer
24300,m03,BRD-A34788695-003-04-5,bacterial 30S ribosomal subunit inhibitor
24300,m04,BRD-A34806832-001-02-7,ATPase inhibitor
24300,m07,BRD-A35033682-001-01-0,cytochrome P450 inhibitor
24300,m08,BRD-A35338386-001-04-6,adenosine receptor agonist
24300,m11,BRD-A35511923-019-01-6,Somatostatin receptor agonist
24300,m12,BRD-A35623999-001-03-2,mitochondrial Na+/Ca2+ exchanger antagonist|sodium/calcium exchange inhibitor
24300,m16,BRD-A35931254-003-02-7,dopamine receptor agonist
24300,m18,BRD-A36066264-001-02-3,Estrogen receptor agonist
24300,m19,BRD-A36074203-003-03-5,Glutamate receptor antagonist
24300,m20,BRD-A36217750-001-04-9,Uricosuric blocker
24300,m21,BRD-A36267905-003-02-8,Adrenergic receptor agonist
24300,m22,BRD-A36318220-001-01-3,RIPK inhibitor
24300,m23,BRD-A36471396-003-02-2,Acetylcholine receptor antagonist
24300,n01,BRD-A37347161-003-01-8,opioid receptor agonist
24300,n02,BRD-A37432947-004-02-5,acetylcholine receptor antagonist
24300,n03,BRD-A37441042-003-02-2,adrenergic receptor agonist
24300,n04,BRD-A37492983-001-03-8,radiopaque medium
24300,n06,BRD-A37704979-001-02-4,p38 MAPK inhibitor
24300,n07,BRD-A37776212-003-02-5,opioid receptor agonist
24300,n17,BRD-A38747044-001-01-5,Imidazoline receptor ligand
24300,n18,BRD-A38898897-003-01-0,Leukocyte elastase inhibitor
24300,n19,BRD-A38913120-001-01-0,BCL inhibitor
24300,n21,BRD-A39230911-001-03-7,Muscle relaxant
24300,n22,BRD-A39255369-001-01-5,Chloride channel blocker
24300,n23,BRD-A39268308-001-02-0,Acetylcholine receptor agonist
24300,o01,BRD-A39522003-001-01-0,FAAH inhibitor|FAAH reuptake inhibitor
24300,o03,BRD-A39747742-001-02-7,estrogen receptor agonist
24300,o05,BRD-A39969961-001-01-3,Cytochrome P450 inhibitor
24300,o06,BRD-A40022950-001-02-9,ATPase inhibitor
24300,o08,BRD-A40639672-234-04-0,Cyclooxygenase inhibitor
24300,o10,BRD-A41112154-001-02-1,G protein-coupled receptor agonist
24300,o13,BRD-A41145729-001-02-7,Retinoid receptor agonist
24300,o14,BRD-A41250306-001-03-4,Thiazide diuretic
24300,o15,BRD-A41301928-001-02-5,"Mitochondrial ADP, ATP translocase inhibitor"
24300,o16,BRD-A41304429-001-04-9,Adrenergic receptor antagonist
24300,o17,BRD-A41451487-001-01-3,Benzodiazepine receptor antagonist
24300,o18,BRD-A41519720-001-02-2,Niemann-Pick C1-like 1 protein antagonist
24300,o19,BRD-A41722204-003-01-5,adenosine receptor antagonist
24300,o20,BRD-A41833852-001-01-9,Opioid receptor antagonist
24300,o22,BRD-A41941932-001-03-0,Antioxidant
24300,o23,BRD-A42167015-003-03-7,Adrenergic receptor antagonist
24300,o24,BRD-A42335949-300-04-9,phosphatidylglycerophosphatase inhibitor
24300,p01,BRD-A42346008-003-03-6,epinephrine metabolite
24300,p02,BRD-A42553870-001-05-1,neuropeptide receptor antagonist
24300,p03,BRD-A42571354-300-01-3,histamine receptor antagonist
24300,p04,BRD-A42628519-001-04-1,radiopaque medium
24300,p05,BRD-A42759514-001-03-1,Antiprotozoal
24300,p06,BRD-A42831637-001-02-2,anti-inflammatory|Cannabinoid metabolite
24300,p07,BRD-A43076080-001-03-3,protein phosphatase inhibitor
24300,p09,BRD-A43150328-001-02-0,other antibiotic
24300,p13,BRD-A43671941-003-03-6,Adrenergic receptor antagonist
24300,p14,BRD-A43849199-001-02-3,Phytotoxin
24300,p15,BRD-A43930669-003-01-0,oxytocin receptor antagonist
24300,p16,BRD-A43940795-001-02-8,serotonin release inhibitor
24300,p17,BRD-A43974499-066-01-1,Adrenergic receptor antagonist
24300,p19,BRD-A44008656-036-04-3,Histamine receptor antagonist
24300,p20,BRD-A44090213-001-04-1,Cyclooxygenase inhibitor
24300,p21,BRD-A44133049-001-01-5,Serotonin receptor antagonist
24300,p22,BRD-A44448661-001-02-2,Barbiturate antiepileptic
24300,p23,BRD-A44551378-001-01-9,EGFR inhibitor
24300,p24,BRD-A44863528-001-04-1,CCK receptor antagonist
25967,a01,BRD-K18250272-003-03-7,local anesthetic
25967,a02,BRD-K18316707-001-01-9,cannabinoid receptor antagonist
25967,a04,BRD-K18550767-001-02-8,interleukin inhibitor
25967,a05,BRD-K18574842-323-03-3,bacterial cell wall synthesis inhibitor
25967,a06,BRD-K18619710-001-03-7,steroid
25967,a07,BRD-K18742343-001-03-2,PKA inhibitor
25967,a08,BRD-K18757346-001-02-9,thromboxane receptor agonist
25967,a09,BRD-K18779551-003-03-7,acetylcholine release stimulant|adrenergic transmitter uptake inhibitor|reducing agent
25967,a10,BRD-K18787491-001-05-2,MEK inhibitor
25967,a11,BRD-K18799075-001-01-0,cannabinoid receptor partial agonist
25967,a12,BRD-K18816859-001-01-4,Serotonin receptor agonist
25967,a15,BRD-K18909381-001-01-4,serotonin receptor agonist
25967,a16,BRD-K18910433-001-04-4,estrogen receptor agonist
25967,a19,BRD-K19111024-001-04-3,PPAR receptor agonist
25967,a20,BRD-K19295594-001-04-4,BCL inhibitor|MCL1 inhibitor
25967,a21,BRD-K19309090-300-03-0,acetylcholine receptor agonist
25967,a22,BRD-K19352500-332-03-7,dopamine receptor antagonist
25967,a23,BRD-K19360254-001-01-3,Dopamine receptor agonist
25967,b01,BRD-K19462402-003-03-0,adrenergic receptor antagonist|calcium channel blocker
25967,b03,BRD-K19533706-001-01-9,Angiogenesis inhibitor
25967,b04,BRD-K19554809-001-01-1,serotonin receptor agonist
25967,b05,BRD-K19605405-001-01-9,adenosine receptor antagonist
25967,b07,BRD-K20141153-003-03-8,norepinephrine transporter inhibitor|adrenergic transmitter uptake inhibitor
25967,b08,BRD-K20152659-001-02-0,Cholesterol inhibitor
25967,b10,BRD-K20620780-001-01-0,dopamine receptor antagonist
25967,b11,BRD-K20655524-003-04-7,psychoactive drug
25967,b15,BRD-K20714604-001-01-5,Serotonin receptor partial agonist
25967,b16,BRD-K20742498-001-01-5,serotonin receptor antagonist
25967,b17,BRD-K20755323-001-01-8,sphingosine kinase inhibitor
25967,b18,BRD-K20995441-001-01-7,Opioid receptor agonist
25967,b19,BRD-K21283037-001-02-5,glutamate inhibitor
25967,b20,BRD-K21350491-001-02-1,acid sensing ion channel blocker|sodium channel blockers|TRPP3 channel inhibitor|TRPV modulator
25967,b21,BRD-K21450440-001-04-7,carbonic anhydrase inhibitor
25967,b22,BRD-K21520694-001-02-4,PABA antagonist
25967,b23,BRD-K21548250-001-01-3,sodium channel blocker
25967,b24,BRD-K21565985-001-04-3,adrenergic receptor agonist
25967,c01,BRD-K21667562-001-01-4,FAAH transport inhibitor|anandamide transport inhibitor|nucelar factor of activated T-cells inhibitor|TRPV agonist
25967,c02,BRD-K21680192-300-05-2,topoisomerase inhibitor
25967,c03,BRD-K21733600-001-02-6,cyclooxygenase inhibitor
25967,c04,BRD-K21853356-001-04-4,EGFR inhibitor
25967,c07,BRD-K22031190-001-04-6,Prostanoid receptor antagonist
25967,c08,BRD-K22134346-001-04-1,HMGCR inhibitor
25967,c09,BRD-K22193694-001-04-5,Topical sunscreen agent
25967,c10,BRD-K22385716-001-01-7,casein kinase inhibitor|mTOR inhibitor|PI3K inhibitor
25967,c17,BRD-K22861715-001-03-4,breast cancer resistance protein inhibitor
25967,c19,BRD-K22969690-001-02-6,bacterial 50S ribosomal subunit inhibitor
25967,c21,BRD-K23301018-001-02-6,antiprotozoal agent
25967,c23,BRD-K23335153-300-01-7,glutamate receptor positive allosteric modulator
25967,c24,BRD-K23383398-001-01-6,LXR agonist|ABC transporter expression enhancer|ROR inverse agonist
25967,d02,BRD-K23478508-001-03-7,ATPase inhibitor
25967,d03,BRD-K23541596-300-04-9,histamine receptor agonist
25967,d04,BRD-K23566484-001-04-5,androgen receptor antagonist
25967,d05,BRD-K23583188-001-05-6,EGFR inhibitor|tyrosine kinase inhibitor
25967,d06,BRD-K23704908-001-03-2,serine protease inhibitor
25967,d07,BRD-K23913458-001-02-5,Vitamin K antagonist
25967,d08,BRD-K23922020-075-01-1,acetylcholine receptor agonist
25967,d10,BRD-K24084088-001-02-2,adenosine receptor antagonist
25967,d13,BRD-K24132293-001-02-0,glutathione transferase inhibitor
25967,d14,BRD-K24201553-003-02-4,Serotonin receptor antagonist
25967,d17,BRD-K24240364-003-02-1,Glutamate receptor antagonist
25967,d18,BRD-K24396733-001-01-1,dopamine receptor agonist
25967,d20,BRD-K24526313-001-08-6,Potassium channel activator
25967,e05,BRD-K25224017-001-04-5,serotonin receptor antagonist
25967,e07,BRD-K25394294-001-04-0,Cyclooxygenase inhibitor
25967,e11,BRD-K25433859-003-11-4,norepinephrine reputake inhibitor|tricyclic antidepressant
25967,e13,BRD-K25741894-001-03-8,acetylcholinesterase inhibitor
25967,e15,BRD-K25875056-001-01-2,Protein tyrosine kinase activator
25967,e16,BRD-K25906698-303-01-9,histamine receptor agonist
25967,e21,BRD-K26160755-003-01-8,Imidazoline receptor agonist
25967,e22,BRD-K26373640-001-02-8,IKK inhibitor
25967,f03,BRD-K26429091-051-01-9,acetylcholine receptor antagonist
25967,f04,BRD-K26521938-001-04-9,prostanoid receptor agonist
25967,f05,BRD-K26548821-001-01-8,Dopamine receptor agonist
25967,f06,BRD-K26573499-300-01-3,Adrenergic receptor agonist
25967,f12,BRD-K26979635-001-01-1,Glutamate receptor antagonist
25967,f13,BRD-K26997899-001-01-4,microtubule inhibitor|tubulin inhibitor
25967,f15,BRD-K27141178-001-01-0,Serotonin receptor antagonist
25967,f20,BRD-K27305650-001-04-2,mTOR inhibitor|PI3K inhibitor|DNA dependent protein kinase inhibitor|phosphodiesterase inhibitor|PLK inhibitor
25967,f21,BRD-K27316855-001-02-6,vitamin D receptor agonist
25967,f23,BRD-K27351809-001-02-0,progesterone receptor agonist
25967,g01,BRD-K27450477-001-03-9,Adenosine deaminase inhibitor
25967,g02,BRD-K27499107-001-02-6,IP receptor activator
25967,g06,BRD-K27710560-001-02-6,SIRT inhibitor
25967,g07,BRD-K27737647-001-03-4,PKA inhibitor
25967,g09,BRD-K27871032-001-02-6,Ergoline alkaloid
25967,g11,BRD-K28115081-001-01-9,Platelet activating factor receptor antagonist
25967,g12,BRD-K28137194-003-01-3,GABA receptor agonist
25967,g13,BRD-K28143534-001-01-4,histamine receptor antagonist
25967,g15,BRD-K28183345-003-05-6,Dihydrofolate reductase inhibitor
25967,g17,BRD-K28307902-001-04-3,androgen receptor antagonist
25967,g18,BRD-K28453807-003-05-4,Cholinergic receptor antagonist
25967,g23,BRD-K28578425-001-01-3,phosphodiesterase inhibitor
25967,g24,BRD-K28667196-001-02-9,Increases arterial blood pressure
25967,h01,BRD-K28680267-001-01-8,CCK receptor antagonist
25967,h02,BRD-K28761384-003-03-6,dopamine receptor antagonist
25967,h05,BRD-K28761891-001-01-0,melatonin receptor agonist
25967,h06,BRD-K28806945-001-01-9,dopamine receptor antagonist
25967,h07,BRD-K28863208-001-01-2,Cholinergic receptor agonist
25967,h08,BRD-K28907958-001-01-9,retinoid receptor agonist
25967,h09,BRD-K28936863-051-04-1,histamine receptor agonist|leukotriene receptor antagonist|phosphodiesterase inhibitor
25967,h10,BRD-K29113274-001-03-6,Sterol demethylase inhibitor
25967,h12,BRD-K29178788-001-02-0,Furoquinoline alkaloid
25967,h13,BRD-K29359156-001-04-6,H+/K+-ATPase inhibitor
25967,h16,BRD-K29555132-001-02-2,Cannabinoid receptor agonist
25967,h17,BRD-K29582677-001-02-7,Calcium channel blocker
25967,h18,BRD-K29668683-300-01-4,sigma receptor antagonist
25967,h21,BRD-K29673530-001-03-9,tyrosine kinase inhibitor
25967,h22,BRD-K29950728-048-02-6,estrogen receptor antagonist
25967,h23,BRD-K30197592-001-01-5,Serotonin receptor agonist
25967,i01,BRD-K30240666-051-05-0,histamine receptor antagonist
25967,i02,BRD-K30421593-050-02-3,adrenergic receptor antagonist
25967,i03,BRD-K30480208-001-04-5,Electrolyte reabsorption inhibitor
25967,i08,BRD-K30685142-001-04-8,thyroid hormone stimulant
25967,i09,BRD-K30867024-001-01-1,serotonin receptor antagonist
25967,i11,BRD-K30990140-003-01-6,Cyclooxygenase inhibitor
25967,i12,BRD-K31054881-300-01-3,Adrenergic receptor antagonist
25967,i13,BRD-K31238592-001-01-6,CCK receptor antagonist|gastrin inhibitor
25967,i16,BRD-K31342827-001-05-4,PKC inhibitor
25967,i18,BRD-K31491153-001-01-2,serotonin receptor agonist
25967,i19,BRD-K31542390-001-01-5,dehydrogenase inhibitor|inositol monophosphatase inhibitor
25967,i20,BRD-K31611373-001-02-7,Prostanoid receptor agonist
25967,i23,BRD-K31627533-001-03-8,glucocorticoid receptor agonist
25967,i24,BRD-K31633810-003-01-0,Acetylcholine receptor antagonist
25967,j03,BRD-K31699485-001-01-9,glutamate receptor modulator
25967,j04,BRD-K31792052-004-01-9,interleukin receptor antagonist
25967,j09,BRD-K31843556-001-01-7,PPAR receptor anatagonist|PPAR receptor antagonist
25967,j10,BRD-K31912990-003-01-0,neuropeptide receptor antagonist
25967,j12,BRD-K31987754-001-01-2,Cannabinoid receptor agonist
25967,j15,BRD-K32164935-001-06-8,ATP channel blocker
25967,j16,BRD-K32247306-001-04-7,GABA receptor antagonist
25967,j19,BRD-K32292990-001-01-0,EGFR inhibitor
25967,j20,BRD-K32412559-001-01-7,Adrenergic receptor antagonist
25967,j23,BRD-K32501161-001-01-7,dopamine uptake inhibitor
25967,j24,BRD-K32526544-001-01-2,Potassium channel activator
25967,k02,BRD-K32584078-001-02-3,AKT inhibitor|HCV NS5B RdRp inhibitor
25967,k04,BRD-K32645441-001-01-4,serotonin receptor agonist
25967,k05,BRD-K32696739-001-02-6,Monoamine oxidase inhibitor
25967,k06,BRD-K32744045-001-04-9,aldehyde dehydrogenase inhibitor|DNA methyltransferase inhibitor|TRPV agonist
25967,k09,BRD-K32755366-003-03-4,Norepinephrine transporter inhibitor
25967,k10,BRD-K32821942-001-04-9,dehydrogenase inhibitor
25967,k11,BRD-K32828673-001-01-5,tubulin polymerization inhibitor
25967,k12,BRD-K32830106-003-11-3,adrenergic receptor agonist
25967,k14,BRD-K33204703-001-04-6,PDGFR receptor inhibitor
25967,k17,BRD-K33211335-337-03-7,glutamate receptor antagonist|sigma receptor agonist
25967,k19,BRD-K33308633-001-01-6,calcineurin inhibitor
25967,k20,BRD-K33396764-001-02-0,Omega 3 fatty acid stimulant
25967,k22,BRD-K33453211-003-03-2,Histamine receptor antagonist
25967,l01,BRD-K33459542-001-02-5,sigma receptor agonist
25967,l02,BRD-K33583600-001-03-9,guanylate cyclase activator
25967,l03,BRD-K33710385-001-05-4,mycolic synthesis inhibitor
25967,l04,BRD-K33818169-003-01-2,LXR agonist|ABC transporter expression enhancer
25967,l05,BRD-K33864865-001-01-7,CCK receptor antagonist
25967,l06,BRD-K33882852-003-01-0,benzodiazepine receptor agonist
25967,l10,BRD-K34014345-001-02-6,Anti-inflammatory
25967,l11,BRD-K34034388-300-01-0,dopamine uptake inhibitor
25967,l12,BRD-K34092021-001-02-3,TRPV agonist|cannabinoid receptor agonist
25967,l13,BRD-K34154330-003-04-9,GABA receptor modulator
25967,l17,BRD-K34170797-001-01-1,FXR agonist
25967,l20,BRD-K34415467-003-04-9,histamine receptor antagonist
25967,l21,BRD-K34568562-001-02-7,interferon inducer
25967,l22,BRD-K34608650-001-01-6,Cannabinoid receptor agonist
25967,m02,BRD-K34685430-001-01-1,dopamine receptor antagonist|serotonin receptor antagonist
25967,m03,BRD-K34995470-001-02-3,receptor tyrosine protein kinase inhibitor|vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor|VEGFR inhibitor
25967,m06,BRD-K35240538-001-03-1,glucocorticoid receptor agonist
25967,m07,BRD-K35430135-003-01-5,Adrenergic receptor antagonist
25967,m08,BRD-K35458079-001-04-2,Nootropic agent
25967,m11,BRD-K35498378-001-03-8,Aldose reductase inhibitor
25967,m15,BRD-K35629949-001-01-2,CCK receptor antagonist
25967,m16,BRD-K35708212-331-03-1,ATPase inhibitor
25967,m17,BRD-K35941380-001-01-7,Serotonin receptor antagonist
25967,m18,BRD-K35960502-001-04-4,DNA replication inhibitor|STAT inhibitor
25967,m20,BRD-K36007650-300-02-3,protein synthesis inhibitor
25967,m21,BRD-K36009368-001-01-8,Opioid receptor agonist
25967,m22,BRD-K36021395-300-01-6,adenosine kinase inhibitor
25967,m23,BRD-K36055864-001-04-4,protein synthesis inhibitor
25967,m24,BRD-K36116267-001-05-4,psychoactive drug
25967,n01,BRD-K36198571-001-01-2,metalloproteinase inhibitor
25967,n02,BRD-K36258877-001-01-5,caspase inhibitor
25967,n05,BRD-K36638830-001-02-2,acetylcholine receptor agonist
25967,n06,BRD-K36756879-003-04-6,calcium channel blocker
25967,n11,BRD-K36862742-001-04-1,sodium/potassium/chloride transporter inhibitor
25967,n12,BRD-K36864847-303-01-7,Adrenergic receptor antagonist
25967,n15,BRD-K36927236-001-06-0,Sulfonylurea
25967,n16,BRD-K36965586-001-01-7,serotonin receptor agonist
25967,n18,BRD-K37249724-001-04-2,histamine receptor antagonist
25967,n19,BRD-K37270826-001-03-7,glucocorticoid receptor antagonist|progesterone receptor antagonist
25967,n21,BRD-K37289225-001-07-5,Dopamine receptor antagonist
25967,n22,BRD-K37392901-003-01-7,ubiquitin hydrolase inhibitor|ubiquitin isopeptidase inhibitor
25967,n23,BRD-K37447567-001-01-8,Opioid receptor antagonist
25967,n24,BRD-K37561857-001-04-9,phosphodiesterase inhibitor
25967,o02,BRD-K37618799-001-01-4,adenosine receptor antagonist
25967,o03,BRD-K37682401-001-05-1,bacterial DNA gyrase inhibitor
25967,o04,BRD-K37688416-003-04-0,psychoactive drug
25967,o05,BRD-K37691127-001-02-2,tyrosinase inhibitor
25967,o07,BRD-K37792168-001-01-0,Phosphodiesterase inhibitor
25967,o08,BRD-K37798499-001-02-5,topoisomerase inhibitor
25967,o09,BRD-K37848908-001-03-1,penicillin binding protein inhibitor
25967,o10,BRD-K37865504-001-01-7,FAAH inhibitor|FAAH reuptake inhibitor
25967,o14,BRD-K37991163-050-05-1,selective serotonin reuptake inhibitor (SSRI)
25967,o15,BRD-K38003476-001-03-4,steroid
25967,o16,BRD-K38055836-001-03-9,respiratory stimulant
25967,o17,BRD-K38197229-001-06-7,solute carrier family member inhibitor
25967,o18,BRD-K38251852-001-02-5,ABC transporter expression enhancer|high conductance calcium activated potassium blocker|LXR agonist|potassium channel blocker
25967,o19,BRD-K38305202-001-01-8,dopamine receptor antagonist
25967,o20,BRD-K38323065-001-05-8,cyclooxygenase inhibitor
25967,o21,BRD-K38347298-001-02-3,adenosine receptor antagonist
25967,o22,BRD-K38436528-003-04-8,norepinephrine reputake inhibitor|serotonin reuptake inhibitor
25967,o23,BRD-K38449220-001-03-8,cytochrome P450 inhibitor
25967,o24,BRD-K38477985-001-01-8,protein tyrosine kinase inhibitor|tyrosine kinase inhibitor
25967,p01,BRD-K38684403-001-02-1,bacterial 50S ribosomal subunit inhibitor
25967,p03,BRD-K38775274-001-02-3,glucocorticoid receptor agonist
25967,p04,BRD-K38903228-001-02-8,flavanone glycoside
25967,p05,BRD-K39120595-304-02-1,autotaxin inhibitor
25967,p07,BRD-K39187410-001-01-7,antiamyloidogenic agent
25967,p08,BRD-K39188321-001-03-9,glucocorticoid receptor agonist
25967,p09,BRD-K39339537-001-03-8,cyclooxygenase inhibitor
25967,p10,BRD-K39356024-001-02-4,acetylcholine release enhancer|dopamine release enhancer|GABA receptor negative allosteric modulator|glutamate receptor modulator|progesterone receptor agonist|steroid hormone inhibitor of CYP17A1 and SULT2B1
25967,p13,BRD-K39484304-001-02-5,RNA polymerase inhibitor
25967,p14,BRD-K39670393-303-01-3,histamine receptor agonist
25967,p15,BRD-K39733634-001-01-8,prostanoid receptor antagonist|angiotensin receptor antagonist
25967,p16,BRD-K39746403-084-02-3,NFkB pathway inhibitor|50S ribosomal subunit inhibitor|motilin receptor agonist|RPLV inhibitor
25967,p17,BRD-K39915878-036-04-6,dopamine receptor antagonist|serotonin receptor antagonist
25967,p18,BRD-K39965020-001-02-6,PPAR receptor agonist
25967,p19,BRD-K39987650-001-04-3,laxative
25967,p20,BRD-K40255344-001-05-1,protein tyrosine kinase inhibitor|tyrosine kinase inhibitor
25967,p21,BRD-K40530731-001-02-5,acetylcholine receptor inhibitor
25967,p22,BRD-K40578143-001-01-8,adenosine receptor agonist
25967,p23,BRD-K40656405-001-01-5,PPAR receptor agonist
25967,p24,BRD-K40742111-001-02-6,lipoxygenase inhibitor
25989,a01,BRD-K90382497-001-01-6,PLK inhibitor
25989,a02,BRD-K92723993-066-02-9,PDGFR tyrosine kinase receptor inhibitor|Bcr-Abl kinase inhibitor|KIT inhibitor|Abl kinase inhibitor|apoptosis stimulant|breast cancer resistance protein inhibitor|colony stimulating factor receptor inhibitor
25989,a03,BRD-K07762753-001-03-6,CDK inhibitor|tyrosine kinase inhibitor
25989,a04,BRD-K09991945-001-02-0,glycogen synthase kinase inhibitor|PKC inhibitor|superoxide dismutase expression inhibitor
25989,a05,BRD-K37312348-001-05-1,CDK inhibitor|glycogen synthase kinase inhibitor
25989,a06,BRD-K46678324-001-03-7,rho associated kinase inhibitor
25989,a07,BRD-K67860401-001-02-3,glycogen synthase kinase inhibitor
25989,a08,BRD-K52620403-001-01-8,calcium/calmodulin dependent protein kinase inhibitor|calmodulin inhibitor
25989,a09,BRD-K68336408-001-03-4,EGFR inhibitor
25989,a10,BRD-K72703948-001-01-0,Aurora kinase inhibitor
25989,a11,BRD-K93201660-001-05-7,myosin light chain kinase inhibitor
25989,a15,BRD-A47633927-001-01-8,ICAM1 antagonist
25989,a16,BRD-A68039575-001-02-5,Aromatase inhibitor
25989,a17,BRD-A75455249-001-02-0,calcium channel modulator|mTOR inhibitor|sodium channel blocker
25989,a18,BRD-K01555864-001-02-8,antineoplastic
25989,a19,BRD-K09497549-001-03-6,calcium channel modulator|mTOR inhibitor|sodium channel blocker
25989,a20,BRD-K14536225-001-02-7,Glucosidase inhibitor
25989,a21,BRD-K15086322-103-01-0,histamine receptor antagonist|histamine receptor silent antagonist
25989,a23,BRD-K23623876-001-01-6,ultrasound contrast agent
25989,a24,BRD-K36377456-001-02-0,angiogenesis inhibitor
25989,b01,BRD-K36395411-003-01-4,serotonin receptor antagonist|serotonin receptor partial agonist
25989,b03,BRD-K41160163-001-01-9,Glutamate receptor antagonist
25989,b04,BRD-K42095107-001-02-3,estrogen receptor agonist
25989,b05,BRD-K43797669-001-02-3,tyrosine kinase inhibitor
25989,b06,BRD-K45988865-001-01-0,organosilicon compound used as an internal standard in NMR spectroscopy
25989,b07,BRD-K49061529-001-01-0,GABA benzodiazepine site receptor inverse agonist
25989,b09,BRD-K59331372-001-01-2,TRPV antagonist
25989,b11,BRD-K60690191-003-02-1,glutamate receptor antagonist
25989,b12,BRD-K61177364-003-01-1,CRF receptor antagonist
25989,b17,BRD-K61250553-001-02-9,opioid receptor agonist
25989,b18,BRD-K61269089-001-01-4,Protein kinase inhibitor
25989,b19,BRD-K61271364-001-02-4,GABA receptor antagonist
25989,b20,BRD-K61323504-001-02-4,CC chemokine receptor antagonist
25989,b22,BRD-K61496577-001-03-8,glucocorticoid receptor agonist
25989,b23,BRD-K61590534-001-01-4,EGFR inhibitor
25989,c01,BRD-K61737877-001-01-6,VEGFR inhibitor
25989,c03,BRD-K61951118-001-01-2,GABA benzodiazepine site receptor inverse agonist
25989,c04,BRD-K62008436-001-03-1,tubulin polymerization inhibitor
25989,c05,BRD-K62056274-001-01-9,Serotonin receptor agonist
25989,c07,BRD-K62206109-303-01-1,histamine receptor antagonist
25989,c08,BRD-K62221994-001-01-8,gonadotropin releasing factor hormone receptor antagonist
25989,c10,BRD-K62289640-003-01-9,Cannabinoid receptor agonist
25989,c13,BRD-K62310379-001-03-0,glucocorticoid receptor agonist
25989,c17,BRD-K62353524-001-01-8,estrogen receptor agonist
25989,c18,BRD-K62363391-001-04-1,bacterial antifolate
25989,c23,BRD-K62607865-001-03-0,bacterial cell wall synthesis inhibitor
25989,c24,BRD-K62609077-001-02-2,adrenergic receptor antagonist|GABA receptor antagonist|serotonin receptor antagonist
25989,d01,BRD-K62810658-001-05-6,MEK inhibitor
25989,d02,BRD-K62929068-001-01-7,Purinergic receptor activator
25989,d04,BRD-K62996583-001-03-8,calcium channel blocker
25989,d05,BRD-K63089472-001-02-7,Inhibitor of methyl esterification of farnesylated proteins
25989,d06,BRD-K63150726-001-01-3,cannabinoid receptor inverse agonist
25989,d07,BRD-K63151507-001-01-6,Lymphocyte inhibitor
25989,d08,BRD-K63165456-001-03-3,Adrenergic receptor agonist
25989,d09,BRD-K63430059-001-03-2,DNA synthesis inhibitor
25989,d10,BRD-K63504947-001-05-5,VEGFR inhibitor
25989,d13,BRD-K63516691-001-01-6,Phosphodiesterase inhibitor
25989,d14,BRD-K63533170-001-01-1,cannabinoid receptor antagonist|cannabinoid receptor inverse agonist
25989,d17,BRD-K63606607-001-01-8,ATPase inhibitor|chloride channel activator
25989,d18,BRD-K63630713-001-04-3,sodium/potassium/chloride transporter inhibitor
25989,d19,BRD-K63750851-001-03-3,dehydrogenase inhibitor|inositol monophosphatase inhibitor
25989,d21,BRD-K63784565-001-02-1,Topoisomerase inhibitor
25989,d22,BRD-K63792901-075-01-3,acetylcholine receptor agonist
25989,d23,BRD-K63828191-003-07-3,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)
25989,e03,BRD-K63874012-103-01-5,histamine receptor antagonist|histamine receptor inverse agonist
25989,e04,BRD-K63913457-001-02-7,vasodilator
25989,e06,BRD-K63945320-001-02-4,Phospholipase inhibitor
25989,e07,BRD-K63979671-001-03-6,Compound used in hepatobiliary scans of the liver
25989,e08,BRD-K64044582-001-02-8,ACAT inhibitor
25989,e11,BRD-K64157027-003-01-9,Adrenergic receptor agonist
25989,e14,BRD-K64245000-001-01-7,FXR agonist
25989,e16,BRD-K64341947-003-01-6,guanylate cyclase activator
25989,e20,BRD-K64402243-001-01-1,Caspase inhibitor
25989,e22,BRD-K64670467-001-01-2,glutamate receptor antagonist
25989,f03,BRD-K64755930-003-01-6,phosphodiesterase inhibitor
25989,f04,BRD-K64862097-001-03-9,glucocorticoid receptor agonist
25989,f06,BRD-K64994968-001-03-6,Progesterone receptor agonist
25989,f07,BRD-K65146499-001-04-8,Cyclooxygenase inhibitor
25989,f11,BRD-K65285700-001-01-5,cannabinoid receptor agonist
25989,f12,BRD-K65417056-003-03-6,Local anesthetic
25989,f13,BRD-K65503129-001-01-4,HSP inhibitor|HSP antagonist
25989,f15,BRD-K65639003-001-02-5,phosphodiesterase inhibitor
25989,f16,BRD-K65667145-001-04-1,cell division inducer
25989,f19,BRD-K65786282-001-02-6,GABA receptor modulator
25989,f20,BRD-K65814004-001-02-3,nitric oxide synthase inhibitor|aldehyde dehydrogenase inhibitor|cytochrome P450 inhibitor|NADPH oxidase inhibitor|xanthine oxidase inhibitor
25989,f23,BRD-K66093087-001-01-5,Benzodiazepine receptor agonist
25989,f24,BRD-K66206289-003-03-1,Acetylcholine receptor antagonist
25989,g02,BRD-K66353228-001-05-4,myorelaxant
25989,g05,BRD-K66404838-003-03-8,opioid receptor agonist|opioid receptor antagonist
25989,g08,BRD-K66707493-001-02-6,Coloring agent
25989,g09,BRD-K66715657-001-01-3,dopamine receptor antagonist
25989,g10,BRD-K66782112-001-01-2,Histamine receptor antagonist
25989,g11,BRD-K66874953-001-02-7,TP53 inhibitor
25989,g12,BRD-K66898851-001-03-7,apoptosis stimulant
25989,g13,BRD-K66944906-001-02-6,Carbonic anhydrase inhibitor
25989,g14,BRD-K67013324-001-01-5,melatonin receptor antagonist
25989,g16,BRD-K67017579-001-13-3,Phosphodiesterase inhibitor
25989,g17,BRD-K67043667-001-04-1,DNA synthesis inhibitor
25989,g18,BRD-K67080878-001-05-5,phosphodiesterase inhibitor
25989,g21,BRD-K67102207-236-01-0,HDAC inhibitor
25989,g23,BRD-K67261995-001-03-4,Contrast agent
25989,g24,BRD-K67277431-002-03-0,thromboxane receptor antagonist|thromboxane synthase inhibitor
25989,h01,BRD-K67298865-001-02-5,TGF beta receptor inhibitor
25989,h02,BRD-K67352070-364-01-5,Acetylcholine receptor agonist
25989,h05,BRD-K67439147-001-01-7,glutamate receptor antagonist
25989,h06,BRD-K67445247-001-01-3,Urease inhibitor
25989,h08,BRD-K67537649-001-01-1,insulin growth factor receptor inhibitor
25989,h12,BRD-K67680372-003-01-8,GAT inhibitor
25989,h13,BRD-K67783091-001-05-5,Dopamine receptor antagonist
25989,h14,BRD-K67831364-003-01-7,vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor|VEGFR inhibitor
25989,h17,BRD-K68095457-001-04-4,Cannabinoid receptor agonist
25989,h18,BRD-K68103045-001-01-1,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist
25989,h21,BRD-K68143200-001-04-2,CDC inhibitor
25989,h24,BRD-K68190965-001-01-4,Serotonin receptor agonist
25989,i01,BRD-K68246049-001-01-4,Retinoid receptor agonist
25989,i02,BRD-K68264559-001-07-6,Adrenergic receptor agonist
25989,i03,BRD-K68332390-001-03-3,aldose reductase inhibitor|reductase inhibitor
25989,i04,BRD-K68341547-003-01-6,calmodulin antagonist
25989,i07,BRD-K68392338-003-01-2,Benzodiazepine receptor antagonist
25989,i08,BRD-K68402494-001-04-7,myosin light chain kinase inhibitor
25989,i10,BRD-K68507560-003-04-8,acetylcholine receptor antagonist
25989,i12,BRD-K68552125-001-03-8,PKC activator|CD antagonist
25989,i13,BRD-K68553471-003-04-0,antihypertensive agent
25989,i14,BRD-K68558722-001-02-4,Cyclooxygenase inhibitor
25989,i15,BRD-K68620903-001-03-1,progesterone receptor agonist
25989,i17,BRD-K68873215-001-01-3,phosphodiesterase inhibitor
25989,i18,BRD-K69023402-001-02-5,ATPase inhibitor|calcium channel blocker|PKC activator
25989,i19,BRD-K69032158-001-02-2,Dipeptidyl peptidase inhibitor
25989,i20,BRD-K69195780-001-01-5,Serotonin receptor agonist
25989,i23,BRD-K69556541-001-02-6,Calcium channel blocker
25989,j01,BRD-K69763916-001-01-7,Glutamate receptor antagonist
25989,j02,BRD-K69837166-003-01-2,Nociceptin/orphanin FQ (NOP) receptor antagonist
25989,j03,BRD-K70241288-001-01-1,Growth hormone releasing peptide ligand agonist
25989,j04,BRD-K70246307-001-02-5,vitamin B2
25989,j07,BRD-K70281171-001-01-7,Dopamine receptor antagonist
25989,j08,BRD-K70330367-001-02-4,Glutamate receptor antagonist
25989,j10,BRD-K70487031-001-01-0,dopamine receptor antagonist
25989,j12,BRD-K70778732-003-04-4,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor
25989,j13,BRD-K70792160-003-01-2,AKT inhibitor
25989,j15,BRD-K70881766-001-02-3,Acetylcholinesterase inhibitor
25989,j16,BRD-K70914287-300-01-0,EGFR inhibitor|tyrosine kinase inhibitor
25989,j17,BRD-K70976396-236-04-7,Bacterial cell wall synthesis inhibitor
25989,j18,BRD-K71003802-001-02-9,Plant alkaloid
25989,j19,BRD-K13356952-001-11-1,carbonic anhydrase inhibitor
25989,k03,BRD-K71266197-236-01-9,NTPDase inhibitor
25989,k04,BRD-K71430621-303-01-5,histamine receptor antagonist|histamine receptor inverse agonist
25989,k06,BRD-K71499074-001-03-8,Carbonic anhydrase inhibitor
25989,k09,BRD-K71534238-001-03-5,Free fatty acid receptor agonist
25989,k11,BRD-K71726959-001-05-9,CDK inhibitor
25989,k12,BRD-K71731651-001-01-9,Acetylcholine receptor agonist
25989,k13,BRD-K71799778-001-02-2,CDK inhibitor
25989,k14,BRD-K71799949-001-04-2,Carboxamide antiepileptic
25989,k17,BRD-K71860425-001-01-1,CDK inhibitor
25989,k18,BRD-K72024482-001-01-3,adenosine receptor antagonist
25989,k19,BRD-K72034655-001-02-1,apoptosis inducer|antileukemic
25989,k22,BRD-K72222507-003-02-8,ACE inhibitor
25989,l04,BRD-K72676686-103-01-8,selective serotonin reuptake inhibitor (SSRI)|serotonin reuptake inhibitor|serotonin uptake inhibitor
25989,l05,BRD-K72726508-001-01-3,CDK inhibitor
25989,l06,BRD-K72783841-001-01-0,CDK inhibitor|epidermal growth factor receptor (EGFR) inhibitor|tyrosine kinase inhibitor|EGFR inhibitor
25989,l09,BRD-K72895815-001-01-4,leukocyte elastase inhibitor
25989,l10,BRD-K72903603-001-03-8,Reverse transcriptase inhibitor
25989,l13,BRD-K73109821-001-05-2,Potassium channel activator
25989,l18,BRD-K73196317-003-06-4,adrenergic receptor antagonist
25989,l21,BRD-K73290745-003-01-8,opioid receptor agonist
25989,l22,BRD-K73323637-003-03-4,adrenergic receptor antagonist
25989,m02,BRD-K73391359-003-03-7,Local anesthetic
25989,m05,BRD-K73397362-001-01-7,smoothened receptor agonist
25989,m06,BRD-K73589401-001-03-8,mineralocorticoid receptor agonist
25989,m12,BRD-K73789395-001-04-0,RAF inhibitor
25989,m15,BRD-K73991644-001-01-7,aldose reductase inhibitor|falcipain inhibitor
25989,m17,BRD-K74112339-001-02-7,Urease inhibitor
25989,m18,BRD-K74141488-003-03-9,Fungal squalene epoxidase inhibitor
25989,m20,BRD-K74195153-050-03-0,Phosphodiesterase inhibitor
25989,m21,BRD-K74212935-001-03-1,Dopamine agonist
25989,m23,BRD-K74305673-001-01-3,IKK inhibitor|NFkB pathway inhibitor|protein kinase inhibitor
25989,m24,BRD-K74430258-001-01-2,hepatotoxicant
25989,n02,BRD-K74765201-001-01-9,Leukotriene receptor antagonist
25989,n03,BRD-K74913225-001-03-3,Carbonic anhydrase inhibitor
25989,n05,BRD-K75089421-001-02-5,sodium channel blocker
25989,n06,BRD-K75181824-001-02-3,inhibitor of methyl esterification of geranylgeranylated proteins
25989,n11,BRD-K75478907-001-01-5,GABA receptor modulator|GABA receptor positive allosteric modulator
25989,n16,BRD-K75615183-001-01-7,Adrenergic receptor agonist
25989,n17,BRD-K75641298-001-01-5,Dopamine receptor antagonist
25989,n21,BRD-K75958195-001-01-7,serotonin receptor antagonist
25989,n24,BRD-K76064317-001-04-0,FLT3 inhibitor
25989,o01,BRD-K76133116-001-01-2,Membrane integrity inhibitor
25989,o03,BRD-K76274772-001-02-7,Ceramidase inhibitor
25989,o05,BRD-K76304753-003-04-7,local anesthetic
25989,o07,BRD-K76568384-001-01-4,estrogen receptor antagonist
25989,o08,BRD-K76587808-001-02-0,Antioxidant
25989,o09,BRD-K76617868-001-02-2,rho associated kinase inhibitor
25989,o10,BRD-K76634210-001-02-2,DNA directed DNA polymerase inhibitor
25989,o13,BRD-K76674262-001-01-7,apoptosis stimulant|protein synthesis inhibitor
25989,o15,BRD-K76723084-001-05-9,retinoid receptor agonist
25989,o16,BRD-K76775527-001-06-2,Cyclooxygenase inhibitor
25989,o17,BRD-K76805682-001-05-0,glycogen synthase kinase inhibitor
25989,o18,BRD-K76810206-001-05-7,adrenergic receptor antagonist
25989,o20,BRD-K76840893-003-01-7,adrenergic receptor antagonist
25989,o22,BRD-K76872913-001-02-8,Aromatic hydrocarbon derivative
25989,o23,BRD-K76927775-001-04-3,DNA inhibitor
25989,o24,BRD-K77133231-001-01-1,p38 MAPK inhibitor
25989,p01,BRD-K77171813-050-01-4,histamine receptor modulator
25989,p03,BRD-K77554836-001-03-3,glucocorticoid receptor agonist
25989,p07,BRD-K77641333-003-04-0,adrenergic receptor agonist
25989,p08,BRD-K77677632-003-01-8,serotonin receptor antagonist
25989,p09,BRD-K77695569-001-04-5,angiogenesis inhibitor
25989,p10,BRD-K77771411-003-03-2,imidazoline receptor agonist
25989,p13,BRD-K77793136-003-01-4,rho associated kinase inhibitor
25989,p15,BRD-K77925998-001-01-3,serotonin receptor agonist
25989,p16,BRD-K77947974-001-04-9,dopamine receptor antagonist
25989,p17,BRD-K77987382-001-05-8,acetylcholinesterase inhibitor|microtubule inhibitor|tubulin inhibitor
25989,p18,BRD-K78010432-001-04-1,diuretic
25989,p20,BRD-K78084463-003-01-0,calmodulin antagonist
25989,p21,BRD-K78113049-001-04-8,topoisomerase inhibitor
25989,p22,BRD-K78122587-300-01-9,T-type calcium channel blocker
25989,p23,BRD-K78280988-001-02-2,cannabinoid receptor agonist|potassium channel blocker|TRPV agonist
24302,a01,BRD-A44966919-001-03-1,acetylcholine receptor antagonist
24302,a02,BRD-A45140972-060-02-4,bacterial 50S ribosomal subunit inhibitor
24302,a03,BRD-A45499626-001-01-0,Glutamate receptor antagonist
24302,a04,BRD-A45543382-001-02-7,radiopaque medium
24302,a05,BRD-A46066006-004-04-4,muscarinic antagonist
24302,a10,BRD-A47144777-001-02-5,HSP90 inhibitor
24302,a11,BRD-A47494775-003-03-0,Adrenergic receptor agonist
24302,a12,BRD-A47513740-001-02-5,protein phosphatase inhibitor
24302,a15,BRD-A47598013-004-02-0,selective serotonin reuptake inhibitor (SSRI)
24302,a17,BRD-A48257147-001-01-9,glutamate receptor agonist
24302,a18,BRD-A48300215-001-01-4,sodium channel blocker
24302,a21,BRD-A48809242-001-02-9,adenosine receptor agonist
24302,a23,BRD-A49046702-001-01-2,GABA uptake inhibitor
24302,a24,BRD-A49172652-001-13-1,ATPase inhibitor
24302,b01,BRD-A49225603-045-02-7,histamine receptor agonist
24302,b02,BRD-A49358627-001-03-9,PPAR receptor agonist
24302,b03,BRD-A49370193-051-01-7,serotonin receptor agonist
24302,b05,BRD-A49680073-001-01-9,JAK inhibitor|Lipocortin synthesis stimulant|STAT inhibitor
24302,b06,BRD-A49734948-001-03-3,Plant alkaloid
24302,b07,BRD-A49906757-004-03-1,Acetylcholine receptor antagonist
24302,b09,BRD-A50157456-065-02-4,adrenergic receptor agonist
24302,b10,BRD-A50311610-300-04-7,CAR agonist
24302,b11,BRD-A50675702-001-03-0,chloride channel blocker|GABA gated chloride channel blocker
24302,b12,BRD-A50684349-001-01-5,dopamine receptor agonist
24302,b15,BRD-A50737080-001-01-4,ATR kinase inhibitor
24302,b16,BRD-A50764878-001-01-4,serotonin receptor antagonist
24302,b19,BRD-A51410489-001-01-4,adrenergic receptor antagonist
24302,b21,BRD-A51714012-001-02-3,Adrenergic inhibitor
24302,b22,BRD-A51820102-008-04-0,Bacterial cell wall synthesis inhibitor
24302,b23,BRD-A51829654-001-01-4,Serotonin receptor antagonist
24302,c01,BRD-A52588987-004-04-1,Dopamine receptor antagonist
24302,c02,BRD-A52660433-066-01-3,Monoamine oxidase inhibitor
24302,c04,BRD-A52922642-001-02-9,L-type calcium channel blocker
24302,c05,BRD-A53077924-236-01-4,Selective serotonin reuptake enhancer (SSRE)
24302,c07,BRD-A53416814-001-01-5,nitric oxide production inhibitor|phosphoenolpyruvate carboxylase activator|serine/threonine protein phosphatase activator
24302,c09,BRD-A53576514-003-03-1,Acetylcholine receptor antagonist
24302,c10,BRD-A53952395-003-04-6,local anesthetic
24302,c13,BRD-A54029483-001-01-5,endothelin receptor antagonist
24302,c14,BRD-A54236247-003-02-7,Adrenergic receptor agonist
24302,c17,BRD-A54490543-066-04-4,monoamine oxidase inhibitor
24302,c18,BRD-A54845972-066-01-5,serotonin receptor agonist|adrenergic receptor partial agonist|dopamine receptor agonist
24302,c19,BRD-A54927599-001-07-8,P-selectin inhibitor
24302,c22,BRD-A55272860-001-03-9,dopamine receptor antagonist
24302,c23,BRD-A55369275-001-01-6,GABA receptor antagonist
24302,c24,BRD-A55393291-001-02-4,Androgen receptor agonist
24302,d01,BRD-A55424491-001-04-1,dihydrofolate reductase inhibitor
24302,d04,BRD-A55756846-001-05-5,PKA inhibitor
24302,d05,BRD-A55913614-316-04-7,antimalarial agent|DNA inhibitor
24302,d07,BRD-A56020723-001-02-0,cathepsin inhibitor|antiamyloidogenic agent
24302,d08,BRD-A56675431-001-04-0,Thiazide diuretic
24302,d13,BRD-A56987319-001-03-8,Adenylyl cyclase inhibitor
24302,d14,BRD-A57133233-003-03-7,histamine receptor antagonist
24302,d17,BRD-A57382968-001-06-8,Cyclooxygenase inhibitor
24302,d20,BRD-A58048407-001-06-3,Calcium channel blocker
24302,d24,BRD-A59215453-003-03-3,Acetylcholine receptor antagonist
24302,e03,BRD-A59303141-001-03-9,Thiazide diuretic
24302,e06,BRD-A60197193-001-05-4,Dopamine receptor antagonist
24302,e12,BRD-A61154809-001-03-5,ATP channel blocker|insulin secretagogue
24302,e14,BRD-A61392169-001-01-9,glutamate receptor antagonist
24302,e15,BRD-A61470182-001-02-4,macrophage activator
24302,e16,BRD-A61793559-001-04-0,Carbonic anhydrase inhibitor
24302,e19,BRD-A61856038-001-01-2,Lipoxygenase inhibitor
24302,e22,BRD-A62021152-003-01-8,serotonin receptor agonist
24302,e23,BRD-A62057054-001-01-5,Serotonin receptor antagonist
24302,f04,BRD-A62428732-096-02-6,antihistamine
24302,f05,BRD-A62505706-001-02-3,DNA directed DNA polymerase inhibitor
24302,f06,BRD-A62525898-001-02-9,Glucocorticoid receptor agonist
24302,f08,BRD-A63346720-300-01-1,sigma receptor antagonist|dopamine reuptake inhibitor
24302,f11,BRD-A63546914-003-01-2,Glutamate receptor antagonist
24302,f12,BRD-A63667919-103-01-9,dopamine receptor antagonist|partial serotonin receptor agonist
24302,f14,BRD-A63836183-362-01-1,angiotensin receptor antagonist
24302,f15,BRD-A63894585-001-03-4,glucocorticoid receptor agonist
24302,f16,BRD-A64092382-003-03-5,Sodium channel blocker
24302,f19,BRD-A64125466-236-02-0,choleretic agent
24302,f20,BRD-A64227845-004-02-8,Dopamine receptor agonist
24302,f21,BRD-A64228451-001-03-5,BTK inhibitor
24302,f23,BRD-A64485570-001-02-9,DNA directed DNA polymerase inhibitor|thymidylate synthase inhibitor
24302,g02,BRD-A64933752-001-01-0,adenosine receptor agonist
24302,g06,BRD-A64977602-001-01-9,Adrenergic receptor antagonist
24302,g07,BRD-A65013509-003-03-8,Acetylcholine receptor antagonist
24302,g08,BRD-A65051990-001-03-8,vitamin K antagonist
24302,g09,BRD-A65076780-001-01-3,adrenergic receptor antagonist|prolactin inhibitor
24302,g10,BRD-A65145453-001-02-0,glutamate receptor agonist
24302,g11,BRD-A65280694-003-03-8,Dopamine receptor antagonist
24302,g12,BRD-A65440446-001-02-5,Adrenergic receptor agonist
24302,g13,BRD-A65597028-003-02-4,Adrenergic receptor antagonist
24302,g14,BRD-A65615053-003-01-4,Serotonin receptor antagonist
24302,g15,BRD-A65671304-001-02-6,angiotensin receptor antagonist
24302,g17,BRD-A66025870-237-05-1,bacterial cell wall synthesis inhibitor
24302,g18,BRD-A66199457-001-02-2,antineoplastic
24302,g22,BRD-A66435872-313-01-8,Histamine receptor agonist
24302,g23,BRD-A66563878-003-01-8,Adrenergic receptor agonist
24302,h01,BRD-A66927094-001-01-7,Dopamine receptor antagonist
24302,h07,BRD-A67552019-001-02-2,ATPase inhibitor
24302,h09,BRD-A67862938-034-04-0,Adrenergic receptor antagonist
24302,h10,BRD-A68281735-001-02-0,Leukotriene receptor antagonist
24302,h12,BRD-A68723818-050-04-4,Histamine receptor antagonist
24302,h13,BRD-A68888262-003-02-9,histamine receptor antagonist
24302,h14,BRD-A68929948-001-01-9,antiamyloidogenic agent|gamma secretase inhibitor
24302,h15,BRD-A69636825-003-02-1,Calcium channel blocker
24302,h17,BRD-A69777949-001-04-4,topoisomerase inhibitor
24302,h18,BRD-A69786436-003-02-5,acetylcholine receptor antagonist
24302,h23,BRD-A70083328-001-02-9,Acetylcholinesterase inhibitor
24302,h24,BRD-A70268693-103-01-9,Acetylcholine receptor agonist
24302,i01,BRD-A70407468-001-01-2,adenosine receptor antagonist
24302,i02,BRD-A70514680-003-03-9,Local anesthetic
24302,i03,BRD-A70649075-008-04-3,sterol demethylase inhibitor
24302,i08,BRD-A71157293-003-03-5,Vitamin B
24302,i09,BRD-A71203467-001-01-5,Dopamine receptor antagonist
24302,i10,BRD-A71774530-001-01-8,chitin inhibitor
24302,i12,BRD-A71816415-236-02-7,HMGCR inhibitor
24302,i13,BRD-A72066420-001-01-1,PPAR receptor antagonist
24302,i14,BRD-A72483914-001-01-1,Serotonin receptor antagonist
24302,i15,BRD-A72596465-001-01-3,PPAR receptor antagonist
24302,i16,BRD-A72703248-001-02-7,calcium channel blocker|cytochrome P450 inhibitor
24302,i17,BRD-A72711497-236-02-0,bacterial permeability inducer
24302,i18,BRD-A72988804-001-03-8,Cyclooxygenase inhibitor
24302,i19,BRD-A73368467-003-02-8,Histamine receptor antagonist
24302,i23,BRD-A73859745-236-01-8,Apoptosis stimulant
24302,j02,BRD-A74667430-001-04-6,Cyclooxygenase inhibitor
24302,j03,BRD-A74904029-001-04-0,Casein kinase inhibitor
24302,j07,BRD-A74980173-001-02-8,Bacterial DNA gyrase inhibitor
24302,j09,BRD-A75478957-001-01-6,collagenase inhibitor|metalloproteinase inhibitor|stromelysin inhibitor
24302,j10,BRD-A75552914-001-04-4,Cyclooxygenase inhibitor
24302,j12,BRD-A75769826-003-01-3,opioid receptor antagonist
24302,j13,BRD-A75817871-001-02-6,ATPase inhibitor
24302,j14,BRD-A75850590-003-04-9,bacterial DNA gyrase inhibitor
24302,j16,BRD-A76093993-001-01-8,Potassium channel activator
24302,j24,BRD-A77291778-003-04-8,acetylcholine receptor antagonist
24302,k01,BRD-A77299732-001-01-6,Eukaryotic translation initiation factor inhibitor
24302,k02,BRD-A77349281-001-02-2,heparanase inhibitor|tyrosine phosphatase inhibitor
24302,k06,BRD-A78295502-337-03-5,anti-arrhythmia agent
24302,k10,BRD-A78377521-001-02-2,Kinesin-like spindle protein inhibitor
24302,k11,BRD-A78877355-003-03-6,Cyclooxygenase inhibitor
24302,k12,BRD-A78942461-003-01-3,Adrenergic receptor antagonist
24302,k13,BRD-A79226577-003-01-1,serotonin receptor antagonist|polarization inhibitor|sodium channel blocker
24302,k17,BRD-A79672927-001-04-1,Acetylcholine receptor antagonist
24302,k18,BRD-A79981887-003-04-0,adrenergic receptor agonist
24302,k19,BRD-A80017228-001-04-2,Sodium/potassium/chloride transporter inhibitor
24302,k21,BRD-A80213327-305-01-8,Ras GTPase inhibitor
24302,k22,BRD-A80594172-001-02-0,glucocorticoid receptor agonist
24302,l01,BRD-A80641450-001-01-4,Endothelin receptor antagonist
24302,l05,BRD-A81177136-001-03-6,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist
24302,l10,BRD-A81615860-001-02-9,tryptophan hydroxylase inhibitor
24302,l11,BRD-A81795050-003-01-7,oxidosqualene cyclase inhibitor
24302,l12,BRD-A81866333-003-01-5,Adenosine receptor agonist
24302,l13,BRD-A82238138-001-01-7,glucocorticoid receptor agonist
24302,l17,BRD-A82371568-001-01-5,ribonucleoside reductase inhibitor|DNA polymerase inhibitor|DNA repair enzyme inhibitor|DNA synthesis inhibitor|ribonucleotide reductase inhibitor
24302,l19,BRD-A82590476-001-01-1,tachykinin antagonist
24302,l20,BRD-A82656074-003-01-2,opioid receptor antagonist
24302,l22,BRD-A83326220-001-02-6,Nitric oxide production inhibitor
24302,m02,BRD-A83431637-001-01-3,Cytochrome P450 inhibitor
24302,m04,BRD-A83695761-001-01-1,Potassium channel blocker
24302,m05,BRD-A83855350-003-01-4,Opioid receptor antagonist
24302,m07,BRD-A83937277-001-03-0,Hydantoin antiepileptic
24302,m08,BRD-A84174393-001-02-0,Cyclooxygenase inhibitor
24302,m11,BRD-A84174873-001-06-0,benzodiazepine receptor agonist
24302,m12,BRD-A84389091-001-01-1,GABA receptor inverse agonist
24302,m15,BRD-A84389633-001-01-6,serotonin receptor antagonist
24302,m19,BRD-A85137183-001-01-2,bacterial cell wall synthesis inhibitor
24302,m21,BRD-A85234536-001-04-5,Adenosine receptor agonist
24302,m22,BRD-A85280935-003-01-7,Dopamine receptor agonist
24302,m23,BRD-A85472596-001-01-4,Prostanoid receptor antagonist
24302,m24,BRD-A85587465-001-01-7,Serotonin receptor antagonist
24302,n01,BRD-A86044036-001-04-2,cyclooxygenase inhibitor
24302,n06,BRD-A87479750-001-01-9,Cyclooxygenase inhibitor
24302,n08,BRD-A87719232-001-02-4,Cyclooxygenase inhibitor
24302,n11,BRD-A88254928-001-04-6,adrenergic receptor agonist
24302,n12,BRD-A88282067-001-02-2,Antiarrhythmic
24302,n15,BRD-A88548664-001-01-5,dopamine receptor agonist
24302,n18,BRD-A89434049-001-02-1,ATPase inhibitor
24302,n19,BRD-A89585551-003-03-4,adenosine receptor antagonist|hemoglobin antagonist
24302,n20,BRD-A89672324-001-02-2,GABA receptor antagonist
24302,n22,BRD-A89947015-001-01-4,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor
24302,n24,BRD-A90311807-236-01-4,Dehydropeptidase inhibitor
24302,o01,BRD-A90462498-003-02-1,antineoplastic
24302,o02,BRD-A90490067-001-01-9,estrogen receptor antagonist|DNA directed DNA polymerase inhibitor|soluble epoxide hydrolase inhibitor
24302,o03,BRD-A90515964-001-05-8,expectorant
24302,o04,BRD-A90799790-001-04-1,calcium channel blocker
24302,o06,BRD-A91008255-001-02-8,calcium channel blocker
24302,o08,BRD-A91699651-316-04-2,Antimalarial
24302,o09,BRD-A91866971-001-02-2,Thromboxane receptor antagonist
24302,o13,BRD-A92161634-001-02-6,Acetylcholine receptor antagonist
24302,o14,BRD-A92585442-237-01-0,Cytochrome P450 inhibitor
24302,o15,BRD-A92670106-003-03-9,Sodium channel blocker
24302,o16,BRD-A92826379-009-02-6,Sodium channel blocker
24302,o18,BRD-A93000692-001-03-2,PPAR receptor agonist
24302,o19,BRD-A93206962-001-01-2,adrenergic receptor agonist|adrenergic receptor partial agonist
24302,o20,BRD-A93255169-001-06-9,TNF production inhibitor
24302,o24,BRD-A93477898-001-01-8,caspase activator
24302,p01,BRD-A93659613-051-03-6,Opioid receptor agonist
24302,p02,BRD-A93739713-065-02-7,muscarinic antagonist
24302,p05,BRD-A94413429-003-01-6,neuropeptide receptor antagonist
24302,p06,BRD-A94543220-001-02-3,Sterol demethylase inhibitor
24302,p07,BRD-A94624445-236-02-2,adenosine receptor agonist|cAMP stimulant
24302,p08,BRD-A94669766-001-02-6,Aromatase inhibitor
24302,p10,BRD-A94709349-001-02-6,Muscle relaxant
24302,p13,BRD-A95096829-300-01-4,dopamine receptor antagonist
24302,p14,BRD-A95207036-001-02-8,androgen receptor antagonist
24302,p15,BRD-A95445494-001-02-9,interleukin synthesis inhibitor|sodium/glucose cotransporter inhibitor
24302,p16,BRD-A95513702-001-02-2,aromatase inhibitor
24302,p17,BRD-A95696066-003-06-2,Norepinephrine reuptake inhibitor
24302,p18,BRD-A95869247-001-03-8,thiazide diuretic
24302,p19,BRD-A95939040-008-03-3,sterol demethylase inhibitor
24302,p20,BRD-A96456596-001-01-4,Leukotriene receptor antagonist
24302,p21,BRD-A96485169-001-02-8,Aldose reductase inhibitor
24302,p23,BRD-A96882008-001-01-3,Tachykinin antagonist
24302,p24,BRD-A96897502-001-02-0,lipid peroxidase inhibitor
24308,a01,BRD-K18250272-003-03-7,local anesthetic
24308,a02,BRD-K18316707-001-01-9,cannabinoid receptor antagonist
24308,a04,BRD-K18550767-001-02-8,interleukin inhibitor
24308,a05,BRD-K18574842-323-03-3,bacterial cell wall synthesis inhibitor
24308,a06,BRD-K18619710-001-03-7,steroid
24308,a07,BRD-K18742343-001-03-2,PKA inhibitor
24308,a08,BRD-K18757346-001-02-9,thromboxane receptor agonist
24308,a09,BRD-K18779551-003-03-7,acetylcholine release stimulant|adrenergic transmitter uptake inhibitor|reducing agent
24308,a10,BRD-K18787491-001-05-2,MEK inhibitor
24308,a11,BRD-K18799075-001-01-0,cannabinoid receptor partial agonist
24308,a12,BRD-K18816859-001-01-4,Serotonin receptor agonist
24308,a15,BRD-K18909381-001-01-4,serotonin receptor agonist
24308,a16,BRD-K18910433-001-04-4,estrogen receptor agonist
24308,a19,BRD-K19111024-001-04-3,PPAR receptor agonist
24308,a20,BRD-K19295594-001-04-4,BCL inhibitor|MCL1 inhibitor
24308,a21,BRD-K19309090-300-03-0,acetylcholine receptor agonist
24308,a22,BRD-K19352500-332-03-7,dopamine receptor antagonist
24308,a23,BRD-K19360254-001-01-3,Dopamine receptor agonist
24308,b01,BRD-K19462402-003-03-0,adrenergic receptor antagonist|calcium channel blocker
24308,b03,BRD-K19533706-001-01-9,Angiogenesis inhibitor
24308,b04,BRD-K19554809-001-01-1,serotonin receptor agonist
24308,b05,BRD-K19605405-001-01-9,adenosine receptor antagonist
24308,b07,BRD-K20141153-003-03-8,norepinephrine transporter inhibitor|adrenergic transmitter uptake inhibitor
24308,b08,BRD-K20152659-001-02-0,Cholesterol inhibitor
24308,b10,BRD-K20620780-001-01-0,dopamine receptor antagonist
24308,b11,BRD-K20655524-003-04-7,psychoactive drug
24308,b15,BRD-K20714604-001-01-5,Serotonin receptor partial agonist
24308,b16,BRD-K20742498-001-01-5,serotonin receptor antagonist
24308,b17,BRD-K20755323-001-01-8,sphingosine kinase inhibitor
24308,b18,BRD-K20995441-001-01-7,Opioid receptor agonist
24308,b19,BRD-K21283037-001-02-5,glutamate inhibitor
24308,b20,BRD-K21350491-001-02-1,acid sensing ion channel blocker|sodium channel blockers|TRPP3 channel inhibitor|TRPV modulator
24308,b21,BRD-K21450440-001-04-7,carbonic anhydrase inhibitor
24308,b22,BRD-K21520694-001-02-4,PABA antagonist
24308,b23,BRD-K21548250-001-01-3,sodium channel blocker
24308,b24,BRD-K21565985-001-04-3,adrenergic receptor agonist
24308,c01,BRD-K21667562-001-01-4,FAAH transport inhibitor|anandamide transport inhibitor|nucelar factor of activated T-cells inhibitor|TRPV agonist
24308,c02,BRD-K21680192-300-05-2,topoisomerase inhibitor
24308,c03,BRD-K21733600-001-02-6,cyclooxygenase inhibitor
24308,c04,BRD-K21853356-001-04-4,EGFR inhibitor
24308,c07,BRD-K22031190-001-04-6,Prostanoid receptor antagonist
24308,c08,BRD-K22134346-001-04-1,HMGCR inhibitor
24308,c09,BRD-K22193694-001-04-5,Topical sunscreen agent
24308,c10,BRD-K22385716-001-01-7,casein kinase inhibitor|mTOR inhibitor|PI3K inhibitor
24308,c17,BRD-K22861715-001-03-4,breast cancer resistance protein inhibitor
24308,c19,BRD-K22969690-001-02-6,bacterial 50S ribosomal subunit inhibitor
24308,c21,BRD-K23301018-001-02-6,antiprotozoal agent
24308,c23,BRD-K23335153-300-01-7,glutamate receptor positive allosteric modulator
24308,c24,BRD-K23383398-001-01-6,LXR agonist|ABC transporter expression enhancer|ROR inverse agonist
24308,d02,BRD-K23478508-001-03-7,ATPase inhibitor
24308,d03,BRD-K23541596-300-04-9,histamine receptor agonist
24308,d04,BRD-K23566484-001-04-5,androgen receptor antagonist
24308,d05,BRD-K23583188-001-05-6,EGFR inhibitor|tyrosine kinase inhibitor
24308,d06,BRD-K23704908-001-03-2,serine protease inhibitor
24308,d07,BRD-K23913458-001-02-5,Vitamin K antagonist
24308,d08,BRD-K23922020-075-01-1,acetylcholine receptor agonist
24308,d10,BRD-K24084088-001-02-2,adenosine receptor antagonist
24308,d13,BRD-K24132293-001-02-0,glutathione transferase inhibitor
24308,d14,BRD-K24201553-003-02-4,Serotonin receptor antagonist
24308,d17,BRD-K24240364-003-02-1,Glutamate receptor antagonist
24308,d18,BRD-K24396733-001-01-1,dopamine receptor agonist
24308,d20,BRD-K24526313-001-08-6,Potassium channel activator
24308,e05,BRD-K25224017-001-04-5,serotonin receptor antagonist
24308,e07,BRD-K25394294-001-04-0,Cyclooxygenase inhibitor
24308,e11,BRD-K25433859-003-11-4,norepinephrine reputake inhibitor|tricyclic antidepressant
24308,e13,BRD-K25741894-001-03-8,acetylcholinesterase inhibitor
24308,e15,BRD-K25875056-001-01-2,Protein tyrosine kinase activator
24308,e16,BRD-K25906698-303-01-9,histamine receptor agonist
24308,e21,BRD-K26160755-003-01-8,Imidazoline receptor agonist
24308,e22,BRD-K26373640-001-02-8,IKK inhibitor
24308,f03,BRD-K26429091-051-01-9,acetylcholine receptor antagonist
24308,f04,BRD-K26521938-001-04-9,prostanoid receptor agonist
24308,f05,BRD-K26548821-001-01-8,Dopamine receptor agonist
24308,f06,BRD-K26573499-300-01-3,Adrenergic receptor agonist
24308,f12,BRD-K26979635-001-01-1,Glutamate receptor antagonist
24308,f13,BRD-K26997899-001-01-4,microtubule inhibitor|tubulin inhibitor
24308,f15,BRD-K27141178-001-01-0,Serotonin receptor antagonist
24308,f20,BRD-K27305650-001-04-2,mTOR inhibitor|PI3K inhibitor|DNA dependent protein kinase inhibitor|phosphodiesterase inhibitor|PLK inhibitor
24308,f21,BRD-K27316855-001-02-6,vitamin D receptor agonist
24308,f23,BRD-K27351809-001-02-0,progesterone receptor agonist
24308,g01,BRD-K27450477-001-03-9,Adenosine deaminase inhibitor
24308,g02,BRD-K27499107-001-02-6,IP receptor activator
24308,g06,BRD-K27710560-001-02-6,SIRT inhibitor
24308,g07,BRD-K27737647-001-03-4,PKA inhibitor
24308,g09,BRD-K27871032-001-02-6,Ergoline alkaloid
24308,g11,BRD-K28115081-001-01-9,Platelet activating factor receptor antagonist
24308,g12,BRD-K28137194-003-01-3,GABA receptor agonist
24308,g13,BRD-K28143534-001-01-4,histamine receptor antagonist
24308,g15,BRD-K28183345-003-05-6,Dihydrofolate reductase inhibitor
24308,g17,BRD-K28307902-001-04-3,androgen receptor antagonist
24308,g18,BRD-K28453807-003-05-4,Cholinergic receptor antagonist
24308,g23,BRD-K28578425-001-01-3,phosphodiesterase inhibitor
24308,g24,BRD-K28667196-001-02-9,Increases arterial blood pressure
24308,h01,BRD-K28680267-001-01-8,CCK receptor antagonist
24308,h02,BRD-K28761384-003-03-6,dopamine receptor antagonist
24308,h05,BRD-K28761891-001-01-0,melatonin receptor agonist
24308,h06,BRD-K28806945-001-01-9,dopamine receptor antagonist
24308,h07,BRD-K28863208-001-01-2,Cholinergic receptor agonist
24308,h08,BRD-K28907958-001-01-9,retinoid receptor agonist
24308,h09,BRD-K28936863-051-04-1,histamine receptor agonist|leukotriene receptor antagonist|phosphodiesterase inhibitor
24308,h10,BRD-K29113274-001-03-6,Sterol demethylase inhibitor
24308,h12,BRD-K29178788-001-02-0,Furoquinoline alkaloid
24308,h13,BRD-K29359156-001-04-6,H+/K+-ATPase inhibitor
24308,h16,BRD-K29555132-001-02-2,Cannabinoid receptor agonist
24308,h17,BRD-K29582677-001-02-7,Calcium channel blocker
24308,h18,BRD-K29668683-300-01-4,sigma receptor antagonist
24308,h21,BRD-K29673530-001-03-9,tyrosine kinase inhibitor
24308,h22,BRD-K29950728-048-02-6,estrogen receptor antagonist
24308,h23,BRD-K30197592-001-01-5,Serotonin receptor agonist
24308,i01,BRD-K30240666-051-05-0,histamine receptor antagonist
24308,i02,BRD-K30421593-050-02-3,adrenergic receptor antagonist
24308,i03,BRD-K30480208-001-04-5,Electrolyte reabsorption inhibitor
24308,i08,BRD-K30685142-001-04-8,thyroid hormone stimulant
24308,i09,BRD-K30867024-001-01-1,serotonin receptor antagonist
24308,i11,BRD-K30990140-003-01-6,Cyclooxygenase inhibitor
24308,i12,BRD-K31054881-300-01-3,Adrenergic receptor antagonist
24308,i13,BRD-K31238592-001-01-6,CCK receptor antagonist|gastrin inhibitor
24308,i16,BRD-K31342827-001-05-4,PKC inhibitor
24308,i18,BRD-K31491153-001-01-2,serotonin receptor agonist
24308,i19,BRD-K31542390-001-01-5,dehydrogenase inhibitor|inositol monophosphatase inhibitor
24308,i20,BRD-K31611373-001-02-7,Prostanoid receptor agonist
24308,i23,BRD-K31627533-001-03-8,glucocorticoid receptor agonist
24308,i24,BRD-K31633810-003-01-0,Acetylcholine receptor antagonist
24308,j03,BRD-K31699485-001-01-9,glutamate receptor modulator
24308,j04,BRD-K31792052-004-01-9,interleukin receptor antagonist
24308,j09,BRD-K31843556-001-01-7,PPAR receptor anatagonist|PPAR receptor antagonist
24308,j10,BRD-K31912990-003-01-0,neuropeptide receptor antagonist
24308,j12,BRD-K31987754-001-01-2,Cannabinoid receptor agonist
24308,j15,BRD-K32164935-001-06-8,ATP channel blocker
24308,j16,BRD-K32247306-001-04-7,GABA receptor antagonist
24308,j19,BRD-K32292990-001-01-0,EGFR inhibitor
24308,j20,BRD-K32412559-001-01-7,Adrenergic receptor antagonist
24308,j23,BRD-K32501161-001-01-7,dopamine uptake inhibitor
24308,j24,BRD-K32526544-001-01-2,Potassium channel activator
24308,k02,BRD-K32584078-001-02-3,AKT inhibitor|HCV NS5B RdRp inhibitor
24308,k04,BRD-K32645441-001-01-4,serotonin receptor agonist
24308,k05,BRD-K32696739-001-02-6,Monoamine oxidase inhibitor
24308,k06,BRD-K32744045-001-04-9,aldehyde dehydrogenase inhibitor|DNA methyltransferase inhibitor|TRPV agonist
24308,k09,BRD-K32755366-003-03-4,Norepinephrine transporter inhibitor
24308,k10,BRD-K32821942-001-04-9,dehydrogenase inhibitor
24308,k11,BRD-K32828673-001-01-5,tubulin polymerization inhibitor
24308,k12,BRD-K32830106-003-11-3,adrenergic receptor agonist
24308,k14,BRD-K33204703-001-04-6,PDGFR receptor inhibitor
24308,k17,BRD-K33211335-337-03-7,glutamate receptor antagonist|sigma receptor agonist
24308,k19,BRD-K33308633-001-01-6,calcineurin inhibitor
24308,k20,BRD-K33396764-001-02-0,Omega 3 fatty acid stimulant
24308,k22,BRD-K33453211-003-03-2,Histamine receptor antagonist
24308,l01,BRD-K33459542-001-02-5,sigma receptor agonist
24308,l02,BRD-K33583600-001-03-9,guanylate cyclase activator
24308,l03,BRD-K33710385-001-05-4,mycolic synthesis inhibitor
24308,l04,BRD-K33818169-003-01-2,LXR agonist|ABC transporter expression enhancer
24308,l05,BRD-K33864865-001-01-7,CCK receptor antagonist
24308,l06,BRD-K33882852-003-01-0,benzodiazepine receptor agonist
24308,l10,BRD-K34014345-001-02-6,Anti-inflammatory
24308,l11,BRD-K34034388-300-01-0,dopamine uptake inhibitor
24308,l12,BRD-K34092021-001-02-3,TRPV agonist|cannabinoid receptor agonist
24308,l13,BRD-K34154330-003-04-9,GABA receptor modulator
24308,l17,BRD-K34170797-001-01-1,FXR agonist
24308,l20,BRD-K34415467-003-04-9,histamine receptor antagonist
24308,l21,BRD-K34568562-001-02-7,interferon inducer
24308,l22,BRD-K34608650-001-01-6,Cannabinoid receptor agonist
24308,m02,BRD-K34685430-001-01-1,dopamine receptor antagonist|serotonin receptor antagonist
24308,m03,BRD-K34995470-001-02-3,receptor tyrosine protein kinase inhibitor|vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor|VEGFR inhibitor
24308,m06,BRD-K35240538-001-03-1,glucocorticoid receptor agonist
24308,m07,BRD-K35430135-003-01-5,Adrenergic receptor antagonist
24308,m08,BRD-K35458079-001-04-2,Nootropic agent
24308,m11,BRD-K35498378-001-03-8,Aldose reductase inhibitor
24308,m15,BRD-K35629949-001-01-2,CCK receptor antagonist
24308,m16,BRD-K35708212-331-03-1,ATPase inhibitor
24308,m17,BRD-K35941380-001-01-7,Serotonin receptor antagonist
24308,m18,BRD-K35960502-001-04-4,DNA replication inhibitor|STAT inhibitor
24308,m20,BRD-K36007650-300-02-3,protein synthesis inhibitor
24308,m21,BRD-K36009368-001-01-8,Opioid receptor agonist
24308,m22,BRD-K36021395-300-01-6,adenosine kinase inhibitor
24308,m23,BRD-K36055864-001-04-4,protein synthesis inhibitor
24308,m24,BRD-K36116267-001-05-4,psychoactive drug
24308,n01,BRD-K36198571-001-01-2,metalloproteinase inhibitor
24308,n02,BRD-K36258877-001-01-5,caspase inhibitor
24308,n05,BRD-K36638830-001-02-2,acetylcholine receptor agonist
24308,n06,BRD-K36756879-003-04-6,calcium channel blocker
24308,n11,BRD-K36862742-001-04-1,sodium/potassium/chloride transporter inhibitor
24308,n12,BRD-K36864847-303-01-7,Adrenergic receptor antagonist
24308,n15,BRD-K36927236-001-06-0,Sulfonylurea
24308,n16,BRD-K36965586-001-01-7,serotonin receptor agonist
24308,n18,BRD-K37249724-001-04-2,histamine receptor antagonist
24308,n19,BRD-K37270826-001-03-7,glucocorticoid receptor antagonist|progesterone receptor antagonist
24308,n21,BRD-K37289225-001-07-5,Dopamine receptor antagonist
24308,n22,BRD-K37392901-003-01-7,ubiquitin hydrolase inhibitor|ubiquitin isopeptidase inhibitor
24308,n23,BRD-K37447567-001-01-8,Opioid receptor antagonist
24308,n24,BRD-K37561857-001-04-9,phosphodiesterase inhibitor
24308,o02,BRD-K37618799-001-01-4,adenosine receptor antagonist
24308,o03,BRD-K37682401-001-05-1,bacterial DNA gyrase inhibitor
24308,o04,BRD-K37688416-003-04-0,psychoactive drug
24308,o05,BRD-K37691127-001-02-2,tyrosinase inhibitor
24308,o07,BRD-K37792168-001-01-0,Phosphodiesterase inhibitor
24308,o08,BRD-K37798499-001-02-5,topoisomerase inhibitor
24308,o09,BRD-K37848908-001-03-1,penicillin binding protein inhibitor
24308,o10,BRD-K37865504-001-01-7,FAAH inhibitor|FAAH reuptake inhibitor
24308,o14,BRD-K37991163-050-05-1,selective serotonin reuptake inhibitor (SSRI)
24308,o15,BRD-K38003476-001-03-4,steroid
24308,o16,BRD-K38055836-001-03-9,respiratory stimulant
24308,o17,BRD-K38197229-001-06-7,solute carrier family member inhibitor
24308,o18,BRD-K38251852-001-02-5,ABC transporter expression enhancer|high conductance calcium activated potassium blocker|LXR agonist|potassium channel blocker
24308,o19,BRD-K38305202-001-01-8,dopamine receptor antagonist
24308,o20,BRD-K38323065-001-05-8,cyclooxygenase inhibitor
24308,o21,BRD-K38347298-001-02-3,adenosine receptor antagonist
24308,o22,BRD-K38436528-003-04-8,norepinephrine reputake inhibitor|serotonin reuptake inhibitor
24308,o23,BRD-K38449220-001-03-8,cytochrome P450 inhibitor
24308,o24,BRD-K38477985-001-01-8,protein tyrosine kinase inhibitor|tyrosine kinase inhibitor
24308,p01,BRD-K38684403-001-02-1,bacterial 50S ribosomal subunit inhibitor
24308,p03,BRD-K38775274-001-02-3,glucocorticoid receptor agonist
24308,p04,BRD-K38903228-001-02-8,flavanone glycoside
24308,p05,BRD-K39120595-304-02-1,autotaxin inhibitor
24308,p07,BRD-K39187410-001-01-7,antiamyloidogenic agent
24308,p08,BRD-K39188321-001-03-9,glucocorticoid receptor agonist
24308,p09,BRD-K39339537-001-03-8,cyclooxygenase inhibitor
24308,p10,BRD-K39356024-001-02-4,acetylcholine release enhancer|dopamine release enhancer|GABA receptor negative allosteric modulator|glutamate receptor modulator|progesterone receptor agonist|steroid hormone inhibitor of CYP17A1 and SULT2B1
24308,p13,BRD-K39484304-001-02-5,RNA polymerase inhibitor
24308,p14,BRD-K39670393-303-01-3,histamine receptor agonist
24308,p15,BRD-K39733634-001-01-8,prostanoid receptor antagonist|angiotensin receptor antagonist
24308,p16,BRD-K39746403-084-02-3,NFkB pathway inhibitor|50S ribosomal subunit inhibitor|motilin receptor agonist|RPLV inhibitor
24308,p17,BRD-K39915878-036-04-6,dopamine receptor antagonist|serotonin receptor antagonist
24308,p18,BRD-K39965020-001-02-6,PPAR receptor agonist
24308,p19,BRD-K39987650-001-04-3,laxative
24308,p20,BRD-K40255344-001-05-1,protein tyrosine kinase inhibitor|tyrosine kinase inhibitor
24308,p21,BRD-K40530731-001-02-5,acetylcholine receptor inhibitor
24308,p22,BRD-K40578143-001-01-8,adenosine receptor agonist
24308,p23,BRD-K40656405-001-01-5,PPAR receptor agonist
24308,p24,BRD-K40742111-001-02-6,lipoxygenase inhibitor
25944,a01,BRD-A44966919-001-03-1,acetylcholine receptor antagonist
25944,a02,BRD-A45140972-060-02-4,bacterial 50S ribosomal subunit inhibitor
25944,a03,BRD-A45499626-001-01-0,Glutamate receptor antagonist
25944,a04,BRD-A45543382-001-02-7,radiopaque medium
25944,a05,BRD-A46066006-004-04-4,muscarinic antagonist
25944,a10,BRD-A47144777-001-02-5,HSP90 inhibitor
25944,a11,BRD-A47494775-003-03-0,Adrenergic receptor agonist
25944,a12,BRD-A47513740-001-02-5,protein phosphatase inhibitor
25944,a15,BRD-A47598013-004-02-0,selective serotonin reuptake inhibitor (SSRI)
25944,a17,BRD-A48257147-001-01-9,glutamate receptor agonist
25944,a18,BRD-A48300215-001-01-4,sodium channel blocker
25944,a21,BRD-A48809242-001-02-9,adenosine receptor agonist
25944,a23,BRD-A49046702-001-01-2,GABA uptake inhibitor
25944,a24,BRD-A49172652-001-13-1,ATPase inhibitor
25944,b01,BRD-A49225603-045-02-7,histamine receptor agonist
25944,b02,BRD-A49358627-001-03-9,PPAR receptor agonist
25944,b03,BRD-A49370193-051-01-7,serotonin receptor agonist
25944,b05,BRD-A49680073-001-01-9,JAK inhibitor|Lipocortin synthesis stimulant|STAT inhibitor
25944,b06,BRD-A49734948-001-03-3,Plant alkaloid
25944,b07,BRD-A49906757-004-03-1,Acetylcholine receptor antagonist
25944,b09,BRD-A50157456-065-02-4,adrenergic receptor agonist
25944,b10,BRD-A50311610-300-04-7,CAR agonist
25944,b11,BRD-A50675702-001-03-0,chloride channel blocker|GABA gated chloride channel blocker
25944,b12,BRD-A50684349-001-01-5,dopamine receptor agonist
25944,b15,BRD-A50737080-001-01-4,ATR kinase inhibitor
25944,b16,BRD-A50764878-001-01-4,serotonin receptor antagonist
25944,b19,BRD-A51410489-001-01-4,adrenergic receptor antagonist
25944,b21,BRD-A51714012-001-02-3,Adrenergic inhibitor
25944,b22,BRD-A51820102-008-04-0,Bacterial cell wall synthesis inhibitor
25944,b23,BRD-A51829654-001-01-4,Serotonin receptor antagonist
25944,c01,BRD-A52588987-004-04-1,Dopamine receptor antagonist
25944,c02,BRD-A52660433-066-01-3,Monoamine oxidase inhibitor
25944,c04,BRD-A52922642-001-02-9,L-type calcium channel blocker
25944,c05,BRD-A53077924-236-01-4,Selective serotonin reuptake enhancer (SSRE)
25944,c07,BRD-A53416814-001-01-5,nitric oxide production inhibitor|phosphoenolpyruvate carboxylase activator|serine/threonine protein phosphatase activator
25944,c09,BRD-A53576514-003-03-1,Acetylcholine receptor antagonist
25944,c10,BRD-A53952395-003-04-6,local anesthetic
25944,c13,BRD-A54029483-001-01-5,endothelin receptor antagonist
25944,c14,BRD-A54236247-003-02-7,Adrenergic receptor agonist
25944,c17,BRD-A54490543-066-04-4,monoamine oxidase inhibitor
25944,c18,BRD-A54845972-066-01-5,serotonin receptor agonist|adrenergic receptor partial agonist|dopamine receptor agonist
25944,c19,BRD-A54927599-001-07-8,P-selectin inhibitor
25944,c22,BRD-A55272860-001-03-9,dopamine receptor antagonist
25944,c23,BRD-A55369275-001-01-6,GABA receptor antagonist
25944,c24,BRD-A55393291-001-02-4,Androgen receptor agonist
25944,d01,BRD-A55424491-001-04-1,dihydrofolate reductase inhibitor
25944,d04,BRD-A55756846-001-05-5,PKA inhibitor
25944,d05,BRD-A55913614-316-04-7,antimalarial agent|DNA inhibitor
25944,d07,BRD-A56020723-001-02-0,cathepsin inhibitor|antiamyloidogenic agent
25944,d08,BRD-A56675431-001-04-0,Thiazide diuretic
25944,d13,BRD-A56987319-001-03-8,Adenylyl cyclase inhibitor
25944,d14,BRD-A57133233-003-03-7,histamine receptor antagonist
25944,d17,BRD-A57382968-001-06-8,Cyclooxygenase inhibitor
25944,d20,BRD-A58048407-001-06-3,Calcium channel blocker
25944,d24,BRD-A59215453-003-03-3,Acetylcholine receptor antagonist
25944,e03,BRD-A59303141-001-03-9,Thiazide diuretic
25944,e06,BRD-A60197193-001-05-4,Dopamine receptor antagonist
25944,e12,BRD-A61154809-001-03-5,ATP channel blocker|insulin secretagogue
25944,e14,BRD-A61392169-001-01-9,glutamate receptor antagonist
25944,e15,BRD-A61470182-001-02-4,macrophage activator
25944,e16,BRD-A61793559-001-04-0,Carbonic anhydrase inhibitor
25944,e19,BRD-A61856038-001-01-2,Lipoxygenase inhibitor
25944,e22,BRD-A62021152-003-01-8,serotonin receptor agonist
25944,e23,BRD-A62057054-001-01-5,Serotonin receptor antagonist
25944,f04,BRD-A62428732-096-02-6,antihistamine
25944,f05,BRD-A62505706-001-02-3,DNA directed DNA polymerase inhibitor
25944,f06,BRD-A62525898-001-02-9,Glucocorticoid receptor agonist
25944,f08,BRD-A63346720-300-01-1,sigma receptor antagonist|dopamine reuptake inhibitor
25944,f11,BRD-A63546914-003-01-2,Glutamate receptor antagonist
25944,f12,BRD-A63667919-103-01-9,dopamine receptor antagonist|partial serotonin receptor agonist
25944,f14,BRD-A63836183-362-01-1,angiotensin receptor antagonist
25944,f15,BRD-A63894585-001-03-4,glucocorticoid receptor agonist
25944,f16,BRD-A64092382-003-03-5,Sodium channel blocker
25944,f19,BRD-A64125466-236-02-0,choleretic agent
25944,f20,BRD-A64227845-004-02-8,Dopamine receptor agonist
25944,f21,BRD-A64228451-001-03-5,BTK inhibitor
25944,f23,BRD-A64485570-001-02-9,DNA directed DNA polymerase inhibitor|thymidylate synthase inhibitor
25944,g02,BRD-A64933752-001-01-0,adenosine receptor agonist
25944,g06,BRD-A64977602-001-01-9,Adrenergic receptor antagonist
25944,g07,BRD-A65013509-003-03-8,Acetylcholine receptor antagonist
25944,g08,BRD-A65051990-001-03-8,vitamin K antagonist
25944,g09,BRD-A65076780-001-01-3,adrenergic receptor antagonist|prolactin inhibitor
25944,g10,BRD-A65145453-001-02-0,glutamate receptor agonist
25944,g11,BRD-A65280694-003-03-8,Dopamine receptor antagonist
25944,g12,BRD-A65440446-001-02-5,Adrenergic receptor agonist
25944,g13,BRD-A65597028-003-02-4,Adrenergic receptor antagonist
25944,g14,BRD-A65615053-003-01-4,Serotonin receptor antagonist
25944,g15,BRD-A65671304-001-02-6,angiotensin receptor antagonist
25944,g17,BRD-A66025870-237-05-1,bacterial cell wall synthesis inhibitor
25944,g18,BRD-A66199457-001-02-2,antineoplastic
25944,g22,BRD-A66435872-313-01-8,Histamine receptor agonist
25944,g23,BRD-A66563878-003-01-8,Adrenergic receptor agonist
25944,h01,BRD-A66927094-001-01-7,Dopamine receptor antagonist
25944,h07,BRD-A67552019-001-02-2,ATPase inhibitor
25944,h09,BRD-A67862938-034-04-0,Adrenergic receptor antagonist
25944,h10,BRD-A68281735-001-02-0,Leukotriene receptor antagonist
25944,h12,BRD-A68723818-050-04-4,Histamine receptor antagonist
25944,h13,BRD-A68888262-003-02-9,histamine receptor antagonist
25944,h14,BRD-A68929948-001-01-9,antiamyloidogenic agent|gamma secretase inhibitor
25944,h15,BRD-A69636825-003-02-1,Calcium channel blocker
25944,h17,BRD-A69777949-001-04-4,topoisomerase inhibitor
25944,h18,BRD-A69786436-003-02-5,acetylcholine receptor antagonist
25944,h23,BRD-A70083328-001-02-9,Acetylcholinesterase inhibitor
25944,h24,BRD-A70268693-103-01-9,Acetylcholine receptor agonist
25944,i01,BRD-A70407468-001-01-2,adenosine receptor antagonist
25944,i02,BRD-A70514680-003-03-9,Local anesthetic
25944,i03,BRD-A70649075-008-04-3,sterol demethylase inhibitor
25944,i08,BRD-A71157293-003-03-5,Vitamin B
25944,i09,BRD-A71203467-001-01-5,Dopamine receptor antagonist
25944,i10,BRD-A71774530-001-01-8,chitin inhibitor
25944,i12,BRD-A71816415-236-02-7,HMGCR inhibitor
25944,i13,BRD-A72066420-001-01-1,PPAR receptor antagonist
25944,i14,BRD-A72483914-001-01-1,Serotonin receptor antagonist
25944,i15,BRD-A72596465-001-01-3,PPAR receptor antagonist
25944,i16,BRD-A72703248-001-02-7,calcium channel blocker|cytochrome P450 inhibitor
25944,i17,BRD-A72711497-236-02-0,bacterial permeability inducer
25944,i18,BRD-A72988804-001-03-8,Cyclooxygenase inhibitor
25944,i19,BRD-A73368467-003-02-8,Histamine receptor antagonist
25944,i23,BRD-A73859745-236-01-8,Apoptosis stimulant
25944,j02,BRD-A74667430-001-04-6,Cyclooxygenase inhibitor
25944,j03,BRD-A74904029-001-04-0,Casein kinase inhibitor
25944,j07,BRD-A74980173-001-02-8,Bacterial DNA gyrase inhibitor
25944,j09,BRD-A75478957-001-01-6,collagenase inhibitor|metalloproteinase inhibitor|stromelysin inhibitor
25944,j10,BRD-A75552914-001-04-4,Cyclooxygenase inhibitor
25944,j12,BRD-A75769826-003-01-3,opioid receptor antagonist
25944,j13,BRD-A75817871-001-02-6,ATPase inhibitor
25944,j14,BRD-A75850590-003-04-9,bacterial DNA gyrase inhibitor
25944,j16,BRD-A76093993-001-01-8,Potassium channel activator
25944,j24,BRD-A77291778-003-04-8,acetylcholine receptor antagonist
25944,k01,BRD-A77299732-001-01-6,Eukaryotic translation initiation factor inhibitor
25944,k02,BRD-A77349281-001-02-2,heparanase inhibitor|tyrosine phosphatase inhibitor
25944,k06,BRD-A78295502-337-03-5,anti-arrhythmia agent
25944,k10,BRD-A78377521-001-02-2,Kinesin-like spindle protein inhibitor
25944,k11,BRD-A78877355-003-03-6,Cyclooxygenase inhibitor
25944,k12,BRD-A78942461-003-01-3,Adrenergic receptor antagonist
25944,k13,BRD-A79226577-003-01-1,serotonin receptor antagonist|polarization inhibitor|sodium channel blocker
25944,k17,BRD-A79672927-001-04-1,Acetylcholine receptor antagonist
25944,k18,BRD-A79981887-003-04-0,adrenergic receptor agonist
25944,k19,BRD-A80017228-001-04-2,Sodium/potassium/chloride transporter inhibitor
25944,k21,BRD-A80213327-305-01-8,Ras GTPase inhibitor
25944,k22,BRD-A80594172-001-02-0,glucocorticoid receptor agonist
25944,l01,BRD-A80641450-001-01-4,Endothelin receptor antagonist
25944,l05,BRD-A81177136-001-03-6,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist
25944,l10,BRD-A81615860-001-02-9,tryptophan hydroxylase inhibitor
25944,l11,BRD-A81795050-003-01-7,oxidosqualene cyclase inhibitor
25944,l12,BRD-A81866333-003-01-5,Adenosine receptor agonist
25944,l13,BRD-A82238138-001-01-7,glucocorticoid receptor agonist
25944,l17,BRD-A82371568-001-01-5,ribonucleoside reductase inhibitor|DNA polymerase inhibitor|DNA repair enzyme inhibitor|DNA synthesis inhibitor|ribonucleotide reductase inhibitor
25944,l19,BRD-A82590476-001-01-1,tachykinin antagonist
25944,l20,BRD-A82656074-003-01-2,opioid receptor antagonist
25944,l22,BRD-A83326220-001-02-6,Nitric oxide production inhibitor
25944,m02,BRD-A83431637-001-01-3,Cytochrome P450 inhibitor
25944,m04,BRD-A83695761-001-01-1,Potassium channel blocker
25944,m05,BRD-A83855350-003-01-4,Opioid receptor antagonist
25944,m07,BRD-A83937277-001-03-0,Hydantoin antiepileptic
25944,m08,BRD-A84174393-001-02-0,Cyclooxygenase inhibitor
25944,m11,BRD-A84174873-001-06-0,benzodiazepine receptor agonist
25944,m12,BRD-A84389091-001-01-1,GABA receptor inverse agonist
25944,m15,BRD-A84389633-001-01-6,serotonin receptor antagonist
25944,m19,BRD-A85137183-001-01-2,bacterial cell wall synthesis inhibitor
25944,m21,BRD-A85234536-001-04-5,Adenosine receptor agonist
25944,m22,BRD-A85280935-003-01-7,Dopamine receptor agonist
25944,m23,BRD-A85472596-001-01-4,Prostanoid receptor antagonist
25944,m24,BRD-A85587465-001-01-7,Serotonin receptor antagonist
25944,n01,BRD-A86044036-001-04-2,cyclooxygenase inhibitor
25944,n06,BRD-A87479750-001-01-9,Cyclooxygenase inhibitor
25944,n08,BRD-A87719232-001-02-4,Cyclooxygenase inhibitor
25944,n11,BRD-A88254928-001-04-6,adrenergic receptor agonist
25944,n12,BRD-A88282067-001-02-2,Antiarrhythmic
25944,n15,BRD-A88548664-001-01-5,dopamine receptor agonist
25944,n18,BRD-A89434049-001-02-1,ATPase inhibitor
25944,n19,BRD-A89585551-003-03-4,adenosine receptor antagonist|hemoglobin antagonist
25944,n20,BRD-A89672324-001-02-2,GABA receptor antagonist
25944,n22,BRD-A89947015-001-01-4,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor
25944,n24,BRD-A90311807-236-01-4,Dehydropeptidase inhibitor
25944,o01,BRD-A90462498-003-02-1,antineoplastic
25944,o02,BRD-A90490067-001-01-9,estrogen receptor antagonist|DNA directed DNA polymerase inhibitor|soluble epoxide hydrolase inhibitor
25944,o03,BRD-A90515964-001-05-8,expectorant
25944,o04,BRD-A90799790-001-04-1,calcium channel blocker
25944,o06,BRD-A91008255-001-02-8,calcium channel blocker
25944,o08,BRD-A91699651-316-04-2,Antimalarial
25944,o09,BRD-A91866971-001-02-2,Thromboxane receptor antagonist
25944,o13,BRD-A92161634-001-02-6,Acetylcholine receptor antagonist
25944,o14,BRD-A92585442-237-01-0,Cytochrome P450 inhibitor
25944,o15,BRD-A92670106-003-03-9,Sodium channel blocker
25944,o16,BRD-A92826379-009-02-6,Sodium channel blocker
25944,o18,BRD-A93000692-001-03-2,PPAR receptor agonist
25944,o19,BRD-A93206962-001-01-2,adrenergic receptor agonist|adrenergic receptor partial agonist
25944,o20,BRD-A93255169-001-06-9,TNF production inhibitor
25944,o24,BRD-A93477898-001-01-8,caspase activator
25944,p01,BRD-A93659613-051-03-6,Opioid receptor agonist
25944,p02,BRD-A93739713-065-02-7,muscarinic antagonist
25944,p05,BRD-A94413429-003-01-6,neuropeptide receptor antagonist
25944,p06,BRD-A94543220-001-02-3,Sterol demethylase inhibitor
25944,p07,BRD-A94624445-236-02-2,adenosine receptor agonist|cAMP stimulant
25944,p08,BRD-A94669766-001-02-6,Aromatase inhibitor
25944,p10,BRD-A94709349-001-02-6,Muscle relaxant
25944,p13,BRD-A95096829-300-01-4,dopamine receptor antagonist
25944,p14,BRD-A95207036-001-02-8,androgen receptor antagonist
25944,p15,BRD-A95445494-001-02-9,interleukin synthesis inhibitor|sodium/glucose cotransporter inhibitor
25944,p16,BRD-A95513702-001-02-2,aromatase inhibitor
25944,p17,BRD-A95696066-003-06-2,Norepinephrine reuptake inhibitor
25944,p18,BRD-A95869247-001-03-8,thiazide diuretic
25944,p19,BRD-A95939040-008-03-3,sterol demethylase inhibitor
25944,p20,BRD-A96456596-001-01-4,Leukotriene receptor antagonist
25944,p21,BRD-A96485169-001-02-8,Aldose reductase inhibitor
25944,p23,BRD-A96882008-001-01-3,Tachykinin antagonist
25944,p24,BRD-A96897502-001-02-0,lipid peroxidase inhibitor
24294,a01,BRD-A00100033-001-04-8,DNA inhibitor
24294,a02,BRD-A00267231-001-01-1,Adenosine receptor agonist
24294,a04,BRD-A00520476-001-03-3,Acetylcholine receptor antagonist
24294,a06,BRD-A00993607-003-04-8,Adrenergic receptor antagonist
24294,a07,BRD-A01078468-001-04-9,synthetic estrogen
24294,a08,BRD-A01295252-001-01-5,Dopamine receptor ligand
24294,a09,BRD-A01320529-001-05-9,adrenergic receptor agonist
24294,a11,BRD-A01593789-001-01-5,5 alpha reductase inhibitor
24294,a12,BRD-A01636364-003-04-5,sodium channel blocker
24294,a15,BRD-A01787639-003-08-6,adrenergic receptor antagonist
24294,a16,BRD-A02006392-001-06-5,calcium channel blocker
24294,a17,BRD-A02176148-001-02-2,Mitochondrial complex I inhibitor
24294,a19,BRD-A02710418-003-03-5,opioid receptor agonist
24294,a20,BRD-A02713983-001-02-0,growth factor receptor activator
24294,a21,BRD-A02759312-003-11-2,Adrenergic receptor antagonist
24294,a23,BRD-A03216249-003-02-9,Potassium channel blocker
24294,a24,BRD-A03359064-001-01-5,Adrenergic receptor antagonist
24294,b02,BRD-A03623303-045-02-0,Adrenergic receptor antagonist
24294,b03,BRD-A03816571-001-01-0,cannabinoid receptor agonist|CC chemokine receptor antagonist
24294,b09,BRD-A04322457-003-03-9,adrenergic receptor agonist
24294,b10,BRD-A04438777-001-01-4,dopamine receptor agonist
24294,b11,BRD-A04553218-050-03-0,histamine receptor antagonist
24294,b15,BRD-A04668240-001-01-5,GABA receptor antagonist
24294,b16,BRD-A04706586-236-01-7,Adenosine receptor agonist
24294,b18,BRD-A05186015-003-04-0,dopamine uptake inhibitor
24294,b24,BRD-A06352418-001-03-6,Histamine receptor antagonist
24294,c01,BRD-A06352508-001-02-9,CHK inhibitor
24294,c02,BRD-A06390036-001-02-0,Antiarrhythmic
24294,c03,BRD-A06726973-001-02-0,cGMP analog
24294,c04,BRD-A06935312-001-02-7,bacterial 30S ribosomal subunit inhibitor
24294,c06,BRD-A07207424-001-04-1,phosphodiesterase inhibitor
24294,c08,BRD-A07440155-003-04-9,Adrenergic receptor antagonist
24294,c09,BRD-A07780951-001-02-2,Adrenergic receptor agonist
24294,c10,BRD-A07824748-001-02-6,11-beta hydroxysteroid dehydrogenase inhibitor
24294,c14,BRD-A07875874-001-01-6,calcium channel blocker
24294,c17,BRD-A07932845-001-01-1,anti-HCVE2
24294,c18,BRD-A07952294-001-02-3,farnesyltransferase inhibitors
24294,c19,BRD-A08187463-001-03-8,enkephalinase inhibitor
24294,c22,BRD-A08709697-001-02-9,pyrrolizidine alkaloid
24294,c23,BRD-A08877921-001-02-2,Protein synthesis inhibitor
24294,c24,BRD-A09056319-003-03-6,Adrenergic receptor antagonist
24294,d01,BRD-A09062839-003-03-5,Local anesthetic
24294,d02,BRD-A09094913-001-02-3,acetylcholine receptor antagonist
24294,d03,BRD-A09161221-001-01-9,HSP inhibitor
24294,d04,BRD-A09349126-001-02-4,progesterone receptor agonist
24294,d05,BRD-A09467419-003-04-2,acetylcholine receptor antagonist
24294,d06,BRD-A09472452-001-02-8,Sodium channel blocker
24294,d07,BRD-A09533288-001-02-7,calcium channel blocker
24294,d08,BRD-A09539288-004-02-8,Acetylcholine receptor antagonist
24294,d09,BRD-A09828896-004-04-5,Dopamine receptor agonist
24294,d10,BRD-A09925278-003-03-1,Adrenergic receptor agonist
24294,d14,BRD-A10070317-003-05-1,adrenergic receptor antagonist
24294,d17,BRD-A10355991-003-01-8,Glutamate receptor antagonist
24294,d18,BRD-A10715913-001-02-0,Dopamine receptor antagonist
24294,d19,BRD-A10739734-003-01-5,adrenergic receptor antagonist
24294,d20,BRD-A10903566-003-02-8,Adrenergic receptor antagonist
24294,d21,BRD-A10969569-001-02-0,Plant alkaloid
24294,d22,BRD-A10977446-001-04-8,Adrenergic receptor antagonist
24294,e03,BRD-A11605036-001-03-2,GABA receptor antagonist
24294,e04,BRD-A11609859-303-01-2,opioid receptor agonist
24294,e05,BRD-A11678676-001-02-6,PI3K inhibitor
24294,e07,BRD-A11813248-001-02-8,Potassium channel blocker
24294,e08,BRD-A12016240-001-01-7,Serotonin receptor antagonist
24294,e14,BRD-A13188892-066-03-3,Adrenergic receptor antagonist
24294,e15,BRD-A13650332-236-03-9,Bacterial cell wall synthesis inhibitor
24294,e16,BRD-A13946108-001-03-1,Cyclooxygenase inhibitor
24294,e23,BRD-A14395271-001-01-5,Dopamine receptor antagonist
24294,e24,BRD-A14566392-004-03-5,acetylcholine receptor antagonist
24294,f03,BRD-A14574269-051-01-4,Acetylcholine receptor agonist
24294,f04,BRD-A15034104-002-03-6,interleukin inhibitor
24294,f05,BRD-A15070535-323-02-1,adenosine receptor agonist|cAMP stimulant
24294,f06,BRD-A15415227-003-01-1,PPAR receptor agonist
24294,f07,BRD-A15435692-003-01-5,sigma receptor antagonist|glutamate receptor antagonist|serotonin receptor agonist
24294,f11,BRD-A15530910-001-01-3,adrenergic receptor antagonist|serotonin receptor antagonist
24294,f14,BRD-A15914070-001-01-5,cytotoxic lipid peroxidation product
24294,f15,BRD-A16332958-001-02-4,Adrenergic receptor agonist
24294,f16,BRD-A16665823-008-03-3,Bacterial cell wall synthesis inhibitor
24294,f19,BRD-A16694057-001-02-7,PPAR receptor antagonist
24294,f21,BRD-A17065207-001-06-9,protein synthesis inhibitor
24294,f23,BRD-A17428743-001-01-1,Serotonin receptor agonist
24294,f24,BRD-A17453586-001-01-9,Serotonin receptor agonist
24294,g02,BRD-A17535965-001-02-2,Acetylcholine receptor antagonist
24294,g05,BRD-A17655518-001-02-0,Cyclooxygenase inhibitor
24294,g08,BRD-A18043272-001-03-2,succinimide antiepileptic
24294,g09,BRD-A18202423-001-01-6,Glutamate receptor antagonist
24294,g10,BRD-A18497530-001-04-6,adenosine kinase inhibitor|nucleoside transporter inhibitor
24294,g11,BRD-A18579359-001-03-1,Neural Wiskott-Aldrich syndrome protein inhibitor
24294,g12,BRD-A18696154-003-11-9,adrenergic receptor antagonist
24294,g13,BRD-A18763547-019-01-0,Cytochrome C release inhibitor
24294,g15,BRD-A19053259-003-03-3,Anthelmintic
24294,g17,BRD-A19195498-050-04-2,Norepinephrine reuptake inhibitor
24294,g18,BRD-A19736161-310-01-3,Serotonin receptor antagonist
24294,g23,BRD-A20239487-001-02-5,Adrenergic receptor antagonist
24294,h01,BRD-A20348246-001-04-2,GABA receptor modulator
24294,h06,BRD-A20968261-001-01-3,glutamate transporter inhibitor
24294,h08,BRD-A21723284-066-01-7,Opioid receptor antagonist
24294,h09,BRD-A21858158-001-04-5,Anthelmintic
24294,h14,BRD-A22305049-003-04-5,gluconeogenesis inhibitor
24294,h15,BRD-A22380646-001-01-5,ATPase inhibitor
24294,h16,BRD-A22684332-003-02-3,adrenergic receptor agonist
24294,h17,BRD-A22707317-001-02-5,GABA receptor modulator
24294,h21,BRD-A22769835-300-03-2,Antihistamine
24294,h22,BRD-A22783572-065-01-3,microtubule formation inhibitor|tubulin inhibitor|tubulin polymerisation inhibitor
24294,h23,BRD-A22844106-001-04-7,Cyclooxygenase inhibitor
24294,h24,BRD-A23034328-003-03-4,protein synthesis inhibitor
24294,i01,BRD-A23072235-050-04-5,Histamine receptor antagonist
24294,i02,BRD-A23226398-001-02-7,estrogen receptor agonist
24294,i03,BRD-A23683907-334-01-0,serotonin receptor antagonist
24294,i04,BRD-A23723433-001-01-2,tubulin inhibitor|microtubule stabilizing agent|microtubule stimulant|P glycoprotein inhibitor|taxane
24294,i08,BRD-A24122750-001-01-1,GABA receptor antagonist
24294,i09,BRD-A24191444-045-03-1,Adrenergic receptor antagonist
24294,i10,BRD-A24228527-001-04-2,Bacterial DNA gyrase inhibitor
24294,i13,BRD-A24514565-236-01-6,Vitamin K antagonist
24294,i15,BRD-A24587114-066-03-5,adrenergic receptor agonist
24294,i16,BRD-A24817035-001-04-7,central nervous system agent
24294,i17,BRD-A25234499-001-04-3,glucocorticoid receptor antagonist
24294,i20,BRD-A25775766-001-03-3,GABA receptor antagonist|TP53 activator
24294,i23,BRD-A26032986-050-01-3,Calmodulin antagonist
24294,i24,BRD-A26222320-001-02-6,protein synthesis inhibitor
24294,j01,BRD-A26334849-001-02-1,Antiarrhythmic
24294,j02,BRD-A26384407-001-04-6,Carbonic anhydrase inhibitor
24294,j03,BRD-A26711594-001-02-7,calcium channel blocker
24294,j07,BRD-A26845397-001-01-4,Adrenergic receptor antagonist
24294,j09,BRD-A27143604-001-01-2,Estrogen receptor agonist
24294,j14,BRD-A28318179-003-03-6,Nitric oxide synthase inhibitor
24294,j15,BRD-A28856712-003-04-7,adrenergic receptor agonist
24294,j18,BRD-A29260609-003-04-7,adrenergic receptor antagonist
24294,j19,BRD-A29289453-001-02-1,platelet activating factor receptor antagonist
24294,j20,BRD-A29322418-237-02-4,mineralocorticoid receptor antagonist
24294,k01,BRD-A29426959-050-04-1,Histamine receptor antagonist
24294,k02,BRD-A29437505-001-01-6,TLR agonist
24294,k04,BRD-A29644307-050-04-8,Dopamine uptake inhibitor
24294,k05,BRD-A29734509-011-02-9,Sodium channel blocker
24294,k10,BRD-A30590053-003-01-1,Acetylcholine release enhancer
24294,k11,BRD-A30655177-001-04-1,BTK inhibitor
24294,k13,BRD-A30717181-001-02-7,glucocorticoid receptor agonist
24294,k14,BRD-A30815329-001-03-0,Calcium channel blocker
24294,k17,BRD-A31007383-001-01-0,Adenosine receptor agonist
24294,k18,BRD-A31159102-001-01-9,Selective serotonin reuptake inhibitor (SSRI)
24294,k19,BRD-A31195449-004-01-9,Serotonin receptor agonist
24294,k20,BRD-A31521121-001-04-1,Muscle relaxant
24294,k21,BRD-A31575449-300-01-4,Adrenergic receptor antagonist
24294,l02,BRD-A31800922-003-04-6,acetylcholine receptor antagonist
24294,l05,BRD-A32164164-048-01-4,Acetylcholine receptor antagonist
24294,l06,BRD-A32505112-001-02-8,angiotensin converting enzyme inhibitor
24294,l09,BRD-A32673558-003-02-1,acetylcholine receptor agonist
24294,l10,BRD-A32949107-001-01-7,calcium channel blocker
24294,l12,BRD-A33168282-003-06-5,Adrenergic receptor antagonist
24294,l13,BRD-A33447119-001-02-5,Anthelmintic
24294,l14,BRD-A33711280-311-02-0,Acetylcholine receptor antagonist
24294,l19,BRD-A34255068-001-04-8,phosphodiesterase inhibitor
24294,l20,BRD-A34309505-001-08-5,benzodiazepine receptor agonist
24294,l22,BRD-A34706053-003-01-9,Adrenergic receptor agonist
24294,m01,BRD-A34751532-001-03-6,HSP inducer
24294,m03,BRD-A34788695-003-04-5,bacterial 30S ribosomal subunit inhibitor
24294,m04,BRD-A34806832-001-02-7,ATPase inhibitor
24294,m07,BRD-A35033682-001-01-0,cytochrome P450 inhibitor
24294,m08,BRD-A35338386-001-04-6,adenosine receptor agonist
24294,m11,BRD-A35511923-019-01-6,Somatostatin receptor agonist
24294,m12,BRD-A35623999-001-03-2,mitochondrial Na+/Ca2+ exchanger antagonist|sodium/calcium exchange inhibitor
24294,m16,BRD-A35931254-003-02-7,dopamine receptor agonist
24294,m18,BRD-A36066264-001-02-3,Estrogen receptor agonist
24294,m19,BRD-A36074203-003-03-5,Glutamate receptor antagonist
24294,m20,BRD-A36217750-001-04-9,Uricosuric blocker
24294,m21,BRD-A36267905-003-02-8,Adrenergic receptor agonist
24294,m22,BRD-A36318220-001-01-3,RIPK inhibitor
24294,m23,BRD-A36471396-003-02-2,Acetylcholine receptor antagonist
24294,n01,BRD-A37347161-003-01-8,opioid receptor agonist
24294,n02,BRD-A37432947-004-02-5,acetylcholine receptor antagonist
24294,n03,BRD-A37441042-003-02-2,adrenergic receptor agonist
24294,n04,BRD-A37492983-001-03-8,radiopaque medium
24294,n06,BRD-A37704979-001-02-4,p38 MAPK inhibitor
24294,n07,BRD-A37776212-003-02-5,opioid receptor agonist
24294,n17,BRD-A38747044-001-01-5,Imidazoline receptor ligand
24294,n18,BRD-A38898897-003-01-0,Leukocyte elastase inhibitor
24294,n19,BRD-A38913120-001-01-0,BCL inhibitor
24294,n21,BRD-A39230911-001-03-7,Muscle relaxant
24294,n22,BRD-A39255369-001-01-5,Chloride channel blocker
24294,n23,BRD-A39268308-001-02-0,Acetylcholine receptor agonist
24294,o01,BRD-A39522003-001-01-0,FAAH inhibitor|FAAH reuptake inhibitor
24294,o03,BRD-A39747742-001-02-7,estrogen receptor agonist
24294,o05,BRD-A39969961-001-01-3,Cytochrome P450 inhibitor
24294,o06,BRD-A40022950-001-02-9,ATPase inhibitor
24294,o08,BRD-A40639672-234-04-0,Cyclooxygenase inhibitor
24294,o10,BRD-A41112154-001-02-1,G protein-coupled receptor agonist
24294,o13,BRD-A41145729-001-02-7,Retinoid receptor agonist
24294,o14,BRD-A41250306-001-03-4,Thiazide diuretic
24294,o15,BRD-A41301928-001-02-5,"Mitochondrial ADP, ATP translocase inhibitor"
24294,o16,BRD-A41304429-001-04-9,Adrenergic receptor antagonist
24294,o17,BRD-A41451487-001-01-3,Benzodiazepine receptor antagonist
24294,o18,BRD-A41519720-001-02-2,Niemann-Pick C1-like 1 protein antagonist
24294,o19,BRD-A41722204-003-01-5,adenosine receptor antagonist
24294,o20,BRD-A41833852-001-01-9,Opioid receptor antagonist
24294,o22,BRD-A41941932-001-03-0,Antioxidant
24294,o23,BRD-A42167015-003-03-7,Adrenergic receptor antagonist
24294,o24,BRD-A42335949-300-04-9,phosphatidylglycerophosphatase inhibitor
24294,p01,BRD-A42346008-003-03-6,epinephrine metabolite
24294,p02,BRD-A42553870-001-05-1,neuropeptide receptor antagonist
24294,p03,BRD-A42571354-300-01-3,histamine receptor antagonist
24294,p04,BRD-A42628519-001-04-1,radiopaque medium
24294,p05,BRD-A42759514-001-03-1,Antiprotozoal
24294,p06,BRD-A42831637-001-02-2,anti-inflammatory|Cannabinoid metabolite
24294,p07,BRD-A43076080-001-03-3,protein phosphatase inhibitor
24294,p09,BRD-A43150328-001-02-0,other antibiotic
24294,p13,BRD-A43671941-003-03-6,Adrenergic receptor antagonist
24294,p14,BRD-A43849199-001-02-3,Phytotoxin
24294,p15,BRD-A43930669-003-01-0,oxytocin receptor antagonist
24294,p16,BRD-A43940795-001-02-8,serotonin release inhibitor
24294,p17,BRD-A43974499-066-01-1,Adrenergic receptor antagonist
24294,p19,BRD-A44008656-036-04-3,Histamine receptor antagonist
24294,p20,BRD-A44090213-001-04-1,Cyclooxygenase inhibitor
24294,p21,BRD-A44133049-001-01-5,Serotonin receptor antagonist
24294,p22,BRD-A44448661-001-02-2,Barbiturate antiepileptic
24294,p23,BRD-A44551378-001-01-9,EGFR inhibitor
24294,p24,BRD-A44863528-001-04-1,CCK receptor antagonist
25949,a01,BRD-A44966919-001-03-1,acetylcholine receptor antagonist
25949,a02,BRD-A45140972-060-02-4,bacterial 50S ribosomal subunit inhibitor
25949,a03,BRD-A45499626-001-01-0,Glutamate receptor antagonist
25949,a04,BRD-A45543382-001-02-7,radiopaque medium
25949,a05,BRD-A46066006-004-04-4,muscarinic antagonist
25949,a10,BRD-A47144777-001-02-5,HSP90 inhibitor
25949,a11,BRD-A47494775-003-03-0,Adrenergic receptor agonist
25949,a12,BRD-A47513740-001-02-5,protein phosphatase inhibitor
25949,a15,BRD-A47598013-004-02-0,selective serotonin reuptake inhibitor (SSRI)
25949,a17,BRD-A48257147-001-01-9,glutamate receptor agonist
25949,a18,BRD-A48300215-001-01-4,sodium channel blocker
25949,a21,BRD-A48809242-001-02-9,adenosine receptor agonist
25949,a23,BRD-A49046702-001-01-2,GABA uptake inhibitor
25949,a24,BRD-A49172652-001-13-1,ATPase inhibitor
25949,b01,BRD-A49225603-045-02-7,histamine receptor agonist
25949,b02,BRD-A49358627-001-03-9,PPAR receptor agonist
25949,b03,BRD-A49370193-051-01-7,serotonin receptor agonist
25949,b05,BRD-A49680073-001-01-9,JAK inhibitor|Lipocortin synthesis stimulant|STAT inhibitor
25949,b06,BRD-A49734948-001-03-3,Plant alkaloid
25949,b07,BRD-A49906757-004-03-1,Acetylcholine receptor antagonist
25949,b09,BRD-A50157456-065-02-4,adrenergic receptor agonist
25949,b10,BRD-A50311610-300-04-7,CAR agonist
25949,b11,BRD-A50675702-001-03-0,chloride channel blocker|GABA gated chloride channel blocker
25949,b12,BRD-A50684349-001-01-5,dopamine receptor agonist
25949,b15,BRD-A50737080-001-01-4,ATR kinase inhibitor
25949,b16,BRD-A50764878-001-01-4,serotonin receptor antagonist
25949,b19,BRD-A51410489-001-01-4,adrenergic receptor antagonist
25949,b21,BRD-A51714012-001-02-3,Adrenergic inhibitor
25949,b22,BRD-A51820102-008-04-0,Bacterial cell wall synthesis inhibitor
25949,b23,BRD-A51829654-001-01-4,Serotonin receptor antagonist
25949,c01,BRD-A52588987-004-04-1,Dopamine receptor antagonist
25949,c02,BRD-A52660433-066-01-3,Monoamine oxidase inhibitor
25949,c04,BRD-A52922642-001-02-9,L-type calcium channel blocker
25949,c05,BRD-A53077924-236-01-4,Selective serotonin reuptake enhancer (SSRE)
25949,c07,BRD-A53416814-001-01-5,nitric oxide production inhibitor|phosphoenolpyruvate carboxylase activator|serine/threonine protein phosphatase activator
25949,c09,BRD-A53576514-003-03-1,Acetylcholine receptor antagonist
25949,c10,BRD-A53952395-003-04-6,local anesthetic
25949,c13,BRD-A54029483-001-01-5,endothelin receptor antagonist
25949,c14,BRD-A54236247-003-02-7,Adrenergic receptor agonist
25949,c17,BRD-A54490543-066-04-4,monoamine oxidase inhibitor
25949,c18,BRD-A54845972-066-01-5,serotonin receptor agonist|adrenergic receptor partial agonist|dopamine receptor agonist
25949,c19,BRD-A54927599-001-07-8,P-selectin inhibitor
25949,c22,BRD-A55272860-001-03-9,dopamine receptor antagonist
25949,c23,BRD-A55369275-001-01-6,GABA receptor antagonist
25949,c24,BRD-A55393291-001-02-4,Androgen receptor agonist
25949,d01,BRD-A55424491-001-04-1,dihydrofolate reductase inhibitor
25949,d04,BRD-A55756846-001-05-5,PKA inhibitor
25949,d05,BRD-A55913614-316-04-7,antimalarial agent|DNA inhibitor
25949,d07,BRD-A56020723-001-02-0,cathepsin inhibitor|antiamyloidogenic agent
25949,d08,BRD-A56675431-001-04-0,Thiazide diuretic
25949,d13,BRD-A56987319-001-03-8,Adenylyl cyclase inhibitor
25949,d14,BRD-A57133233-003-03-7,histamine receptor antagonist
25949,d17,BRD-A57382968-001-06-8,Cyclooxygenase inhibitor
25949,d20,BRD-A58048407-001-06-3,Calcium channel blocker
25949,d24,BRD-A59215453-003-03-3,Acetylcholine receptor antagonist
25949,e03,BRD-A59303141-001-03-9,Thiazide diuretic
25949,e06,BRD-A60197193-001-05-4,Dopamine receptor antagonist
25949,e12,BRD-A61154809-001-03-5,ATP channel blocker|insulin secretagogue
25949,e14,BRD-A61392169-001-01-9,glutamate receptor antagonist
25949,e15,BRD-A61470182-001-02-4,macrophage activator
25949,e16,BRD-A61793559-001-04-0,Carbonic anhydrase inhibitor
25949,e19,BRD-A61856038-001-01-2,Lipoxygenase inhibitor
25949,e22,BRD-A62021152-003-01-8,serotonin receptor agonist
25949,e23,BRD-A62057054-001-01-5,Serotonin receptor antagonist
25949,f04,BRD-A62428732-096-02-6,antihistamine
25949,f05,BRD-A62505706-001-02-3,DNA directed DNA polymerase inhibitor
25949,f06,BRD-A62525898-001-02-9,Glucocorticoid receptor agonist
25949,f08,BRD-A63346720-300-01-1,sigma receptor antagonist|dopamine reuptake inhibitor
25949,f11,BRD-A63546914-003-01-2,Glutamate receptor antagonist
25949,f12,BRD-A63667919-103-01-9,dopamine receptor antagonist|partial serotonin receptor agonist
25949,f14,BRD-A63836183-362-01-1,angiotensin receptor antagonist
25949,f15,BRD-A63894585-001-03-4,glucocorticoid receptor agonist
25949,f16,BRD-A64092382-003-03-5,Sodium channel blocker
25949,f19,BRD-A64125466-236-02-0,choleretic agent
25949,f20,BRD-A64227845-004-02-8,Dopamine receptor agonist
25949,f21,BRD-A64228451-001-03-5,BTK inhibitor
25949,f23,BRD-A64485570-001-02-9,DNA directed DNA polymerase inhibitor|thymidylate synthase inhibitor
25949,g02,BRD-A64933752-001-01-0,adenosine receptor agonist
25949,g06,BRD-A64977602-001-01-9,Adrenergic receptor antagonist
25949,g07,BRD-A65013509-003-03-8,Acetylcholine receptor antagonist
25949,g08,BRD-A65051990-001-03-8,vitamin K antagonist
25949,g09,BRD-A65076780-001-01-3,adrenergic receptor antagonist|prolactin inhibitor
25949,g10,BRD-A65145453-001-02-0,glutamate receptor agonist
25949,g11,BRD-A65280694-003-03-8,Dopamine receptor antagonist
25949,g12,BRD-A65440446-001-02-5,Adrenergic receptor agonist
25949,g13,BRD-A65597028-003-02-4,Adrenergic receptor antagonist
25949,g14,BRD-A65615053-003-01-4,Serotonin receptor antagonist
25949,g15,BRD-A65671304-001-02-6,angiotensin receptor antagonist
25949,g17,BRD-A66025870-237-05-1,bacterial cell wall synthesis inhibitor
25949,g18,BRD-A66199457-001-02-2,antineoplastic
25949,g22,BRD-A66435872-313-01-8,Histamine receptor agonist
25949,g23,BRD-A66563878-003-01-8,Adrenergic receptor agonist
25949,h01,BRD-A66927094-001-01-7,Dopamine receptor antagonist
25949,h07,BRD-A67552019-001-02-2,ATPase inhibitor
25949,h09,BRD-A67862938-034-04-0,Adrenergic receptor antagonist
25949,h10,BRD-A68281735-001-02-0,Leukotriene receptor antagonist
25949,h12,BRD-A68723818-050-04-4,Histamine receptor antagonist
25949,h13,BRD-A68888262-003-02-9,histamine receptor antagonist
25949,h14,BRD-A68929948-001-01-9,antiamyloidogenic agent|gamma secretase inhibitor
25949,h15,BRD-A69636825-003-02-1,Calcium channel blocker
25949,h17,BRD-A69777949-001-04-4,topoisomerase inhibitor
25949,h18,BRD-A69786436-003-02-5,acetylcholine receptor antagonist
25949,h23,BRD-A70083328-001-02-9,Acetylcholinesterase inhibitor
25949,h24,BRD-A70268693-103-01-9,Acetylcholine receptor agonist
25949,i01,BRD-A70407468-001-01-2,adenosine receptor antagonist
25949,i02,BRD-A70514680-003-03-9,Local anesthetic
25949,i03,BRD-A70649075-008-04-3,sterol demethylase inhibitor
25949,i08,BRD-A71157293-003-03-5,Vitamin B
25949,i09,BRD-A71203467-001-01-5,Dopamine receptor antagonist
25949,i10,BRD-A71774530-001-01-8,chitin inhibitor
25949,i12,BRD-A71816415-236-02-7,HMGCR inhibitor
25949,i13,BRD-A72066420-001-01-1,PPAR receptor antagonist
25949,i14,BRD-A72483914-001-01-1,Serotonin receptor antagonist
25949,i15,BRD-A72596465-001-01-3,PPAR receptor antagonist
25949,i16,BRD-A72703248-001-02-7,calcium channel blocker|cytochrome P450 inhibitor
25949,i17,BRD-A72711497-236-02-0,bacterial permeability inducer
25949,i18,BRD-A72988804-001-03-8,Cyclooxygenase inhibitor
25949,i19,BRD-A73368467-003-02-8,Histamine receptor antagonist
25949,i23,BRD-A73859745-236-01-8,Apoptosis stimulant
25949,j02,BRD-A74667430-001-04-6,Cyclooxygenase inhibitor
25949,j03,BRD-A74904029-001-04-0,Casein kinase inhibitor
25949,j07,BRD-A74980173-001-02-8,Bacterial DNA gyrase inhibitor
25949,j09,BRD-A75478957-001-01-6,collagenase inhibitor|metalloproteinase inhibitor|stromelysin inhibitor
25949,j10,BRD-A75552914-001-04-4,Cyclooxygenase inhibitor
25949,j12,BRD-A75769826-003-01-3,opioid receptor antagonist
25949,j13,BRD-A75817871-001-02-6,ATPase inhibitor
25949,j14,BRD-A75850590-003-04-9,bacterial DNA gyrase inhibitor
25949,j16,BRD-A76093993-001-01-8,Potassium channel activator
25949,j24,BRD-A77291778-003-04-8,acetylcholine receptor antagonist
25949,k01,BRD-A77299732-001-01-6,Eukaryotic translation initiation factor inhibitor
25949,k02,BRD-A77349281-001-02-2,heparanase inhibitor|tyrosine phosphatase inhibitor
25949,k06,BRD-A78295502-337-03-5,anti-arrhythmia agent
25949,k10,BRD-A78377521-001-02-2,Kinesin-like spindle protein inhibitor
25949,k11,BRD-A78877355-003-03-6,Cyclooxygenase inhibitor
25949,k12,BRD-A78942461-003-01-3,Adrenergic receptor antagonist
25949,k13,BRD-A79226577-003-01-1,serotonin receptor antagonist|polarization inhibitor|sodium channel blocker
25949,k17,BRD-A79672927-001-04-1,Acetylcholine receptor antagonist
25949,k18,BRD-A79981887-003-04-0,adrenergic receptor agonist
25949,k19,BRD-A80017228-001-04-2,Sodium/potassium/chloride transporter inhibitor
25949,k21,BRD-A80213327-305-01-8,Ras GTPase inhibitor
25949,k22,BRD-A80594172-001-02-0,glucocorticoid receptor agonist
25949,l01,BRD-A80641450-001-01-4,Endothelin receptor antagonist
25949,l05,BRD-A81177136-001-03-6,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist
25949,l10,BRD-A81615860-001-02-9,tryptophan hydroxylase inhibitor
25949,l11,BRD-A81795050-003-01-7,oxidosqualene cyclase inhibitor
25949,l12,BRD-A81866333-003-01-5,Adenosine receptor agonist
25949,l13,BRD-A82238138-001-01-7,glucocorticoid receptor agonist
25949,l17,BRD-A82371568-001-01-5,ribonucleoside reductase inhibitor|DNA polymerase inhibitor|DNA repair enzyme inhibitor|DNA synthesis inhibitor|ribonucleotide reductase inhibitor
25949,l19,BRD-A82590476-001-01-1,tachykinin antagonist
25949,l20,BRD-A82656074-003-01-2,opioid receptor antagonist
25949,l22,BRD-A83326220-001-02-6,Nitric oxide production inhibitor
25949,m02,BRD-A83431637-001-01-3,Cytochrome P450 inhibitor
25949,m04,BRD-A83695761-001-01-1,Potassium channel blocker
25949,m05,BRD-A83855350-003-01-4,Opioid receptor antagonist
25949,m07,BRD-A83937277-001-03-0,Hydantoin antiepileptic
25949,m08,BRD-A84174393-001-02-0,Cyclooxygenase inhibitor
25949,m11,BRD-A84174873-001-06-0,benzodiazepine receptor agonist
25949,m12,BRD-A84389091-001-01-1,GABA receptor inverse agonist
25949,m15,BRD-A84389633-001-01-6,serotonin receptor antagonist
25949,m19,BRD-A85137183-001-01-2,bacterial cell wall synthesis inhibitor
25949,m21,BRD-A85234536-001-04-5,Adenosine receptor agonist
25949,m22,BRD-A85280935-003-01-7,Dopamine receptor agonist
25949,m23,BRD-A85472596-001-01-4,Prostanoid receptor antagonist
25949,m24,BRD-A85587465-001-01-7,Serotonin receptor antagonist
25949,n01,BRD-A86044036-001-04-2,cyclooxygenase inhibitor
25949,n06,BRD-A87479750-001-01-9,Cyclooxygenase inhibitor
25949,n08,BRD-A87719232-001-02-4,Cyclooxygenase inhibitor
25949,n11,BRD-A88254928-001-04-6,adrenergic receptor agonist
25949,n12,BRD-A88282067-001-02-2,Antiarrhythmic
25949,n15,BRD-A88548664-001-01-5,dopamine receptor agonist
25949,n18,BRD-A89434049-001-02-1,ATPase inhibitor
25949,n19,BRD-A89585551-003-03-4,adenosine receptor antagonist|hemoglobin antagonist
25949,n20,BRD-A89672324-001-02-2,GABA receptor antagonist
25949,n22,BRD-A89947015-001-01-4,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor
25949,n24,BRD-A90311807-236-01-4,Dehydropeptidase inhibitor
25949,o01,BRD-A90462498-003-02-1,antineoplastic
25949,o02,BRD-A90490067-001-01-9,estrogen receptor antagonist|DNA directed DNA polymerase inhibitor|soluble epoxide hydrolase inhibitor
25949,o03,BRD-A90515964-001-05-8,expectorant
25949,o04,BRD-A90799790-001-04-1,calcium channel blocker
25949,o06,BRD-A91008255-001-02-8,calcium channel blocker
25949,o08,BRD-A91699651-316-04-2,Antimalarial
25949,o09,BRD-A91866971-001-02-2,Thromboxane receptor antagonist
25949,o13,BRD-A92161634-001-02-6,Acetylcholine receptor antagonist
25949,o14,BRD-A92585442-237-01-0,Cytochrome P450 inhibitor
25949,o15,BRD-A92670106-003-03-9,Sodium channel blocker
25949,o16,BRD-A92826379-009-02-6,Sodium channel blocker
25949,o18,BRD-A93000692-001-03-2,PPAR receptor agonist
25949,o19,BRD-A93206962-001-01-2,adrenergic receptor agonist|adrenergic receptor partial agonist
25949,o20,BRD-A93255169-001-06-9,TNF production inhibitor
25949,o24,BRD-A93477898-001-01-8,caspase activator
25949,p01,BRD-A93659613-051-03-6,Opioid receptor agonist
25949,p02,BRD-A93739713-065-02-7,muscarinic antagonist
25949,p05,BRD-A94413429-003-01-6,neuropeptide receptor antagonist
25949,p06,BRD-A94543220-001-02-3,Sterol demethylase inhibitor
25949,p07,BRD-A94624445-236-02-2,adenosine receptor agonist|cAMP stimulant
25949,p08,BRD-A94669766-001-02-6,Aromatase inhibitor
25949,p10,BRD-A94709349-001-02-6,Muscle relaxant
25949,p13,BRD-A95096829-300-01-4,dopamine receptor antagonist
25949,p14,BRD-A95207036-001-02-8,androgen receptor antagonist
25949,p15,BRD-A95445494-001-02-9,interleukin synthesis inhibitor|sodium/glucose cotransporter inhibitor
25949,p16,BRD-A95513702-001-02-2,aromatase inhibitor
25949,p17,BRD-A95696066-003-06-2,Norepinephrine reuptake inhibitor
25949,p18,BRD-A95869247-001-03-8,thiazide diuretic
25949,p19,BRD-A95939040-008-03-3,sterol demethylase inhibitor
25949,p20,BRD-A96456596-001-01-4,Leukotriene receptor antagonist
25949,p21,BRD-A96485169-001-02-8,Aldose reductase inhibitor
25949,p23,BRD-A96882008-001-01-3,Tachykinin antagonist
25949,p24,BRD-A96897502-001-02-0,lipid peroxidase inhibitor
25986,a01,BRD-K40782193-003-01-1,sodium channel blocker
25986,a02,BRD-K40887525-001-02-9,serotonin receptor antagonist
25986,a03,BRD-K40901640-001-01-0,serotonin receptor antagonist
25986,a04,BRD-K40905133-001-02-3,sodium channel blocker
25986,a05,BRD-K40965114-001-01-2,Adrenergic receptor antagonist
25986,a06,BRD-K40990712-001-02-4,gonadotropin releasing factor hormone receptor antagonist|sodium/hydrogen antiport inhibitor|sodium/hydrogen exchanger inhibitor|urokinase inhibitor
25986,a07,BRD-K41143549-003-01-6,glutamate receptor antagonist
25986,a08,BRD-K41337261-001-01-4,Src and Abl inhibitor|vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor
25986,a09,BRD-K41406082-001-04-8,PABA antagonist
25986,a11,BRD-K41445866-001-03-0,Chloride channel agonist
25986,a12,BRD-K41524689-001-05-2,cyclooxygenase inhibitor
25986,a15,BRD-K41564320-001-01-2,tyrosine kinase inhibitor
25986,a16,BRD-K41567364-001-01-2,orexin receptor antagonist
25986,a19,BRD-K41707108-001-02-3,Phosphoenolpyruvate carboxylase activator
25986,a20,BRD-K41713976-001-02-0,potassium channel blocker
25986,a23,BRD-K41868777-003-02-9,calmodulin antagonist
25986,b01,BRD-K41876534-001-02-0,carbonic anhydrase inhibitor
25986,b02,BRD-K41996876-001-05-5,EGFR inhibitor
25986,b03,BRD-K42098891-003-03-1,tricyclic antidepressant
25986,b04,BRD-K42221274-001-01-4,GAT inhibitor
25986,b05,BRD-K42348709-003-04-0,adrenergic receptor agonist|serotonin receptor agonist
25986,b07,BRD-K42452249-001-01-7,p38 MAPK inhibitor
25986,b08,BRD-K42500029-001-01-9,"MAP kinase inhibitor|MAPK-interacting kinase inhibitor,"
25986,b10,BRD-K42635745-001-02-4,adrenergic receptor antagonist
25986,b12,BRD-K42679050-001-01-3,potassium channel activator|potassium channel agonist
25986,b16,BRD-K42748308-300-01-2,acetylcholine release enhancer|potassium channel blocker|voltage-gated potassium channel blocker
25986,b18,BRD-K43068349-001-01-9,TRPV antagonist
25986,b19,BRD-K43149758-001-04-5,Androgen receptor agonist
25986,b21,BRD-K43245338-001-02-4,calpain inhibitor|cathepsin inhibitor
25986,b22,BRD-K43290182-001-01-9,Serotonin receptor antagonist
25986,b23,BRD-K43330982-001-01-5,lysophospholipid receptor antagonist
25986,b24,BRD-K43389675-003-02-7,RNA synthesis inhibitor|topoisomerase inhibitor
25986,c01,BRD-K43405658-001-01-8,protein tyrosine kinase inhibitor
25986,c02,BRD-K43457670-001-04-7,carbonic anhydrase inhibitor
25986,c03,BRD-K43468059-001-02-9,Mycotoxin
25986,c05,BRD-K43736954-001-03-3,glucocorticoid receptor agonist
25986,c06,BRD-K43744935-048-01-6,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)|estrogen receptor agonist|estrogen receptor modulator|PKC inhibitor
25986,c07,BRD-K43796186-001-01-1,EGFR inhibitor
25986,c08,BRD-K43860855-065-03-6,antineoplastic agent
25986,c09,BRD-K44067360-001-06-3,chloride channel blocker
25986,c10,BRD-K44084986-001-03-9,rho associated kinase inhibitor
25986,c18,BRD-K44849676-001-03-0,TRPV agonist
25986,c19,BRD-K44876623-001-01-1,Benzodiazepine receptor agonist
25986,c20,BRD-K44899736-003-02-1,Monoamine oxidase inhibitor
25986,c22,BRD-K45033733-001-02-3,DNA polymerase inhibitor
25986,c24,BRD-K45068323-003-01-3,Calmodulin antagonist
25986,d02,BRD-K45117373-001-01-1,potassium channel activator|potassium channel agonist
25986,d03,BRD-K45158365-001-02-3,angiotensin receptor antagonist
25986,d04,BRD-K45296539-003-01-0,Adrenergic receptor agonist
25986,d05,BRD-K45330754-001-04-3,estrogen receptor agonist
25986,d06,BRD-K45401373-001-05-0,Apoptosis stimulant
25986,d07,BRD-K45435259-001-01-6,Dopamine receptor antagonist
25986,d09,BRD-K45479396-001-01-8,Serotonin receptor agonist
25986,d13,BRD-K45542189-048-04-9,Lipoxygenase inhibitor
25986,d14,BRD-K45662124-001-01-8,dopamine receptor ligand
25986,d17,BRD-K45861246-001-04-3,Dopamine receptor antagonist
25986,d19,BRD-K46018455-001-06-0,PPAR receptor agonist
25986,d20,BRD-K46137903-001-03-3,phospholipase activator
25986,d21,BRD-K46142322-003-01-6,serotonin receptor partial agonist
25986,d22,BRD-K46211610-003-05-1,Adrenergic receptor antagonist
25986,d23,BRD-K46317332-003-04-6,Nitric oxide synthase inhibitor
25986,d24,BRD-K46384212-001-01-1,phospholipase activator
25986,e03,BRD-K46424862-001-04-2,Monoamine oxidase inhibitor
25986,e04,BRD-K46435977-003-01-2,DNA polymerase inhibitor
25986,e05,BRD-K46441700-001-01-8,serotonin receptor antagonist
25986,e06,BRD-K46469693-001-01-8,adenosine receptor antagonist
25986,e08,BRD-K46556543-237-03-0,Mineralocorticoid receptor antagonist
25986,e13,BRD-K46766488-003-01-2,Serotonin receptor agonist
25986,e14,BRD-K46862739-001-03-6,cytochrome P450 inhibitor
25986,e15,BRD-K46937689-001-05-1,Cyclooxygenase inhibitor
25986,e16,BRD-K47105409-001-05-3,JAK inhibitor
25986,e20,BRD-K47150025-001-01-2,PDGFR alpha and c-Kit inhibitor|vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor|VEGFR inhibitor
25986,e21,BRD-K47192521-001-02-1,Platelet aggregation inhibitor
25986,e22,BRD-K47207162-312-02-2,Serotonin reuptake inhibitor
25986,e23,BRD-K47278471-003-04-0,Histamine receptor antagonist
25986,e24,BRD-K47323024-003-04-6,Histamine receptor antagonist
25986,f03,BRD-K47328134-001-02-0,heparin activation inhibitor
25986,f07,BRD-K47598052-001-04-2,src inhibitor
25986,f08,BRD-K47608922-001-02-1,chelating agent
25986,f11,BRD-K47631482-003-02-1,Mucolytic agent
25986,f12,BRD-K47635719-001-03-9,glucocorticoid receptor agonist
25986,f13,BRD-K47639036-003-03-3,Acetylcholine receptor antagonist
25986,f14,BRD-K47659338-003-01-0,serotonin receptor agonist
25986,f15,BRD-K47693913-001-02-4,Furoquinoline alkaloid
25986,f16,BRD-K47717570-304-01-5,Glutamate receptor antagonist
25986,f21,BRD-K47869605-001-04-9,microtubule inhibitor|tubulin polymerization inhibitor
25986,f23,BRD-K47936004-001-01-9,dopamine receptor agonist
25986,f24,BRD-K47943470-001-02-8,EGFR inhibitor
25986,g05,BRD-K48168960-001-05-1,Thyroid peroxidase inhibitor
25986,g07,BRD-K48300629-001-03-8,Sodium channel blocker
25986,g11,BRD-K48692744-001-01-2,PARP inhibitor
25986,g12,BRD-K48722258-300-04-5,adenosine reuptake inhibitor
25986,g13,BRD-K48735772-001-01-4,EGFR inhibitor|epidermal growth factor receptor (EGFR) inhibitor
25986,g15,BRD-K49027941-237-01-1,Adenosine receptor antagonist
25986,g16,BRD-K49049886-001-03-8,adenosine receptor antagonist
25986,g17,BRD-K49111258-001-02-8,Adrenergic receptor antagonist
25986,g23,BRD-K49294207-300-01-2,EGFR inhibitor
25986,g24,BRD-K49448285-001-01-3,CDK inhibitor
25986,h01,BRD-K49481516-004-03-5,Acetylcholinesterase inhibitor
25986,h02,BRD-K49519092-303-01-4,Histamine receptor agonist
25986,h05,BRD-K49577446-001-03-1,cytochrome P450 inhibitor
25986,h06,BRD-K49657628-001-02-3,EGFR inhibitor|tyrosine kinase inhibitor
25986,h07,BRD-K49671696-001-02-1,Serotonin receptor antagonist
25986,h11,BRD-K49890030-236-01-6,Glutamate receptor antagonist
25986,h12,BRD-K49945136-001-03-5,Serotonin receptor antagonist
25986,h13,BRD-K50018155-003-01-3,Serotonin receptor partial agonist
25986,h15,BRD-K50135270-001-01-9,dopamine uptake inhibitor
25986,h17,BRD-K50214219-001-02-4,PARP inhibitor
25986,h21,BRD-K50325075-001-01-3,potassium channel blocker|slow afterhyperpolarization channel blocker
25986,h22,BRD-K50388907-001-04-9,PPAR receptor agonist
25986,h23,BRD-K50398167-236-02-9,Cyclooxygenase inhibitor
25986,i01,BRD-K50417881-003-05-9,Dopamine receptor antagonist
25986,i02,BRD-K50422030-001-01-2,GABA receptor antagonist
25986,i03,BRD-K50464341-001-02-6,calmodulin antagonist
25986,i04,BRD-K50495309-001-01-2,src inhibitor
25986,i07,BRD-K50660797-001-02-8,Bacterial DNA gyrase inhibitor
25986,i08,BRD-K50836978-001-01-7,CDK inhibitor
25986,i09,BRD-K50841342-001-01-6,caspase activator
25986,i10,BRD-K50859149-001-04-7,bacterial antifolate
25986,i11,BRD-K50891186-001-01-0,dopamine receptor antagonist
25986,i14,BRD-K51276371-001-01-8,CDK inhibitor|CFTR channel activator|glycogen synthase kinase inhibitor|JNK inhibitor
25986,i15,BRD-K51318897-001-04-7,tubulin polymerization inhibitor
25986,i17,BRD-K51465424-003-03-6,adrenergic receptor agonist
25986,i18,BRD-K51476772-001-01-9,tyrosine kinase inhibitor
25986,i19,BRD-K51541829-001-01-3,Ionotropic glutamate receptor antagonist
25986,i23,BRD-K51575138-001-01-7,IKK inhibitor
25986,i24,BRD-K51671335-001-01-5,Dopamine receptor antagonist
25986,j01,BRD-K51751936-001-03-4,benzodiazepine receptor agonist
25986,j03,BRD-K51918615-303-01-1,histamine receptor antagonist|histamine receptor inhibitor|ionotropic glutamate receptor antagonist
25986,j07,BRD-K52020312-001-04-5,DNA inhibitor
25986,j08,BRD-K52075040-001-02-2,fatty acid synthase inhibitor
25986,j10,BRD-K52219182-001-01-6,Phosphodiesterase inhibitor
25986,j11,BRD-K52313696-001-01-6,HDAC inhibitor
25986,j13,BRD-K52394958-001-01-9,tachykinin antagonist
25986,j14,BRD-K52397688-001-01-9,dopamine receptor antagonist|FAAH inhibitor|serotonin receptor antagonist
25986,j15,BRD-K52459643-001-10-2,Prostanoid receptor agonist
25986,j16,BRD-K52512893-001-03-0,Prostanoid receptor antagonist
25986,j18,BRD-K52662033-001-02-6,histamine receptor agonist
25986,j19,BRD-K52721684-001-02-2,potassium channel activator
25986,j20,BRD-K52850071-001-01-2,JAK inhibitor
25986,j23,BRD-K52930707-001-04-8,ACE inhibitor
25986,k01,BRD-K52989797-001-01-1,serotonin transporter (SERT) inhibitor
25986,k03,BRD-K53123955-001-03-0,Phosphofructokinase inhibitor
25986,k05,BRD-K53263234-001-02-9,constitutive androstane receptor (CAR) agonist
25986,k06,BRD-K53318339-001-04-1,Phosphodiesterase inhibitor
25986,k09,BRD-K53523901-001-01-0,adiponectin receptor agonist|AP inhibitor|aryl hydrocarbon receptor antagonist|HIV integrase inhibitor|MEK inhibitor|NFkB pathway inhibitor|topoisomerase inhibitor
25986,k11,BRD-K53545112-304-01-6,Glutamate receptor antagonist
25986,k13,BRD-K53737926-003-04-7,Norepinephrine inhibitor
25986,k14,BRD-K53857191-001-04-5,Dopamine receptor antagonist
25986,k17,BRD-K53878242-001-02-4,phosphodiesterase inhibitor
25986,k19,BRD-K53979406-003-01-0,glycine transporter inhibitor|GlyT-1 inhibitor
25986,k20,BRD-K54094468-001-01-6,dopamine receptor antagonist
25986,k21,BRD-K54095730-001-01-5,p38 MAPK inhibitor
25986,k22,BRD-K54142781-001-02-1,Adrenergic receptor agonist
25986,l01,BRD-K54210043-001-02-0,calcium channel activator|large conductance potassium channel activator
25986,l02,BRD-K54233340-300-01-0,AMPK inhibitor|DNA damaging|TGF beta receptor inhibitor
25986,l03,BRD-K54330070-001-05-5,p38 MAPK inhibitor
25986,l04,BRD-K54411430-001-02-5,cAMP inhibitor
25986,l06,BRD-K54529596-001-04-0,ACE inhibitor
25986,l10,BRD-K54665485-001-01-2,Diacylglycerol kinase inhibitor
25986,l11,BRD-K54704028-001-01-3,glutamate receptor antagonist
25986,l12,BRD-K54708045-001-01-3,PPAR receptor agonist
25986,l13,BRD-K54759182-003-02-3,Norepinephrine reuptake inhibitor
25986,l14,BRD-K54771420-001-03-2,Cholesterol inhibitor
25986,l17,BRD-K54790157-001-03-1,DNA synthesis inhibitor
25986,l19,BRD-K55034111-066-02-3,bacterial DNA gyrase inhibitor
25986,l21,BRD-K55191674-236-03-7,Penicillin binding protein inhibitor
25986,m01,BRD-K55344148-003-01-8,Imidazoline receptor ligand
25986,m02,BRD-K55424922-001-01-4,Serotonin receptor agonist
25986,m03,BRD-K55430733-003-01-6,Serotonin receptor agonist
25986,m04,BRD-K55454768-001-01-8,voltage-independent calcium influx blocker
25986,m05,BRD-K55468218-001-04-8,dopamine receptor antagonist
25986,m06,BRD-K55529781-236-02-0,thromboxane synthase inhibitor
25986,m07,BRD-K55567017-001-02-4,alcohol dehydrogenase inhibitor
25986,m08,BRD-K55677650-003-01-1,ionotropic glutamate receptor antagonist
25986,m11,BRD-K55748775-001-01-4,ATPase inhibitor|potassium-competitive acid antagonist
25986,m16,BRD-K55930204-001-02-7,Hydantoin antiepileptic
25986,m17,BRD-K56047318-001-02-2,Triacylglycerol lipase inhibitor
25986,m18,BRD-K56064827-001-04-7,PKC inhibitor
25986,m20,BRD-K56115039-003-01-3,Imidazoline receptor ligand
25986,m22,BRD-K56403959-300-01-9,CC chemokine receptor ligand
25986,m23,BRD-K56429665-001-03-9,vitamin D receptor agonist
25986,m24,BRD-K56509348-003-01-3,Endothelin receptor antagonist
25986,n02,BRD-K56558538-003-02-8,Sodium channel blocker
25986,n03,BRD-K56596464-004-02-4,Sodium channel blocker
25986,n04,BRD-K56699285-001-03-7,dopamine receptor agonist|serotonin receptor antagonist
25986,n08,BRD-K57033106-048-02-8,Histamine receptor antagonist
25986,n11,BRD-K57179821-001-04-8,Antipruritic
25986,n12,BRD-K57222227-001-06-1,cyclooxygenase inhibitor
25986,n16,BRD-K57304726-003-03-6,Sigma receptor agonist
25986,n18,BRD-K57545991-050-03-3,angiotensin converting enzyme inhibitor
25986,n19,BRD-K57569181-001-04-4,Phosphodiesterase inhibitor
25986,n21,BRD-K57718010-001-06-9,GABA receptor antagonist
25986,n22,BRD-K57886322-001-03-4,glucocorticoid receptor agonist
25986,n23,BRD-K57926513-001-02-9,PDGFR receptor inhibitor
25986,o01,BRD-K58220566-001-02-2,PKC inhibitor|sodium channel blocker|calcium channel blocker
25986,o02,BRD-K58265391-001-03-6,diuretic
25986,o03,BRD-K58299615-001-02-7,amyloid precursor protein inhibitor|beta amyloid aggregation inhibitor
25986,o05,BRD-K58466253-003-04-1,serotonin release inhibitor
25986,o06,BRD-K58685305-001-02-2,11-beta hydroxysteroid dehydrogenase inhibitor
25986,o08,BRD-K58930050-001-01-1,glutamate receptor antagonist
25986,o09,BRD-K58938839-001-03-8,smoothened receptor antagonist|hedgehog pathway inhibitor
25986,o10,BRD-K59037100-001-04-8,lipase inhibitor
25986,o13,BRD-K59058766-003-03-7,dopamine receptor antagonist
25986,o15,BRD-K59184148-001-04-2,glycogen synthase kinase inhibitor
25986,o18,BRD-K59273480-001-01-5,adenosine reuptake inhibitor|phosphodiesterase inhibitor
25986,o20,BRD-K59332007-300-01-9,acetylcholine release enhancer|acetylcholine release stimulant|neurotransmitter agonist|voltage-gated potassium channel blocker
25986,o22,BRD-K59419204-001-01-9,cannabinoid receptor antagonist|cannabinoid receptor inhibitor
25986,o23,BRD-K59469039-001-04-9,Angiogenesis inhibitor
25986,o24,BRD-K59522102-001-04-7,monoamine oxidase inhibitor
25986,p01,BRD-K59574735-001-02-7,leukotriene synthesis inhibitor
25986,p02,BRD-K59637651-001-01-4,protein synthesis inhibitor|botulin neurotoxin inhibitor|mur synthetase inhibitor
25986,p03,BRD-K59650319-003-01-7,glutamate receptor antagonist
25986,p04,BRD-K59753853-001-01-5,glutamate receptor antagonist
25986,p06,BRD-K59851896-001-02-4,GABA release inhibitor
25986,p07,BRD-K59983611-001-05-2,bacterial antifolate
25986,p09,BRD-K60060639-005-01-4,antiarrhythmic medication
25986,p10,BRD-K60174629-001-02-2,prolyl endopeptidase inhibitor
25986,p13,BRD-K60184833-001-02-3,tyrosine kinase inhibitor
25986,p14,BRD-K60230970-001-04-3,proteasome inhibitor
25986,p15,BRD-K60274257-001-01-1,tyrosine phosphatase inhibitor
25986,p17,BRD-K60298136-001-01-7,aryl hydrocarbon receptor agonist|aryl hydrocarbon receptor ligand
25986,p18,BRD-K60476892-001-02-1,activator of soluble guanylyl cyclase|guanylate cyclase activator|hypoxia inducible factor inhibitor
25986,p19,BRD-K60511616-236-01-4,HMGCR inhibitor
25986,p20,BRD-K60640630-001-03-7,glucocorticoid receptor agonist
25986,p22,BRD-K60923938-001-02-8,sodium channel activator
25986,p23,BRD-K60932973-001-01-7,dopamine receptor agonist
25986,p24,BRD-K61097567-001-03-6,tachykinin antagonist
24307,a01,BRD-A97104540-004-04-4,adrenergic receptor agonist
24307,a04,BRD-A97479839-003-04-2,Acetylcholine receptor antagonist
24307,a05,BRD-A97701745-001-04-6,adrenergic receptor antagonist|serotonin receptor antagonist
24307,a06,BRD-A97730597-003-03-2,sodium channel blocker
24307,a07,BRD-A97739905-001-04-2,cyclooxygenase inhibitor
24307,a08,BRD-A98299281-050-03-9,calcium channel activator
24307,a09,BRD-A98378129-001-01-4,cyclooxygenase inhibitor|calcium channel blocker|calcium-activated chloride channel blocker|mucin production inhibitor
24307,a10,BRD-A98702003-304-02-2,11-beta-HSD1 inhibitor
24307,a11,BRD-A98725278-103-01-9,serotonin receptor antagonist
24307,a15,BRD-A99177642-001-02-5,acetylcholine receptor antagonist
24307,a16,BRD-A99402294-236-02-0,bacterial cell wall synthesis inhibitor
24307,a17,BRD-A99411506-002-01-3,antioxidant
24307,a18,BRD-A99449986-001-01-4,adenine nucleotide translocase inhibitor|caspase activator|neurotrophic agent
24307,a19,BRD-A99571536-001-01-0,anti-epileptic
24307,a20,BRD-K00141480-001-03-0,anti-inflammatory agent|interleukin inhibitor
24307,a21,BRD-K00184207-001-02-4,aryl hydrocarbon receptor ligand
24307,a22,BRD-K00206590-001-01-2,ATP channel activator
24307,a23,BRD-K00259736-001-03-2,microtubule inhibitor
24307,a24,BRD-K00312224-001-03-8,estrogen receptor agonist
24307,b03,BRD-K00603606-003-03-4,purinergic receptor antagonist|platelet aggregation inhibitor
24307,b04,BRD-K00610438-003-01-7,serotonin receptor antagonist|collagen stimulant
24307,b05,BRD-K00662280-001-01-1,GABA receptor agonist
24307,b06,BRD-K00673382-001-04-9,histamine receptor antagonist
24307,b07,BRD-K00675675-003-01-2,metalloproteinase inhibitor
24307,b09,BRD-K00824317-001-03-0,glucocorticoid receptor agonist
24307,b11,BRD-K01095011-001-03-5,5 alpha reductase inhibitor
24307,b15,BRD-K01244426-236-04-8,bacterial cell wall synthesis inhibitor
24307,b16,BRD-K01292756-001-06-0,dopamine receptor antagonist
24307,b19,BRD-K01567962-001-06-5,JNK inhibitor
24307,b20,BRD-K01624546-001-02-8,LTB4 inhibitor
24307,b21,BRD-K01648091-001-04-2,Dopamine receptor antagonist
24307,b22,BRD-K01663662-003-03-8,muscarinic antagonist
24307,b23,BRD-K01815685-001-02-3,aryl hydrocarbon receptor agonist
24307,c01,BRD-K01868942-001-01-3,serotonin receptor antagonist
24307,c02,BRD-K01902415-001-03-4,PPAR receptor agonist
24307,c05,BRD-K02265150-001-04-2,norepinephrine reputake inhibitor
24307,c06,BRD-K02275692-003-03-4,bacterial cell wall synthesis inhibitor
24307,c07,BRD-K02283807-003-01-4,thromboxane receptor antagonist
24307,c09,BRD-K02404261-001-02-7,Adenosine receptor antagonist
24307,c10,BRD-K02407574-001-03-0,tubulin polymerization inhibitor
24307,c14,BRD-K02581333-001-01-8,Tyrosine phosphatase inhibitor
24307,c17,BRD-K02590140-001-01-2,cannabinoid receptor antagonist
24307,c18,BRD-K02607075-333-03-6,Acetylcholine receptor antagonist
24307,c19,BRD-K02637541-001-02-4,Cyclooxygenase inhibitor
24307,c22,BRD-K02764365-001-03-7,anthelmintic agent
24307,c23,BRD-K02867583-300-04-8,serotonin reuptake inhibitor
24307,c24,BRD-K02900412-001-02-2,protein synthesis inhibitor
24307,d01,BRD-K02953697-001-01-9,cytochrome P450 inhibitor
24307,d03,BRD-K03015355-003-01-5,adenylyl cyclase activator|Adenylate cyclase stimulant|growth hormone receptor agonist|phosphokinase stimulant
24307,d04,BRD-K03067624-300-02-9,protein synthesis inhibitor
24307,d06,BRD-K03109492-001-01-4,CDC inhibitor
24307,d07,BRD-K03384561-001-01-9,Angiogenesis inhibitor
24307,d08,BRD-K03440695-001-02-6,Acetylcholine receptor antagonist
24307,d13,BRD-K03600606-001-02-3,Beta secretase inhibitor
24307,d14,BRD-K03602135-236-02-1,HMGCR inhibitor
24307,d17,BRD-K03642198-300-01-7,hedgehog pathway inhibitor
24307,d18,BRD-K03670461-001-02-0,EGFR inhibitor
24307,d19,BRD-K03842655-001-02-1,potassium channel blocker
24307,d20,BRD-K03981224-001-02-9,Progestogen hormone
24307,d21,BRD-K04010869-001-02-6,HSP inducer|NFKB pathway inhibitor
24307,d22,BRD-K04046242-001-03-6,Estrogen receptor agonist
24307,d23,BRD-K04111260-001-01-9,Dopamine receptor antagonist
24307,d24,BRD-K04170657-001-02-4,Ras GTPase inhibitor
24307,e03,BRD-K04185004-003-03-6,Local anesthetic
24307,e04,BRD-K04414442-001-03-4,tachykinin antagonist
24307,e05,BRD-K04430056-001-02-9,nitric oxide synthase inhibitor
24307,e06,BRD-K04704168-003-03-6,HCV inhibitor
24307,e08,BRD-K04976539-001-01-0,PKC inhibitor|src inhibitor
24307,e11,BRD-K05151076-001-01-8,estrogen receptor antagonist
24307,e12,BRD-K05181084-003-02-9,dopamine receptor antagonist
24307,e13,BRD-K05181463-001-01-6,Dopamine receptor antagonist
24307,e16,BRD-K05434375-001-04-0,calcium channel blocker
24307,e19,BRD-K05464208-001-01-6,p38 MAPK inhibitor
24307,e21,BRD-K05653692-001-02-5,Glucosyltransferase inhibitor
24307,e22,BRD-K05673000-323-02-8,Bacterial cell wall synthesis inhibitor
24307,e23,BRD-K05901394-001-01-1,Dopamine receptor agonist
24307,e24,BRD-K05906022-001-02-8,HIV protease inhibitor
24307,f03,BRD-K05977355-001-02-6,sterol demethylase inhibitor
24307,f05,BRD-K06014311-001-01-2,Melatonin receptor antagonist
24307,f06,BRD-K06024458-001-01-4,cannabinoid receptor agonist
24307,f07,BRD-K06147391-003-01-9,Acetylcholine receptor antagonist
24307,f08,BRD-K06159959-001-01-2,Inhibitor of the binding of homoquinolinic acid to non-NMDA sensitive sites
24307,f12,BRD-K06208435-001-02-9,Calcium channel blocker
24307,f13,BRD-K06221026-001-03-5,Cyclooxygenase inhibitor
24307,f14,BRD-K06234293-001-01-8,TGF beta receptor inhibitor|p38 MAPK inhibitor
24307,f15,BRD-K06426971-001-01-9,histone lyinse methyltransferase inhibitor
24307,f19,BRD-K06467078-001-01-5,Adrenergic receptor antagonist
24307,f20,BRD-K06543683-001-03-6,PKC inhibitor|glycogen synthase kinase inhibitor|leucine rich repeat kinase inhibitor|SIRT inhibitor
24307,f21,BRD-K06593056-001-01-4,retinoid receptor agonist
24307,f22,BRD-K06753942-001-02-0,MEK inhibitor
24307,f23,BRD-K06854232-001-03-3,retinoid receptor agonist
24307,f24,BRD-K06980535-003-04-4,Dopamine receptor antagonist
24307,g02,BRD-K07117950-001-02-6,CDK inhibitor
24307,g06,BRD-K07212038-001-02-1,Mast cell stabilizer
24307,g07,BRD-K07220430-001-03-6,Calcium channel blocker
24307,g08,BRD-K07325606-001-02-3,PKC inhibitor
24307,g10,BRD-K07507905-236-01-8,adrenergic receptor agonist
24307,g13,BRD-K07691486-001-05-6,CDK inhibitor
24307,g14,BRD-K07888196-001-01-8,IGF-1 inhibitor
24307,g15,BRD-K08078237-001-04-0,calcium channel blocker
24307,g16,BRD-K08109516-001-01-1,glutamate receptor antagonist
24307,g17,BRD-K08115555-001-02-8,catechol O methyltransferase inhibitor|tumor necrosis factor inhibitor
24307,g18,BRD-K08132273-001-01-6,EGFR inhibitor
24307,g22,BRD-K08219523-001-01-9,Serotonin receptor agonist
24307,g23,BRD-K08252256-236-04-9,Cyclooxygenase inhibitor
24307,g24,BRD-K08287586-001-03-6,DNA synthesis inhibitor
24307,h01,BRD-K08316444-001-02-7,inhibitor of mitochondrial electron transport
24307,h05,BRD-K08438429-001-01-0,glucosylceramidase inhibitor|somatostatin receptor agonist
24307,h07,BRD-K08554278-001-02-4,DNA binding agent
24307,h09,BRD-K08619574-334-03-9,Dopamine receptor antagonist
24307,h10,BRD-K08619838-300-03-2,Acetylcholine receptor agonist
24307,h11,BRD-K08640512-003-01-5,Adrenergic receptor antagonist
24307,h13,BRD-K08806317-050-03-6,Adrenergic receptor antagonist
24307,h14,BRD-K08890269-001-01-5,Sodium channel blocker
24307,h16,BRD-K08973992-001-01-3,Oxidative stress inducer
24307,h17,BRD-K08996725-313-01-7,histamine receptor antagonist
24307,h18,BRD-K08998509-001-01-6,dopamine receptor antagonist|serotonin receptor antagonist
24307,h23,BRD-K09132007-001-01-8,casein kinase inhibitor|TGF beta receptor inhibitor
24307,i01,BRD-K09255212-001-03-4,chelating agent
24307,i02,BRD-K09397065-001-01-6,Serotonin receptor agonist
24307,i03,BRD-K09416995-001-16-7,HMGCR inhibitor
24307,i04,BRD-K09471561-001-02-6,bacterial DNA gyrase inhibitor
24307,i07,BRD-K09537769-001-01-6,DNA dependent protein kinase inhibitor|mTOR inhibitor|PI3K inhibitor
24307,i08,BRD-K09549677-300-01-8,T-type calcium channel blocker|angiogenesis inhibitor|calcium channel blocker|calcium channel inhibitor|L-type calcium channel blocker|sodium channel blocker
24307,i09,BRD-K09598619-065-01-5,tubulin polymerization inhibitor
24307,i10,BRD-K09631521-001-02-4,cytochrome P450 inhibitor
24307,i11,BRD-K09635134-001-02-4,negative control for D-erythro-MAPP
24307,i12,BRD-K09635314-001-01-8,phospholipase activator
24307,i13,BRD-K09668667-001-02-0,Carcinogen
24307,i14,BRD-K09764130-001-02-6,Cannabinoid receptor agonist
24307,i15,BRD-K09778810-001-01-5,inositol monophosphatase inhibitor
24307,i17,BRD-K09963420-066-03-4,HIV protease inhibitor
24307,i18,BRD-K10042277-001-02-7,cetylcholine receptor agonist|dopamine receptor agonist|dopamine receptor antagonist|dopamine receptor partial agonist|serotonin receptor antagonist|serotonin receptor inverse agonist
24307,i19,BRD-K10065684-001-02-5,laxative
24307,i23,BRD-K10176267-001-01-7,glutamate receptor antagonist
24307,i24,BRD-K10177585-003-01-6,Adenosine receptor antagonist
24307,j01,BRD-K10207760-236-03-0,bacterial permeability inducer
24307,j02,BRD-K10314788-003-04-4,nootropic agent
24307,j07,BRD-K10670311-001-04-9,Antirheumatic
24307,j10,BRD-K10705233-001-01-4,Cannabinoid receptor agonist
24307,j11,BRD-K10843433-001-02-9,Cyclooxygenase inhibitor
24307,j12,BRD-K10870738-001-02-4,lipoxygenase inhibitor
24307,j13,BRD-K10974103-001-03-9,Protein synthesis inhibitor
24307,j15,BRD-K10995081-001-05-5,Dopamine receptor antagonist
24307,j16,BRD-K11107424-001-01-1,histamine receptor antagonist
24307,j17,BRD-K11129031-001-04-4,Lipoprotein lipase activator
24307,j18,BRD-K11158509-001-02-0,EGFR inhibitor
24307,j19,BRD-K11163873-001-02-8,PARP inhibitor
24307,j24,BRD-K11298197-001-03-9,protein synthesis inhibitor
24307,k01,BRD-K11373525-003-01-3,Angiotensin receptor antagonist
24307,k02,BRD-K11399644-003-03-0,AMPK activator
24307,k04,BRD-K11634954-300-01-8,dopamine uptake inhibitor
24307,k06,BRD-K11696279-003-01-5,Imidazoline receptor agonist
24307,k09,BRD-K11717138-001-03-0,chloride channel blocker
24307,k10,BRD-K11742128-003-04-4,histamine receptor antagonist
24307,k13,BRD-K11911061-003-02-8,serotonin receptor antagonist
24307,k14,BRD-K11927976-050-01-1,mediator release inhibitor|syk inhibitor
24307,k17,BRD-K12102668-001-04-0,Monoamine oxidase inhibitor
24307,k18,BRD-K12120659-305-01-4,Integrin antagonist
24307,k20,BRD-K12184470-300-01-8,calcium channel blocker|T-type calcium channel blocker
24307,k21,BRD-K12219985-001-04-8,Sulfonylurea
24307,k22,BRD-K12244279-001-01-7,MEK inhibitor
24307,l03,BRD-K12357156-001-01-5,EGFR inhibitor|ErbB2 inhibitor|JAK2 inhibitor
24307,l04,BRD-K12513978-001-04-3,cyclooxygenase inhibitor
24307,l05,BRD-K12539581-001-06-2,tubulin polymerization inhibitor
24307,l12,BRD-K12932420-001-01-5,Phosphodiesterase inhibitor
24307,l14,BRD-K12994359-001-02-8,Cyclooxygenase inhibitor
24307,l19,BRD-K13169950-001-04-5,HDAC inhibitor
24307,l20,BRD-K13211965-001-01-4,dopamine receptor antagonist
24307,l21,BRD-K13261168-001-01-4,Dopamine receptor agonist
24307,m01,BRD-K13533483-001-03-0,calcineurin inhibitor|cyclophilin inhibitor|immunosuppressant|insulin expression inhibitor|T cell inhibitor
24307,m02,BRD-K13544237-001-01-0,dopamine receptor agonist|antiamyloidogenic agent
24307,m03,BRD-K13571841-001-03-7,Aspartic protease inhibitor
24307,m04,BRD-K13642330-001-02-6,cytochrome P450 inhibitor
24307,m05,BRD-K13819402-003-02-9,Acetylcholinesterase inhibitor
24307,m07,BRD-K13994703-001-02-0,adrenergic receptor antagonist
24307,m11,BRD-K14200658-001-02-6,Vesicular monoamine transporter inhibitor
24307,m12,BRD-K14221570-236-01-1,HIV entry inhibitor
24307,m16,BRD-K14282469-001-01-5,serotonin receptor antagonist
24307,m18,BRD-K14441456-001-01-2,EGFR inhibitor
24307,m19,BRD-K14496212-001-01-1,dopamine receptor agonist
24307,m21,BRD-K14618467-003-01-8,IKK inhibitor
24307,n01,BRD-K14765469-003-02-3,acetylcholinesterase inhibitor
24307,n02,BRD-K14767410-001-01-5,cyclooxygenase inhibitor
24307,n03,BRD-K14807180-001-01-7,serotonin receptor antagonist
24307,n04,BRD-K14821540-001-02-1,mitochondrial oxidative phosphorylation uncoupler
24307,n06,BRD-K14888893-001-02-3,KATP activator
24307,n07,BRD-K14965640-001-03-3,Cyclooxygenase inhibitor
24307,n08,BRD-K14993104-001-03-4,Chemoreceptor agonist
24307,n11,BRD-K15025317-001-04-5,NFkB pathway inhibitor
24307,n12,BRD-K15164005-001-01-5,carboxylesterase inhibitor
24307,n15,BRD-K15196155-001-01-5,Hydroxycarboxylic acid receptor agonist
24307,n17,BRD-K15519488-001-01-6,dopamine receptor agonist
24307,n19,BRD-K15567136-001-01-1,phosphodiesterase inhibitor
24307,n21,BRD-K15588452-003-01-9,serotonin receptor antagonist
24307,n22,BRD-K15601958-001-01-3,Lysophospholipid receptor agonist
24307,n23,BRD-K15616905-001-01-5,mitochondrial oxidative phosphorylation uncoupler
24307,n24,BRD-K15715913-001-01-5,dopamine receptor antagonist|serotonin receptor antagonist
24307,o01,BRD-K15766189-001-02-3,bacterial cell wall synthesis inhibitor
24307,o02,BRD-K15791587-003-01-7,tachykinin antagonist
24307,o04,BRD-K15868788-001-01-4,Serotonin receptor antagonist
24307,o05,BRD-K15916496-001-04-8,cytochrome P450 inhibitor|imidazoline receptor ligand
24307,o06,BRD-K15933101-003-01-2,dopamine receptor agonist|dopamine receptor modulator
24307,o07,BRD-K15935639-001-02-0,PGPH inhibitor|proteasome inhibitor
24307,o08,BRD-K15957397-001-02-6,CDC inhibitor
24307,o09,BRD-K16195444-001-01-7,Adrenergic receptor agonist
24307,o10,BRD-K16444452-001-03-4,phosphodiesterase inhibitor|leukotriene receptor antagonist|toll-like receptor antagonist|macrophage migration inhibiting factor inhibitor|macrophage migration inhibiting factor modulator|mediator release inhibitor|nitric oxide synthase inhibitor
24307,o14,BRD-K16485616-001-01-4,HDAC inhibitor|cell cycle inhibitor
24307,o15,BRD-K16508793-001-01-8,benzodiazepine receptor agonist
24307,o16,BRD-K16542329-001-05-1,phosphodiesterase inhibitor
24307,o17,BRD-K16551401-003-01-8,serotonin receptor agonist
24307,o19,BRD-K16604360-001-01-8,antiamyloidogenic agent|dopamine receptor agonist
24307,o20,BRD-K16664969-001-01-7,FLT3 inhibitor|tyrosine kinase inhibitor
24307,o22,BRD-K16977723-001-01-0,EGFR inhibitor
24307,o23,BRD-K17016787-001-03-5,estrogen receptor agonist
24307,p01,BRD-K17140735-300-01-6,Proteasome inhibitor
24307,p03,BRD-K17294426-050-04-0,dopamine receptor antagonist
24307,p04,BRD-K17368287-001-03-5,11-beta hydroxysteroid dehydrogenase inhibitor
24307,p05,BRD-K17378184-300-03-4,Dopamine receptor agonist
24307,p06,BRD-K17415526-001-02-7,protein tyrosine kinase inhibitor
24307,p07,BRD-K17497770-001-01-0,EGFR inhibitor|src inhibitor
24307,p08,BRD-K17565903-066-04-1,muscle relaxant
24307,p09,BRD-K17674993-001-03-1,Corticosteroid agonist
24307,p10,BRD-K17693482-001-03-9,potassium channel activator
24307,p14,BRD-K17743125-001-01-9,HDAC inhibitor|cell cycle inhibitor
24307,p15,BRD-K17743697-066-01-0,sodium/calcium exchange inhibitor
24307,p16,BRD-K17796732-001-02-0,cannabinoid receptor agonist
24307,p19,BRD-K17894950-001-04-4,CDK inhibitor|glycogen synthase kinase inhibitor
24307,p20,BRD-K17896185-001-01-2,opioid receptor agonist
24307,p21,BRD-K18059238-001-02-1,cyclooxygenase inhibitor|prostanoid receptor stimulant|thromboxane synthase stimulant
24307,p24,BRD-K18194590-065-02-3,adrenergic receptor agonist
26224,a01,BRD-K78364995-236-03-5,bacterial cell wall synthesis inhibitor
26224,a03,BRD-K78485176-001-02-9,angiotensin receptor antagonist
26224,a05,BRD-K78599730-001-02-6,farnesyltransferase inhibitor|NFkB pathway inhibitor|ras farnesyltransferase inhibitor
26224,a07,BRD-K78633253-001-01-2,ARF inhibitor
26224,a08,BRD-K78637815-001-01-4,cannabinoid receptor antagonist
26224,a09,BRD-K78643075-001-03-3,dopamine receptor antagonist
26224,a10,BRD-K78692225-001-11-2,dihydroorotate dehydrogenase inhibitor|PDGFR tyrosine kinase receptor inhibitor
26224,a11,BRD-K78815826-001-04-7,cyclooxygenase inhibitor
26224,a12,BRD-K78838262-001-02-4,hypolipidemic
26224,a16,BRD-K78959463-001-02-5,calcium channel activator
26224,a18,BRD-K79092138-001-04-5,POXB inhibitor|bacterial DNA inhibitor
26224,a19,BRD-K79116891-003-03-7,sodium channel blocker
26224,a20,BRD-K79124250-001-03-0,radiopaque medium
26224,a21,BRD-K79131256-001-03-9,tubulin polymerization inhibitor
26224,a22,BRD-K79145749-001-01-8,norepinephrine reputake inhibitor
26224,a24,BRD-K79366068-236-01-5,NTPDase inhibitor
26224,b01,BRD-K79425933-001-03-6,dopamine receptor antagonist
26224,b02,BRD-K79437791-001-02-4,Inhibitor of methylation of endogenous isoprenylated proteins
26224,b03,BRD-K79501723-003-03-4,histamine receptor modulator
26224,b04,BRD-K79684402-300-01-0,dopamine receptor partial agonist
26224,b05,BRD-K79711234-001-04-3,bacterial 50S ribosomal subunit inhibitor
26224,b06,BRD-K79759585-001-02-1,phosphodiesterase inhibitor
26224,b07,BRD-K79930101-300-01-1,EGFR inhibitor|epidermal growth factor receptor (EGFR) inhibitor|ErbB2 tyrosine kinase inhibitor|receptor tyrosine protein kinase inhibitor
26224,b09,BRD-K80315159-051-01-2,histamine receptor antagonist
26224,b12,BRD-K80334323-001-03-5,progestogen hormone
26224,b15,BRD-K80353807-001-03-0,vasodilator
26224,b16,BRD-K80396088-001-03-9,Sulfonylurea
26224,b17,BRD-K80451230-051-01-8,acetylcholine receptor antagonist
26224,b19,BRD-K80639402-003-01-1,serotonin receptor antagonist
26224,b20,BRD-K80725821-300-01-1,serotonin receptor antagonist
26224,b21,BRD-K80738081-001-06-2,cytochrome P450 inhibitor|SIRT activator
26224,b22,BRD-K80778372-001-01-7,GABA benzodiazepine site receptor inverse agonist
26224,b24,BRD-K80946661-001-02-8,p53 activator
26224,c01,BRD-K80970344-201-02-9,NFkB pathway inhibitor
26224,c02,BRD-K81029756-001-02-8,L-type calcium channel blocker|calcium channel antagonist|calcium channel blocker
26224,c04,BRD-K81209159-001-02-9,Acetylcholinesterase inhibitor
26224,c05,BRD-K81209512-001-01-3,EGFR inhibitor|epidermal growth factor receptor (EGFR) inhibitor|tyrosine kinase inhibitor
26224,c06,BRD-K81225797-001-01-5,adenosine receptor antagonist
26224,c07,BRD-K81272440-001-02-6,calcium channel blocker
26224,c09,BRD-K81376179-001-01-4,FLT3 inhibitor
26224,c14,BRD-K81709173-001-03-8,glucocorticoid receptor agonist
26224,c17,BRD-K81729199-001-01-0,acetylcholine receptor antagonist
26224,c20,BRD-K81839095-001-02-0,Estrogen receptor agonist
26224,c21,BRD-K81876028-300-01-2,Serotonin receptor agonist
26224,c23,BRD-K82103381-003-03-7,vasodilator
26224,d03,BRD-K82255054-001-04-3,GABA receptor agonist
26224,d04,BRD-K82484965-003-02-7,dopamine receptor agonist
26224,d05,BRD-K82561139-001-01-9,casein kinase inhibitor
26224,d06,BRD-K82562631-236-02-0,Cyclooxygenase inhibitor
26224,d07,BRD-K82577285-001-01-7,Dopamine receptor agonist
26224,d08,BRD-K82731415-001-04-7,CDK inhibitor
26224,d09,BRD-K82795137-001-02-3,Histamine receptor antagonist
26224,d10,BRD-K82823076-001-01-8,GABA benzodiazepine site receptor inverse agonist
26224,d13,BRD-K82846253-001-03-0,Insulin secretagogue
26224,d14,BRD-K82865713-001-02-6,cAMP inhibitor
26224,d17,BRD-K83023055-001-01-9,Melatonin receptor agonist
26224,d19,BRD-K83063356-003-01-7,CC chemokine receptor antagonist|CCR antagonist
26224,d23,BRD-K83302049-001-01-6,Histamine receptor antagonist
26224,d24,BRD-K83322645-103-01-6,sigma receptor antagonist|sigma receptor ligand
26224,e04,BRD-K83459933-001-02-1,angiogenesis inhibitor
26224,e05,BRD-K83508485-001-01-9,tachykinin antagonist
26224,e06,BRD-K83597974-003-05-7,Monoamine oxidase inhibitor
26224,e07,BRD-K83637872-001-01-7,Smoothened receptor antagonist
26224,e08,BRD-K84175871-003-02-2,Adrenergic receptor agonist
26224,e12,BRD-K84266862-001-01-6,phosphodiesterase inhibitor
26224,e13,BRD-K84421793-001-01-1,dopamine receptor agonist
26224,e14,BRD-K84595254-001-03-0,ATPase inhibitor
26224,e15,BRD-K84663978-001-02-3,phosphodiesterase inhibitor|platelet aggregation inhibitor|potassium channel blocker
26224,e16,BRD-K84709232-001-02-6,lipoxygenase inhibitor|HIV integrase inhibitor|NFkB pathway inhibitor|nitric oxide production inhibitor|PPAR receptor modulator|tumor necrosis factor production inhibitor
26224,e19,BRD-K85015012-003-01-1,GABA uptake inhibitor|GAT inhibitor
26224,e20,BRD-K85090592-003-08-7,Acetylcholine receptor agonist
26224,e22,BRD-K85119730-001-06-5,ATP channel blocker
26224,e23,BRD-K85242180-001-01-1,"indoleamine 2,3-dioxygenase inhibitor"
26224,e24,BRD-K85266041-304-01-7,glutamate receptor antagonist
26224,f04,BRD-K85383046-001-02-5,chloride channel blocker
26224,f06,BRD-K85871428-001-01-9,p38 MAPK inhibitor
26224,f11,BRD-K85883481-001-02-6,glucocorticoid receptor agonist
26224,f12,BRD-K86204871-001-02-2,sterol demethylase inhibitor
26224,f13,BRD-K86301799-001-14-0,phosphodiesterase inhibitor
26224,f14,BRD-K86434416-001-02-7,Monoamine oxidase inhibitor
26224,f15,BRD-K84663978-001-03-1,phosphodiesterase inhibitor|platelet aggregation inhibitor|potassium channel blocker
26224,f16,BRD-K86509404-001-02-0,CDK inhibitor
26224,f19,BRD-K86600316-003-01-2,Adrenergic receptor antagonist
26224,f20,BRD-K86727142-001-06-6,HCV inhibitor|XIAP inhibitor
26224,f21,BRD-K86873305-236-03-0,Bacterial cell wall synthesis inhibitor
26224,f22,BRD-K86882815-001-01-6,dopamine receptor agonist|prolactin inhibitor|prolactin secretion inhibitor
26224,f23,BRD-K86958018-001-01-9,TRPV agonist
26224,f24,BRD-K87048468-003-01-9,Serotonin receptor antagonist
26224,g01,BRD-K87049188-001-03-6,chelating agent|dopamine beta hydroxylase inhibitor
26224,g08,BRD-K87510569-001-01-0,CC chemokine receptor antagonist
26224,g09,BRD-K87696786-003-01-0,glutamate receptor antagonist
26224,g14,BRD-K87990216-001-03-7,Glucocorticoid receptor agonist
26224,g15,BRD-K87991767-001-02-0,carbonic anhydrase inhibitor|cyclooxygenase inhibitor
26224,g16,BRD-K88090157-050-03-3,antihistamine
26224,g21,BRD-K88282786-066-04-9,cannabinoid receptor agonist
26224,g22,BRD-K88358234-003-01-4,serotonin receptor agonist|nerve growth factor agonist|neurotrophic factor enhancer
26224,g23,BRD-K88366685-300-03-7,3-ketoacyl CoA thiolase inhibitor
26224,g24,BRD-K88405679-003-01-5,antihistamine
26224,h01,BRD-K88429204-001-04-7,dihydrofolate reductase inhibitor
26224,h02,BRD-K88544581-001-01-2,ACAT inhibitor
26224,h05,BRD-K88568253-065-02-1,monoamine oxidase inhibitor
26224,h06,BRD-K88611939-001-01-8,Glutamate receptor agonist
26224,h08,BRD-K88677950-001-01-3,MAP kinase inhibitor|MEK inhibitor
26224,h10,BRD-K88741031-001-01-0,EGFR inhibitor|tyrosine kinase inhibitor
26224,h11,BRD-K88743730-001-01-0,serotonin receptor partial agonist
26224,h12,BRD-K88759641-003-01-0,Angiotensin receptor antagonist
26224,h13,BRD-K88789588-001-03-2,aromatase inhibitor
26224,h14,BRD-K88809146-003-02-1,monoamine oxidase inhibitor
26224,h15,BRD-K88849294-001-02-1,Tyrosine phosphatase inhibitor
26224,h16,BRD-K88871508-001-01-9,Dopamine receptor agonist
26224,h18,BRD-K89046952-001-03-4,bacterial cell wall synthesis inhibitor
26224,h21,BRD-K89055274-048-03-7,muscle relaxant
26224,h22,BRD-K89085489-001-02-6,apoptosis stimulant|retinoid receptor agonist
26224,h23,BRD-K89125793-001-05-4,antiprotozoal agent
26224,h24,BRD-K89152108-001-03-3,thyroid hormone stimulant
26224,i01,BRD-K89210380-001-03-8,vitamin B
26224,i04,BRD-K89272762-001-04-4,chloride channel blocker
26224,i07,BRD-K89274813-001-01-5,acetylcholine release enhancer
26224,i08,BRD-K89375097-300-04-7,Acetylcholine receptor antagonist
26224,i09,BRD-K89402695-001-01-5,Thromboxane receptor antagonist
26224,i13,BRD-K89732114-001-02-6,dopamine receptor antagonist
26224,i14,BRD-K89923877-003-02-4,acetylcholine receptor antagonist
26224,i15,BRD-K89930444-001-01-9,tyrosine kinase inhibitor
26224,i16,BRD-K89997465-001-02-0,dopamine receptor antagonist
26224,i17,BRD-K90027355-001-03-4,mineralocorticoid receptor antagonist
26224,i23,BRD-K90259198-003-04-8,calmodulin antagonist|potassium channel blocker|squalene monooxygenase channel blocker
26224,i24,BRD-K90333595-001-02-8,adrenergic receptor antagonist
26224,j01,BRD-K90524085-001-05-2,phosphodiesterase inhibitor|platelet aggregation inhibitor
26224,j04,BRD-K90574421-001-01-9,Serotonin receptor agonist
26224,j08,BRD-K90789829-003-03-3,Adrenergic inhibitor
26224,j09,BRD-K90976994-001-02-1,Bile acid
26224,j10,BRD-K91243525-001-01-5,Neurotensin receptor antagonist
26224,j11,BRD-K91263825-001-02-8,tricyclic antidepressant
26224,j13,BRD-K91315211-334-02-3,Histamine receptor agonist
26224,j15,BRD-K91336023-001-01-4,Dopamine receptor agonist
26224,j16,BRD-K91370081-001-04-6,DNA synthesis inhibitor
26224,j19,BRD-K91904471-001-01-6,p38 MAPK inhibitor
26224,j20,BRD-K92000912-001-06-8,cannabinoid receptor antagonist
26224,j24,BRD-K92015269-001-01-6,dopamine uptake inhibitor
26224,k02,BRD-K92049597-001-04-2,sodium channel blocker
26224,k04,BRD-K92093830-003-05-0,topoisomerase inhibitor
26224,k05,BRD-K92138166-001-01-0,other antibiotic
26224,k09,BRD-K92492521-001-01-1,Leukotriene receptor antagonist
26224,k12,BRD-K92678294-001-01-0,Isoflavone
26224,k14,BRD-K92726801-003-02-7,Haemostatic agent
26224,k17,BRD-K92731339-227-02-3,ACE inhibitor
26224,k18,BRD-K92758126-001-06-3,NFkB pathway inhibitor
26224,k19,BRD-K92778217-001-04-6,Cyclooxygenase inhibitor
26224,k20,BRD-K92830582-003-04-8,adrenergic receptor antagonist
26224,k22,BRD-K92984783-003-02-4,Serotonin receptor antagonist
26224,l01,BRD-K93080877-001-02-1,tripeptidyl peptidase inhibitor
26224,l02,BRD-K93176058-001-01-0,retinoid receptor agonist
26224,l03,BRD-K93188295-300-01-4,adrenergic receptor antagonist
26224,l05,BRD-K93258693-001-02-5,PPAR receptor antagonist
26224,l06,BRD-K93280214-004-02-3,GABA receptor antagonist
26224,l09,BRD-K93325701-001-03-0,SRC inhibitor
26224,l10,BRD-K93332168-001-03-2,Monoamine oxidase inhibitor
26224,l11,BRD-K93441486-067-03-7,Acetylcholine receptor antagonist
26224,l12,BRD-K93460210-001-01-3,Serotonin receptor antagonist
26224,l13,BRD-K93461745-001-01-5,Serotonin receptor agonist
26224,l14,BRD-K93480852-001-02-2,calcium/calmodulin dependent protein kinase inhibitor
26224,l19,BRD-K93568044-001-03-1,glucocorticoid receptor agonist
26224,l20,BRD-K93658967-001-01-7,CDK inhibitor|CFTR channel activator|glycogen synthase kinase inhibitor|JNK inhibitor
26224,l21,BRD-K93754473-001-02-9,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)
26224,l22,BRD-K94144010-001-05-5,nicotine metabolite
26224,m04,BRD-K94270326-004-01-0,dopamine receptor antagonist
26224,m06,BRD-K94379058-001-03-5,cannabinoid receptor inverse agonist
26224,m07,BRD-K94441233-001-03-1,HMGCR inhibitor
26224,m08,BRD-K94512704-001-01-3,dopamine receptor antagonist
26224,m12,BRD-K94689771-001-02-5,CYP1B1 inhibitor
26224,m17,BRD-K94832621-001-01-5,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)
26224,m19,BRD-K94841585-001-02-8,laxative|free radical generator
26224,m21,BRD-K94887716-001-01-5,Serotonin receptor agonist
26224,m22,BRD-K94920105-001-01-3,PARP inhibitor
26224,m24,BRD-K95202259-001-01-9,p38 MAPK inhibitor
26224,n01,BRD-K95237249-001-04-2,Uricosuric blocker
26224,n02,BRD-K95309561-001-04-9,estrogen receptor agonist
26224,n04,BRD-K95435023-001-01-0,c-Met inhibitor|hepatocyte growth factor receptor inhibitor
26224,n07,BRD-K95603879-001-03-4,ATPase inhibitor
26224,n08,BRD-K95609758-001-01-1,potassium channel activator
26224,n11,BRD-K95655893-001-01-0,VEGFR kinase inhibitor
26224,n12,BRD-K95676198-001-02-6,JAK inhibitor
26224,n15,BRD-K95739795-001-01-1,Vesicular monoamine transporter inhibitor
26224,n16,BRD-K95763993-001-03-7,PDGFR receptor inhibitor
26224,n17,BRD-K95785537-001-04-1,src inhibitor
26224,n20,BRD-K95851186-001-02-9,GABA receptor modulator
26224,n21,BRD-K95899059-003-01-0,Serotonin receptor agonist
26224,n22,BRD-K95992530-001-02-4,integrin antagonist
26224,n23,BRD-K96119599-001-04-7,Melanin inhibitor
26224,n24,BRD-K96144918-001-02-3,KPL-1 tumor suppressor
26224,o04,BRD-K96263742-001-02-3,PPAR receptor agonist
26224,o05,BRD-K96271548-001-02-2,antioxidant
26224,o07,BRD-K96402602-001-01-8,PPMTase inhibitor
26224,o08,BRD-K96527333-001-03-4,GABA receptor modulator
26224,o10,BRD-K96670504-001-01-9,Glucokinase inhibitor
26224,o13,BRD-K96720755-001-01-8,Vasopressin receptor antagonist
26224,o14,BRD-K96799727-001-01-7,HSP inhibitor
26224,o15,BRD-K96809896-001-01-9,p38 MAPK inhibitor
26224,o16,BRD-K96862998-001-03-1,TGF beta receptor inhibitor
26224,o17,BRD-K97061094-001-03-2,Histamine receptor antagonist
26224,o18,BRD-K97118047-001-01-2,Casein kinase inhibitor
26224,o19,BRD-K97158071-001-04-1,Dopamine receptor antagonist
26224,o20,BRD-K97181089-001-02-7,sodium channel blocker
26224,o22,BRD-K97330509-001-01-4,src inhibitor
26224,o23,BRD-K97354755-001-01-5,src inhibitor
26224,o24,BRD-K97365803-001-01-3,PI3K inhibitor
26224,p01,BRD-K97399794-001-07-0,polar auxin transport inhibitor
26224,p02,BRD-K97440753-066-03-3,adrenergic receptor antagonist|prolactin inhibitor
26224,p04,BRD-K97509413-001-01-8,AGE inhibitor|estrogen receptor agonist|estrogen receptor ligand
26224,p05,BRD-K97521363-001-03-9,glycolysis inhibitor
26224,p06,BRD-K97530723-001-04-3,melatonin receptor agonist|nitric oxide synthase inhibitor
26224,p07,BRD-K97564742-103-01-9,histamine receptor antagonist
26224,p10,BRD-K97688263-001-02-9,sodium channel blocker
26224,p13,BRD-K97746869-001-04-9,ATP channel blocker
26224,p14,BRD-K97752965-001-01-6,ATP channel activator|nitric oxide donor|potassium channel agonist
26224,p15,BRD-K97799481-002-03-6,Adenosine receptor antagonist
26224,p16,BRD-K97810537-001-03-7,glucocorticoid receptor agonist
26224,p17,BRD-K98039984-001-03-0,glucocorticoid receptor agonist
26224,p18,BRD-K98143437-001-01-7,p38 MAPK inhibitor|interleukin inhibitor|tumor necrosis factor production inhibitor
26224,p20,BRD-K98157055-001-04-2,glutamate receptor antagonist
26224,p21,BRD-K98174813-001-05-7,bacterial 30S ribosomal subunit inhibitor
26224,p23,BRD-K98297262-001-01-1,"1,3-beta-glucan synthase inhibitor"
26224,p24,BRD-K98521173-001-03-8,mineralocorticoid receptor agonist
24297,a01,BRD-A00100033-001-04-8,DNA inhibitor
24297,a02,BRD-A00267231-001-01-1,Adenosine receptor agonist
24297,a04,BRD-A00520476-001-03-3,Acetylcholine receptor antagonist
24297,a06,BRD-A00993607-003-04-8,Adrenergic receptor antagonist
24297,a07,BRD-A01078468-001-04-9,synthetic estrogen
24297,a08,BRD-A01295252-001-01-5,Dopamine receptor ligand
24297,a09,BRD-A01320529-001-05-9,adrenergic receptor agonist
24297,a11,BRD-A01593789-001-01-5,5 alpha reductase inhibitor
24297,a12,BRD-A01636364-003-04-5,sodium channel blocker
24297,a15,BRD-A01787639-003-08-6,adrenergic receptor antagonist
24297,a16,BRD-A02006392-001-06-5,calcium channel blocker
24297,a17,BRD-A02176148-001-02-2,Mitochondrial complex I inhibitor
24297,a19,BRD-A02710418-003-03-5,opioid receptor agonist
24297,a20,BRD-A02713983-001-02-0,growth factor receptor activator
24297,a21,BRD-A02759312-003-11-2,Adrenergic receptor antagonist
24297,a23,BRD-A03216249-003-02-9,Potassium channel blocker
24297,a24,BRD-A03359064-001-01-5,Adrenergic receptor antagonist
24297,b02,BRD-A03623303-045-02-0,Adrenergic receptor antagonist
24297,b03,BRD-A03816571-001-01-0,cannabinoid receptor agonist|CC chemokine receptor antagonist
24297,b09,BRD-A04322457-003-03-9,adrenergic receptor agonist
24297,b10,BRD-A04438777-001-01-4,dopamine receptor agonist
24297,b11,BRD-A04553218-050-03-0,histamine receptor antagonist
24297,b15,BRD-A04668240-001-01-5,GABA receptor antagonist
24297,b16,BRD-A04706586-236-01-7,Adenosine receptor agonist
24297,b18,BRD-A05186015-003-04-0,dopamine uptake inhibitor
24297,b24,BRD-A06352418-001-03-6,Histamine receptor antagonist
24297,c01,BRD-A06352508-001-02-9,CHK inhibitor
24297,c02,BRD-A06390036-001-02-0,Antiarrhythmic
24297,c03,BRD-A06726973-001-02-0,cGMP analog
24297,c04,BRD-A06935312-001-02-7,bacterial 30S ribosomal subunit inhibitor
24297,c06,BRD-A07207424-001-04-1,phosphodiesterase inhibitor
24297,c08,BRD-A07440155-003-04-9,Adrenergic receptor antagonist
24297,c09,BRD-A07780951-001-02-2,Adrenergic receptor agonist
24297,c10,BRD-A07824748-001-02-6,11-beta hydroxysteroid dehydrogenase inhibitor
24297,c14,BRD-A07875874-001-01-6,calcium channel blocker
24297,c17,BRD-A07932845-001-01-1,anti-HCVE2
24297,c18,BRD-A07952294-001-02-3,farnesyltransferase inhibitors
24297,c19,BRD-A08187463-001-03-8,enkephalinase inhibitor
24297,c22,BRD-A08709697-001-02-9,pyrrolizidine alkaloid
24297,c23,BRD-A08877921-001-02-2,Protein synthesis inhibitor
24297,c24,BRD-A09056319-003-03-6,Adrenergic receptor antagonist
24297,d01,BRD-A09062839-003-03-5,Local anesthetic
24297,d02,BRD-A09094913-001-02-3,acetylcholine receptor antagonist
24297,d03,BRD-A09161221-001-01-9,HSP inhibitor
24297,d04,BRD-A09349126-001-02-4,progesterone receptor agonist
24297,d05,BRD-A09467419-003-04-2,acetylcholine receptor antagonist
24297,d06,BRD-A09472452-001-02-8,Sodium channel blocker
24297,d07,BRD-A09533288-001-02-7,calcium channel blocker
24297,d08,BRD-A09539288-004-02-8,Acetylcholine receptor antagonist
24297,d09,BRD-A09828896-004-04-5,Dopamine receptor agonist
24297,d10,BRD-A09925278-003-03-1,Adrenergic receptor agonist
24297,d14,BRD-A10070317-003-05-1,adrenergic receptor antagonist
24297,d17,BRD-A10355991-003-01-8,Glutamate receptor antagonist
24297,d18,BRD-A10715913-001-02-0,Dopamine receptor antagonist
24297,d19,BRD-A10739734-003-01-5,adrenergic receptor antagonist
24297,d20,BRD-A10903566-003-02-8,Adrenergic receptor antagonist
24297,d21,BRD-A10969569-001-02-0,Plant alkaloid
24297,d22,BRD-A10977446-001-04-8,Adrenergic receptor antagonist
24297,e03,BRD-A11605036-001-03-2,GABA receptor antagonist
24297,e04,BRD-A11609859-303-01-2,opioid receptor agonist
24297,e05,BRD-A11678676-001-02-6,PI3K inhibitor
24297,e07,BRD-A11813248-001-02-8,Potassium channel blocker
24297,e08,BRD-A12016240-001-01-7,Serotonin receptor antagonist
24297,e14,BRD-A13188892-066-03-3,Adrenergic receptor antagonist
24297,e15,BRD-A13650332-236-03-9,Bacterial cell wall synthesis inhibitor
24297,e16,BRD-A13946108-001-03-1,Cyclooxygenase inhibitor
24297,e23,BRD-A14395271-001-01-5,Dopamine receptor antagonist
24297,e24,BRD-A14566392-004-03-5,acetylcholine receptor antagonist
24297,f03,BRD-A14574269-051-01-4,Acetylcholine receptor agonist
24297,f04,BRD-A15034104-002-03-6,interleukin inhibitor
24297,f05,BRD-A15070535-323-02-1,adenosine receptor agonist|cAMP stimulant
24297,f06,BRD-A15415227-003-01-1,PPAR receptor agonist
24297,f07,BRD-A15435692-003-01-5,sigma receptor antagonist|glutamate receptor antagonist|serotonin receptor agonist
24297,f11,BRD-A15530910-001-01-3,adrenergic receptor antagonist|serotonin receptor antagonist
24297,f14,BRD-A15914070-001-01-5,cytotoxic lipid peroxidation product
24297,f15,BRD-A16332958-001-02-4,Adrenergic receptor agonist
24297,f16,BRD-A16665823-008-03-3,Bacterial cell wall synthesis inhibitor
24297,f19,BRD-A16694057-001-02-7,PPAR receptor antagonist
24297,f21,BRD-A17065207-001-06-9,protein synthesis inhibitor
24297,f23,BRD-A17428743-001-01-1,Serotonin receptor agonist
24297,f24,BRD-A17453586-001-01-9,Serotonin receptor agonist
24297,g02,BRD-A17535965-001-02-2,Acetylcholine receptor antagonist
24297,g05,BRD-A17655518-001-02-0,Cyclooxygenase inhibitor
24297,g08,BRD-A18043272-001-03-2,succinimide antiepileptic
24297,g09,BRD-A18202423-001-01-6,Glutamate receptor antagonist
24297,g10,BRD-A18497530-001-04-6,adenosine kinase inhibitor|nucleoside transporter inhibitor
24297,g11,BRD-A18579359-001-03-1,Neural Wiskott-Aldrich syndrome protein inhibitor
24297,g12,BRD-A18696154-003-11-9,adrenergic receptor antagonist
24297,g13,BRD-A18763547-019-01-0,Cytochrome C release inhibitor
24297,g15,BRD-A19053259-003-03-3,Anthelmintic
24297,g17,BRD-A19195498-050-04-2,Norepinephrine reuptake inhibitor
24297,g18,BRD-A19736161-310-01-3,Serotonin receptor antagonist
24297,g23,BRD-A20239487-001-02-5,Adrenergic receptor antagonist
24297,h01,BRD-A20348246-001-04-2,GABA receptor modulator
24297,h06,BRD-A20968261-001-01-3,glutamate transporter inhibitor
24297,h08,BRD-A21723284-066-01-7,Opioid receptor antagonist
24297,h09,BRD-A21858158-001-04-5,Anthelmintic
24297,h14,BRD-A22305049-003-04-5,gluconeogenesis inhibitor
24297,h15,BRD-A22380646-001-01-5,ATPase inhibitor
24297,h16,BRD-A22684332-003-02-3,adrenergic receptor agonist
24297,h17,BRD-A22707317-001-02-5,GABA receptor modulator
24297,h21,BRD-A22769835-300-03-2,Antihistamine
24297,h22,BRD-A22783572-065-01-3,microtubule formation inhibitor|tubulin inhibitor|tubulin polymerisation inhibitor
24297,h23,BRD-A22844106-001-04-7,Cyclooxygenase inhibitor
24297,h24,BRD-A23034328-003-03-4,protein synthesis inhibitor
24297,i01,BRD-A23072235-050-04-5,Histamine receptor antagonist
24297,i02,BRD-A23226398-001-02-7,estrogen receptor agonist
24297,i03,BRD-A23683907-334-01-0,serotonin receptor antagonist
24297,i04,BRD-A23723433-001-01-2,tubulin inhibitor|microtubule stabilizing agent|microtubule stimulant|P glycoprotein inhibitor|taxane
24297,i08,BRD-A24122750-001-01-1,GABA receptor antagonist
24297,i09,BRD-A24191444-045-03-1,Adrenergic receptor antagonist
24297,i10,BRD-A24228527-001-04-2,Bacterial DNA gyrase inhibitor
24297,i13,BRD-A24514565-236-01-6,Vitamin K antagonist
24297,i15,BRD-A24587114-066-03-5,adrenergic receptor agonist
24297,i16,BRD-A24817035-001-04-7,central nervous system agent
24297,i17,BRD-A25234499-001-04-3,glucocorticoid receptor antagonist
24297,i20,BRD-A25775766-001-03-3,GABA receptor antagonist|TP53 activator
24297,i23,BRD-A26032986-050-01-3,Calmodulin antagonist
24297,i24,BRD-A26222320-001-02-6,protein synthesis inhibitor
24297,j01,BRD-A26334849-001-02-1,Antiarrhythmic
24297,j02,BRD-A26384407-001-04-6,Carbonic anhydrase inhibitor
24297,j03,BRD-A26711594-001-02-7,calcium channel blocker
24297,j07,BRD-A26845397-001-01-4,Adrenergic receptor antagonist
24297,j09,BRD-A27143604-001-01-2,Estrogen receptor agonist
24297,j14,BRD-A28318179-003-03-6,Nitric oxide synthase inhibitor
24297,j15,BRD-A28856712-003-04-7,adrenergic receptor agonist
24297,j18,BRD-A29260609-003-04-7,adrenergic receptor antagonist
24297,j19,BRD-A29289453-001-02-1,platelet activating factor receptor antagonist
24297,j20,BRD-A29322418-237-02-4,mineralocorticoid receptor antagonist
24297,k01,BRD-A29426959-050-04-1,Histamine receptor antagonist
24297,k02,BRD-A29437505-001-01-6,TLR agonist
24297,k04,BRD-A29644307-050-04-8,Dopamine uptake inhibitor
24297,k05,BRD-A29734509-011-02-9,Sodium channel blocker
24297,k10,BRD-A30590053-003-01-1,Acetylcholine release enhancer
24297,k11,BRD-A30655177-001-04-1,BTK inhibitor
24297,k13,BRD-A30717181-001-02-7,glucocorticoid receptor agonist
24297,k14,BRD-A30815329-001-03-0,Calcium channel blocker
24297,k17,BRD-A31007383-001-01-0,Adenosine receptor agonist
24297,k18,BRD-A31159102-001-01-9,Selective serotonin reuptake inhibitor (SSRI)
24297,k19,BRD-A31195449-004-01-9,Serotonin receptor agonist
24297,k20,BRD-A31521121-001-04-1,Muscle relaxant
24297,k21,BRD-A31575449-300-01-4,Adrenergic receptor antagonist
24297,l02,BRD-A31800922-003-04-6,acetylcholine receptor antagonist
24297,l05,BRD-A32164164-048-01-4,Acetylcholine receptor antagonist
24297,l06,BRD-A32505112-001-02-8,angiotensin converting enzyme inhibitor
24297,l09,BRD-A32673558-003-02-1,acetylcholine receptor agonist
24297,l10,BRD-A32949107-001-01-7,calcium channel blocker
24297,l12,BRD-A33168282-003-06-5,Adrenergic receptor antagonist
24297,l13,BRD-A33447119-001-02-5,Anthelmintic
24297,l14,BRD-A33711280-311-02-0,Acetylcholine receptor antagonist
24297,l19,BRD-A34255068-001-04-8,phosphodiesterase inhibitor
24297,l20,BRD-A34309505-001-08-5,benzodiazepine receptor agonist
24297,l22,BRD-A34706053-003-01-9,Adrenergic receptor agonist
24297,m01,BRD-A34751532-001-03-6,HSP inducer
24297,m03,BRD-A34788695-003-04-5,bacterial 30S ribosomal subunit inhibitor
24297,m04,BRD-A34806832-001-02-7,ATPase inhibitor
24297,m07,BRD-A35033682-001-01-0,cytochrome P450 inhibitor
24297,m08,BRD-A35338386-001-04-6,adenosine receptor agonist
24297,m11,BRD-A35511923-019-01-6,Somatostatin receptor agonist
24297,m12,BRD-A35623999-001-03-2,mitochondrial Na+/Ca2+ exchanger antagonist|sodium/calcium exchange inhibitor
24297,m16,BRD-A35931254-003-02-7,dopamine receptor agonist
24297,m18,BRD-A36066264-001-02-3,Estrogen receptor agonist
24297,m19,BRD-A36074203-003-03-5,Glutamate receptor antagonist
24297,m20,BRD-A36217750-001-04-9,Uricosuric blocker
24297,m21,BRD-A36267905-003-02-8,Adrenergic receptor agonist
24297,m22,BRD-A36318220-001-01-3,RIPK inhibitor
24297,m23,BRD-A36471396-003-02-2,Acetylcholine receptor antagonist
24297,n01,BRD-A37347161-003-01-8,opioid receptor agonist
24297,n02,BRD-A37432947-004-02-5,acetylcholine receptor antagonist
24297,n03,BRD-A37441042-003-02-2,adrenergic receptor agonist
24297,n04,BRD-A37492983-001-03-8,radiopaque medium
24297,n06,BRD-A37704979-001-02-4,p38 MAPK inhibitor
24297,n07,BRD-A37776212-003-02-5,opioid receptor agonist
24297,n17,BRD-A38747044-001-01-5,Imidazoline receptor ligand
24297,n18,BRD-A38898897-003-01-0,Leukocyte elastase inhibitor
24297,n19,BRD-A38913120-001-01-0,BCL inhibitor
24297,n21,BRD-A39230911-001-03-7,Muscle relaxant
24297,n22,BRD-A39255369-001-01-5,Chloride channel blocker
24297,n23,BRD-A39268308-001-02-0,Acetylcholine receptor agonist
24297,o01,BRD-A39522003-001-01-0,FAAH inhibitor|FAAH reuptake inhibitor
24297,o03,BRD-A39747742-001-02-7,estrogen receptor agonist
24297,o05,BRD-A39969961-001-01-3,Cytochrome P450 inhibitor
24297,o06,BRD-A40022950-001-02-9,ATPase inhibitor
24297,o08,BRD-A40639672-234-04-0,Cyclooxygenase inhibitor
24297,o10,BRD-A41112154-001-02-1,G protein-coupled receptor agonist
24297,o13,BRD-A41145729-001-02-7,Retinoid receptor agonist
24297,o14,BRD-A41250306-001-03-4,Thiazide diuretic
24297,o15,BRD-A41301928-001-02-5,"Mitochondrial ADP, ATP translocase inhibitor"
24297,o16,BRD-A41304429-001-04-9,Adrenergic receptor antagonist
24297,o17,BRD-A41451487-001-01-3,Benzodiazepine receptor antagonist
24297,o18,BRD-A41519720-001-02-2,Niemann-Pick C1-like 1 protein antagonist
24297,o19,BRD-A41722204-003-01-5,adenosine receptor antagonist
24297,o20,BRD-A41833852-001-01-9,Opioid receptor antagonist
24297,o22,BRD-A41941932-001-03-0,Antioxidant
24297,o23,BRD-A42167015-003-03-7,Adrenergic receptor antagonist
24297,o24,BRD-A42335949-300-04-9,phosphatidylglycerophosphatase inhibitor
24297,p01,BRD-A42346008-003-03-6,epinephrine metabolite
24297,p02,BRD-A42553870-001-05-1,neuropeptide receptor antagonist
24297,p03,BRD-A42571354-300-01-3,histamine receptor antagonist
24297,p04,BRD-A42628519-001-04-1,radiopaque medium
24297,p05,BRD-A42759514-001-03-1,Antiprotozoal
24297,p06,BRD-A42831637-001-02-2,anti-inflammatory|Cannabinoid metabolite
24297,p07,BRD-A43076080-001-03-3,protein phosphatase inhibitor
24297,p09,BRD-A43150328-001-02-0,other antibiotic
24297,p13,BRD-A43671941-003-03-6,Adrenergic receptor antagonist
24297,p14,BRD-A43849199-001-02-3,Phytotoxin
24297,p15,BRD-A43930669-003-01-0,oxytocin receptor antagonist
24297,p16,BRD-A43940795-001-02-8,serotonin release inhibitor
24297,p17,BRD-A43974499-066-01-1,Adrenergic receptor antagonist
24297,p19,BRD-A44008656-036-04-3,Histamine receptor antagonist
24297,p20,BRD-A44090213-001-04-1,Cyclooxygenase inhibitor
24297,p21,BRD-A44133049-001-01-5,Serotonin receptor antagonist
24297,p22,BRD-A44448661-001-02-2,Barbiturate antiepileptic
24297,p23,BRD-A44551378-001-01-9,EGFR inhibitor
24297,p24,BRD-A44863528-001-04-1,CCK receptor antagonist
24303,a01,BRD-A44966919-001-03-1,acetylcholine receptor antagonist
24303,a02,BRD-A45140972-060-02-4,bacterial 50S ribosomal subunit inhibitor
24303,a03,BRD-A45499626-001-01-0,Glutamate receptor antagonist
24303,a04,BRD-A45543382-001-02-7,radiopaque medium
24303,a05,BRD-A46066006-004-04-4,muscarinic antagonist
24303,a10,BRD-A47144777-001-02-5,HSP90 inhibitor
24303,a11,BRD-A47494775-003-03-0,Adrenergic receptor agonist
24303,a12,BRD-A47513740-001-02-5,protein phosphatase inhibitor
24303,a15,BRD-A47598013-004-02-0,selective serotonin reuptake inhibitor (SSRI)
24303,a17,BRD-A48257147-001-01-9,glutamate receptor agonist
24303,a18,BRD-A48300215-001-01-4,sodium channel blocker
24303,a21,BRD-A48809242-001-02-9,adenosine receptor agonist
24303,a23,BRD-A49046702-001-01-2,GABA uptake inhibitor
24303,a24,BRD-A49172652-001-13-1,ATPase inhibitor
24303,b01,BRD-A49225603-045-02-7,histamine receptor agonist
24303,b02,BRD-A49358627-001-03-9,PPAR receptor agonist
24303,b03,BRD-A49370193-051-01-7,serotonin receptor agonist
24303,b05,BRD-A49680073-001-01-9,JAK inhibitor|Lipocortin synthesis stimulant|STAT inhibitor
24303,b06,BRD-A49734948-001-03-3,Plant alkaloid
24303,b07,BRD-A49906757-004-03-1,Acetylcholine receptor antagonist
24303,b09,BRD-A50157456-065-02-4,adrenergic receptor agonist
24303,b10,BRD-A50311610-300-04-7,CAR agonist
24303,b11,BRD-A50675702-001-03-0,chloride channel blocker|GABA gated chloride channel blocker
24303,b12,BRD-A50684349-001-01-5,dopamine receptor agonist
24303,b15,BRD-A50737080-001-01-4,ATR kinase inhibitor
24303,b16,BRD-A50764878-001-01-4,serotonin receptor antagonist
24303,b19,BRD-A51410489-001-01-4,adrenergic receptor antagonist
24303,b21,BRD-A51714012-001-02-3,Adrenergic inhibitor
24303,b22,BRD-A51820102-008-04-0,Bacterial cell wall synthesis inhibitor
24303,b23,BRD-A51829654-001-01-4,Serotonin receptor antagonist
24303,c01,BRD-A52588987-004-04-1,Dopamine receptor antagonist
24303,c02,BRD-A52660433-066-01-3,Monoamine oxidase inhibitor
24303,c04,BRD-A52922642-001-02-9,L-type calcium channel blocker
24303,c05,BRD-A53077924-236-01-4,Selective serotonin reuptake enhancer (SSRE)
24303,c07,BRD-A53416814-001-01-5,nitric oxide production inhibitor|phosphoenolpyruvate carboxylase activator|serine/threonine protein phosphatase activator
24303,c09,BRD-A53576514-003-03-1,Acetylcholine receptor antagonist
24303,c10,BRD-A53952395-003-04-6,local anesthetic
24303,c13,BRD-A54029483-001-01-5,endothelin receptor antagonist
24303,c14,BRD-A54236247-003-02-7,Adrenergic receptor agonist
24303,c17,BRD-A54490543-066-04-4,monoamine oxidase inhibitor
24303,c18,BRD-A54845972-066-01-5,serotonin receptor agonist|adrenergic receptor partial agonist|dopamine receptor agonist
24303,c19,BRD-A54927599-001-07-8,P-selectin inhibitor
24303,c22,BRD-A55272860-001-03-9,dopamine receptor antagonist
24303,c23,BRD-A55369275-001-01-6,GABA receptor antagonist
24303,c24,BRD-A55393291-001-02-4,Androgen receptor agonist
24303,d01,BRD-A55424491-001-04-1,dihydrofolate reductase inhibitor
24303,d04,BRD-A55756846-001-05-5,PKA inhibitor
24303,d05,BRD-A55913614-316-04-7,antimalarial agent|DNA inhibitor
24303,d07,BRD-A56020723-001-02-0,cathepsin inhibitor|antiamyloidogenic agent
24303,d08,BRD-A56675431-001-04-0,Thiazide diuretic
24303,d13,BRD-A56987319-001-03-8,Adenylyl cyclase inhibitor
24303,d14,BRD-A57133233-003-03-7,histamine receptor antagonist
24303,d17,BRD-A57382968-001-06-8,Cyclooxygenase inhibitor
24303,d20,BRD-A58048407-001-06-3,Calcium channel blocker
24303,d24,BRD-A59215453-003-03-3,Acetylcholine receptor antagonist
24303,e03,BRD-A59303141-001-03-9,Thiazide diuretic
24303,e06,BRD-A60197193-001-05-4,Dopamine receptor antagonist
24303,e12,BRD-A61154809-001-03-5,ATP channel blocker|insulin secretagogue
24303,e14,BRD-A61392169-001-01-9,glutamate receptor antagonist
24303,e15,BRD-A61470182-001-02-4,macrophage activator
24303,e16,BRD-A61793559-001-04-0,Carbonic anhydrase inhibitor
24303,e19,BRD-A61856038-001-01-2,Lipoxygenase inhibitor
24303,e22,BRD-A62021152-003-01-8,serotonin receptor agonist
24303,e23,BRD-A62057054-001-01-5,Serotonin receptor antagonist
24303,f04,BRD-A62428732-096-02-6,antihistamine
24303,f05,BRD-A62505706-001-02-3,DNA directed DNA polymerase inhibitor
24303,f06,BRD-A62525898-001-02-9,Glucocorticoid receptor agonist
24303,f08,BRD-A63346720-300-01-1,sigma receptor antagonist|dopamine reuptake inhibitor
24303,f11,BRD-A63546914-003-01-2,Glutamate receptor antagonist
24303,f12,BRD-A63667919-103-01-9,dopamine receptor antagonist|partial serotonin receptor agonist
24303,f14,BRD-A63836183-362-01-1,angiotensin receptor antagonist
24303,f15,BRD-A63894585-001-03-4,glucocorticoid receptor agonist
24303,f16,BRD-A64092382-003-03-5,Sodium channel blocker
24303,f19,BRD-A64125466-236-02-0,choleretic agent
24303,f20,BRD-A64227845-004-02-8,Dopamine receptor agonist
24303,f21,BRD-A64228451-001-03-5,BTK inhibitor
24303,f23,BRD-A64485570-001-02-9,DNA directed DNA polymerase inhibitor|thymidylate synthase inhibitor
24303,g02,BRD-A64933752-001-01-0,adenosine receptor agonist
24303,g06,BRD-A64977602-001-01-9,Adrenergic receptor antagonist
24303,g07,BRD-A65013509-003-03-8,Acetylcholine receptor antagonist
24303,g08,BRD-A65051990-001-03-8,vitamin K antagonist
24303,g09,BRD-A65076780-001-01-3,adrenergic receptor antagonist|prolactin inhibitor
24303,g10,BRD-A65145453-001-02-0,glutamate receptor agonist
24303,g11,BRD-A65280694-003-03-8,Dopamine receptor antagonist
24303,g12,BRD-A65440446-001-02-5,Adrenergic receptor agonist
24303,g13,BRD-A65597028-003-02-4,Adrenergic receptor antagonist
24303,g14,BRD-A65615053-003-01-4,Serotonin receptor antagonist
24303,g15,BRD-A65671304-001-02-6,angiotensin receptor antagonist
24303,g17,BRD-A66025870-237-05-1,bacterial cell wall synthesis inhibitor
24303,g18,BRD-A66199457-001-02-2,antineoplastic
24303,g22,BRD-A66435872-313-01-8,Histamine receptor agonist
24303,g23,BRD-A66563878-003-01-8,Adrenergic receptor agonist
24303,h01,BRD-A66927094-001-01-7,Dopamine receptor antagonist
24303,h07,BRD-A67552019-001-02-2,ATPase inhibitor
24303,h09,BRD-A67862938-034-04-0,Adrenergic receptor antagonist
24303,h10,BRD-A68281735-001-02-0,Leukotriene receptor antagonist
24303,h12,BRD-A68723818-050-04-4,Histamine receptor antagonist
24303,h13,BRD-A68888262-003-02-9,histamine receptor antagonist
24303,h14,BRD-A68929948-001-01-9,antiamyloidogenic agent|gamma secretase inhibitor
24303,h15,BRD-A69636825-003-02-1,Calcium channel blocker
24303,h17,BRD-A69777949-001-04-4,topoisomerase inhibitor
24303,h18,BRD-A69786436-003-02-5,acetylcholine receptor antagonist
24303,h23,BRD-A70083328-001-02-9,Acetylcholinesterase inhibitor
24303,h24,BRD-A70268693-103-01-9,Acetylcholine receptor agonist
24303,i01,BRD-A70407468-001-01-2,adenosine receptor antagonist
24303,i02,BRD-A70514680-003-03-9,Local anesthetic
24303,i03,BRD-A70649075-008-04-3,sterol demethylase inhibitor
24303,i08,BRD-A71157293-003-03-5,Vitamin B
24303,i09,BRD-A71203467-001-01-5,Dopamine receptor antagonist
24303,i10,BRD-A71774530-001-01-8,chitin inhibitor
24303,i12,BRD-A71816415-236-02-7,HMGCR inhibitor
24303,i13,BRD-A72066420-001-01-1,PPAR receptor antagonist
24303,i14,BRD-A72483914-001-01-1,Serotonin receptor antagonist
24303,i15,BRD-A72596465-001-01-3,PPAR receptor antagonist
24303,i16,BRD-A72703248-001-02-7,calcium channel blocker|cytochrome P450 inhibitor
24303,i17,BRD-A72711497-236-02-0,bacterial permeability inducer
24303,i18,BRD-A72988804-001-03-8,Cyclooxygenase inhibitor
24303,i19,BRD-A73368467-003-02-8,Histamine receptor antagonist
24303,i23,BRD-A73859745-236-01-8,Apoptosis stimulant
24303,j02,BRD-A74667430-001-04-6,Cyclooxygenase inhibitor
24303,j03,BRD-A74904029-001-04-0,Casein kinase inhibitor
24303,j07,BRD-A74980173-001-02-8,Bacterial DNA gyrase inhibitor
24303,j09,BRD-A75478957-001-01-6,collagenase inhibitor|metalloproteinase inhibitor|stromelysin inhibitor
24303,j10,BRD-A75552914-001-04-4,Cyclooxygenase inhibitor
24303,j12,BRD-A75769826-003-01-3,opioid receptor antagonist
24303,j13,BRD-A75817871-001-02-6,ATPase inhibitor
24303,j14,BRD-A75850590-003-04-9,bacterial DNA gyrase inhibitor
24303,j16,BRD-A76093993-001-01-8,Potassium channel activator
24303,j24,BRD-A77291778-003-04-8,acetylcholine receptor antagonist
24303,k01,BRD-A77299732-001-01-6,Eukaryotic translation initiation factor inhibitor
24303,k02,BRD-A77349281-001-02-2,heparanase inhibitor|tyrosine phosphatase inhibitor
24303,k06,BRD-A78295502-337-03-5,anti-arrhythmia agent
24303,k10,BRD-A78377521-001-02-2,Kinesin-like spindle protein inhibitor
24303,k11,BRD-A78877355-003-03-6,Cyclooxygenase inhibitor
24303,k12,BRD-A78942461-003-01-3,Adrenergic receptor antagonist
24303,k13,BRD-A79226577-003-01-1,serotonin receptor antagonist|polarization inhibitor|sodium channel blocker
24303,k17,BRD-A79672927-001-04-1,Acetylcholine receptor antagonist
24303,k18,BRD-A79981887-003-04-0,adrenergic receptor agonist
24303,k19,BRD-A80017228-001-04-2,Sodium/potassium/chloride transporter inhibitor
24303,k21,BRD-A80213327-305-01-8,Ras GTPase inhibitor
24303,k22,BRD-A80594172-001-02-0,glucocorticoid receptor agonist
24303,l01,BRD-A80641450-001-01-4,Endothelin receptor antagonist
24303,l05,BRD-A81177136-001-03-6,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist
24303,l10,BRD-A81615860-001-02-9,tryptophan hydroxylase inhibitor
24303,l11,BRD-A81795050-003-01-7,oxidosqualene cyclase inhibitor
24303,l12,BRD-A81866333-003-01-5,Adenosine receptor agonist
24303,l13,BRD-A82238138-001-01-7,glucocorticoid receptor agonist
24303,l17,BRD-A82371568-001-01-5,ribonucleoside reductase inhibitor|DNA polymerase inhibitor|DNA repair enzyme inhibitor|DNA synthesis inhibitor|ribonucleotide reductase inhibitor
24303,l19,BRD-A82590476-001-01-1,tachykinin antagonist
24303,l20,BRD-A82656074-003-01-2,opioid receptor antagonist
24303,l22,BRD-A83326220-001-02-6,Nitric oxide production inhibitor
24303,m02,BRD-A83431637-001-01-3,Cytochrome P450 inhibitor
24303,m04,BRD-A83695761-001-01-1,Potassium channel blocker
24303,m05,BRD-A83855350-003-01-4,Opioid receptor antagonist
24303,m07,BRD-A83937277-001-03-0,Hydantoin antiepileptic
24303,m08,BRD-A84174393-001-02-0,Cyclooxygenase inhibitor
24303,m11,BRD-A84174873-001-06-0,benzodiazepine receptor agonist
24303,m12,BRD-A84389091-001-01-1,GABA receptor inverse agonist
24303,m15,BRD-A84389633-001-01-6,serotonin receptor antagonist
24303,m19,BRD-A85137183-001-01-2,bacterial cell wall synthesis inhibitor
24303,m21,BRD-A85234536-001-04-5,Adenosine receptor agonist
24303,m22,BRD-A85280935-003-01-7,Dopamine receptor agonist
24303,m23,BRD-A85472596-001-01-4,Prostanoid receptor antagonist
24303,m24,BRD-A85587465-001-01-7,Serotonin receptor antagonist
24303,n01,BRD-A86044036-001-04-2,cyclooxygenase inhibitor
24303,n06,BRD-A87479750-001-01-9,Cyclooxygenase inhibitor
24303,n08,BRD-A87719232-001-02-4,Cyclooxygenase inhibitor
24303,n11,BRD-A88254928-001-04-6,adrenergic receptor agonist
24303,n12,BRD-A88282067-001-02-2,Antiarrhythmic
24303,n15,BRD-A88548664-001-01-5,dopamine receptor agonist
24303,n18,BRD-A89434049-001-02-1,ATPase inhibitor
24303,n19,BRD-A89585551-003-03-4,adenosine receptor antagonist|hemoglobin antagonist
24303,n20,BRD-A89672324-001-02-2,GABA receptor antagonist
24303,n22,BRD-A89947015-001-01-4,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor
24303,n24,BRD-A90311807-236-01-4,Dehydropeptidase inhibitor
24303,o01,BRD-A90462498-003-02-1,antineoplastic
24303,o02,BRD-A90490067-001-01-9,estrogen receptor antagonist|DNA directed DNA polymerase inhibitor|soluble epoxide hydrolase inhibitor
24303,o03,BRD-A90515964-001-05-8,expectorant
24303,o04,BRD-A90799790-001-04-1,calcium channel blocker
24303,o06,BRD-A91008255-001-02-8,calcium channel blocker
24303,o08,BRD-A91699651-316-04-2,Antimalarial
24303,o09,BRD-A91866971-001-02-2,Thromboxane receptor antagonist
24303,o13,BRD-A92161634-001-02-6,Acetylcholine receptor antagonist
24303,o14,BRD-A92585442-237-01-0,Cytochrome P450 inhibitor
24303,o15,BRD-A92670106-003-03-9,Sodium channel blocker
24303,o16,BRD-A92826379-009-02-6,Sodium channel blocker
24303,o18,BRD-A93000692-001-03-2,PPAR receptor agonist
24303,o19,BRD-A93206962-001-01-2,adrenergic receptor agonist|adrenergic receptor partial agonist
24303,o20,BRD-A93255169-001-06-9,TNF production inhibitor
24303,o24,BRD-A93477898-001-01-8,caspase activator
24303,p01,BRD-A93659613-051-03-6,Opioid receptor agonist
24303,p02,BRD-A93739713-065-02-7,muscarinic antagonist
24303,p05,BRD-A94413429-003-01-6,neuropeptide receptor antagonist
24303,p06,BRD-A94543220-001-02-3,Sterol demethylase inhibitor
24303,p07,BRD-A94624445-236-02-2,adenosine receptor agonist|cAMP stimulant
24303,p08,BRD-A94669766-001-02-6,Aromatase inhibitor
24303,p10,BRD-A94709349-001-02-6,Muscle relaxant
24303,p13,BRD-A95096829-300-01-4,dopamine receptor antagonist
24303,p14,BRD-A95207036-001-02-8,androgen receptor antagonist
24303,p15,BRD-A95445494-001-02-9,interleukin synthesis inhibitor|sodium/glucose cotransporter inhibitor
24303,p16,BRD-A95513702-001-02-2,aromatase inhibitor
24303,p17,BRD-A95696066-003-06-2,Norepinephrine reuptake inhibitor
24303,p18,BRD-A95869247-001-03-8,thiazide diuretic
24303,p19,BRD-A95939040-008-03-3,sterol demethylase inhibitor
24303,p20,BRD-A96456596-001-01-4,Leukotriene receptor antagonist
24303,p21,BRD-A96485169-001-02-8,Aldose reductase inhibitor
24303,p23,BRD-A96882008-001-01-3,Tachykinin antagonist
24303,p24,BRD-A96897502-001-02-0,lipid peroxidase inhibitor
25955,a01,BRD-A97104540-004-04-4,adrenergic receptor agonist
25955,a04,BRD-A97479839-003-04-2,Acetylcholine receptor antagonist
25955,a05,BRD-A97701745-001-04-6,adrenergic receptor antagonist|serotonin receptor antagonist
25955,a06,BRD-A97730597-003-03-2,sodium channel blocker
25955,a07,BRD-A97739905-001-04-2,cyclooxygenase inhibitor
25955,a08,BRD-A98299281-050-03-9,calcium channel activator
25955,a09,BRD-A98378129-001-01-4,cyclooxygenase inhibitor|calcium channel blocker|calcium-activated chloride channel blocker|mucin production inhibitor
25955,a10,BRD-A98702003-304-02-2,11-beta-HSD1 inhibitor
25955,a11,BRD-A98725278-103-01-9,serotonin receptor antagonist
25955,a15,BRD-A99177642-001-02-5,acetylcholine receptor antagonist
25955,a16,BRD-A99402294-236-02-0,bacterial cell wall synthesis inhibitor
25955,a17,BRD-A99411506-002-01-3,antioxidant
25955,a18,BRD-A99449986-001-01-4,adenine nucleotide translocase inhibitor|caspase activator|neurotrophic agent
25955,a19,BRD-A99571536-001-01-0,anti-epileptic
25955,a20,BRD-K00141480-001-03-0,anti-inflammatory agent|interleukin inhibitor
25955,a21,BRD-K00184207-001-02-4,aryl hydrocarbon receptor ligand
25955,a22,BRD-K00206590-001-01-2,ATP channel activator
25955,a23,BRD-K00259736-001-03-2,microtubule inhibitor
25955,a24,BRD-K00312224-001-03-8,estrogen receptor agonist
25955,b03,BRD-K00603606-003-03-4,purinergic receptor antagonist|platelet aggregation inhibitor
25955,b04,BRD-K00610438-003-01-7,serotonin receptor antagonist|collagen stimulant
25955,b05,BRD-K00662280-001-01-1,GABA receptor agonist
25955,b06,BRD-K00673382-001-04-9,histamine receptor antagonist
25955,b07,BRD-K00675675-003-01-2,metalloproteinase inhibitor
25955,b09,BRD-K00824317-001-03-0,glucocorticoid receptor agonist
25955,b11,BRD-K01095011-001-03-5,5 alpha reductase inhibitor
25955,b15,BRD-K01244426-236-04-8,bacterial cell wall synthesis inhibitor
25955,b16,BRD-K01292756-001-06-0,dopamine receptor antagonist
25955,b19,BRD-K01567962-001-06-5,JNK inhibitor
25955,b20,BRD-K01624546-001-02-8,LTB4 inhibitor
25955,b21,BRD-K01648091-001-04-2,Dopamine receptor antagonist
25955,b22,BRD-K01663662-003-03-8,muscarinic antagonist
25955,b23,BRD-K01815685-001-02-3,aryl hydrocarbon receptor agonist
25955,c01,BRD-K01868942-001-01-3,serotonin receptor antagonist
25955,c02,BRD-K01902415-001-03-4,PPAR receptor agonist
25955,c05,BRD-K02265150-001-04-2,norepinephrine reputake inhibitor
25955,c06,BRD-K02275692-003-03-4,bacterial cell wall synthesis inhibitor
25955,c07,BRD-K02283807-003-01-4,thromboxane receptor antagonist
25955,c09,BRD-K02404261-001-02-7,Adenosine receptor antagonist
25955,c10,BRD-K02407574-001-03-0,tubulin polymerization inhibitor
25955,c14,BRD-K02581333-001-01-8,Tyrosine phosphatase inhibitor
25955,c17,BRD-K02590140-001-01-2,cannabinoid receptor antagonist
25955,c18,BRD-K02607075-333-03-6,Acetylcholine receptor antagonist
25955,c19,BRD-K02637541-001-02-4,Cyclooxygenase inhibitor
25955,c22,BRD-K02764365-001-03-7,anthelmintic agent
25955,c23,BRD-K02867583-300-04-8,serotonin reuptake inhibitor
25955,c24,BRD-K02900412-001-02-2,protein synthesis inhibitor
25955,d01,BRD-K02953697-001-01-9,cytochrome P450 inhibitor
25955,d03,BRD-K03015355-003-01-5,adenylyl cyclase activator|Adenylate cyclase stimulant|growth hormone receptor agonist|phosphokinase stimulant
25955,d04,BRD-K03067624-300-02-9,protein synthesis inhibitor
25955,d06,BRD-K03109492-001-01-4,CDC inhibitor
25955,d07,BRD-K03384561-001-01-9,Angiogenesis inhibitor
25955,d08,BRD-K03440695-001-02-6,Acetylcholine receptor antagonist
25955,d13,BRD-K03600606-001-02-3,Beta secretase inhibitor
25955,d14,BRD-K03602135-236-02-1,HMGCR inhibitor
25955,d17,BRD-K03642198-300-01-7,hedgehog pathway inhibitor
25955,d18,BRD-K03670461-001-02-0,EGFR inhibitor
25955,d19,BRD-K03842655-001-02-1,potassium channel blocker
25955,d20,BRD-K03981224-001-02-9,Progestogen hormone
25955,d21,BRD-K04010869-001-02-6,HSP inducer|NFKB pathway inhibitor
25955,d22,BRD-K04046242-001-03-6,Estrogen receptor agonist
25955,d23,BRD-K04111260-001-01-9,Dopamine receptor antagonist
25955,d24,BRD-K04170657-001-02-4,Ras GTPase inhibitor
25955,e03,BRD-K04185004-003-03-6,Local anesthetic
25955,e04,BRD-K04414442-001-03-4,tachykinin antagonist
25955,e05,BRD-K04430056-001-02-9,nitric oxide synthase inhibitor
25955,e06,BRD-K04704168-003-03-6,HCV inhibitor
25955,e08,BRD-K04976539-001-01-0,PKC inhibitor|src inhibitor
25955,e11,BRD-K05151076-001-01-8,estrogen receptor antagonist
25955,e12,BRD-K05181084-003-02-9,dopamine receptor antagonist
25955,e13,BRD-K05181463-001-01-6,Dopamine receptor antagonist
25955,e16,BRD-K05434375-001-04-0,calcium channel blocker
25955,e19,BRD-K05464208-001-01-6,p38 MAPK inhibitor
25955,e21,BRD-K05653692-001-02-5,Glucosyltransferase inhibitor
25955,e22,BRD-K05673000-323-02-8,Bacterial cell wall synthesis inhibitor
25955,e23,BRD-K05901394-001-01-1,Dopamine receptor agonist
25955,e24,BRD-K05906022-001-02-8,HIV protease inhibitor
25955,f03,BRD-K05977355-001-02-6,sterol demethylase inhibitor
25955,f05,BRD-K06014311-001-01-2,Melatonin receptor antagonist
25955,f06,BRD-K06024458-001-01-4,cannabinoid receptor agonist
25955,f07,BRD-K06147391-003-01-9,Acetylcholine receptor antagonist
25955,f08,BRD-K06159959-001-01-2,Inhibitor of the binding of homoquinolinic acid to non-NMDA sensitive sites
25955,f12,BRD-K06208435-001-02-9,Calcium channel blocker
25955,f13,BRD-K06221026-001-03-5,Cyclooxygenase inhibitor
25955,f14,BRD-K06234293-001-01-8,TGF beta receptor inhibitor|p38 MAPK inhibitor
25955,f15,BRD-K06426971-001-01-9,histone lyinse methyltransferase inhibitor
25955,f19,BRD-K06467078-001-01-5,Adrenergic receptor antagonist
25955,f20,BRD-K06543683-001-03-6,PKC inhibitor|glycogen synthase kinase inhibitor|leucine rich repeat kinase inhibitor|SIRT inhibitor
25955,f21,BRD-K06593056-001-01-4,retinoid receptor agonist
25955,f22,BRD-K06753942-001-02-0,MEK inhibitor
25955,f23,BRD-K06854232-001-03-3,retinoid receptor agonist
25955,f24,BRD-K06980535-003-04-4,Dopamine receptor antagonist
25955,g02,BRD-K07117950-001-02-6,CDK inhibitor
25955,g06,BRD-K07212038-001-02-1,Mast cell stabilizer
25955,g07,BRD-K07220430-001-03-6,Calcium channel blocker
25955,g08,BRD-K07325606-001-02-3,PKC inhibitor
25955,g10,BRD-K07507905-236-01-8,adrenergic receptor agonist
25955,g13,BRD-K07691486-001-05-6,CDK inhibitor
25955,g14,BRD-K07888196-001-01-8,IGF-1 inhibitor
25955,g15,BRD-K08078237-001-04-0,calcium channel blocker
25955,g16,BRD-K08109516-001-01-1,glutamate receptor antagonist
25955,g17,BRD-K08115555-001-02-8,catechol O methyltransferase inhibitor|tumor necrosis factor inhibitor
25955,g18,BRD-K08132273-001-01-6,EGFR inhibitor
25955,g22,BRD-K08219523-001-01-9,Serotonin receptor agonist
25955,g23,BRD-K08252256-236-04-9,Cyclooxygenase inhibitor
25955,g24,BRD-K08287586-001-03-6,DNA synthesis inhibitor
25955,h01,BRD-K08316444-001-02-7,inhibitor of mitochondrial electron transport
25955,h05,BRD-K08438429-001-01-0,glucosylceramidase inhibitor|somatostatin receptor agonist
25955,h07,BRD-K08554278-001-02-4,DNA binding agent
25955,h09,BRD-K08619574-334-03-9,Dopamine receptor antagonist
25955,h10,BRD-K08619838-300-03-2,Acetylcholine receptor agonist
25955,h11,BRD-K08640512-003-01-5,Adrenergic receptor antagonist
25955,h13,BRD-K08806317-050-03-6,Adrenergic receptor antagonist
25955,h14,BRD-K08890269-001-01-5,Sodium channel blocker
25955,h16,BRD-K08973992-001-01-3,Oxidative stress inducer
25955,h17,BRD-K08996725-313-01-7,histamine receptor antagonist
25955,h18,BRD-K08998509-001-01-6,dopamine receptor antagonist|serotonin receptor antagonist
25955,h23,BRD-K09132007-001-01-8,casein kinase inhibitor|TGF beta receptor inhibitor
25955,i01,BRD-K09255212-001-03-4,chelating agent
25955,i02,BRD-K09397065-001-01-6,Serotonin receptor agonist
25955,i03,BRD-K09416995-001-16-7,HMGCR inhibitor
25955,i04,BRD-K09471561-001-02-6,bacterial DNA gyrase inhibitor
25955,i07,BRD-K09537769-001-01-6,DNA dependent protein kinase inhibitor|mTOR inhibitor|PI3K inhibitor
25955,i08,BRD-K09549677-300-01-8,T-type calcium channel blocker|angiogenesis inhibitor|calcium channel blocker|calcium channel inhibitor|L-type calcium channel blocker|sodium channel blocker
25955,i09,BRD-K09598619-065-01-5,tubulin polymerization inhibitor
25955,i10,BRD-K09631521-001-02-4,cytochrome P450 inhibitor
25955,i11,BRD-K09635134-001-02-4,negative control for D-erythro-MAPP
25955,i12,BRD-K09635314-001-01-8,phospholipase activator
25955,i13,BRD-K09668667-001-02-0,Carcinogen
25955,i14,BRD-K09764130-001-02-6,Cannabinoid receptor agonist
25955,i15,BRD-K09778810-001-01-5,inositol monophosphatase inhibitor
25955,i17,BRD-K09963420-066-03-4,HIV protease inhibitor
25955,i18,BRD-K10042277-001-02-7,cetylcholine receptor agonist|dopamine receptor agonist|dopamine receptor antagonist|dopamine receptor partial agonist|serotonin receptor antagonist|serotonin receptor inverse agonist
25955,i19,BRD-K10065684-001-02-5,laxative
25955,i23,BRD-K10176267-001-01-7,glutamate receptor antagonist
25955,i24,BRD-K10177585-003-01-6,Adenosine receptor antagonist
25955,j01,BRD-K10207760-236-03-0,bacterial permeability inducer
25955,j02,BRD-K10314788-003-04-4,nootropic agent
25955,j07,BRD-K10670311-001-04-9,Antirheumatic
25955,j10,BRD-K10705233-001-01-4,Cannabinoid receptor agonist
25955,j11,BRD-K10843433-001-02-9,Cyclooxygenase inhibitor
25955,j12,BRD-K10870738-001-02-4,lipoxygenase inhibitor
25955,j13,BRD-K10974103-001-03-9,Protein synthesis inhibitor
25955,j15,BRD-K10995081-001-05-5,Dopamine receptor antagonist
25955,j16,BRD-K11107424-001-01-1,histamine receptor antagonist
25955,j17,BRD-K11129031-001-04-4,Lipoprotein lipase activator
25955,j18,BRD-K11158509-001-02-0,EGFR inhibitor
25955,j19,BRD-K11163873-001-02-8,PARP inhibitor
25955,j24,BRD-K11298197-001-03-9,protein synthesis inhibitor
25955,k01,BRD-K11373525-003-01-3,Angiotensin receptor antagonist
25955,k02,BRD-K11399644-003-03-0,AMPK activator
25955,k04,BRD-K11634954-300-01-8,dopamine uptake inhibitor
25955,k06,BRD-K11696279-003-01-5,Imidazoline receptor agonist
25955,k09,BRD-K11717138-001-03-0,chloride channel blocker
25955,k10,BRD-K11742128-003-04-4,histamine receptor antagonist
25955,k13,BRD-K11911061-003-02-8,serotonin receptor antagonist
25955,k14,BRD-K11927976-050-01-1,mediator release inhibitor|syk inhibitor
25955,k17,BRD-K12102668-001-04-0,Monoamine oxidase inhibitor
25955,k18,BRD-K12120659-305-01-4,Integrin antagonist
25955,k20,BRD-K12184470-300-01-8,calcium channel blocker|T-type calcium channel blocker
25955,k21,BRD-K12219985-001-04-8,Sulfonylurea
25955,k22,BRD-K12244279-001-01-7,MEK inhibitor
25955,l03,BRD-K12357156-001-01-5,EGFR inhibitor|ErbB2 inhibitor|JAK2 inhibitor
25955,l04,BRD-K12513978-001-04-3,cyclooxygenase inhibitor
25955,l05,BRD-K12539581-001-06-2,tubulin polymerization inhibitor
25955,l12,BRD-K12932420-001-01-5,Phosphodiesterase inhibitor
25955,l14,BRD-K12994359-001-02-8,Cyclooxygenase inhibitor
25955,l19,BRD-K13169950-001-04-5,HDAC inhibitor
25955,l20,BRD-K13211965-001-01-4,dopamine receptor antagonist
25955,l21,BRD-K13261168-001-01-4,Dopamine receptor agonist
25955,m01,BRD-K13533483-001-03-0,calcineurin inhibitor|cyclophilin inhibitor|immunosuppressant|insulin expression inhibitor|T cell inhibitor
25955,m02,BRD-K13544237-001-01-0,dopamine receptor agonist|antiamyloidogenic agent
25955,m03,BRD-K13571841-001-03-7,Aspartic protease inhibitor
25955,m04,BRD-K13642330-001-02-6,cytochrome P450 inhibitor
25955,m05,BRD-K13819402-003-02-9,Acetylcholinesterase inhibitor
25955,m07,BRD-K13994703-001-02-0,adrenergic receptor antagonist
25955,m11,BRD-K14200658-001-02-6,Vesicular monoamine transporter inhibitor
25955,m12,BRD-K14221570-236-01-1,HIV entry inhibitor
25955,m16,BRD-K14282469-001-01-5,serotonin receptor antagonist
25955,m18,BRD-K14441456-001-01-2,EGFR inhibitor
25955,m19,BRD-K14496212-001-01-1,dopamine receptor agonist
25955,m21,BRD-K14618467-003-01-8,IKK inhibitor
25955,n01,BRD-K14765469-003-02-3,acetylcholinesterase inhibitor
25955,n02,BRD-K14767410-001-01-5,cyclooxygenase inhibitor
25955,n03,BRD-K14807180-001-01-7,serotonin receptor antagonist
25955,n04,BRD-K14821540-001-02-1,mitochondrial oxidative phosphorylation uncoupler
25955,n06,BRD-K14888893-001-02-3,KATP activator
25955,n07,BRD-K14965640-001-03-3,Cyclooxygenase inhibitor
25955,n08,BRD-K14993104-001-03-4,Chemoreceptor agonist
25955,n11,BRD-K15025317-001-04-5,NFkB pathway inhibitor
25955,n12,BRD-K15164005-001-01-5,carboxylesterase inhibitor
25955,n15,BRD-K15196155-001-01-5,Hydroxycarboxylic acid receptor agonist
25955,n17,BRD-K15519488-001-01-6,dopamine receptor agonist
25955,n19,BRD-K15567136-001-01-1,phosphodiesterase inhibitor
25955,n21,BRD-K15588452-003-01-9,serotonin receptor antagonist
25955,n22,BRD-K15601958-001-01-3,Lysophospholipid receptor agonist
25955,n23,BRD-K15616905-001-01-5,mitochondrial oxidative phosphorylation uncoupler
25955,n24,BRD-K15715913-001-01-5,dopamine receptor antagonist|serotonin receptor antagonist
25955,o01,BRD-K15766189-001-02-3,bacterial cell wall synthesis inhibitor
25955,o02,BRD-K15791587-003-01-7,tachykinin antagonist
25955,o04,BRD-K15868788-001-01-4,Serotonin receptor antagonist
25955,o05,BRD-K15916496-001-04-8,cytochrome P450 inhibitor|imidazoline receptor ligand
25955,o06,BRD-K15933101-003-01-2,dopamine receptor agonist|dopamine receptor modulator
25955,o07,BRD-K15935639-001-02-0,PGPH inhibitor|proteasome inhibitor
25955,o08,BRD-K15957397-001-02-6,CDC inhibitor
25955,o09,BRD-K16195444-001-01-7,Adrenergic receptor agonist
25955,o10,BRD-K16444452-001-03-4,phosphodiesterase inhibitor|leukotriene receptor antagonist|toll-like receptor antagonist|macrophage migration inhibiting factor inhibitor|macrophage migration inhibiting factor modulator|mediator release inhibitor|nitric oxide synthase inhibitor
25955,o14,BRD-K16485616-001-01-4,HDAC inhibitor|cell cycle inhibitor
25955,o15,BRD-K16508793-001-01-8,benzodiazepine receptor agonist
25955,o16,BRD-K16542329-001-05-1,phosphodiesterase inhibitor
25955,o17,BRD-K16551401-003-01-8,serotonin receptor agonist
25955,o19,BRD-K16604360-001-01-8,antiamyloidogenic agent|dopamine receptor agonist
25955,o20,BRD-K16664969-001-01-7,FLT3 inhibitor|tyrosine kinase inhibitor
25955,o22,BRD-K16977723-001-01-0,EGFR inhibitor
25955,o23,BRD-K17016787-001-03-5,estrogen receptor agonist
25955,p01,BRD-K17140735-300-01-6,Proteasome inhibitor
25955,p03,BRD-K17294426-050-04-0,dopamine receptor antagonist
25955,p04,BRD-K17368287-001-03-5,11-beta hydroxysteroid dehydrogenase inhibitor
25955,p05,BRD-K17378184-300-03-4,Dopamine receptor agonist
25955,p06,BRD-K17415526-001-02-7,protein tyrosine kinase inhibitor
25955,p07,BRD-K17497770-001-01-0,EGFR inhibitor|src inhibitor
25955,p08,BRD-K17565903-066-04-1,muscle relaxant
25955,p09,BRD-K17674993-001-03-1,Corticosteroid agonist
25955,p10,BRD-K17693482-001-03-9,potassium channel activator
25955,p13,BRD-K17705806-003-01-0,opioid receptor antagonist
25955,p14,BRD-K17743125-001-01-9,HDAC inhibitor|cell cycle inhibitor
25955,p15,BRD-K17743697-066-01-0,sodium/calcium exchange inhibitor
25955,p16,BRD-K17796732-001-02-0,cannabinoid receptor agonist
25955,p19,BRD-K17894950-001-04-4,CDK inhibitor|glycogen synthase kinase inhibitor
25955,p20,BRD-K17896185-001-01-2,opioid receptor agonist
25955,p21,BRD-K18059238-001-02-1,cyclooxygenase inhibitor|prostanoid receptor stimulant|thromboxane synthase stimulant
25955,p24,BRD-K18194590-065-02-3,adrenergic receptor agonist
24352,a01,BRD-A97104540-004-04-4,adrenergic receptor agonist
24352,a04,BRD-A97479839-003-04-2,Acetylcholine receptor antagonist
24352,a05,BRD-A97701745-001-04-6,adrenergic receptor antagonist|serotonin receptor antagonist
24352,a06,BRD-A97730597-003-03-2,sodium channel blocker
24352,a07,BRD-A97739905-001-04-2,cyclooxygenase inhibitor
24352,a08,BRD-A98299281-050-03-9,calcium channel activator
24352,a09,BRD-A98378129-001-01-4,cyclooxygenase inhibitor|calcium channel blocker|calcium-activated chloride channel blocker|mucin production inhibitor
24352,a10,BRD-A98702003-304-02-2,11-beta-HSD1 inhibitor
24352,a11,BRD-A98725278-103-01-9,serotonin receptor antagonist
24352,a15,BRD-A99177642-001-02-5,acetylcholine receptor antagonist
24352,a16,BRD-A99402294-236-02-0,bacterial cell wall synthesis inhibitor
24352,a17,BRD-A99411506-002-01-3,antioxidant
24352,a18,BRD-A99449986-001-01-4,adenine nucleotide translocase inhibitor|caspase activator|neurotrophic agent
24352,a19,BRD-A99571536-001-01-0,anti-epileptic
24352,a20,BRD-K00141480-001-03-0,anti-inflammatory agent|interleukin inhibitor
24352,a21,BRD-K00184207-001-02-4,aryl hydrocarbon receptor ligand
24352,a22,BRD-K00206590-001-01-2,ATP channel activator
24352,a23,BRD-K00259736-001-03-2,microtubule inhibitor
24352,a24,BRD-K00312224-001-03-8,estrogen receptor agonist
24352,b03,BRD-K00603606-003-03-4,purinergic receptor antagonist|platelet aggregation inhibitor
24352,b04,BRD-K00610438-003-01-7,serotonin receptor antagonist|collagen stimulant
24352,b05,BRD-K00662280-001-01-1,GABA receptor agonist
24352,b06,BRD-K00673382-001-04-9,histamine receptor antagonist
24352,b07,BRD-K00675675-003-01-2,metalloproteinase inhibitor
24352,b09,BRD-K00824317-001-03-0,glucocorticoid receptor agonist
24352,b11,BRD-K01095011-001-03-5,5 alpha reductase inhibitor
24352,b15,BRD-K01244426-236-04-8,bacterial cell wall synthesis inhibitor
24352,b16,BRD-K01292756-001-06-0,dopamine receptor antagonist
24352,b19,BRD-K01567962-001-06-5,JNK inhibitor
24352,b20,BRD-K01624546-001-02-8,LTB4 inhibitor
24352,b21,BRD-K01648091-001-04-2,Dopamine receptor antagonist
24352,b22,BRD-K01663662-003-03-8,muscarinic antagonist
24352,b23,BRD-K01815685-001-02-3,aryl hydrocarbon receptor agonist
24352,c01,BRD-K01868942-001-01-3,serotonin receptor antagonist
24352,c02,BRD-K01902415-001-03-4,PPAR receptor agonist
24352,c05,BRD-K02265150-001-04-2,norepinephrine reputake inhibitor
24352,c06,BRD-K02275692-003-03-4,bacterial cell wall synthesis inhibitor
24352,c07,BRD-K02283807-003-01-4,thromboxane receptor antagonist
24352,c09,BRD-K02404261-001-02-7,Adenosine receptor antagonist
24352,c10,BRD-K02407574-001-03-0,tubulin polymerization inhibitor
24352,c14,BRD-K02581333-001-01-8,Tyrosine phosphatase inhibitor
24352,c17,BRD-K02590140-001-01-2,cannabinoid receptor antagonist
24352,c18,BRD-K02607075-333-03-6,Acetylcholine receptor antagonist
24352,c19,BRD-K02637541-001-02-4,Cyclooxygenase inhibitor
24352,c22,BRD-K02764365-001-03-7,anthelmintic agent
24352,c23,BRD-K02867583-300-04-8,serotonin reuptake inhibitor
24352,c24,BRD-K02900412-001-02-2,protein synthesis inhibitor
24352,d01,BRD-K02953697-001-01-9,cytochrome P450 inhibitor
24352,d03,BRD-K03015355-003-01-5,adenylyl cyclase activator|Adenylate cyclase stimulant|growth hormone receptor agonist|phosphokinase stimulant
24352,d04,BRD-K03067624-300-02-9,protein synthesis inhibitor
24352,d06,BRD-K03109492-001-01-4,CDC inhibitor
24352,d07,BRD-K03384561-001-01-9,Angiogenesis inhibitor
24352,d08,BRD-K03440695-001-02-6,Acetylcholine receptor antagonist
24352,d13,BRD-K03600606-001-02-3,Beta secretase inhibitor
24352,d14,BRD-K03602135-236-02-1,HMGCR inhibitor
24352,d17,BRD-K03642198-300-01-7,hedgehog pathway inhibitor
24352,d18,BRD-K03670461-001-02-0,EGFR inhibitor
24352,d19,BRD-K03842655-001-02-1,potassium channel blocker
24352,d20,BRD-K03981224-001-02-9,Progestogen hormone
24352,d21,BRD-K04010869-001-02-6,HSP inducer|NFKB pathway inhibitor
24352,d22,BRD-K04046242-001-03-6,Estrogen receptor agonist
24352,d23,BRD-K04111260-001-01-9,Dopamine receptor antagonist
24352,d24,BRD-K04170657-001-02-4,Ras GTPase inhibitor
24352,e03,BRD-K04185004-003-03-6,Local anesthetic
24352,e04,BRD-K04414442-001-03-4,tachykinin antagonist
24352,e05,BRD-K04430056-001-02-9,nitric oxide synthase inhibitor
24352,e06,BRD-K04704168-003-03-6,HCV inhibitor
24352,e08,BRD-K04976539-001-01-0,PKC inhibitor|src inhibitor
24352,e11,BRD-K05151076-001-01-8,estrogen receptor antagonist
24352,e12,BRD-K05181084-003-02-9,dopamine receptor antagonist
24352,e13,BRD-K05181463-001-01-6,Dopamine receptor antagonist
24352,e16,BRD-K05434375-001-04-0,calcium channel blocker
24352,e19,BRD-K05464208-001-01-6,p38 MAPK inhibitor
24352,e21,BRD-K05653692-001-02-5,Glucosyltransferase inhibitor
24352,e22,BRD-K05673000-323-02-8,Bacterial cell wall synthesis inhibitor
24352,e23,BRD-K05901394-001-01-1,Dopamine receptor agonist
24352,e24,BRD-K05906022-001-02-8,HIV protease inhibitor
24352,f03,BRD-K05977355-001-02-6,sterol demethylase inhibitor
24352,f05,BRD-K06014311-001-01-2,Melatonin receptor antagonist
24352,f06,BRD-K06024458-001-01-4,cannabinoid receptor agonist
24352,f07,BRD-K06147391-003-01-9,Acetylcholine receptor antagonist
24352,f08,BRD-K06159959-001-01-2,Inhibitor of the binding of homoquinolinic acid to non-NMDA sensitive sites
24352,f12,BRD-K06208435-001-02-9,Calcium channel blocker
24352,f13,BRD-K06221026-001-03-5,Cyclooxygenase inhibitor
24352,f14,BRD-K06234293-001-01-8,TGF beta receptor inhibitor|p38 MAPK inhibitor
24352,f15,BRD-K06426971-001-01-9,histone lyinse methyltransferase inhibitor
24352,f19,BRD-K06467078-001-01-5,Adrenergic receptor antagonist
24352,f20,BRD-K06543683-001-03-6,PKC inhibitor|glycogen synthase kinase inhibitor|leucine rich repeat kinase inhibitor|SIRT inhibitor
24352,f21,BRD-K06593056-001-01-4,retinoid receptor agonist
24352,f22,BRD-K06753942-001-02-0,MEK inhibitor
24352,f23,BRD-K06854232-001-03-3,retinoid receptor agonist
24352,f24,BRD-K06980535-003-04-4,Dopamine receptor antagonist
24352,g02,BRD-K07117950-001-02-6,CDK inhibitor
24352,g06,BRD-K07212038-001-02-1,Mast cell stabilizer
24352,g07,BRD-K07220430-001-03-6,Calcium channel blocker
24352,g08,BRD-K07325606-001-02-3,PKC inhibitor
24352,g10,BRD-K07507905-236-01-8,adrenergic receptor agonist
24352,g13,BRD-K07691486-001-05-6,CDK inhibitor
24352,g14,BRD-K07888196-001-01-8,IGF-1 inhibitor
24352,g15,BRD-K08078237-001-04-0,calcium channel blocker
24352,g16,BRD-K08109516-001-01-1,glutamate receptor antagonist
24352,g17,BRD-K08115555-001-02-8,catechol O methyltransferase inhibitor|tumor necrosis factor inhibitor
24352,g18,BRD-K08132273-001-01-6,EGFR inhibitor
24352,g22,BRD-K08219523-001-01-9,Serotonin receptor agonist
24352,g23,BRD-K08252256-236-04-9,Cyclooxygenase inhibitor
24352,g24,BRD-K08287586-001-03-6,DNA synthesis inhibitor
24352,h01,BRD-K08316444-001-02-7,inhibitor of mitochondrial electron transport
24352,h05,BRD-K08438429-001-01-0,glucosylceramidase inhibitor|somatostatin receptor agonist
24352,h07,BRD-K08554278-001-02-4,DNA binding agent
24352,h09,BRD-K08619574-334-03-9,Dopamine receptor antagonist
24352,h10,BRD-K08619838-300-03-2,Acetylcholine receptor agonist
24352,h11,BRD-K08640512-003-01-5,Adrenergic receptor antagonist
24352,h13,BRD-K08806317-050-03-6,Adrenergic receptor antagonist
24352,h14,BRD-K08890269-001-01-5,Sodium channel blocker
24352,h16,BRD-K08973992-001-01-3,Oxidative stress inducer
24352,h17,BRD-K08996725-313-01-7,histamine receptor antagonist
24352,h18,BRD-K08998509-001-01-6,dopamine receptor antagonist|serotonin receptor antagonist
24352,h23,BRD-K09132007-001-01-8,casein kinase inhibitor|TGF beta receptor inhibitor
24352,i01,BRD-K09255212-001-03-4,chelating agent
24352,i02,BRD-K09397065-001-01-6,Serotonin receptor agonist
24352,i03,BRD-K09416995-001-16-7,HMGCR inhibitor
24352,i04,BRD-K09471561-001-02-6,bacterial DNA gyrase inhibitor
24352,i07,BRD-K09537769-001-01-6,DNA dependent protein kinase inhibitor|mTOR inhibitor|PI3K inhibitor
24352,i08,BRD-K09549677-300-01-8,T-type calcium channel blocker|angiogenesis inhibitor|calcium channel blocker|calcium channel inhibitor|L-type calcium channel blocker|sodium channel blocker
24352,i09,BRD-K09598619-065-01-5,tubulin polymerization inhibitor
24352,i10,BRD-K09631521-001-02-4,cytochrome P450 inhibitor
24352,i11,BRD-K09635134-001-02-4,negative control for D-erythro-MAPP
24352,i12,BRD-K09635314-001-01-8,phospholipase activator
24352,i13,BRD-K09668667-001-02-0,Carcinogen
24352,i14,BRD-K09764130-001-02-6,Cannabinoid receptor agonist
24352,i15,BRD-K09778810-001-01-5,inositol monophosphatase inhibitor
24352,i17,BRD-K09963420-066-03-4,HIV protease inhibitor
24352,i18,BRD-K10042277-001-02-7,cetylcholine receptor agonist|dopamine receptor agonist|dopamine receptor antagonist|dopamine receptor partial agonist|serotonin receptor antagonist|serotonin receptor inverse agonist
24352,i19,BRD-K10065684-001-02-5,laxative
24352,i23,BRD-K10176267-001-01-7,glutamate receptor antagonist
24352,i24,BRD-K10177585-003-01-6,Adenosine receptor antagonist
24352,j01,BRD-K10207760-236-03-0,bacterial permeability inducer
24352,j02,BRD-K10314788-003-04-4,nootropic agent
24352,j07,BRD-K10670311-001-04-9,Antirheumatic
24352,j10,BRD-K10705233-001-01-4,Cannabinoid receptor agonist
24352,j11,BRD-K10843433-001-02-9,Cyclooxygenase inhibitor
24352,j12,BRD-K10870738-001-02-4,lipoxygenase inhibitor
24352,j13,BRD-K10974103-001-03-9,Protein synthesis inhibitor
24352,j15,BRD-K10995081-001-05-5,Dopamine receptor antagonist
24352,j16,BRD-K11107424-001-01-1,histamine receptor antagonist
24352,j17,BRD-K11129031-001-04-4,Lipoprotein lipase activator
24352,j18,BRD-K11158509-001-02-0,EGFR inhibitor
24352,j19,BRD-K11163873-001-02-8,PARP inhibitor
24352,j24,BRD-K11298197-001-03-9,protein synthesis inhibitor
24352,k01,BRD-K11373525-003-01-3,Angiotensin receptor antagonist
24352,k02,BRD-K11399644-003-03-0,AMPK activator
24352,k04,BRD-K11634954-300-01-8,dopamine uptake inhibitor
24352,k06,BRD-K11696279-003-01-5,Imidazoline receptor agonist
24352,k09,BRD-K11717138-001-03-0,chloride channel blocker
24352,k10,BRD-K11742128-003-04-4,histamine receptor antagonist
24352,k13,BRD-K11911061-003-02-8,serotonin receptor antagonist
24352,k14,BRD-K11927976-050-01-1,mediator release inhibitor|syk inhibitor
24352,k17,BRD-K12102668-001-04-0,Monoamine oxidase inhibitor
24352,k18,BRD-K12120659-305-01-4,Integrin antagonist
24352,k20,BRD-K12184470-300-01-8,calcium channel blocker|T-type calcium channel blocker
24352,k21,BRD-K12219985-001-04-8,Sulfonylurea
24352,k22,BRD-K12244279-001-01-7,MEK inhibitor
24352,l03,BRD-K12357156-001-01-5,EGFR inhibitor|ErbB2 inhibitor|JAK2 inhibitor
24352,l04,BRD-K12513978-001-04-3,cyclooxygenase inhibitor
24352,l05,BRD-K12539581-001-06-2,tubulin polymerization inhibitor
24352,l12,BRD-K12932420-001-01-5,Phosphodiesterase inhibitor
24352,l14,BRD-K12994359-001-02-8,Cyclooxygenase inhibitor
24352,l19,BRD-K13169950-001-04-5,HDAC inhibitor
24352,l20,BRD-K13211965-001-01-4,dopamine receptor antagonist
24352,l21,BRD-K13261168-001-01-4,Dopamine receptor agonist
24352,m01,BRD-K13533483-001-03-0,calcineurin inhibitor|cyclophilin inhibitor|immunosuppressant|insulin expression inhibitor|T cell inhibitor
24352,m02,BRD-K13544237-001-01-0,dopamine receptor agonist|antiamyloidogenic agent
24352,m03,BRD-K13571841-001-03-7,Aspartic protease inhibitor
24352,m04,BRD-K13642330-001-02-6,cytochrome P450 inhibitor
24352,m05,BRD-K13819402-003-02-9,Acetylcholinesterase inhibitor
24352,m07,BRD-K13994703-001-02-0,adrenergic receptor antagonist
24352,m11,BRD-K14200658-001-02-6,Vesicular monoamine transporter inhibitor
24352,m12,BRD-K14221570-236-01-1,HIV entry inhibitor
24352,m16,BRD-K14282469-001-01-5,serotonin receptor antagonist
24352,m18,BRD-K14441456-001-01-2,EGFR inhibitor
24352,m19,BRD-K14496212-001-01-1,dopamine receptor agonist
24352,m21,BRD-K14618467-003-01-8,IKK inhibitor
24352,n01,BRD-K14765469-003-02-3,acetylcholinesterase inhibitor
24352,n02,BRD-K14767410-001-01-5,cyclooxygenase inhibitor
24352,n03,BRD-K14807180-001-01-7,serotonin receptor antagonist
24352,n04,BRD-K14821540-001-02-1,mitochondrial oxidative phosphorylation uncoupler
24352,n06,BRD-K14888893-001-02-3,KATP activator
24352,n07,BRD-K14965640-001-03-3,Cyclooxygenase inhibitor
24352,n08,BRD-K14993104-001-03-4,Chemoreceptor agonist
24352,n11,BRD-K15025317-001-04-5,NFkB pathway inhibitor
24352,n12,BRD-K15164005-001-01-5,carboxylesterase inhibitor
24352,n15,BRD-K15196155-001-01-5,Hydroxycarboxylic acid receptor agonist
24352,n17,BRD-K15519488-001-01-6,dopamine receptor agonist
24352,n19,BRD-K15567136-001-01-1,phosphodiesterase inhibitor
24352,n21,BRD-K15588452-003-01-9,serotonin receptor antagonist
24352,n22,BRD-K15601958-001-01-3,Lysophospholipid receptor agonist
24352,n23,BRD-K15616905-001-01-5,mitochondrial oxidative phosphorylation uncoupler
24352,n24,BRD-K15715913-001-01-5,dopamine receptor antagonist|serotonin receptor antagonist
24352,o01,BRD-K15766189-001-02-3,bacterial cell wall synthesis inhibitor
24352,o02,BRD-K15791587-003-01-7,tachykinin antagonist
24352,o04,BRD-K15868788-001-01-4,Serotonin receptor antagonist
24352,o05,BRD-K15916496-001-04-8,cytochrome P450 inhibitor|imidazoline receptor ligand
24352,o06,BRD-K15933101-003-01-2,dopamine receptor agonist|dopamine receptor modulator
24352,o07,BRD-K15935639-001-02-0,PGPH inhibitor|proteasome inhibitor
24352,o08,BRD-K15957397-001-02-6,CDC inhibitor
24352,o09,BRD-K16195444-001-01-7,Adrenergic receptor agonist
24352,o10,BRD-K16444452-001-03-4,phosphodiesterase inhibitor|leukotriene receptor antagonist|toll-like receptor antagonist|macrophage migration inhibiting factor inhibitor|macrophage migration inhibiting factor modulator|mediator release inhibitor|nitric oxide synthase inhibitor
24352,o14,BRD-K16485616-001-01-4,HDAC inhibitor|cell cycle inhibitor
24352,o15,BRD-K16508793-001-01-8,benzodiazepine receptor agonist
24352,o16,BRD-K16542329-001-05-1,phosphodiesterase inhibitor
24352,o17,BRD-K16551401-003-01-8,serotonin receptor agonist
24352,o19,BRD-K16604360-001-01-8,antiamyloidogenic agent|dopamine receptor agonist
24352,o20,BRD-K16664969-001-01-7,FLT3 inhibitor|tyrosine kinase inhibitor
24352,o22,BRD-K16977723-001-01-0,EGFR inhibitor
24352,o23,BRD-K17016787-001-03-5,estrogen receptor agonist
24352,p01,BRD-K17140735-300-01-6,Proteasome inhibitor
24352,p03,BRD-K17294426-050-04-0,dopamine receptor antagonist
24352,p04,BRD-K17368287-001-03-5,11-beta hydroxysteroid dehydrogenase inhibitor
24352,p05,BRD-K17378184-300-03-4,Dopamine receptor agonist
24352,p06,BRD-K17415526-001-02-7,protein tyrosine kinase inhibitor
24352,p07,BRD-K17497770-001-01-0,EGFR inhibitor|src inhibitor
24352,p08,BRD-K17565903-066-04-1,muscle relaxant
24352,p09,BRD-K17674993-001-03-1,Corticosteroid agonist
24352,p10,BRD-K17693482-001-03-9,potassium channel activator
24352,p14,BRD-K17743125-001-01-9,HDAC inhibitor|cell cycle inhibitor
24352,p15,BRD-K17743697-066-01-0,sodium/calcium exchange inhibitor
24352,p16,BRD-K17796732-001-02-0,cannabinoid receptor agonist
24352,p19,BRD-K17894950-001-04-4,CDK inhibitor|glycogen synthase kinase inhibitor
24352,p20,BRD-K17896185-001-01-2,opioid receptor agonist
24352,p21,BRD-K18059238-001-02-1,cyclooxygenase inhibitor|prostanoid receptor stimulant|thromboxane synthase stimulant
24352,p24,BRD-K18194590-065-02-3,adrenergic receptor agonist
24293,a01,BRD-K78364995-236-03-5,bacterial cell wall synthesis inhibitor
24293,a03,BRD-K78485176-001-02-9,angiotensin receptor antagonist
24293,a05,BRD-K78599730-001-02-6,farnesyltransferase inhibitor|NFkB pathway inhibitor|ras farnesyltransferase inhibitor
24293,a07,BRD-K78633253-001-01-2,ARF inhibitor
24293,a08,BRD-K78637815-001-01-4,cannabinoid receptor antagonist
24293,a09,BRD-K78643075-001-03-3,dopamine receptor antagonist
24293,a10,BRD-K78692225-001-11-2,dihydroorotate dehydrogenase inhibitor|PDGFR tyrosine kinase receptor inhibitor
24293,a11,BRD-K78815826-001-04-7,cyclooxygenase inhibitor
24293,a12,BRD-K78838262-001-02-4,hypolipidemic
24293,a16,BRD-K78959463-001-02-5,calcium channel activator
24293,a18,BRD-K79092138-001-04-5,POXB inhibitor|bacterial DNA inhibitor
24293,a19,BRD-K79116891-003-03-7,sodium channel blocker
24293,a20,BRD-K79124250-001-03-0,radiopaque medium
24293,a21,BRD-K79131256-001-03-9,tubulin polymerization inhibitor
24293,a22,BRD-K79145749-001-01-8,norepinephrine reputake inhibitor
24293,a24,BRD-K79366068-236-01-5,NTPDase inhibitor
24293,b01,BRD-K79425933-001-03-6,dopamine receptor antagonist
24293,b02,BRD-K79437791-001-02-4,Inhibitor of methylation of endogenous isoprenylated proteins
24293,b03,BRD-K79501723-003-03-4,histamine receptor modulator
24293,b04,BRD-K79684402-300-01-0,dopamine receptor partial agonist
24293,b05,BRD-K79711234-001-04-3,bacterial 50S ribosomal subunit inhibitor
24293,b06,BRD-K79759585-001-02-1,phosphodiesterase inhibitor
24293,b07,BRD-K79930101-300-01-1,EGFR inhibitor|epidermal growth factor receptor (EGFR) inhibitor|ErbB2 tyrosine kinase inhibitor|receptor tyrosine protein kinase inhibitor
24293,b09,BRD-K80315159-051-01-2,histamine receptor antagonist
24293,b12,BRD-K80334323-001-03-5,progestogen hormone
24293,b15,BRD-K80353807-001-03-0,vasodilator
24293,b16,BRD-K80396088-001-03-9,Sulfonylurea
24293,b17,BRD-K80451230-051-01-8,acetylcholine receptor antagonist
24293,b19,BRD-K80639402-003-01-1,serotonin receptor antagonist
24293,b20,BRD-K80725821-300-01-1,serotonin receptor antagonist
24293,b21,BRD-K80738081-001-06-2,cytochrome P450 inhibitor|SIRT activator
24293,b22,BRD-K80778372-001-01-7,GABA benzodiazepine site receptor inverse agonist
24293,b24,BRD-K80946661-001-02-8,p53 activator
24293,c01,BRD-K80970344-201-02-9,NFkB pathway inhibitor
24293,c02,BRD-K81029756-001-02-8,L-type calcium channel blocker|calcium channel antagonist|calcium channel blocker
24293,c04,BRD-K81209159-001-02-9,Acetylcholinesterase inhibitor
24293,c05,BRD-K81209512-001-01-3,EGFR inhibitor|epidermal growth factor receptor (EGFR) inhibitor|tyrosine kinase inhibitor
24293,c06,BRD-K81225797-001-01-5,adenosine receptor antagonist
24293,c07,BRD-K81272440-001-02-6,calcium channel blocker
24293,c09,BRD-K81376179-001-01-4,FLT3 inhibitor
24293,c14,BRD-K81709173-001-03-8,glucocorticoid receptor agonist
24293,c17,BRD-K81729199-001-01-0,acetylcholine receptor antagonist
24293,c20,BRD-K81839095-001-02-0,Estrogen receptor agonist
24293,c21,BRD-K81876028-300-01-2,Serotonin receptor agonist
24293,c23,BRD-K82103381-003-03-7,vasodilator
24293,d03,BRD-K82255054-001-04-3,GABA receptor agonist
24293,d04,BRD-K82484965-003-02-7,dopamine receptor agonist
24293,d05,BRD-K82561139-001-01-9,casein kinase inhibitor
24293,d06,BRD-K82562631-236-02-0,Cyclooxygenase inhibitor
24293,d07,BRD-K82577285-001-01-7,Dopamine receptor agonist
24293,d08,BRD-K82731415-001-04-7,CDK inhibitor
24293,d09,BRD-K82795137-001-02-3,Histamine receptor antagonist
24293,d10,BRD-K82823076-001-01-8,GABA benzodiazepine site receptor inverse agonist
24293,d13,BRD-K82846253-001-03-0,Insulin secretagogue
24293,d14,BRD-K82865713-001-02-6,cAMP inhibitor
24293,d17,BRD-K83023055-001-01-9,Melatonin receptor agonist
24293,d19,BRD-K83063356-003-01-7,CC chemokine receptor antagonist|CCR antagonist
24293,d23,BRD-K83302049-001-01-6,Histamine receptor antagonist
24293,d24,BRD-K83322645-103-01-6,sigma receptor antagonist|sigma receptor ligand
24293,e04,BRD-K83459933-001-02-1,angiogenesis inhibitor
24293,e05,BRD-K83508485-001-01-9,tachykinin antagonist
24293,e06,BRD-K83597974-003-05-7,Monoamine oxidase inhibitor
24293,e07,BRD-K83637872-001-01-7,Smoothened receptor antagonist
24293,e08,BRD-K84175871-003-02-2,Adrenergic receptor agonist
24293,e12,BRD-K84266862-001-01-6,phosphodiesterase inhibitor
24293,e13,BRD-K84421793-001-01-1,dopamine receptor agonist
24293,e14,BRD-K84595254-001-03-0,ATPase inhibitor
24293,e15,BRD-K84663978-001-02-3,phosphodiesterase inhibitor|platelet aggregation inhibitor|potassium channel blocker
24293,e16,BRD-K84709232-001-02-6,lipoxygenase inhibitor|HIV integrase inhibitor|NFkB pathway inhibitor|nitric oxide production inhibitor|PPAR receptor modulator|tumor necrosis factor production inhibitor
24293,e19,BRD-K85015012-003-01-1,GABA uptake inhibitor|GAT inhibitor
24293,e20,BRD-K85090592-003-08-7,Acetylcholine receptor agonist
24293,e22,BRD-K85119730-001-06-5,ATP channel blocker
24293,e23,BRD-K85242180-001-01-1,"indoleamine 2,3-dioxygenase inhibitor"
24293,e24,BRD-K85266041-304-01-7,glutamate receptor antagonist
24293,f04,BRD-K85383046-001-02-5,chloride channel blocker
24293,f06,BRD-K85871428-001-01-9,p38 MAPK inhibitor
24293,f11,BRD-K85883481-001-02-6,glucocorticoid receptor agonist
24293,f12,BRD-K86204871-001-02-2,sterol demethylase inhibitor
24293,f13,BRD-K86301799-001-14-0,phosphodiesterase inhibitor
24293,f14,BRD-K86434416-001-02-7,Monoamine oxidase inhibitor
24293,f15,BRD-K84663978-001-03-1,phosphodiesterase inhibitor|platelet aggregation inhibitor|potassium channel blocker
24293,f16,BRD-K86509404-001-02-0,CDK inhibitor
24293,f19,BRD-K86600316-003-01-2,Adrenergic receptor antagonist
24293,f20,BRD-K86727142-001-06-6,HCV inhibitor|XIAP inhibitor
24293,f21,BRD-K86873305-236-03-0,Bacterial cell wall synthesis inhibitor
24293,f22,BRD-K86882815-001-01-6,dopamine receptor agonist|prolactin inhibitor|prolactin secretion inhibitor
24293,f23,BRD-K86958018-001-01-9,TRPV agonist
24293,f24,BRD-K87048468-003-01-9,Serotonin receptor antagonist
24293,g01,BRD-K87049188-001-03-6,chelating agent|dopamine beta hydroxylase inhibitor
24293,g08,BRD-K87510569-001-01-0,CC chemokine receptor antagonist
24293,g09,BRD-K87696786-003-01-0,glutamate receptor antagonist
24293,g14,BRD-K87990216-001-03-7,Glucocorticoid receptor agonist
24293,g15,BRD-K87991767-001-02-0,carbonic anhydrase inhibitor|cyclooxygenase inhibitor
24293,g16,BRD-K88090157-050-03-3,antihistamine
24293,g21,BRD-K88282786-066-04-9,cannabinoid receptor agonist
24293,g22,BRD-K88358234-003-01-4,serotonin receptor agonist|nerve growth factor agonist|neurotrophic factor enhancer
24293,g23,BRD-K88366685-300-03-7,3-ketoacyl CoA thiolase inhibitor
24293,g24,BRD-K88405679-003-01-5,antihistamine
24293,h01,BRD-K88429204-001-04-7,dihydrofolate reductase inhibitor
24293,h02,BRD-K88544581-001-01-2,ACAT inhibitor
24293,h05,BRD-K88568253-065-02-1,monoamine oxidase inhibitor
24293,h06,BRD-K88611939-001-01-8,Glutamate receptor agonist
24293,h08,BRD-K88677950-001-01-3,MAP kinase inhibitor|MEK inhibitor
24293,h10,BRD-K88741031-001-01-0,EGFR inhibitor|tyrosine kinase inhibitor
24293,h11,BRD-K88743730-001-01-0,serotonin receptor partial agonist
24293,h12,BRD-K88759641-003-01-0,Angiotensin receptor antagonist
24293,h13,BRD-K88789588-001-03-2,aromatase inhibitor
24293,h14,BRD-K88809146-003-02-1,monoamine oxidase inhibitor
24293,h15,BRD-K88849294-001-02-1,Tyrosine phosphatase inhibitor
24293,h16,BRD-K88871508-001-01-9,Dopamine receptor agonist
24293,h18,BRD-K89046952-001-03-4,bacterial cell wall synthesis inhibitor
24293,h21,BRD-K89055274-048-03-7,muscle relaxant
24293,h22,BRD-K89085489-001-02-6,apoptosis stimulant|retinoid receptor agonist
24293,h23,BRD-K89125793-001-05-4,antiprotozoal agent
24293,h24,BRD-K89152108-001-03-3,thyroid hormone stimulant
24293,i01,BRD-K89210380-001-03-8,vitamin B
24293,i04,BRD-K89272762-001-04-4,chloride channel blocker
24293,i07,BRD-K89274813-001-01-5,acetylcholine release enhancer
24293,i08,BRD-K89375097-300-04-7,Acetylcholine receptor antagonist
24293,i09,BRD-K89402695-001-01-5,Thromboxane receptor antagonist
24293,i13,BRD-K89732114-001-02-6,dopamine receptor antagonist
24293,i14,BRD-K89923877-003-02-4,acetylcholine receptor antagonist
24293,i15,BRD-K89930444-001-01-9,tyrosine kinase inhibitor
24293,i16,BRD-K89997465-001-02-0,dopamine receptor antagonist
24293,i17,BRD-K90027355-001-03-4,mineralocorticoid receptor antagonist
24293,i23,BRD-K90259198-003-04-8,calmodulin antagonist|potassium channel blocker|squalene monooxygenase channel blocker
24293,i24,BRD-K90333595-001-02-8,adrenergic receptor antagonist
24293,j01,BRD-K90524085-001-05-2,phosphodiesterase inhibitor|platelet aggregation inhibitor
24293,j04,BRD-K90574421-001-01-9,Serotonin receptor agonist
24293,j08,BRD-K90789829-003-03-3,Adrenergic inhibitor
24293,j09,BRD-K90976994-001-02-1,Bile acid
24293,j10,BRD-K91243525-001-01-5,Neurotensin receptor antagonist
24293,j11,BRD-K91263825-001-02-8,tricyclic antidepressant
24293,j13,BRD-K91315211-334-02-3,Histamine receptor agonist
24293,j15,BRD-K91336023-001-01-4,Dopamine receptor agonist
24293,j16,BRD-K91370081-001-04-6,DNA synthesis inhibitor
24293,j19,BRD-K91904471-001-01-6,p38 MAPK inhibitor
24293,j20,BRD-K92000912-001-06-8,cannabinoid receptor antagonist
24293,j24,BRD-K92015269-001-01-6,dopamine uptake inhibitor
24293,k02,BRD-K92049597-001-04-2,sodium channel blocker
24293,k04,BRD-K92093830-003-05-0,topoisomerase inhibitor
24293,k05,BRD-K92138166-001-01-0,other antibiotic
24293,k09,BRD-K92492521-001-01-1,Leukotriene receptor antagonist
24293,k12,BRD-K92678294-001-01-0,Isoflavone
24293,k14,BRD-K92726801-003-02-7,Haemostatic agent
24293,k17,BRD-K92731339-227-02-3,ACE inhibitor
24293,k18,BRD-K92758126-001-06-3,NFkB pathway inhibitor
24293,k19,BRD-K92778217-001-04-6,Cyclooxygenase inhibitor
24293,k20,BRD-K92830582-003-04-8,adrenergic receptor antagonist
24293,k22,BRD-K92984783-003-02-4,Serotonin receptor antagonist
24293,l01,BRD-K93080877-001-02-1,tripeptidyl peptidase inhibitor
24293,l02,BRD-K93176058-001-01-0,retinoid receptor agonist
24293,l03,BRD-K93188295-300-01-4,adrenergic receptor antagonist
24293,l05,BRD-K93258693-001-02-5,PPAR receptor antagonist
24293,l06,BRD-K93280214-004-02-3,GABA receptor antagonist
24293,l09,BRD-K93325701-001-03-0,SRC inhibitor
24293,l10,BRD-K93332168-001-03-2,Monoamine oxidase inhibitor
24293,l11,BRD-K93441486-067-03-7,Acetylcholine receptor antagonist
24293,l12,BRD-K93460210-001-01-3,Serotonin receptor antagonist
24293,l13,BRD-K93461745-001-01-5,Serotonin receptor agonist
24293,l14,BRD-K93480852-001-02-2,calcium/calmodulin dependent protein kinase inhibitor
24293,l19,BRD-K93568044-001-03-1,glucocorticoid receptor agonist
24293,l20,BRD-K93658967-001-01-7,CDK inhibitor|CFTR channel activator|glycogen synthase kinase inhibitor|JNK inhibitor
24293,l21,BRD-K93754473-001-02-9,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)
24293,l22,BRD-K94144010-001-05-5,nicotine metabolite
24293,m04,BRD-K94270326-004-01-0,dopamine receptor antagonist
24293,m06,BRD-K94379058-001-03-5,cannabinoid receptor inverse agonist
24293,m07,BRD-K94441233-001-03-1,HMGCR inhibitor
24293,m08,BRD-K94512704-001-01-3,dopamine receptor antagonist
24293,m12,BRD-K94689771-001-02-5,CYP1B1 inhibitor
24293,m17,BRD-K94832621-001-01-5,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)
24293,m19,BRD-K94841585-001-02-8,laxative|free radical generator
24293,m21,BRD-K94887716-001-01-5,Serotonin receptor agonist
24293,m22,BRD-K94920105-001-01-3,PARP inhibitor
24293,m24,BRD-K95202259-001-01-9,p38 MAPK inhibitor
24293,n01,BRD-K95237249-001-04-2,Uricosuric blocker
24293,n02,BRD-K95309561-001-04-9,estrogen receptor agonist
24293,n04,BRD-K95435023-001-01-0,c-Met inhibitor|hepatocyte growth factor receptor inhibitor
24293,n07,BRD-K95603879-001-03-4,ATPase inhibitor
24293,n08,BRD-K95609758-001-01-1,potassium channel activator
24293,n11,BRD-K95655893-001-01-0,VEGFR kinase inhibitor
24293,n12,BRD-K95676198-001-02-6,JAK inhibitor
24293,n15,BRD-K95739795-001-01-1,Vesicular monoamine transporter inhibitor
24293,n16,BRD-K95763993-001-03-7,PDGFR receptor inhibitor
24293,n17,BRD-K95785537-001-04-1,src inhibitor
24293,n20,BRD-K95851186-001-02-9,GABA receptor modulator
24293,n21,BRD-K95899059-003-01-0,Serotonin receptor agonist
24293,n22,BRD-K95992530-001-02-4,integrin antagonist
24293,n23,BRD-K96119599-001-04-7,Melanin inhibitor
24293,n24,BRD-K96144918-001-02-3,KPL-1 tumor suppressor
24293,o04,BRD-K96263742-001-02-3,PPAR receptor agonist
24293,o05,BRD-K96271548-001-02-2,antioxidant
24293,o07,BRD-K96402602-001-01-8,PPMTase inhibitor
24293,o08,BRD-K96527333-001-03-4,GABA receptor modulator
24293,o10,BRD-K96670504-001-01-9,Glucokinase inhibitor
24293,o13,BRD-K96720755-001-01-8,Vasopressin receptor antagonist
24293,o14,BRD-K96799727-001-01-7,HSP inhibitor
24293,o15,BRD-K96809896-001-01-9,p38 MAPK inhibitor
24293,o16,BRD-K96862998-001-03-1,TGF beta receptor inhibitor
24293,o17,BRD-K97061094-001-03-2,Histamine receptor antagonist
24293,o18,BRD-K97118047-001-01-2,Casein kinase inhibitor
24293,o19,BRD-K97158071-001-04-1,Dopamine receptor antagonist
24293,o20,BRD-K97181089-001-02-7,sodium channel blocker
24293,o22,BRD-K97330509-001-01-4,src inhibitor
24293,o23,BRD-K97354755-001-01-5,src inhibitor
24293,o24,BRD-K97365803-001-01-3,PI3K inhibitor
24293,p01,BRD-K97399794-001-07-0,polar auxin transport inhibitor
24293,p02,BRD-K97440753-066-03-3,adrenergic receptor antagonist|prolactin inhibitor
24293,p04,BRD-K97509413-001-01-8,AGE inhibitor|estrogen receptor agonist|estrogen receptor ligand
24293,p05,BRD-K97521363-001-03-9,glycolysis inhibitor
24293,p06,BRD-K97530723-001-04-3,melatonin receptor agonist|nitric oxide synthase inhibitor
24293,p07,BRD-K97564742-103-01-9,histamine receptor antagonist
24293,p10,BRD-K97688263-001-02-9,sodium channel blocker
24293,p13,BRD-K97746869-001-04-9,ATP channel blocker
24293,p14,BRD-K97752965-001-01-6,ATP channel activator|nitric oxide donor|potassium channel agonist
24293,p15,BRD-K97799481-002-03-6,Adenosine receptor antagonist
24293,p16,BRD-K97810537-001-03-7,glucocorticoid receptor agonist
24293,p17,BRD-K98039984-001-03-0,glucocorticoid receptor agonist
24293,p18,BRD-K98143437-001-01-7,p38 MAPK inhibitor|interleukin inhibitor|tumor necrosis factor production inhibitor
24293,p20,BRD-K98157055-001-04-2,glutamate receptor antagonist
24293,p21,BRD-K98174813-001-05-7,bacterial 30S ribosomal subunit inhibitor
24293,p23,BRD-K98297262-001-01-1,"1,3-beta-glucan synthase inhibitor"
24293,p24,BRD-K98521173-001-03-8,mineralocorticoid receptor agonist
25988,a01,BRD-K40782193-003-01-1,sodium channel blocker
25988,a02,BRD-K40887525-001-02-9,serotonin receptor antagonist
25988,a03,BRD-K40901640-001-01-0,serotonin receptor antagonist
25988,a04,BRD-K40905133-001-02-3,sodium channel blocker
25988,a05,BRD-K40965114-001-01-2,Adrenergic receptor antagonist
25988,a06,BRD-K40990712-001-02-4,gonadotropin releasing factor hormone receptor antagonist|sodium/hydrogen antiport inhibitor|sodium/hydrogen exchanger inhibitor|urokinase inhibitor
25988,a07,BRD-K41143549-003-01-6,glutamate receptor antagonist
25988,a08,BRD-K41337261-001-01-4,Src and Abl inhibitor|vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor
25988,a09,BRD-K41406082-001-04-8,PABA antagonist
25988,a11,BRD-K41445866-001-03-0,Chloride channel agonist
25988,a12,BRD-K41524689-001-05-2,cyclooxygenase inhibitor
25988,a15,BRD-K41564320-001-01-2,tyrosine kinase inhibitor
25988,a16,BRD-K41567364-001-01-2,orexin receptor antagonist
25988,a19,BRD-K41707108-001-02-3,Phosphoenolpyruvate carboxylase activator
25988,a20,BRD-K41713976-001-02-0,potassium channel blocker
25988,a23,BRD-K41868777-003-02-9,calmodulin antagonist
25988,b01,BRD-K41876534-001-02-0,carbonic anhydrase inhibitor
25988,b02,BRD-K41996876-001-05-5,EGFR inhibitor
25988,b03,BRD-K42098891-003-03-1,tricyclic antidepressant
25988,b04,BRD-K42221274-001-01-4,GAT inhibitor
25988,b05,BRD-K42348709-003-04-0,adrenergic receptor agonist|serotonin receptor agonist
25988,b07,BRD-K42452249-001-01-7,p38 MAPK inhibitor
25988,b08,BRD-K42500029-001-01-9,"MAP kinase inhibitor|MAPK-interacting kinase inhibitor,"
25988,b10,BRD-K42635745-001-02-4,adrenergic receptor antagonist
25988,b12,BRD-K42679050-001-01-3,potassium channel activator|potassium channel agonist
25988,b16,BRD-K42748308-300-01-2,acetylcholine release enhancer|potassium channel blocker|voltage-gated potassium channel blocker
25988,b18,BRD-K43068349-001-01-9,TRPV antagonist
25988,b19,BRD-K43149758-001-04-5,Androgen receptor agonist
25988,b21,BRD-K43245338-001-02-4,calpain inhibitor|cathepsin inhibitor
25988,b22,BRD-K43290182-001-01-9,Serotonin receptor antagonist
25988,b23,BRD-K43330982-001-01-5,lysophospholipid receptor antagonist
25988,b24,BRD-K43389675-003-02-7,RNA synthesis inhibitor|topoisomerase inhibitor
25988,c01,BRD-K43405658-001-01-8,protein tyrosine kinase inhibitor
25988,c02,BRD-K43457670-001-04-7,carbonic anhydrase inhibitor
25988,c03,BRD-K43468059-001-02-9,Mycotoxin
25988,c05,BRD-K43736954-001-03-3,glucocorticoid receptor agonist
25988,c06,BRD-K43744935-048-01-6,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)|estrogen receptor agonist|estrogen receptor modulator|PKC inhibitor
25988,c07,BRD-K43796186-001-01-1,EGFR inhibitor
25988,c08,BRD-K43860855-065-03-6,antineoplastic agent
25988,c09,BRD-K44067360-001-06-3,chloride channel blocker
25988,c10,BRD-K44084986-001-03-9,rho associated kinase inhibitor
25988,c18,BRD-K44849676-001-03-0,TRPV agonist
25988,c19,BRD-K44876623-001-01-1,Benzodiazepine receptor agonist
25988,c20,BRD-K44899736-003-02-1,Monoamine oxidase inhibitor
25988,c22,BRD-K45033733-001-02-3,DNA polymerase inhibitor
25988,c24,BRD-K45068323-003-01-3,Calmodulin antagonist
25988,d02,BRD-K45117373-001-01-1,potassium channel activator|potassium channel agonist
25988,d03,BRD-K45158365-001-02-3,angiotensin receptor antagonist
25988,d04,BRD-K45296539-003-01-0,Adrenergic receptor agonist
25988,d05,BRD-K45330754-001-04-3,estrogen receptor agonist
25988,d06,BRD-K45401373-001-05-0,Apoptosis stimulant
25988,d07,BRD-K45435259-001-01-6,Dopamine receptor antagonist
25988,d09,BRD-K45479396-001-01-8,Serotonin receptor agonist
25988,d13,BRD-K45542189-048-04-9,Lipoxygenase inhibitor
25988,d14,BRD-K45662124-001-01-8,dopamine receptor ligand
25988,d17,BRD-K45861246-001-04-3,Dopamine receptor antagonist
25988,d19,BRD-K46018455-001-06-0,PPAR receptor agonist
25988,d20,BRD-K46137903-001-03-3,phospholipase activator
25988,d21,BRD-K46142322-003-01-6,serotonin receptor partial agonist
25988,d22,BRD-K46211610-003-05-1,Adrenergic receptor antagonist
25988,d23,BRD-K46317332-003-04-6,Nitric oxide synthase inhibitor
25988,d24,BRD-K46384212-001-01-1,phospholipase activator
25988,e03,BRD-K46424862-001-04-2,Monoamine oxidase inhibitor
25988,e04,BRD-K46435977-003-01-2,DNA polymerase inhibitor
25988,e05,BRD-K46441700-001-01-8,serotonin receptor antagonist
25988,e06,BRD-K46469693-001-01-8,adenosine receptor antagonist
25988,e08,BRD-K46556543-237-03-0,Mineralocorticoid receptor antagonist
25988,e13,BRD-K46766488-003-01-2,Serotonin receptor agonist
25988,e14,BRD-K46862739-001-03-6,cytochrome P450 inhibitor
25988,e15,BRD-K46937689-001-05-1,Cyclooxygenase inhibitor
25988,e16,BRD-K47105409-001-05-3,JAK inhibitor
25988,e20,BRD-K47150025-001-01-2,PDGFR alpha and c-Kit inhibitor|vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor|VEGFR inhibitor
25988,e21,BRD-K47192521-001-02-1,Platelet aggregation inhibitor
25988,e22,BRD-K47207162-312-02-2,Serotonin reuptake inhibitor
25988,e23,BRD-K47278471-003-04-0,Histamine receptor antagonist
25988,e24,BRD-K47323024-003-04-6,Histamine receptor antagonist
25988,f03,BRD-K47328134-001-02-0,heparin activation inhibitor
25988,f07,BRD-K47598052-001-04-2,src inhibitor
25988,f08,BRD-K47608922-001-02-1,chelating agent
25988,f11,BRD-K47631482-003-02-1,Mucolytic agent
25988,f12,BRD-K47635719-001-03-9,glucocorticoid receptor agonist
25988,f13,BRD-K47639036-003-03-3,Acetylcholine receptor antagonist
25988,f14,BRD-K47659338-003-01-0,serotonin receptor agonist
25988,f15,BRD-K47693913-001-02-4,Furoquinoline alkaloid
25988,f16,BRD-K47717570-304-01-5,Glutamate receptor antagonist
25988,f21,BRD-K47869605-001-04-9,microtubule inhibitor|tubulin polymerization inhibitor
25988,f23,BRD-K47936004-001-01-9,dopamine receptor agonist
25988,f24,BRD-K47943470-001-02-8,EGFR inhibitor
25988,g05,BRD-K48168960-001-05-1,Thyroid peroxidase inhibitor
25988,g07,BRD-K48300629-001-03-8,Sodium channel blocker
25988,g11,BRD-K48692744-001-01-2,PARP inhibitor
25988,g12,BRD-K48722258-300-04-5,adenosine reuptake inhibitor
25988,g13,BRD-K48735772-001-01-4,EGFR inhibitor|epidermal growth factor receptor (EGFR) inhibitor
25988,g15,BRD-K49027941-237-01-1,Adenosine receptor antagonist
25988,g16,BRD-K49049886-001-03-8,adenosine receptor antagonist
25988,g17,BRD-K49111258-001-02-8,Adrenergic receptor antagonist
25988,g23,BRD-K49294207-300-01-2,EGFR inhibitor
25988,g24,BRD-K49448285-001-01-3,CDK inhibitor
25988,h01,BRD-K49481516-004-03-5,Acetylcholinesterase inhibitor
25988,h02,BRD-K49519092-303-01-4,Histamine receptor agonist
25988,h05,BRD-K49577446-001-03-1,cytochrome P450 inhibitor
25988,h06,BRD-K49657628-001-02-3,EGFR inhibitor|tyrosine kinase inhibitor
25988,h07,BRD-K49671696-001-02-1,Serotonin receptor antagonist
25988,h11,BRD-K49890030-236-01-6,Glutamate receptor antagonist
25988,h12,BRD-K49945136-001-03-5,Serotonin receptor antagonist
25988,h13,BRD-K50018155-003-01-3,Serotonin receptor partial agonist
25988,h15,BRD-K50135270-001-01-9,dopamine uptake inhibitor
25988,h17,BRD-K50214219-001-02-4,PARP inhibitor
25988,h21,BRD-K50325075-001-01-3,potassium channel blocker|slow afterhyperpolarization channel blocker
25988,h22,BRD-K50388907-001-04-9,PPAR receptor agonist
25988,h23,BRD-K50398167-236-02-9,Cyclooxygenase inhibitor
25988,i01,BRD-K50417881-003-05-9,Dopamine receptor antagonist
25988,i02,BRD-K50422030-001-01-2,GABA receptor antagonist
25988,i03,BRD-K50464341-001-02-6,calmodulin antagonist
25988,i04,BRD-K50495309-001-01-2,src inhibitor
25988,i07,BRD-K50660797-001-02-8,Bacterial DNA gyrase inhibitor
25988,i08,BRD-K50836978-001-01-7,CDK inhibitor
25988,i09,BRD-K50841342-001-01-6,caspase activator
25988,i10,BRD-K50859149-001-04-7,bacterial antifolate
25988,i11,BRD-K50891186-001-01-0,dopamine receptor antagonist
25988,i14,BRD-K51276371-001-01-8,CDK inhibitor|CFTR channel activator|glycogen synthase kinase inhibitor|JNK inhibitor
25988,i15,BRD-K51318897-001-04-7,tubulin polymerization inhibitor
25988,i17,BRD-K51465424-003-03-6,adrenergic receptor agonist
25988,i18,BRD-K51476772-001-01-9,tyrosine kinase inhibitor
25988,i19,BRD-K51541829-001-01-3,Ionotropic glutamate receptor antagonist
25988,i23,BRD-K51575138-001-01-7,IKK inhibitor
25988,i24,BRD-K51671335-001-01-5,Dopamine receptor antagonist
25988,j01,BRD-K51751936-001-03-4,benzodiazepine receptor agonist
25988,j03,BRD-K51918615-303-01-1,histamine receptor antagonist|histamine receptor inhibitor|ionotropic glutamate receptor antagonist
25988,j07,BRD-K52020312-001-04-5,DNA inhibitor
25988,j08,BRD-K52075040-001-02-2,fatty acid synthase inhibitor
25988,j10,BRD-K52219182-001-01-6,Phosphodiesterase inhibitor
25988,j11,BRD-K52313696-001-01-6,HDAC inhibitor
25988,j13,BRD-K52394958-001-01-9,tachykinin antagonist
25988,j14,BRD-K52397688-001-01-9,dopamine receptor antagonist|FAAH inhibitor|serotonin receptor antagonist
25988,j15,BRD-K52459643-001-10-2,Prostanoid receptor agonist
25988,j16,BRD-K52512893-001-03-0,Prostanoid receptor antagonist
25988,j18,BRD-K52662033-001-02-6,histamine receptor agonist
25988,j19,BRD-K52721684-001-02-2,potassium channel activator
25988,j20,BRD-K52850071-001-01-2,JAK inhibitor
25988,j23,BRD-K52930707-001-04-8,ACE inhibitor
25988,k01,BRD-K52989797-001-01-1,serotonin transporter (SERT) inhibitor
25988,k03,BRD-K53123955-001-03-0,Phosphofructokinase inhibitor
25988,k05,BRD-K53263234-001-02-9,constitutive androstane receptor (CAR) agonist
25988,k06,BRD-K53318339-001-04-1,Phosphodiesterase inhibitor
25988,k09,BRD-K53523901-001-01-0,adiponectin receptor agonist|AP inhibitor|aryl hydrocarbon receptor antagonist|HIV integrase inhibitor|MEK inhibitor|NFkB pathway inhibitor|topoisomerase inhibitor
25988,k11,BRD-K53545112-304-01-6,Glutamate receptor antagonist
25988,k13,BRD-K53737926-003-04-7,Norepinephrine inhibitor
25988,k14,BRD-K53857191-001-04-5,Dopamine receptor antagonist
25988,k17,BRD-K53878242-001-02-4,phosphodiesterase inhibitor
25988,k19,BRD-K53979406-003-01-0,glycine transporter inhibitor|GlyT-1 inhibitor
25988,k20,BRD-K54094468-001-01-6,dopamine receptor antagonist
25988,k21,BRD-K54095730-001-01-5,p38 MAPK inhibitor
25988,k22,BRD-K54142781-001-02-1,Adrenergic receptor agonist
25988,l01,BRD-K54210043-001-02-0,calcium channel activator|large conductance potassium channel activator
25988,l02,BRD-K54233340-300-01-0,AMPK inhibitor|DNA damaging|TGF beta receptor inhibitor
25988,l03,BRD-K54330070-001-05-5,p38 MAPK inhibitor
25988,l04,BRD-K54411430-001-02-5,cAMP inhibitor
25988,l06,BRD-K54529596-001-04-0,ACE inhibitor
25988,l10,BRD-K54665485-001-01-2,Diacylglycerol kinase inhibitor
25988,l11,BRD-K54704028-001-01-3,glutamate receptor antagonist
25988,l12,BRD-K54708045-001-01-3,PPAR receptor agonist
25988,l13,BRD-K54759182-003-02-3,Norepinephrine reuptake inhibitor
25988,l14,BRD-K54771420-001-03-2,Cholesterol inhibitor
25988,l17,BRD-K54790157-001-03-1,DNA synthesis inhibitor
25988,l19,BRD-K55034111-066-02-3,bacterial DNA gyrase inhibitor
25988,l21,BRD-K55191674-236-03-7,Penicillin binding protein inhibitor
25988,m01,BRD-K55344148-003-01-8,Imidazoline receptor ligand
25988,m02,BRD-K55424922-001-01-4,Serotonin receptor agonist
25988,m03,BRD-K55430733-003-01-6,Serotonin receptor agonist
25988,m04,BRD-K55454768-001-01-8,voltage-independent calcium influx blocker
25988,m05,BRD-K55468218-001-04-8,dopamine receptor antagonist
25988,m06,BRD-K55529781-236-02-0,thromboxane synthase inhibitor
25988,m07,BRD-K55567017-001-02-4,alcohol dehydrogenase inhibitor
25988,m08,BRD-K55677650-003-01-1,ionotropic glutamate receptor antagonist
25988,m11,BRD-K55748775-001-01-4,ATPase inhibitor|potassium-competitive acid antagonist
25988,m16,BRD-K55930204-001-02-7,Hydantoin antiepileptic
25988,m17,BRD-K56047318-001-02-2,Triacylglycerol lipase inhibitor
25988,m18,BRD-K56064827-001-04-7,PKC inhibitor
25988,m20,BRD-K56115039-003-01-3,Imidazoline receptor ligand
25988,m22,BRD-K56403959-300-01-9,CC chemokine receptor ligand
25988,m23,BRD-K56429665-001-03-9,vitamin D receptor agonist
25988,m24,BRD-K56509348-003-01-3,Endothelin receptor antagonist
25988,n02,BRD-K56558538-003-02-8,Sodium channel blocker
25988,n03,BRD-K56596464-004-02-4,Sodium channel blocker
25988,n04,BRD-K56699285-001-03-7,dopamine receptor agonist|serotonin receptor antagonist
25988,n08,BRD-K57033106-048-02-8,Histamine receptor antagonist
25988,n11,BRD-K57179821-001-04-8,Antipruritic
25988,n12,BRD-K57222227-001-06-1,cyclooxygenase inhibitor
25988,n16,BRD-K57304726-003-03-6,Sigma receptor agonist
25988,n18,BRD-K57545991-050-03-3,angiotensin converting enzyme inhibitor
25988,n19,BRD-K57569181-001-04-4,Phosphodiesterase inhibitor
25988,n21,BRD-K57718010-001-06-9,GABA receptor antagonist
25988,n22,BRD-K57886322-001-03-4,glucocorticoid receptor agonist
25988,n23,BRD-K57926513-001-02-9,PDGFR receptor inhibitor
25988,o01,BRD-K58220566-001-02-2,PKC inhibitor|sodium channel blocker|calcium channel blocker
25988,o02,BRD-K58265391-001-03-6,diuretic
25988,o03,BRD-K58299615-001-02-7,amyloid precursor protein inhibitor|beta amyloid aggregation inhibitor
25988,o05,BRD-K58466253-003-04-1,serotonin release inhibitor
25988,o06,BRD-K58685305-001-02-2,11-beta hydroxysteroid dehydrogenase inhibitor
25988,o08,BRD-K58930050-001-01-1,glutamate receptor antagonist
25988,o09,BRD-K58938839-001-03-8,smoothened receptor antagonist|hedgehog pathway inhibitor
25988,o10,BRD-K59037100-001-04-8,lipase inhibitor
25988,o13,BRD-K59058766-003-03-7,dopamine receptor antagonist
25988,o15,BRD-K59184148-001-04-2,glycogen synthase kinase inhibitor
25988,o18,BRD-K59273480-001-01-5,adenosine reuptake inhibitor|phosphodiesterase inhibitor
25988,o20,BRD-K59332007-300-01-9,acetylcholine release enhancer|acetylcholine release stimulant|neurotransmitter agonist|voltage-gated potassium channel blocker
25988,o22,BRD-K59419204-001-01-9,cannabinoid receptor antagonist|cannabinoid receptor inhibitor
25988,o23,BRD-K59469039-001-04-9,Angiogenesis inhibitor
25988,o24,BRD-K59522102-001-04-7,monoamine oxidase inhibitor
25988,p01,BRD-K59574735-001-02-7,leukotriene synthesis inhibitor
25988,p02,BRD-K59637651-001-01-4,protein synthesis inhibitor|botulin neurotoxin inhibitor|mur synthetase inhibitor
25988,p03,BRD-K59650319-003-01-7,glutamate receptor antagonist
25988,p04,BRD-K59753853-001-01-5,glutamate receptor antagonist
25988,p06,BRD-K59851896-001-02-4,GABA release inhibitor
25988,p07,BRD-K59983611-001-05-2,bacterial antifolate
25988,p09,BRD-K60060639-005-01-4,antiarrhythmic medication
25988,p10,BRD-K60174629-001-02-2,prolyl endopeptidase inhibitor
25988,p13,BRD-K60184833-001-02-3,tyrosine kinase inhibitor
25988,p14,BRD-K60230970-001-04-3,proteasome inhibitor
25988,p15,BRD-K60274257-001-01-1,tyrosine phosphatase inhibitor
25988,p17,BRD-K60298136-001-01-7,aryl hydrocarbon receptor agonist|aryl hydrocarbon receptor ligand
25988,p18,BRD-K60476892-001-02-1,activator of soluble guanylyl cyclase|guanylate cyclase activator|hypoxia inducible factor inhibitor
25988,p19,BRD-K60511616-236-01-4,HMGCR inhibitor
25988,p20,BRD-K60640630-001-03-7,glucocorticoid receptor agonist
25988,p22,BRD-K60923938-001-02-8,sodium channel activator
25988,p23,BRD-K60932973-001-01-7,dopamine receptor agonist
25988,p24,BRD-K61097567-001-03-6,tachykinin antagonist
25990,a01,BRD-K90382497-001-01-6,PLK inhibitor
25990,a02,BRD-K92723993-066-02-9,PDGFR tyrosine kinase receptor inhibitor|Bcr-Abl kinase inhibitor|KIT inhibitor|Abl kinase inhibitor|apoptosis stimulant|breast cancer resistance protein inhibitor|colony stimulating factor receptor inhibitor
25990,a03,BRD-K07762753-001-03-6,CDK inhibitor|tyrosine kinase inhibitor
25990,a04,BRD-K09991945-001-02-0,glycogen synthase kinase inhibitor|PKC inhibitor|superoxide dismutase expression inhibitor
25990,a05,BRD-K37312348-001-05-1,CDK inhibitor|glycogen synthase kinase inhibitor
25990,a06,BRD-K46678324-001-03-7,rho associated kinase inhibitor
25990,a07,BRD-K67860401-001-02-3,glycogen synthase kinase inhibitor
25990,a08,BRD-K52620403-001-01-8,calcium/calmodulin dependent protein kinase inhibitor|calmodulin inhibitor
25990,a09,BRD-K68336408-001-03-4,EGFR inhibitor
25990,a10,BRD-K72703948-001-01-0,Aurora kinase inhibitor
25990,a11,BRD-K93201660-001-05-7,myosin light chain kinase inhibitor
25990,a15,BRD-A47633927-001-01-8,ICAM1 antagonist
25990,a16,BRD-A68039575-001-02-5,Aromatase inhibitor
25990,a17,BRD-A75455249-001-02-0,calcium channel modulator|mTOR inhibitor|sodium channel blocker
25990,a18,BRD-K01555864-001-02-8,antineoplastic
25990,a19,BRD-K09497549-001-03-6,calcium channel modulator|mTOR inhibitor|sodium channel blocker
25990,a20,BRD-K14536225-001-02-7,Glucosidase inhibitor
25990,a21,BRD-K15086322-103-01-0,histamine receptor antagonist|histamine receptor silent antagonist
25990,a23,BRD-K23623876-001-01-6,ultrasound contrast agent
25990,a24,BRD-K36377456-001-02-0,angiogenesis inhibitor
25990,b01,BRD-K36395411-003-01-4,serotonin receptor antagonist|serotonin receptor partial agonist
25990,b03,BRD-K41160163-001-01-9,Glutamate receptor antagonist
25990,b04,BRD-K42095107-001-02-3,estrogen receptor agonist
25990,b05,BRD-K43797669-001-02-3,tyrosine kinase inhibitor
25990,b06,BRD-K45988865-001-01-0,organosilicon compound used as an internal standard in NMR spectroscopy
25990,b07,BRD-K49061529-001-01-0,GABA benzodiazepine site receptor inverse agonist
25990,b09,BRD-K59331372-001-01-2,TRPV antagonist
25990,b11,BRD-K60690191-003-02-1,glutamate receptor antagonist
25990,b12,BRD-K61177364-003-01-1,CRF receptor antagonist
25990,b17,BRD-K61250553-001-02-9,opioid receptor agonist
25990,b18,BRD-K61269089-001-01-4,Protein kinase inhibitor
25990,b19,BRD-K61271364-001-02-4,GABA receptor antagonist
25990,b20,BRD-K61323504-001-02-4,CC chemokine receptor antagonist
25990,b22,BRD-K61496577-001-03-8,glucocorticoid receptor agonist
25990,b23,BRD-K61590534-001-01-4,EGFR inhibitor
25990,c01,BRD-K61737877-001-01-6,VEGFR inhibitor
25990,c03,BRD-K61951118-001-01-2,GABA benzodiazepine site receptor inverse agonist
25990,c04,BRD-K62008436-001-03-1,tubulin polymerization inhibitor
25990,c05,BRD-K62056274-001-01-9,Serotonin receptor agonist
25990,c07,BRD-K62206109-303-01-1,histamine receptor antagonist
25990,c08,BRD-K62221994-001-01-8,gonadotropin releasing factor hormone receptor antagonist
25990,c10,BRD-K62289640-003-01-9,Cannabinoid receptor agonist
25990,c13,BRD-K62310379-001-03-0,glucocorticoid receptor agonist
25990,c17,BRD-K62353524-001-01-8,estrogen receptor agonist
25990,c18,BRD-K62363391-001-04-1,bacterial antifolate
25990,c23,BRD-K62607865-001-03-0,bacterial cell wall synthesis inhibitor
25990,c24,BRD-K62609077-001-02-2,adrenergic receptor antagonist|GABA receptor antagonist|serotonin receptor antagonist
25990,d01,BRD-K62810658-001-05-6,MEK inhibitor
25990,d02,BRD-K62929068-001-01-7,Purinergic receptor activator
25990,d04,BRD-K62996583-001-03-8,calcium channel blocker
25990,d05,BRD-K63089472-001-02-7,Inhibitor of methyl esterification of farnesylated proteins
25990,d06,BRD-K63150726-001-01-3,cannabinoid receptor inverse agonist
25990,d07,BRD-K63151507-001-01-6,Lymphocyte inhibitor
25990,d08,BRD-K63165456-001-03-3,Adrenergic receptor agonist
25990,d09,BRD-K63430059-001-03-2,DNA synthesis inhibitor
25990,d10,BRD-K63504947-001-05-5,VEGFR inhibitor
25990,d13,BRD-K63516691-001-01-6,Phosphodiesterase inhibitor
25990,d14,BRD-K63533170-001-01-1,cannabinoid receptor antagonist|cannabinoid receptor inverse agonist
25990,d17,BRD-K63606607-001-01-8,ATPase inhibitor|chloride channel activator
25990,d18,BRD-K63630713-001-04-3,sodium/potassium/chloride transporter inhibitor
25990,d19,BRD-K63750851-001-03-3,dehydrogenase inhibitor|inositol monophosphatase inhibitor
25990,d21,BRD-K63784565-001-02-1,Topoisomerase inhibitor
25990,d22,BRD-K63792901-075-01-3,acetylcholine receptor agonist
25990,d23,BRD-K63828191-003-07-3,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)
25990,e03,BRD-K63874012-103-01-5,histamine receptor antagonist|histamine receptor inverse agonist
25990,e04,BRD-K63913457-001-02-7,vasodilator
25990,e06,BRD-K63945320-001-02-4,Phospholipase inhibitor
25990,e07,BRD-K63979671-001-03-6,Compound used in hepatobiliary scans of the liver
25990,e08,BRD-K64044582-001-02-8,ACAT inhibitor
25990,e11,BRD-K64157027-003-01-9,Adrenergic receptor agonist
25990,e14,BRD-K64245000-001-01-7,FXR agonist
25990,e16,BRD-K64341947-003-01-6,guanylate cyclase activator
25990,e20,BRD-K64402243-001-01-1,Caspase inhibitor
25990,e22,BRD-K64670467-001-01-2,glutamate receptor antagonist
25990,f03,BRD-K64755930-003-01-6,phosphodiesterase inhibitor
25990,f04,BRD-K64862097-001-03-9,glucocorticoid receptor agonist
25990,f06,BRD-K64994968-001-03-6,Progesterone receptor agonist
25990,f07,BRD-K65146499-001-04-8,Cyclooxygenase inhibitor
25990,f11,BRD-K65285700-001-01-5,cannabinoid receptor agonist
25990,f12,BRD-K65417056-003-03-6,Local anesthetic
25990,f13,BRD-K65503129-001-01-4,HSP inhibitor|HSP antagonist
25990,f15,BRD-K65639003-001-02-5,phosphodiesterase inhibitor
25990,f16,BRD-K65667145-001-04-1,cell division inducer
25990,f19,BRD-K65786282-001-02-6,GABA receptor modulator
25990,f20,BRD-K65814004-001-02-3,nitric oxide synthase inhibitor|aldehyde dehydrogenase inhibitor|cytochrome P450 inhibitor|NADPH oxidase inhibitor|xanthine oxidase inhibitor
25990,f23,BRD-K66093087-001-01-5,Benzodiazepine receptor agonist
25990,f24,BRD-K66206289-003-03-1,Acetylcholine receptor antagonist
25990,g02,BRD-K66353228-001-05-4,myorelaxant
25990,g05,BRD-K66404838-003-03-8,opioid receptor agonist|opioid receptor antagonist
25990,g08,BRD-K66707493-001-02-6,Coloring agent
25990,g09,BRD-K66715657-001-01-3,dopamine receptor antagonist
25990,g10,BRD-K66782112-001-01-2,Histamine receptor antagonist
25990,g11,BRD-K66874953-001-02-7,TP53 inhibitor
25990,g12,BRD-K66898851-001-03-7,apoptosis stimulant
25990,g13,BRD-K66944906-001-02-6,Carbonic anhydrase inhibitor
25990,g14,BRD-K67013324-001-01-5,melatonin receptor antagonist
25990,g16,BRD-K67017579-001-13-3,Phosphodiesterase inhibitor
25990,g17,BRD-K67043667-001-04-1,DNA synthesis inhibitor
25990,g18,BRD-K67080878-001-05-5,phosphodiesterase inhibitor
25990,g21,BRD-K67102207-236-01-0,HDAC inhibitor
25990,g23,BRD-K67261995-001-03-4,Contrast agent
25990,g24,BRD-K67277431-002-03-0,thromboxane receptor antagonist|thromboxane synthase inhibitor
25990,h01,BRD-K67298865-001-02-5,TGF beta receptor inhibitor
25990,h02,BRD-K67352070-364-01-5,Acetylcholine receptor agonist
25990,h05,BRD-K67439147-001-01-7,glutamate receptor antagonist
25990,h06,BRD-K67445247-001-01-3,Urease inhibitor
25990,h08,BRD-K67537649-001-01-1,insulin growth factor receptor inhibitor
25990,h12,BRD-K67680372-003-01-8,GAT inhibitor
25990,h13,BRD-K67783091-001-05-5,Dopamine receptor antagonist
25990,h14,BRD-K67831364-003-01-7,vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor|VEGFR inhibitor
25990,h17,BRD-K68095457-001-04-4,Cannabinoid receptor agonist
25990,h18,BRD-K68103045-001-01-1,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist
25990,h21,BRD-K68143200-001-04-2,CDC inhibitor
25990,h24,BRD-K68190965-001-01-4,Serotonin receptor agonist
25990,i01,BRD-K68246049-001-01-4,Retinoid receptor agonist
25990,i02,BRD-K68264559-001-07-6,Adrenergic receptor agonist
25990,i03,BRD-K68332390-001-03-3,aldose reductase inhibitor|reductase inhibitor
25990,i04,BRD-K68341547-003-01-6,calmodulin antagonist
25990,i07,BRD-K68392338-003-01-2,Benzodiazepine receptor antagonist
25990,i08,BRD-K68402494-001-04-7,myosin light chain kinase inhibitor
25990,i10,BRD-K68507560-003-04-8,acetylcholine receptor antagonist
25990,i12,BRD-K68552125-001-03-8,PKC activator|CD antagonist
25990,i13,BRD-K68553471-003-04-0,antihypertensive agent
25990,i14,BRD-K68558722-001-02-4,Cyclooxygenase inhibitor
25990,i15,BRD-K68620903-001-03-1,progesterone receptor agonist
25990,i17,BRD-K68873215-001-01-3,phosphodiesterase inhibitor
25990,i18,BRD-K69023402-001-02-5,ATPase inhibitor|calcium channel blocker|PKC activator
25990,i19,BRD-K69032158-001-02-2,Dipeptidyl peptidase inhibitor
25990,i20,BRD-K69195780-001-01-5,Serotonin receptor agonist
25990,i23,BRD-K69556541-001-02-6,Calcium channel blocker
25990,j01,BRD-K69763916-001-01-7,Glutamate receptor antagonist
25990,j02,BRD-K69837166-003-01-2,Nociceptin/orphanin FQ (NOP) receptor antagonist
25990,j03,BRD-K70241288-001-01-1,Growth hormone releasing peptide ligand agonist
25990,j04,BRD-K70246307-001-02-5,vitamin B2
25990,j07,BRD-K70281171-001-01-7,Dopamine receptor antagonist
25990,j08,BRD-K70330367-001-02-4,Glutamate receptor antagonist
25990,j10,BRD-K70487031-001-01-0,dopamine receptor antagonist
25990,j12,BRD-K70778732-003-04-4,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor
25990,j13,BRD-K70792160-003-01-2,AKT inhibitor
25990,j15,BRD-K70881766-001-02-3,Acetylcholinesterase inhibitor
25990,j16,BRD-K70914287-300-01-0,EGFR inhibitor|tyrosine kinase inhibitor
25990,j17,BRD-K70976396-236-04-7,Bacterial cell wall synthesis inhibitor
25990,j18,BRD-K71003802-001-02-9,Plant alkaloid
25990,j19,BRD-K13356952-001-11-1,carbonic anhydrase inhibitor
25990,k03,BRD-K71266197-236-01-9,NTPDase inhibitor
25990,k04,BRD-K71430621-303-01-5,histamine receptor antagonist|histamine receptor inverse agonist
25990,k06,BRD-K71499074-001-03-8,Carbonic anhydrase inhibitor
25990,k09,BRD-K71534238-001-03-5,Free fatty acid receptor agonist
25990,k11,BRD-K71726959-001-05-9,CDK inhibitor
25990,k12,BRD-K71731651-001-01-9,Acetylcholine receptor agonist
25990,k13,BRD-K71799778-001-02-2,CDK inhibitor
25990,k14,BRD-K71799949-001-04-2,Carboxamide antiepileptic
25990,k17,BRD-K71860425-001-01-1,CDK inhibitor
25990,k18,BRD-K72024482-001-01-3,adenosine receptor antagonist
25990,k19,BRD-K72034655-001-02-1,apoptosis inducer|antileukemic
25990,k22,BRD-K72222507-003-02-8,ACE inhibitor
25990,l04,BRD-K72676686-103-01-8,selective serotonin reuptake inhibitor (SSRI)|serotonin reuptake inhibitor|serotonin uptake inhibitor
25990,l05,BRD-K72726508-001-01-3,CDK inhibitor
25990,l06,BRD-K72783841-001-01-0,CDK inhibitor|epidermal growth factor receptor (EGFR) inhibitor|tyrosine kinase inhibitor|EGFR inhibitor
25990,l09,BRD-K72895815-001-01-4,leukocyte elastase inhibitor
25990,l10,BRD-K72903603-001-03-8,Reverse transcriptase inhibitor
25990,l13,BRD-K73109821-001-05-2,Potassium channel activator
25990,l18,BRD-K73196317-003-06-4,adrenergic receptor antagonist
25990,l21,BRD-K73290745-003-01-8,opioid receptor agonist
25990,l22,BRD-K73323637-003-03-4,adrenergic receptor antagonist
25990,m02,BRD-K73391359-003-03-7,Local anesthetic
25990,m05,BRD-K73397362-001-01-7,smoothened receptor agonist
25990,m06,BRD-K73589401-001-03-8,mineralocorticoid receptor agonist
25990,m12,BRD-K73789395-001-04-0,RAF inhibitor
25990,m15,BRD-K73991644-001-01-7,aldose reductase inhibitor|falcipain inhibitor
25990,m17,BRD-K74112339-001-02-7,Urease inhibitor
25990,m18,BRD-K74141488-003-03-9,Fungal squalene epoxidase inhibitor
25990,m20,BRD-K74195153-050-03-0,Phosphodiesterase inhibitor
25990,m21,BRD-K74212935-001-03-1,Dopamine agonist
25990,m23,BRD-K74305673-001-01-3,IKK inhibitor|NFkB pathway inhibitor|protein kinase inhibitor
25990,m24,BRD-K74430258-001-01-2,hepatotoxicant
25990,n02,BRD-K74765201-001-01-9,Leukotriene receptor antagonist
25990,n03,BRD-K74913225-001-03-3,Carbonic anhydrase inhibitor
25990,n05,BRD-K75089421-001-02-5,sodium channel blocker
25990,n06,BRD-K75181824-001-02-3,inhibitor of methyl esterification of geranylgeranylated proteins
25990,n11,BRD-K75478907-001-01-5,GABA receptor modulator|GABA receptor positive allosteric modulator
25990,n16,BRD-K75615183-001-01-7,Adrenergic receptor agonist
25990,n17,BRD-K75641298-001-01-5,Dopamine receptor antagonist
25990,n21,BRD-K75958195-001-01-7,serotonin receptor antagonist
25990,n24,BRD-K76064317-001-04-0,FLT3 inhibitor
25990,o01,BRD-K76133116-001-01-2,Membrane integrity inhibitor
25990,o03,BRD-K76274772-001-02-7,Ceramidase inhibitor
25990,o05,BRD-K76304753-003-04-7,local anesthetic
25990,o07,BRD-K76568384-001-01-4,estrogen receptor antagonist
25990,o08,BRD-K76587808-001-02-0,Antioxidant
25990,o09,BRD-K76617868-001-02-2,rho associated kinase inhibitor
25990,o10,BRD-K76634210-001-02-2,DNA directed DNA polymerase inhibitor
25990,o13,BRD-K76674262-001-01-7,apoptosis stimulant|protein synthesis inhibitor
25990,o15,BRD-K76723084-001-05-9,retinoid receptor agonist
25990,o16,BRD-K76775527-001-06-2,Cyclooxygenase inhibitor
25990,o17,BRD-K76805682-001-05-0,glycogen synthase kinase inhibitor
25990,o18,BRD-K76810206-001-05-7,adrenergic receptor antagonist
25990,o20,BRD-K76840893-003-01-7,adrenergic receptor antagonist
25990,o22,BRD-K76872913-001-02-8,Aromatic hydrocarbon derivative
25990,o23,BRD-K76927775-001-04-3,DNA inhibitor
25990,o24,BRD-K77133231-001-01-1,p38 MAPK inhibitor
25990,p01,BRD-K77171813-050-01-4,histamine receptor modulator
25990,p03,BRD-K77554836-001-03-3,glucocorticoid receptor agonist
25990,p07,BRD-K77641333-003-04-0,adrenergic receptor agonist
25990,p08,BRD-K77677632-003-01-8,serotonin receptor antagonist
25990,p09,BRD-K77695569-001-04-5,angiogenesis inhibitor
25990,p10,BRD-K77771411-003-03-2,imidazoline receptor agonist
25990,p13,BRD-K77793136-003-01-4,rho associated kinase inhibitor
25990,p15,BRD-K77925998-001-01-3,serotonin receptor agonist
25990,p16,BRD-K77947974-001-04-9,dopamine receptor antagonist
25990,p17,BRD-K77987382-001-05-8,acetylcholinesterase inhibitor|microtubule inhibitor|tubulin inhibitor
25990,p18,BRD-K78010432-001-04-1,diuretic
25990,p20,BRD-K78084463-003-01-0,calmodulin antagonist
25990,p21,BRD-K78113049-001-04-8,topoisomerase inhibitor
25990,p22,BRD-K78122587-300-01-9,T-type calcium channel blocker
25990,p23,BRD-K78280988-001-02-2,cannabinoid receptor agonist|potassium channel blocker|TRPV agonist
25987,a01,BRD-K40782193-003-01-1,sodium channel blocker
25987,a02,BRD-K40887525-001-02-9,serotonin receptor antagonist
25987,a03,BRD-K40901640-001-01-0,serotonin receptor antagonist
25987,a04,BRD-K40905133-001-02-3,sodium channel blocker
25987,a05,BRD-K40965114-001-01-2,Adrenergic receptor antagonist
25987,a06,BRD-K40990712-001-02-4,gonadotropin releasing factor hormone receptor antagonist|sodium/hydrogen antiport inhibitor|sodium/hydrogen exchanger inhibitor|urokinase inhibitor
25987,a07,BRD-K41143549-003-01-6,glutamate receptor antagonist
25987,a08,BRD-K41337261-001-01-4,Src and Abl inhibitor|vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor
25987,a09,BRD-K41406082-001-04-8,PABA antagonist
25987,a11,BRD-K41445866-001-03-0,Chloride channel agonist
25987,a12,BRD-K41524689-001-05-2,cyclooxygenase inhibitor
25987,a15,BRD-K41564320-001-01-2,tyrosine kinase inhibitor
25987,a16,BRD-K41567364-001-01-2,orexin receptor antagonist
25987,a19,BRD-K41707108-001-02-3,Phosphoenolpyruvate carboxylase activator
25987,a20,BRD-K41713976-001-02-0,potassium channel blocker
25987,a23,BRD-K41868777-003-02-9,calmodulin antagonist
25987,b01,BRD-K41876534-001-02-0,carbonic anhydrase inhibitor
25987,b02,BRD-K41996876-001-05-5,EGFR inhibitor
25987,b03,BRD-K42098891-003-03-1,tricyclic antidepressant
25987,b04,BRD-K42221274-001-01-4,GAT inhibitor
25987,b05,BRD-K42348709-003-04-0,adrenergic receptor agonist|serotonin receptor agonist
25987,b07,BRD-K42452249-001-01-7,p38 MAPK inhibitor
25987,b08,BRD-K42500029-001-01-9,"MAP kinase inhibitor|MAPK-interacting kinase inhibitor,"
25987,b10,BRD-K42635745-001-02-4,adrenergic receptor antagonist
25987,b12,BRD-K42679050-001-01-3,potassium channel activator|potassium channel agonist
25987,b16,BRD-K42748308-300-01-2,acetylcholine release enhancer|potassium channel blocker|voltage-gated potassium channel blocker
25987,b18,BRD-K43068349-001-01-9,TRPV antagonist
25987,b19,BRD-K43149758-001-04-5,Androgen receptor agonist
25987,b21,BRD-K43245338-001-02-4,calpain inhibitor|cathepsin inhibitor
25987,b22,BRD-K43290182-001-01-9,Serotonin receptor antagonist
25987,b23,BRD-K43330982-001-01-5,lysophospholipid receptor antagonist
25987,b24,BRD-K43389675-003-02-7,RNA synthesis inhibitor|topoisomerase inhibitor
25987,c01,BRD-K43405658-001-01-8,protein tyrosine kinase inhibitor
25987,c02,BRD-K43457670-001-04-7,carbonic anhydrase inhibitor
25987,c03,BRD-K43468059-001-02-9,Mycotoxin
25987,c05,BRD-K43736954-001-03-3,glucocorticoid receptor agonist
25987,c06,BRD-K43744935-048-01-6,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)|estrogen receptor agonist|estrogen receptor modulator|PKC inhibitor
25987,c07,BRD-K43796186-001-01-1,EGFR inhibitor
25987,c08,BRD-K43860855-065-03-6,antineoplastic agent
25987,c09,BRD-K44067360-001-06-3,chloride channel blocker
25987,c10,BRD-K44084986-001-03-9,rho associated kinase inhibitor
25987,c18,BRD-K44849676-001-03-0,TRPV agonist
25987,c19,BRD-K44876623-001-01-1,Benzodiazepine receptor agonist
25987,c20,BRD-K44899736-003-02-1,Monoamine oxidase inhibitor
25987,c22,BRD-K45033733-001-02-3,DNA polymerase inhibitor
25987,c24,BRD-K45068323-003-01-3,Calmodulin antagonist
25987,d02,BRD-K45117373-001-01-1,potassium channel activator|potassium channel agonist
25987,d03,BRD-K45158365-001-02-3,angiotensin receptor antagonist
25987,d04,BRD-K45296539-003-01-0,Adrenergic receptor agonist
25987,d05,BRD-K45330754-001-04-3,estrogen receptor agonist
25987,d06,BRD-K45401373-001-05-0,Apoptosis stimulant
25987,d07,BRD-K45435259-001-01-6,Dopamine receptor antagonist
25987,d09,BRD-K45479396-001-01-8,Serotonin receptor agonist
25987,d13,BRD-K45542189-048-04-9,Lipoxygenase inhibitor
25987,d14,BRD-K45662124-001-01-8,dopamine receptor ligand
25987,d17,BRD-K45861246-001-04-3,Dopamine receptor antagonist
25987,d19,BRD-K46018455-001-06-0,PPAR receptor agonist
25987,d20,BRD-K46137903-001-03-3,phospholipase activator
25987,d21,BRD-K46142322-003-01-6,serotonin receptor partial agonist
25987,d22,BRD-K46211610-003-05-1,Adrenergic receptor antagonist
25987,d23,BRD-K46317332-003-04-6,Nitric oxide synthase inhibitor
25987,d24,BRD-K46384212-001-01-1,phospholipase activator
25987,e03,BRD-K46424862-001-04-2,Monoamine oxidase inhibitor
25987,e04,BRD-K46435977-003-01-2,DNA polymerase inhibitor
25987,e05,BRD-K46441700-001-01-8,serotonin receptor antagonist
25987,e06,BRD-K46469693-001-01-8,adenosine receptor antagonist
25987,e08,BRD-K46556543-237-03-0,Mineralocorticoid receptor antagonist
25987,e13,BRD-K46766488-003-01-2,Serotonin receptor agonist
25987,e14,BRD-K46862739-001-03-6,cytochrome P450 inhibitor
25987,e15,BRD-K46937689-001-05-1,Cyclooxygenase inhibitor
25987,e16,BRD-K47105409-001-05-3,JAK inhibitor
25987,e20,BRD-K47150025-001-01-2,PDGFR alpha and c-Kit inhibitor|vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor|VEGFR inhibitor
25987,e21,BRD-K47192521-001-02-1,Platelet aggregation inhibitor
25987,e22,BRD-K47207162-312-02-2,Serotonin reuptake inhibitor
25987,e23,BRD-K47278471-003-04-0,Histamine receptor antagonist
25987,e24,BRD-K47323024-003-04-6,Histamine receptor antagonist
25987,f03,BRD-K47328134-001-02-0,heparin activation inhibitor
25987,f07,BRD-K47598052-001-04-2,src inhibitor
25987,f08,BRD-K47608922-001-02-1,chelating agent
25987,f11,BRD-K47631482-003-02-1,Mucolytic agent
25987,f12,BRD-K47635719-001-03-9,glucocorticoid receptor agonist
25987,f13,BRD-K47639036-003-03-3,Acetylcholine receptor antagonist
25987,f14,BRD-K47659338-003-01-0,serotonin receptor agonist
25987,f15,BRD-K47693913-001-02-4,Furoquinoline alkaloid
25987,f16,BRD-K47717570-304-01-5,Glutamate receptor antagonist
25987,f21,BRD-K47869605-001-04-9,microtubule inhibitor|tubulin polymerization inhibitor
25987,f23,BRD-K47936004-001-01-9,dopamine receptor agonist
25987,f24,BRD-K47943470-001-02-8,EGFR inhibitor
25987,g05,BRD-K48168960-001-05-1,Thyroid peroxidase inhibitor
25987,g07,BRD-K48300629-001-03-8,Sodium channel blocker
25987,g11,BRD-K48692744-001-01-2,PARP inhibitor
25987,g12,BRD-K48722258-300-04-5,adenosine reuptake inhibitor
25987,g13,BRD-K48735772-001-01-4,EGFR inhibitor|epidermal growth factor receptor (EGFR) inhibitor
25987,g15,BRD-K49027941-237-01-1,Adenosine receptor antagonist
25987,g16,BRD-K49049886-001-03-8,adenosine receptor antagonist
25987,g17,BRD-K49111258-001-02-8,Adrenergic receptor antagonist
25987,g23,BRD-K49294207-300-01-2,EGFR inhibitor
25987,g24,BRD-K49448285-001-01-3,CDK inhibitor
25987,h01,BRD-K49481516-004-03-5,Acetylcholinesterase inhibitor
25987,h02,BRD-K49519092-303-01-4,Histamine receptor agonist
25987,h05,BRD-K49577446-001-03-1,cytochrome P450 inhibitor
25987,h06,BRD-K49657628-001-02-3,EGFR inhibitor|tyrosine kinase inhibitor
25987,h07,BRD-K49671696-001-02-1,Serotonin receptor antagonist
25987,h11,BRD-K49890030-236-01-6,Glutamate receptor antagonist
25987,h12,BRD-K49945136-001-03-5,Serotonin receptor antagonist
25987,h13,BRD-K50018155-003-01-3,Serotonin receptor partial agonist
25987,h15,BRD-K50135270-001-01-9,dopamine uptake inhibitor
25987,h17,BRD-K50214219-001-02-4,PARP inhibitor
25987,h21,BRD-K50325075-001-01-3,potassium channel blocker|slow afterhyperpolarization channel blocker
25987,h22,BRD-K50388907-001-04-9,PPAR receptor agonist
25987,h23,BRD-K50398167-236-02-9,Cyclooxygenase inhibitor
25987,i01,BRD-K50417881-003-05-9,Dopamine receptor antagonist
25987,i02,BRD-K50422030-001-01-2,GABA receptor antagonist
25987,i03,BRD-K50464341-001-02-6,calmodulin antagonist
25987,i04,BRD-K50495309-001-01-2,src inhibitor
25987,i07,BRD-K50660797-001-02-8,Bacterial DNA gyrase inhibitor
25987,i08,BRD-K50836978-001-01-7,CDK inhibitor
25987,i09,BRD-K50841342-001-01-6,caspase activator
25987,i10,BRD-K50859149-001-04-7,bacterial antifolate
25987,i11,BRD-K50891186-001-01-0,dopamine receptor antagonist
25987,i14,BRD-K51276371-001-01-8,CDK inhibitor|CFTR channel activator|glycogen synthase kinase inhibitor|JNK inhibitor
25987,i15,BRD-K51318897-001-04-7,tubulin polymerization inhibitor
25987,i17,BRD-K51465424-003-03-6,adrenergic receptor agonist
25987,i18,BRD-K51476772-001-01-9,tyrosine kinase inhibitor
25987,i19,BRD-K51541829-001-01-3,Ionotropic glutamate receptor antagonist
25987,i23,BRD-K51575138-001-01-7,IKK inhibitor
25987,i24,BRD-K51671335-001-01-5,Dopamine receptor antagonist
25987,j01,BRD-K51751936-001-03-4,benzodiazepine receptor agonist
25987,j03,BRD-K51918615-303-01-1,histamine receptor antagonist|histamine receptor inhibitor|ionotropic glutamate receptor antagonist
25987,j07,BRD-K52020312-001-04-5,DNA inhibitor
25987,j08,BRD-K52075040-001-02-2,fatty acid synthase inhibitor
25987,j10,BRD-K52219182-001-01-6,Phosphodiesterase inhibitor
25987,j11,BRD-K52313696-001-01-6,HDAC inhibitor
25987,j13,BRD-K52394958-001-01-9,tachykinin antagonist
25987,j14,BRD-K52397688-001-01-9,dopamine receptor antagonist|FAAH inhibitor|serotonin receptor antagonist
25987,j15,BRD-K52459643-001-10-2,Prostanoid receptor agonist
25987,j16,BRD-K52512893-001-03-0,Prostanoid receptor antagonist
25987,j18,BRD-K52662033-001-02-6,histamine receptor agonist
25987,j19,BRD-K52721684-001-02-2,potassium channel activator
25987,j20,BRD-K52850071-001-01-2,JAK inhibitor
25987,j23,BRD-K52930707-001-04-8,ACE inhibitor
25987,k01,BRD-K52989797-001-01-1,serotonin transporter (SERT) inhibitor
25987,k03,BRD-K53123955-001-03-0,Phosphofructokinase inhibitor
25987,k05,BRD-K53263234-001-02-9,constitutive androstane receptor (CAR) agonist
25987,k06,BRD-K53318339-001-04-1,Phosphodiesterase inhibitor
25987,k09,BRD-K53523901-001-01-0,adiponectin receptor agonist|AP inhibitor|aryl hydrocarbon receptor antagonist|HIV integrase inhibitor|MEK inhibitor|NFkB pathway inhibitor|topoisomerase inhibitor
25987,k11,BRD-K53545112-304-01-6,Glutamate receptor antagonist
25987,k13,BRD-K53737926-003-04-7,Norepinephrine inhibitor
25987,k14,BRD-K53857191-001-04-5,Dopamine receptor antagonist
25987,k17,BRD-K53878242-001-02-4,phosphodiesterase inhibitor
25987,k19,BRD-K53979406-003-01-0,glycine transporter inhibitor|GlyT-1 inhibitor
25987,k20,BRD-K54094468-001-01-6,dopamine receptor antagonist
25987,k21,BRD-K54095730-001-01-5,p38 MAPK inhibitor
25987,k22,BRD-K54142781-001-02-1,Adrenergic receptor agonist
25987,l01,BRD-K54210043-001-02-0,calcium channel activator|large conductance potassium channel activator
25987,l02,BRD-K54233340-300-01-0,AMPK inhibitor|DNA damaging|TGF beta receptor inhibitor
25987,l03,BRD-K54330070-001-05-5,p38 MAPK inhibitor
25987,l04,BRD-K54411430-001-02-5,cAMP inhibitor
25987,l06,BRD-K54529596-001-04-0,ACE inhibitor
25987,l10,BRD-K54665485-001-01-2,Diacylglycerol kinase inhibitor
25987,l11,BRD-K54704028-001-01-3,glutamate receptor antagonist
25987,l12,BRD-K54708045-001-01-3,PPAR receptor agonist
25987,l13,BRD-K54759182-003-02-3,Norepinephrine reuptake inhibitor
25987,l14,BRD-K54771420-001-03-2,Cholesterol inhibitor
25987,l17,BRD-K54790157-001-03-1,DNA synthesis inhibitor
25987,l19,BRD-K55034111-066-02-3,bacterial DNA gyrase inhibitor
25987,l21,BRD-K55191674-236-03-7,Penicillin binding protein inhibitor
25987,m01,BRD-K55344148-003-01-8,Imidazoline receptor ligand
25987,m02,BRD-K55424922-001-01-4,Serotonin receptor agonist
25987,m03,BRD-K55430733-003-01-6,Serotonin receptor agonist
25987,m04,BRD-K55454768-001-01-8,voltage-independent calcium influx blocker
25987,m05,BRD-K55468218-001-04-8,dopamine receptor antagonist
25987,m06,BRD-K55529781-236-02-0,thromboxane synthase inhibitor
25987,m07,BRD-K55567017-001-02-4,alcohol dehydrogenase inhibitor
25987,m08,BRD-K55677650-003-01-1,ionotropic glutamate receptor antagonist
25987,m11,BRD-K55748775-001-01-4,ATPase inhibitor|potassium-competitive acid antagonist
25987,m16,BRD-K55930204-001-02-7,Hydantoin antiepileptic
25987,m17,BRD-K56047318-001-02-2,Triacylglycerol lipase inhibitor
25987,m18,BRD-K56064827-001-04-7,PKC inhibitor
25987,m20,BRD-K56115039-003-01-3,Imidazoline receptor ligand
25987,m22,BRD-K56403959-300-01-9,CC chemokine receptor ligand
25987,m23,BRD-K56429665-001-03-9,vitamin D receptor agonist
25987,m24,BRD-K56509348-003-01-3,Endothelin receptor antagonist
25987,n02,BRD-K56558538-003-02-8,Sodium channel blocker
25987,n03,BRD-K56596464-004-02-4,Sodium channel blocker
25987,n04,BRD-K56699285-001-03-7,dopamine receptor agonist|serotonin receptor antagonist
25987,n08,BRD-K57033106-048-02-8,Histamine receptor antagonist
25987,n11,BRD-K57179821-001-04-8,Antipruritic
25987,n12,BRD-K57222227-001-06-1,cyclooxygenase inhibitor
25987,n16,BRD-K57304726-003-03-6,Sigma receptor agonist
25987,n18,BRD-K57545991-050-03-3,angiotensin converting enzyme inhibitor
25987,n19,BRD-K57569181-001-04-4,Phosphodiesterase inhibitor
25987,n21,BRD-K57718010-001-06-9,GABA receptor antagonist
25987,n22,BRD-K57886322-001-03-4,glucocorticoid receptor agonist
25987,n23,BRD-K57926513-001-02-9,PDGFR receptor inhibitor
25987,o01,BRD-K58220566-001-02-2,PKC inhibitor|sodium channel blocker|calcium channel blocker
25987,o02,BRD-K58265391-001-03-6,diuretic
25987,o03,BRD-K58299615-001-02-7,amyloid precursor protein inhibitor|beta amyloid aggregation inhibitor
25987,o05,BRD-K58466253-003-04-1,serotonin release inhibitor
25987,o06,BRD-K58685305-001-02-2,11-beta hydroxysteroid dehydrogenase inhibitor
25987,o08,BRD-K58930050-001-01-1,glutamate receptor antagonist
25987,o09,BRD-K58938839-001-03-8,smoothened receptor antagonist|hedgehog pathway inhibitor
25987,o10,BRD-K59037100-001-04-8,lipase inhibitor
25987,o13,BRD-K59058766-003-03-7,dopamine receptor antagonist
25987,o15,BRD-K59184148-001-04-2,glycogen synthase kinase inhibitor
25987,o18,BRD-K59273480-001-01-5,adenosine reuptake inhibitor|phosphodiesterase inhibitor
25987,o20,BRD-K59332007-300-01-9,acetylcholine release enhancer|acetylcholine release stimulant|neurotransmitter agonist|voltage-gated potassium channel blocker
25987,o22,BRD-K59419204-001-01-9,cannabinoid receptor antagonist|cannabinoid receptor inhibitor
25987,o23,BRD-K59469039-001-04-9,Angiogenesis inhibitor
25987,o24,BRD-K59522102-001-04-7,monoamine oxidase inhibitor
25987,p01,BRD-K59574735-001-02-7,leukotriene synthesis inhibitor
25987,p02,BRD-K59637651-001-01-4,protein synthesis inhibitor|botulin neurotoxin inhibitor|mur synthetase inhibitor
25987,p03,BRD-K59650319-003-01-7,glutamate receptor antagonist
25987,p04,BRD-K59753853-001-01-5,glutamate receptor antagonist
25987,p06,BRD-K59851896-001-02-4,GABA release inhibitor
25987,p07,BRD-K59983611-001-05-2,bacterial antifolate
25987,p09,BRD-K60060639-005-01-4,antiarrhythmic medication
25987,p10,BRD-K60174629-001-02-2,prolyl endopeptidase inhibitor
25987,p13,BRD-K60184833-001-02-3,tyrosine kinase inhibitor
25987,p14,BRD-K60230970-001-04-3,proteasome inhibitor
25987,p15,BRD-K60274257-001-01-1,tyrosine phosphatase inhibitor
25987,p17,BRD-K60298136-001-01-7,aryl hydrocarbon receptor agonist|aryl hydrocarbon receptor ligand
25987,p18,BRD-K60476892-001-02-1,activator of soluble guanylyl cyclase|guanylate cyclase activator|hypoxia inducible factor inhibitor
25987,p19,BRD-K60511616-236-01-4,HMGCR inhibitor
25987,p20,BRD-K60640630-001-03-7,glucocorticoid receptor agonist
25987,p22,BRD-K60923938-001-02-8,sodium channel activator
25987,p23,BRD-K60932973-001-01-7,dopamine receptor agonist
25987,p24,BRD-K61097567-001-03-6,tachykinin antagonist
25939,a01,BRD-A00100033-001-04-8,DNA inhibitor
25939,a02,BRD-A00267231-001-01-1,Adenosine receptor agonist
25939,a04,BRD-A00520476-001-03-3,Acetylcholine receptor antagonist
25939,a06,BRD-A00993607-003-04-8,Adrenergic receptor antagonist
25939,a07,BRD-A01078468-001-04-9,synthetic estrogen
25939,a08,BRD-A01295252-001-01-5,Dopamine receptor ligand
25939,a09,BRD-A01320529-001-05-9,adrenergic receptor agonist
25939,a11,BRD-A01593789-001-01-5,5 alpha reductase inhibitor
25939,a12,BRD-A01636364-003-04-5,sodium channel blocker
25939,a15,BRD-A01787639-003-08-6,adrenergic receptor antagonist
25939,a16,BRD-A02006392-001-06-5,calcium channel blocker
25939,a17,BRD-A02176148-001-02-2,Mitochondrial complex I inhibitor
25939,a19,BRD-A02710418-003-03-5,opioid receptor agonist
25939,a20,BRD-A02713983-001-02-0,growth factor receptor activator
25939,a21,BRD-A02759312-003-11-2,Adrenergic receptor antagonist
25939,a23,BRD-A03216249-003-02-9,Potassium channel blocker
25939,a24,BRD-A03359064-001-01-5,Adrenergic receptor antagonist
25939,b02,BRD-A03623303-045-02-0,Adrenergic receptor antagonist
25939,b03,BRD-A03816571-001-01-0,cannabinoid receptor agonist|CC chemokine receptor antagonist
25939,b09,BRD-A04322457-003-03-9,adrenergic receptor agonist
25939,b10,BRD-A04438777-001-01-4,dopamine receptor agonist
25939,b11,BRD-A04553218-050-03-0,histamine receptor antagonist
25939,b15,BRD-A04668240-001-01-5,GABA receptor antagonist
25939,b16,BRD-A04706586-236-01-7,Adenosine receptor agonist
25939,b18,BRD-A05186015-003-04-0,dopamine uptake inhibitor
25939,b24,BRD-A06352418-001-03-6,Histamine receptor antagonist
25939,c01,BRD-A06352508-001-02-9,CHK inhibitor
25939,c02,BRD-A06390036-001-02-0,Antiarrhythmic
25939,c03,BRD-A06726973-001-02-0,cGMP analog
25939,c04,BRD-A06935312-001-02-7,bacterial 30S ribosomal subunit inhibitor
25939,c06,BRD-A07207424-001-04-1,phosphodiesterase inhibitor
25939,c08,BRD-A07440155-003-04-9,Adrenergic receptor antagonist
25939,c09,BRD-A07780951-001-02-2,Adrenergic receptor agonist
25939,c10,BRD-A07824748-001-02-6,11-beta hydroxysteroid dehydrogenase inhibitor
25939,c14,BRD-A07875874-001-01-6,calcium channel blocker
25939,c17,BRD-A07932845-001-01-1,anti-HCVE2
25939,c18,BRD-A07952294-001-02-3,farnesyltransferase inhibitors
25939,c19,BRD-A08187463-001-03-8,enkephalinase inhibitor
25939,c22,BRD-A08709697-001-02-9,pyrrolizidine alkaloid
25939,c23,BRD-A08877921-001-02-2,Protein synthesis inhibitor
25939,c24,BRD-A09056319-003-03-6,Adrenergic receptor antagonist
25939,d01,BRD-A09062839-003-03-5,Local anesthetic
25939,d02,BRD-A09094913-001-02-3,acetylcholine receptor antagonist
25939,d03,BRD-A09161221-001-01-9,HSP inhibitor
25939,d04,BRD-A09349126-001-02-4,progesterone receptor agonist
25939,d05,BRD-A09467419-003-04-2,acetylcholine receptor antagonist
25939,d06,BRD-A09472452-001-02-8,Sodium channel blocker
25939,d07,BRD-A09533288-001-02-7,calcium channel blocker
25939,d08,BRD-A09539288-004-02-8,Acetylcholine receptor antagonist
25939,d09,BRD-A09828896-004-04-5,Dopamine receptor agonist
25939,d10,BRD-A09925278-003-03-1,Adrenergic receptor agonist
25939,d14,BRD-A10070317-003-05-1,adrenergic receptor antagonist
25939,d17,BRD-A10355991-003-01-8,Glutamate receptor antagonist
25939,d18,BRD-A10715913-001-02-0,Dopamine receptor antagonist
25939,d19,BRD-A10739734-003-01-5,adrenergic receptor antagonist
25939,d20,BRD-A10903566-003-02-8,Adrenergic receptor antagonist
25939,d21,BRD-A10969569-001-02-0,Plant alkaloid
25939,d22,BRD-A10977446-001-04-8,Adrenergic receptor antagonist
25939,e03,BRD-A11605036-001-03-2,GABA receptor antagonist
25939,e04,BRD-A11609859-303-01-2,opioid receptor agonist
25939,e05,BRD-A11678676-001-02-6,PI3K inhibitor
25939,e07,BRD-A11813248-001-02-8,Potassium channel blocker
25939,e08,BRD-A12016240-001-01-7,Serotonin receptor antagonist
25939,e14,BRD-A13188892-066-03-3,Adrenergic receptor antagonist
25939,e15,BRD-A13650332-236-03-9,Bacterial cell wall synthesis inhibitor
25939,e16,BRD-A13946108-001-03-1,Cyclooxygenase inhibitor
25939,e23,BRD-A14395271-001-01-5,Dopamine receptor antagonist
25939,e24,BRD-A14566392-004-03-5,acetylcholine receptor antagonist
25939,f03,BRD-A14574269-051-01-4,Acetylcholine receptor agonist
25939,f04,BRD-A15034104-002-03-6,interleukin inhibitor
25939,f05,BRD-A15070535-323-02-1,adenosine receptor agonist|cAMP stimulant
25939,f06,BRD-A15415227-003-01-1,PPAR receptor agonist
25939,f07,BRD-A15435692-003-01-5,sigma receptor antagonist|glutamate receptor antagonist|serotonin receptor agonist
25939,f11,BRD-A15530910-001-01-3,adrenergic receptor antagonist|serotonin receptor antagonist
25939,f14,BRD-A15914070-001-01-5,cytotoxic lipid peroxidation product
25939,f15,BRD-A16332958-001-02-4,Adrenergic receptor agonist
25939,f16,BRD-A16665823-008-03-3,Bacterial cell wall synthesis inhibitor
25939,f19,BRD-A16694057-001-02-7,PPAR receptor antagonist
25939,f21,BRD-A17065207-001-06-9,protein synthesis inhibitor
25939,f23,BRD-A17428743-001-01-1,Serotonin receptor agonist
25939,f24,BRD-A17453586-001-01-9,Serotonin receptor agonist
25939,g02,BRD-A17535965-001-02-2,Acetylcholine receptor antagonist
25939,g05,BRD-A17655518-001-02-0,Cyclooxygenase inhibitor
25939,g08,BRD-A18043272-001-03-2,succinimide antiepileptic
25939,g09,BRD-A18202423-001-01-6,Glutamate receptor antagonist
25939,g10,BRD-A18497530-001-04-6,adenosine kinase inhibitor|nucleoside transporter inhibitor
25939,g11,BRD-A18579359-001-03-1,Neural Wiskott-Aldrich syndrome protein inhibitor
25939,g12,BRD-A18696154-003-11-9,adrenergic receptor antagonist
25939,g13,BRD-A18763547-019-01-0,Cytochrome C release inhibitor
25939,g15,BRD-A19053259-003-03-3,Anthelmintic
25939,g17,BRD-A19195498-050-04-2,Norepinephrine reuptake inhibitor
25939,g18,BRD-A19736161-310-01-3,Serotonin receptor antagonist
25939,g23,BRD-A20239487-001-02-5,Adrenergic receptor antagonist
25939,h01,BRD-A20348246-001-04-2,GABA receptor modulator
25939,h06,BRD-A20968261-001-01-3,glutamate transporter inhibitor
25939,h08,BRD-A21723284-066-01-7,Opioid receptor antagonist
25939,h09,BRD-A21858158-001-04-5,Anthelmintic
25939,h14,BRD-A22305049-003-04-5,gluconeogenesis inhibitor
25939,h15,BRD-A22380646-001-01-5,ATPase inhibitor
25939,h16,BRD-A22684332-003-02-3,adrenergic receptor agonist
25939,h17,BRD-A22707317-001-02-5,GABA receptor modulator
25939,h21,BRD-A22769835-300-03-2,Antihistamine
25939,h22,BRD-A22783572-065-01-3,microtubule formation inhibitor|tubulin inhibitor|tubulin polymerisation inhibitor
25939,h23,BRD-A22844106-001-04-7,Cyclooxygenase inhibitor
25939,h24,BRD-A23034328-003-03-4,protein synthesis inhibitor
25939,i01,BRD-A23072235-050-04-5,Histamine receptor antagonist
25939,i02,BRD-A23226398-001-02-7,estrogen receptor agonist
25939,i03,BRD-A23683907-334-01-0,serotonin receptor antagonist
25939,i04,BRD-A23723433-001-01-2,tubulin inhibitor|microtubule stabilizing agent|microtubule stimulant|P glycoprotein inhibitor|taxane
25939,i08,BRD-A24122750-001-01-1,GABA receptor antagonist
25939,i09,BRD-A24191444-045-03-1,Adrenergic receptor antagonist
25939,i10,BRD-A24228527-001-04-2,Bacterial DNA gyrase inhibitor
25939,i13,BRD-A24514565-236-01-6,Vitamin K antagonist
25939,i15,BRD-A24587114-066-03-5,adrenergic receptor agonist
25939,i16,BRD-A24817035-001-04-7,central nervous system agent
25939,i17,BRD-A25234499-001-04-3,glucocorticoid receptor antagonist
25939,i20,BRD-A25775766-001-03-3,GABA receptor antagonist|TP53 activator
25939,i23,BRD-A26032986-050-01-3,Calmodulin antagonist
25939,i24,BRD-A26222320-001-02-6,protein synthesis inhibitor
25939,j01,BRD-A26334849-001-02-1,Antiarrhythmic
25939,j02,BRD-A26384407-001-04-6,Carbonic anhydrase inhibitor
25939,j03,BRD-A26711594-001-02-7,calcium channel blocker
25939,j07,BRD-A26845397-001-01-4,Adrenergic receptor antagonist
25939,j09,BRD-A27143604-001-01-2,Estrogen receptor agonist
25939,j14,BRD-A28318179-003-03-6,Nitric oxide synthase inhibitor
25939,j15,BRD-A28856712-003-04-7,adrenergic receptor agonist
25939,j18,BRD-A29260609-003-04-7,adrenergic receptor antagonist
25939,j19,BRD-A29289453-001-02-1,platelet activating factor receptor antagonist
25939,j20,BRD-A29322418-237-02-4,mineralocorticoid receptor antagonist
25939,k01,BRD-A29426959-050-04-1,Histamine receptor antagonist
25939,k02,BRD-A29437505-001-01-6,TLR agonist
25939,k04,BRD-A29644307-050-04-8,Dopamine uptake inhibitor
25939,k05,BRD-A29734509-011-02-9,Sodium channel blocker
25939,k10,BRD-A30590053-003-01-1,Acetylcholine release enhancer
25939,k11,BRD-A30655177-001-04-1,BTK inhibitor
25939,k13,BRD-A30717181-001-02-7,glucocorticoid receptor agonist
25939,k14,BRD-A30815329-001-03-0,Calcium channel blocker
25939,k17,BRD-A31007383-001-01-0,Adenosine receptor agonist
25939,k18,BRD-A31159102-001-01-9,Selective serotonin reuptake inhibitor (SSRI)
25939,k19,BRD-A31195449-004-01-9,Serotonin receptor agonist
25939,k20,BRD-A31521121-001-04-1,Muscle relaxant
25939,k21,BRD-A31575449-300-01-4,Adrenergic receptor antagonist
25939,l02,BRD-A31800922-003-04-6,acetylcholine receptor antagonist
25939,l05,BRD-A32164164-048-01-4,Acetylcholine receptor antagonist
25939,l06,BRD-A32505112-001-02-8,angiotensin converting enzyme inhibitor
25939,l09,BRD-A32673558-003-02-1,acetylcholine receptor agonist
25939,l10,BRD-A32949107-001-01-7,calcium channel blocker
25939,l12,BRD-A33168282-003-06-5,Adrenergic receptor antagonist
25939,l13,BRD-A33447119-001-02-5,Anthelmintic
25939,l14,BRD-A33711280-311-02-0,Acetylcholine receptor antagonist
25939,l19,BRD-A34255068-001-04-8,phosphodiesterase inhibitor
25939,l20,BRD-A34309505-001-08-5,benzodiazepine receptor agonist
25939,l22,BRD-A34706053-003-01-9,Adrenergic receptor agonist
25939,m01,BRD-A34751532-001-03-6,HSP inducer
25939,m03,BRD-A34788695-003-04-5,bacterial 30S ribosomal subunit inhibitor
25939,m04,BRD-A34806832-001-02-7,ATPase inhibitor
25939,m07,BRD-A35033682-001-01-0,cytochrome P450 inhibitor
25939,m08,BRD-A35338386-001-04-6,adenosine receptor agonist
25939,m11,BRD-A35511923-019-01-6,Somatostatin receptor agonist
25939,m12,BRD-A35623999-001-03-2,mitochondrial Na+/Ca2+ exchanger antagonist|sodium/calcium exchange inhibitor
25939,m16,BRD-A35931254-003-02-7,dopamine receptor agonist
25939,m18,BRD-A36066264-001-02-3,Estrogen receptor agonist
25939,m19,BRD-A36074203-003-03-5,Glutamate receptor antagonist
25939,m20,BRD-A36217750-001-04-9,Uricosuric blocker
25939,m21,BRD-A36267905-003-02-8,Adrenergic receptor agonist
25939,m22,BRD-A36318220-001-01-3,RIPK inhibitor
25939,m23,BRD-A36471396-003-02-2,Acetylcholine receptor antagonist
25939,n01,BRD-A37347161-003-01-8,opioid receptor agonist
25939,n02,BRD-A37432947-004-02-5,acetylcholine receptor antagonist
25939,n03,BRD-A37441042-003-02-2,adrenergic receptor agonist
25939,n04,BRD-A37492983-001-03-8,radiopaque medium
25939,n06,BRD-A37704979-001-02-4,p38 MAPK inhibitor
25939,n07,BRD-A37776212-003-02-5,opioid receptor agonist
25939,n17,BRD-A38747044-001-01-5,Imidazoline receptor ligand
25939,n18,BRD-A38898897-003-01-0,Leukocyte elastase inhibitor
25939,n19,BRD-A38913120-001-01-0,BCL inhibitor
25939,n21,BRD-A39230911-001-03-7,Muscle relaxant
25939,n22,BRD-A39255369-001-01-5,Chloride channel blocker
25939,n23,BRD-A39268308-001-02-0,Acetylcholine receptor agonist
25939,o01,BRD-A39522003-001-01-0,FAAH inhibitor|FAAH reuptake inhibitor
25939,o03,BRD-A39747742-001-02-7,estrogen receptor agonist
25939,o05,BRD-A39969961-001-01-3,Cytochrome P450 inhibitor
25939,o06,BRD-A40022950-001-02-9,ATPase inhibitor
25939,o08,BRD-A40639672-234-04-0,Cyclooxygenase inhibitor
25939,o10,BRD-A41112154-001-02-1,G protein-coupled receptor agonist
25939,o13,BRD-A41145729-001-02-7,Retinoid receptor agonist
25939,o14,BRD-A41250306-001-03-4,Thiazide diuretic
25939,o15,BRD-A41301928-001-02-5,"Mitochondrial ADP, ATP translocase inhibitor"
25939,o16,BRD-A41304429-001-04-9,Adrenergic receptor antagonist
25939,o17,BRD-A41451487-001-01-3,Benzodiazepine receptor antagonist
25939,o18,BRD-A41519720-001-02-2,Niemann-Pick C1-like 1 protein antagonist
25939,o19,BRD-A41722204-003-01-5,adenosine receptor antagonist
25939,o20,BRD-A41833852-001-01-9,Opioid receptor antagonist
25939,o22,BRD-A41941932-001-03-0,Antioxidant
25939,o23,BRD-A42167015-003-03-7,Adrenergic receptor antagonist
25939,o24,BRD-A42335949-300-04-9,phosphatidylglycerophosphatase inhibitor
25939,p01,BRD-A42346008-003-03-6,epinephrine metabolite
25939,p02,BRD-A42553870-001-05-1,neuropeptide receptor antagonist
25939,p03,BRD-A42571354-300-01-3,histamine receptor antagonist
25939,p04,BRD-A42628519-001-04-1,radiopaque medium
25939,p05,BRD-A42759514-001-03-1,Antiprotozoal
25939,p06,BRD-A42831637-001-02-2,anti-inflammatory|Cannabinoid metabolite
25939,p07,BRD-A43076080-001-03-3,protein phosphatase inhibitor
25939,p09,BRD-A43150328-001-02-0,other antibiotic
25939,p13,BRD-A43671941-003-03-6,Adrenergic receptor antagonist
25939,p14,BRD-A43849199-001-02-3,Phytotoxin
25939,p15,BRD-A43930669-003-01-0,oxytocin receptor antagonist
25939,p16,BRD-A43940795-001-02-8,serotonin release inhibitor
25939,p17,BRD-A43974499-066-01-1,Adrenergic receptor antagonist
25939,p19,BRD-A44008656-036-04-3,Histamine receptor antagonist
25939,p20,BRD-A44090213-001-04-1,Cyclooxygenase inhibitor
25939,p21,BRD-A44133049-001-01-5,Serotonin receptor antagonist
25939,p22,BRD-A44448661-001-02-2,Barbiturate antiepileptic
25939,p23,BRD-A44551378-001-01-9,EGFR inhibitor
25939,p24,BRD-A44863528-001-04-1,CCK receptor antagonist
26247,a01,BRD-K78364995-236-03-5,bacterial cell wall synthesis inhibitor
26247,a03,BRD-K78485176-001-02-9,angiotensin receptor antagonist
26247,a05,BRD-K78599730-001-02-6,farnesyltransferase inhibitor|NFkB pathway inhibitor|ras farnesyltransferase inhibitor
26247,a07,BRD-K78633253-001-01-2,ARF inhibitor
26247,a08,BRD-K78637815-001-01-4,cannabinoid receptor antagonist
26247,a09,BRD-K78643075-001-03-3,dopamine receptor antagonist
26247,a10,BRD-K78692225-001-11-2,dihydroorotate dehydrogenase inhibitor|PDGFR tyrosine kinase receptor inhibitor
26247,a11,BRD-K78815826-001-04-7,cyclooxygenase inhibitor
26247,a12,BRD-K78838262-001-02-4,hypolipidemic
26247,a16,BRD-K78959463-001-02-5,calcium channel activator
26247,a18,BRD-K79092138-001-04-5,POXB inhibitor|bacterial DNA inhibitor
26247,a19,BRD-K79116891-003-03-7,sodium channel blocker
26247,a20,BRD-K79124250-001-03-0,radiopaque medium
26247,a21,BRD-K79131256-001-03-9,tubulin polymerization inhibitor
26247,a22,BRD-K79145749-001-01-8,norepinephrine reputake inhibitor
26247,a24,BRD-K79366068-236-01-5,NTPDase inhibitor
26247,b01,BRD-K79425933-001-03-6,dopamine receptor antagonist
26247,b02,BRD-K79437791-001-02-4,Inhibitor of methylation of endogenous isoprenylated proteins
26247,b03,BRD-K79501723-003-03-4,histamine receptor modulator
26247,b04,BRD-K79684402-300-01-0,dopamine receptor partial agonist
26247,b05,BRD-K79711234-001-04-3,bacterial 50S ribosomal subunit inhibitor
26247,b06,BRD-K79759585-001-02-1,phosphodiesterase inhibitor
26247,b07,BRD-K79930101-300-01-1,EGFR inhibitor|epidermal growth factor receptor (EGFR) inhibitor|ErbB2 tyrosine kinase inhibitor|receptor tyrosine protein kinase inhibitor
26247,b09,BRD-K80315159-051-01-2,histamine receptor antagonist
26247,b12,BRD-K80334323-001-03-5,progestogen hormone
26247,b15,BRD-K80353807-001-03-0,vasodilator
26247,b16,BRD-K80396088-001-03-9,Sulfonylurea
26247,b17,BRD-K80451230-051-01-8,acetylcholine receptor antagonist
26247,b19,BRD-K80639402-003-01-1,serotonin receptor antagonist
26247,b20,BRD-K80725821-300-01-1,serotonin receptor antagonist
26247,b21,BRD-K80738081-001-06-2,cytochrome P450 inhibitor|SIRT activator
26247,b22,BRD-K80778372-001-01-7,GABA benzodiazepine site receptor inverse agonist
26247,b24,BRD-K80946661-001-02-8,p53 activator
26247,c01,BRD-K80970344-201-02-9,NFkB pathway inhibitor
26247,c02,BRD-K81029756-001-02-8,L-type calcium channel blocker|calcium channel antagonist|calcium channel blocker
26247,c04,BRD-K81209159-001-02-9,Acetylcholinesterase inhibitor
26247,c05,BRD-K81209512-001-01-3,EGFR inhibitor|epidermal growth factor receptor (EGFR) inhibitor|tyrosine kinase inhibitor
26247,c06,BRD-K81225797-001-01-5,adenosine receptor antagonist
26247,c07,BRD-K81272440-001-02-6,calcium channel blocker
26247,c09,BRD-K81376179-001-01-4,FLT3 inhibitor
26247,c14,BRD-K81709173-001-03-8,glucocorticoid receptor agonist
26247,c17,BRD-K81729199-001-01-0,acetylcholine receptor antagonist
26247,c20,BRD-K81839095-001-02-0,Estrogen receptor agonist
26247,c21,BRD-K81876028-300-01-2,Serotonin receptor agonist
26247,c23,BRD-K82103381-003-03-7,vasodilator
26247,d03,BRD-K82255054-001-04-3,GABA receptor agonist
26247,d04,BRD-K82484965-003-02-7,dopamine receptor agonist
26247,d05,BRD-K82561139-001-01-9,casein kinase inhibitor
26247,d06,BRD-K82562631-236-02-0,Cyclooxygenase inhibitor
26247,d07,BRD-K82577285-001-01-7,Dopamine receptor agonist
26247,d08,BRD-K82731415-001-04-7,CDK inhibitor
26247,d09,BRD-K82795137-001-02-3,Histamine receptor antagonist
26247,d10,BRD-K82823076-001-01-8,GABA benzodiazepine site receptor inverse agonist
26247,d13,BRD-K82846253-001-03-0,Insulin secretagogue
26247,d14,BRD-K82865713-001-02-6,cAMP inhibitor
26247,d17,BRD-K83023055-001-01-9,Melatonin receptor agonist
26247,d19,BRD-K83063356-003-01-7,CC chemokine receptor antagonist|CCR antagonist
26247,d23,BRD-K83302049-001-01-6,Histamine receptor antagonist
26247,d24,BRD-K83322645-103-01-6,sigma receptor antagonist|sigma receptor ligand
26247,e04,BRD-K83459933-001-02-1,angiogenesis inhibitor
26247,e05,BRD-K83508485-001-01-9,tachykinin antagonist
26247,e06,BRD-K83597974-003-05-7,Monoamine oxidase inhibitor
26247,e07,BRD-K83637872-001-01-7,Smoothened receptor antagonist
26247,e08,BRD-K84175871-003-02-2,Adrenergic receptor agonist
26247,e12,BRD-K84266862-001-01-6,phosphodiesterase inhibitor
26247,e13,BRD-K84421793-001-01-1,dopamine receptor agonist
26247,e14,BRD-K84595254-001-03-0,ATPase inhibitor
26247,e15,BRD-K84663978-001-02-3,phosphodiesterase inhibitor|platelet aggregation inhibitor|potassium channel blocker
26247,e16,BRD-K84709232-001-02-6,lipoxygenase inhibitor|HIV integrase inhibitor|NFkB pathway inhibitor|nitric oxide production inhibitor|PPAR receptor modulator|tumor necrosis factor production inhibitor
26247,e19,BRD-K85015012-003-01-1,GABA uptake inhibitor|GAT inhibitor
26247,e20,BRD-K85090592-003-08-7,Acetylcholine receptor agonist
26247,e22,BRD-K85119730-001-06-5,ATP channel blocker
26247,e23,BRD-K85242180-001-01-1,"indoleamine 2,3-dioxygenase inhibitor"
26247,e24,BRD-K85266041-304-01-7,glutamate receptor antagonist
26247,f04,BRD-K85383046-001-02-5,chloride channel blocker
26247,f06,BRD-K85871428-001-01-9,p38 MAPK inhibitor
26247,f11,BRD-K85883481-001-02-6,glucocorticoid receptor agonist
26247,f12,BRD-K86204871-001-02-2,sterol demethylase inhibitor
26247,f13,BRD-K86301799-001-14-0,phosphodiesterase inhibitor
26247,f14,BRD-K86434416-001-02-7,Monoamine oxidase inhibitor
26247,f15,BRD-K84663978-001-03-1,phosphodiesterase inhibitor|platelet aggregation inhibitor|potassium channel blocker
26247,f16,BRD-K86509404-001-02-0,CDK inhibitor
26247,f19,BRD-K86600316-003-01-2,Adrenergic receptor antagonist
26247,f20,BRD-K86727142-001-06-6,HCV inhibitor|XIAP inhibitor
26247,f21,BRD-K86873305-236-03-0,Bacterial cell wall synthesis inhibitor
26247,f22,BRD-K86882815-001-01-6,dopamine receptor agonist|prolactin inhibitor|prolactin secretion inhibitor
26247,f23,BRD-K86958018-001-01-9,TRPV agonist
26247,f24,BRD-K87048468-003-01-9,Serotonin receptor antagonist
26247,g01,BRD-K87049188-001-03-6,chelating agent|dopamine beta hydroxylase inhibitor
26247,g08,BRD-K87510569-001-01-0,CC chemokine receptor antagonist
26247,g09,BRD-K87696786-003-01-0,glutamate receptor antagonist
26247,g14,BRD-K87990216-001-03-7,Glucocorticoid receptor agonist
26247,g15,BRD-K87991767-001-02-0,carbonic anhydrase inhibitor|cyclooxygenase inhibitor
26247,g16,BRD-K88090157-050-03-3,antihistamine
26247,g21,BRD-K88282786-066-04-9,cannabinoid receptor agonist
26247,g22,BRD-K88358234-003-01-4,serotonin receptor agonist|nerve growth factor agonist|neurotrophic factor enhancer
26247,g23,BRD-K88366685-300-03-7,3-ketoacyl CoA thiolase inhibitor
26247,g24,BRD-K88405679-003-01-5,antihistamine
26247,h01,BRD-K88429204-001-04-7,dihydrofolate reductase inhibitor
26247,h02,BRD-K88544581-001-01-2,ACAT inhibitor
26247,h05,BRD-K88568253-065-02-1,monoamine oxidase inhibitor
26247,h06,BRD-K88611939-001-01-8,Glutamate receptor agonist
26247,h08,BRD-K88677950-001-01-3,MAP kinase inhibitor|MEK inhibitor
26247,h10,BRD-K88741031-001-01-0,EGFR inhibitor|tyrosine kinase inhibitor
26247,h11,BRD-K88743730-001-01-0,serotonin receptor partial agonist
26247,h12,BRD-K88759641-003-01-0,Angiotensin receptor antagonist
26247,h13,BRD-K88789588-001-03-2,aromatase inhibitor
26247,h14,BRD-K88809146-003-02-1,monoamine oxidase inhibitor
26247,h15,BRD-K88849294-001-02-1,Tyrosine phosphatase inhibitor
26247,h16,BRD-K88871508-001-01-9,Dopamine receptor agonist
26247,h18,BRD-K89046952-001-03-4,bacterial cell wall synthesis inhibitor
26247,h21,BRD-K89055274-048-03-7,muscle relaxant
26247,h22,BRD-K89085489-001-02-6,apoptosis stimulant|retinoid receptor agonist
26247,h23,BRD-K89125793-001-05-4,antiprotozoal agent
26247,h24,BRD-K89152108-001-03-3,thyroid hormone stimulant
26247,i01,BRD-K89210380-001-03-8,vitamin B
26247,i04,BRD-K89272762-001-04-4,chloride channel blocker
26247,i07,BRD-K89274813-001-01-5,acetylcholine release enhancer
26247,i08,BRD-K89375097-300-04-7,Acetylcholine receptor antagonist
26247,i09,BRD-K89402695-001-01-5,Thromboxane receptor antagonist
26247,i13,BRD-K89732114-001-02-6,dopamine receptor antagonist
26247,i14,BRD-K89923877-003-02-4,acetylcholine receptor antagonist
26247,i15,BRD-K89930444-001-01-9,tyrosine kinase inhibitor
26247,i16,BRD-K89997465-001-02-0,dopamine receptor antagonist
26247,i17,BRD-K90027355-001-03-4,mineralocorticoid receptor antagonist
26247,i23,BRD-K90259198-003-04-8,calmodulin antagonist|potassium channel blocker|squalene monooxygenase channel blocker
26247,i24,BRD-K90333595-001-02-8,adrenergic receptor antagonist
26247,j01,BRD-K90524085-001-05-2,phosphodiesterase inhibitor|platelet aggregation inhibitor
26247,j04,BRD-K90574421-001-01-9,Serotonin receptor agonist
26247,j08,BRD-K90789829-003-03-3,Adrenergic inhibitor
26247,j09,BRD-K90976994-001-02-1,Bile acid
26247,j10,BRD-K91243525-001-01-5,Neurotensin receptor antagonist
26247,j11,BRD-K91263825-001-02-8,tricyclic antidepressant
26247,j13,BRD-K91315211-334-02-3,Histamine receptor agonist
26247,j15,BRD-K91336023-001-01-4,Dopamine receptor agonist
26247,j16,BRD-K91370081-001-04-6,DNA synthesis inhibitor
26247,j19,BRD-K91904471-001-01-6,p38 MAPK inhibitor
26247,j20,BRD-K92000912-001-06-8,cannabinoid receptor antagonist
26247,j24,BRD-K92015269-001-01-6,dopamine uptake inhibitor
26247,k02,BRD-K92049597-001-04-2,sodium channel blocker
26247,k04,BRD-K92093830-003-05-0,topoisomerase inhibitor
26247,k05,BRD-K92138166-001-01-0,other antibiotic
26247,k09,BRD-K92492521-001-01-1,Leukotriene receptor antagonist
26247,k12,BRD-K92678294-001-01-0,Isoflavone
26247,k14,BRD-K92726801-003-02-7,Haemostatic agent
26247,k17,BRD-K92731339-227-02-3,ACE inhibitor
26247,k18,BRD-K92758126-001-06-3,NFkB pathway inhibitor
26247,k19,BRD-K92778217-001-04-6,Cyclooxygenase inhibitor
26247,k20,BRD-K92830582-003-04-8,adrenergic receptor antagonist
26247,k22,BRD-K92984783-003-02-4,Serotonin receptor antagonist
26247,l01,BRD-K93080877-001-02-1,tripeptidyl peptidase inhibitor
26247,l02,BRD-K93176058-001-01-0,retinoid receptor agonist
26247,l03,BRD-K93188295-300-01-4,adrenergic receptor antagonist
26247,l05,BRD-K93258693-001-02-5,PPAR receptor antagonist
26247,l06,BRD-K93280214-004-02-3,GABA receptor antagonist
26247,l09,BRD-K93325701-001-03-0,SRC inhibitor
26247,l10,BRD-K93332168-001-03-2,Monoamine oxidase inhibitor
26247,l11,BRD-K93441486-067-03-7,Acetylcholine receptor antagonist
26247,l12,BRD-K93460210-001-01-3,Serotonin receptor antagonist
26247,l13,BRD-K93461745-001-01-5,Serotonin receptor agonist
26247,l14,BRD-K93480852-001-02-2,calcium/calmodulin dependent protein kinase inhibitor
26247,l19,BRD-K93568044-001-03-1,glucocorticoid receptor agonist
26247,l20,BRD-K93658967-001-01-7,CDK inhibitor|CFTR channel activator|glycogen synthase kinase inhibitor|JNK inhibitor
26247,l21,BRD-K93754473-001-02-9,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)
26247,l22,BRD-K94144010-001-05-5,nicotine metabolite
26247,m04,BRD-K94270326-004-01-0,dopamine receptor antagonist
26247,m06,BRD-K94379058-001-03-5,cannabinoid receptor inverse agonist
26247,m07,BRD-K94441233-001-03-1,HMGCR inhibitor
26247,m08,BRD-K94512704-001-01-3,dopamine receptor antagonist
26247,m12,BRD-K94689771-001-02-5,CYP1B1 inhibitor
26247,m17,BRD-K94832621-001-01-5,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)
26247,m19,BRD-K94841585-001-02-8,laxative|free radical generator
26247,m21,BRD-K94887716-001-01-5,Serotonin receptor agonist
26247,m22,BRD-K94920105-001-01-3,PARP inhibitor
26247,m24,BRD-K95202259-001-01-9,p38 MAPK inhibitor
26247,n01,BRD-K95237249-001-04-2,Uricosuric blocker
26247,n02,BRD-K95309561-001-04-9,estrogen receptor agonist
26247,n04,BRD-K95435023-001-01-0,c-Met inhibitor|hepatocyte growth factor receptor inhibitor
26247,n07,BRD-K95603879-001-03-4,ATPase inhibitor
26247,n08,BRD-K95609758-001-01-1,potassium channel activator
26247,n11,BRD-K95655893-001-01-0,VEGFR kinase inhibitor
26247,n12,BRD-K95676198-001-02-6,JAK inhibitor
26247,n15,BRD-K95739795-001-01-1,Vesicular monoamine transporter inhibitor
26247,n16,BRD-K95763993-001-03-7,PDGFR receptor inhibitor
26247,n17,BRD-K95785537-001-04-1,src inhibitor
26247,n20,BRD-K95851186-001-02-9,GABA receptor modulator
26247,n21,BRD-K95899059-003-01-0,Serotonin receptor agonist
26247,n22,BRD-K95992530-001-02-4,integrin antagonist
26247,n23,BRD-K96119599-001-04-7,Melanin inhibitor
26247,n24,BRD-K96144918-001-02-3,KPL-1 tumor suppressor
26247,o04,BRD-K96263742-001-02-3,PPAR receptor agonist
26247,o05,BRD-K96271548-001-02-2,antioxidant
26247,o07,BRD-K96402602-001-01-8,PPMTase inhibitor
26247,o08,BRD-K96527333-001-03-4,GABA receptor modulator
26247,o10,BRD-K96670504-001-01-9,Glucokinase inhibitor
26247,o13,BRD-K96720755-001-01-8,Vasopressin receptor antagonist
26247,o14,BRD-K96799727-001-01-7,HSP inhibitor
26247,o15,BRD-K96809896-001-01-9,p38 MAPK inhibitor
26247,o16,BRD-K96862998-001-03-1,TGF beta receptor inhibitor
26247,o17,BRD-K97061094-001-03-2,Histamine receptor antagonist
26247,o18,BRD-K97118047-001-01-2,Casein kinase inhibitor
26247,o19,BRD-K97158071-001-04-1,Dopamine receptor antagonist
26247,o20,BRD-K97181089-001-02-7,sodium channel blocker
26247,o22,BRD-K97330509-001-01-4,src inhibitor
26247,o23,BRD-K97354755-001-01-5,src inhibitor
26247,o24,BRD-K97365803-001-01-3,PI3K inhibitor
26247,p01,BRD-K97399794-001-07-0,polar auxin transport inhibitor
26247,p02,BRD-K97440753-066-03-3,adrenergic receptor antagonist|prolactin inhibitor
26247,p04,BRD-K97509413-001-01-8,AGE inhibitor|estrogen receptor agonist|estrogen receptor ligand
26247,p05,BRD-K97521363-001-03-9,glycolysis inhibitor
26247,p06,BRD-K97530723-001-04-3,melatonin receptor agonist|nitric oxide synthase inhibitor
26247,p07,BRD-K97564742-103-01-9,histamine receptor antagonist
26247,p10,BRD-K97688263-001-02-9,sodium channel blocker
26247,p13,BRD-K97746869-001-04-9,ATP channel blocker
26247,p14,BRD-K97752965-001-01-6,ATP channel activator|nitric oxide donor|potassium channel agonist
26247,p15,BRD-K97799481-002-03-6,Adenosine receptor antagonist
26247,p16,BRD-K97810537-001-03-7,glucocorticoid receptor agonist
26247,p17,BRD-K98039984-001-03-0,glucocorticoid receptor agonist
26247,p18,BRD-K98143437-001-01-7,p38 MAPK inhibitor|interleukin inhibitor|tumor necrosis factor production inhibitor
26247,p20,BRD-K98157055-001-04-2,glutamate receptor antagonist
26247,p21,BRD-K98174813-001-05-7,bacterial 30S ribosomal subunit inhibitor
26247,p23,BRD-K98297262-001-01-1,"1,3-beta-glucan synthase inhibitor"
26247,p24,BRD-K98521173-001-03-8,mineralocorticoid receptor agonist
25943,a01,BRD-A00100033-001-04-8,DNA inhibitor
25943,a02,BRD-A00267231-001-01-1,Adenosine receptor agonist
25943,a04,BRD-A00520476-001-03-3,Acetylcholine receptor antagonist
25943,a06,BRD-A00993607-003-04-8,Adrenergic receptor antagonist
25943,a07,BRD-A01078468-001-04-9,synthetic estrogen
25943,a08,BRD-A01295252-001-01-5,Dopamine receptor ligand
25943,a09,BRD-A01320529-001-05-9,adrenergic receptor agonist
25943,a11,BRD-A01593789-001-01-5,5 alpha reductase inhibitor
25943,a12,BRD-A01636364-003-04-5,sodium channel blocker
25943,a15,BRD-A01787639-003-08-6,adrenergic receptor antagonist
25943,a16,BRD-A02006392-001-06-5,calcium channel blocker
25943,a17,BRD-A02176148-001-02-2,Mitochondrial complex I inhibitor
25943,a19,BRD-A02710418-003-03-5,opioid receptor agonist
25943,a20,BRD-A02713983-001-02-0,growth factor receptor activator
25943,a21,BRD-A02759312-003-11-2,Adrenergic receptor antagonist
25943,a23,BRD-A03216249-003-02-9,Potassium channel blocker
25943,a24,BRD-A03359064-001-01-5,Adrenergic receptor antagonist
25943,b02,BRD-A03623303-045-02-0,Adrenergic receptor antagonist
25943,b03,BRD-A03816571-001-01-0,cannabinoid receptor agonist|CC chemokine receptor antagonist
25943,b09,BRD-A04322457-003-03-9,adrenergic receptor agonist
25943,b10,BRD-A04438777-001-01-4,dopamine receptor agonist
25943,b11,BRD-A04553218-050-03-0,histamine receptor antagonist
25943,b15,BRD-A04668240-001-01-5,GABA receptor antagonist
25943,b16,BRD-A04706586-236-01-7,Adenosine receptor agonist
25943,b18,BRD-A05186015-003-04-0,dopamine uptake inhibitor
25943,b24,BRD-A06352418-001-03-6,Histamine receptor antagonist
25943,c01,BRD-A06352508-001-02-9,CHK inhibitor
25943,c02,BRD-A06390036-001-02-0,Antiarrhythmic
25943,c03,BRD-A06726973-001-02-0,cGMP analog
25943,c04,BRD-A06935312-001-02-7,bacterial 30S ribosomal subunit inhibitor
25943,c06,BRD-A07207424-001-04-1,phosphodiesterase inhibitor
25943,c08,BRD-A07440155-003-04-9,Adrenergic receptor antagonist
25943,c09,BRD-A07780951-001-02-2,Adrenergic receptor agonist
25943,c10,BRD-A07824748-001-02-6,11-beta hydroxysteroid dehydrogenase inhibitor
25943,c14,BRD-A07875874-001-01-6,calcium channel blocker
25943,c17,BRD-A07932845-001-01-1,anti-HCVE2
25943,c18,BRD-A07952294-001-02-3,farnesyltransferase inhibitors
25943,c19,BRD-A08187463-001-03-8,enkephalinase inhibitor
25943,c22,BRD-A08709697-001-02-9,pyrrolizidine alkaloid
25943,c23,BRD-A08877921-001-02-2,Protein synthesis inhibitor
25943,c24,BRD-A09056319-003-03-6,Adrenergic receptor antagonist
25943,d01,BRD-A09062839-003-03-5,Local anesthetic
25943,d02,BRD-A09094913-001-02-3,acetylcholine receptor antagonist
25943,d03,BRD-A09161221-001-01-9,HSP inhibitor
25943,d04,BRD-A09349126-001-02-4,progesterone receptor agonist
25943,d05,BRD-A09467419-003-04-2,acetylcholine receptor antagonist
25943,d06,BRD-A09472452-001-02-8,Sodium channel blocker
25943,d07,BRD-A09533288-001-02-7,calcium channel blocker
25943,d08,BRD-A09539288-004-02-8,Acetylcholine receptor antagonist
25943,d09,BRD-A09828896-004-04-5,Dopamine receptor agonist
25943,d10,BRD-A09925278-003-03-1,Adrenergic receptor agonist
25943,d14,BRD-A10070317-003-05-1,adrenergic receptor antagonist
25943,d17,BRD-A10355991-003-01-8,Glutamate receptor antagonist
25943,d18,BRD-A10715913-001-02-0,Dopamine receptor antagonist
25943,d19,BRD-A10739734-003-01-5,adrenergic receptor antagonist
25943,d20,BRD-A10903566-003-02-8,Adrenergic receptor antagonist
25943,d21,BRD-A10969569-001-02-0,Plant alkaloid
25943,d22,BRD-A10977446-001-04-8,Adrenergic receptor antagonist
25943,e03,BRD-A11605036-001-03-2,GABA receptor antagonist
25943,e04,BRD-A11609859-303-01-2,opioid receptor agonist
25943,e05,BRD-A11678676-001-02-6,PI3K inhibitor
25943,e07,BRD-A11813248-001-02-8,Potassium channel blocker
25943,e08,BRD-A12016240-001-01-7,Serotonin receptor antagonist
25943,e14,BRD-A13188892-066-03-3,Adrenergic receptor antagonist
25943,e15,BRD-A13650332-236-03-9,Bacterial cell wall synthesis inhibitor
25943,e16,BRD-A13946108-001-03-1,Cyclooxygenase inhibitor
25943,e23,BRD-A14395271-001-01-5,Dopamine receptor antagonist
25943,e24,BRD-A14566392-004-03-5,acetylcholine receptor antagonist
25943,f03,BRD-A14574269-051-01-4,Acetylcholine receptor agonist
25943,f04,BRD-A15034104-002-03-6,interleukin inhibitor
25943,f05,BRD-A15070535-323-02-1,adenosine receptor agonist|cAMP stimulant
25943,f06,BRD-A15415227-003-01-1,PPAR receptor agonist
25943,f07,BRD-A15435692-003-01-5,sigma receptor antagonist|glutamate receptor antagonist|serotonin receptor agonist
25943,f11,BRD-A15530910-001-01-3,adrenergic receptor antagonist|serotonin receptor antagonist
25943,f14,BRD-A15914070-001-01-5,cytotoxic lipid peroxidation product
25943,f15,BRD-A16332958-001-02-4,Adrenergic receptor agonist
25943,f16,BRD-A16665823-008-03-3,Bacterial cell wall synthesis inhibitor
25943,f19,BRD-A16694057-001-02-7,PPAR receptor antagonist
25943,f21,BRD-A17065207-001-06-9,protein synthesis inhibitor
25943,f23,BRD-A17428743-001-01-1,Serotonin receptor agonist
25943,f24,BRD-A17453586-001-01-9,Serotonin receptor agonist
25943,g02,BRD-A17535965-001-02-2,Acetylcholine receptor antagonist
25943,g05,BRD-A17655518-001-02-0,Cyclooxygenase inhibitor
25943,g08,BRD-A18043272-001-03-2,succinimide antiepileptic
25943,g09,BRD-A18202423-001-01-6,Glutamate receptor antagonist
25943,g10,BRD-A18497530-001-04-6,adenosine kinase inhibitor|nucleoside transporter inhibitor
25943,g11,BRD-A18579359-001-03-1,Neural Wiskott-Aldrich syndrome protein inhibitor
25943,g12,BRD-A18696154-003-11-9,adrenergic receptor antagonist
25943,g13,BRD-A18763547-019-01-0,Cytochrome C release inhibitor
25943,g15,BRD-A19053259-003-03-3,Anthelmintic
25943,g17,BRD-A19195498-050-04-2,Norepinephrine reuptake inhibitor
25943,g18,BRD-A19736161-310-01-3,Serotonin receptor antagonist
25943,g23,BRD-A20239487-001-02-5,Adrenergic receptor antagonist
25943,h01,BRD-A20348246-001-04-2,GABA receptor modulator
25943,h06,BRD-A20968261-001-01-3,glutamate transporter inhibitor
25943,h08,BRD-A21723284-066-01-7,Opioid receptor antagonist
25943,h09,BRD-A21858158-001-04-5,Anthelmintic
25943,h14,BRD-A22305049-003-04-5,gluconeogenesis inhibitor
25943,h15,BRD-A22380646-001-01-5,ATPase inhibitor
25943,h16,BRD-A22684332-003-02-3,adrenergic receptor agonist
25943,h17,BRD-A22707317-001-02-5,GABA receptor modulator
25943,h21,BRD-A22769835-300-03-2,Antihistamine
25943,h22,BRD-A22783572-065-01-3,microtubule formation inhibitor|tubulin inhibitor|tubulin polymerisation inhibitor
25943,h23,BRD-A22844106-001-04-7,Cyclooxygenase inhibitor
25943,h24,BRD-A23034328-003-03-4,protein synthesis inhibitor
25943,i01,BRD-A23072235-050-04-5,Histamine receptor antagonist
25943,i02,BRD-A23226398-001-02-7,estrogen receptor agonist
25943,i03,BRD-A23683907-334-01-0,serotonin receptor antagonist
25943,i04,BRD-A23723433-001-01-2,tubulin inhibitor|microtubule stabilizing agent|microtubule stimulant|P glycoprotein inhibitor|taxane
25943,i08,BRD-A24122750-001-01-1,GABA receptor antagonist
25943,i09,BRD-A24191444-045-03-1,Adrenergic receptor antagonist
25943,i10,BRD-A24228527-001-04-2,Bacterial DNA gyrase inhibitor
25943,i13,BRD-A24514565-236-01-6,Vitamin K antagonist
25943,i15,BRD-A24587114-066-03-5,adrenergic receptor agonist
25943,i16,BRD-A24817035-001-04-7,central nervous system agent
25943,i17,BRD-A25234499-001-04-3,glucocorticoid receptor antagonist
25943,i20,BRD-A25775766-001-03-3,GABA receptor antagonist|TP53 activator
25943,i23,BRD-A26032986-050-01-3,Calmodulin antagonist
25943,i24,BRD-A26222320-001-02-6,protein synthesis inhibitor
25943,j01,BRD-A26334849-001-02-1,Antiarrhythmic
25943,j02,BRD-A26384407-001-04-6,Carbonic anhydrase inhibitor
25943,j03,BRD-A26711594-001-02-7,calcium channel blocker
25943,j07,BRD-A26845397-001-01-4,Adrenergic receptor antagonist
25943,j09,BRD-A27143604-001-01-2,Estrogen receptor agonist
25943,j14,BRD-A28318179-003-03-6,Nitric oxide synthase inhibitor
25943,j15,BRD-A28856712-003-04-7,adrenergic receptor agonist
25943,j18,BRD-A29260609-003-04-7,adrenergic receptor antagonist
25943,j19,BRD-A29289453-001-02-1,platelet activating factor receptor antagonist
25943,j20,BRD-A29322418-237-02-4,mineralocorticoid receptor antagonist
25943,k01,BRD-A29426959-050-04-1,Histamine receptor antagonist
25943,k02,BRD-A29437505-001-01-6,TLR agonist
25943,k04,BRD-A29644307-050-04-8,Dopamine uptake inhibitor
25943,k05,BRD-A29734509-011-02-9,Sodium channel blocker
25943,k10,BRD-A30590053-003-01-1,Acetylcholine release enhancer
25943,k11,BRD-A30655177-001-04-1,BTK inhibitor
25943,k13,BRD-A30717181-001-02-7,glucocorticoid receptor agonist
25943,k14,BRD-A30815329-001-03-0,Calcium channel blocker
25943,k17,BRD-A31007383-001-01-0,Adenosine receptor agonist
25943,k18,BRD-A31159102-001-01-9,Selective serotonin reuptake inhibitor (SSRI)
25943,k19,BRD-A31195449-004-01-9,Serotonin receptor agonist
25943,k20,BRD-A31521121-001-04-1,Muscle relaxant
25943,k21,BRD-A31575449-300-01-4,Adrenergic receptor antagonist
25943,l02,BRD-A31800922-003-04-6,acetylcholine receptor antagonist
25943,l05,BRD-A32164164-048-01-4,Acetylcholine receptor antagonist
25943,l06,BRD-A32505112-001-02-8,angiotensin converting enzyme inhibitor
25943,l09,BRD-A32673558-003-02-1,acetylcholine receptor agonist
25943,l10,BRD-A32949107-001-01-7,calcium channel blocker
25943,l12,BRD-A33168282-003-06-5,Adrenergic receptor antagonist
25943,l13,BRD-A33447119-001-02-5,Anthelmintic
25943,l14,BRD-A33711280-311-02-0,Acetylcholine receptor antagonist
25943,l19,BRD-A34255068-001-04-8,phosphodiesterase inhibitor
25943,l20,BRD-A34309505-001-08-5,benzodiazepine receptor agonist
25943,l22,BRD-A34706053-003-01-9,Adrenergic receptor agonist
25943,m01,BRD-A34751532-001-03-6,HSP inducer
25943,m03,BRD-A34788695-003-04-5,bacterial 30S ribosomal subunit inhibitor
25943,m04,BRD-A34806832-001-02-7,ATPase inhibitor
25943,m07,BRD-A35033682-001-01-0,cytochrome P450 inhibitor
25943,m08,BRD-A35338386-001-04-6,adenosine receptor agonist
25943,m11,BRD-A35511923-019-01-6,Somatostatin receptor agonist
25943,m12,BRD-A35623999-001-03-2,mitochondrial Na+/Ca2+ exchanger antagonist|sodium/calcium exchange inhibitor
25943,m16,BRD-A35931254-003-02-7,dopamine receptor agonist
25943,m18,BRD-A36066264-001-02-3,Estrogen receptor agonist
25943,m19,BRD-A36074203-003-03-5,Glutamate receptor antagonist
25943,m20,BRD-A36217750-001-04-9,Uricosuric blocker
25943,m21,BRD-A36267905-003-02-8,Adrenergic receptor agonist
25943,m22,BRD-A36318220-001-01-3,RIPK inhibitor
25943,m23,BRD-A36471396-003-02-2,Acetylcholine receptor antagonist
25943,n01,BRD-A37347161-003-01-8,opioid receptor agonist
25943,n02,BRD-A37432947-004-02-5,acetylcholine receptor antagonist
25943,n03,BRD-A37441042-003-02-2,adrenergic receptor agonist
25943,n04,BRD-A37492983-001-03-8,radiopaque medium
25943,n06,BRD-A37704979-001-02-4,p38 MAPK inhibitor
25943,n07,BRD-A37776212-003-02-5,opioid receptor agonist
25943,n17,BRD-A38747044-001-01-5,Imidazoline receptor ligand
25943,n18,BRD-A38898897-003-01-0,Leukocyte elastase inhibitor
25943,n19,BRD-A38913120-001-01-0,BCL inhibitor
25943,n21,BRD-A39230911-001-03-7,Muscle relaxant
25943,n22,BRD-A39255369-001-01-5,Chloride channel blocker
25943,n23,BRD-A39268308-001-02-0,Acetylcholine receptor agonist
25943,o01,BRD-A39522003-001-01-0,FAAH inhibitor|FAAH reuptake inhibitor
25943,o03,BRD-A39747742-001-02-7,estrogen receptor agonist
25943,o05,BRD-A39969961-001-01-3,Cytochrome P450 inhibitor
25943,o06,BRD-A40022950-001-02-9,ATPase inhibitor
25943,o08,BRD-A40639672-234-04-0,Cyclooxygenase inhibitor
25943,o10,BRD-A41112154-001-02-1,G protein-coupled receptor agonist
25943,o13,BRD-A41145729-001-02-7,Retinoid receptor agonist
25943,o14,BRD-A41250306-001-03-4,Thiazide diuretic
25943,o15,BRD-A41301928-001-02-5,"Mitochondrial ADP, ATP translocase inhibitor"
25943,o16,BRD-A41304429-001-04-9,Adrenergic receptor antagonist
25943,o17,BRD-A41451487-001-01-3,Benzodiazepine receptor antagonist
25943,o18,BRD-A41519720-001-02-2,Niemann-Pick C1-like 1 protein antagonist
25943,o19,BRD-A41722204-003-01-5,adenosine receptor antagonist
25943,o20,BRD-A41833852-001-01-9,Opioid receptor antagonist
25943,o22,BRD-A41941932-001-03-0,Antioxidant
25943,o23,BRD-A42167015-003-03-7,Adrenergic receptor antagonist
25943,o24,BRD-A42335949-300-04-9,phosphatidylglycerophosphatase inhibitor
25943,p01,BRD-A42346008-003-03-6,epinephrine metabolite
25943,p02,BRD-A42553870-001-05-1,neuropeptide receptor antagonist
25943,p03,BRD-A42571354-300-01-3,histamine receptor antagonist
25943,p04,BRD-A42628519-001-04-1,radiopaque medium
25943,p05,BRD-A42759514-001-03-1,Antiprotozoal
25943,p06,BRD-A42831637-001-02-2,anti-inflammatory|Cannabinoid metabolite
25943,p07,BRD-A43076080-001-03-3,protein phosphatase inhibitor
25943,p09,BRD-A43150328-001-02-0,other antibiotic
25943,p13,BRD-A43671941-003-03-6,Adrenergic receptor antagonist
25943,p14,BRD-A43849199-001-02-3,Phytotoxin
25943,p15,BRD-A43930669-003-01-0,oxytocin receptor antagonist
25943,p16,BRD-A43940795-001-02-8,serotonin release inhibitor
25943,p17,BRD-A43974499-066-01-1,Adrenergic receptor antagonist
25943,p19,BRD-A44008656-036-04-3,Histamine receptor antagonist
25943,p20,BRD-A44090213-001-04-1,Cyclooxygenase inhibitor
25943,p21,BRD-A44133049-001-01-5,Serotonin receptor antagonist
25943,p22,BRD-A44448661-001-02-2,Barbiturate antiepileptic
25943,p23,BRD-A44551378-001-01-9,EGFR inhibitor
25943,p24,BRD-A44863528-001-04-1,CCK receptor antagonist
24296,a01,BRD-K18250272-003-03-7,local anesthetic
24296,a02,BRD-K18316707-001-01-9,cannabinoid receptor antagonist
24296,a04,BRD-K18550767-001-02-8,interleukin inhibitor
24296,a05,BRD-K18574842-323-03-3,bacterial cell wall synthesis inhibitor
24296,a06,BRD-K18619710-001-03-7,steroid
24296,a07,BRD-K18742343-001-03-2,PKA inhibitor
24296,a08,BRD-K18757346-001-02-9,thromboxane receptor agonist
24296,a09,BRD-K18779551-003-03-7,acetylcholine release stimulant|adrenergic transmitter uptake inhibitor|reducing agent
24296,a10,BRD-K18787491-001-05-2,MEK inhibitor
24296,a11,BRD-K18799075-001-01-0,cannabinoid receptor partial agonist
24296,a12,BRD-K18816859-001-01-4,Serotonin receptor agonist
24296,a15,BRD-K18909381-001-01-4,serotonin receptor agonist
24296,a16,BRD-K18910433-001-04-4,estrogen receptor agonist
24296,a19,BRD-K19111024-001-04-3,PPAR receptor agonist
24296,a20,BRD-K19295594-001-04-4,BCL inhibitor|MCL1 inhibitor
24296,a21,BRD-K19309090-300-03-0,acetylcholine receptor agonist
24296,a22,BRD-K19352500-332-03-7,dopamine receptor antagonist
24296,a23,BRD-K19360254-001-01-3,Dopamine receptor agonist
24296,b01,BRD-K19462402-003-03-0,adrenergic receptor antagonist|calcium channel blocker
24296,b03,BRD-K19533706-001-01-9,Angiogenesis inhibitor
24296,b04,BRD-K19554809-001-01-1,serotonin receptor agonist
24296,b05,BRD-K19605405-001-01-9,adenosine receptor antagonist
24296,b07,BRD-K20141153-003-03-8,norepinephrine transporter inhibitor|adrenergic transmitter uptake inhibitor
24296,b08,BRD-K20152659-001-02-0,Cholesterol inhibitor
24296,b10,BRD-K20620780-001-01-0,dopamine receptor antagonist
24296,b11,BRD-K20655524-003-04-7,psychoactive drug
24296,b15,BRD-K20714604-001-01-5,Serotonin receptor partial agonist
24296,b16,BRD-K20742498-001-01-5,serotonin receptor antagonist
24296,b17,BRD-K20755323-001-01-8,sphingosine kinase inhibitor
24296,b18,BRD-K20995441-001-01-7,Opioid receptor agonist
24296,b19,BRD-K21283037-001-02-5,glutamate inhibitor
24296,b20,BRD-K21350491-001-02-1,acid sensing ion channel blocker|sodium channel blockers|TRPP3 channel inhibitor|TRPV modulator
24296,b21,BRD-K21450440-001-04-7,carbonic anhydrase inhibitor
24296,b22,BRD-K21520694-001-02-4,PABA antagonist
24296,b23,BRD-K21548250-001-01-3,sodium channel blocker
24296,b24,BRD-K21565985-001-04-3,adrenergic receptor agonist
24296,c01,BRD-K21667562-001-01-4,FAAH transport inhibitor|anandamide transport inhibitor|nucelar factor of activated T-cells inhibitor|TRPV agonist
24296,c02,BRD-K21680192-300-05-2,topoisomerase inhibitor
24296,c03,BRD-K21733600-001-02-6,cyclooxygenase inhibitor
24296,c04,BRD-K21853356-001-04-4,EGFR inhibitor
24296,c07,BRD-K22031190-001-04-6,Prostanoid receptor antagonist
24296,c08,BRD-K22134346-001-04-1,HMGCR inhibitor
24296,c09,BRD-K22193694-001-04-5,Topical sunscreen agent
24296,c10,BRD-K22385716-001-01-7,casein kinase inhibitor|mTOR inhibitor|PI3K inhibitor
24296,c17,BRD-K22861715-001-03-4,breast cancer resistance protein inhibitor
24296,c19,BRD-K22969690-001-02-6,bacterial 50S ribosomal subunit inhibitor
24296,c21,BRD-K23301018-001-02-6,antiprotozoal agent
24296,c23,BRD-K23335153-300-01-7,glutamate receptor positive allosteric modulator
24296,c24,BRD-K23383398-001-01-6,LXR agonist|ABC transporter expression enhancer|ROR inverse agonist
24296,d02,BRD-K23478508-001-03-7,ATPase inhibitor
24296,d03,BRD-K23541596-300-04-9,histamine receptor agonist
24296,d04,BRD-K23566484-001-04-5,androgen receptor antagonist
24296,d05,BRD-K23583188-001-05-6,EGFR inhibitor|tyrosine kinase inhibitor
24296,d06,BRD-K23704908-001-03-2,serine protease inhibitor
24296,d07,BRD-K23913458-001-02-5,Vitamin K antagonist
24296,d08,BRD-K23922020-075-01-1,acetylcholine receptor agonist
24296,d10,BRD-K24084088-001-02-2,adenosine receptor antagonist
24296,d13,BRD-K24132293-001-02-0,glutathione transferase inhibitor
24296,d14,BRD-K24201553-003-02-4,Serotonin receptor antagonist
24296,d17,BRD-K24240364-003-02-1,Glutamate receptor antagonist
24296,d18,BRD-K24396733-001-01-1,dopamine receptor agonist
24296,d20,BRD-K24526313-001-08-6,Potassium channel activator
24296,e05,BRD-K25224017-001-04-5,serotonin receptor antagonist
24296,e07,BRD-K25394294-001-04-0,Cyclooxygenase inhibitor
24296,e11,BRD-K25433859-003-11-4,norepinephrine reputake inhibitor|tricyclic antidepressant
24296,e13,BRD-K25741894-001-03-8,acetylcholinesterase inhibitor
24296,e15,BRD-K25875056-001-01-2,Protein tyrosine kinase activator
24296,e16,BRD-K25906698-303-01-9,histamine receptor agonist
24296,e21,BRD-K26160755-003-01-8,Imidazoline receptor agonist
24296,e22,BRD-K26373640-001-02-8,IKK inhibitor
24296,f03,BRD-K26429091-051-01-9,acetylcholine receptor antagonist
24296,f04,BRD-K26521938-001-04-9,prostanoid receptor agonist
24296,f05,BRD-K26548821-001-01-8,Dopamine receptor agonist
24296,f06,BRD-K26573499-300-01-3,Adrenergic receptor agonist
24296,f12,BRD-K26979635-001-01-1,Glutamate receptor antagonist
24296,f13,BRD-K26997899-001-01-4,microtubule inhibitor|tubulin inhibitor
24296,f15,BRD-K27141178-001-01-0,Serotonin receptor antagonist
24296,f20,BRD-K27305650-001-04-2,mTOR inhibitor|PI3K inhibitor|DNA dependent protein kinase inhibitor|phosphodiesterase inhibitor|PLK inhibitor
24296,f21,BRD-K27316855-001-02-6,vitamin D receptor agonist
24296,f23,BRD-K27351809-001-02-0,progesterone receptor agonist
24296,g01,BRD-K27450477-001-03-9,Adenosine deaminase inhibitor
24296,g02,BRD-K27499107-001-02-6,IP receptor activator
24296,g06,BRD-K27710560-001-02-6,SIRT inhibitor
24296,g07,BRD-K27737647-001-03-4,PKA inhibitor
24296,g09,BRD-K27871032-001-02-6,Ergoline alkaloid
24296,g11,BRD-K28115081-001-01-9,Platelet activating factor receptor antagonist
24296,g12,BRD-K28137194-003-01-3,GABA receptor agonist
24296,g13,BRD-K28143534-001-01-4,histamine receptor antagonist
24296,g15,BRD-K28183345-003-05-6,Dihydrofolate reductase inhibitor
24296,g17,BRD-K28307902-001-04-3,androgen receptor antagonist
24296,g18,BRD-K28453807-003-05-4,Cholinergic receptor antagonist
24296,g23,BRD-K28578425-001-01-3,phosphodiesterase inhibitor
24296,g24,BRD-K28667196-001-02-9,Increases arterial blood pressure
24296,h01,BRD-K28680267-001-01-8,CCK receptor antagonist
24296,h02,BRD-K28761384-003-03-6,dopamine receptor antagonist
24296,h05,BRD-K28761891-001-01-0,melatonin receptor agonist
24296,h06,BRD-K28806945-001-01-9,dopamine receptor antagonist
24296,h07,BRD-K28863208-001-01-2,Cholinergic receptor agonist
24296,h08,BRD-K28907958-001-01-9,retinoid receptor agonist
24296,h09,BRD-K28936863-051-04-1,histamine receptor agonist|leukotriene receptor antagonist|phosphodiesterase inhibitor
24296,h10,BRD-K29113274-001-03-6,Sterol demethylase inhibitor
24296,h12,BRD-K29178788-001-02-0,Furoquinoline alkaloid
24296,h13,BRD-K29359156-001-04-6,H+/K+-ATPase inhibitor
24296,h16,BRD-K29555132-001-02-2,Cannabinoid receptor agonist
24296,h17,BRD-K29582677-001-02-7,Calcium channel blocker
24296,h18,BRD-K29668683-300-01-4,sigma receptor antagonist
24296,h21,BRD-K29673530-001-03-9,tyrosine kinase inhibitor
24296,h22,BRD-K29950728-048-02-6,estrogen receptor antagonist
24296,h23,BRD-K30197592-001-01-5,Serotonin receptor agonist
24296,i01,BRD-K30240666-051-05-0,histamine receptor antagonist
24296,i02,BRD-K30421593-050-02-3,adrenergic receptor antagonist
24296,i03,BRD-K30480208-001-04-5,Electrolyte reabsorption inhibitor
24296,i08,BRD-K30685142-001-04-8,thyroid hormone stimulant
24296,i09,BRD-K30867024-001-01-1,serotonin receptor antagonist
24296,i11,BRD-K30990140-003-01-6,Cyclooxygenase inhibitor
24296,i12,BRD-K31054881-300-01-3,Adrenergic receptor antagonist
24296,i13,BRD-K31238592-001-01-6,CCK receptor antagonist|gastrin inhibitor
24296,i16,BRD-K31342827-001-05-4,PKC inhibitor
24296,i18,BRD-K31491153-001-01-2,serotonin receptor agonist
24296,i19,BRD-K31542390-001-01-5,dehydrogenase inhibitor|inositol monophosphatase inhibitor
24296,i20,BRD-K31611373-001-02-7,Prostanoid receptor agonist
24296,i23,BRD-K31627533-001-03-8,glucocorticoid receptor agonist
24296,i24,BRD-K31633810-003-01-0,Acetylcholine receptor antagonist
24296,j03,BRD-K31699485-001-01-9,glutamate receptor modulator
24296,j04,BRD-K31792052-004-01-9,interleukin receptor antagonist
24296,j09,BRD-K31843556-001-01-7,PPAR receptor anatagonist|PPAR receptor antagonist
24296,j10,BRD-K31912990-003-01-0,neuropeptide receptor antagonist
24296,j12,BRD-K31987754-001-01-2,Cannabinoid receptor agonist
24296,j15,BRD-K32164935-001-06-8,ATP channel blocker
24296,j16,BRD-K32247306-001-04-7,GABA receptor antagonist
24296,j19,BRD-K32292990-001-01-0,EGFR inhibitor
24296,j20,BRD-K32412559-001-01-7,Adrenergic receptor antagonist
24296,j23,BRD-K32501161-001-01-7,dopamine uptake inhibitor
24296,j24,BRD-K32526544-001-01-2,Potassium channel activator
24296,k02,BRD-K32584078-001-02-3,AKT inhibitor|HCV NS5B RdRp inhibitor
24296,k04,BRD-K32645441-001-01-4,serotonin receptor agonist
24296,k05,BRD-K32696739-001-02-6,Monoamine oxidase inhibitor
24296,k06,BRD-K32744045-001-04-9,aldehyde dehydrogenase inhibitor|DNA methyltransferase inhibitor|TRPV agonist
24296,k09,BRD-K32755366-003-03-4,Norepinephrine transporter inhibitor
24296,k10,BRD-K32821942-001-04-9,dehydrogenase inhibitor
24296,k11,BRD-K32828673-001-01-5,tubulin polymerization inhibitor
24296,k12,BRD-K32830106-003-11-3,adrenergic receptor agonist
24296,k14,BRD-K33204703-001-04-6,PDGFR receptor inhibitor
24296,k17,BRD-K33211335-337-03-7,glutamate receptor antagonist|sigma receptor agonist
24296,k19,BRD-K33308633-001-01-6,calcineurin inhibitor
24296,k20,BRD-K33396764-001-02-0,Omega 3 fatty acid stimulant
24296,k22,BRD-K33453211-003-03-2,Histamine receptor antagonist
24296,l01,BRD-K33459542-001-02-5,sigma receptor agonist
24296,l02,BRD-K33583600-001-03-9,guanylate cyclase activator
24296,l03,BRD-K33710385-001-05-4,mycolic synthesis inhibitor
24296,l04,BRD-K33818169-003-01-2,LXR agonist|ABC transporter expression enhancer
24296,l05,BRD-K33864865-001-01-7,CCK receptor antagonist
24296,l06,BRD-K33882852-003-01-0,benzodiazepine receptor agonist
24296,l10,BRD-K34014345-001-02-6,Anti-inflammatory
24296,l11,BRD-K34034388-300-01-0,dopamine uptake inhibitor
24296,l12,BRD-K34092021-001-02-3,TRPV agonist|cannabinoid receptor agonist
24296,l13,BRD-K34154330-003-04-9,GABA receptor modulator
24296,l17,BRD-K34170797-001-01-1,FXR agonist
24296,l20,BRD-K34415467-003-04-9,histamine receptor antagonist
24296,l21,BRD-K34568562-001-02-7,interferon inducer
24296,l22,BRD-K34608650-001-01-6,Cannabinoid receptor agonist
24296,m02,BRD-K34685430-001-01-1,dopamine receptor antagonist|serotonin receptor antagonist
24296,m03,BRD-K34995470-001-02-3,receptor tyrosine protein kinase inhibitor|vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor|VEGFR inhibitor
24296,m06,BRD-K35240538-001-03-1,glucocorticoid receptor agonist
24296,m07,BRD-K35430135-003-01-5,Adrenergic receptor antagonist
24296,m08,BRD-K35458079-001-04-2,Nootropic agent
24296,m11,BRD-K35498378-001-03-8,Aldose reductase inhibitor
24296,m15,BRD-K35629949-001-01-2,CCK receptor antagonist
24296,m16,BRD-K35708212-331-03-1,ATPase inhibitor
24296,m17,BRD-K35941380-001-01-7,Serotonin receptor antagonist
24296,m18,BRD-K35960502-001-04-4,DNA replication inhibitor|STAT inhibitor
24296,m20,BRD-K36007650-300-02-3,protein synthesis inhibitor
24296,m21,BRD-K36009368-001-01-8,Opioid receptor agonist
24296,m22,BRD-K36021395-300-01-6,adenosine kinase inhibitor
24296,m23,BRD-K36055864-001-04-4,protein synthesis inhibitor
24296,m24,BRD-K36116267-001-05-4,psychoactive drug
24296,n01,BRD-K36198571-001-01-2,metalloproteinase inhibitor
24296,n02,BRD-K36258877-001-01-5,caspase inhibitor
24296,n05,BRD-K36638830-001-02-2,acetylcholine receptor agonist
24296,n06,BRD-K36756879-003-04-6,calcium channel blocker
24296,n11,BRD-K36862742-001-04-1,sodium/potassium/chloride transporter inhibitor
24296,n12,BRD-K36864847-303-01-7,Adrenergic receptor antagonist
24296,n15,BRD-K36927236-001-06-0,Sulfonylurea
24296,n16,BRD-K36965586-001-01-7,serotonin receptor agonist
24296,n18,BRD-K37249724-001-04-2,histamine receptor antagonist
24296,n19,BRD-K37270826-001-03-7,glucocorticoid receptor antagonist|progesterone receptor antagonist
24296,n21,BRD-K37289225-001-07-5,Dopamine receptor antagonist
24296,n22,BRD-K37392901-003-01-7,ubiquitin hydrolase inhibitor|ubiquitin isopeptidase inhibitor
24296,n23,BRD-K37447567-001-01-8,Opioid receptor antagonist
24296,n24,BRD-K37561857-001-04-9,phosphodiesterase inhibitor
24296,o02,BRD-K37618799-001-01-4,adenosine receptor antagonist
24296,o03,BRD-K37682401-001-05-1,bacterial DNA gyrase inhibitor
24296,o04,BRD-K37688416-003-04-0,psychoactive drug
24296,o05,BRD-K37691127-001-02-2,tyrosinase inhibitor
24296,o07,BRD-K37792168-001-01-0,Phosphodiesterase inhibitor
24296,o08,BRD-K37798499-001-02-5,topoisomerase inhibitor
24296,o09,BRD-K37848908-001-03-1,penicillin binding protein inhibitor
24296,o10,BRD-K37865504-001-01-7,FAAH inhibitor|FAAH reuptake inhibitor
24296,o14,BRD-K37991163-050-05-1,selective serotonin reuptake inhibitor (SSRI)
24296,o15,BRD-K38003476-001-03-4,steroid
24296,o16,BRD-K38055836-001-03-9,respiratory stimulant
24296,o17,BRD-K38197229-001-06-7,solute carrier family member inhibitor
24296,o18,BRD-K38251852-001-02-5,ABC transporter expression enhancer|high conductance calcium activated potassium blocker|LXR agonist|potassium channel blocker
24296,o19,BRD-K38305202-001-01-8,dopamine receptor antagonist
24296,o20,BRD-K38323065-001-05-8,cyclooxygenase inhibitor
24296,o21,BRD-K38347298-001-02-3,adenosine receptor antagonist
24296,o22,BRD-K38436528-003-04-8,norepinephrine reputake inhibitor|serotonin reuptake inhibitor
24296,o23,BRD-K38449220-001-03-8,cytochrome P450 inhibitor
24296,o24,BRD-K38477985-001-01-8,protein tyrosine kinase inhibitor|tyrosine kinase inhibitor
24296,p01,BRD-K38684403-001-02-1,bacterial 50S ribosomal subunit inhibitor
24296,p03,BRD-K38775274-001-02-3,glucocorticoid receptor agonist
24296,p04,BRD-K38903228-001-02-8,flavanone glycoside
24296,p05,BRD-K39120595-304-02-1,autotaxin inhibitor
24296,p07,BRD-K39187410-001-01-7,antiamyloidogenic agent
24296,p08,BRD-K39188321-001-03-9,glucocorticoid receptor agonist
24296,p09,BRD-K39339537-001-03-8,cyclooxygenase inhibitor
24296,p10,BRD-K39356024-001-02-4,acetylcholine release enhancer|dopamine release enhancer|GABA receptor negative allosteric modulator|glutamate receptor modulator|progesterone receptor agonist|steroid hormone inhibitor of CYP17A1 and SULT2B1
24296,p13,BRD-K39484304-001-02-5,RNA polymerase inhibitor
24296,p14,BRD-K39670393-303-01-3,histamine receptor agonist
24296,p15,BRD-K39733634-001-01-8,prostanoid receptor antagonist|angiotensin receptor antagonist
24296,p16,BRD-K39746403-084-02-3,NFkB pathway inhibitor|50S ribosomal subunit inhibitor|motilin receptor agonist|RPLV inhibitor
24296,p17,BRD-K39915878-036-04-6,dopamine receptor antagonist|serotonin receptor antagonist
24296,p18,BRD-K39965020-001-02-6,PPAR receptor agonist
24296,p19,BRD-K39987650-001-04-3,laxative
24296,p20,BRD-K40255344-001-05-1,protein tyrosine kinase inhibitor|tyrosine kinase inhibitor
24296,p21,BRD-K40530731-001-02-5,acetylcholine receptor inhibitor
24296,p22,BRD-K40578143-001-01-8,adenosine receptor agonist
24296,p23,BRD-K40656405-001-01-5,PPAR receptor agonist
24296,p24,BRD-K40742111-001-02-6,lipoxygenase inhibitor
25965,a01,BRD-A97104540-004-04-4,adrenergic receptor agonist
25965,a04,BRD-A97479839-003-04-2,Acetylcholine receptor antagonist
25965,a05,BRD-A97701745-001-04-6,adrenergic receptor antagonist|serotonin receptor antagonist
25965,a06,BRD-A97730597-003-03-2,sodium channel blocker
25965,a07,BRD-A97739905-001-04-2,cyclooxygenase inhibitor
25965,a08,BRD-A98299281-050-03-9,calcium channel activator
25965,a09,BRD-A98378129-001-01-4,cyclooxygenase inhibitor|calcium channel blocker|calcium-activated chloride channel blocker|mucin production inhibitor
25965,a10,BRD-A98702003-304-02-2,11-beta-HSD1 inhibitor
25965,a11,BRD-A98725278-103-01-9,serotonin receptor antagonist
25965,a15,BRD-A99177642-001-02-5,acetylcholine receptor antagonist
25965,a16,BRD-A99402294-236-02-0,bacterial cell wall synthesis inhibitor
25965,a17,BRD-A99411506-002-01-3,antioxidant
25965,a18,BRD-A99449986-001-01-4,adenine nucleotide translocase inhibitor|caspase activator|neurotrophic agent
25965,a19,BRD-A99571536-001-01-0,anti-epileptic
25965,a20,BRD-K00141480-001-03-0,anti-inflammatory agent|interleukin inhibitor
25965,a21,BRD-K00184207-001-02-4,aryl hydrocarbon receptor ligand
25965,a22,BRD-K00206590-001-01-2,ATP channel activator
25965,a23,BRD-K00259736-001-03-2,microtubule inhibitor
25965,a24,BRD-K00312224-001-03-8,estrogen receptor agonist
25965,b03,BRD-K00603606-003-03-4,purinergic receptor antagonist|platelet aggregation inhibitor
25965,b04,BRD-K00610438-003-01-7,serotonin receptor antagonist|collagen stimulant
25965,b05,BRD-K00662280-001-01-1,GABA receptor agonist
25965,b06,BRD-K00673382-001-04-9,histamine receptor antagonist
25965,b07,BRD-K00675675-003-01-2,metalloproteinase inhibitor
25965,b09,BRD-K00824317-001-03-0,glucocorticoid receptor agonist
25965,b11,BRD-K01095011-001-03-5,5 alpha reductase inhibitor
25965,b15,BRD-K01244426-236-04-8,bacterial cell wall synthesis inhibitor
25965,b16,BRD-K01292756-001-06-0,dopamine receptor antagonist
25965,b19,BRD-K01567962-001-06-5,JNK inhibitor
25965,b20,BRD-K01624546-001-02-8,LTB4 inhibitor
25965,b21,BRD-K01648091-001-04-2,Dopamine receptor antagonist
25965,b22,BRD-K01663662-003-03-8,muscarinic antagonist
25965,b23,BRD-K01815685-001-02-3,aryl hydrocarbon receptor agonist
25965,c01,BRD-K01868942-001-01-3,serotonin receptor antagonist
25965,c02,BRD-K01902415-001-03-4,PPAR receptor agonist
25965,c05,BRD-K02265150-001-04-2,norepinephrine reputake inhibitor
25965,c06,BRD-K02275692-003-03-4,bacterial cell wall synthesis inhibitor
25965,c07,BRD-K02283807-003-01-4,thromboxane receptor antagonist
25965,c09,BRD-K02404261-001-02-7,Adenosine receptor antagonist
25965,c10,BRD-K02407574-001-03-0,tubulin polymerization inhibitor
25965,c14,BRD-K02581333-001-01-8,Tyrosine phosphatase inhibitor
25965,c17,BRD-K02590140-001-01-2,cannabinoid receptor antagonist
25965,c18,BRD-K02607075-333-03-6,Acetylcholine receptor antagonist
25965,c19,BRD-K02637541-001-02-4,Cyclooxygenase inhibitor
25965,c22,BRD-K02764365-001-03-7,anthelmintic agent
25965,c23,BRD-K02867583-300-04-8,serotonin reuptake inhibitor
25965,c24,BRD-K02900412-001-02-2,protein synthesis inhibitor
25965,d01,BRD-K02953697-001-01-9,cytochrome P450 inhibitor
25965,d03,BRD-K03015355-003-01-5,adenylyl cyclase activator|Adenylate cyclase stimulant|growth hormone receptor agonist|phosphokinase stimulant
25965,d04,BRD-K03067624-300-02-9,protein synthesis inhibitor
25965,d06,BRD-K03109492-001-01-4,CDC inhibitor
25965,d07,BRD-K03384561-001-01-9,Angiogenesis inhibitor
25965,d08,BRD-K03440695-001-02-6,Acetylcholine receptor antagonist
25965,d13,BRD-K03600606-001-02-3,Beta secretase inhibitor
25965,d14,BRD-K03602135-236-02-1,HMGCR inhibitor
25965,d17,BRD-K03642198-300-01-7,hedgehog pathway inhibitor
25965,d18,BRD-K03670461-001-02-0,EGFR inhibitor
25965,d19,BRD-K03842655-001-02-1,potassium channel blocker
25965,d20,BRD-K03981224-001-02-9,Progestogen hormone
25965,d21,BRD-K04010869-001-02-6,HSP inducer|NFKB pathway inhibitor
25965,d22,BRD-K04046242-001-03-6,Estrogen receptor agonist
25965,d23,BRD-K04111260-001-01-9,Dopamine receptor antagonist
25965,d24,BRD-K04170657-001-02-4,Ras GTPase inhibitor
25965,e03,BRD-K04185004-003-03-6,Local anesthetic
25965,e04,BRD-K04414442-001-03-4,tachykinin antagonist
25965,e05,BRD-K04430056-001-02-9,nitric oxide synthase inhibitor
25965,e06,BRD-K04704168-003-03-6,HCV inhibitor
25965,e08,BRD-K04976539-001-01-0,PKC inhibitor|src inhibitor
25965,e11,BRD-K05151076-001-01-8,estrogen receptor antagonist
25965,e12,BRD-K05181084-003-02-9,dopamine receptor antagonist
25965,e13,BRD-K05181463-001-01-6,Dopamine receptor antagonist
25965,e16,BRD-K05434375-001-04-0,calcium channel blocker
25965,e19,BRD-K05464208-001-01-6,p38 MAPK inhibitor
25965,e21,BRD-K05653692-001-02-5,Glucosyltransferase inhibitor
25965,e22,BRD-K05673000-323-02-8,Bacterial cell wall synthesis inhibitor
25965,e23,BRD-K05901394-001-01-1,Dopamine receptor agonist
25965,e24,BRD-K05906022-001-02-8,HIV protease inhibitor
25965,f03,BRD-K05977355-001-02-6,sterol demethylase inhibitor
25965,f05,BRD-K06014311-001-01-2,Melatonin receptor antagonist
25965,f06,BRD-K06024458-001-01-4,cannabinoid receptor agonist
25965,f07,BRD-K06147391-003-01-9,Acetylcholine receptor antagonist
25965,f08,BRD-K06159959-001-01-2,Inhibitor of the binding of homoquinolinic acid to non-NMDA sensitive sites
25965,f12,BRD-K06208435-001-02-9,Calcium channel blocker
25965,f13,BRD-K06221026-001-03-5,Cyclooxygenase inhibitor
25965,f14,BRD-K06234293-001-01-8,TGF beta receptor inhibitor|p38 MAPK inhibitor
25965,f15,BRD-K06426971-001-01-9,histone lyinse methyltransferase inhibitor
25965,f19,BRD-K06467078-001-01-5,Adrenergic receptor antagonist
25965,f20,BRD-K06543683-001-03-6,PKC inhibitor|glycogen synthase kinase inhibitor|leucine rich repeat kinase inhibitor|SIRT inhibitor
25965,f21,BRD-K06593056-001-01-4,retinoid receptor agonist
25965,f22,BRD-K06753942-001-02-0,MEK inhibitor
25965,f23,BRD-K06854232-001-03-3,retinoid receptor agonist
25965,f24,BRD-K06980535-003-04-4,Dopamine receptor antagonist
25965,g02,BRD-K07117950-001-02-6,CDK inhibitor
25965,g06,BRD-K07212038-001-02-1,Mast cell stabilizer
25965,g07,BRD-K07220430-001-03-6,Calcium channel blocker
25965,g08,BRD-K07325606-001-02-3,PKC inhibitor
25965,g10,BRD-K07507905-236-01-8,adrenergic receptor agonist
25965,g13,BRD-K07691486-001-05-6,CDK inhibitor
25965,g14,BRD-K07888196-001-01-8,IGF-1 inhibitor
25965,g15,BRD-K08078237-001-04-0,calcium channel blocker
25965,g16,BRD-K08109516-001-01-1,glutamate receptor antagonist
25965,g17,BRD-K08115555-001-02-8,catechol O methyltransferase inhibitor|tumor necrosis factor inhibitor
25965,g18,BRD-K08132273-001-01-6,EGFR inhibitor
25965,g22,BRD-K08219523-001-01-9,Serotonin receptor agonist
25965,g23,BRD-K08252256-236-04-9,Cyclooxygenase inhibitor
25965,g24,BRD-K08287586-001-03-6,DNA synthesis inhibitor
25965,h01,BRD-K08316444-001-02-7,inhibitor of mitochondrial electron transport
25965,h05,BRD-K08438429-001-01-0,glucosylceramidase inhibitor|somatostatin receptor agonist
25965,h07,BRD-K08554278-001-02-4,DNA binding agent
25965,h09,BRD-K08619574-334-03-9,Dopamine receptor antagonist
25965,h10,BRD-K08619838-300-03-2,Acetylcholine receptor agonist
25965,h11,BRD-K08640512-003-01-5,Adrenergic receptor antagonist
25965,h13,BRD-K08806317-050-03-6,Adrenergic receptor antagonist
25965,h14,BRD-K08890269-001-01-5,Sodium channel blocker
25965,h16,BRD-K08973992-001-01-3,Oxidative stress inducer
25965,h17,BRD-K08996725-313-01-7,histamine receptor antagonist
25965,h18,BRD-K08998509-001-01-6,dopamine receptor antagonist|serotonin receptor antagonist
25965,h23,BRD-K09132007-001-01-8,casein kinase inhibitor|TGF beta receptor inhibitor
25965,i01,BRD-K09255212-001-03-4,chelating agent
25965,i02,BRD-K09397065-001-01-6,Serotonin receptor agonist
25965,i03,BRD-K09416995-001-16-7,HMGCR inhibitor
25965,i04,BRD-K09471561-001-02-6,bacterial DNA gyrase inhibitor
25965,i07,BRD-K09537769-001-01-6,DNA dependent protein kinase inhibitor|mTOR inhibitor|PI3K inhibitor
25965,i08,BRD-K09549677-300-01-8,T-type calcium channel blocker|angiogenesis inhibitor|calcium channel blocker|calcium channel inhibitor|L-type calcium channel blocker|sodium channel blocker
25965,i09,BRD-K09598619-065-01-5,tubulin polymerization inhibitor
25965,i10,BRD-K09631521-001-02-4,cytochrome P450 inhibitor
25965,i11,BRD-K09635134-001-02-4,negative control for D-erythro-MAPP
25965,i12,BRD-K09635314-001-01-8,phospholipase activator
25965,i13,BRD-K09668667-001-02-0,Carcinogen
25965,i14,BRD-K09764130-001-02-6,Cannabinoid receptor agonist
25965,i15,BRD-K09778810-001-01-5,inositol monophosphatase inhibitor
25965,i17,BRD-K09963420-066-03-4,HIV protease inhibitor
25965,i18,BRD-K10042277-001-02-7,cetylcholine receptor agonist|dopamine receptor agonist|dopamine receptor antagonist|dopamine receptor partial agonist|serotonin receptor antagonist|serotonin receptor inverse agonist
25965,i19,BRD-K10065684-001-02-5,laxative
25965,i23,BRD-K10176267-001-01-7,glutamate receptor antagonist
25965,i24,BRD-K10177585-003-01-6,Adenosine receptor antagonist
25965,j01,BRD-K10207760-236-03-0,bacterial permeability inducer
25965,j02,BRD-K10314788-003-04-4,nootropic agent
25965,j07,BRD-K10670311-001-04-9,Antirheumatic
25965,j10,BRD-K10705233-001-01-4,Cannabinoid receptor agonist
25965,j11,BRD-K10843433-001-02-9,Cyclooxygenase inhibitor
25965,j12,BRD-K10870738-001-02-4,lipoxygenase inhibitor
25965,j13,BRD-K10974103-001-03-9,Protein synthesis inhibitor
25965,j15,BRD-K10995081-001-05-5,Dopamine receptor antagonist
25965,j16,BRD-K11107424-001-01-1,histamine receptor antagonist
25965,j17,BRD-K11129031-001-04-4,Lipoprotein lipase activator
25965,j18,BRD-K11158509-001-02-0,EGFR inhibitor
25965,j19,BRD-K11163873-001-02-8,PARP inhibitor
25965,j24,BRD-K11298197-001-03-9,protein synthesis inhibitor
25965,k01,BRD-K11373525-003-01-3,Angiotensin receptor antagonist
25965,k02,BRD-K11399644-003-03-0,AMPK activator
25965,k04,BRD-K11634954-300-01-8,dopamine uptake inhibitor
25965,k06,BRD-K11696279-003-01-5,Imidazoline receptor agonist
25965,k09,BRD-K11717138-001-03-0,chloride channel blocker
25965,k10,BRD-K11742128-003-04-4,histamine receptor antagonist
25965,k13,BRD-K11911061-003-02-8,serotonin receptor antagonist
25965,k14,BRD-K11927976-050-01-1,mediator release inhibitor|syk inhibitor
25965,k17,BRD-K12102668-001-04-0,Monoamine oxidase inhibitor
25965,k18,BRD-K12120659-305-01-4,Integrin antagonist
25965,k20,BRD-K12184470-300-01-8,calcium channel blocker|T-type calcium channel blocker
25965,k21,BRD-K12219985-001-04-8,Sulfonylurea
25965,k22,BRD-K12244279-001-01-7,MEK inhibitor
25965,l03,BRD-K12357156-001-01-5,EGFR inhibitor|ErbB2 inhibitor|JAK2 inhibitor
25965,l04,BRD-K12513978-001-04-3,cyclooxygenase inhibitor
25965,l05,BRD-K12539581-001-06-2,tubulin polymerization inhibitor
25965,l12,BRD-K12932420-001-01-5,Phosphodiesterase inhibitor
25965,l14,BRD-K12994359-001-02-8,Cyclooxygenase inhibitor
25965,l19,BRD-K13169950-001-04-5,HDAC inhibitor
25965,l20,BRD-K13211965-001-01-4,dopamine receptor antagonist
25965,l21,BRD-K13261168-001-01-4,Dopamine receptor agonist
25965,m01,BRD-K13533483-001-03-0,calcineurin inhibitor|cyclophilin inhibitor|immunosuppressant|insulin expression inhibitor|T cell inhibitor
25965,m02,BRD-K13544237-001-01-0,dopamine receptor agonist|antiamyloidogenic agent
25965,m03,BRD-K13571841-001-03-7,Aspartic protease inhibitor
25965,m04,BRD-K13642330-001-02-6,cytochrome P450 inhibitor
25965,m05,BRD-K13819402-003-02-9,Acetylcholinesterase inhibitor
25965,m07,BRD-K13994703-001-02-0,adrenergic receptor antagonist
25965,m11,BRD-K14200658-001-02-6,Vesicular monoamine transporter inhibitor
25965,m12,BRD-K14221570-236-01-1,HIV entry inhibitor
25965,m16,BRD-K14282469-001-01-5,serotonin receptor antagonist
25965,m18,BRD-K14441456-001-01-2,EGFR inhibitor
25965,m19,BRD-K14496212-001-01-1,dopamine receptor agonist
25965,m21,BRD-K14618467-003-01-8,IKK inhibitor
25965,n01,BRD-K14765469-003-02-3,acetylcholinesterase inhibitor
25965,n02,BRD-K14767410-001-01-5,cyclooxygenase inhibitor
25965,n03,BRD-K14807180-001-01-7,serotonin receptor antagonist
25965,n04,BRD-K14821540-001-02-1,mitochondrial oxidative phosphorylation uncoupler
25965,n06,BRD-K14888893-001-02-3,KATP activator
25965,n07,BRD-K14965640-001-03-3,Cyclooxygenase inhibitor
25965,n08,BRD-K14993104-001-03-4,Chemoreceptor agonist
25965,n11,BRD-K15025317-001-04-5,NFkB pathway inhibitor
25965,n12,BRD-K15164005-001-01-5,carboxylesterase inhibitor
25965,n15,BRD-K15196155-001-01-5,Hydroxycarboxylic acid receptor agonist
25965,n17,BRD-K15519488-001-01-6,dopamine receptor agonist
25965,n19,BRD-K15567136-001-01-1,phosphodiesterase inhibitor
25965,n21,BRD-K15588452-003-01-9,serotonin receptor antagonist
25965,n22,BRD-K15601958-001-01-3,Lysophospholipid receptor agonist
25965,n23,BRD-K15616905-001-01-5,mitochondrial oxidative phosphorylation uncoupler
25965,n24,BRD-K15715913-001-01-5,dopamine receptor antagonist|serotonin receptor antagonist
25965,o01,BRD-K15766189-001-02-3,bacterial cell wall synthesis inhibitor
25965,o02,BRD-K15791587-003-01-7,tachykinin antagonist
25965,o04,BRD-K15868788-001-01-4,Serotonin receptor antagonist
25965,o05,BRD-K15916496-001-04-8,cytochrome P450 inhibitor|imidazoline receptor ligand
25965,o06,BRD-K15933101-003-01-2,dopamine receptor agonist|dopamine receptor modulator
25965,o07,BRD-K15935639-001-02-0,PGPH inhibitor|proteasome inhibitor
25965,o08,BRD-K15957397-001-02-6,CDC inhibitor
25965,o09,BRD-K16195444-001-01-7,Adrenergic receptor agonist
25965,o10,BRD-K16444452-001-03-4,phosphodiesterase inhibitor|leukotriene receptor antagonist|toll-like receptor antagonist|macrophage migration inhibiting factor inhibitor|macrophage migration inhibiting factor modulator|mediator release inhibitor|nitric oxide synthase inhibitor
25965,o14,BRD-K16485616-001-01-4,HDAC inhibitor|cell cycle inhibitor
25965,o15,BRD-K16508793-001-01-8,benzodiazepine receptor agonist
25965,o16,BRD-K16542329-001-05-1,phosphodiesterase inhibitor
25965,o17,BRD-K16551401-003-01-8,serotonin receptor agonist
25965,o19,BRD-K16604360-001-01-8,antiamyloidogenic agent|dopamine receptor agonist
25965,o20,BRD-K16664969-001-01-7,FLT3 inhibitor|tyrosine kinase inhibitor
25965,o22,BRD-K16977723-001-01-0,EGFR inhibitor
25965,o23,BRD-K17016787-001-03-5,estrogen receptor agonist
25965,p01,BRD-K17140735-300-01-6,Proteasome inhibitor
25965,p03,BRD-K17294426-050-04-0,dopamine receptor antagonist
25965,p04,BRD-K17368287-001-03-5,11-beta hydroxysteroid dehydrogenase inhibitor
25965,p05,BRD-K17378184-300-03-4,Dopamine receptor agonist
25965,p06,BRD-K17415526-001-02-7,protein tyrosine kinase inhibitor
25965,p07,BRD-K17497770-001-01-0,EGFR inhibitor|src inhibitor
25965,p08,BRD-K17565903-066-04-1,muscle relaxant
25965,p09,BRD-K17674993-001-03-1,Corticosteroid agonist
25965,p10,BRD-K17693482-001-03-9,potassium channel activator
25965,p13,BRD-K17705806-003-01-0,opioid receptor antagonist
25965,p14,BRD-K17743125-001-01-9,HDAC inhibitor|cell cycle inhibitor
25965,p15,BRD-K17743697-066-01-0,sodium/calcium exchange inhibitor
25965,p16,BRD-K17796732-001-02-0,cannabinoid receptor agonist
25965,p19,BRD-K17894950-001-04-4,CDK inhibitor|glycogen synthase kinase inhibitor
25965,p20,BRD-K17896185-001-01-2,opioid receptor agonist
25965,p21,BRD-K18059238-001-02-1,cyclooxygenase inhibitor|prostanoid receptor stimulant|thromboxane synthase stimulant
25965,p24,BRD-K18194590-065-02-3,adrenergic receptor agonist
24310,a01,BRD-K40782193-003-01-1,sodium channel blocker
24310,a02,BRD-K40887525-001-02-9,serotonin receptor antagonist
24310,a03,BRD-K40901640-001-01-0,serotonin receptor antagonist
24310,a04,BRD-K40905133-001-02-3,sodium channel blocker
24310,a05,BRD-K40965114-001-01-2,Adrenergic receptor antagonist
24310,a06,BRD-K40990712-001-02-4,gonadotropin releasing factor hormone receptor antagonist|sodium/hydrogen antiport inhibitor|sodium/hydrogen exchanger inhibitor|urokinase inhibitor
24310,a07,BRD-K41143549-003-01-6,glutamate receptor antagonist
24310,a08,BRD-K41337261-001-01-4,Src and Abl inhibitor|vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor
24310,a09,BRD-K41406082-001-04-8,PABA antagonist
24310,a11,BRD-K41445866-001-03-0,Chloride channel agonist
24310,a12,BRD-K41524689-001-05-2,cyclooxygenase inhibitor
24310,a15,BRD-K41564320-001-01-2,tyrosine kinase inhibitor
24310,a16,BRD-K41567364-001-01-2,orexin receptor antagonist
24310,a19,BRD-K41707108-001-02-3,Phosphoenolpyruvate carboxylase activator
24310,a20,BRD-K41713976-001-02-0,potassium channel blocker
24310,a23,BRD-K41868777-003-02-9,calmodulin antagonist
24310,b01,BRD-K41876534-001-02-0,carbonic anhydrase inhibitor
24310,b02,BRD-K41996876-001-05-5,EGFR inhibitor
24310,b03,BRD-K42098891-003-03-1,tricyclic antidepressant
24310,b04,BRD-K42221274-001-01-4,GAT inhibitor
24310,b05,BRD-K42348709-003-04-0,adrenergic receptor agonist|serotonin receptor agonist
24310,b07,BRD-K42452249-001-01-7,p38 MAPK inhibitor
24310,b08,BRD-K42500029-001-01-9,"MAP kinase inhibitor|MAPK-interacting kinase inhibitor,"
24310,b10,BRD-K42635745-001-02-4,adrenergic receptor antagonist
24310,b12,BRD-K42679050-001-01-3,potassium channel activator|potassium channel agonist
24310,b16,BRD-K42748308-300-01-2,acetylcholine release enhancer|potassium channel blocker|voltage-gated potassium channel blocker
24310,b18,BRD-K43068349-001-01-9,TRPV antagonist
24310,b19,BRD-K43149758-001-04-5,Androgen receptor agonist
24310,b21,BRD-K43245338-001-02-4,calpain inhibitor|cathepsin inhibitor
24310,b22,BRD-K43290182-001-01-9,Serotonin receptor antagonist
24310,b23,BRD-K43330982-001-01-5,lysophospholipid receptor antagonist
24310,b24,BRD-K43389675-003-02-7,RNA synthesis inhibitor|topoisomerase inhibitor
24310,c01,BRD-K43405658-001-01-8,protein tyrosine kinase inhibitor
24310,c02,BRD-K43457670-001-04-7,carbonic anhydrase inhibitor
24310,c03,BRD-K43468059-001-02-9,Mycotoxin
24310,c05,BRD-K43736954-001-03-3,glucocorticoid receptor agonist
24310,c06,BRD-K43744935-048-01-6,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)|estrogen receptor agonist|estrogen receptor modulator|PKC inhibitor
24310,c07,BRD-K43796186-001-01-1,EGFR inhibitor
24310,c08,BRD-K43860855-065-03-6,antineoplastic agent
24310,c09,BRD-K44067360-001-06-3,chloride channel blocker
24310,c10,BRD-K44084986-001-03-9,rho associated kinase inhibitor
24310,c18,BRD-K44849676-001-03-0,TRPV agonist
24310,c19,BRD-K44876623-001-01-1,Benzodiazepine receptor agonist
24310,c20,BRD-K44899736-003-02-1,Monoamine oxidase inhibitor
24310,c22,BRD-K45033733-001-02-3,DNA polymerase inhibitor
24310,c24,BRD-K45068323-003-01-3,Calmodulin antagonist
24310,d02,BRD-K45117373-001-01-1,potassium channel activator|potassium channel agonist
24310,d03,BRD-K45158365-001-02-3,angiotensin receptor antagonist
24310,d04,BRD-K45296539-003-01-0,Adrenergic receptor agonist
24310,d05,BRD-K45330754-001-04-3,estrogen receptor agonist
24310,d06,BRD-K45401373-001-05-0,Apoptosis stimulant
24310,d07,BRD-K45435259-001-01-6,Dopamine receptor antagonist
24310,d09,BRD-K45479396-001-01-8,Serotonin receptor agonist
24310,d13,BRD-K45542189-048-04-9,Lipoxygenase inhibitor
24310,d14,BRD-K45662124-001-01-8,dopamine receptor ligand
24310,d17,BRD-K45861246-001-04-3,Dopamine receptor antagonist
24310,d19,BRD-K46018455-001-06-0,PPAR receptor agonist
24310,d20,BRD-K46137903-001-03-3,phospholipase activator
24310,d21,BRD-K46142322-003-01-6,serotonin receptor partial agonist
24310,d22,BRD-K46211610-003-05-1,Adrenergic receptor antagonist
24310,d23,BRD-K46317332-003-04-6,Nitric oxide synthase inhibitor
24310,d24,BRD-K46384212-001-01-1,phospholipase activator
24310,e03,BRD-K46424862-001-04-2,Monoamine oxidase inhibitor
24310,e04,BRD-K46435977-003-01-2,DNA polymerase inhibitor
24310,e05,BRD-K46441700-001-01-8,serotonin receptor antagonist
24310,e06,BRD-K46469693-001-01-8,adenosine receptor antagonist
24310,e08,BRD-K46556543-237-03-0,Mineralocorticoid receptor antagonist
24310,e13,BRD-K46766488-003-01-2,Serotonin receptor agonist
24310,e14,BRD-K46862739-001-03-6,cytochrome P450 inhibitor
24310,e15,BRD-K46937689-001-05-1,Cyclooxygenase inhibitor
24310,e16,BRD-K47105409-001-05-3,JAK inhibitor
24310,e20,BRD-K47150025-001-01-2,PDGFR alpha and c-Kit inhibitor|vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor|VEGFR inhibitor
24310,e21,BRD-K47192521-001-02-1,Platelet aggregation inhibitor
24310,e22,BRD-K47207162-312-02-2,Serotonin reuptake inhibitor
24310,e23,BRD-K47278471-003-04-0,Histamine receptor antagonist
24310,e24,BRD-K47323024-003-04-6,Histamine receptor antagonist
24310,f03,BRD-K47328134-001-02-0,heparin activation inhibitor
24310,f07,BRD-K47598052-001-04-2,src inhibitor
24310,f08,BRD-K47608922-001-02-1,chelating agent
24310,f11,BRD-K47631482-003-02-1,Mucolytic agent
24310,f12,BRD-K47635719-001-03-9,glucocorticoid receptor agonist
24310,f13,BRD-K47639036-003-03-3,Acetylcholine receptor antagonist
24310,f14,BRD-K47659338-003-01-0,serotonin receptor agonist
24310,f15,BRD-K47693913-001-02-4,Furoquinoline alkaloid
24310,f16,BRD-K47717570-304-01-5,Glutamate receptor antagonist
24310,f21,BRD-K47869605-001-04-9,microtubule inhibitor|tubulin polymerization inhibitor
24310,f23,BRD-K47936004-001-01-9,dopamine receptor agonist
24310,f24,BRD-K47943470-001-02-8,EGFR inhibitor
24310,g05,BRD-K48168960-001-05-1,Thyroid peroxidase inhibitor
24310,g07,BRD-K48300629-001-03-8,Sodium channel blocker
24310,g11,BRD-K48692744-001-01-2,PARP inhibitor
24310,g12,BRD-K48722258-300-04-5,adenosine reuptake inhibitor
24310,g13,BRD-K48735772-001-01-4,EGFR inhibitor|epidermal growth factor receptor (EGFR) inhibitor
24310,g15,BRD-K49027941-237-01-1,Adenosine receptor antagonist
24310,g16,BRD-K49049886-001-03-8,adenosine receptor antagonist
24310,g17,BRD-K49111258-001-02-8,Adrenergic receptor antagonist
24310,g23,BRD-K49294207-300-01-2,EGFR inhibitor
24310,g24,BRD-K49448285-001-01-3,CDK inhibitor
24310,h01,BRD-K49481516-004-03-5,Acetylcholinesterase inhibitor
24310,h02,BRD-K49519092-303-01-4,Histamine receptor agonist
24310,h05,BRD-K49577446-001-03-1,cytochrome P450 inhibitor
24310,h06,BRD-K49657628-001-02-3,EGFR inhibitor|tyrosine kinase inhibitor
24310,h07,BRD-K49671696-001-02-1,Serotonin receptor antagonist
24310,h11,BRD-K49890030-236-01-6,Glutamate receptor antagonist
24310,h12,BRD-K49945136-001-03-5,Serotonin receptor antagonist
24310,h13,BRD-K50018155-003-01-3,Serotonin receptor partial agonist
24310,h15,BRD-K50135270-001-01-9,dopamine uptake inhibitor
24310,h17,BRD-K50214219-001-02-4,PARP inhibitor
24310,h21,BRD-K50325075-001-01-3,potassium channel blocker|slow afterhyperpolarization channel blocker
24310,h22,BRD-K50388907-001-04-9,PPAR receptor agonist
24310,h23,BRD-K50398167-236-02-9,Cyclooxygenase inhibitor
24310,i01,BRD-K50417881-003-05-9,Dopamine receptor antagonist
24310,i02,BRD-K50422030-001-01-2,GABA receptor antagonist
24310,i03,BRD-K50464341-001-02-6,calmodulin antagonist
24310,i04,BRD-K50495309-001-01-2,src inhibitor
24310,i07,BRD-K50660797-001-02-8,Bacterial DNA gyrase inhibitor
24310,i08,BRD-K50836978-001-01-7,CDK inhibitor
24310,i09,BRD-K50841342-001-01-6,caspase activator
24310,i10,BRD-K50859149-001-04-7,bacterial antifolate
24310,i11,BRD-K50891186-001-01-0,dopamine receptor antagonist
24310,i14,BRD-K51276371-001-01-8,CDK inhibitor|CFTR channel activator|glycogen synthase kinase inhibitor|JNK inhibitor
24310,i15,BRD-K51318897-001-04-7,tubulin polymerization inhibitor
24310,i17,BRD-K51465424-003-03-6,adrenergic receptor agonist
24310,i18,BRD-K51476772-001-01-9,tyrosine kinase inhibitor
24310,i19,BRD-K51541829-001-01-3,Ionotropic glutamate receptor antagonist
24310,i23,BRD-K51575138-001-01-7,IKK inhibitor
24310,i24,BRD-K51671335-001-01-5,Dopamine receptor antagonist
24310,j01,BRD-K51751936-001-03-4,benzodiazepine receptor agonist
24310,j03,BRD-K51918615-303-01-1,histamine receptor antagonist|histamine receptor inhibitor|ionotropic glutamate receptor antagonist
24310,j07,BRD-K52020312-001-04-5,DNA inhibitor
24310,j08,BRD-K52075040-001-02-2,fatty acid synthase inhibitor
24310,j10,BRD-K52219182-001-01-6,Phosphodiesterase inhibitor
24310,j11,BRD-K52313696-001-01-6,HDAC inhibitor
24310,j13,BRD-K52394958-001-01-9,tachykinin antagonist
24310,j14,BRD-K52397688-001-01-9,dopamine receptor antagonist|FAAH inhibitor|serotonin receptor antagonist
24310,j15,BRD-K52459643-001-10-2,Prostanoid receptor agonist
24310,j16,BRD-K52512893-001-03-0,Prostanoid receptor antagonist
24310,j18,BRD-K52662033-001-02-6,histamine receptor agonist
24310,j19,BRD-K52721684-001-02-2,potassium channel activator
24310,j20,BRD-K52850071-001-01-2,JAK inhibitor
24310,j23,BRD-K52930707-001-04-8,ACE inhibitor
24310,k01,BRD-K52989797-001-01-1,serotonin transporter (SERT) inhibitor
24310,k03,BRD-K53123955-001-03-0,Phosphofructokinase inhibitor
24310,k05,BRD-K53263234-001-02-9,constitutive androstane receptor (CAR) agonist
24310,k06,BRD-K53318339-001-04-1,Phosphodiesterase inhibitor
24310,k09,BRD-K53523901-001-01-0,adiponectin receptor agonist|AP inhibitor|aryl hydrocarbon receptor antagonist|HIV integrase inhibitor|MEK inhibitor|NFkB pathway inhibitor|topoisomerase inhibitor
24310,k11,BRD-K53545112-304-01-6,Glutamate receptor antagonist
24310,k13,BRD-K53737926-003-04-7,Norepinephrine inhibitor
24310,k14,BRD-K53857191-001-04-5,Dopamine receptor antagonist
24310,k17,BRD-K53878242-001-02-4,phosphodiesterase inhibitor
24310,k19,BRD-K53979406-003-01-0,glycine transporter inhibitor|GlyT-1 inhibitor
24310,k20,BRD-K54094468-001-01-6,dopamine receptor antagonist
24310,k21,BRD-K54095730-001-01-5,p38 MAPK inhibitor
24310,k22,BRD-K54142781-001-02-1,Adrenergic receptor agonist
24310,l01,BRD-K54210043-001-02-0,calcium channel activator|large conductance potassium channel activator
24310,l02,BRD-K54233340-300-01-0,AMPK inhibitor|DNA damaging|TGF beta receptor inhibitor
24310,l03,BRD-K54330070-001-05-5,p38 MAPK inhibitor
24310,l04,BRD-K54411430-001-02-5,cAMP inhibitor
24310,l06,BRD-K54529596-001-04-0,ACE inhibitor
24310,l10,BRD-K54665485-001-01-2,Diacylglycerol kinase inhibitor
24310,l11,BRD-K54704028-001-01-3,glutamate receptor antagonist
24310,l12,BRD-K54708045-001-01-3,PPAR receptor agonist
24310,l13,BRD-K54759182-003-02-3,Norepinephrine reuptake inhibitor
24310,l14,BRD-K54771420-001-03-2,Cholesterol inhibitor
24310,l17,BRD-K54790157-001-03-1,DNA synthesis inhibitor
24310,l19,BRD-K55034111-066-02-3,bacterial DNA gyrase inhibitor
24310,l21,BRD-K55191674-236-03-7,Penicillin binding protein inhibitor
24310,m01,BRD-K55344148-003-01-8,Imidazoline receptor ligand
24310,m02,BRD-K55424922-001-01-4,Serotonin receptor agonist
24310,m03,BRD-K55430733-003-01-6,Serotonin receptor agonist
24310,m04,BRD-K55454768-001-01-8,voltage-independent calcium influx blocker
24310,m05,BRD-K55468218-001-04-8,dopamine receptor antagonist
24310,m06,BRD-K55529781-236-02-0,thromboxane synthase inhibitor
24310,m07,BRD-K55567017-001-02-4,alcohol dehydrogenase inhibitor
24310,m08,BRD-K55677650-003-01-1,ionotropic glutamate receptor antagonist
24310,m11,BRD-K55748775-001-01-4,ATPase inhibitor|potassium-competitive acid antagonist
24310,m16,BRD-K55930204-001-02-7,Hydantoin antiepileptic
24310,m17,BRD-K56047318-001-02-2,Triacylglycerol lipase inhibitor
24310,m18,BRD-K56064827-001-04-7,PKC inhibitor
24310,m20,BRD-K56115039-003-01-3,Imidazoline receptor ligand
24310,m22,BRD-K56403959-300-01-9,CC chemokine receptor ligand
24310,m23,BRD-K56429665-001-03-9,vitamin D receptor agonist
24310,m24,BRD-K56509348-003-01-3,Endothelin receptor antagonist
24310,n02,BRD-K56558538-003-02-8,Sodium channel blocker
24310,n03,BRD-K56596464-004-02-4,Sodium channel blocker
24310,n04,BRD-K56699285-001-03-7,dopamine receptor agonist|serotonin receptor antagonist
24310,n08,BRD-K57033106-048-02-8,Histamine receptor antagonist
24310,n11,BRD-K57179821-001-04-8,Antipruritic
24310,n12,BRD-K57222227-001-06-1,cyclooxygenase inhibitor
24310,n16,BRD-K57304726-003-03-6,Sigma receptor agonist
24310,n18,BRD-K57545991-050-03-3,angiotensin converting enzyme inhibitor
24310,n19,BRD-K57569181-001-04-4,Phosphodiesterase inhibitor
24310,n21,BRD-K57718010-001-06-9,GABA receptor antagonist
24310,n22,BRD-K57886322-001-03-4,glucocorticoid receptor agonist
24310,n23,BRD-K57926513-001-02-9,PDGFR receptor inhibitor
24310,o01,BRD-K58220566-001-02-2,PKC inhibitor|sodium channel blocker|calcium channel blocker
24310,o02,BRD-K58265391-001-03-6,diuretic
24310,o03,BRD-K58299615-001-02-7,amyloid precursor protein inhibitor|beta amyloid aggregation inhibitor
24310,o05,BRD-K58466253-003-04-1,serotonin release inhibitor
24310,o06,BRD-K58685305-001-02-2,11-beta hydroxysteroid dehydrogenase inhibitor
24310,o08,BRD-K58930050-001-01-1,glutamate receptor antagonist
24310,o09,BRD-K58938839-001-03-8,smoothened receptor antagonist|hedgehog pathway inhibitor
24310,o10,BRD-K59037100-001-04-8,lipase inhibitor
24310,o13,BRD-K59058766-003-03-7,dopamine receptor antagonist
24310,o15,BRD-K59184148-001-04-2,glycogen synthase kinase inhibitor
24310,o18,BRD-K59273480-001-01-5,adenosine reuptake inhibitor|phosphodiesterase inhibitor
24310,o20,BRD-K59332007-300-01-9,acetylcholine release enhancer|acetylcholine release stimulant|neurotransmitter agonist|voltage-gated potassium channel blocker
24310,o22,BRD-K59419204-001-01-9,cannabinoid receptor antagonist|cannabinoid receptor inhibitor
24310,o23,BRD-K59469039-001-04-9,Angiogenesis inhibitor
24310,o24,BRD-K59522102-001-04-7,monoamine oxidase inhibitor
24310,p01,BRD-K59574735-001-02-7,leukotriene synthesis inhibitor
24310,p02,BRD-K59637651-001-01-4,protein synthesis inhibitor|botulin neurotoxin inhibitor|mur synthetase inhibitor
24310,p03,BRD-K59650319-003-01-7,glutamate receptor antagonist
24310,p04,BRD-K59753853-001-01-5,glutamate receptor antagonist
24310,p06,BRD-K59851896-001-02-4,GABA release inhibitor
24310,p07,BRD-K59983611-001-05-2,bacterial antifolate
24310,p09,BRD-K60060639-005-01-4,antiarrhythmic medication
24310,p10,BRD-K60174629-001-02-2,prolyl endopeptidase inhibitor
24310,p13,BRD-K60184833-001-02-3,tyrosine kinase inhibitor
24310,p14,BRD-K60230970-001-04-3,proteasome inhibitor
24310,p15,BRD-K60274257-001-01-1,tyrosine phosphatase inhibitor
24310,p17,BRD-K60298136-001-01-7,aryl hydrocarbon receptor agonist|aryl hydrocarbon receptor ligand
24310,p18,BRD-K60476892-001-02-1,activator of soluble guanylyl cyclase|guanylate cyclase activator|hypoxia inducible factor inhibitor
24310,p19,BRD-K60511616-236-01-4,HMGCR inhibitor
24310,p20,BRD-K60640630-001-03-7,glucocorticoid receptor agonist
24310,p22,BRD-K60923938-001-02-8,sodium channel activator
24310,p23,BRD-K60932973-001-01-7,dopamine receptor agonist
24310,p24,BRD-K61097567-001-03-6,tachykinin antagonist
25984,a01,BRD-K18250272-003-03-7,local anesthetic
25984,a02,BRD-K18316707-001-01-9,cannabinoid receptor antagonist
25984,a04,BRD-K18550767-001-02-8,interleukin inhibitor
25984,a05,BRD-K18574842-323-03-3,bacterial cell wall synthesis inhibitor
25984,a06,BRD-K18619710-001-03-7,steroid
25984,a07,BRD-K18742343-001-03-2,PKA inhibitor
25984,a08,BRD-K18757346-001-02-9,thromboxane receptor agonist
25984,a09,BRD-K18779551-003-03-7,acetylcholine release stimulant|adrenergic transmitter uptake inhibitor|reducing agent
25984,a10,BRD-K18787491-001-05-2,MEK inhibitor
25984,a11,BRD-K18799075-001-01-0,cannabinoid receptor partial agonist
25984,a12,BRD-K18816859-001-01-4,Serotonin receptor agonist
25984,a15,BRD-K18909381-001-01-4,serotonin receptor agonist
25984,a16,BRD-K18910433-001-04-4,estrogen receptor agonist
25984,a19,BRD-K19111024-001-04-3,PPAR receptor agonist
25984,a20,BRD-K19295594-001-04-4,BCL inhibitor|MCL1 inhibitor
25984,a21,BRD-K19309090-300-03-0,acetylcholine receptor agonist
25984,a22,BRD-K19352500-332-03-7,dopamine receptor antagonist
25984,a23,BRD-K19360254-001-01-3,Dopamine receptor agonist
25984,b01,BRD-K19462402-003-03-0,adrenergic receptor antagonist|calcium channel blocker
25984,b03,BRD-K19533706-001-01-9,Angiogenesis inhibitor
25984,b04,BRD-K19554809-001-01-1,serotonin receptor agonist
25984,b05,BRD-K19605405-001-01-9,adenosine receptor antagonist
25984,b07,BRD-K20141153-003-03-8,norepinephrine transporter inhibitor|adrenergic transmitter uptake inhibitor
25984,b08,BRD-K20152659-001-02-0,Cholesterol inhibitor
25984,b10,BRD-K20620780-001-01-0,dopamine receptor antagonist
25984,b11,BRD-K20655524-003-04-7,psychoactive drug
25984,b15,BRD-K20714604-001-01-5,Serotonin receptor partial agonist
25984,b16,BRD-K20742498-001-01-5,serotonin receptor antagonist
25984,b17,BRD-K20755323-001-01-8,sphingosine kinase inhibitor
25984,b18,BRD-K20995441-001-01-7,Opioid receptor agonist
25984,b19,BRD-K21283037-001-02-5,glutamate inhibitor
25984,b20,BRD-K21350491-001-02-1,acid sensing ion channel blocker|sodium channel blockers|TRPP3 channel inhibitor|TRPV modulator
25984,b21,BRD-K21450440-001-04-7,carbonic anhydrase inhibitor
25984,b22,BRD-K21520694-001-02-4,PABA antagonist
25984,b23,BRD-K21548250-001-01-3,sodium channel blocker
25984,b24,BRD-K21565985-001-04-3,adrenergic receptor agonist
25984,c01,BRD-K21667562-001-01-4,FAAH transport inhibitor|anandamide transport inhibitor|nucelar factor of activated T-cells inhibitor|TRPV agonist
25984,c02,BRD-K21680192-300-05-2,topoisomerase inhibitor
25984,c03,BRD-K21733600-001-02-6,cyclooxygenase inhibitor
25984,c04,BRD-K21853356-001-04-4,EGFR inhibitor
25984,c07,BRD-K22031190-001-04-6,Prostanoid receptor antagonist
25984,c08,BRD-K22134346-001-04-1,HMGCR inhibitor
25984,c09,BRD-K22193694-001-04-5,Topical sunscreen agent
25984,c10,BRD-K22385716-001-01-7,casein kinase inhibitor|mTOR inhibitor|PI3K inhibitor
25984,c17,BRD-K22861715-001-03-4,breast cancer resistance protein inhibitor
25984,c19,BRD-K22969690-001-02-6,bacterial 50S ribosomal subunit inhibitor
25984,c21,BRD-K23301018-001-02-6,antiprotozoal agent
25984,c23,BRD-K23335153-300-01-7,glutamate receptor positive allosteric modulator
25984,c24,BRD-K23383398-001-01-6,LXR agonist|ABC transporter expression enhancer|ROR inverse agonist
25984,d02,BRD-K23478508-001-03-7,ATPase inhibitor
25984,d03,BRD-K23541596-300-04-9,histamine receptor agonist
25984,d04,BRD-K23566484-001-04-5,androgen receptor antagonist
25984,d05,BRD-K23583188-001-05-6,EGFR inhibitor|tyrosine kinase inhibitor
25984,d06,BRD-K23704908-001-03-2,serine protease inhibitor
25984,d07,BRD-K23913458-001-02-5,Vitamin K antagonist
25984,d08,BRD-K23922020-075-01-1,acetylcholine receptor agonist
25984,d10,BRD-K24084088-001-02-2,adenosine receptor antagonist
25984,d13,BRD-K24132293-001-02-0,glutathione transferase inhibitor
25984,d14,BRD-K24201553-003-02-4,Serotonin receptor antagonist
25984,d17,BRD-K24240364-003-02-1,Glutamate receptor antagonist
25984,d18,BRD-K24396733-001-01-1,dopamine receptor agonist
25984,d20,BRD-K24526313-001-08-6,Potassium channel activator
25984,e05,BRD-K25224017-001-04-5,serotonin receptor antagonist
25984,e07,BRD-K25394294-001-04-0,Cyclooxygenase inhibitor
25984,e11,BRD-K25433859-003-11-4,norepinephrine reputake inhibitor|tricyclic antidepressant
25984,e13,BRD-K25741894-001-03-8,acetylcholinesterase inhibitor
25984,e15,BRD-K25875056-001-01-2,Protein tyrosine kinase activator
25984,e16,BRD-K25906698-303-01-9,histamine receptor agonist
25984,e21,BRD-K26160755-003-01-8,Imidazoline receptor agonist
25984,e22,BRD-K26373640-001-02-8,IKK inhibitor
25984,f03,BRD-K26429091-051-01-9,acetylcholine receptor antagonist
25984,f04,BRD-K26521938-001-04-9,prostanoid receptor agonist
25984,f05,BRD-K26548821-001-01-8,Dopamine receptor agonist
25984,f06,BRD-K26573499-300-01-3,Adrenergic receptor agonist
25984,f12,BRD-K26979635-001-01-1,Glutamate receptor antagonist
25984,f13,BRD-K26997899-001-01-4,microtubule inhibitor|tubulin inhibitor
25984,f15,BRD-K27141178-001-01-0,Serotonin receptor antagonist
25984,f20,BRD-K27305650-001-04-2,mTOR inhibitor|PI3K inhibitor|DNA dependent protein kinase inhibitor|phosphodiesterase inhibitor|PLK inhibitor
25984,f21,BRD-K27316855-001-02-6,vitamin D receptor agonist
25984,f23,BRD-K27351809-001-02-0,progesterone receptor agonist
25984,g01,BRD-K27450477-001-03-9,Adenosine deaminase inhibitor
25984,g02,BRD-K27499107-001-02-6,IP receptor activator
25984,g06,BRD-K27710560-001-02-6,SIRT inhibitor
25984,g07,BRD-K27737647-001-03-4,PKA inhibitor
25984,g09,BRD-K27871032-001-02-6,Ergoline alkaloid
25984,g11,BRD-K28115081-001-01-9,Platelet activating factor receptor antagonist
25984,g12,BRD-K28137194-003-01-3,GABA receptor agonist
25984,g13,BRD-K28143534-001-01-4,histamine receptor antagonist
25984,g15,BRD-K28183345-003-05-6,Dihydrofolate reductase inhibitor
25984,g17,BRD-K28307902-001-04-3,androgen receptor antagonist
25984,g18,BRD-K28453807-003-05-4,Cholinergic receptor antagonist
25984,g23,BRD-K28578425-001-01-3,phosphodiesterase inhibitor
25984,g24,BRD-K28667196-001-02-9,Increases arterial blood pressure
25984,h01,BRD-K28680267-001-01-8,CCK receptor antagonist
25984,h02,BRD-K28761384-003-03-6,dopamine receptor antagonist
25984,h05,BRD-K28761891-001-01-0,melatonin receptor agonist
25984,h06,BRD-K28806945-001-01-9,dopamine receptor antagonist
25984,h07,BRD-K28863208-001-01-2,Cholinergic receptor agonist
25984,h08,BRD-K28907958-001-01-9,retinoid receptor agonist
25984,h09,BRD-K28936863-051-04-1,histamine receptor agonist|leukotriene receptor antagonist|phosphodiesterase inhibitor
25984,h10,BRD-K29113274-001-03-6,Sterol demethylase inhibitor
25984,h12,BRD-K29178788-001-02-0,Furoquinoline alkaloid
25984,h13,BRD-K29359156-001-04-6,H+/K+-ATPase inhibitor
25984,h16,BRD-K29555132-001-02-2,Cannabinoid receptor agonist
25984,h17,BRD-K29582677-001-02-7,Calcium channel blocker
25984,h18,BRD-K29668683-300-01-4,sigma receptor antagonist
25984,h21,BRD-K29673530-001-03-9,tyrosine kinase inhibitor
25984,h22,BRD-K29950728-048-02-6,estrogen receptor antagonist
25984,h23,BRD-K30197592-001-01-5,Serotonin receptor agonist
25984,i01,BRD-K30240666-051-05-0,histamine receptor antagonist
25984,i02,BRD-K30421593-050-02-3,adrenergic receptor antagonist
25984,i03,BRD-K30480208-001-04-5,Electrolyte reabsorption inhibitor
25984,i08,BRD-K30685142-001-04-8,thyroid hormone stimulant
25984,i09,BRD-K30867024-001-01-1,serotonin receptor antagonist
25984,i11,BRD-K30990140-003-01-6,Cyclooxygenase inhibitor
25984,i12,BRD-K31054881-300-01-3,Adrenergic receptor antagonist
25984,i13,BRD-K31238592-001-01-6,CCK receptor antagonist|gastrin inhibitor
25984,i16,BRD-K31342827-001-05-4,PKC inhibitor
25984,i18,BRD-K31491153-001-01-2,serotonin receptor agonist
25984,i19,BRD-K31542390-001-01-5,dehydrogenase inhibitor|inositol monophosphatase inhibitor
25984,i20,BRD-K31611373-001-02-7,Prostanoid receptor agonist
25984,i23,BRD-K31627533-001-03-8,glucocorticoid receptor agonist
25984,i24,BRD-K31633810-003-01-0,Acetylcholine receptor antagonist
25984,j03,BRD-K31699485-001-01-9,glutamate receptor modulator
25984,j04,BRD-K31792052-004-01-9,interleukin receptor antagonist
25984,j09,BRD-K31843556-001-01-7,PPAR receptor anatagonist|PPAR receptor antagonist
25984,j10,BRD-K31912990-003-01-0,neuropeptide receptor antagonist
25984,j12,BRD-K31987754-001-01-2,Cannabinoid receptor agonist
25984,j15,BRD-K32164935-001-06-8,ATP channel blocker
25984,j16,BRD-K32247306-001-04-7,GABA receptor antagonist
25984,j19,BRD-K32292990-001-01-0,EGFR inhibitor
25984,j20,BRD-K32412559-001-01-7,Adrenergic receptor antagonist
25984,j23,BRD-K32501161-001-01-7,dopamine uptake inhibitor
25984,j24,BRD-K32526544-001-01-2,Potassium channel activator
25984,k02,BRD-K32584078-001-02-3,AKT inhibitor|HCV NS5B RdRp inhibitor
25984,k04,BRD-K32645441-001-01-4,serotonin receptor agonist
25984,k05,BRD-K32696739-001-02-6,Monoamine oxidase inhibitor
25984,k06,BRD-K32744045-001-04-9,aldehyde dehydrogenase inhibitor|DNA methyltransferase inhibitor|TRPV agonist
25984,k09,BRD-K32755366-003-03-4,Norepinephrine transporter inhibitor
25984,k10,BRD-K32821942-001-04-9,dehydrogenase inhibitor
25984,k11,BRD-K32828673-001-01-5,tubulin polymerization inhibitor
25984,k12,BRD-K32830106-003-11-3,adrenergic receptor agonist
25984,k14,BRD-K33204703-001-04-6,PDGFR receptor inhibitor
25984,k17,BRD-K33211335-337-03-7,glutamate receptor antagonist|sigma receptor agonist
25984,k19,BRD-K33308633-001-01-6,calcineurin inhibitor
25984,k20,BRD-K33396764-001-02-0,Omega 3 fatty acid stimulant
25984,k22,BRD-K33453211-003-03-2,Histamine receptor antagonist
25984,l01,BRD-K33459542-001-02-5,sigma receptor agonist
25984,l02,BRD-K33583600-001-03-9,guanylate cyclase activator
25984,l03,BRD-K33710385-001-05-4,mycolic synthesis inhibitor
25984,l04,BRD-K33818169-003-01-2,LXR agonist|ABC transporter expression enhancer
25984,l05,BRD-K33864865-001-01-7,CCK receptor antagonist
25984,l06,BRD-K33882852-003-01-0,benzodiazepine receptor agonist
25984,l10,BRD-K34014345-001-02-6,Anti-inflammatory
25984,l11,BRD-K34034388-300-01-0,dopamine uptake inhibitor
25984,l12,BRD-K34092021-001-02-3,TRPV agonist|cannabinoid receptor agonist
25984,l13,BRD-K34154330-003-04-9,GABA receptor modulator
25984,l17,BRD-K34170797-001-01-1,FXR agonist
25984,l20,BRD-K34415467-003-04-9,histamine receptor antagonist
25984,l21,BRD-K34568562-001-02-7,interferon inducer
25984,l22,BRD-K34608650-001-01-6,Cannabinoid receptor agonist
25984,m02,BRD-K34685430-001-01-1,dopamine receptor antagonist|serotonin receptor antagonist
25984,m03,BRD-K34995470-001-02-3,receptor tyrosine protein kinase inhibitor|vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor|VEGFR inhibitor
25984,m06,BRD-K35240538-001-03-1,glucocorticoid receptor agonist
25984,m07,BRD-K35430135-003-01-5,Adrenergic receptor antagonist
25984,m08,BRD-K35458079-001-04-2,Nootropic agent
25984,m11,BRD-K35498378-001-03-8,Aldose reductase inhibitor
25984,m15,BRD-K35629949-001-01-2,CCK receptor antagonist
25984,m16,BRD-K35708212-331-03-1,ATPase inhibitor
25984,m17,BRD-K35941380-001-01-7,Serotonin receptor antagonist
25984,m18,BRD-K35960502-001-04-4,DNA replication inhibitor|STAT inhibitor
25984,m20,BRD-K36007650-300-02-3,protein synthesis inhibitor
25984,m21,BRD-K36009368-001-01-8,Opioid receptor agonist
25984,m22,BRD-K36021395-300-01-6,adenosine kinase inhibitor
25984,m23,BRD-K36055864-001-04-4,protein synthesis inhibitor
25984,m24,BRD-K36116267-001-05-4,psychoactive drug
25984,n01,BRD-K36198571-001-01-2,metalloproteinase inhibitor
25984,n02,BRD-K36258877-001-01-5,caspase inhibitor
25984,n05,BRD-K36638830-001-02-2,acetylcholine receptor agonist
25984,n06,BRD-K36756879-003-04-6,calcium channel blocker
25984,n11,BRD-K36862742-001-04-1,sodium/potassium/chloride transporter inhibitor
25984,n12,BRD-K36864847-303-01-7,Adrenergic receptor antagonist
25984,n15,BRD-K36927236-001-06-0,Sulfonylurea
25984,n16,BRD-K36965586-001-01-7,serotonin receptor agonist
25984,n18,BRD-K37249724-001-04-2,histamine receptor antagonist
25984,n19,BRD-K37270826-001-03-7,glucocorticoid receptor antagonist|progesterone receptor antagonist
25984,n21,BRD-K37289225-001-07-5,Dopamine receptor antagonist
25984,n22,BRD-K37392901-003-01-7,ubiquitin hydrolase inhibitor|ubiquitin isopeptidase inhibitor
25984,n23,BRD-K37447567-001-01-8,Opioid receptor antagonist
25984,n24,BRD-K37561857-001-04-9,phosphodiesterase inhibitor
25984,o02,BRD-K37618799-001-01-4,adenosine receptor antagonist
25984,o03,BRD-K37682401-001-05-1,bacterial DNA gyrase inhibitor
25984,o04,BRD-K37688416-003-04-0,psychoactive drug
25984,o05,BRD-K37691127-001-02-2,tyrosinase inhibitor
25984,o07,BRD-K37792168-001-01-0,Phosphodiesterase inhibitor
25984,o08,BRD-K37798499-001-02-5,topoisomerase inhibitor
25984,o09,BRD-K37848908-001-03-1,penicillin binding protein inhibitor
25984,o10,BRD-K37865504-001-01-7,FAAH inhibitor|FAAH reuptake inhibitor
25984,o14,BRD-K37991163-050-05-1,selective serotonin reuptake inhibitor (SSRI)
25984,o15,BRD-K38003476-001-03-4,steroid
25984,o16,BRD-K38055836-001-03-9,respiratory stimulant
25984,o17,BRD-K38197229-001-06-7,solute carrier family member inhibitor
25984,o18,BRD-K38251852-001-02-5,ABC transporter expression enhancer|high conductance calcium activated potassium blocker|LXR agonist|potassium channel blocker
25984,o19,BRD-K38305202-001-01-8,dopamine receptor antagonist
25984,o20,BRD-K38323065-001-05-8,cyclooxygenase inhibitor
25984,o21,BRD-K38347298-001-02-3,adenosine receptor antagonist
25984,o22,BRD-K38436528-003-04-8,norepinephrine reputake inhibitor|serotonin reuptake inhibitor
25984,o23,BRD-K38449220-001-03-8,cytochrome P450 inhibitor
25984,o24,BRD-K38477985-001-01-8,protein tyrosine kinase inhibitor|tyrosine kinase inhibitor
25984,p01,BRD-K38684403-001-02-1,bacterial 50S ribosomal subunit inhibitor
25984,p03,BRD-K38775274-001-02-3,glucocorticoid receptor agonist
25984,p04,BRD-K38903228-001-02-8,flavanone glycoside
25984,p05,BRD-K39120595-304-02-1,autotaxin inhibitor
25984,p07,BRD-K39187410-001-01-7,antiamyloidogenic agent
25984,p08,BRD-K39188321-001-03-9,glucocorticoid receptor agonist
25984,p09,BRD-K39339537-001-03-8,cyclooxygenase inhibitor
25984,p10,BRD-K39356024-001-02-4,acetylcholine release enhancer|dopamine release enhancer|GABA receptor negative allosteric modulator|glutamate receptor modulator|progesterone receptor agonist|steroid hormone inhibitor of CYP17A1 and SULT2B1
25984,p13,BRD-K39484304-001-02-5,RNA polymerase inhibitor
25984,p14,BRD-K39670393-303-01-3,histamine receptor agonist
25984,p15,BRD-K39733634-001-01-8,prostanoid receptor antagonist|angiotensin receptor antagonist
25984,p16,BRD-K39746403-084-02-3,NFkB pathway inhibitor|50S ribosomal subunit inhibitor|motilin receptor agonist|RPLV inhibitor
25984,p17,BRD-K39915878-036-04-6,dopamine receptor antagonist|serotonin receptor antagonist
25984,p18,BRD-K39965020-001-02-6,PPAR receptor agonist
25984,p19,BRD-K39987650-001-04-3,laxative
25984,p20,BRD-K40255344-001-05-1,protein tyrosine kinase inhibitor|tyrosine kinase inhibitor
25984,p21,BRD-K40530731-001-02-5,acetylcholine receptor inhibitor
25984,p22,BRD-K40578143-001-01-8,adenosine receptor agonist
25984,p23,BRD-K40656405-001-01-5,PPAR receptor agonist
25984,p24,BRD-K40742111-001-02-6,lipoxygenase inhibitor
26239,a01,BRD-K78364995-236-03-5,bacterial cell wall synthesis inhibitor
26239,a03,BRD-K78485176-001-02-9,angiotensin receptor antagonist
26239,a05,BRD-K78599730-001-02-6,farnesyltransferase inhibitor|NFkB pathway inhibitor|ras farnesyltransferase inhibitor
26239,a07,BRD-K78633253-001-01-2,ARF inhibitor
26239,a08,BRD-K78637815-001-01-4,cannabinoid receptor antagonist
26239,a09,BRD-K78643075-001-03-3,dopamine receptor antagonist
26239,a10,BRD-K78692225-001-11-2,dihydroorotate dehydrogenase inhibitor|PDGFR tyrosine kinase receptor inhibitor
26239,a11,BRD-K78815826-001-04-7,cyclooxygenase inhibitor
26239,a12,BRD-K78838262-001-02-4,hypolipidemic
26239,a16,BRD-K78959463-001-02-5,calcium channel activator
26239,a18,BRD-K79092138-001-04-5,POXB inhibitor|bacterial DNA inhibitor
26239,a19,BRD-K79116891-003-03-7,sodium channel blocker
26239,a20,BRD-K79124250-001-03-0,radiopaque medium
26239,a21,BRD-K79131256-001-03-9,tubulin polymerization inhibitor
26239,a22,BRD-K79145749-001-01-8,norepinephrine reputake inhibitor
26239,a24,BRD-K79366068-236-01-5,NTPDase inhibitor
26239,b01,BRD-K79425933-001-03-6,dopamine receptor antagonist
26239,b02,BRD-K79437791-001-02-4,Inhibitor of methylation of endogenous isoprenylated proteins
26239,b03,BRD-K79501723-003-03-4,histamine receptor modulator
26239,b04,BRD-K79684402-300-01-0,dopamine receptor partial agonist
26239,b05,BRD-K79711234-001-04-3,bacterial 50S ribosomal subunit inhibitor
26239,b06,BRD-K79759585-001-02-1,phosphodiesterase inhibitor
26239,b07,BRD-K79930101-300-01-1,EGFR inhibitor|epidermal growth factor receptor (EGFR) inhibitor|ErbB2 tyrosine kinase inhibitor|receptor tyrosine protein kinase inhibitor
26239,b09,BRD-K80315159-051-01-2,histamine receptor antagonist
26239,b12,BRD-K80334323-001-03-5,progestogen hormone
26239,b15,BRD-K80353807-001-03-0,vasodilator
26239,b16,BRD-K80396088-001-03-9,Sulfonylurea
26239,b17,BRD-K80451230-051-01-8,acetylcholine receptor antagonist
26239,b19,BRD-K80639402-003-01-1,serotonin receptor antagonist
26239,b20,BRD-K80725821-300-01-1,serotonin receptor antagonist
26239,b21,BRD-K80738081-001-06-2,cytochrome P450 inhibitor|SIRT activator
26239,b22,BRD-K80778372-001-01-7,GABA benzodiazepine site receptor inverse agonist
26239,b24,BRD-K80946661-001-02-8,p53 activator
26239,c01,BRD-K80970344-201-02-9,NFkB pathway inhibitor
26239,c02,BRD-K81029756-001-02-8,L-type calcium channel blocker|calcium channel antagonist|calcium channel blocker
26239,c04,BRD-K81209159-001-02-9,Acetylcholinesterase inhibitor
26239,c05,BRD-K81209512-001-01-3,EGFR inhibitor|epidermal growth factor receptor (EGFR) inhibitor|tyrosine kinase inhibitor
26239,c06,BRD-K81225797-001-01-5,adenosine receptor antagonist
26239,c07,BRD-K81272440-001-02-6,calcium channel blocker
26239,c09,BRD-K81376179-001-01-4,FLT3 inhibitor
26239,c14,BRD-K81709173-001-03-8,glucocorticoid receptor agonist
26239,c17,BRD-K81729199-001-01-0,acetylcholine receptor antagonist
26239,c20,BRD-K81839095-001-02-0,Estrogen receptor agonist
26239,c21,BRD-K81876028-300-01-2,Serotonin receptor agonist
26239,c23,BRD-K82103381-003-03-7,vasodilator
26239,d03,BRD-K82255054-001-04-3,GABA receptor agonist
26239,d04,BRD-K82484965-003-02-7,dopamine receptor agonist
26239,d05,BRD-K82561139-001-01-9,casein kinase inhibitor
26239,d06,BRD-K82562631-236-02-0,Cyclooxygenase inhibitor
26239,d07,BRD-K82577285-001-01-7,Dopamine receptor agonist
26239,d08,BRD-K82731415-001-04-7,CDK inhibitor
26239,d09,BRD-K82795137-001-02-3,Histamine receptor antagonist
26239,d10,BRD-K82823076-001-01-8,GABA benzodiazepine site receptor inverse agonist
26239,d13,BRD-K82846253-001-03-0,Insulin secretagogue
26239,d14,BRD-K82865713-001-02-6,cAMP inhibitor
26239,d17,BRD-K83023055-001-01-9,Melatonin receptor agonist
26239,d19,BRD-K83063356-003-01-7,CC chemokine receptor antagonist|CCR antagonist
26239,d23,BRD-K83302049-001-01-6,Histamine receptor antagonist
26239,d24,BRD-K83322645-103-01-6,sigma receptor antagonist|sigma receptor ligand
26239,e04,BRD-K83459933-001-02-1,angiogenesis inhibitor
26239,e05,BRD-K83508485-001-01-9,tachykinin antagonist
26239,e06,BRD-K83597974-003-05-7,Monoamine oxidase inhibitor
26239,e07,BRD-K83637872-001-01-7,Smoothened receptor antagonist
26239,e08,BRD-K84175871-003-02-2,Adrenergic receptor agonist
26239,e12,BRD-K84266862-001-01-6,phosphodiesterase inhibitor
26239,e13,BRD-K84421793-001-01-1,dopamine receptor agonist
26239,e14,BRD-K84595254-001-03-0,ATPase inhibitor
26239,e15,BRD-K84663978-001-02-3,phosphodiesterase inhibitor|platelet aggregation inhibitor|potassium channel blocker
26239,e16,BRD-K84709232-001-02-6,lipoxygenase inhibitor|HIV integrase inhibitor|NFkB pathway inhibitor|nitric oxide production inhibitor|PPAR receptor modulator|tumor necrosis factor production inhibitor
26239,e20,BRD-K85090592-003-08-7,Acetylcholine receptor agonist
26239,e22,BRD-K85119730-001-06-5,ATP channel blocker
26239,e23,BRD-K85242180-001-01-1,"indoleamine 2,3-dioxygenase inhibitor"
26239,e24,BRD-K85266041-304-01-7,glutamate receptor antagonist
26239,f04,BRD-K85383046-001-02-5,chloride channel blocker
26239,f06,BRD-K85871428-001-01-9,p38 MAPK inhibitor
26239,f11,BRD-K85883481-001-02-6,glucocorticoid receptor agonist
26239,f12,BRD-K86204871-001-02-2,sterol demethylase inhibitor
26239,f13,BRD-K86301799-001-14-0,phosphodiesterase inhibitor
26239,f14,BRD-K86434416-001-02-7,Monoamine oxidase inhibitor
26239,f15,BRD-K84663978-001-03-1,phosphodiesterase inhibitor|platelet aggregation inhibitor|potassium channel blocker
26239,f16,BRD-K86509404-001-02-0,CDK inhibitor
26239,f19,BRD-K86600316-003-01-2,Adrenergic receptor antagonist
26239,f20,BRD-K86727142-001-06-6,HCV inhibitor|XIAP inhibitor
26239,f21,BRD-K86873305-236-03-0,Bacterial cell wall synthesis inhibitor
26239,f22,BRD-K86882815-001-01-6,dopamine receptor agonist|prolactin inhibitor|prolactin secretion inhibitor
26239,f23,BRD-K86958018-001-01-9,TRPV agonist
26239,f24,BRD-K87048468-003-01-9,Serotonin receptor antagonist
26239,g01,BRD-K87049188-001-03-6,chelating agent|dopamine beta hydroxylase inhibitor
26239,g08,BRD-K87510569-001-01-0,CC chemokine receptor antagonist
26239,g09,BRD-K87696786-003-01-0,glutamate receptor antagonist
26239,g14,BRD-K87990216-001-03-7,Glucocorticoid receptor agonist
26239,g15,BRD-K87991767-001-02-0,carbonic anhydrase inhibitor|cyclooxygenase inhibitor
26239,g16,BRD-K88090157-050-03-3,antihistamine
26239,g21,BRD-K88282786-066-04-9,cannabinoid receptor agonist
26239,g22,BRD-K88358234-003-01-4,serotonin receptor agonist|nerve growth factor agonist|neurotrophic factor enhancer
26239,g23,BRD-K88366685-300-03-7,3-ketoacyl CoA thiolase inhibitor
26239,g24,BRD-K88405679-003-01-5,antihistamine
26239,h01,BRD-K88429204-001-04-7,dihydrofolate reductase inhibitor
26239,h02,BRD-K88544581-001-01-2,ACAT inhibitor
26239,h05,BRD-K88568253-065-02-1,monoamine oxidase inhibitor
26239,h06,BRD-K88611939-001-01-8,Glutamate receptor agonist
26239,h08,BRD-K88677950-001-01-3,MAP kinase inhibitor|MEK inhibitor
26239,h10,BRD-K88741031-001-01-0,EGFR inhibitor|tyrosine kinase inhibitor
26239,h11,BRD-K88743730-001-01-0,serotonin receptor partial agonist
26239,h12,BRD-K88759641-003-01-0,Angiotensin receptor antagonist
26239,h13,BRD-K88789588-001-03-2,aromatase inhibitor
26239,h14,BRD-K88809146-003-02-1,monoamine oxidase inhibitor
26239,h15,BRD-K88849294-001-02-1,Tyrosine phosphatase inhibitor
26239,h16,BRD-K88871508-001-01-9,Dopamine receptor agonist
26239,h18,BRD-K89046952-001-03-4,bacterial cell wall synthesis inhibitor
26239,h21,BRD-K89055274-048-03-7,muscle relaxant
26239,h22,BRD-K89085489-001-02-6,apoptosis stimulant|retinoid receptor agonist
26239,h23,BRD-K89125793-001-05-4,antiprotozoal agent
26239,h24,BRD-K89152108-001-03-3,thyroid hormone stimulant
26239,i01,BRD-K89210380-001-03-8,vitamin B
26239,i04,BRD-K89272762-001-04-4,chloride channel blocker
26239,i07,BRD-K89274813-001-01-5,acetylcholine release enhancer
26239,i08,BRD-K89375097-300-04-7,Acetylcholine receptor antagonist
26239,i09,BRD-K89402695-001-01-5,Thromboxane receptor antagonist
26239,i13,BRD-K89732114-001-02-6,dopamine receptor antagonist
26239,i14,BRD-K89923877-003-02-4,acetylcholine receptor antagonist
26239,i15,BRD-K89930444-001-01-9,tyrosine kinase inhibitor
26239,i16,BRD-K89997465-001-02-0,dopamine receptor antagonist
26239,i17,BRD-K90027355-001-03-4,mineralocorticoid receptor antagonist
26239,i23,BRD-K90259198-003-04-8,calmodulin antagonist|potassium channel blocker|squalene monooxygenase channel blocker
26239,i24,BRD-K90333595-001-02-8,adrenergic receptor antagonist
26239,j01,BRD-K90524085-001-05-2,phosphodiesterase inhibitor|platelet aggregation inhibitor
26239,j04,BRD-K90574421-001-01-9,Serotonin receptor agonist
26239,j08,BRD-K90789829-003-03-3,Adrenergic inhibitor
26239,j09,BRD-K90976994-001-02-1,Bile acid
26239,j10,BRD-K91243525-001-01-5,Neurotensin receptor antagonist
26239,j11,BRD-K91263825-001-02-8,tricyclic antidepressant
26239,j13,BRD-K91315211-334-02-3,Histamine receptor agonist
26239,j15,BRD-K91336023-001-01-4,Dopamine receptor agonist
26239,j16,BRD-K91370081-001-04-6,DNA synthesis inhibitor
26239,j19,BRD-K91904471-001-01-6,p38 MAPK inhibitor
26239,j20,BRD-K92000912-001-06-8,cannabinoid receptor antagonist
26239,j24,BRD-K92015269-001-01-6,dopamine uptake inhibitor
26239,k02,BRD-K92049597-001-04-2,sodium channel blocker
26239,k04,BRD-K92093830-003-05-0,topoisomerase inhibitor
26239,k05,BRD-K92138166-001-01-0,other antibiotic
26239,k09,BRD-K92492521-001-01-1,Leukotriene receptor antagonist
26239,k12,BRD-K92678294-001-01-0,Isoflavone
26239,k14,BRD-K92726801-003-02-7,Haemostatic agent
26239,k17,BRD-K92731339-227-02-3,ACE inhibitor
26239,k18,BRD-K92758126-001-06-3,NFkB pathway inhibitor
26239,k19,BRD-K92778217-001-04-6,Cyclooxygenase inhibitor
26239,k20,BRD-K92830582-003-04-8,adrenergic receptor antagonist
26239,k22,BRD-K92984783-003-02-4,Serotonin receptor antagonist
26239,l01,BRD-K93080877-001-02-1,tripeptidyl peptidase inhibitor
26239,l02,BRD-K93176058-001-01-0,retinoid receptor agonist
26239,l03,BRD-K93188295-300-01-4,adrenergic receptor antagonist
26239,l05,BRD-K93258693-001-02-5,PPAR receptor antagonist
26239,l06,BRD-K93280214-004-02-3,GABA receptor antagonist
26239,l09,BRD-K93325701-001-03-0,SRC inhibitor
26239,l10,BRD-K93332168-001-03-2,Monoamine oxidase inhibitor
26239,l11,BRD-K93441486-067-03-7,Acetylcholine receptor antagonist
26239,l12,BRD-K93460210-001-01-3,Serotonin receptor antagonist
26239,l13,BRD-K93461745-001-01-5,Serotonin receptor agonist
26239,l14,BRD-K93480852-001-02-2,calcium/calmodulin dependent protein kinase inhibitor
26239,l19,BRD-K93568044-001-03-1,glucocorticoid receptor agonist
26239,l20,BRD-K93658967-001-01-7,CDK inhibitor|CFTR channel activator|glycogen synthase kinase inhibitor|JNK inhibitor
26239,l21,BRD-K93754473-001-02-9,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)
26239,l22,BRD-K94144010-001-05-5,nicotine metabolite
26239,m04,BRD-K94270326-004-01-0,dopamine receptor antagonist
26239,m06,BRD-K94379058-001-03-5,cannabinoid receptor inverse agonist
26239,m07,BRD-K94441233-001-03-1,HMGCR inhibitor
26239,m08,BRD-K94512704-001-01-3,dopamine receptor antagonist
26239,m12,BRD-K94689771-001-02-5,CYP1B1 inhibitor
26239,m17,BRD-K94832621-001-01-5,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)
26239,m19,BRD-K94841585-001-02-8,laxative|free radical generator
26239,m21,BRD-K94887716-001-01-5,Serotonin receptor agonist
26239,m22,BRD-K94920105-001-01-3,PARP inhibitor
26239,m24,BRD-K95202259-001-01-9,p38 MAPK inhibitor
26239,n01,BRD-K95237249-001-04-2,Uricosuric blocker
26239,n02,BRD-K95309561-001-04-9,estrogen receptor agonist
26239,n04,BRD-K95435023-001-01-0,c-Met inhibitor|hepatocyte growth factor receptor inhibitor
26239,n07,BRD-K95603879-001-03-4,ATPase inhibitor
26239,n08,BRD-K95609758-001-01-1,potassium channel activator
26239,n11,BRD-K95655893-001-01-0,VEGFR kinase inhibitor
26239,n12,BRD-K95676198-001-02-6,JAK inhibitor
26239,n15,BRD-K95739795-001-01-1,Vesicular monoamine transporter inhibitor
26239,n16,BRD-K95763993-001-03-7,PDGFR receptor inhibitor
26239,n17,BRD-K95785537-001-04-1,src inhibitor
26239,n20,BRD-K95851186-001-02-9,GABA receptor modulator
26239,n21,BRD-K95899059-003-01-0,Serotonin receptor agonist
26239,n22,BRD-K95992530-001-02-4,integrin antagonist
26239,n23,BRD-K96119599-001-04-7,Melanin inhibitor
26239,n24,BRD-K96144918-001-02-3,KPL-1 tumor suppressor
26239,o04,BRD-K96263742-001-02-3,PPAR receptor agonist
26239,o05,BRD-K96271548-001-02-2,antioxidant
26239,o07,BRD-K96402602-001-01-8,PPMTase inhibitor
26239,o08,BRD-K96527333-001-03-4,GABA receptor modulator
26239,o10,BRD-K96670504-001-01-9,Glucokinase inhibitor
26239,o13,BRD-K96720755-001-01-8,Vasopressin receptor antagonist
26239,o14,BRD-K96799727-001-01-7,HSP inhibitor
26239,o15,BRD-K96809896-001-01-9,p38 MAPK inhibitor
26239,o16,BRD-K96862998-001-03-1,TGF beta receptor inhibitor
26239,o17,BRD-K97061094-001-03-2,Histamine receptor antagonist
26239,o18,BRD-K97118047-001-01-2,Casein kinase inhibitor
26239,o19,BRD-K97158071-001-04-1,Dopamine receptor antagonist
26239,o20,BRD-K97181089-001-02-7,sodium channel blocker
26239,o22,BRD-K97330509-001-01-4,src inhibitor
26239,o23,BRD-K97354755-001-01-5,src inhibitor
26239,o24,BRD-K97365803-001-01-3,PI3K inhibitor
26239,p01,BRD-K97399794-001-07-0,polar auxin transport inhibitor
26239,p02,BRD-K97440753-066-03-3,adrenergic receptor antagonist|prolactin inhibitor
26239,p04,BRD-K97509413-001-01-8,AGE inhibitor|estrogen receptor agonist|estrogen receptor ligand
26239,p05,BRD-K97521363-001-03-9,glycolysis inhibitor
26239,p06,BRD-K97530723-001-04-3,melatonin receptor agonist|nitric oxide synthase inhibitor
26239,p07,BRD-K97564742-103-01-9,histamine receptor antagonist
26239,p10,BRD-K97688263-001-02-9,sodium channel blocker
26239,p13,BRD-K97746869-001-04-9,ATP channel blocker
26239,p14,BRD-K97752965-001-01-6,ATP channel activator|nitric oxide donor|potassium channel agonist
26239,p15,BRD-K97799481-002-03-6,Adenosine receptor antagonist
26239,p16,BRD-K97810537-001-03-7,glucocorticoid receptor agonist
26239,p17,BRD-K98039984-001-03-0,glucocorticoid receptor agonist
26239,p18,BRD-K98143437-001-01-7,p38 MAPK inhibitor|interleukin inhibitor|tumor necrosis factor production inhibitor
26239,p20,BRD-K98157055-001-04-2,glutamate receptor antagonist
26239,p21,BRD-K98174813-001-05-7,bacterial 30S ribosomal subunit inhibitor
26239,p23,BRD-K98297262-001-01-1,"1,3-beta-glucan synthase inhibitor"
26239,p24,BRD-K98521173-001-03-8,mineralocorticoid receptor agonist
24277,a01,BRD-K18250272-003-03-7,local anesthetic
24277,a02,BRD-K18316707-001-01-9,cannabinoid receptor antagonist
24277,a04,BRD-K18550767-001-02-8,interleukin inhibitor
24277,a05,BRD-K18574842-323-03-3,bacterial cell wall synthesis inhibitor
24277,a06,BRD-K18619710-001-03-7,steroid
24277,a07,BRD-K18742343-001-03-2,PKA inhibitor
24277,a08,BRD-K18757346-001-02-9,thromboxane receptor agonist
24277,a09,BRD-K18779551-003-03-7,acetylcholine release stimulant|adrenergic transmitter uptake inhibitor|reducing agent
24277,a10,BRD-K18787491-001-05-2,MEK inhibitor
24277,a11,BRD-K18799075-001-01-0,cannabinoid receptor partial agonist
24277,a12,BRD-K18816859-001-01-4,Serotonin receptor agonist
24277,a15,BRD-K18909381-001-01-4,serotonin receptor agonist
24277,a16,BRD-K18910433-001-04-4,estrogen receptor agonist
24277,a19,BRD-K19111024-001-04-3,PPAR receptor agonist
24277,a20,BRD-K19295594-001-04-4,BCL inhibitor|MCL1 inhibitor
24277,a21,BRD-K19309090-300-03-0,acetylcholine receptor agonist
24277,a22,BRD-K19352500-332-03-7,dopamine receptor antagonist
24277,a23,BRD-K19360254-001-01-3,Dopamine receptor agonist
24277,b01,BRD-K19462402-003-03-0,adrenergic receptor antagonist|calcium channel blocker
24277,b03,BRD-K19533706-001-01-9,Angiogenesis inhibitor
24277,b04,BRD-K19554809-001-01-1,serotonin receptor agonist
24277,b05,BRD-K19605405-001-01-9,adenosine receptor antagonist
24277,b07,BRD-K20141153-003-03-8,norepinephrine transporter inhibitor|adrenergic transmitter uptake inhibitor
24277,b08,BRD-K20152659-001-02-0,Cholesterol inhibitor
24277,b10,BRD-K20620780-001-01-0,dopamine receptor antagonist
24277,b11,BRD-K20655524-003-04-7,psychoactive drug
24277,b15,BRD-K20714604-001-01-5,Serotonin receptor partial agonist
24277,b16,BRD-K20742498-001-01-5,serotonin receptor antagonist
24277,b17,BRD-K20755323-001-01-8,sphingosine kinase inhibitor
24277,b18,BRD-K20995441-001-01-7,Opioid receptor agonist
24277,b19,BRD-K21283037-001-02-5,glutamate inhibitor
24277,b20,BRD-K21350491-001-02-1,acid sensing ion channel blocker|sodium channel blockers|TRPP3 channel inhibitor|TRPV modulator
24277,b21,BRD-K21450440-001-04-7,carbonic anhydrase inhibitor
24277,b22,BRD-K21520694-001-02-4,PABA antagonist
24277,b23,BRD-K21548250-001-01-3,sodium channel blocker
24277,b24,BRD-K21565985-001-04-3,adrenergic receptor agonist
24277,c01,BRD-K21667562-001-01-4,FAAH transport inhibitor|anandamide transport inhibitor|nucelar factor of activated T-cells inhibitor|TRPV agonist
24277,c02,BRD-K21680192-300-05-2,topoisomerase inhibitor
24277,c03,BRD-K21733600-001-02-6,cyclooxygenase inhibitor
24277,c04,BRD-K21853356-001-04-4,EGFR inhibitor
24277,c07,BRD-K22031190-001-04-6,Prostanoid receptor antagonist
24277,c08,BRD-K22134346-001-04-1,HMGCR inhibitor
24277,c09,BRD-K22193694-001-04-5,Topical sunscreen agent
24277,c10,BRD-K22385716-001-01-7,casein kinase inhibitor|mTOR inhibitor|PI3K inhibitor
24277,c17,BRD-K22861715-001-03-4,breast cancer resistance protein inhibitor
24277,c19,BRD-K22969690-001-02-6,bacterial 50S ribosomal subunit inhibitor
24277,c21,BRD-K23301018-001-02-6,antiprotozoal agent
24277,c23,BRD-K23335153-300-01-7,glutamate receptor positive allosteric modulator
24277,c24,BRD-K23383398-001-01-6,LXR agonist|ABC transporter expression enhancer|ROR inverse agonist
24277,d02,BRD-K23478508-001-03-7,ATPase inhibitor
24277,d03,BRD-K23541596-300-04-9,histamine receptor agonist
24277,d04,BRD-K23566484-001-04-5,androgen receptor antagonist
24277,d05,BRD-K23583188-001-05-6,EGFR inhibitor|tyrosine kinase inhibitor
24277,d06,BRD-K23704908-001-03-2,serine protease inhibitor
24277,d07,BRD-K23913458-001-02-5,Vitamin K antagonist
24277,d08,BRD-K23922020-075-01-1,acetylcholine receptor agonist
24277,d10,BRD-K24084088-001-02-2,adenosine receptor antagonist
24277,d13,BRD-K24132293-001-02-0,glutathione transferase inhibitor
24277,d14,BRD-K24201553-003-02-4,Serotonin receptor antagonist
24277,d17,BRD-K24240364-003-02-1,Glutamate receptor antagonist
24277,d18,BRD-K24396733-001-01-1,dopamine receptor agonist
24277,d20,BRD-K24526313-001-08-6,Potassium channel activator
24277,e05,BRD-K25224017-001-04-5,serotonin receptor antagonist
24277,e07,BRD-K25394294-001-04-0,Cyclooxygenase inhibitor
24277,e11,BRD-K25433859-003-11-4,norepinephrine reputake inhibitor|tricyclic antidepressant
24277,e13,BRD-K25741894-001-03-8,acetylcholinesterase inhibitor
24277,e15,BRD-K25875056-001-01-2,Protein tyrosine kinase activator
24277,e16,BRD-K25906698-303-01-9,histamine receptor agonist
24277,e21,BRD-K26160755-003-01-8,Imidazoline receptor agonist
24277,e22,BRD-K26373640-001-02-8,IKK inhibitor
24277,f03,BRD-K26429091-051-01-9,acetylcholine receptor antagonist
24277,f04,BRD-K26521938-001-04-9,prostanoid receptor agonist
24277,f05,BRD-K26548821-001-01-8,Dopamine receptor agonist
24277,f06,BRD-K26573499-300-01-3,Adrenergic receptor agonist
24277,f12,BRD-K26979635-001-01-1,Glutamate receptor antagonist
24277,f13,BRD-K26997899-001-01-4,microtubule inhibitor|tubulin inhibitor
24277,f15,BRD-K27141178-001-01-0,Serotonin receptor antagonist
24277,f20,BRD-K27305650-001-04-2,mTOR inhibitor|PI3K inhibitor|DNA dependent protein kinase inhibitor|phosphodiesterase inhibitor|PLK inhibitor
24277,f21,BRD-K27316855-001-02-6,vitamin D receptor agonist
24277,f23,BRD-K27351809-001-02-0,progesterone receptor agonist
24277,g01,BRD-K27450477-001-03-9,Adenosine deaminase inhibitor
24277,g02,BRD-K27499107-001-02-6,IP receptor activator
24277,g06,BRD-K27710560-001-02-6,SIRT inhibitor
24277,g07,BRD-K27737647-001-03-4,PKA inhibitor
24277,g09,BRD-K27871032-001-02-6,Ergoline alkaloid
24277,g11,BRD-K28115081-001-01-9,Platelet activating factor receptor antagonist
24277,g12,BRD-K28137194-003-01-3,GABA receptor agonist
24277,g13,BRD-K28143534-001-01-4,histamine receptor antagonist
24277,g15,BRD-K28183345-003-05-6,Dihydrofolate reductase inhibitor
24277,g17,BRD-K28307902-001-04-3,androgen receptor antagonist
24277,g18,BRD-K28453807-003-05-4,Cholinergic receptor antagonist
24277,g23,BRD-K28578425-001-01-3,phosphodiesterase inhibitor
24277,g24,BRD-K28667196-001-02-9,Increases arterial blood pressure
24277,h01,BRD-K28680267-001-01-8,CCK receptor antagonist
24277,h02,BRD-K28761384-003-03-6,dopamine receptor antagonist
24277,h05,BRD-K28761891-001-01-0,melatonin receptor agonist
24277,h06,BRD-K28806945-001-01-9,dopamine receptor antagonist
24277,h07,BRD-K28863208-001-01-2,Cholinergic receptor agonist
24277,h08,BRD-K28907958-001-01-9,retinoid receptor agonist
24277,h09,BRD-K28936863-051-04-1,histamine receptor agonist|leukotriene receptor antagonist|phosphodiesterase inhibitor
24277,h10,BRD-K29113274-001-03-6,Sterol demethylase inhibitor
24277,h12,BRD-K29178788-001-02-0,Furoquinoline alkaloid
24277,h13,BRD-K29359156-001-04-6,H+/K+-ATPase inhibitor
24277,h16,BRD-K29555132-001-02-2,Cannabinoid receptor agonist
24277,h17,BRD-K29582677-001-02-7,Calcium channel blocker
24277,h18,BRD-K29668683-300-01-4,sigma receptor antagonist
24277,h21,BRD-K29673530-001-03-9,tyrosine kinase inhibitor
24277,h22,BRD-K29950728-048-02-6,estrogen receptor antagonist
24277,h23,BRD-K30197592-001-01-5,Serotonin receptor agonist
24277,i01,BRD-K30240666-051-05-0,histamine receptor antagonist
24277,i02,BRD-K30421593-050-02-3,adrenergic receptor antagonist
24277,i03,BRD-K30480208-001-04-5,Electrolyte reabsorption inhibitor
24277,i08,BRD-K30685142-001-04-8,thyroid hormone stimulant
24277,i09,BRD-K30867024-001-01-1,serotonin receptor antagonist
24277,i11,BRD-K30990140-003-01-6,Cyclooxygenase inhibitor
24277,i12,BRD-K31054881-300-01-3,Adrenergic receptor antagonist
24277,i13,BRD-K31238592-001-01-6,CCK receptor antagonist|gastrin inhibitor
24277,i16,BRD-K31342827-001-05-4,PKC inhibitor
24277,i18,BRD-K31491153-001-01-2,serotonin receptor agonist
24277,i19,BRD-K31542390-001-01-5,dehydrogenase inhibitor|inositol monophosphatase inhibitor
24277,i20,BRD-K31611373-001-02-7,Prostanoid receptor agonist
24277,i23,BRD-K31627533-001-03-8,glucocorticoid receptor agonist
24277,i24,BRD-K31633810-003-01-0,Acetylcholine receptor antagonist
24277,j03,BRD-K31699485-001-01-9,glutamate receptor modulator
24277,j04,BRD-K31792052-004-01-9,interleukin receptor antagonist
24277,j09,BRD-K31843556-001-01-7,PPAR receptor anatagonist|PPAR receptor antagonist
24277,j10,BRD-K31912990-003-01-0,neuropeptide receptor antagonist
24277,j12,BRD-K31987754-001-01-2,Cannabinoid receptor agonist
24277,j15,BRD-K32164935-001-06-8,ATP channel blocker
24277,j16,BRD-K32247306-001-04-7,GABA receptor antagonist
24277,j19,BRD-K32292990-001-01-0,EGFR inhibitor
24277,j20,BRD-K32412559-001-01-7,Adrenergic receptor antagonist
24277,j23,BRD-K32501161-001-01-7,dopamine uptake inhibitor
24277,j24,BRD-K32526544-001-01-2,Potassium channel activator
24277,k02,BRD-K32584078-001-02-3,AKT inhibitor|HCV NS5B RdRp inhibitor
24277,k04,BRD-K32645441-001-01-4,serotonin receptor agonist
24277,k05,BRD-K32696739-001-02-6,Monoamine oxidase inhibitor
24277,k06,BRD-K32744045-001-04-9,aldehyde dehydrogenase inhibitor|DNA methyltransferase inhibitor|TRPV agonist
24277,k09,BRD-K32755366-003-03-4,Norepinephrine transporter inhibitor
24277,k10,BRD-K32821942-001-04-9,dehydrogenase inhibitor
24277,k11,BRD-K32828673-001-01-5,tubulin polymerization inhibitor
24277,k12,BRD-K32830106-003-11-3,adrenergic receptor agonist
24277,k14,BRD-K33204703-001-04-6,PDGFR receptor inhibitor
24277,k17,BRD-K33211335-337-03-7,glutamate receptor antagonist|sigma receptor agonist
24277,k19,BRD-K33308633-001-01-6,calcineurin inhibitor
24277,k20,BRD-K33396764-001-02-0,Omega 3 fatty acid stimulant
24277,k22,BRD-K33453211-003-03-2,Histamine receptor antagonist
24277,l01,BRD-K33459542-001-02-5,sigma receptor agonist
24277,l02,BRD-K33583600-001-03-9,guanylate cyclase activator
24277,l03,BRD-K33710385-001-05-4,mycolic synthesis inhibitor
24277,l04,BRD-K33818169-003-01-2,LXR agonist|ABC transporter expression enhancer
24277,l05,BRD-K33864865-001-01-7,CCK receptor antagonist
24277,l06,BRD-K33882852-003-01-0,benzodiazepine receptor agonist
24277,l10,BRD-K34014345-001-02-6,Anti-inflammatory
24277,l11,BRD-K34034388-300-01-0,dopamine uptake inhibitor
24277,l12,BRD-K34092021-001-02-3,TRPV agonist|cannabinoid receptor agonist
24277,l13,BRD-K34154330-003-04-9,GABA receptor modulator
24277,l17,BRD-K34170797-001-01-1,FXR agonist
24277,l20,BRD-K34415467-003-04-9,histamine receptor antagonist
24277,l21,BRD-K34568562-001-02-7,interferon inducer
24277,l22,BRD-K34608650-001-01-6,Cannabinoid receptor agonist
24277,m02,BRD-K34685430-001-01-1,dopamine receptor antagonist|serotonin receptor antagonist
24277,m03,BRD-K34995470-001-02-3,receptor tyrosine protein kinase inhibitor|vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor|VEGFR inhibitor
24277,m06,BRD-K35240538-001-03-1,glucocorticoid receptor agonist
24277,m07,BRD-K35430135-003-01-5,Adrenergic receptor antagonist
24277,m08,BRD-K35458079-001-04-2,Nootropic agent
24277,m11,BRD-K35498378-001-03-8,Aldose reductase inhibitor
24277,m15,BRD-K35629949-001-01-2,CCK receptor antagonist
24277,m16,BRD-K35708212-331-03-1,ATPase inhibitor
24277,m17,BRD-K35941380-001-01-7,Serotonin receptor antagonist
24277,m18,BRD-K35960502-001-04-4,DNA replication inhibitor|STAT inhibitor
24277,m20,BRD-K36007650-300-02-3,protein synthesis inhibitor
24277,m21,BRD-K36009368-001-01-8,Opioid receptor agonist
24277,m22,BRD-K36021395-300-01-6,adenosine kinase inhibitor
24277,m23,BRD-K36055864-001-04-4,protein synthesis inhibitor
24277,m24,BRD-K36116267-001-05-4,psychoactive drug
24277,n01,BRD-K36198571-001-01-2,metalloproteinase inhibitor
24277,n02,BRD-K36258877-001-01-5,caspase inhibitor
24277,n05,BRD-K36638830-001-02-2,acetylcholine receptor agonist
24277,n06,BRD-K36756879-003-04-6,calcium channel blocker
24277,n11,BRD-K36862742-001-04-1,sodium/potassium/chloride transporter inhibitor
24277,n12,BRD-K36864847-303-01-7,Adrenergic receptor antagonist
24277,n15,BRD-K36927236-001-06-0,Sulfonylurea
24277,n16,BRD-K36965586-001-01-7,serotonin receptor agonist
24277,n18,BRD-K37249724-001-04-2,histamine receptor antagonist
24277,n19,BRD-K37270826-001-03-7,glucocorticoid receptor antagonist|progesterone receptor antagonist
24277,n21,BRD-K37289225-001-07-5,Dopamine receptor antagonist
24277,n22,BRD-K37392901-003-01-7,ubiquitin hydrolase inhibitor|ubiquitin isopeptidase inhibitor
24277,n23,BRD-K37447567-001-01-8,Opioid receptor antagonist
24277,n24,BRD-K37561857-001-04-9,phosphodiesterase inhibitor
24277,o02,BRD-K37618799-001-01-4,adenosine receptor antagonist
24277,o03,BRD-K37682401-001-05-1,bacterial DNA gyrase inhibitor
24277,o04,BRD-K37688416-003-04-0,psychoactive drug
24277,o05,BRD-K37691127-001-02-2,tyrosinase inhibitor
24277,o07,BRD-K37792168-001-01-0,Phosphodiesterase inhibitor
24277,o08,BRD-K37798499-001-02-5,topoisomerase inhibitor
24277,o09,BRD-K37848908-001-03-1,penicillin binding protein inhibitor
24277,o10,BRD-K37865504-001-01-7,FAAH inhibitor|FAAH reuptake inhibitor
24277,o14,BRD-K37991163-050-05-1,selective serotonin reuptake inhibitor (SSRI)
24277,o15,BRD-K38003476-001-03-4,steroid
24277,o16,BRD-K38055836-001-03-9,respiratory stimulant
24277,o17,BRD-K38197229-001-06-7,solute carrier family member inhibitor
24277,o18,BRD-K38251852-001-02-5,ABC transporter expression enhancer|high conductance calcium activated potassium blocker|LXR agonist|potassium channel blocker
24277,o19,BRD-K38305202-001-01-8,dopamine receptor antagonist
24277,o20,BRD-K38323065-001-05-8,cyclooxygenase inhibitor
24277,o21,BRD-K38347298-001-02-3,adenosine receptor antagonist
24277,o22,BRD-K38436528-003-04-8,norepinephrine reputake inhibitor|serotonin reuptake inhibitor
24277,o23,BRD-K38449220-001-03-8,cytochrome P450 inhibitor
24277,o24,BRD-K38477985-001-01-8,protein tyrosine kinase inhibitor|tyrosine kinase inhibitor
24277,p01,BRD-K38684403-001-02-1,bacterial 50S ribosomal subunit inhibitor
24277,p03,BRD-K38775274-001-02-3,glucocorticoid receptor agonist
24277,p04,BRD-K38903228-001-02-8,flavanone glycoside
24277,p05,BRD-K39120595-304-02-1,autotaxin inhibitor
24277,p07,BRD-K39187410-001-01-7,antiamyloidogenic agent
24277,p08,BRD-K39188321-001-03-9,glucocorticoid receptor agonist
24277,p09,BRD-K39339537-001-03-8,cyclooxygenase inhibitor
24277,p10,BRD-K39356024-001-02-4,acetylcholine release enhancer|dopamine release enhancer|GABA receptor negative allosteric modulator|glutamate receptor modulator|progesterone receptor agonist|steroid hormone inhibitor of CYP17A1 and SULT2B1
24277,p13,BRD-K39484304-001-02-5,RNA polymerase inhibitor
24277,p14,BRD-K39670393-303-01-3,histamine receptor agonist
24277,p15,BRD-K39733634-001-01-8,prostanoid receptor antagonist|angiotensin receptor antagonist
24277,p16,BRD-K39746403-084-02-3,NFkB pathway inhibitor|50S ribosomal subunit inhibitor|motilin receptor agonist|RPLV inhibitor
24277,p17,BRD-K39915878-036-04-6,dopamine receptor antagonist|serotonin receptor antagonist
24277,p18,BRD-K39965020-001-02-6,PPAR receptor agonist
24277,p19,BRD-K39987650-001-04-3,laxative
24277,p20,BRD-K40255344-001-05-1,protein tyrosine kinase inhibitor|tyrosine kinase inhibitor
24277,p21,BRD-K40530731-001-02-5,acetylcholine receptor inhibitor
24277,p22,BRD-K40578143-001-01-8,adenosine receptor agonist
24277,p23,BRD-K40656405-001-01-5,PPAR receptor agonist
24277,p24,BRD-K40742111-001-02-6,lipoxygenase inhibitor
25937,a01,BRD-A00100033-001-04-8,DNA inhibitor
25937,a02,BRD-A00267231-001-01-1,Adenosine receptor agonist
25937,a04,BRD-A00520476-001-03-3,Acetylcholine receptor antagonist
25937,a06,BRD-A00993607-003-04-8,Adrenergic receptor antagonist
25937,a07,BRD-A01078468-001-04-9,synthetic estrogen
25937,a08,BRD-A01295252-001-01-5,Dopamine receptor ligand
25937,a09,BRD-A01320529-001-05-9,adrenergic receptor agonist
25937,a11,BRD-A01593789-001-01-5,5 alpha reductase inhibitor
25937,a12,BRD-A01636364-003-04-5,sodium channel blocker
25937,a15,BRD-A01787639-003-08-6,adrenergic receptor antagonist
25937,a16,BRD-A02006392-001-06-5,calcium channel blocker
25937,a17,BRD-A02176148-001-02-2,Mitochondrial complex I inhibitor
25937,a19,BRD-A02710418-003-03-5,opioid receptor agonist
25937,a20,BRD-A02713983-001-02-0,growth factor receptor activator
25937,a21,BRD-A02759312-003-11-2,Adrenergic receptor antagonist
25937,a23,BRD-A03216249-003-02-9,Potassium channel blocker
25937,a24,BRD-A03359064-001-01-5,Adrenergic receptor antagonist
25937,b02,BRD-A03623303-045-02-0,Adrenergic receptor antagonist
25937,b03,BRD-A03816571-001-01-0,cannabinoid receptor agonist|CC chemokine receptor antagonist
25937,b09,BRD-A04322457-003-03-9,adrenergic receptor agonist
25937,b10,BRD-A04438777-001-01-4,dopamine receptor agonist
25937,b11,BRD-A04553218-050-03-0,histamine receptor antagonist
25937,b15,BRD-A04668240-001-01-5,GABA receptor antagonist
25937,b16,BRD-A04706586-236-01-7,Adenosine receptor agonist
25937,b18,BRD-A05186015-003-04-0,dopamine uptake inhibitor
25937,b24,BRD-A06352418-001-03-6,Histamine receptor antagonist
25937,c01,BRD-A06352508-001-02-9,CHK inhibitor
25937,c02,BRD-A06390036-001-02-0,Antiarrhythmic
25937,c03,BRD-A06726973-001-02-0,cGMP analog
25937,c04,BRD-A06935312-001-02-7,bacterial 30S ribosomal subunit inhibitor
25937,c06,BRD-A07207424-001-04-1,phosphodiesterase inhibitor
25937,c08,BRD-A07440155-003-04-9,Adrenergic receptor antagonist
25937,c09,BRD-A07780951-001-02-2,Adrenergic receptor agonist
25937,c10,BRD-A07824748-001-02-6,11-beta hydroxysteroid dehydrogenase inhibitor
25937,c14,BRD-A07875874-001-01-6,calcium channel blocker
25937,c17,BRD-A07932845-001-01-1,anti-HCVE2
25937,c18,BRD-A07952294-001-02-3,farnesyltransferase inhibitors
25937,c19,BRD-A08187463-001-03-8,enkephalinase inhibitor
25937,c22,BRD-A08709697-001-02-9,pyrrolizidine alkaloid
25937,c23,BRD-A08877921-001-02-2,Protein synthesis inhibitor
25937,c24,BRD-A09056319-003-03-6,Adrenergic receptor antagonist
25937,d01,BRD-A09062839-003-03-5,Local anesthetic
25937,d02,BRD-A09094913-001-02-3,acetylcholine receptor antagonist
25937,d03,BRD-A09161221-001-01-9,HSP inhibitor
25937,d04,BRD-A09349126-001-02-4,progesterone receptor agonist
25937,d05,BRD-A09467419-003-04-2,acetylcholine receptor antagonist
25937,d06,BRD-A09472452-001-02-8,Sodium channel blocker
25937,d07,BRD-A09533288-001-02-7,calcium channel blocker
25937,d08,BRD-A09539288-004-02-8,Acetylcholine receptor antagonist
25937,d09,BRD-A09828896-004-04-5,Dopamine receptor agonist
25937,d10,BRD-A09925278-003-03-1,Adrenergic receptor agonist
25937,d14,BRD-A10070317-003-05-1,adrenergic receptor antagonist
25937,d17,BRD-A10355991-003-01-8,Glutamate receptor antagonist
25937,d18,BRD-A10715913-001-02-0,Dopamine receptor antagonist
25937,d19,BRD-A10739734-003-01-5,adrenergic receptor antagonist
25937,d20,BRD-A10903566-003-02-8,Adrenergic receptor antagonist
25937,d21,BRD-A10969569-001-02-0,Plant alkaloid
25937,d22,BRD-A10977446-001-04-8,Adrenergic receptor antagonist
25937,e03,BRD-A11605036-001-03-2,GABA receptor antagonist
25937,e04,BRD-A11609859-303-01-2,opioid receptor agonist
25937,e05,BRD-A11678676-001-02-6,PI3K inhibitor
25937,e07,BRD-A11813248-001-02-8,Potassium channel blocker
25937,e08,BRD-A12016240-001-01-7,Serotonin receptor antagonist
25937,e14,BRD-A13188892-066-03-3,Adrenergic receptor antagonist
25937,e15,BRD-A13650332-236-03-9,Bacterial cell wall synthesis inhibitor
25937,e16,BRD-A13946108-001-03-1,Cyclooxygenase inhibitor
25937,e23,BRD-A14395271-001-01-5,Dopamine receptor antagonist
25937,e24,BRD-A14566392-004-03-5,acetylcholine receptor antagonist
25937,f03,BRD-A14574269-051-01-4,Acetylcholine receptor agonist
25937,f04,BRD-A15034104-002-03-6,interleukin inhibitor
25937,f05,BRD-A15070535-323-02-1,adenosine receptor agonist|cAMP stimulant
25937,f06,BRD-A15415227-003-01-1,PPAR receptor agonist
25937,f07,BRD-A15435692-003-01-5,sigma receptor antagonist|glutamate receptor antagonist|serotonin receptor agonist
25937,f11,BRD-A15530910-001-01-3,adrenergic receptor antagonist|serotonin receptor antagonist
25937,f14,BRD-A15914070-001-01-5,cytotoxic lipid peroxidation product
25937,f15,BRD-A16332958-001-02-4,Adrenergic receptor agonist
25937,f16,BRD-A16665823-008-03-3,Bacterial cell wall synthesis inhibitor
25937,f19,BRD-A16694057-001-02-7,PPAR receptor antagonist
25937,f21,BRD-A17065207-001-06-9,protein synthesis inhibitor
25937,f23,BRD-A17428743-001-01-1,Serotonin receptor agonist
25937,f24,BRD-A17453586-001-01-9,Serotonin receptor agonist
25937,g02,BRD-A17535965-001-02-2,Acetylcholine receptor antagonist
25937,g05,BRD-A17655518-001-02-0,Cyclooxygenase inhibitor
25937,g08,BRD-A18043272-001-03-2,succinimide antiepileptic
25937,g09,BRD-A18202423-001-01-6,Glutamate receptor antagonist
25937,g10,BRD-A18497530-001-04-6,adenosine kinase inhibitor|nucleoside transporter inhibitor
25937,g11,BRD-A18579359-001-03-1,Neural Wiskott-Aldrich syndrome protein inhibitor
25937,g12,BRD-A18696154-003-11-9,adrenergic receptor antagonist
25937,g13,BRD-A18763547-019-01-0,Cytochrome C release inhibitor
25937,g15,BRD-A19053259-003-03-3,Anthelmintic
25937,g17,BRD-A19195498-050-04-2,Norepinephrine reuptake inhibitor
25937,g18,BRD-A19736161-310-01-3,Serotonin receptor antagonist
25937,g23,BRD-A20239487-001-02-5,Adrenergic receptor antagonist
25937,h01,BRD-A20348246-001-04-2,GABA receptor modulator
25937,h06,BRD-A20968261-001-01-3,glutamate transporter inhibitor
25937,h08,BRD-A21723284-066-01-7,Opioid receptor antagonist
25937,h09,BRD-A21858158-001-04-5,Anthelmintic
25937,h14,BRD-A22305049-003-04-5,gluconeogenesis inhibitor
25937,h15,BRD-A22380646-001-01-5,ATPase inhibitor
25937,h16,BRD-A22684332-003-02-3,adrenergic receptor agonist
25937,h17,BRD-A22707317-001-02-5,GABA receptor modulator
25937,h21,BRD-A22769835-300-03-2,Antihistamine
25937,h22,BRD-A22783572-065-01-3,microtubule formation inhibitor|tubulin inhibitor|tubulin polymerisation inhibitor
25937,h23,BRD-A22844106-001-04-7,Cyclooxygenase inhibitor
25937,h24,BRD-A23034328-003-03-4,protein synthesis inhibitor
25937,i01,BRD-A23072235-050-04-5,Histamine receptor antagonist
25937,i02,BRD-A23226398-001-02-7,estrogen receptor agonist
25937,i03,BRD-A23683907-334-01-0,serotonin receptor antagonist
25937,i04,BRD-A23723433-001-01-2,tubulin inhibitor|microtubule stabilizing agent|microtubule stimulant|P glycoprotein inhibitor|taxane
25937,i08,BRD-A24122750-001-01-1,GABA receptor antagonist
25937,i09,BRD-A24191444-045-03-1,Adrenergic receptor antagonist
25937,i10,BRD-A24228527-001-04-2,Bacterial DNA gyrase inhibitor
25937,i13,BRD-A24514565-236-01-6,Vitamin K antagonist
25937,i15,BRD-A24587114-066-03-5,adrenergic receptor agonist
25937,i16,BRD-A24817035-001-04-7,central nervous system agent
25937,i17,BRD-A25234499-001-04-3,glucocorticoid receptor antagonist
25937,i20,BRD-A25775766-001-03-3,GABA receptor antagonist|TP53 activator
25937,i23,BRD-A26032986-050-01-3,Calmodulin antagonist
25937,i24,BRD-A26222320-001-02-6,protein synthesis inhibitor
25937,j01,BRD-A26334849-001-02-1,Antiarrhythmic
25937,j02,BRD-A26384407-001-04-6,Carbonic anhydrase inhibitor
25937,j03,BRD-A26711594-001-02-7,calcium channel blocker
25937,j07,BRD-A26845397-001-01-4,Adrenergic receptor antagonist
25937,j09,BRD-A27143604-001-01-2,Estrogen receptor agonist
25937,j14,BRD-A28318179-003-03-6,Nitric oxide synthase inhibitor
25937,j15,BRD-A28856712-003-04-7,adrenergic receptor agonist
25937,j18,BRD-A29260609-003-04-7,adrenergic receptor antagonist
25937,j19,BRD-A29289453-001-02-1,platelet activating factor receptor antagonist
25937,j20,BRD-A29322418-237-02-4,mineralocorticoid receptor antagonist
25937,k01,BRD-A29426959-050-04-1,Histamine receptor antagonist
25937,k02,BRD-A29437505-001-01-6,TLR agonist
25937,k04,BRD-A29644307-050-04-8,Dopamine uptake inhibitor
25937,k05,BRD-A29734509-011-02-9,Sodium channel blocker
25937,k10,BRD-A30590053-003-01-1,Acetylcholine release enhancer
25937,k11,BRD-A30655177-001-04-1,BTK inhibitor
25937,k13,BRD-A30717181-001-02-7,glucocorticoid receptor agonist
25937,k14,BRD-A30815329-001-03-0,Calcium channel blocker
25937,k17,BRD-A31007383-001-01-0,Adenosine receptor agonist
25937,k18,BRD-A31159102-001-01-9,Selective serotonin reuptake inhibitor (SSRI)
25937,k19,BRD-A31195449-004-01-9,Serotonin receptor agonist
25937,k20,BRD-A31521121-001-04-1,Muscle relaxant
25937,k21,BRD-A31575449-300-01-4,Adrenergic receptor antagonist
25937,l02,BRD-A31800922-003-04-6,acetylcholine receptor antagonist
25937,l05,BRD-A32164164-048-01-4,Acetylcholine receptor antagonist
25937,l06,BRD-A32505112-001-02-8,angiotensin converting enzyme inhibitor
25937,l09,BRD-A32673558-003-02-1,acetylcholine receptor agonist
25937,l10,BRD-A32949107-001-01-7,calcium channel blocker
25937,l12,BRD-A33168282-003-06-5,Adrenergic receptor antagonist
25937,l13,BRD-A33447119-001-02-5,Anthelmintic
25937,l14,BRD-A33711280-311-02-0,Acetylcholine receptor antagonist
25937,l19,BRD-A34255068-001-04-8,phosphodiesterase inhibitor
25937,l20,BRD-A34309505-001-08-5,benzodiazepine receptor agonist
25937,l22,BRD-A34706053-003-01-9,Adrenergic receptor agonist
25937,m01,BRD-A34751532-001-03-6,HSP inducer
25937,m03,BRD-A34788695-003-04-5,bacterial 30S ribosomal subunit inhibitor
25937,m04,BRD-A34806832-001-02-7,ATPase inhibitor
25937,m07,BRD-A35033682-001-01-0,cytochrome P450 inhibitor
25937,m08,BRD-A35338386-001-04-6,adenosine receptor agonist
25937,m11,BRD-A35511923-019-01-6,Somatostatin receptor agonist
25937,m12,BRD-A35623999-001-03-2,mitochondrial Na+/Ca2+ exchanger antagonist|sodium/calcium exchange inhibitor
25937,m16,BRD-A35931254-003-02-7,dopamine receptor agonist
25937,m18,BRD-A36066264-001-02-3,Estrogen receptor agonist
25937,m19,BRD-A36074203-003-03-5,Glutamate receptor antagonist
25937,m20,BRD-A36217750-001-04-9,Uricosuric blocker
25937,m21,BRD-A36267905-003-02-8,Adrenergic receptor agonist
25937,m22,BRD-A36318220-001-01-3,RIPK inhibitor
25937,m23,BRD-A36471396-003-02-2,Acetylcholine receptor antagonist
25937,n01,BRD-A37347161-003-01-8,opioid receptor agonist
25937,n02,BRD-A37432947-004-02-5,acetylcholine receptor antagonist
25937,n03,BRD-A37441042-003-02-2,adrenergic receptor agonist
25937,n04,BRD-A37492983-001-03-8,radiopaque medium
25937,n06,BRD-A37704979-001-02-4,p38 MAPK inhibitor
25937,n07,BRD-A37776212-003-02-5,opioid receptor agonist
25937,n17,BRD-A38747044-001-01-5,Imidazoline receptor ligand
25937,n18,BRD-A38898897-003-01-0,Leukocyte elastase inhibitor
25937,n19,BRD-A38913120-001-01-0,BCL inhibitor
25937,n21,BRD-A39230911-001-03-7,Muscle relaxant
25937,n22,BRD-A39255369-001-01-5,Chloride channel blocker
25937,n23,BRD-A39268308-001-02-0,Acetylcholine receptor agonist
25937,o01,BRD-A39522003-001-01-0,FAAH inhibitor|FAAH reuptake inhibitor
25937,o03,BRD-A39747742-001-02-7,estrogen receptor agonist
25937,o05,BRD-A39969961-001-01-3,Cytochrome P450 inhibitor
25937,o06,BRD-A40022950-001-02-9,ATPase inhibitor
25937,o08,BRD-A40639672-234-04-0,Cyclooxygenase inhibitor
25937,o10,BRD-A41112154-001-02-1,G protein-coupled receptor agonist
25937,o13,BRD-A41145729-001-02-7,Retinoid receptor agonist
25937,o14,BRD-A41250306-001-03-4,Thiazide diuretic
25937,o15,BRD-A41301928-001-02-5,"Mitochondrial ADP, ATP translocase inhibitor"
25937,o16,BRD-A41304429-001-04-9,Adrenergic receptor antagonist
25937,o17,BRD-A41451487-001-01-3,Benzodiazepine receptor antagonist
25937,o18,BRD-A41519720-001-02-2,Niemann-Pick C1-like 1 protein antagonist
25937,o19,BRD-A41722204-003-01-5,adenosine receptor antagonist
25937,o20,BRD-A41833852-001-01-9,Opioid receptor antagonist
25937,o22,BRD-A41941932-001-03-0,Antioxidant
25937,o23,BRD-A42167015-003-03-7,Adrenergic receptor antagonist
25937,o24,BRD-A42335949-300-04-9,phosphatidylglycerophosphatase inhibitor
25937,p01,BRD-A42346008-003-03-6,epinephrine metabolite
25937,p02,BRD-A42553870-001-05-1,neuropeptide receptor antagonist
25937,p03,BRD-A42571354-300-01-3,histamine receptor antagonist
25937,p04,BRD-A42628519-001-04-1,radiopaque medium
25937,p05,BRD-A42759514-001-03-1,Antiprotozoal
25937,p06,BRD-A42831637-001-02-2,anti-inflammatory|Cannabinoid metabolite
25937,p07,BRD-A43076080-001-03-3,protein phosphatase inhibitor
25937,p09,BRD-A43150328-001-02-0,other antibiotic
25937,p13,BRD-A43671941-003-03-6,Adrenergic receptor antagonist
25937,p14,BRD-A43849199-001-02-3,Phytotoxin
25937,p15,BRD-A43930669-003-01-0,oxytocin receptor antagonist
25937,p16,BRD-A43940795-001-02-8,serotonin release inhibitor
25937,p17,BRD-A43974499-066-01-1,Adrenergic receptor antagonist
25937,p19,BRD-A44008656-036-04-3,Histamine receptor antagonist
25937,p20,BRD-A44090213-001-04-1,Cyclooxygenase inhibitor
25937,p21,BRD-A44133049-001-01-5,Serotonin receptor antagonist
25937,p22,BRD-A44448661-001-02-2,Barbiturate antiepileptic
25937,p23,BRD-A44551378-001-01-9,EGFR inhibitor
25937,p24,BRD-A44863528-001-04-1,CCK receptor antagonist
25966,a01,BRD-A97104540-004-04-4,adrenergic receptor agonist
25966,a04,BRD-A97479839-003-04-2,Acetylcholine receptor antagonist
25966,a05,BRD-A97701745-001-04-6,adrenergic receptor antagonist|serotonin receptor antagonist
25966,a06,BRD-A97730597-003-03-2,sodium channel blocker
25966,a07,BRD-A97739905-001-04-2,cyclooxygenase inhibitor
25966,a08,BRD-A98299281-050-03-9,calcium channel activator
25966,a09,BRD-A98378129-001-01-4,cyclooxygenase inhibitor|calcium channel blocker|calcium-activated chloride channel blocker|mucin production inhibitor
25966,a10,BRD-A98702003-304-02-2,11-beta-HSD1 inhibitor
25966,a11,BRD-A98725278-103-01-9,serotonin receptor antagonist
25966,a15,BRD-A99177642-001-02-5,acetylcholine receptor antagonist
25966,a16,BRD-A99402294-236-02-0,bacterial cell wall synthesis inhibitor
25966,a17,BRD-A99411506-002-01-3,antioxidant
25966,a18,BRD-A99449986-001-01-4,adenine nucleotide translocase inhibitor|caspase activator|neurotrophic agent
25966,a19,BRD-A99571536-001-01-0,anti-epileptic
25966,a20,BRD-K00141480-001-03-0,anti-inflammatory agent|interleukin inhibitor
25966,a21,BRD-K00184207-001-02-4,aryl hydrocarbon receptor ligand
25966,a22,BRD-K00206590-001-01-2,ATP channel activator
25966,a23,BRD-K00259736-001-03-2,microtubule inhibitor
25966,a24,BRD-K00312224-001-03-8,estrogen receptor agonist
25966,b03,BRD-K00603606-003-03-4,purinergic receptor antagonist|platelet aggregation inhibitor
25966,b04,BRD-K00610438-003-01-7,serotonin receptor antagonist|collagen stimulant
25966,b05,BRD-K00662280-001-01-1,GABA receptor agonist
25966,b06,BRD-K00673382-001-04-9,histamine receptor antagonist
25966,b07,BRD-K00675675-003-01-2,metalloproteinase inhibitor
25966,b09,BRD-K00824317-001-03-0,glucocorticoid receptor agonist
25966,b11,BRD-K01095011-001-03-5,5 alpha reductase inhibitor
25966,b15,BRD-K01244426-236-04-8,bacterial cell wall synthesis inhibitor
25966,b16,BRD-K01292756-001-06-0,dopamine receptor antagonist
25966,b19,BRD-K01567962-001-06-5,JNK inhibitor
25966,b20,BRD-K01624546-001-02-8,LTB4 inhibitor
25966,b21,BRD-K01648091-001-04-2,Dopamine receptor antagonist
25966,b22,BRD-K01663662-003-03-8,muscarinic antagonist
25966,b23,BRD-K01815685-001-02-3,aryl hydrocarbon receptor agonist
25966,c01,BRD-K01868942-001-01-3,serotonin receptor antagonist
25966,c02,BRD-K01902415-001-03-4,PPAR receptor agonist
25966,c05,BRD-K02265150-001-04-2,norepinephrine reputake inhibitor
25966,c06,BRD-K02275692-003-03-4,bacterial cell wall synthesis inhibitor
25966,c07,BRD-K02283807-003-01-4,thromboxane receptor antagonist
25966,c09,BRD-K02404261-001-02-7,Adenosine receptor antagonist
25966,c10,BRD-K02407574-001-03-0,tubulin polymerization inhibitor
25966,c14,BRD-K02581333-001-01-8,Tyrosine phosphatase inhibitor
25966,c17,BRD-K02590140-001-01-2,cannabinoid receptor antagonist
25966,c18,BRD-K02607075-333-03-6,Acetylcholine receptor antagonist
25966,c19,BRD-K02637541-001-02-4,Cyclooxygenase inhibitor
25966,c22,BRD-K02764365-001-03-7,anthelmintic agent
25966,c23,BRD-K02867583-300-04-8,serotonin reuptake inhibitor
25966,c24,BRD-K02900412-001-02-2,protein synthesis inhibitor
25966,d01,BRD-K02953697-001-01-9,cytochrome P450 inhibitor
25966,d03,BRD-K03015355-003-01-5,adenylyl cyclase activator|Adenylate cyclase stimulant|growth hormone receptor agonist|phosphokinase stimulant
25966,d04,BRD-K03067624-300-02-9,protein synthesis inhibitor
25966,d06,BRD-K03109492-001-01-4,CDC inhibitor
25966,d07,BRD-K03384561-001-01-9,Angiogenesis inhibitor
25966,d08,BRD-K03440695-001-02-6,Acetylcholine receptor antagonist
25966,d13,BRD-K03600606-001-02-3,Beta secretase inhibitor
25966,d14,BRD-K03602135-236-02-1,HMGCR inhibitor
25966,d17,BRD-K03642198-300-01-7,hedgehog pathway inhibitor
25966,d18,BRD-K03670461-001-02-0,EGFR inhibitor
25966,d19,BRD-K03842655-001-02-1,potassium channel blocker
25966,d20,BRD-K03981224-001-02-9,Progestogen hormone
25966,d21,BRD-K04010869-001-02-6,HSP inducer|NFKB pathway inhibitor
25966,d22,BRD-K04046242-001-03-6,Estrogen receptor agonist
25966,d23,BRD-K04111260-001-01-9,Dopamine receptor antagonist
25966,d24,BRD-K04170657-001-02-4,Ras GTPase inhibitor
25966,e03,BRD-K04185004-003-03-6,Local anesthetic
25966,e04,BRD-K04414442-001-03-4,tachykinin antagonist
25966,e05,BRD-K04430056-001-02-9,nitric oxide synthase inhibitor
25966,e06,BRD-K04704168-003-03-6,HCV inhibitor
25966,e08,BRD-K04976539-001-01-0,PKC inhibitor|src inhibitor
25966,e11,BRD-K05151076-001-01-8,estrogen receptor antagonist
25966,e12,BRD-K05181084-003-02-9,dopamine receptor antagonist
25966,e13,BRD-K05181463-001-01-6,Dopamine receptor antagonist
25966,e16,BRD-K05434375-001-04-0,calcium channel blocker
25966,e19,BRD-K05464208-001-01-6,p38 MAPK inhibitor
25966,e21,BRD-K05653692-001-02-5,Glucosyltransferase inhibitor
25966,e22,BRD-K05673000-323-02-8,Bacterial cell wall synthesis inhibitor
25966,e23,BRD-K05901394-001-01-1,Dopamine receptor agonist
25966,e24,BRD-K05906022-001-02-8,HIV protease inhibitor
25966,f03,BRD-K05977355-001-02-6,sterol demethylase inhibitor
25966,f05,BRD-K06014311-001-01-2,Melatonin receptor antagonist
25966,f06,BRD-K06024458-001-01-4,cannabinoid receptor agonist
25966,f07,BRD-K06147391-003-01-9,Acetylcholine receptor antagonist
25966,f08,BRD-K06159959-001-01-2,Inhibitor of the binding of homoquinolinic acid to non-NMDA sensitive sites
25966,f12,BRD-K06208435-001-02-9,Calcium channel blocker
25966,f13,BRD-K06221026-001-03-5,Cyclooxygenase inhibitor
25966,f14,BRD-K06234293-001-01-8,TGF beta receptor inhibitor|p38 MAPK inhibitor
25966,f15,BRD-K06426971-001-01-9,histone lyinse methyltransferase inhibitor
25966,f19,BRD-K06467078-001-01-5,Adrenergic receptor antagonist
25966,f20,BRD-K06543683-001-03-6,PKC inhibitor|glycogen synthase kinase inhibitor|leucine rich repeat kinase inhibitor|SIRT inhibitor
25966,f21,BRD-K06593056-001-01-4,retinoid receptor agonist
25966,f22,BRD-K06753942-001-02-0,MEK inhibitor
25966,f23,BRD-K06854232-001-03-3,retinoid receptor agonist
25966,f24,BRD-K06980535-003-04-4,Dopamine receptor antagonist
25966,g02,BRD-K07117950-001-02-6,CDK inhibitor
25966,g06,BRD-K07212038-001-02-1,Mast cell stabilizer
25966,g07,BRD-K07220430-001-03-6,Calcium channel blocker
25966,g08,BRD-K07325606-001-02-3,PKC inhibitor
25966,g10,BRD-K07507905-236-01-8,adrenergic receptor agonist
25966,g13,BRD-K07691486-001-05-6,CDK inhibitor
25966,g14,BRD-K07888196-001-01-8,IGF-1 inhibitor
25966,g15,BRD-K08078237-001-04-0,calcium channel blocker
25966,g16,BRD-K08109516-001-01-1,glutamate receptor antagonist
25966,g17,BRD-K08115555-001-02-8,catechol O methyltransferase inhibitor|tumor necrosis factor inhibitor
25966,g18,BRD-K08132273-001-01-6,EGFR inhibitor
25966,g22,BRD-K08219523-001-01-9,Serotonin receptor agonist
25966,g23,BRD-K08252256-236-04-9,Cyclooxygenase inhibitor
25966,g24,BRD-K08287586-001-03-6,DNA synthesis inhibitor
25966,h01,BRD-K08316444-001-02-7,inhibitor of mitochondrial electron transport
25966,h05,BRD-K08438429-001-01-0,glucosylceramidase inhibitor|somatostatin receptor agonist
25966,h07,BRD-K08554278-001-02-4,DNA binding agent
25966,h09,BRD-K08619574-334-03-9,Dopamine receptor antagonist
25966,h10,BRD-K08619838-300-03-2,Acetylcholine receptor agonist
25966,h11,BRD-K08640512-003-01-5,Adrenergic receptor antagonist
25966,h13,BRD-K08806317-050-03-6,Adrenergic receptor antagonist
25966,h14,BRD-K08890269-001-01-5,Sodium channel blocker
25966,h16,BRD-K08973992-001-01-3,Oxidative stress inducer
25966,h17,BRD-K08996725-313-01-7,histamine receptor antagonist
25966,h18,BRD-K08998509-001-01-6,dopamine receptor antagonist|serotonin receptor antagonist
25966,h23,BRD-K09132007-001-01-8,casein kinase inhibitor|TGF beta receptor inhibitor
25966,i01,BRD-K09255212-001-03-4,chelating agent
25966,i02,BRD-K09397065-001-01-6,Serotonin receptor agonist
25966,i03,BRD-K09416995-001-16-7,HMGCR inhibitor
25966,i04,BRD-K09471561-001-02-6,bacterial DNA gyrase inhibitor
25966,i07,BRD-K09537769-001-01-6,DNA dependent protein kinase inhibitor|mTOR inhibitor|PI3K inhibitor
25966,i08,BRD-K09549677-300-01-8,T-type calcium channel blocker|angiogenesis inhibitor|calcium channel blocker|calcium channel inhibitor|L-type calcium channel blocker|sodium channel blocker
25966,i09,BRD-K09598619-065-01-5,tubulin polymerization inhibitor
25966,i10,BRD-K09631521-001-02-4,cytochrome P450 inhibitor
25966,i11,BRD-K09635134-001-02-4,negative control for D-erythro-MAPP
25966,i12,BRD-K09635314-001-01-8,phospholipase activator
25966,i13,BRD-K09668667-001-02-0,Carcinogen
25966,i14,BRD-K09764130-001-02-6,Cannabinoid receptor agonist
25966,i15,BRD-K09778810-001-01-5,inositol monophosphatase inhibitor
25966,i17,BRD-K09963420-066-03-4,HIV protease inhibitor
25966,i18,BRD-K10042277-001-02-7,cetylcholine receptor agonist|dopamine receptor agonist|dopamine receptor antagonist|dopamine receptor partial agonist|serotonin receptor antagonist|serotonin receptor inverse agonist
25966,i19,BRD-K10065684-001-02-5,laxative
25966,i23,BRD-K10176267-001-01-7,glutamate receptor antagonist
25966,i24,BRD-K10177585-003-01-6,Adenosine receptor antagonist
25966,j01,BRD-K10207760-236-03-0,bacterial permeability inducer
25966,j02,BRD-K10314788-003-04-4,nootropic agent
25966,j07,BRD-K10670311-001-04-9,Antirheumatic
25966,j10,BRD-K10705233-001-01-4,Cannabinoid receptor agonist
25966,j11,BRD-K10843433-001-02-9,Cyclooxygenase inhibitor
25966,j12,BRD-K10870738-001-02-4,lipoxygenase inhibitor
25966,j13,BRD-K10974103-001-03-9,Protein synthesis inhibitor
25966,j15,BRD-K10995081-001-05-5,Dopamine receptor antagonist
25966,j16,BRD-K11107424-001-01-1,histamine receptor antagonist
25966,j17,BRD-K11129031-001-04-4,Lipoprotein lipase activator
25966,j18,BRD-K11158509-001-02-0,EGFR inhibitor
25966,j19,BRD-K11163873-001-02-8,PARP inhibitor
25966,j24,BRD-K11298197-001-03-9,protein synthesis inhibitor
25966,k01,BRD-K11373525-003-01-3,Angiotensin receptor antagonist
25966,k02,BRD-K11399644-003-03-0,AMPK activator
25966,k04,BRD-K11634954-300-01-8,dopamine uptake inhibitor
25966,k06,BRD-K11696279-003-01-5,Imidazoline receptor agonist
25966,k09,BRD-K11717138-001-03-0,chloride channel blocker
25966,k10,BRD-K11742128-003-04-4,histamine receptor antagonist
25966,k13,BRD-K11911061-003-02-8,serotonin receptor antagonist
25966,k14,BRD-K11927976-050-01-1,mediator release inhibitor|syk inhibitor
25966,k17,BRD-K12102668-001-04-0,Monoamine oxidase inhibitor
25966,k18,BRD-K12120659-305-01-4,Integrin antagonist
25966,k20,BRD-K12184470-300-01-8,calcium channel blocker|T-type calcium channel blocker
25966,k21,BRD-K12219985-001-04-8,Sulfonylurea
25966,k22,BRD-K12244279-001-01-7,MEK inhibitor
25966,l03,BRD-K12357156-001-01-5,EGFR inhibitor|ErbB2 inhibitor|JAK2 inhibitor
25966,l04,BRD-K12513978-001-04-3,cyclooxygenase inhibitor
25966,l05,BRD-K12539581-001-06-2,tubulin polymerization inhibitor
25966,l12,BRD-K12932420-001-01-5,Phosphodiesterase inhibitor
25966,l14,BRD-K12994359-001-02-8,Cyclooxygenase inhibitor
25966,l19,BRD-K13169950-001-04-5,HDAC inhibitor
25966,l20,BRD-K13211965-001-01-4,dopamine receptor antagonist
25966,l21,BRD-K13261168-001-01-4,Dopamine receptor agonist
25966,m01,BRD-K13533483-001-03-0,calcineurin inhibitor|cyclophilin inhibitor|immunosuppressant|insulin expression inhibitor|T cell inhibitor
25966,m02,BRD-K13544237-001-01-0,dopamine receptor agonist|antiamyloidogenic agent
25966,m03,BRD-K13571841-001-03-7,Aspartic protease inhibitor
25966,m04,BRD-K13642330-001-02-6,cytochrome P450 inhibitor
25966,m05,BRD-K13819402-003-02-9,Acetylcholinesterase inhibitor
25966,m07,BRD-K13994703-001-02-0,adrenergic receptor antagonist
25966,m11,BRD-K14200658-001-02-6,Vesicular monoamine transporter inhibitor
25966,m12,BRD-K14221570-236-01-1,HIV entry inhibitor
25966,m16,BRD-K14282469-001-01-5,serotonin receptor antagonist
25966,m18,BRD-K14441456-001-01-2,EGFR inhibitor
25966,m19,BRD-K14496212-001-01-1,dopamine receptor agonist
25966,m21,BRD-K14618467-003-01-8,IKK inhibitor
25966,n01,BRD-K14765469-003-02-3,acetylcholinesterase inhibitor
25966,n02,BRD-K14767410-001-01-5,cyclooxygenase inhibitor
25966,n03,BRD-K14807180-001-01-7,serotonin receptor antagonist
25966,n04,BRD-K14821540-001-02-1,mitochondrial oxidative phosphorylation uncoupler
25966,n06,BRD-K14888893-001-02-3,KATP activator
25966,n07,BRD-K14965640-001-03-3,Cyclooxygenase inhibitor
25966,n08,BRD-K14993104-001-03-4,Chemoreceptor agonist
25966,n11,BRD-K15025317-001-04-5,NFkB pathway inhibitor
25966,n12,BRD-K15164005-001-01-5,carboxylesterase inhibitor
25966,n15,BRD-K15196155-001-01-5,Hydroxycarboxylic acid receptor agonist
25966,n17,BRD-K15519488-001-01-6,dopamine receptor agonist
25966,n19,BRD-K15567136-001-01-1,phosphodiesterase inhibitor
25966,n21,BRD-K15588452-003-01-9,serotonin receptor antagonist
25966,n22,BRD-K15601958-001-01-3,Lysophospholipid receptor agonist
25966,n23,BRD-K15616905-001-01-5,mitochondrial oxidative phosphorylation uncoupler
25966,n24,BRD-K15715913-001-01-5,dopamine receptor antagonist|serotonin receptor antagonist
25966,o01,BRD-K15766189-001-02-3,bacterial cell wall synthesis inhibitor
25966,o02,BRD-K15791587-003-01-7,tachykinin antagonist
25966,o04,BRD-K15868788-001-01-4,Serotonin receptor antagonist
25966,o05,BRD-K15916496-001-04-8,cytochrome P450 inhibitor|imidazoline receptor ligand
25966,o06,BRD-K15933101-003-01-2,dopamine receptor agonist|dopamine receptor modulator
25966,o07,BRD-K15935639-001-02-0,PGPH inhibitor|proteasome inhibitor
25966,o08,BRD-K15957397-001-02-6,CDC inhibitor
25966,o09,BRD-K16195444-001-01-7,Adrenergic receptor agonist
25966,o10,BRD-K16444452-001-03-4,phosphodiesterase inhibitor|leukotriene receptor antagonist|toll-like receptor antagonist|macrophage migration inhibiting factor inhibitor|macrophage migration inhibiting factor modulator|mediator release inhibitor|nitric oxide synthase inhibitor
25966,o14,BRD-K16485616-001-01-4,HDAC inhibitor|cell cycle inhibitor
25966,o15,BRD-K16508793-001-01-8,benzodiazepine receptor agonist
25966,o16,BRD-K16542329-001-05-1,phosphodiesterase inhibitor
25966,o17,BRD-K16551401-003-01-8,serotonin receptor agonist
25966,o19,BRD-K16604360-001-01-8,antiamyloidogenic agent|dopamine receptor agonist
25966,o20,BRD-K16664969-001-01-7,FLT3 inhibitor|tyrosine kinase inhibitor
25966,o22,BRD-K16977723-001-01-0,EGFR inhibitor
25966,o23,BRD-K17016787-001-03-5,estrogen receptor agonist
25966,p01,BRD-K17140735-300-01-6,Proteasome inhibitor
25966,p03,BRD-K17294426-050-04-0,dopamine receptor antagonist
25966,p04,BRD-K17368287-001-03-5,11-beta hydroxysteroid dehydrogenase inhibitor
25966,p05,BRD-K17378184-300-03-4,Dopamine receptor agonist
25966,p06,BRD-K17415526-001-02-7,protein tyrosine kinase inhibitor
25966,p07,BRD-K17497770-001-01-0,EGFR inhibitor|src inhibitor
25966,p08,BRD-K17565903-066-04-1,muscle relaxant
25966,p09,BRD-K17674993-001-03-1,Corticosteroid agonist
25966,p10,BRD-K17693482-001-03-9,potassium channel activator
25966,p13,BRD-K17705806-003-01-0,opioid receptor antagonist
25966,p14,BRD-K17743125-001-01-9,HDAC inhibitor|cell cycle inhibitor
25966,p15,BRD-K17743697-066-01-0,sodium/calcium exchange inhibitor
25966,p16,BRD-K17796732-001-02-0,cannabinoid receptor agonist
25966,p19,BRD-K17894950-001-04-4,CDK inhibitor|glycogen synthase kinase inhibitor
25966,p20,BRD-K17896185-001-01-2,opioid receptor agonist
25966,p21,BRD-K18059238-001-02-1,cyclooxygenase inhibitor|prostanoid receptor stimulant|thromboxane synthase stimulant
25966,p24,BRD-K18194590-065-02-3,adrenergic receptor agonist
24295,a01,BRD-A00100033-001-04-8,DNA inhibitor
24295,a02,BRD-A00267231-001-01-1,Adenosine receptor agonist
24295,a04,BRD-A00520476-001-03-3,Acetylcholine receptor antagonist
24295,a06,BRD-A00993607-003-04-8,Adrenergic receptor antagonist
24295,a07,BRD-A01078468-001-04-9,synthetic estrogen
24295,a08,BRD-A01295252-001-01-5,Dopamine receptor ligand
24295,a09,BRD-A01320529-001-05-9,adrenergic receptor agonist
24295,a11,BRD-A01593789-001-01-5,5 alpha reductase inhibitor
24295,a12,BRD-A01636364-003-04-5,sodium channel blocker
24295,a15,BRD-A01787639-003-08-6,adrenergic receptor antagonist
24295,a16,BRD-A02006392-001-06-5,calcium channel blocker
24295,a17,BRD-A02176148-001-02-2,Mitochondrial complex I inhibitor
24295,a19,BRD-A02710418-003-03-5,opioid receptor agonist
24295,a20,BRD-A02713983-001-02-0,growth factor receptor activator
24295,a21,BRD-A02759312-003-11-2,Adrenergic receptor antagonist
24295,a23,BRD-A03216249-003-02-9,Potassium channel blocker
24295,a24,BRD-A03359064-001-01-5,Adrenergic receptor antagonist
24295,b02,BRD-A03623303-045-02-0,Adrenergic receptor antagonist
24295,b03,BRD-A03816571-001-01-0,cannabinoid receptor agonist|CC chemokine receptor antagonist
24295,b09,BRD-A04322457-003-03-9,adrenergic receptor agonist
24295,b10,BRD-A04438777-001-01-4,dopamine receptor agonist
24295,b11,BRD-A04553218-050-03-0,histamine receptor antagonist
24295,b15,BRD-A04668240-001-01-5,GABA receptor antagonist
24295,b16,BRD-A04706586-236-01-7,Adenosine receptor agonist
24295,b18,BRD-A05186015-003-04-0,dopamine uptake inhibitor
24295,b24,BRD-A06352418-001-03-6,Histamine receptor antagonist
24295,c01,BRD-A06352508-001-02-9,CHK inhibitor
24295,c02,BRD-A06390036-001-02-0,Antiarrhythmic
24295,c03,BRD-A06726973-001-02-0,cGMP analog
24295,c04,BRD-A06935312-001-02-7,bacterial 30S ribosomal subunit inhibitor
24295,c06,BRD-A07207424-001-04-1,phosphodiesterase inhibitor
24295,c08,BRD-A07440155-003-04-9,Adrenergic receptor antagonist
24295,c09,BRD-A07780951-001-02-2,Adrenergic receptor agonist
24295,c10,BRD-A07824748-001-02-6,11-beta hydroxysteroid dehydrogenase inhibitor
24295,c14,BRD-A07875874-001-01-6,calcium channel blocker
24295,c17,BRD-A07932845-001-01-1,anti-HCVE2
24295,c18,BRD-A07952294-001-02-3,farnesyltransferase inhibitors
24295,c19,BRD-A08187463-001-03-8,enkephalinase inhibitor
24295,c22,BRD-A08709697-001-02-9,pyrrolizidine alkaloid
24295,c23,BRD-A08877921-001-02-2,Protein synthesis inhibitor
24295,c24,BRD-A09056319-003-03-6,Adrenergic receptor antagonist
24295,d01,BRD-A09062839-003-03-5,Local anesthetic
24295,d02,BRD-A09094913-001-02-3,acetylcholine receptor antagonist
24295,d03,BRD-A09161221-001-01-9,HSP inhibitor
24295,d04,BRD-A09349126-001-02-4,progesterone receptor agonist
24295,d05,BRD-A09467419-003-04-2,acetylcholine receptor antagonist
24295,d06,BRD-A09472452-001-02-8,Sodium channel blocker
24295,d07,BRD-A09533288-001-02-7,calcium channel blocker
24295,d08,BRD-A09539288-004-02-8,Acetylcholine receptor antagonist
24295,d09,BRD-A09828896-004-04-5,Dopamine receptor agonist
24295,d10,BRD-A09925278-003-03-1,Adrenergic receptor agonist
24295,d14,BRD-A10070317-003-05-1,adrenergic receptor antagonist
24295,d17,BRD-A10355991-003-01-8,Glutamate receptor antagonist
24295,d18,BRD-A10715913-001-02-0,Dopamine receptor antagonist
24295,d19,BRD-A10739734-003-01-5,adrenergic receptor antagonist
24295,d20,BRD-A10903566-003-02-8,Adrenergic receptor antagonist
24295,d21,BRD-A10969569-001-02-0,Plant alkaloid
24295,d22,BRD-A10977446-001-04-8,Adrenergic receptor antagonist
24295,e03,BRD-A11605036-001-03-2,GABA receptor antagonist
24295,e04,BRD-A11609859-303-01-2,opioid receptor agonist
24295,e05,BRD-A11678676-001-02-6,PI3K inhibitor
24295,e07,BRD-A11813248-001-02-8,Potassium channel blocker
24295,e08,BRD-A12016240-001-01-7,Serotonin receptor antagonist
24295,e14,BRD-A13188892-066-03-3,Adrenergic receptor antagonist
24295,e15,BRD-A13650332-236-03-9,Bacterial cell wall synthesis inhibitor
24295,e16,BRD-A13946108-001-03-1,Cyclooxygenase inhibitor
24295,e23,BRD-A14395271-001-01-5,Dopamine receptor antagonist
24295,e24,BRD-A14566392-004-03-5,acetylcholine receptor antagonist
24295,f03,BRD-A14574269-051-01-4,Acetylcholine receptor agonist
24295,f04,BRD-A15034104-002-03-6,interleukin inhibitor
24295,f05,BRD-A15070535-323-02-1,adenosine receptor agonist|cAMP stimulant
24295,f06,BRD-A15415227-003-01-1,PPAR receptor agonist
24295,f07,BRD-A15435692-003-01-5,sigma receptor antagonist|glutamate receptor antagonist|serotonin receptor agonist
24295,f11,BRD-A15530910-001-01-3,adrenergic receptor antagonist|serotonin receptor antagonist
24295,f14,BRD-A15914070-001-01-5,cytotoxic lipid peroxidation product
24295,f15,BRD-A16332958-001-02-4,Adrenergic receptor agonist
24295,f16,BRD-A16665823-008-03-3,Bacterial cell wall synthesis inhibitor
24295,f19,BRD-A16694057-001-02-7,PPAR receptor antagonist
24295,f21,BRD-A17065207-001-06-9,protein synthesis inhibitor
24295,f23,BRD-A17428743-001-01-1,Serotonin receptor agonist
24295,f24,BRD-A17453586-001-01-9,Serotonin receptor agonist
24295,g02,BRD-A17535965-001-02-2,Acetylcholine receptor antagonist
24295,g05,BRD-A17655518-001-02-0,Cyclooxygenase inhibitor
24295,g08,BRD-A18043272-001-03-2,succinimide antiepileptic
24295,g09,BRD-A18202423-001-01-6,Glutamate receptor antagonist
24295,g10,BRD-A18497530-001-04-6,adenosine kinase inhibitor|nucleoside transporter inhibitor
24295,g11,BRD-A18579359-001-03-1,Neural Wiskott-Aldrich syndrome protein inhibitor
24295,g12,BRD-A18696154-003-11-9,adrenergic receptor antagonist
24295,g13,BRD-A18763547-019-01-0,Cytochrome C release inhibitor
24295,g15,BRD-A19053259-003-03-3,Anthelmintic
24295,g17,BRD-A19195498-050-04-2,Norepinephrine reuptake inhibitor
24295,g18,BRD-A19736161-310-01-3,Serotonin receptor antagonist
24295,g23,BRD-A20239487-001-02-5,Adrenergic receptor antagonist
24295,h01,BRD-A20348246-001-04-2,GABA receptor modulator
24295,h06,BRD-A20968261-001-01-3,glutamate transporter inhibitor
24295,h08,BRD-A21723284-066-01-7,Opioid receptor antagonist
24295,h09,BRD-A21858158-001-04-5,Anthelmintic
24295,h14,BRD-A22305049-003-04-5,gluconeogenesis inhibitor
24295,h15,BRD-A22380646-001-01-5,ATPase inhibitor
24295,h16,BRD-A22684332-003-02-3,adrenergic receptor agonist
24295,h17,BRD-A22707317-001-02-5,GABA receptor modulator
24295,h21,BRD-A22769835-300-03-2,Antihistamine
24295,h22,BRD-A22783572-065-01-3,microtubule formation inhibitor|tubulin inhibitor|tubulin polymerisation inhibitor
24295,h23,BRD-A22844106-001-04-7,Cyclooxygenase inhibitor
24295,h24,BRD-A23034328-003-03-4,protein synthesis inhibitor
24295,i01,BRD-A23072235-050-04-5,Histamine receptor antagonist
24295,i02,BRD-A23226398-001-02-7,estrogen receptor agonist
24295,i03,BRD-A23683907-334-01-0,serotonin receptor antagonist
24295,i04,BRD-A23723433-001-01-2,tubulin inhibitor|microtubule stabilizing agent|microtubule stimulant|P glycoprotein inhibitor|taxane
24295,i08,BRD-A24122750-001-01-1,GABA receptor antagonist
24295,i09,BRD-A24191444-045-03-1,Adrenergic receptor antagonist
24295,i10,BRD-A24228527-001-04-2,Bacterial DNA gyrase inhibitor
24295,i13,BRD-A24514565-236-01-6,Vitamin K antagonist
24295,i15,BRD-A24587114-066-03-5,adrenergic receptor agonist
24295,i16,BRD-A24817035-001-04-7,central nervous system agent
24295,i17,BRD-A25234499-001-04-3,glucocorticoid receptor antagonist
24295,i20,BRD-A25775766-001-03-3,GABA receptor antagonist|TP53 activator
24295,i23,BRD-A26032986-050-01-3,Calmodulin antagonist
24295,i24,BRD-A26222320-001-02-6,protein synthesis inhibitor
24295,j01,BRD-A26334849-001-02-1,Antiarrhythmic
24295,j02,BRD-A26384407-001-04-6,Carbonic anhydrase inhibitor
24295,j03,BRD-A26711594-001-02-7,calcium channel blocker
24295,j07,BRD-A26845397-001-01-4,Adrenergic receptor antagonist
24295,j09,BRD-A27143604-001-01-2,Estrogen receptor agonist
24295,j14,BRD-A28318179-003-03-6,Nitric oxide synthase inhibitor
24295,j15,BRD-A28856712-003-04-7,adrenergic receptor agonist
24295,j18,BRD-A29260609-003-04-7,adrenergic receptor antagonist
24295,j19,BRD-A29289453-001-02-1,platelet activating factor receptor antagonist
24295,j20,BRD-A29322418-237-02-4,mineralocorticoid receptor antagonist
24295,k01,BRD-A29426959-050-04-1,Histamine receptor antagonist
24295,k02,BRD-A29437505-001-01-6,TLR agonist
24295,k04,BRD-A29644307-050-04-8,Dopamine uptake inhibitor
24295,k05,BRD-A29734509-011-02-9,Sodium channel blocker
24295,k10,BRD-A30590053-003-01-1,Acetylcholine release enhancer
24295,k11,BRD-A30655177-001-04-1,BTK inhibitor
24295,k13,BRD-A30717181-001-02-7,glucocorticoid receptor agonist
24295,k14,BRD-A30815329-001-03-0,Calcium channel blocker
24295,k17,BRD-A31007383-001-01-0,Adenosine receptor agonist
24295,k18,BRD-A31159102-001-01-9,Selective serotonin reuptake inhibitor (SSRI)
24295,k19,BRD-A31195449-004-01-9,Serotonin receptor agonist
24295,k20,BRD-A31521121-001-04-1,Muscle relaxant
24295,k21,BRD-A31575449-300-01-4,Adrenergic receptor antagonist
24295,l02,BRD-A31800922-003-04-6,acetylcholine receptor antagonist
24295,l05,BRD-A32164164-048-01-4,Acetylcholine receptor antagonist
24295,l06,BRD-A32505112-001-02-8,angiotensin converting enzyme inhibitor
24295,l09,BRD-A32673558-003-02-1,acetylcholine receptor agonist
24295,l10,BRD-A32949107-001-01-7,calcium channel blocker
24295,l12,BRD-A33168282-003-06-5,Adrenergic receptor antagonist
24295,l13,BRD-A33447119-001-02-5,Anthelmintic
24295,l14,BRD-A33711280-311-02-0,Acetylcholine receptor antagonist
24295,l19,BRD-A34255068-001-04-8,phosphodiesterase inhibitor
24295,l20,BRD-A34309505-001-08-5,benzodiazepine receptor agonist
24295,l22,BRD-A34706053-003-01-9,Adrenergic receptor agonist
24295,m01,BRD-A34751532-001-03-6,HSP inducer
24295,m03,BRD-A34788695-003-04-5,bacterial 30S ribosomal subunit inhibitor
24295,m04,BRD-A34806832-001-02-7,ATPase inhibitor
24295,m07,BRD-A35033682-001-01-0,cytochrome P450 inhibitor
24295,m08,BRD-A35338386-001-04-6,adenosine receptor agonist
24295,m11,BRD-A35511923-019-01-6,Somatostatin receptor agonist
24295,m12,BRD-A35623999-001-03-2,mitochondrial Na+/Ca2+ exchanger antagonist|sodium/calcium exchange inhibitor
24295,m16,BRD-A35931254-003-02-7,dopamine receptor agonist
24295,m18,BRD-A36066264-001-02-3,Estrogen receptor agonist
24295,m19,BRD-A36074203-003-03-5,Glutamate receptor antagonist
24295,m20,BRD-A36217750-001-04-9,Uricosuric blocker
24295,m21,BRD-A36267905-003-02-8,Adrenergic receptor agonist
24295,m22,BRD-A36318220-001-01-3,RIPK inhibitor
24295,m23,BRD-A36471396-003-02-2,Acetylcholine receptor antagonist
24295,n01,BRD-A37347161-003-01-8,opioid receptor agonist
24295,n02,BRD-A37432947-004-02-5,acetylcholine receptor antagonist
24295,n03,BRD-A37441042-003-02-2,adrenergic receptor agonist
24295,n04,BRD-A37492983-001-03-8,radiopaque medium
24295,n06,BRD-A37704979-001-02-4,p38 MAPK inhibitor
24295,n07,BRD-A37776212-003-02-5,opioid receptor agonist
24295,n17,BRD-A38747044-001-01-5,Imidazoline receptor ligand
24295,n18,BRD-A38898897-003-01-0,Leukocyte elastase inhibitor
24295,n19,BRD-A38913120-001-01-0,BCL inhibitor
24295,n21,BRD-A39230911-001-03-7,Muscle relaxant
24295,n22,BRD-A39255369-001-01-5,Chloride channel blocker
24295,n23,BRD-A39268308-001-02-0,Acetylcholine receptor agonist
24295,o01,BRD-A39522003-001-01-0,FAAH inhibitor|FAAH reuptake inhibitor
24295,o03,BRD-A39747742-001-02-7,estrogen receptor agonist
24295,o05,BRD-A39969961-001-01-3,Cytochrome P450 inhibitor
24295,o06,BRD-A40022950-001-02-9,ATPase inhibitor
24295,o08,BRD-A40639672-234-04-0,Cyclooxygenase inhibitor
24295,o10,BRD-A41112154-001-02-1,G protein-coupled receptor agonist
24295,o13,BRD-A41145729-001-02-7,Retinoid receptor agonist
24295,o14,BRD-A41250306-001-03-4,Thiazide diuretic
24295,o15,BRD-A41301928-001-02-5,"Mitochondrial ADP, ATP translocase inhibitor"
24295,o16,BRD-A41304429-001-04-9,Adrenergic receptor antagonist
24295,o17,BRD-A41451487-001-01-3,Benzodiazepine receptor antagonist
24295,o18,BRD-A41519720-001-02-2,Niemann-Pick C1-like 1 protein antagonist
24295,o19,BRD-A41722204-003-01-5,adenosine receptor antagonist
24295,o20,BRD-A41833852-001-01-9,Opioid receptor antagonist
24295,o22,BRD-A41941932-001-03-0,Antioxidant
24295,o23,BRD-A42167015-003-03-7,Adrenergic receptor antagonist
24295,o24,BRD-A42335949-300-04-9,phosphatidylglycerophosphatase inhibitor
24295,p01,BRD-A42346008-003-03-6,epinephrine metabolite
24295,p02,BRD-A42553870-001-05-1,neuropeptide receptor antagonist
24295,p03,BRD-A42571354-300-01-3,histamine receptor antagonist
24295,p04,BRD-A42628519-001-04-1,radiopaque medium
24295,p05,BRD-A42759514-001-03-1,Antiprotozoal
24295,p06,BRD-A42831637-001-02-2,anti-inflammatory|Cannabinoid metabolite
24295,p07,BRD-A43076080-001-03-3,protein phosphatase inhibitor
24295,p09,BRD-A43150328-001-02-0,other antibiotic
24295,p13,BRD-A43671941-003-03-6,Adrenergic receptor antagonist
24295,p14,BRD-A43849199-001-02-3,Phytotoxin
24295,p15,BRD-A43930669-003-01-0,oxytocin receptor antagonist
24295,p16,BRD-A43940795-001-02-8,serotonin release inhibitor
24295,p17,BRD-A43974499-066-01-1,Adrenergic receptor antagonist
24295,p19,BRD-A44008656-036-04-3,Histamine receptor antagonist
24295,p20,BRD-A44090213-001-04-1,Cyclooxygenase inhibitor
24295,p21,BRD-A44133049-001-01-5,Serotonin receptor antagonist
24295,p22,BRD-A44448661-001-02-2,Barbiturate antiepileptic
24295,p23,BRD-A44551378-001-01-9,EGFR inhibitor
24295,p24,BRD-A44863528-001-04-1,CCK receptor antagonist
25985,a01,BRD-K40782193-003-01-1,sodium channel blocker
25985,a02,BRD-K40887525-001-02-9,serotonin receptor antagonist
25985,a03,BRD-K40901640-001-01-0,serotonin receptor antagonist
25985,a04,BRD-K40905133-001-02-3,sodium channel blocker
25985,a05,BRD-K40965114-001-01-2,Adrenergic receptor antagonist
25985,a06,BRD-K40990712-001-02-4,gonadotropin releasing factor hormone receptor antagonist|sodium/hydrogen antiport inhibitor|sodium/hydrogen exchanger inhibitor|urokinase inhibitor
25985,a07,BRD-K41143549-003-01-6,glutamate receptor antagonist
25985,a08,BRD-K41337261-001-01-4,Src and Abl inhibitor|vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor
25985,a09,BRD-K41406082-001-04-8,PABA antagonist
25985,a11,BRD-K41445866-001-03-0,Chloride channel agonist
25985,a12,BRD-K41524689-001-05-2,cyclooxygenase inhibitor
25985,a15,BRD-K41564320-001-01-2,tyrosine kinase inhibitor
25985,a16,BRD-K41567364-001-01-2,orexin receptor antagonist
25985,a19,BRD-K41707108-001-02-3,Phosphoenolpyruvate carboxylase activator
25985,a20,BRD-K41713976-001-02-0,potassium channel blocker
25985,a23,BRD-K41868777-003-02-9,calmodulin antagonist
25985,b01,BRD-K41876534-001-02-0,carbonic anhydrase inhibitor
25985,b02,BRD-K41996876-001-05-5,EGFR inhibitor
25985,b03,BRD-K42098891-003-03-1,tricyclic antidepressant
25985,b04,BRD-K42221274-001-01-4,GAT inhibitor
25985,b05,BRD-K42348709-003-04-0,adrenergic receptor agonist|serotonin receptor agonist
25985,b07,BRD-K42452249-001-01-7,p38 MAPK inhibitor
25985,b08,BRD-K42500029-001-01-9,"MAP kinase inhibitor|MAPK-interacting kinase inhibitor,"
25985,b10,BRD-K42635745-001-02-4,adrenergic receptor antagonist
25985,b12,BRD-K42679050-001-01-3,potassium channel activator|potassium channel agonist
25985,b16,BRD-K42748308-300-01-2,acetylcholine release enhancer|potassium channel blocker|voltage-gated potassium channel blocker
25985,b18,BRD-K43068349-001-01-9,TRPV antagonist
25985,b19,BRD-K43149758-001-04-5,Androgen receptor agonist
25985,b21,BRD-K43245338-001-02-4,calpain inhibitor|cathepsin inhibitor
25985,b22,BRD-K43290182-001-01-9,Serotonin receptor antagonist
25985,b23,BRD-K43330982-001-01-5,lysophospholipid receptor antagonist
25985,b24,BRD-K43389675-003-02-7,RNA synthesis inhibitor|topoisomerase inhibitor
25985,c01,BRD-K43405658-001-01-8,protein tyrosine kinase inhibitor
25985,c02,BRD-K43457670-001-04-7,carbonic anhydrase inhibitor
25985,c03,BRD-K43468059-001-02-9,Mycotoxin
25985,c05,BRD-K43736954-001-03-3,glucocorticoid receptor agonist
25985,c06,BRD-K43744935-048-01-6,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)|estrogen receptor agonist|estrogen receptor modulator|PKC inhibitor
25985,c07,BRD-K43796186-001-01-1,EGFR inhibitor
25985,c08,BRD-K43860855-065-03-6,antineoplastic agent
25985,c09,BRD-K44067360-001-06-3,chloride channel blocker
25985,c10,BRD-K44084986-001-03-9,rho associated kinase inhibitor
25985,c18,BRD-K44849676-001-03-0,TRPV agonist
25985,c19,BRD-K44876623-001-01-1,Benzodiazepine receptor agonist
25985,c20,BRD-K44899736-003-02-1,Monoamine oxidase inhibitor
25985,c22,BRD-K45033733-001-02-3,DNA polymerase inhibitor
25985,c24,BRD-K45068323-003-01-3,Calmodulin antagonist
25985,d02,BRD-K45117373-001-01-1,potassium channel activator|potassium channel agonist
25985,d03,BRD-K45158365-001-02-3,angiotensin receptor antagonist
25985,d04,BRD-K45296539-003-01-0,Adrenergic receptor agonist
25985,d05,BRD-K45330754-001-04-3,estrogen receptor agonist
25985,d06,BRD-K45401373-001-05-0,Apoptosis stimulant
25985,d07,BRD-K45435259-001-01-6,Dopamine receptor antagonist
25985,d09,BRD-K45479396-001-01-8,Serotonin receptor agonist
25985,d13,BRD-K45542189-048-04-9,Lipoxygenase inhibitor
25985,d14,BRD-K45662124-001-01-8,dopamine receptor ligand
25985,d17,BRD-K45861246-001-04-3,Dopamine receptor antagonist
25985,d19,BRD-K46018455-001-06-0,PPAR receptor agonist
25985,d20,BRD-K46137903-001-03-3,phospholipase activator
25985,d21,BRD-K46142322-003-01-6,serotonin receptor partial agonist
25985,d22,BRD-K46211610-003-05-1,Adrenergic receptor antagonist
25985,d23,BRD-K46317332-003-04-6,Nitric oxide synthase inhibitor
25985,d24,BRD-K46384212-001-01-1,phospholipase activator
25985,e03,BRD-K46424862-001-04-2,Monoamine oxidase inhibitor
25985,e04,BRD-K46435977-003-01-2,DNA polymerase inhibitor
25985,e05,BRD-K46441700-001-01-8,serotonin receptor antagonist
25985,e06,BRD-K46469693-001-01-8,adenosine receptor antagonist
25985,e08,BRD-K46556543-237-03-0,Mineralocorticoid receptor antagonist
25985,e13,BRD-K46766488-003-01-2,Serotonin receptor agonist
25985,e14,BRD-K46862739-001-03-6,cytochrome P450 inhibitor
25985,e15,BRD-K46937689-001-05-1,Cyclooxygenase inhibitor
25985,e16,BRD-K47105409-001-05-3,JAK inhibitor
25985,e20,BRD-K47150025-001-01-2,PDGFR alpha and c-Kit inhibitor|vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor|VEGFR inhibitor
25985,e21,BRD-K47192521-001-02-1,Platelet aggregation inhibitor
25985,e22,BRD-K47207162-312-02-2,Serotonin reuptake inhibitor
25985,e23,BRD-K47278471-003-04-0,Histamine receptor antagonist
25985,e24,BRD-K47323024-003-04-6,Histamine receptor antagonist
25985,f03,BRD-K47328134-001-02-0,heparin activation inhibitor
25985,f07,BRD-K47598052-001-04-2,src inhibitor
25985,f08,BRD-K47608922-001-02-1,chelating agent
25985,f11,BRD-K47631482-003-02-1,Mucolytic agent
25985,f12,BRD-K47635719-001-03-9,glucocorticoid receptor agonist
25985,f13,BRD-K47639036-003-03-3,Acetylcholine receptor antagonist
25985,f14,BRD-K47659338-003-01-0,serotonin receptor agonist
25985,f15,BRD-K47693913-001-02-4,Furoquinoline alkaloid
25985,f16,BRD-K47717570-304-01-5,Glutamate receptor antagonist
25985,f21,BRD-K47869605-001-04-9,microtubule inhibitor|tubulin polymerization inhibitor
25985,f23,BRD-K47936004-001-01-9,dopamine receptor agonist
25985,f24,BRD-K47943470-001-02-8,EGFR inhibitor
25985,g05,BRD-K48168960-001-05-1,Thyroid peroxidase inhibitor
25985,g07,BRD-K48300629-001-03-8,Sodium channel blocker
25985,g11,BRD-K48692744-001-01-2,PARP inhibitor
25985,g12,BRD-K48722258-300-04-5,adenosine reuptake inhibitor
25985,g13,BRD-K48735772-001-01-4,EGFR inhibitor|epidermal growth factor receptor (EGFR) inhibitor
25985,g15,BRD-K49027941-237-01-1,Adenosine receptor antagonist
25985,g16,BRD-K49049886-001-03-8,adenosine receptor antagonist
25985,g17,BRD-K49111258-001-02-8,Adrenergic receptor antagonist
25985,g23,BRD-K49294207-300-01-2,EGFR inhibitor
25985,g24,BRD-K49448285-001-01-3,CDK inhibitor
25985,h01,BRD-K49481516-004-03-5,Acetylcholinesterase inhibitor
25985,h02,BRD-K49519092-303-01-4,Histamine receptor agonist
25985,h05,BRD-K49577446-001-03-1,cytochrome P450 inhibitor
25985,h06,BRD-K49657628-001-02-3,EGFR inhibitor|tyrosine kinase inhibitor
25985,h07,BRD-K49671696-001-02-1,Serotonin receptor antagonist
25985,h11,BRD-K49890030-236-01-6,Glutamate receptor antagonist
25985,h12,BRD-K49945136-001-03-5,Serotonin receptor antagonist
25985,h13,BRD-K50018155-003-01-3,Serotonin receptor partial agonist
25985,h15,BRD-K50135270-001-01-9,dopamine uptake inhibitor
25985,h17,BRD-K50214219-001-02-4,PARP inhibitor
25985,h21,BRD-K50325075-001-01-3,potassium channel blocker|slow afterhyperpolarization channel blocker
25985,h22,BRD-K50388907-001-04-9,PPAR receptor agonist
25985,h23,BRD-K50398167-236-02-9,Cyclooxygenase inhibitor
25985,i01,BRD-K50417881-003-05-9,Dopamine receptor antagonist
25985,i02,BRD-K50422030-001-01-2,GABA receptor antagonist
25985,i03,BRD-K50464341-001-02-6,calmodulin antagonist
25985,i04,BRD-K50495309-001-01-2,src inhibitor
25985,i07,BRD-K50660797-001-02-8,Bacterial DNA gyrase inhibitor
25985,i08,BRD-K50836978-001-01-7,CDK inhibitor
25985,i09,BRD-K50841342-001-01-6,caspase activator
25985,i10,BRD-K50859149-001-04-7,bacterial antifolate
25985,i11,BRD-K50891186-001-01-0,dopamine receptor antagonist
25985,i14,BRD-K51276371-001-01-8,CDK inhibitor|CFTR channel activator|glycogen synthase kinase inhibitor|JNK inhibitor
25985,i15,BRD-K51318897-001-04-7,tubulin polymerization inhibitor
25985,i17,BRD-K51465424-003-03-6,adrenergic receptor agonist
25985,i18,BRD-K51476772-001-01-9,tyrosine kinase inhibitor
25985,i19,BRD-K51541829-001-01-3,Ionotropic glutamate receptor antagonist
25985,i23,BRD-K51575138-001-01-7,IKK inhibitor
25985,i24,BRD-K51671335-001-01-5,Dopamine receptor antagonist
25985,j01,BRD-K51751936-001-03-4,benzodiazepine receptor agonist
25985,j03,BRD-K51918615-303-01-1,histamine receptor antagonist|histamine receptor inhibitor|ionotropic glutamate receptor antagonist
25985,j07,BRD-K52020312-001-04-5,DNA inhibitor
25985,j08,BRD-K52075040-001-02-2,fatty acid synthase inhibitor
25985,j10,BRD-K52219182-001-01-6,Phosphodiesterase inhibitor
25985,j11,BRD-K52313696-001-01-6,HDAC inhibitor
25985,j13,BRD-K52394958-001-01-9,tachykinin antagonist
25985,j14,BRD-K52397688-001-01-9,dopamine receptor antagonist|FAAH inhibitor|serotonin receptor antagonist
25985,j15,BRD-K52459643-001-10-2,Prostanoid receptor agonist
25985,j16,BRD-K52512893-001-03-0,Prostanoid receptor antagonist
25985,j18,BRD-K52662033-001-02-6,histamine receptor agonist
25985,j19,BRD-K52721684-001-02-2,potassium channel activator
25985,j20,BRD-K52850071-001-01-2,JAK inhibitor
25985,j23,BRD-K52930707-001-04-8,ACE inhibitor
25985,k01,BRD-K52989797-001-01-1,serotonin transporter (SERT) inhibitor
25985,k03,BRD-K53123955-001-03-0,Phosphofructokinase inhibitor
25985,k05,BRD-K53263234-001-02-9,constitutive androstane receptor (CAR) agonist
25985,k06,BRD-K53318339-001-04-1,Phosphodiesterase inhibitor
25985,k09,BRD-K53523901-001-01-0,adiponectin receptor agonist|AP inhibitor|aryl hydrocarbon receptor antagonist|HIV integrase inhibitor|MEK inhibitor|NFkB pathway inhibitor|topoisomerase inhibitor
25985,k11,BRD-K53545112-304-01-6,Glutamate receptor antagonist
25985,k13,BRD-K53737926-003-04-7,Norepinephrine inhibitor
25985,k14,BRD-K53857191-001-04-5,Dopamine receptor antagonist
25985,k17,BRD-K53878242-001-02-4,phosphodiesterase inhibitor
25985,k19,BRD-K53979406-003-01-0,glycine transporter inhibitor|GlyT-1 inhibitor
25985,k20,BRD-K54094468-001-01-6,dopamine receptor antagonist
25985,k21,BRD-K54095730-001-01-5,p38 MAPK inhibitor
25985,k22,BRD-K54142781-001-02-1,Adrenergic receptor agonist
25985,l01,BRD-K54210043-001-02-0,calcium channel activator|large conductance potassium channel activator
25985,l02,BRD-K54233340-300-01-0,AMPK inhibitor|DNA damaging|TGF beta receptor inhibitor
25985,l03,BRD-K54330070-001-05-5,p38 MAPK inhibitor
25985,l04,BRD-K54411430-001-02-5,cAMP inhibitor
25985,l06,BRD-K54529596-001-04-0,ACE inhibitor
25985,l10,BRD-K54665485-001-01-2,Diacylglycerol kinase inhibitor
25985,l11,BRD-K54704028-001-01-3,glutamate receptor antagonist
25985,l12,BRD-K54708045-001-01-3,PPAR receptor agonist
25985,l13,BRD-K54759182-003-02-3,Norepinephrine reuptake inhibitor
25985,l14,BRD-K54771420-001-03-2,Cholesterol inhibitor
25985,l17,BRD-K54790157-001-03-1,DNA synthesis inhibitor
25985,l19,BRD-K55034111-066-02-3,bacterial DNA gyrase inhibitor
25985,l21,BRD-K55191674-236-03-7,Penicillin binding protein inhibitor
25985,m01,BRD-K55344148-003-01-8,Imidazoline receptor ligand
25985,m02,BRD-K55424922-001-01-4,Serotonin receptor agonist
25985,m03,BRD-K55430733-003-01-6,Serotonin receptor agonist
25985,m04,BRD-K55454768-001-01-8,voltage-independent calcium influx blocker
25985,m05,BRD-K55468218-001-04-8,dopamine receptor antagonist
25985,m06,BRD-K55529781-236-02-0,thromboxane synthase inhibitor
25985,m07,BRD-K55567017-001-02-4,alcohol dehydrogenase inhibitor
25985,m08,BRD-K55677650-003-01-1,ionotropic glutamate receptor antagonist
25985,m11,BRD-K55748775-001-01-4,ATPase inhibitor|potassium-competitive acid antagonist
25985,m16,BRD-K55930204-001-02-7,Hydantoin antiepileptic
25985,m17,BRD-K56047318-001-02-2,Triacylglycerol lipase inhibitor
25985,m18,BRD-K56064827-001-04-7,PKC inhibitor
25985,m20,BRD-K56115039-003-01-3,Imidazoline receptor ligand
25985,m22,BRD-K56403959-300-01-9,CC chemokine receptor ligand
25985,m23,BRD-K56429665-001-03-9,vitamin D receptor agonist
25985,m24,BRD-K56509348-003-01-3,Endothelin receptor antagonist
25985,n02,BRD-K56558538-003-02-8,Sodium channel blocker
25985,n03,BRD-K56596464-004-02-4,Sodium channel blocker
25985,n04,BRD-K56699285-001-03-7,dopamine receptor agonist|serotonin receptor antagonist
25985,n08,BRD-K57033106-048-02-8,Histamine receptor antagonist
25985,n11,BRD-K57179821-001-04-8,Antipruritic
25985,n12,BRD-K57222227-001-06-1,cyclooxygenase inhibitor
25985,n16,BRD-K57304726-003-03-6,Sigma receptor agonist
25985,n18,BRD-K57545991-050-03-3,angiotensin converting enzyme inhibitor
25985,n19,BRD-K57569181-001-04-4,Phosphodiesterase inhibitor
25985,n21,BRD-K57718010-001-06-9,GABA receptor antagonist
25985,n22,BRD-K57886322-001-03-4,glucocorticoid receptor agonist
25985,n23,BRD-K57926513-001-02-9,PDGFR receptor inhibitor
25985,o01,BRD-K58220566-001-02-2,PKC inhibitor|sodium channel blocker|calcium channel blocker
25985,o02,BRD-K58265391-001-03-6,diuretic
25985,o03,BRD-K58299615-001-02-7,amyloid precursor protein inhibitor|beta amyloid aggregation inhibitor
25985,o05,BRD-K58466253-003-04-1,serotonin release inhibitor
25985,o06,BRD-K58685305-001-02-2,11-beta hydroxysteroid dehydrogenase inhibitor
25985,o08,BRD-K58930050-001-01-1,glutamate receptor antagonist
25985,o09,BRD-K58938839-001-03-8,smoothened receptor antagonist|hedgehog pathway inhibitor
25985,o10,BRD-K59037100-001-04-8,lipase inhibitor
25985,o13,BRD-K59058766-003-03-7,dopamine receptor antagonist
25985,o15,BRD-K59184148-001-04-2,glycogen synthase kinase inhibitor
25985,o18,BRD-K59273480-001-01-5,adenosine reuptake inhibitor|phosphodiesterase inhibitor
25985,o20,BRD-K59332007-300-01-9,acetylcholine release enhancer|acetylcholine release stimulant|neurotransmitter agonist|voltage-gated potassium channel blocker
25985,o22,BRD-K59419204-001-01-9,cannabinoid receptor antagonist|cannabinoid receptor inhibitor
25985,o23,BRD-K59469039-001-04-9,Angiogenesis inhibitor
25985,o24,BRD-K59522102-001-04-7,monoamine oxidase inhibitor
25985,p01,BRD-K59574735-001-02-7,leukotriene synthesis inhibitor
25985,p02,BRD-K59637651-001-01-4,protein synthesis inhibitor|botulin neurotoxin inhibitor|mur synthetase inhibitor
25985,p03,BRD-K59650319-003-01-7,glutamate receptor antagonist
25985,p04,BRD-K59753853-001-01-5,glutamate receptor antagonist
25985,p06,BRD-K59851896-001-02-4,GABA release inhibitor
25985,p07,BRD-K59983611-001-05-2,bacterial antifolate
25985,p09,BRD-K60060639-005-01-4,antiarrhythmic medication
25985,p10,BRD-K60174629-001-02-2,prolyl endopeptidase inhibitor
25985,p13,BRD-K60184833-001-02-3,tyrosine kinase inhibitor
25985,p14,BRD-K60230970-001-04-3,proteasome inhibitor
25985,p15,BRD-K60274257-001-01-1,tyrosine phosphatase inhibitor
25985,p17,BRD-K60298136-001-01-7,aryl hydrocarbon receptor agonist|aryl hydrocarbon receptor ligand
25985,p18,BRD-K60476892-001-02-1,activator of soluble guanylyl cyclase|guanylate cyclase activator|hypoxia inducible factor inhibitor
25985,p19,BRD-K60511616-236-01-4,HMGCR inhibitor
25985,p20,BRD-K60640630-001-03-7,glucocorticoid receptor agonist
25985,p22,BRD-K60923938-001-02-8,sodium channel activator
25985,p23,BRD-K60932973-001-01-7,dopamine receptor agonist
25985,p24,BRD-K61097567-001-03-6,tachykinin antagonist
24320,a01,BRD-K90382497-001-01-6,PLK inhibitor
24320,a02,BRD-K92723993-066-02-9,PDGFR tyrosine kinase receptor inhibitor|Bcr-Abl kinase inhibitor|KIT inhibitor|Abl kinase inhibitor|apoptosis stimulant|breast cancer resistance protein inhibitor|colony stimulating factor receptor inhibitor
24320,a03,BRD-K07762753-001-03-6,CDK inhibitor|tyrosine kinase inhibitor
24320,a04,BRD-K09991945-001-02-0,glycogen synthase kinase inhibitor|PKC inhibitor|superoxide dismutase expression inhibitor
24320,a05,BRD-K37312348-001-05-1,CDK inhibitor|glycogen synthase kinase inhibitor
24320,a06,BRD-K46678324-001-03-7,rho associated kinase inhibitor
24320,a07,BRD-K67860401-001-02-3,glycogen synthase kinase inhibitor
24320,a08,BRD-K52620403-001-01-8,calcium/calmodulin dependent protein kinase inhibitor|calmodulin inhibitor
24320,a09,BRD-K68336408-001-03-4,EGFR inhibitor
24320,a10,BRD-K72703948-001-01-0,Aurora kinase inhibitor
24320,a11,BRD-K93201660-001-05-7,myosin light chain kinase inhibitor
24320,a15,BRD-A47633927-001-01-8,ICAM1 antagonist
24320,a16,BRD-A68039575-001-02-5,Aromatase inhibitor
24320,a17,BRD-A75455249-001-02-0,calcium channel modulator|mTOR inhibitor|sodium channel blocker
24320,a18,BRD-K01555864-001-02-8,antineoplastic
24320,a19,BRD-K09497549-001-03-6,calcium channel modulator|mTOR inhibitor|sodium channel blocker
24320,a20,BRD-K14536225-001-02-7,Glucosidase inhibitor
24320,a21,BRD-K15086322-103-01-0,histamine receptor antagonist|histamine receptor silent antagonist
24320,a23,BRD-K23623876-001-01-6,ultrasound contrast agent
24320,a24,BRD-K36377456-001-02-0,angiogenesis inhibitor
24320,b01,BRD-K36395411-003-01-4,serotonin receptor antagonist|serotonin receptor partial agonist
24320,b03,BRD-K41160163-001-01-9,Glutamate receptor antagonist
24320,b04,BRD-K42095107-001-02-3,estrogen receptor agonist
24320,b05,BRD-K43797669-001-02-3,tyrosine kinase inhibitor
24320,b06,BRD-K45988865-001-01-0,organosilicon compound used as an internal standard in NMR spectroscopy
24320,b07,BRD-K49061529-001-01-0,GABA benzodiazepine site receptor inverse agonist
24320,b09,BRD-K59331372-001-01-2,TRPV antagonist
24320,b11,BRD-K60690191-003-02-1,glutamate receptor antagonist
24320,b12,BRD-K61177364-003-01-1,CRF receptor antagonist
24320,b17,BRD-K61250553-001-02-9,opioid receptor agonist
24320,b18,BRD-K61269089-001-01-4,Protein kinase inhibitor
24320,b19,BRD-K61271364-001-02-4,GABA receptor antagonist
24320,b20,BRD-K61323504-001-02-4,CC chemokine receptor antagonist
24320,b22,BRD-K61496577-001-03-8,glucocorticoid receptor agonist
24320,b23,BRD-K61590534-001-01-4,EGFR inhibitor
24320,c01,BRD-K61737877-001-01-6,VEGFR inhibitor
24320,c03,BRD-K61951118-001-01-2,GABA benzodiazepine site receptor inverse agonist
24320,c04,BRD-K62008436-001-03-1,tubulin polymerization inhibitor
24320,c05,BRD-K62056274-001-01-9,Serotonin receptor agonist
24320,c07,BRD-K62206109-303-01-1,histamine receptor antagonist
24320,c08,BRD-K62221994-001-01-8,gonadotropin releasing factor hormone receptor antagonist
24320,c10,BRD-K62289640-003-01-9,Cannabinoid receptor agonist
24320,c13,BRD-K62310379-001-03-0,glucocorticoid receptor agonist
24320,c17,BRD-K62353524-001-01-8,estrogen receptor agonist
24320,c18,BRD-K62363391-001-04-1,bacterial antifolate
24320,c23,BRD-K62607865-001-03-0,bacterial cell wall synthesis inhibitor
24320,c24,BRD-K62609077-001-02-2,adrenergic receptor antagonist|GABA receptor antagonist|serotonin receptor antagonist
24320,d01,BRD-K62810658-001-05-6,MEK inhibitor
24320,d02,BRD-K62929068-001-01-7,Purinergic receptor activator
24320,d04,BRD-K62996583-001-03-8,calcium channel blocker
24320,d05,BRD-K63089472-001-02-7,Inhibitor of methyl esterification of farnesylated proteins
24320,d06,BRD-K63150726-001-01-3,cannabinoid receptor inverse agonist
24320,d07,BRD-K63151507-001-01-6,Lymphocyte inhibitor
24320,d08,BRD-K63165456-001-03-3,Adrenergic receptor agonist
24320,d09,BRD-K63430059-001-03-2,DNA synthesis inhibitor
24320,d10,BRD-K63504947-001-05-5,VEGFR inhibitor
24320,d13,BRD-K63516691-001-01-6,Phosphodiesterase inhibitor
24320,d14,BRD-K63533170-001-01-1,cannabinoid receptor antagonist|cannabinoid receptor inverse agonist
24320,d17,BRD-K63606607-001-01-8,ATPase inhibitor|chloride channel activator
24320,d18,BRD-K63630713-001-04-3,sodium/potassium/chloride transporter inhibitor
24320,d19,BRD-K63750851-001-03-3,dehydrogenase inhibitor|inositol monophosphatase inhibitor
24320,d21,BRD-K63784565-001-02-1,Topoisomerase inhibitor
24320,d22,BRD-K63792901-075-01-3,acetylcholine receptor agonist
24320,d23,BRD-K63828191-003-07-3,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)
24320,e03,BRD-K63874012-103-01-5,histamine receptor antagonist|histamine receptor inverse agonist
24320,e04,BRD-K63913457-001-02-7,vasodilator
24320,e06,BRD-K63945320-001-02-4,Phospholipase inhibitor
24320,e07,BRD-K63979671-001-03-6,Compound used in hepatobiliary scans of the liver
24320,e08,BRD-K64044582-001-02-8,ACAT inhibitor
24320,e11,BRD-K64157027-003-01-9,Adrenergic receptor agonist
24320,e14,BRD-K64245000-001-01-7,FXR agonist
24320,e16,BRD-K64341947-003-01-6,guanylate cyclase activator
24320,e20,BRD-K64402243-001-01-1,Caspase inhibitor
24320,e22,BRD-K64670467-001-01-2,glutamate receptor antagonist
24320,f03,BRD-K64755930-003-01-6,phosphodiesterase inhibitor
24320,f04,BRD-K64862097-001-03-9,glucocorticoid receptor agonist
24320,f06,BRD-K64994968-001-03-6,Progesterone receptor agonist
24320,f07,BRD-K65146499-001-04-8,Cyclooxygenase inhibitor
24320,f11,BRD-K65285700-001-01-5,cannabinoid receptor agonist
24320,f12,BRD-K65417056-003-03-6,Local anesthetic
24320,f13,BRD-K65503129-001-01-4,HSP inhibitor|HSP antagonist
24320,f15,BRD-K65639003-001-02-5,phosphodiesterase inhibitor
24320,f16,BRD-K65667145-001-04-1,cell division inducer
24320,f19,BRD-K65786282-001-02-6,GABA receptor modulator
24320,f20,BRD-K65814004-001-02-3,nitric oxide synthase inhibitor|aldehyde dehydrogenase inhibitor|cytochrome P450 inhibitor|NADPH oxidase inhibitor|xanthine oxidase inhibitor
24320,f23,BRD-K66093087-001-01-5,Benzodiazepine receptor agonist
24320,f24,BRD-K66206289-003-03-1,Acetylcholine receptor antagonist
24320,g02,BRD-K66353228-001-05-4,myorelaxant
24320,g05,BRD-K66404838-003-03-8,opioid receptor agonist|opioid receptor antagonist
24320,g08,BRD-K66707493-001-02-6,Coloring agent
24320,g09,BRD-K66715657-001-01-3,dopamine receptor antagonist
24320,g10,BRD-K66782112-001-01-2,Histamine receptor antagonist
24320,g11,BRD-K66874953-001-02-7,TP53 inhibitor
24320,g12,BRD-K66898851-001-03-7,apoptosis stimulant
24320,g13,BRD-K66944906-001-02-6,Carbonic anhydrase inhibitor
24320,g14,BRD-K67013324-001-01-5,melatonin receptor antagonist
24320,g16,BRD-K67017579-001-13-3,Phosphodiesterase inhibitor
24320,g17,BRD-K67043667-001-04-1,DNA synthesis inhibitor
24320,g18,BRD-K67080878-001-05-5,phosphodiesterase inhibitor
24320,g21,BRD-K67102207-236-01-0,HDAC inhibitor
24320,g23,BRD-K67261995-001-03-4,Contrast agent
24320,g24,BRD-K67277431-002-03-0,thromboxane receptor antagonist|thromboxane synthase inhibitor
24320,h01,BRD-K67298865-001-02-5,TGF beta receptor inhibitor
24320,h02,BRD-K67352070-364-01-5,Acetylcholine receptor agonist
24320,h05,BRD-K67439147-001-01-7,glutamate receptor antagonist
24320,h06,BRD-K67445247-001-01-3,Urease inhibitor
24320,h08,BRD-K67537649-001-01-1,insulin growth factor receptor inhibitor
24320,h12,BRD-K67680372-003-01-8,GAT inhibitor
24320,h13,BRD-K67783091-001-05-5,Dopamine receptor antagonist
24320,h14,BRD-K67831364-003-01-7,vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor|VEGFR inhibitor
24320,h17,BRD-K68095457-001-04-4,Cannabinoid receptor agonist
24320,h18,BRD-K68103045-001-01-1,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist
24320,h21,BRD-K68143200-001-04-2,CDC inhibitor
24320,h24,BRD-K68190965-001-01-4,Serotonin receptor agonist
24320,i01,BRD-K68246049-001-01-4,Retinoid receptor agonist
24320,i02,BRD-K68264559-001-07-6,Adrenergic receptor agonist
24320,i03,BRD-K68332390-001-03-3,aldose reductase inhibitor|reductase inhibitor
24320,i04,BRD-K68341547-003-01-6,calmodulin antagonist
24320,i07,BRD-K68392338-003-01-2,Benzodiazepine receptor antagonist
24320,i08,BRD-K68402494-001-04-7,myosin light chain kinase inhibitor
24320,i10,BRD-K68507560-003-04-8,acetylcholine receptor antagonist
24320,i12,BRD-K68552125-001-03-8,PKC activator|CD antagonist
24320,i13,BRD-K68553471-003-04-0,antihypertensive agent
24320,i14,BRD-K68558722-001-02-4,Cyclooxygenase inhibitor
24320,i15,BRD-K68620903-001-03-1,progesterone receptor agonist
24320,i17,BRD-K68873215-001-01-3,phosphodiesterase inhibitor
24320,i18,BRD-K69023402-001-02-5,ATPase inhibitor|calcium channel blocker|PKC activator
24320,i19,BRD-K69032158-001-02-2,Dipeptidyl peptidase inhibitor
24320,i20,BRD-K69195780-001-01-5,Serotonin receptor agonist
24320,i23,BRD-K69556541-001-02-6,Calcium channel blocker
24320,j01,BRD-K69763916-001-01-7,Glutamate receptor antagonist
24320,j02,BRD-K69837166-003-01-2,Nociceptin/orphanin FQ (NOP) receptor antagonist
24320,j03,BRD-K70241288-001-01-1,Growth hormone releasing peptide ligand agonist
24320,j04,BRD-K70246307-001-02-5,vitamin B2
24320,j07,BRD-K70281171-001-01-7,Dopamine receptor antagonist
24320,j08,BRD-K70330367-001-02-4,Glutamate receptor antagonist
24320,j10,BRD-K70487031-001-01-0,dopamine receptor antagonist
24320,j12,BRD-K70778732-003-04-4,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor
24320,j13,BRD-K70792160-003-01-2,AKT inhibitor
24320,j15,BRD-K70881766-001-02-3,Acetylcholinesterase inhibitor
24320,j16,BRD-K70914287-300-01-0,EGFR inhibitor|tyrosine kinase inhibitor
24320,j17,BRD-K70976396-236-04-7,Bacterial cell wall synthesis inhibitor
24320,j18,BRD-K71003802-001-02-9,Plant alkaloid
24320,j19,BRD-K13356952-001-11-1,carbonic anhydrase inhibitor
24320,k03,BRD-K71266197-236-01-9,NTPDase inhibitor
24320,k04,BRD-K71430621-303-01-5,histamine receptor antagonist|histamine receptor inverse agonist
24320,k06,BRD-K71499074-001-03-8,Carbonic anhydrase inhibitor
24320,k09,BRD-K71534238-001-03-5,Free fatty acid receptor agonist
24320,k11,BRD-K71726959-001-05-9,CDK inhibitor
24320,k12,BRD-K71731651-001-01-9,Acetylcholine receptor agonist
24320,k13,BRD-K71799778-001-02-2,CDK inhibitor
24320,k14,BRD-K71799949-001-04-2,Carboxamide antiepileptic
24320,k17,BRD-K71860425-001-01-1,CDK inhibitor
24320,k18,BRD-K72024482-001-01-3,adenosine receptor antagonist
24320,k19,BRD-K72034655-001-02-1,apoptosis inducer|antileukemic
24320,k22,BRD-K72222507-003-02-8,ACE inhibitor
24320,l04,BRD-K72676686-103-01-8,selective serotonin reuptake inhibitor (SSRI)|serotonin reuptake inhibitor|serotonin uptake inhibitor
24320,l05,BRD-K72726508-001-01-3,CDK inhibitor
24320,l06,BRD-K72783841-001-01-0,CDK inhibitor|epidermal growth factor receptor (EGFR) inhibitor|tyrosine kinase inhibitor|EGFR inhibitor
24320,l09,BRD-K72895815-001-01-4,leukocyte elastase inhibitor
24320,l10,BRD-K72903603-001-03-8,Reverse transcriptase inhibitor
24320,l13,BRD-K73109821-001-05-2,Potassium channel activator
24320,l18,BRD-K73196317-003-06-4,adrenergic receptor antagonist
24320,l21,BRD-K73290745-003-01-8,opioid receptor agonist
24320,l22,BRD-K73323637-003-03-4,adrenergic receptor antagonist
24320,m02,BRD-K73391359-003-03-7,Local anesthetic
24320,m05,BRD-K73397362-001-01-7,smoothened receptor agonist
24320,m06,BRD-K73589401-001-03-8,mineralocorticoid receptor agonist
24320,m12,BRD-K73789395-001-04-0,RAF inhibitor
24320,m15,BRD-K73991644-001-01-7,aldose reductase inhibitor|falcipain inhibitor
24320,m17,BRD-K74112339-001-02-7,Urease inhibitor
24320,m18,BRD-K74141488-003-03-9,Fungal squalene epoxidase inhibitor
24320,m20,BRD-K74195153-050-03-0,Phosphodiesterase inhibitor
24320,m21,BRD-K74212935-001-03-1,Dopamine agonist
24320,m23,BRD-K74305673-001-01-3,IKK inhibitor|NFkB pathway inhibitor|protein kinase inhibitor
24320,m24,BRD-K74430258-001-01-2,hepatotoxicant
24320,n02,BRD-K74765201-001-01-9,Leukotriene receptor antagonist
24320,n03,BRD-K74913225-001-03-3,Carbonic anhydrase inhibitor
24320,n05,BRD-K75089421-001-02-5,sodium channel blocker
24320,n06,BRD-K75181824-001-02-3,inhibitor of methyl esterification of geranylgeranylated proteins
24320,n11,BRD-K75478907-001-01-5,GABA receptor modulator|GABA receptor positive allosteric modulator
24320,n16,BRD-K75615183-001-01-7,Adrenergic receptor agonist
24320,n17,BRD-K75641298-001-01-5,Dopamine receptor antagonist
24320,n21,BRD-K75958195-001-01-7,serotonin receptor antagonist
24320,n24,BRD-K76064317-001-04-0,FLT3 inhibitor
24320,o01,BRD-K76133116-001-01-2,Membrane integrity inhibitor
24320,o03,BRD-K76274772-001-02-7,Ceramidase inhibitor
24320,o05,BRD-K76304753-003-04-7,local anesthetic
24320,o07,BRD-K76568384-001-01-4,estrogen receptor antagonist
24320,o08,BRD-K76587808-001-02-0,Antioxidant
24320,o09,BRD-K76617868-001-02-2,rho associated kinase inhibitor
24320,o10,BRD-K76634210-001-02-2,DNA directed DNA polymerase inhibitor
24320,o13,BRD-K76674262-001-01-7,apoptosis stimulant|protein synthesis inhibitor
24320,o15,BRD-K76723084-001-05-9,retinoid receptor agonist
24320,o16,BRD-K76775527-001-06-2,Cyclooxygenase inhibitor
24320,o17,BRD-K76805682-001-05-0,glycogen synthase kinase inhibitor
24320,o18,BRD-K76810206-001-05-7,adrenergic receptor antagonist
24320,o22,BRD-K76872913-001-02-8,Aromatic hydrocarbon derivative
24320,o23,BRD-K76927775-001-04-3,DNA inhibitor
24320,o24,BRD-K77133231-001-01-1,p38 MAPK inhibitor
24320,p01,BRD-K77171813-050-01-4,histamine receptor modulator
24320,p03,BRD-K77554836-001-03-3,glucocorticoid receptor agonist
24320,p07,BRD-K77641333-003-04-0,adrenergic receptor agonist
24320,p08,BRD-K77677632-003-01-8,serotonin receptor antagonist
24320,p09,BRD-K77695569-001-04-5,angiogenesis inhibitor
24320,p10,BRD-K77771411-003-03-2,imidazoline receptor agonist
24320,p13,BRD-K77793136-003-01-4,rho associated kinase inhibitor
24320,p15,BRD-K77925998-001-01-3,serotonin receptor agonist
24320,p16,BRD-K77947974-001-04-9,dopamine receptor antagonist
24320,p17,BRD-K77987382-001-05-8,acetylcholinesterase inhibitor|microtubule inhibitor|tubulin inhibitor
24320,p18,BRD-K78010432-001-04-1,diuretic
24320,p20,BRD-K78084463-003-01-0,calmodulin antagonist
24320,p21,BRD-K78113049-001-04-8,topoisomerase inhibitor
24320,p23,BRD-K78280988-001-02-2,cannabinoid receptor agonist|potassium channel blocker|TRPV agonist
25983,a01,BRD-K18250272-003-03-7,local anesthetic
25983,a02,BRD-K18316707-001-01-9,cannabinoid receptor antagonist
25983,a04,BRD-K18550767-001-02-8,interleukin inhibitor
25983,a05,BRD-K18574842-323-03-3,bacterial cell wall synthesis inhibitor
25983,a06,BRD-K18619710-001-03-7,steroid
25983,a07,BRD-K18742343-001-03-2,PKA inhibitor
25983,a08,BRD-K18757346-001-02-9,thromboxane receptor agonist
25983,a09,BRD-K18779551-003-03-7,acetylcholine release stimulant|adrenergic transmitter uptake inhibitor|reducing agent
25983,a10,BRD-K18787491-001-05-2,MEK inhibitor
25983,a11,BRD-K18799075-001-01-0,cannabinoid receptor partial agonist
25983,a12,BRD-K18816859-001-01-4,Serotonin receptor agonist
25983,a15,BRD-K18909381-001-01-4,serotonin receptor agonist
25983,a16,BRD-K18910433-001-04-4,estrogen receptor agonist
25983,a19,BRD-K19111024-001-04-3,PPAR receptor agonist
25983,a20,BRD-K19295594-001-04-4,BCL inhibitor|MCL1 inhibitor
25983,a21,BRD-K19309090-300-03-0,acetylcholine receptor agonist
25983,a22,BRD-K19352500-332-03-7,dopamine receptor antagonist
25983,a23,BRD-K19360254-001-01-3,Dopamine receptor agonist
25983,b01,BRD-K19462402-003-03-0,adrenergic receptor antagonist|calcium channel blocker
25983,b03,BRD-K19533706-001-01-9,Angiogenesis inhibitor
25983,b04,BRD-K19554809-001-01-1,serotonin receptor agonist
25983,b05,BRD-K19605405-001-01-9,adenosine receptor antagonist
25983,b07,BRD-K20141153-003-03-8,norepinephrine transporter inhibitor|adrenergic transmitter uptake inhibitor
25983,b08,BRD-K20152659-001-02-0,Cholesterol inhibitor
25983,b10,BRD-K20620780-001-01-0,dopamine receptor antagonist
25983,b11,BRD-K20655524-003-04-7,psychoactive drug
25983,b15,BRD-K20714604-001-01-5,Serotonin receptor partial agonist
25983,b16,BRD-K20742498-001-01-5,serotonin receptor antagonist
25983,b17,BRD-K20755323-001-01-8,sphingosine kinase inhibitor
25983,b18,BRD-K20995441-001-01-7,Opioid receptor agonist
25983,b19,BRD-K21283037-001-02-5,glutamate inhibitor
25983,b20,BRD-K21350491-001-02-1,acid sensing ion channel blocker|sodium channel blockers|TRPP3 channel inhibitor|TRPV modulator
25983,b21,BRD-K21450440-001-04-7,carbonic anhydrase inhibitor
25983,b22,BRD-K21520694-001-02-4,PABA antagonist
25983,b23,BRD-K21548250-001-01-3,sodium channel blocker
25983,b24,BRD-K21565985-001-04-3,adrenergic receptor agonist
25983,c01,BRD-K21667562-001-01-4,FAAH transport inhibitor|anandamide transport inhibitor|nucelar factor of activated T-cells inhibitor|TRPV agonist
25983,c02,BRD-K21680192-300-05-2,topoisomerase inhibitor
25983,c03,BRD-K21733600-001-02-6,cyclooxygenase inhibitor
25983,c04,BRD-K21853356-001-04-4,EGFR inhibitor
25983,c07,BRD-K22031190-001-04-6,Prostanoid receptor antagonist
25983,c08,BRD-K22134346-001-04-1,HMGCR inhibitor
25983,c09,BRD-K22193694-001-04-5,Topical sunscreen agent
25983,c10,BRD-K22385716-001-01-7,casein kinase inhibitor|mTOR inhibitor|PI3K inhibitor
25983,c17,BRD-K22861715-001-03-4,breast cancer resistance protein inhibitor
25983,c19,BRD-K22969690-001-02-6,bacterial 50S ribosomal subunit inhibitor
25983,c21,BRD-K23301018-001-02-6,antiprotozoal agent
25983,c23,BRD-K23335153-300-01-7,glutamate receptor positive allosteric modulator
25983,c24,BRD-K23383398-001-01-6,LXR agonist|ABC transporter expression enhancer|ROR inverse agonist
25983,d02,BRD-K23478508-001-03-7,ATPase inhibitor
25983,d03,BRD-K23541596-300-04-9,histamine receptor agonist
25983,d04,BRD-K23566484-001-04-5,androgen receptor antagonist
25983,d05,BRD-K23583188-001-05-6,EGFR inhibitor|tyrosine kinase inhibitor
25983,d06,BRD-K23704908-001-03-2,serine protease inhibitor
25983,d07,BRD-K23913458-001-02-5,Vitamin K antagonist
25983,d08,BRD-K23922020-075-01-1,acetylcholine receptor agonist
25983,d10,BRD-K24084088-001-02-2,adenosine receptor antagonist
25983,d13,BRD-K24132293-001-02-0,glutathione transferase inhibitor
25983,d14,BRD-K24201553-003-02-4,Serotonin receptor antagonist
25983,d17,BRD-K24240364-003-02-1,Glutamate receptor antagonist
25983,d18,BRD-K24396733-001-01-1,dopamine receptor agonist
25983,d20,BRD-K24526313-001-08-6,Potassium channel activator
25983,e05,BRD-K25224017-001-04-5,serotonin receptor antagonist
25983,e07,BRD-K25394294-001-04-0,Cyclooxygenase inhibitor
25983,e11,BRD-K25433859-003-11-4,norepinephrine reputake inhibitor|tricyclic antidepressant
25983,e13,BRD-K25741894-001-03-8,acetylcholinesterase inhibitor
25983,e15,BRD-K25875056-001-01-2,Protein tyrosine kinase activator
25983,e16,BRD-K25906698-303-01-9,histamine receptor agonist
25983,e21,BRD-K26160755-003-01-8,Imidazoline receptor agonist
25983,e22,BRD-K26373640-001-02-8,IKK inhibitor
25983,f03,BRD-K26429091-051-01-9,acetylcholine receptor antagonist
25983,f04,BRD-K26521938-001-04-9,prostanoid receptor agonist
25983,f05,BRD-K26548821-001-01-8,Dopamine receptor agonist
25983,f06,BRD-K26573499-300-01-3,Adrenergic receptor agonist
25983,f12,BRD-K26979635-001-01-1,Glutamate receptor antagonist
25983,f13,BRD-K26997899-001-01-4,microtubule inhibitor|tubulin inhibitor
25983,f15,BRD-K27141178-001-01-0,Serotonin receptor antagonist
25983,f20,BRD-K27305650-001-04-2,mTOR inhibitor|PI3K inhibitor|DNA dependent protein kinase inhibitor|phosphodiesterase inhibitor|PLK inhibitor
25983,f21,BRD-K27316855-001-02-6,vitamin D receptor agonist
25983,f23,BRD-K27351809-001-02-0,progesterone receptor agonist
25983,g01,BRD-K27450477-001-03-9,Adenosine deaminase inhibitor
25983,g02,BRD-K27499107-001-02-6,IP receptor activator
25983,g06,BRD-K27710560-001-02-6,SIRT inhibitor
25983,g07,BRD-K27737647-001-03-4,PKA inhibitor
25983,g09,BRD-K27871032-001-02-6,Ergoline alkaloid
25983,g11,BRD-K28115081-001-01-9,Platelet activating factor receptor antagonist
25983,g12,BRD-K28137194-003-01-3,GABA receptor agonist
25983,g13,BRD-K28143534-001-01-4,histamine receptor antagonist
25983,g15,BRD-K28183345-003-05-6,Dihydrofolate reductase inhibitor
25983,g17,BRD-K28307902-001-04-3,androgen receptor antagonist
25983,g18,BRD-K28453807-003-05-4,Cholinergic receptor antagonist
25983,g23,BRD-K28578425-001-01-3,phosphodiesterase inhibitor
25983,g24,BRD-K28667196-001-02-9,Increases arterial blood pressure
25983,h01,BRD-K28680267-001-01-8,CCK receptor antagonist
25983,h02,BRD-K28761384-003-03-6,dopamine receptor antagonist
25983,h05,BRD-K28761891-001-01-0,melatonin receptor agonist
25983,h06,BRD-K28806945-001-01-9,dopamine receptor antagonist
25983,h07,BRD-K28863208-001-01-2,Cholinergic receptor agonist
25983,h08,BRD-K28907958-001-01-9,retinoid receptor agonist
25983,h09,BRD-K28936863-051-04-1,histamine receptor agonist|leukotriene receptor antagonist|phosphodiesterase inhibitor
25983,h10,BRD-K29113274-001-03-6,Sterol demethylase inhibitor
25983,h12,BRD-K29178788-001-02-0,Furoquinoline alkaloid
25983,h13,BRD-K29359156-001-04-6,H+/K+-ATPase inhibitor
25983,h16,BRD-K29555132-001-02-2,Cannabinoid receptor agonist
25983,h17,BRD-K29582677-001-02-7,Calcium channel blocker
25983,h18,BRD-K29668683-300-01-4,sigma receptor antagonist
25983,h21,BRD-K29673530-001-03-9,tyrosine kinase inhibitor
25983,h22,BRD-K29950728-048-02-6,estrogen receptor antagonist
25983,h23,BRD-K30197592-001-01-5,Serotonin receptor agonist
25983,i01,BRD-K30240666-051-05-0,histamine receptor antagonist
25983,i02,BRD-K30421593-050-02-3,adrenergic receptor antagonist
25983,i03,BRD-K30480208-001-04-5,Electrolyte reabsorption inhibitor
25983,i08,BRD-K30685142-001-04-8,thyroid hormone stimulant
25983,i09,BRD-K30867024-001-01-1,serotonin receptor antagonist
25983,i11,BRD-K30990140-003-01-6,Cyclooxygenase inhibitor
25983,i12,BRD-K31054881-300-01-3,Adrenergic receptor antagonist
25983,i13,BRD-K31238592-001-01-6,CCK receptor antagonist|gastrin inhibitor
25983,i16,BRD-K31342827-001-05-4,PKC inhibitor
25983,i18,BRD-K31491153-001-01-2,serotonin receptor agonist
25983,i19,BRD-K31542390-001-01-5,dehydrogenase inhibitor|inositol monophosphatase inhibitor
25983,i20,BRD-K31611373-001-02-7,Prostanoid receptor agonist
25983,i23,BRD-K31627533-001-03-8,glucocorticoid receptor agonist
25983,i24,BRD-K31633810-003-01-0,Acetylcholine receptor antagonist
25983,j03,BRD-K31699485-001-01-9,glutamate receptor modulator
25983,j04,BRD-K31792052-004-01-9,interleukin receptor antagonist
25983,j09,BRD-K31843556-001-01-7,PPAR receptor anatagonist|PPAR receptor antagonist
25983,j10,BRD-K31912990-003-01-0,neuropeptide receptor antagonist
25983,j12,BRD-K31987754-001-01-2,Cannabinoid receptor agonist
25983,j15,BRD-K32164935-001-06-8,ATP channel blocker
25983,j16,BRD-K32247306-001-04-7,GABA receptor antagonist
25983,j19,BRD-K32292990-001-01-0,EGFR inhibitor
25983,j20,BRD-K32412559-001-01-7,Adrenergic receptor antagonist
25983,j23,BRD-K32501161-001-01-7,dopamine uptake inhibitor
25983,j24,BRD-K32526544-001-01-2,Potassium channel activator
25983,k02,BRD-K32584078-001-02-3,AKT inhibitor|HCV NS5B RdRp inhibitor
25983,k04,BRD-K32645441-001-01-4,serotonin receptor agonist
25983,k05,BRD-K32696739-001-02-6,Monoamine oxidase inhibitor
25983,k06,BRD-K32744045-001-04-9,aldehyde dehydrogenase inhibitor|DNA methyltransferase inhibitor|TRPV agonist
25983,k09,BRD-K32755366-003-03-4,Norepinephrine transporter inhibitor
25983,k10,BRD-K32821942-001-04-9,dehydrogenase inhibitor
25983,k11,BRD-K32828673-001-01-5,tubulin polymerization inhibitor
25983,k12,BRD-K32830106-003-11-3,adrenergic receptor agonist
25983,k14,BRD-K33204703-001-04-6,PDGFR receptor inhibitor
25983,k17,BRD-K33211335-337-03-7,glutamate receptor antagonist|sigma receptor agonist
25983,k19,BRD-K33308633-001-01-6,calcineurin inhibitor
25983,k20,BRD-K33396764-001-02-0,Omega 3 fatty acid stimulant
25983,k22,BRD-K33453211-003-03-2,Histamine receptor antagonist
25983,l01,BRD-K33459542-001-02-5,sigma receptor agonist
25983,l02,BRD-K33583600-001-03-9,guanylate cyclase activator
25983,l03,BRD-K33710385-001-05-4,mycolic synthesis inhibitor
25983,l04,BRD-K33818169-003-01-2,LXR agonist|ABC transporter expression enhancer
25983,l05,BRD-K33864865-001-01-7,CCK receptor antagonist
25983,l06,BRD-K33882852-003-01-0,benzodiazepine receptor agonist
25983,l10,BRD-K34014345-001-02-6,Anti-inflammatory
25983,l11,BRD-K34034388-300-01-0,dopamine uptake inhibitor
25983,l12,BRD-K34092021-001-02-3,TRPV agonist|cannabinoid receptor agonist
25983,l13,BRD-K34154330-003-04-9,GABA receptor modulator
25983,l17,BRD-K34170797-001-01-1,FXR agonist
25983,l20,BRD-K34415467-003-04-9,histamine receptor antagonist
25983,l21,BRD-K34568562-001-02-7,interferon inducer
25983,l22,BRD-K34608650-001-01-6,Cannabinoid receptor agonist
25983,m02,BRD-K34685430-001-01-1,dopamine receptor antagonist|serotonin receptor antagonist
25983,m03,BRD-K34995470-001-02-3,receptor tyrosine protein kinase inhibitor|vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor|VEGFR inhibitor
25983,m06,BRD-K35240538-001-03-1,glucocorticoid receptor agonist
25983,m07,BRD-K35430135-003-01-5,Adrenergic receptor antagonist
25983,m08,BRD-K35458079-001-04-2,Nootropic agent
25983,m11,BRD-K35498378-001-03-8,Aldose reductase inhibitor
25983,m15,BRD-K35629949-001-01-2,CCK receptor antagonist
25983,m16,BRD-K35708212-331-03-1,ATPase inhibitor
25983,m17,BRD-K35941380-001-01-7,Serotonin receptor antagonist
25983,m18,BRD-K35960502-001-04-4,DNA replication inhibitor|STAT inhibitor
25983,m20,BRD-K36007650-300-02-3,protein synthesis inhibitor
25983,m21,BRD-K36009368-001-01-8,Opioid receptor agonist
25983,m22,BRD-K36021395-300-01-6,adenosine kinase inhibitor
25983,m23,BRD-K36055864-001-04-4,protein synthesis inhibitor
25983,m24,BRD-K36116267-001-05-4,psychoactive drug
25983,n01,BRD-K36198571-001-01-2,metalloproteinase inhibitor
25983,n02,BRD-K36258877-001-01-5,caspase inhibitor
25983,n05,BRD-K36638830-001-02-2,acetylcholine receptor agonist
25983,n06,BRD-K36756879-003-04-6,calcium channel blocker
25983,n11,BRD-K36862742-001-04-1,sodium/potassium/chloride transporter inhibitor
25983,n12,BRD-K36864847-303-01-7,Adrenergic receptor antagonist
25983,n15,BRD-K36927236-001-06-0,Sulfonylurea
25983,n16,BRD-K36965586-001-01-7,serotonin receptor agonist
25983,n18,BRD-K37249724-001-04-2,histamine receptor antagonist
25983,n19,BRD-K37270826-001-03-7,glucocorticoid receptor antagonist|progesterone receptor antagonist
25983,n21,BRD-K37289225-001-07-5,Dopamine receptor antagonist
25983,n22,BRD-K37392901-003-01-7,ubiquitin hydrolase inhibitor|ubiquitin isopeptidase inhibitor
25983,n23,BRD-K37447567-001-01-8,Opioid receptor antagonist
25983,n24,BRD-K37561857-001-04-9,phosphodiesterase inhibitor
25983,o02,BRD-K37618799-001-01-4,adenosine receptor antagonist
25983,o03,BRD-K37682401-001-05-1,bacterial DNA gyrase inhibitor
25983,o04,BRD-K37688416-003-04-0,psychoactive drug
25983,o05,BRD-K37691127-001-02-2,tyrosinase inhibitor
25983,o07,BRD-K37792168-001-01-0,Phosphodiesterase inhibitor
25983,o08,BRD-K37798499-001-02-5,topoisomerase inhibitor
25983,o09,BRD-K37848908-001-03-1,penicillin binding protein inhibitor
25983,o10,BRD-K37865504-001-01-7,FAAH inhibitor|FAAH reuptake inhibitor
25983,o14,BRD-K37991163-050-05-1,selective serotonin reuptake inhibitor (SSRI)
25983,o15,BRD-K38003476-001-03-4,steroid
25983,o16,BRD-K38055836-001-03-9,respiratory stimulant
25983,o17,BRD-K38197229-001-06-7,solute carrier family member inhibitor
25983,o18,BRD-K38251852-001-02-5,ABC transporter expression enhancer|high conductance calcium activated potassium blocker|LXR agonist|potassium channel blocker
25983,o19,BRD-K38305202-001-01-8,dopamine receptor antagonist
25983,o20,BRD-K38323065-001-05-8,cyclooxygenase inhibitor
25983,o21,BRD-K38347298-001-02-3,adenosine receptor antagonist
25983,o22,BRD-K38436528-003-04-8,norepinephrine reputake inhibitor|serotonin reuptake inhibitor
25983,o23,BRD-K38449220-001-03-8,cytochrome P450 inhibitor
25983,o24,BRD-K38477985-001-01-8,protein tyrosine kinase inhibitor|tyrosine kinase inhibitor
25983,p01,BRD-K38684403-001-02-1,bacterial 50S ribosomal subunit inhibitor
25983,p03,BRD-K38775274-001-02-3,glucocorticoid receptor agonist
25983,p04,BRD-K38903228-001-02-8,flavanone glycoside
25983,p05,BRD-K39120595-304-02-1,autotaxin inhibitor
25983,p07,BRD-K39187410-001-01-7,antiamyloidogenic agent
25983,p08,BRD-K39188321-001-03-9,glucocorticoid receptor agonist
25983,p09,BRD-K39339537-001-03-8,cyclooxygenase inhibitor
25983,p10,BRD-K39356024-001-02-4,acetylcholine release enhancer|dopamine release enhancer|GABA receptor negative allosteric modulator|glutamate receptor modulator|progesterone receptor agonist|steroid hormone inhibitor of CYP17A1 and SULT2B1
25983,p13,BRD-K39484304-001-02-5,RNA polymerase inhibitor
25983,p14,BRD-K39670393-303-01-3,histamine receptor agonist
25983,p15,BRD-K39733634-001-01-8,prostanoid receptor antagonist|angiotensin receptor antagonist
25983,p16,BRD-K39746403-084-02-3,NFkB pathway inhibitor|50S ribosomal subunit inhibitor|motilin receptor agonist|RPLV inhibitor
25983,p17,BRD-K39915878-036-04-6,dopamine receptor antagonist|serotonin receptor antagonist
25983,p18,BRD-K39965020-001-02-6,PPAR receptor agonist
25983,p19,BRD-K39987650-001-04-3,laxative
25983,p20,BRD-K40255344-001-05-1,protein tyrosine kinase inhibitor|tyrosine kinase inhibitor
25983,p21,BRD-K40530731-001-02-5,acetylcholine receptor inhibitor
25983,p22,BRD-K40578143-001-01-8,adenosine receptor agonist
25983,p23,BRD-K40656405-001-01-5,PPAR receptor agonist
25983,p24,BRD-K40742111-001-02-6,lipoxygenase inhibitor
24309,a01,BRD-K18250272-003-03-7,local anesthetic
24309,a02,BRD-K18316707-001-01-9,cannabinoid receptor antagonist
24309,a04,BRD-K18550767-001-02-8,interleukin inhibitor
24309,a05,BRD-K18574842-323-03-3,bacterial cell wall synthesis inhibitor
24309,a06,BRD-K18619710-001-03-7,steroid
24309,a07,BRD-K18742343-001-03-2,PKA inhibitor
24309,a08,BRD-K18757346-001-02-9,thromboxane receptor agonist
24309,a09,BRD-K18779551-003-03-7,acetylcholine release stimulant|adrenergic transmitter uptake inhibitor|reducing agent
24309,a10,BRD-K18787491-001-05-2,MEK inhibitor
24309,a11,BRD-K18799075-001-01-0,cannabinoid receptor partial agonist
24309,a12,BRD-K18816859-001-01-4,Serotonin receptor agonist
24309,a15,BRD-K18909381-001-01-4,serotonin receptor agonist
24309,a16,BRD-K18910433-001-04-4,estrogen receptor agonist
24309,a19,BRD-K19111024-001-04-3,PPAR receptor agonist
24309,a20,BRD-K19295594-001-04-4,BCL inhibitor|MCL1 inhibitor
24309,a21,BRD-K19309090-300-03-0,acetylcholine receptor agonist
24309,a22,BRD-K19352500-332-03-7,dopamine receptor antagonist
24309,a23,BRD-K19360254-001-01-3,Dopamine receptor agonist
24309,b01,BRD-K19462402-003-03-0,adrenergic receptor antagonist|calcium channel blocker
24309,b03,BRD-K19533706-001-01-9,Angiogenesis inhibitor
24309,b04,BRD-K19554809-001-01-1,serotonin receptor agonist
24309,b05,BRD-K19605405-001-01-9,adenosine receptor antagonist
24309,b07,BRD-K20141153-003-03-8,norepinephrine transporter inhibitor|adrenergic transmitter uptake inhibitor
24309,b08,BRD-K20152659-001-02-0,Cholesterol inhibitor
24309,b10,BRD-K20620780-001-01-0,dopamine receptor antagonist
24309,b11,BRD-K20655524-003-04-7,psychoactive drug
24309,b15,BRD-K20714604-001-01-5,Serotonin receptor partial agonist
24309,b16,BRD-K20742498-001-01-5,serotonin receptor antagonist
24309,b17,BRD-K20755323-001-01-8,sphingosine kinase inhibitor
24309,b18,BRD-K20995441-001-01-7,Opioid receptor agonist
24309,b19,BRD-K21283037-001-02-5,glutamate inhibitor
24309,b20,BRD-K21350491-001-02-1,acid sensing ion channel blocker|sodium channel blockers|TRPP3 channel inhibitor|TRPV modulator
24309,b21,BRD-K21450440-001-04-7,carbonic anhydrase inhibitor
24309,b22,BRD-K21520694-001-02-4,PABA antagonist
24309,b23,BRD-K21548250-001-01-3,sodium channel blocker
24309,b24,BRD-K21565985-001-04-3,adrenergic receptor agonist
24309,c01,BRD-K21667562-001-01-4,FAAH transport inhibitor|anandamide transport inhibitor|nucelar factor of activated T-cells inhibitor|TRPV agonist
24309,c02,BRD-K21680192-300-05-2,topoisomerase inhibitor
24309,c03,BRD-K21733600-001-02-6,cyclooxygenase inhibitor
24309,c04,BRD-K21853356-001-04-4,EGFR inhibitor
24309,c07,BRD-K22031190-001-04-6,Prostanoid receptor antagonist
24309,c08,BRD-K22134346-001-04-1,HMGCR inhibitor
24309,c09,BRD-K22193694-001-04-5,Topical sunscreen agent
24309,c10,BRD-K22385716-001-01-7,casein kinase inhibitor|mTOR inhibitor|PI3K inhibitor
24309,c17,BRD-K22861715-001-03-4,breast cancer resistance protein inhibitor
24309,c19,BRD-K22969690-001-02-6,bacterial 50S ribosomal subunit inhibitor
24309,c21,BRD-K23301018-001-02-6,antiprotozoal agent
24309,c23,BRD-K23335153-300-01-7,glutamate receptor positive allosteric modulator
24309,c24,BRD-K23383398-001-01-6,LXR agonist|ABC transporter expression enhancer|ROR inverse agonist
24309,d02,BRD-K23478508-001-03-7,ATPase inhibitor
24309,d03,BRD-K23541596-300-04-9,histamine receptor agonist
24309,d04,BRD-K23566484-001-04-5,androgen receptor antagonist
24309,d05,BRD-K23583188-001-05-6,EGFR inhibitor|tyrosine kinase inhibitor
24309,d06,BRD-K23704908-001-03-2,serine protease inhibitor
24309,d07,BRD-K23913458-001-02-5,Vitamin K antagonist
24309,d08,BRD-K23922020-075-01-1,acetylcholine receptor agonist
24309,d10,BRD-K24084088-001-02-2,adenosine receptor antagonist
24309,d13,BRD-K24132293-001-02-0,glutathione transferase inhibitor
24309,d14,BRD-K24201553-003-02-4,Serotonin receptor antagonist
24309,d17,BRD-K24240364-003-02-1,Glutamate receptor antagonist
24309,d18,BRD-K24396733-001-01-1,dopamine receptor agonist
24309,d20,BRD-K24526313-001-08-6,Potassium channel activator
24309,e05,BRD-K25224017-001-04-5,serotonin receptor antagonist
24309,e07,BRD-K25394294-001-04-0,Cyclooxygenase inhibitor
24309,e11,BRD-K25433859-003-11-4,norepinephrine reputake inhibitor|tricyclic antidepressant
24309,e13,BRD-K25741894-001-03-8,acetylcholinesterase inhibitor
24309,e15,BRD-K25875056-001-01-2,Protein tyrosine kinase activator
24309,e16,BRD-K25906698-303-01-9,histamine receptor agonist
24309,e21,BRD-K26160755-003-01-8,Imidazoline receptor agonist
24309,e22,BRD-K26373640-001-02-8,IKK inhibitor
24309,f03,BRD-K26429091-051-01-9,acetylcholine receptor antagonist
24309,f04,BRD-K26521938-001-04-9,prostanoid receptor agonist
24309,f05,BRD-K26548821-001-01-8,Dopamine receptor agonist
24309,f06,BRD-K26573499-300-01-3,Adrenergic receptor agonist
24309,f12,BRD-K26979635-001-01-1,Glutamate receptor antagonist
24309,f13,BRD-K26997899-001-01-4,microtubule inhibitor|tubulin inhibitor
24309,f15,BRD-K27141178-001-01-0,Serotonin receptor antagonist
24309,f20,BRD-K27305650-001-04-2,mTOR inhibitor|PI3K inhibitor|DNA dependent protein kinase inhibitor|phosphodiesterase inhibitor|PLK inhibitor
24309,f21,BRD-K27316855-001-02-6,vitamin D receptor agonist
24309,f23,BRD-K27351809-001-02-0,progesterone receptor agonist
24309,g01,BRD-K27450477-001-03-9,Adenosine deaminase inhibitor
24309,g02,BRD-K27499107-001-02-6,IP receptor activator
24309,g06,BRD-K27710560-001-02-6,SIRT inhibitor
24309,g07,BRD-K27737647-001-03-4,PKA inhibitor
24309,g09,BRD-K27871032-001-02-6,Ergoline alkaloid
24309,g11,BRD-K28115081-001-01-9,Platelet activating factor receptor antagonist
24309,g12,BRD-K28137194-003-01-3,GABA receptor agonist
24309,g13,BRD-K28143534-001-01-4,histamine receptor antagonist
24309,g15,BRD-K28183345-003-05-6,Dihydrofolate reductase inhibitor
24309,g17,BRD-K28307902-001-04-3,androgen receptor antagonist
24309,g18,BRD-K28453807-003-05-4,Cholinergic receptor antagonist
24309,g23,BRD-K28578425-001-01-3,phosphodiesterase inhibitor
24309,g24,BRD-K28667196-001-02-9,Increases arterial blood pressure
24309,h01,BRD-K28680267-001-01-8,CCK receptor antagonist
24309,h02,BRD-K28761384-003-03-6,dopamine receptor antagonist
24309,h05,BRD-K28761891-001-01-0,melatonin receptor agonist
24309,h06,BRD-K28806945-001-01-9,dopamine receptor antagonist
24309,h07,BRD-K28863208-001-01-2,Cholinergic receptor agonist
24309,h08,BRD-K28907958-001-01-9,retinoid receptor agonist
24309,h09,BRD-K28936863-051-04-1,histamine receptor agonist|leukotriene receptor antagonist|phosphodiesterase inhibitor
24309,h10,BRD-K29113274-001-03-6,Sterol demethylase inhibitor
24309,h12,BRD-K29178788-001-02-0,Furoquinoline alkaloid
24309,h13,BRD-K29359156-001-04-6,H+/K+-ATPase inhibitor
24309,h16,BRD-K29555132-001-02-2,Cannabinoid receptor agonist
24309,h17,BRD-K29582677-001-02-7,Calcium channel blocker
24309,h18,BRD-K29668683-300-01-4,sigma receptor antagonist
24309,h21,BRD-K29673530-001-03-9,tyrosine kinase inhibitor
24309,h22,BRD-K29950728-048-02-6,estrogen receptor antagonist
24309,h23,BRD-K30197592-001-01-5,Serotonin receptor agonist
24309,i01,BRD-K30240666-051-05-0,histamine receptor antagonist
24309,i02,BRD-K30421593-050-02-3,adrenergic receptor antagonist
24309,i03,BRD-K30480208-001-04-5,Electrolyte reabsorption inhibitor
24309,i08,BRD-K30685142-001-04-8,thyroid hormone stimulant
24309,i09,BRD-K30867024-001-01-1,serotonin receptor antagonist
24309,i11,BRD-K30990140-003-01-6,Cyclooxygenase inhibitor
24309,i12,BRD-K31054881-300-01-3,Adrenergic receptor antagonist
24309,i13,BRD-K31238592-001-01-6,CCK receptor antagonist|gastrin inhibitor
24309,i16,BRD-K31342827-001-05-4,PKC inhibitor
24309,i18,BRD-K31491153-001-01-2,serotonin receptor agonist
24309,i19,BRD-K31542390-001-01-5,dehydrogenase inhibitor|inositol monophosphatase inhibitor
24309,i20,BRD-K31611373-001-02-7,Prostanoid receptor agonist
24309,i23,BRD-K31627533-001-03-8,glucocorticoid receptor agonist
24309,i24,BRD-K31633810-003-01-0,Acetylcholine receptor antagonist
24309,j03,BRD-K31699485-001-01-9,glutamate receptor modulator
24309,j04,BRD-K31792052-004-01-9,interleukin receptor antagonist
24309,j09,BRD-K31843556-001-01-7,PPAR receptor anatagonist|PPAR receptor antagonist
24309,j10,BRD-K31912990-003-01-0,neuropeptide receptor antagonist
24309,j12,BRD-K31987754-001-01-2,Cannabinoid receptor agonist
24309,j15,BRD-K32164935-001-06-8,ATP channel blocker
24309,j16,BRD-K32247306-001-04-7,GABA receptor antagonist
24309,j19,BRD-K32292990-001-01-0,EGFR inhibitor
24309,j20,BRD-K32412559-001-01-7,Adrenergic receptor antagonist
24309,j23,BRD-K32501161-001-01-7,dopamine uptake inhibitor
24309,j24,BRD-K32526544-001-01-2,Potassium channel activator
24309,k02,BRD-K32584078-001-02-3,AKT inhibitor|HCV NS5B RdRp inhibitor
24309,k04,BRD-K32645441-001-01-4,serotonin receptor agonist
24309,k05,BRD-K32696739-001-02-6,Monoamine oxidase inhibitor
24309,k06,BRD-K32744045-001-04-9,aldehyde dehydrogenase inhibitor|DNA methyltransferase inhibitor|TRPV agonist
24309,k09,BRD-K32755366-003-03-4,Norepinephrine transporter inhibitor
24309,k10,BRD-K32821942-001-04-9,dehydrogenase inhibitor
24309,k11,BRD-K32828673-001-01-5,tubulin polymerization inhibitor
24309,k12,BRD-K32830106-003-11-3,adrenergic receptor agonist
24309,k14,BRD-K33204703-001-04-6,PDGFR receptor inhibitor
24309,k17,BRD-K33211335-337-03-7,glutamate receptor antagonist|sigma receptor agonist
24309,k19,BRD-K33308633-001-01-6,calcineurin inhibitor
24309,k20,BRD-K33396764-001-02-0,Omega 3 fatty acid stimulant
24309,k22,BRD-K33453211-003-03-2,Histamine receptor antagonist
24309,l01,BRD-K33459542-001-02-5,sigma receptor agonist
24309,l02,BRD-K33583600-001-03-9,guanylate cyclase activator
24309,l03,BRD-K33710385-001-05-4,mycolic synthesis inhibitor
24309,l04,BRD-K33818169-003-01-2,LXR agonist|ABC transporter expression enhancer
24309,l05,BRD-K33864865-001-01-7,CCK receptor antagonist
24309,l06,BRD-K33882852-003-01-0,benzodiazepine receptor agonist
24309,l10,BRD-K34014345-001-02-6,Anti-inflammatory
24309,l11,BRD-K34034388-300-01-0,dopamine uptake inhibitor
24309,l12,BRD-K34092021-001-02-3,TRPV agonist|cannabinoid receptor agonist
24309,l13,BRD-K34154330-003-04-9,GABA receptor modulator
24309,l17,BRD-K34170797-001-01-1,FXR agonist
24309,l20,BRD-K34415467-003-04-9,histamine receptor antagonist
24309,l21,BRD-K34568562-001-02-7,interferon inducer
24309,l22,BRD-K34608650-001-01-6,Cannabinoid receptor agonist
24309,m02,BRD-K34685430-001-01-1,dopamine receptor antagonist|serotonin receptor antagonist
24309,m03,BRD-K34995470-001-02-3,receptor tyrosine protein kinase inhibitor|vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor|VEGFR inhibitor
24309,m06,BRD-K35240538-001-03-1,glucocorticoid receptor agonist
24309,m07,BRD-K35430135-003-01-5,Adrenergic receptor antagonist
24309,m08,BRD-K35458079-001-04-2,Nootropic agent
24309,m11,BRD-K35498378-001-03-8,Aldose reductase inhibitor
24309,m15,BRD-K35629949-001-01-2,CCK receptor antagonist
24309,m16,BRD-K35708212-331-03-1,ATPase inhibitor
24309,m17,BRD-K35941380-001-01-7,Serotonin receptor antagonist
24309,m18,BRD-K35960502-001-04-4,DNA replication inhibitor|STAT inhibitor
24309,m20,BRD-K36007650-300-02-3,protein synthesis inhibitor
24309,m21,BRD-K36009368-001-01-8,Opioid receptor agonist
24309,m22,BRD-K36021395-300-01-6,adenosine kinase inhibitor
24309,m23,BRD-K36055864-001-04-4,protein synthesis inhibitor
24309,m24,BRD-K36116267-001-05-4,psychoactive drug
24309,n01,BRD-K36198571-001-01-2,metalloproteinase inhibitor
24309,n02,BRD-K36258877-001-01-5,caspase inhibitor
24309,n05,BRD-K36638830-001-02-2,acetylcholine receptor agonist
24309,n06,BRD-K36756879-003-04-6,calcium channel blocker
24309,n11,BRD-K36862742-001-04-1,sodium/potassium/chloride transporter inhibitor
24309,n12,BRD-K36864847-303-01-7,Adrenergic receptor antagonist
24309,n15,BRD-K36927236-001-06-0,Sulfonylurea
24309,n16,BRD-K36965586-001-01-7,serotonin receptor agonist
24309,n18,BRD-K37249724-001-04-2,histamine receptor antagonist
24309,n19,BRD-K37270826-001-03-7,glucocorticoid receptor antagonist|progesterone receptor antagonist
24309,n21,BRD-K37289225-001-07-5,Dopamine receptor antagonist
24309,n22,BRD-K37392901-003-01-7,ubiquitin hydrolase inhibitor|ubiquitin isopeptidase inhibitor
24309,n23,BRD-K37447567-001-01-8,Opioid receptor antagonist
24309,n24,BRD-K37561857-001-04-9,phosphodiesterase inhibitor
24309,o02,BRD-K37618799-001-01-4,adenosine receptor antagonist
24309,o03,BRD-K37682401-001-05-1,bacterial DNA gyrase inhibitor
24309,o04,BRD-K37688416-003-04-0,psychoactive drug
24309,o05,BRD-K37691127-001-02-2,tyrosinase inhibitor
24309,o07,BRD-K37792168-001-01-0,Phosphodiesterase inhibitor
24309,o08,BRD-K37798499-001-02-5,topoisomerase inhibitor
24309,o09,BRD-K37848908-001-03-1,penicillin binding protein inhibitor
24309,o10,BRD-K37865504-001-01-7,FAAH inhibitor|FAAH reuptake inhibitor
24309,o14,BRD-K37991163-050-05-1,selective serotonin reuptake inhibitor (SSRI)
24309,o15,BRD-K38003476-001-03-4,steroid
24309,o16,BRD-K38055836-001-03-9,respiratory stimulant
24309,o17,BRD-K38197229-001-06-7,solute carrier family member inhibitor
24309,o18,BRD-K38251852-001-02-5,ABC transporter expression enhancer|high conductance calcium activated potassium blocker|LXR agonist|potassium channel blocker
24309,o19,BRD-K38305202-001-01-8,dopamine receptor antagonist
24309,o20,BRD-K38323065-001-05-8,cyclooxygenase inhibitor
24309,o21,BRD-K38347298-001-02-3,adenosine receptor antagonist
24309,o22,BRD-K38436528-003-04-8,norepinephrine reputake inhibitor|serotonin reuptake inhibitor
24309,o23,BRD-K38449220-001-03-8,cytochrome P450 inhibitor
24309,o24,BRD-K38477985-001-01-8,protein tyrosine kinase inhibitor|tyrosine kinase inhibitor
24309,p01,BRD-K38684403-001-02-1,bacterial 50S ribosomal subunit inhibitor
24309,p03,BRD-K38775274-001-02-3,glucocorticoid receptor agonist
24309,p04,BRD-K38903228-001-02-8,flavanone glycoside
24309,p05,BRD-K39120595-304-02-1,autotaxin inhibitor
24309,p07,BRD-K39187410-001-01-7,antiamyloidogenic agent
24309,p08,BRD-K39188321-001-03-9,glucocorticoid receptor agonist
24309,p09,BRD-K39339537-001-03-8,cyclooxygenase inhibitor
24309,p10,BRD-K39356024-001-02-4,acetylcholine release enhancer|dopamine release enhancer|GABA receptor negative allosteric modulator|glutamate receptor modulator|progesterone receptor agonist|steroid hormone inhibitor of CYP17A1 and SULT2B1
24309,p13,BRD-K39484304-001-02-5,RNA polymerase inhibitor
24309,p14,BRD-K39670393-303-01-3,histamine receptor agonist
24309,p15,BRD-K39733634-001-01-8,prostanoid receptor antagonist|angiotensin receptor antagonist
24309,p16,BRD-K39746403-084-02-3,NFkB pathway inhibitor|50S ribosomal subunit inhibitor|motilin receptor agonist|RPLV inhibitor
24309,p17,BRD-K39915878-036-04-6,dopamine receptor antagonist|serotonin receptor antagonist
24309,p18,BRD-K39965020-001-02-6,PPAR receptor agonist
24309,p19,BRD-K39987650-001-04-3,laxative
24309,p20,BRD-K40255344-001-05-1,protein tyrosine kinase inhibitor|tyrosine kinase inhibitor
24309,p21,BRD-K40530731-001-02-5,acetylcholine receptor inhibitor
24309,p22,BRD-K40578143-001-01-8,adenosine receptor agonist
24309,p23,BRD-K40656405-001-01-5,PPAR receptor agonist
24309,p24,BRD-K40742111-001-02-6,lipoxygenase inhibitor
25962,a01,BRD-A97104540-004-04-4,adrenergic receptor agonist
25962,a04,BRD-A97479839-003-04-2,Acetylcholine receptor antagonist
25962,a05,BRD-A97701745-001-04-6,adrenergic receptor antagonist|serotonin receptor antagonist
25962,a06,BRD-A97730597-003-03-2,sodium channel blocker
25962,a07,BRD-A97739905-001-04-2,cyclooxygenase inhibitor
25962,a08,BRD-A98299281-050-03-9,calcium channel activator
25962,a09,BRD-A98378129-001-01-4,cyclooxygenase inhibitor|calcium channel blocker|calcium-activated chloride channel blocker|mucin production inhibitor
25962,a10,BRD-A98702003-304-02-2,11-beta-HSD1 inhibitor
25962,a11,BRD-A98725278-103-01-9,serotonin receptor antagonist
25962,a15,BRD-A99177642-001-02-5,acetylcholine receptor antagonist
25962,a16,BRD-A99402294-236-02-0,bacterial cell wall synthesis inhibitor
25962,a17,BRD-A99411506-002-01-3,antioxidant
25962,a18,BRD-A99449986-001-01-4,adenine nucleotide translocase inhibitor|caspase activator|neurotrophic agent
25962,a19,BRD-A99571536-001-01-0,anti-epileptic
25962,a20,BRD-K00141480-001-03-0,anti-inflammatory agent|interleukin inhibitor
25962,a21,BRD-K00184207-001-02-4,aryl hydrocarbon receptor ligand
25962,a22,BRD-K00206590-001-01-2,ATP channel activator
25962,a23,BRD-K00259736-001-03-2,microtubule inhibitor
25962,a24,BRD-K00312224-001-03-8,estrogen receptor agonist
25962,b03,BRD-K00603606-003-03-4,purinergic receptor antagonist|platelet aggregation inhibitor
25962,b04,BRD-K00610438-003-01-7,serotonin receptor antagonist|collagen stimulant
25962,b05,BRD-K00662280-001-01-1,GABA receptor agonist
25962,b06,BRD-K00673382-001-04-9,histamine receptor antagonist
25962,b07,BRD-K00675675-003-01-2,metalloproteinase inhibitor
25962,b09,BRD-K00824317-001-03-0,glucocorticoid receptor agonist
25962,b11,BRD-K01095011-001-03-5,5 alpha reductase inhibitor
25962,b15,BRD-K01244426-236-04-8,bacterial cell wall synthesis inhibitor
25962,b16,BRD-K01292756-001-06-0,dopamine receptor antagonist
25962,b19,BRD-K01567962-001-06-5,JNK inhibitor
25962,b20,BRD-K01624546-001-02-8,LTB4 inhibitor
25962,b21,BRD-K01648091-001-04-2,Dopamine receptor antagonist
25962,b22,BRD-K01663662-003-03-8,muscarinic antagonist
25962,b23,BRD-K01815685-001-02-3,aryl hydrocarbon receptor agonist
25962,c01,BRD-K01868942-001-01-3,serotonin receptor antagonist
25962,c02,BRD-K01902415-001-03-4,PPAR receptor agonist
25962,c05,BRD-K02265150-001-04-2,norepinephrine reputake inhibitor
25962,c06,BRD-K02275692-003-03-4,bacterial cell wall synthesis inhibitor
25962,c07,BRD-K02283807-003-01-4,thromboxane receptor antagonist
25962,c09,BRD-K02404261-001-02-7,Adenosine receptor antagonist
25962,c10,BRD-K02407574-001-03-0,tubulin polymerization inhibitor
25962,c14,BRD-K02581333-001-01-8,Tyrosine phosphatase inhibitor
25962,c17,BRD-K02590140-001-01-2,cannabinoid receptor antagonist
25962,c18,BRD-K02607075-333-03-6,Acetylcholine receptor antagonist
25962,c19,BRD-K02637541-001-02-4,Cyclooxygenase inhibitor
25962,c22,BRD-K02764365-001-03-7,anthelmintic agent
25962,c23,BRD-K02867583-300-04-8,serotonin reuptake inhibitor
25962,c24,BRD-K02900412-001-02-2,protein synthesis inhibitor
25962,d01,BRD-K02953697-001-01-9,cytochrome P450 inhibitor
25962,d03,BRD-K03015355-003-01-5,adenylyl cyclase activator|Adenylate cyclase stimulant|growth hormone receptor agonist|phosphokinase stimulant
25962,d04,BRD-K03067624-300-02-9,protein synthesis inhibitor
25962,d07,BRD-K03384561-001-01-9,Angiogenesis inhibitor
25962,d08,BRD-K03440695-001-02-6,Acetylcholine receptor antagonist
25962,d13,BRD-K03600606-001-02-3,Beta secretase inhibitor
25962,d14,BRD-K03602135-236-02-1,HMGCR inhibitor
25962,d17,BRD-K03642198-300-01-7,hedgehog pathway inhibitor
25962,d18,BRD-K03670461-001-02-0,EGFR inhibitor
25962,d19,BRD-K03842655-001-02-1,potassium channel blocker
25962,d20,BRD-K03981224-001-02-9,Progestogen hormone
25962,d21,BRD-K04010869-001-02-6,HSP inducer|NFKB pathway inhibitor
25962,d22,BRD-K04046242-001-03-6,Estrogen receptor agonist
25962,d23,BRD-K04111260-001-01-9,Dopamine receptor antagonist
25962,d24,BRD-K04170657-001-02-4,Ras GTPase inhibitor
25962,e03,BRD-K04185004-003-03-6,Local anesthetic
25962,e04,BRD-K04414442-001-03-4,tachykinin antagonist
25962,e05,BRD-K04430056-001-02-9,nitric oxide synthase inhibitor
25962,e06,BRD-K04704168-003-03-6,HCV inhibitor
25962,e08,BRD-K04976539-001-01-0,PKC inhibitor|src inhibitor
25962,e11,BRD-K05151076-001-01-8,estrogen receptor antagonist
25962,e12,BRD-K05181084-003-02-9,dopamine receptor antagonist
25962,e13,BRD-K05181463-001-01-6,Dopamine receptor antagonist
25962,e16,BRD-K05434375-001-04-0,calcium channel blocker
25962,e19,BRD-K05464208-001-01-6,p38 MAPK inhibitor
25962,e21,BRD-K05653692-001-02-5,Glucosyltransferase inhibitor
25962,e22,BRD-K05673000-323-02-8,Bacterial cell wall synthesis inhibitor
25962,e23,BRD-K05901394-001-01-1,Dopamine receptor agonist
25962,e24,BRD-K05906022-001-02-8,HIV protease inhibitor
25962,f03,BRD-K05977355-001-02-6,sterol demethylase inhibitor
25962,f05,BRD-K06014311-001-01-2,Melatonin receptor antagonist
25962,f06,BRD-K06024458-001-01-4,cannabinoid receptor agonist
25962,f07,BRD-K06147391-003-01-9,Acetylcholine receptor antagonist
25962,f08,BRD-K06159959-001-01-2,Inhibitor of the binding of homoquinolinic acid to non-NMDA sensitive sites
25962,f12,BRD-K06208435-001-02-9,Calcium channel blocker
25962,f13,BRD-K06221026-001-03-5,Cyclooxygenase inhibitor
25962,f14,BRD-K06234293-001-01-8,TGF beta receptor inhibitor|p38 MAPK inhibitor
25962,f15,BRD-K06426971-001-01-9,histone lyinse methyltransferase inhibitor
25962,f19,BRD-K06467078-001-01-5,Adrenergic receptor antagonist
25962,f20,BRD-K06543683-001-03-6,PKC inhibitor|glycogen synthase kinase inhibitor|leucine rich repeat kinase inhibitor|SIRT inhibitor
25962,f21,BRD-K06593056-001-01-4,retinoid receptor agonist
25962,f22,BRD-K06753942-001-02-0,MEK inhibitor
25962,f23,BRD-K06854232-001-03-3,retinoid receptor agonist
25962,f24,BRD-K06980535-003-04-4,Dopamine receptor antagonist
25962,g02,BRD-K07117950-001-02-6,CDK inhibitor
25962,g06,BRD-K07212038-001-02-1,Mast cell stabilizer
25962,g07,BRD-K07220430-001-03-6,Calcium channel blocker
25962,g08,BRD-K07325606-001-02-3,PKC inhibitor
25962,g10,BRD-K07507905-236-01-8,adrenergic receptor agonist
25962,g13,BRD-K07691486-001-05-6,CDK inhibitor
25962,g14,BRD-K07888196-001-01-8,IGF-1 inhibitor
25962,g15,BRD-K08078237-001-04-0,calcium channel blocker
25962,g16,BRD-K08109516-001-01-1,glutamate receptor antagonist
25962,g17,BRD-K08115555-001-02-8,catechol O methyltransferase inhibitor|tumor necrosis factor inhibitor
25962,g18,BRD-K08132273-001-01-6,EGFR inhibitor
25962,g22,BRD-K08219523-001-01-9,Serotonin receptor agonist
25962,g23,BRD-K08252256-236-04-9,Cyclooxygenase inhibitor
25962,g24,BRD-K08287586-001-03-6,DNA synthesis inhibitor
25962,h01,BRD-K08316444-001-02-7,inhibitor of mitochondrial electron transport
25962,h05,BRD-K08438429-001-01-0,glucosylceramidase inhibitor|somatostatin receptor agonist
25962,h07,BRD-K08554278-001-02-4,DNA binding agent
25962,h09,BRD-K08619574-334-03-9,Dopamine receptor antagonist
25962,h10,BRD-K08619838-300-03-2,Acetylcholine receptor agonist
25962,h11,BRD-K08640512-003-01-5,Adrenergic receptor antagonist
25962,h13,BRD-K08806317-050-03-6,Adrenergic receptor antagonist
25962,h14,BRD-K08890269-001-01-5,Sodium channel blocker
25962,h16,BRD-K08973992-001-01-3,Oxidative stress inducer
25962,h17,BRD-K08996725-313-01-7,histamine receptor antagonist
25962,h18,BRD-K08998509-001-01-6,dopamine receptor antagonist|serotonin receptor antagonist
25962,h23,BRD-K09132007-001-01-8,casein kinase inhibitor|TGF beta receptor inhibitor
25962,i01,BRD-K09255212-001-03-4,chelating agent
25962,i02,BRD-K09397065-001-01-6,Serotonin receptor agonist
25962,i03,BRD-K09416995-001-16-7,HMGCR inhibitor
25962,i04,BRD-K09471561-001-02-6,bacterial DNA gyrase inhibitor
25962,i07,BRD-K09537769-001-01-6,DNA dependent protein kinase inhibitor|mTOR inhibitor|PI3K inhibitor
25962,i08,BRD-K09549677-300-01-8,T-type calcium channel blocker|angiogenesis inhibitor|calcium channel blocker|calcium channel inhibitor|L-type calcium channel blocker|sodium channel blocker
25962,i09,BRD-K09598619-065-01-5,tubulin polymerization inhibitor
25962,i10,BRD-K09631521-001-02-4,cytochrome P450 inhibitor
25962,i11,BRD-K09635134-001-02-4,negative control for D-erythro-MAPP
25962,i12,BRD-K09635314-001-01-8,phospholipase activator
25962,i13,BRD-K09668667-001-02-0,Carcinogen
25962,i14,BRD-K09764130-001-02-6,Cannabinoid receptor agonist
25962,i15,BRD-K09778810-001-01-5,inositol monophosphatase inhibitor
25962,i17,BRD-K09963420-066-03-4,HIV protease inhibitor
25962,i18,BRD-K10042277-001-02-7,cetylcholine receptor agonist|dopamine receptor agonist|dopamine receptor antagonist|dopamine receptor partial agonist|serotonin receptor antagonist|serotonin receptor inverse agonist
25962,i19,BRD-K10065684-001-02-5,laxative
25962,i23,BRD-K10176267-001-01-7,glutamate receptor antagonist
25962,i24,BRD-K10177585-003-01-6,Adenosine receptor antagonist
25962,j01,BRD-K10207760-236-03-0,bacterial permeability inducer
25962,j02,BRD-K10314788-003-04-4,nootropic agent
25962,j07,BRD-K10670311-001-04-9,Antirheumatic
25962,j10,BRD-K10705233-001-01-4,Cannabinoid receptor agonist
25962,j11,BRD-K10843433-001-02-9,Cyclooxygenase inhibitor
25962,j12,BRD-K10870738-001-02-4,lipoxygenase inhibitor
25962,j13,BRD-K10974103-001-03-9,Protein synthesis inhibitor
25962,j15,BRD-K10995081-001-05-5,Dopamine receptor antagonist
25962,j16,BRD-K11107424-001-01-1,histamine receptor antagonist
25962,j17,BRD-K11129031-001-04-4,Lipoprotein lipase activator
25962,j18,BRD-K11158509-001-02-0,EGFR inhibitor
25962,j19,BRD-K11163873-001-02-8,PARP inhibitor
25962,j24,BRD-K11298197-001-03-9,protein synthesis inhibitor
25962,k01,BRD-K11373525-003-01-3,Angiotensin receptor antagonist
25962,k02,BRD-K11399644-003-03-0,AMPK activator
25962,k04,BRD-K11634954-300-01-8,dopamine uptake inhibitor
25962,k06,BRD-K11696279-003-01-5,Imidazoline receptor agonist
25962,k09,BRD-K11717138-001-03-0,chloride channel blocker
25962,k10,BRD-K11742128-003-04-4,histamine receptor antagonist
25962,k13,BRD-K11911061-003-02-8,serotonin receptor antagonist
25962,k14,BRD-K11927976-050-01-1,mediator release inhibitor|syk inhibitor
25962,k17,BRD-K12102668-001-04-0,Monoamine oxidase inhibitor
25962,k18,BRD-K12120659-305-01-4,Integrin antagonist
25962,k20,BRD-K12184470-300-01-8,calcium channel blocker|T-type calcium channel blocker
25962,k21,BRD-K12219985-001-04-8,Sulfonylurea
25962,k22,BRD-K12244279-001-01-7,MEK inhibitor
25962,l03,BRD-K12357156-001-01-5,EGFR inhibitor|ErbB2 inhibitor|JAK2 inhibitor
25962,l04,BRD-K12513978-001-04-3,cyclooxygenase inhibitor
25962,l05,BRD-K12539581-001-06-2,tubulin polymerization inhibitor
25962,l12,BRD-K12932420-001-01-5,Phosphodiesterase inhibitor
25962,l14,BRD-K12994359-001-02-8,Cyclooxygenase inhibitor
25962,l19,BRD-K13169950-001-04-5,HDAC inhibitor
25962,l20,BRD-K13211965-001-01-4,dopamine receptor antagonist
25962,l21,BRD-K13261168-001-01-4,Dopamine receptor agonist
25962,m01,BRD-K13533483-001-03-0,calcineurin inhibitor|cyclophilin inhibitor|immunosuppressant|insulin expression inhibitor|T cell inhibitor
25962,m02,BRD-K13544237-001-01-0,dopamine receptor agonist|antiamyloidogenic agent
25962,m03,BRD-K13571841-001-03-7,Aspartic protease inhibitor
25962,m04,BRD-K13642330-001-02-6,cytochrome P450 inhibitor
25962,m05,BRD-K13819402-003-02-9,Acetylcholinesterase inhibitor
25962,m07,BRD-K13994703-001-02-0,adrenergic receptor antagonist
25962,m11,BRD-K14200658-001-02-6,Vesicular monoamine transporter inhibitor
25962,m12,BRD-K14221570-236-01-1,HIV entry inhibitor
25962,m16,BRD-K14282469-001-01-5,serotonin receptor antagonist
25962,m18,BRD-K14441456-001-01-2,EGFR inhibitor
25962,m19,BRD-K14496212-001-01-1,dopamine receptor agonist
25962,m21,BRD-K14618467-003-01-8,IKK inhibitor
25962,n01,BRD-K14765469-003-02-3,acetylcholinesterase inhibitor
25962,n02,BRD-K14767410-001-01-5,cyclooxygenase inhibitor
25962,n03,BRD-K14807180-001-01-7,serotonin receptor antagonist
25962,n04,BRD-K14821540-001-02-1,mitochondrial oxidative phosphorylation uncoupler
25962,n06,BRD-K14888893-001-02-3,KATP activator
25962,n07,BRD-K14965640-001-03-3,Cyclooxygenase inhibitor
25962,n08,BRD-K14993104-001-03-4,Chemoreceptor agonist
25962,n11,BRD-K15025317-001-04-5,NFkB pathway inhibitor
25962,n12,BRD-K15164005-001-01-5,carboxylesterase inhibitor
25962,n15,BRD-K15196155-001-01-5,Hydroxycarboxylic acid receptor agonist
25962,n17,BRD-K15519488-001-01-6,dopamine receptor agonist
25962,n19,BRD-K15567136-001-01-1,phosphodiesterase inhibitor
25962,n21,BRD-K15588452-003-01-9,serotonin receptor antagonist
25962,n22,BRD-K15601958-001-01-3,Lysophospholipid receptor agonist
25962,n23,BRD-K15616905-001-01-5,mitochondrial oxidative phosphorylation uncoupler
25962,n24,BRD-K15715913-001-01-5,dopamine receptor antagonist|serotonin receptor antagonist
25962,o01,BRD-K15766189-001-02-3,bacterial cell wall synthesis inhibitor
25962,o02,BRD-K15791587-003-01-7,tachykinin antagonist
25962,o04,BRD-K15868788-001-01-4,Serotonin receptor antagonist
25962,o05,BRD-K15916496-001-04-8,cytochrome P450 inhibitor|imidazoline receptor ligand
25962,o06,BRD-K15933101-003-01-2,dopamine receptor agonist|dopamine receptor modulator
25962,o07,BRD-K15935639-001-02-0,PGPH inhibitor|proteasome inhibitor
25962,o08,BRD-K15957397-001-02-6,CDC inhibitor
25962,o09,BRD-K16195444-001-01-7,Adrenergic receptor agonist
25962,o10,BRD-K16444452-001-03-4,phosphodiesterase inhibitor|leukotriene receptor antagonist|toll-like receptor antagonist|macrophage migration inhibiting factor inhibitor|macrophage migration inhibiting factor modulator|mediator release inhibitor|nitric oxide synthase inhibitor
25962,o14,BRD-K16485616-001-01-4,HDAC inhibitor|cell cycle inhibitor
25962,o15,BRD-K16508793-001-01-8,benzodiazepine receptor agonist
25962,o16,BRD-K16542329-001-05-1,phosphodiesterase inhibitor
25962,o17,BRD-K16551401-003-01-8,serotonin receptor agonist
25962,o19,BRD-K16604360-001-01-8,antiamyloidogenic agent|dopamine receptor agonist
25962,o20,BRD-K16664969-001-01-7,FLT3 inhibitor|tyrosine kinase inhibitor
25962,o22,BRD-K16977723-001-01-0,EGFR inhibitor
25962,o23,BRD-K17016787-001-03-5,estrogen receptor agonist
25962,p01,BRD-K17140735-300-01-6,Proteasome inhibitor
25962,p03,BRD-K17294426-050-04-0,dopamine receptor antagonist
25962,p04,BRD-K17368287-001-03-5,11-beta hydroxysteroid dehydrogenase inhibitor
25962,p05,BRD-K17378184-300-03-4,Dopamine receptor agonist
25962,p06,BRD-K17415526-001-02-7,protein tyrosine kinase inhibitor
25962,p07,BRD-K17497770-001-01-0,EGFR inhibitor|src inhibitor
25962,p08,BRD-K17565903-066-04-1,muscle relaxant
25962,p09,BRD-K17674993-001-03-1,Corticosteroid agonist
25962,p10,BRD-K17693482-001-03-9,potassium channel activator
25962,p14,BRD-K17743125-001-01-9,HDAC inhibitor|cell cycle inhibitor
25962,p15,BRD-K17743697-066-01-0,sodium/calcium exchange inhibitor
25962,p16,BRD-K17796732-001-02-0,cannabinoid receptor agonist
25962,p19,BRD-K17894950-001-04-4,CDK inhibitor|glycogen synthase kinase inhibitor
25962,p20,BRD-K17896185-001-01-2,opioid receptor agonist
25962,p21,BRD-K18059238-001-02-1,cyclooxygenase inhibitor|prostanoid receptor stimulant|thromboxane synthase stimulant
25962,p24,BRD-K18194590-065-02-3,adrenergic receptor agonist
24306,a01,BRD-A97104540-004-04-4,adrenergic receptor agonist
24306,a04,BRD-A97479839-003-04-2,Acetylcholine receptor antagonist
24306,a05,BRD-A97701745-001-04-6,adrenergic receptor antagonist|serotonin receptor antagonist
24306,a06,BRD-A97730597-003-03-2,sodium channel blocker
24306,a07,BRD-A97739905-001-04-2,cyclooxygenase inhibitor
24306,a08,BRD-A98299281-050-03-9,calcium channel activator
24306,a09,BRD-A98378129-001-01-4,cyclooxygenase inhibitor|calcium channel blocker|calcium-activated chloride channel blocker|mucin production inhibitor
24306,a10,BRD-A98702003-304-02-2,11-beta-HSD1 inhibitor
24306,a11,BRD-A98725278-103-01-9,serotonin receptor antagonist
24306,a15,BRD-A99177642-001-02-5,acetylcholine receptor antagonist
24306,a16,BRD-A99402294-236-02-0,bacterial cell wall synthesis inhibitor
24306,a17,BRD-A99411506-002-01-3,antioxidant
24306,a18,BRD-A99449986-001-01-4,adenine nucleotide translocase inhibitor|caspase activator|neurotrophic agent
24306,a19,BRD-A99571536-001-01-0,anti-epileptic
24306,a20,BRD-K00141480-001-03-0,anti-inflammatory agent|interleukin inhibitor
24306,a21,BRD-K00184207-001-02-4,aryl hydrocarbon receptor ligand
24306,a22,BRD-K00206590-001-01-2,ATP channel activator
24306,a23,BRD-K00259736-001-03-2,microtubule inhibitor
24306,a24,BRD-K00312224-001-03-8,estrogen receptor agonist
24306,b03,BRD-K00603606-003-03-4,purinergic receptor antagonist|platelet aggregation inhibitor
24306,b04,BRD-K00610438-003-01-7,serotonin receptor antagonist|collagen stimulant
24306,b05,BRD-K00662280-001-01-1,GABA receptor agonist
24306,b06,BRD-K00673382-001-04-9,histamine receptor antagonist
24306,b07,BRD-K00675675-003-01-2,metalloproteinase inhibitor
24306,b09,BRD-K00824317-001-03-0,glucocorticoid receptor agonist
24306,b11,BRD-K01095011-001-03-5,5 alpha reductase inhibitor
24306,b15,BRD-K01244426-236-04-8,bacterial cell wall synthesis inhibitor
24306,b16,BRD-K01292756-001-06-0,dopamine receptor antagonist
24306,b19,BRD-K01567962-001-06-5,JNK inhibitor
24306,b20,BRD-K01624546-001-02-8,LTB4 inhibitor
24306,b21,BRD-K01648091-001-04-2,Dopamine receptor antagonist
24306,b22,BRD-K01663662-003-03-8,muscarinic antagonist
24306,b23,BRD-K01815685-001-02-3,aryl hydrocarbon receptor agonist
24306,c01,BRD-K01868942-001-01-3,serotonin receptor antagonist
24306,c02,BRD-K01902415-001-03-4,PPAR receptor agonist
24306,c05,BRD-K02265150-001-04-2,norepinephrine reputake inhibitor
24306,c06,BRD-K02275692-003-03-4,bacterial cell wall synthesis inhibitor
24306,c07,BRD-K02283807-003-01-4,thromboxane receptor antagonist
24306,c09,BRD-K02404261-001-02-7,Adenosine receptor antagonist
24306,c10,BRD-K02407574-001-03-0,tubulin polymerization inhibitor
24306,c14,BRD-K02581333-001-01-8,Tyrosine phosphatase inhibitor
24306,c17,BRD-K02590140-001-01-2,cannabinoid receptor antagonist
24306,c18,BRD-K02607075-333-03-6,Acetylcholine receptor antagonist
24306,c19,BRD-K02637541-001-02-4,Cyclooxygenase inhibitor
24306,c22,BRD-K02764365-001-03-7,anthelmintic agent
24306,c23,BRD-K02867583-300-04-8,serotonin reuptake inhibitor
24306,c24,BRD-K02900412-001-02-2,protein synthesis inhibitor
24306,d01,BRD-K02953697-001-01-9,cytochrome P450 inhibitor
24306,d03,BRD-K03015355-003-01-5,adenylyl cyclase activator|Adenylate cyclase stimulant|growth hormone receptor agonist|phosphokinase stimulant
24306,d04,BRD-K03067624-300-02-9,protein synthesis inhibitor
24306,d06,BRD-K03109492-001-01-4,CDC inhibitor
24306,d07,BRD-K03384561-001-01-9,Angiogenesis inhibitor
24306,d08,BRD-K03440695-001-02-6,Acetylcholine receptor antagonist
24306,d13,BRD-K03600606-001-02-3,Beta secretase inhibitor
24306,d14,BRD-K03602135-236-02-1,HMGCR inhibitor
24306,d17,BRD-K03642198-300-01-7,hedgehog pathway inhibitor
24306,d18,BRD-K03670461-001-02-0,EGFR inhibitor
24306,d19,BRD-K03842655-001-02-1,potassium channel blocker
24306,d20,BRD-K03981224-001-02-9,Progestogen hormone
24306,d21,BRD-K04010869-001-02-6,HSP inducer|NFKB pathway inhibitor
24306,d22,BRD-K04046242-001-03-6,Estrogen receptor agonist
24306,d23,BRD-K04111260-001-01-9,Dopamine receptor antagonist
24306,d24,BRD-K04170657-001-02-4,Ras GTPase inhibitor
24306,e03,BRD-K04185004-003-03-6,Local anesthetic
24306,e04,BRD-K04414442-001-03-4,tachykinin antagonist
24306,e05,BRD-K04430056-001-02-9,nitric oxide synthase inhibitor
24306,e06,BRD-K04704168-003-03-6,HCV inhibitor
24306,e08,BRD-K04976539-001-01-0,PKC inhibitor|src inhibitor
24306,e11,BRD-K05151076-001-01-8,estrogen receptor antagonist
24306,e12,BRD-K05181084-003-02-9,dopamine receptor antagonist
24306,e13,BRD-K05181463-001-01-6,Dopamine receptor antagonist
24306,e16,BRD-K05434375-001-04-0,calcium channel blocker
24306,e19,BRD-K05464208-001-01-6,p38 MAPK inhibitor
24306,e21,BRD-K05653692-001-02-5,Glucosyltransferase inhibitor
24306,e22,BRD-K05673000-323-02-8,Bacterial cell wall synthesis inhibitor
24306,e23,BRD-K05901394-001-01-1,Dopamine receptor agonist
24306,e24,BRD-K05906022-001-02-8,HIV protease inhibitor
24306,f03,BRD-K05977355-001-02-6,sterol demethylase inhibitor
24306,f05,BRD-K06014311-001-01-2,Melatonin receptor antagonist
24306,f06,BRD-K06024458-001-01-4,cannabinoid receptor agonist
24306,f07,BRD-K06147391-003-01-9,Acetylcholine receptor antagonist
24306,f08,BRD-K06159959-001-01-2,Inhibitor of the binding of homoquinolinic acid to non-NMDA sensitive sites
24306,f12,BRD-K06208435-001-02-9,Calcium channel blocker
24306,f13,BRD-K06221026-001-03-5,Cyclooxygenase inhibitor
24306,f14,BRD-K06234293-001-01-8,TGF beta receptor inhibitor|p38 MAPK inhibitor
24306,f15,BRD-K06426971-001-01-9,histone lyinse methyltransferase inhibitor
24306,f19,BRD-K06467078-001-01-5,Adrenergic receptor antagonist
24306,f20,BRD-K06543683-001-03-6,PKC inhibitor|glycogen synthase kinase inhibitor|leucine rich repeat kinase inhibitor|SIRT inhibitor
24306,f21,BRD-K06593056-001-01-4,retinoid receptor agonist
24306,f22,BRD-K06753942-001-02-0,MEK inhibitor
24306,f23,BRD-K06854232-001-03-3,retinoid receptor agonist
24306,f24,BRD-K06980535-003-04-4,Dopamine receptor antagonist
24306,g02,BRD-K07117950-001-02-6,CDK inhibitor
24306,g06,BRD-K07212038-001-02-1,Mast cell stabilizer
24306,g07,BRD-K07220430-001-03-6,Calcium channel blocker
24306,g08,BRD-K07325606-001-02-3,PKC inhibitor
24306,g10,BRD-K07507905-236-01-8,adrenergic receptor agonist
24306,g13,BRD-K07691486-001-05-6,CDK inhibitor
24306,g14,BRD-K07888196-001-01-8,IGF-1 inhibitor
24306,g15,BRD-K08078237-001-04-0,calcium channel blocker
24306,g16,BRD-K08109516-001-01-1,glutamate receptor antagonist
24306,g17,BRD-K08115555-001-02-8,catechol O methyltransferase inhibitor|tumor necrosis factor inhibitor
24306,g18,BRD-K08132273-001-01-6,EGFR inhibitor
24306,g22,BRD-K08219523-001-01-9,Serotonin receptor agonist
24306,g23,BRD-K08252256-236-04-9,Cyclooxygenase inhibitor
24306,g24,BRD-K08287586-001-03-6,DNA synthesis inhibitor
24306,h01,BRD-K08316444-001-02-7,inhibitor of mitochondrial electron transport
24306,h05,BRD-K08438429-001-01-0,glucosylceramidase inhibitor|somatostatin receptor agonist
24306,h07,BRD-K08554278-001-02-4,DNA binding agent
24306,h09,BRD-K08619574-334-03-9,Dopamine receptor antagonist
24306,h10,BRD-K08619838-300-03-2,Acetylcholine receptor agonist
24306,h11,BRD-K08640512-003-01-5,Adrenergic receptor antagonist
24306,h13,BRD-K08806317-050-03-6,Adrenergic receptor antagonist
24306,h14,BRD-K08890269-001-01-5,Sodium channel blocker
24306,h16,BRD-K08973992-001-01-3,Oxidative stress inducer
24306,h17,BRD-K08996725-313-01-7,histamine receptor antagonist
24306,h18,BRD-K08998509-001-01-6,dopamine receptor antagonist|serotonin receptor antagonist
24306,h23,BRD-K09132007-001-01-8,casein kinase inhibitor|TGF beta receptor inhibitor
24306,i01,BRD-K09255212-001-03-4,chelating agent
24306,i02,BRD-K09397065-001-01-6,Serotonin receptor agonist
24306,i03,BRD-K09416995-001-16-7,HMGCR inhibitor
24306,i04,BRD-K09471561-001-02-6,bacterial DNA gyrase inhibitor
24306,i07,BRD-K09537769-001-01-6,DNA dependent protein kinase inhibitor|mTOR inhibitor|PI3K inhibitor
24306,i08,BRD-K09549677-300-01-8,T-type calcium channel blocker|angiogenesis inhibitor|calcium channel blocker|calcium channel inhibitor|L-type calcium channel blocker|sodium channel blocker
24306,i09,BRD-K09598619-065-01-5,tubulin polymerization inhibitor
24306,i10,BRD-K09631521-001-02-4,cytochrome P450 inhibitor
24306,i11,BRD-K09635134-001-02-4,negative control for D-erythro-MAPP
24306,i12,BRD-K09635314-001-01-8,phospholipase activator
24306,i13,BRD-K09668667-001-02-0,Carcinogen
24306,i14,BRD-K09764130-001-02-6,Cannabinoid receptor agonist
24306,i15,BRD-K09778810-001-01-5,inositol monophosphatase inhibitor
24306,i17,BRD-K09963420-066-03-4,HIV protease inhibitor
24306,i18,BRD-K10042277-001-02-7,cetylcholine receptor agonist|dopamine receptor agonist|dopamine receptor antagonist|dopamine receptor partial agonist|serotonin receptor antagonist|serotonin receptor inverse agonist
24306,i19,BRD-K10065684-001-02-5,laxative
24306,i23,BRD-K10176267-001-01-7,glutamate receptor antagonist
24306,i24,BRD-K10177585-003-01-6,Adenosine receptor antagonist
24306,j01,BRD-K10207760-236-03-0,bacterial permeability inducer
24306,j02,BRD-K10314788-003-04-4,nootropic agent
24306,j07,BRD-K10670311-001-04-9,Antirheumatic
24306,j10,BRD-K10705233-001-01-4,Cannabinoid receptor agonist
24306,j11,BRD-K10843433-001-02-9,Cyclooxygenase inhibitor
24306,j12,BRD-K10870738-001-02-4,lipoxygenase inhibitor
24306,j13,BRD-K10974103-001-03-9,Protein synthesis inhibitor
24306,j15,BRD-K10995081-001-05-5,Dopamine receptor antagonist
24306,j16,BRD-K11107424-001-01-1,histamine receptor antagonist
24306,j17,BRD-K11129031-001-04-4,Lipoprotein lipase activator
24306,j18,BRD-K11158509-001-02-0,EGFR inhibitor
24306,j19,BRD-K11163873-001-02-8,PARP inhibitor
24306,j24,BRD-K11298197-001-03-9,protein synthesis inhibitor
24306,k01,BRD-K11373525-003-01-3,Angiotensin receptor antagonist
24306,k02,BRD-K11399644-003-03-0,AMPK activator
24306,k04,BRD-K11634954-300-01-8,dopamine uptake inhibitor
24306,k06,BRD-K11696279-003-01-5,Imidazoline receptor agonist
24306,k09,BRD-K11717138-001-03-0,chloride channel blocker
24306,k10,BRD-K11742128-003-04-4,histamine receptor antagonist
24306,k13,BRD-K11911061-003-02-8,serotonin receptor antagonist
24306,k14,BRD-K11927976-050-01-1,mediator release inhibitor|syk inhibitor
24306,k17,BRD-K12102668-001-04-0,Monoamine oxidase inhibitor
24306,k18,BRD-K12120659-305-01-4,Integrin antagonist
24306,k20,BRD-K12184470-300-01-8,calcium channel blocker|T-type calcium channel blocker
24306,k21,BRD-K12219985-001-04-8,Sulfonylurea
24306,k22,BRD-K12244279-001-01-7,MEK inhibitor
24306,l03,BRD-K12357156-001-01-5,EGFR inhibitor|ErbB2 inhibitor|JAK2 inhibitor
24306,l04,BRD-K12513978-001-04-3,cyclooxygenase inhibitor
24306,l05,BRD-K12539581-001-06-2,tubulin polymerization inhibitor
24306,l12,BRD-K12932420-001-01-5,Phosphodiesterase inhibitor
24306,l14,BRD-K12994359-001-02-8,Cyclooxygenase inhibitor
24306,l19,BRD-K13169950-001-04-5,HDAC inhibitor
24306,l20,BRD-K13211965-001-01-4,dopamine receptor antagonist
24306,l21,BRD-K13261168-001-01-4,Dopamine receptor agonist
24306,m01,BRD-K13533483-001-03-0,calcineurin inhibitor|cyclophilin inhibitor|immunosuppressant|insulin expression inhibitor|T cell inhibitor
24306,m02,BRD-K13544237-001-01-0,dopamine receptor agonist|antiamyloidogenic agent
24306,m03,BRD-K13571841-001-03-7,Aspartic protease inhibitor
24306,m04,BRD-K13642330-001-02-6,cytochrome P450 inhibitor
24306,m05,BRD-K13819402-003-02-9,Acetylcholinesterase inhibitor
24306,m07,BRD-K13994703-001-02-0,adrenergic receptor antagonist
24306,m11,BRD-K14200658-001-02-6,Vesicular monoamine transporter inhibitor
24306,m12,BRD-K14221570-236-01-1,HIV entry inhibitor
24306,m16,BRD-K14282469-001-01-5,serotonin receptor antagonist
24306,m18,BRD-K14441456-001-01-2,EGFR inhibitor
24306,m19,BRD-K14496212-001-01-1,dopamine receptor agonist
24306,m21,BRD-K14618467-003-01-8,IKK inhibitor
24306,n01,BRD-K14765469-003-02-3,acetylcholinesterase inhibitor
24306,n02,BRD-K14767410-001-01-5,cyclooxygenase inhibitor
24306,n03,BRD-K14807180-001-01-7,serotonin receptor antagonist
24306,n04,BRD-K14821540-001-02-1,mitochondrial oxidative phosphorylation uncoupler
24306,n06,BRD-K14888893-001-02-3,KATP activator
24306,n07,BRD-K14965640-001-03-3,Cyclooxygenase inhibitor
24306,n08,BRD-K14993104-001-03-4,Chemoreceptor agonist
24306,n11,BRD-K15025317-001-04-5,NFkB pathway inhibitor
24306,n12,BRD-K15164005-001-01-5,carboxylesterase inhibitor
24306,n15,BRD-K15196155-001-01-5,Hydroxycarboxylic acid receptor agonist
24306,n17,BRD-K15519488-001-01-6,dopamine receptor agonist
24306,n19,BRD-K15567136-001-01-1,phosphodiesterase inhibitor
24306,n21,BRD-K15588452-003-01-9,serotonin receptor antagonist
24306,n22,BRD-K15601958-001-01-3,Lysophospholipid receptor agonist
24306,n23,BRD-K15616905-001-01-5,mitochondrial oxidative phosphorylation uncoupler
24306,n24,BRD-K15715913-001-01-5,dopamine receptor antagonist|serotonin receptor antagonist
24306,o01,BRD-K15766189-001-02-3,bacterial cell wall synthesis inhibitor
24306,o02,BRD-K15791587-003-01-7,tachykinin antagonist
24306,o04,BRD-K15868788-001-01-4,Serotonin receptor antagonist
24306,o05,BRD-K15916496-001-04-8,cytochrome P450 inhibitor|imidazoline receptor ligand
24306,o06,BRD-K15933101-003-01-2,dopamine receptor agonist|dopamine receptor modulator
24306,o07,BRD-K15935639-001-02-0,PGPH inhibitor|proteasome inhibitor
24306,o08,BRD-K15957397-001-02-6,CDC inhibitor
24306,o09,BRD-K16195444-001-01-7,Adrenergic receptor agonist
24306,o10,BRD-K16444452-001-03-4,phosphodiesterase inhibitor|leukotriene receptor antagonist|toll-like receptor antagonist|macrophage migration inhibiting factor inhibitor|macrophage migration inhibiting factor modulator|mediator release inhibitor|nitric oxide synthase inhibitor
24306,o14,BRD-K16485616-001-01-4,HDAC inhibitor|cell cycle inhibitor
24306,o15,BRD-K16508793-001-01-8,benzodiazepine receptor agonist
24306,o16,BRD-K16542329-001-05-1,phosphodiesterase inhibitor
24306,o17,BRD-K16551401-003-01-8,serotonin receptor agonist
24306,o19,BRD-K16604360-001-01-8,antiamyloidogenic agent|dopamine receptor agonist
24306,o20,BRD-K16664969-001-01-7,FLT3 inhibitor|tyrosine kinase inhibitor
24306,o22,BRD-K16977723-001-01-0,EGFR inhibitor
24306,o23,BRD-K17016787-001-03-5,estrogen receptor agonist
24306,p01,BRD-K17140735-300-01-6,Proteasome inhibitor
24306,p03,BRD-K17294426-050-04-0,dopamine receptor antagonist
24306,p04,BRD-K17368287-001-03-5,11-beta hydroxysteroid dehydrogenase inhibitor
24306,p05,BRD-K17378184-300-03-4,Dopamine receptor agonist
24306,p06,BRD-K17415526-001-02-7,protein tyrosine kinase inhibitor
24306,p07,BRD-K17497770-001-01-0,EGFR inhibitor|src inhibitor
24306,p08,BRD-K17565903-066-04-1,muscle relaxant
24306,p09,BRD-K17674993-001-03-1,Corticosteroid agonist
24306,p10,BRD-K17693482-001-03-9,potassium channel activator
24306,p13,BRD-K17705806-003-01-0,opioid receptor antagonist
24306,p14,BRD-K17743125-001-01-9,HDAC inhibitor|cell cycle inhibitor
24306,p15,BRD-K17743697-066-01-0,sodium/calcium exchange inhibitor
24306,p16,BRD-K17796732-001-02-0,cannabinoid receptor agonist
24306,p19,BRD-K17894950-001-04-4,CDK inhibitor|glycogen synthase kinase inhibitor
24306,p20,BRD-K17896185-001-01-2,opioid receptor agonist
24306,p21,BRD-K18059238-001-02-1,cyclooxygenase inhibitor|prostanoid receptor stimulant|thromboxane synthase stimulant
24306,p24,BRD-K18194590-065-02-3,adrenergic receptor agonist
25992,a01,BRD-K90382497-001-01-6,PLK inhibitor
25992,a02,BRD-K92723993-066-02-9,PDGFR tyrosine kinase receptor inhibitor|Bcr-Abl kinase inhibitor|KIT inhibitor|Abl kinase inhibitor|apoptosis stimulant|breast cancer resistance protein inhibitor|colony stimulating factor receptor inhibitor
25992,a03,BRD-K07762753-001-03-6,CDK inhibitor|tyrosine kinase inhibitor
25992,a04,BRD-K09991945-001-02-0,glycogen synthase kinase inhibitor|PKC inhibitor|superoxide dismutase expression inhibitor
25992,a05,BRD-K37312348-001-05-1,CDK inhibitor|glycogen synthase kinase inhibitor
25992,a06,BRD-K46678324-001-03-7,rho associated kinase inhibitor
25992,a07,BRD-K67860401-001-02-3,glycogen synthase kinase inhibitor
25992,a08,BRD-K52620403-001-01-8,calcium/calmodulin dependent protein kinase inhibitor|calmodulin inhibitor
25992,a09,BRD-K68336408-001-03-4,EGFR inhibitor
25992,a10,BRD-K72703948-001-01-0,Aurora kinase inhibitor
25992,a11,BRD-K93201660-001-05-7,myosin light chain kinase inhibitor
25992,a15,BRD-A47633927-001-01-8,ICAM1 antagonist
25992,a16,BRD-A68039575-001-02-5,Aromatase inhibitor
25992,a17,BRD-A75455249-001-02-0,calcium channel modulator|mTOR inhibitor|sodium channel blocker
25992,a18,BRD-K01555864-001-02-8,antineoplastic
25992,a19,BRD-K09497549-001-03-6,calcium channel modulator|mTOR inhibitor|sodium channel blocker
25992,a20,BRD-K14536225-001-02-7,Glucosidase inhibitor
25992,a21,BRD-K15086322-103-01-0,histamine receptor antagonist|histamine receptor silent antagonist
25992,a23,BRD-K23623876-001-01-6,ultrasound contrast agent
25992,a24,BRD-K36377456-001-02-0,angiogenesis inhibitor
25992,b01,BRD-K36395411-003-01-4,serotonin receptor antagonist|serotonin receptor partial agonist
25992,b03,BRD-K41160163-001-01-9,Glutamate receptor antagonist
25992,b04,BRD-K42095107-001-02-3,estrogen receptor agonist
25992,b05,BRD-K43797669-001-02-3,tyrosine kinase inhibitor
25992,b06,BRD-K45988865-001-01-0,organosilicon compound used as an internal standard in NMR spectroscopy
25992,b07,BRD-K49061529-001-01-0,GABA benzodiazepine site receptor inverse agonist
25992,b09,BRD-K59331372-001-01-2,TRPV antagonist
25992,b11,BRD-K60690191-003-02-1,glutamate receptor antagonist
25992,b12,BRD-K61177364-003-01-1,CRF receptor antagonist
25992,b17,BRD-K61250553-001-02-9,opioid receptor agonist
25992,b18,BRD-K61269089-001-01-4,Protein kinase inhibitor
25992,b19,BRD-K61271364-001-02-4,GABA receptor antagonist
25992,b20,BRD-K61323504-001-02-4,CC chemokine receptor antagonist
25992,b22,BRD-K61496577-001-03-8,glucocorticoid receptor agonist
25992,b23,BRD-K61590534-001-01-4,EGFR inhibitor
25992,c01,BRD-K61737877-001-01-6,VEGFR inhibitor
25992,c03,BRD-K61951118-001-01-2,GABA benzodiazepine site receptor inverse agonist
25992,c04,BRD-K62008436-001-03-1,tubulin polymerization inhibitor
25992,c05,BRD-K62056274-001-01-9,Serotonin receptor agonist
25992,c07,BRD-K62206109-303-01-1,histamine receptor antagonist
25992,c08,BRD-K62221994-001-01-8,gonadotropin releasing factor hormone receptor antagonist
25992,c10,BRD-K62289640-003-01-9,Cannabinoid receptor agonist
25992,c13,BRD-K62310379-001-03-0,glucocorticoid receptor agonist
25992,c17,BRD-K62353524-001-01-8,estrogen receptor agonist
25992,c18,BRD-K62363391-001-04-1,bacterial antifolate
25992,c23,BRD-K62607865-001-03-0,bacterial cell wall synthesis inhibitor
25992,c24,BRD-K62609077-001-02-2,adrenergic receptor antagonist|GABA receptor antagonist|serotonin receptor antagonist
25992,d01,BRD-K62810658-001-05-6,MEK inhibitor
25992,d02,BRD-K62929068-001-01-7,Purinergic receptor activator
25992,d04,BRD-K62996583-001-03-8,calcium channel blocker
25992,d05,BRD-K63089472-001-02-7,Inhibitor of methyl esterification of farnesylated proteins
25992,d06,BRD-K63150726-001-01-3,cannabinoid receptor inverse agonist
25992,d07,BRD-K63151507-001-01-6,Lymphocyte inhibitor
25992,d08,BRD-K63165456-001-03-3,Adrenergic receptor agonist
25992,d09,BRD-K63430059-001-03-2,DNA synthesis inhibitor
25992,d10,BRD-K63504947-001-05-5,VEGFR inhibitor
25992,d13,BRD-K63516691-001-01-6,Phosphodiesterase inhibitor
25992,d14,BRD-K63533170-001-01-1,cannabinoid receptor antagonist|cannabinoid receptor inverse agonist
25992,d17,BRD-K63606607-001-01-8,ATPase inhibitor|chloride channel activator
25992,d18,BRD-K63630713-001-04-3,sodium/potassium/chloride transporter inhibitor
25992,d19,BRD-K63750851-001-03-3,dehydrogenase inhibitor|inositol monophosphatase inhibitor
25992,d21,BRD-K63784565-001-02-1,Topoisomerase inhibitor
25992,d22,BRD-K63792901-075-01-3,acetylcholine receptor agonist
25992,d23,BRD-K63828191-003-07-3,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)
25992,e03,BRD-K63874012-103-01-5,histamine receptor antagonist|histamine receptor inverse agonist
25992,e04,BRD-K63913457-001-02-7,vasodilator
25992,e06,BRD-K63945320-001-02-4,Phospholipase inhibitor
25992,e07,BRD-K63979671-001-03-6,Compound used in hepatobiliary scans of the liver
25992,e08,BRD-K64044582-001-02-8,ACAT inhibitor
25992,e11,BRD-K64157027-003-01-9,Adrenergic receptor agonist
25992,e14,BRD-K64245000-001-01-7,FXR agonist
25992,e16,BRD-K64341947-003-01-6,guanylate cyclase activator
25992,e20,BRD-K64402243-001-01-1,Caspase inhibitor
25992,e22,BRD-K64670467-001-01-2,glutamate receptor antagonist
25992,f03,BRD-K64755930-003-01-6,phosphodiesterase inhibitor
25992,f04,BRD-K64862097-001-03-9,glucocorticoid receptor agonist
25992,f06,BRD-K64994968-001-03-6,Progesterone receptor agonist
25992,f07,BRD-K65146499-001-04-8,Cyclooxygenase inhibitor
25992,f11,BRD-K65285700-001-01-5,cannabinoid receptor agonist
25992,f12,BRD-K65417056-003-03-6,Local anesthetic
25992,f13,BRD-K65503129-001-01-4,HSP inhibitor|HSP antagonist
25992,f15,BRD-K65639003-001-02-5,phosphodiesterase inhibitor
25992,f16,BRD-K65667145-001-04-1,cell division inducer
25992,f19,BRD-K65786282-001-02-6,GABA receptor modulator
25992,f20,BRD-K65814004-001-02-3,nitric oxide synthase inhibitor|aldehyde dehydrogenase inhibitor|cytochrome P450 inhibitor|NADPH oxidase inhibitor|xanthine oxidase inhibitor
25992,f23,BRD-K66093087-001-01-5,Benzodiazepine receptor agonist
25992,f24,BRD-K66206289-003-03-1,Acetylcholine receptor antagonist
25992,g02,BRD-K66353228-001-05-4,myorelaxant
25992,g05,BRD-K66404838-003-03-8,opioid receptor agonist|opioid receptor antagonist
25992,g08,BRD-K66707493-001-02-6,Coloring agent
25992,g09,BRD-K66715657-001-01-3,dopamine receptor antagonist
25992,g10,BRD-K66782112-001-01-2,Histamine receptor antagonist
25992,g11,BRD-K66874953-001-02-7,TP53 inhibitor
25992,g12,BRD-K66898851-001-03-7,apoptosis stimulant
25992,g13,BRD-K66944906-001-02-6,Carbonic anhydrase inhibitor
25992,g14,BRD-K67013324-001-01-5,melatonin receptor antagonist
25992,g16,BRD-K67017579-001-13-3,Phosphodiesterase inhibitor
25992,g17,BRD-K67043667-001-04-1,DNA synthesis inhibitor
25992,g18,BRD-K67080878-001-05-5,phosphodiesterase inhibitor
25992,g21,BRD-K67102207-236-01-0,HDAC inhibitor
25992,g23,BRD-K67261995-001-03-4,Contrast agent
25992,g24,BRD-K67277431-002-03-0,thromboxane receptor antagonist|thromboxane synthase inhibitor
25992,h01,BRD-K67298865-001-02-5,TGF beta receptor inhibitor
25992,h02,BRD-K67352070-364-01-5,Acetylcholine receptor agonist
25992,h05,BRD-K67439147-001-01-7,glutamate receptor antagonist
25992,h06,BRD-K67445247-001-01-3,Urease inhibitor
25992,h08,BRD-K67537649-001-01-1,insulin growth factor receptor inhibitor
25992,h12,BRD-K67680372-003-01-8,GAT inhibitor
25992,h13,BRD-K67783091-001-05-5,Dopamine receptor antagonist
25992,h14,BRD-K67831364-003-01-7,vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor|VEGFR inhibitor
25992,h17,BRD-K68095457-001-04-4,Cannabinoid receptor agonist
25992,h18,BRD-K68103045-001-01-1,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist
25992,h21,BRD-K68143200-001-04-2,CDC inhibitor
25992,h24,BRD-K68190965-001-01-4,Serotonin receptor agonist
25992,i01,BRD-K68246049-001-01-4,Retinoid receptor agonist
25992,i02,BRD-K68264559-001-07-6,Adrenergic receptor agonist
25992,i03,BRD-K68332390-001-03-3,aldose reductase inhibitor|reductase inhibitor
25992,i04,BRD-K68341547-003-01-6,calmodulin antagonist
25992,i07,BRD-K68392338-003-01-2,Benzodiazepine receptor antagonist
25992,i08,BRD-K68402494-001-04-7,myosin light chain kinase inhibitor
25992,i10,BRD-K68507560-003-04-8,acetylcholine receptor antagonist
25992,i12,BRD-K68552125-001-03-8,PKC activator|CD antagonist
25992,i13,BRD-K68553471-003-04-0,antihypertensive agent
25992,i14,BRD-K68558722-001-02-4,Cyclooxygenase inhibitor
25992,i15,BRD-K68620903-001-03-1,progesterone receptor agonist
25992,i17,BRD-K68873215-001-01-3,phosphodiesterase inhibitor
25992,i18,BRD-K69023402-001-02-5,ATPase inhibitor|calcium channel blocker|PKC activator
25992,i19,BRD-K69032158-001-02-2,Dipeptidyl peptidase inhibitor
25992,i20,BRD-K69195780-001-01-5,Serotonin receptor agonist
25992,i23,BRD-K69556541-001-02-6,Calcium channel blocker
25992,j01,BRD-K69763916-001-01-7,Glutamate receptor antagonist
25992,j02,BRD-K69837166-003-01-2,Nociceptin/orphanin FQ (NOP) receptor antagonist
25992,j03,BRD-K70241288-001-01-1,Growth hormone releasing peptide ligand agonist
25992,j04,BRD-K70246307-001-02-5,vitamin B2
25992,j07,BRD-K70281171-001-01-7,Dopamine receptor antagonist
25992,j08,BRD-K70330367-001-02-4,Glutamate receptor antagonist
25992,j10,BRD-K70487031-001-01-0,dopamine receptor antagonist
25992,j12,BRD-K70778732-003-04-4,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor
25992,j13,BRD-K70792160-003-01-2,AKT inhibitor
25992,j15,BRD-K70881766-001-02-3,Acetylcholinesterase inhibitor
25992,j16,BRD-K70914287-300-01-0,EGFR inhibitor|tyrosine kinase inhibitor
25992,j17,BRD-K70976396-236-04-7,Bacterial cell wall synthesis inhibitor
25992,j18,BRD-K71003802-001-02-9,Plant alkaloid
25992,j19,BRD-K13356952-001-11-1,carbonic anhydrase inhibitor
25992,k03,BRD-K71266197-236-01-9,NTPDase inhibitor
25992,k04,BRD-K71430621-303-01-5,histamine receptor antagonist|histamine receptor inverse agonist
25992,k06,BRD-K71499074-001-03-8,Carbonic anhydrase inhibitor
25992,k09,BRD-K71534238-001-03-5,Free fatty acid receptor agonist
25992,k11,BRD-K71726959-001-05-9,CDK inhibitor
25992,k12,BRD-K71731651-001-01-9,Acetylcholine receptor agonist
25992,k13,BRD-K71799778-001-02-2,CDK inhibitor
25992,k14,BRD-K71799949-001-04-2,Carboxamide antiepileptic
25992,k17,BRD-K71860425-001-01-1,CDK inhibitor
25992,k18,BRD-K72024482-001-01-3,adenosine receptor antagonist
25992,k19,BRD-K72034655-001-02-1,apoptosis inducer|antileukemic
25992,k22,BRD-K72222507-003-02-8,ACE inhibitor
25992,l04,BRD-K72676686-103-01-8,selective serotonin reuptake inhibitor (SSRI)|serotonin reuptake inhibitor|serotonin uptake inhibitor
25992,l05,BRD-K72726508-001-01-3,CDK inhibitor
25992,l06,BRD-K72783841-001-01-0,CDK inhibitor|epidermal growth factor receptor (EGFR) inhibitor|tyrosine kinase inhibitor|EGFR inhibitor
25992,l09,BRD-K72895815-001-01-4,leukocyte elastase inhibitor
25992,l10,BRD-K72903603-001-03-8,Reverse transcriptase inhibitor
25992,l13,BRD-K73109821-001-05-2,Potassium channel activator
25992,l18,BRD-K73196317-003-06-4,adrenergic receptor antagonist
25992,l21,BRD-K73290745-003-01-8,opioid receptor agonist
25992,l22,BRD-K73323637-003-03-4,adrenergic receptor antagonist
25992,m02,BRD-K73391359-003-03-7,Local anesthetic
25992,m05,BRD-K73397362-001-01-7,smoothened receptor agonist
25992,m06,BRD-K73589401-001-03-8,mineralocorticoid receptor agonist
25992,m12,BRD-K73789395-001-04-0,RAF inhibitor
25992,m15,BRD-K73991644-001-01-7,aldose reductase inhibitor|falcipain inhibitor
25992,m17,BRD-K74112339-001-02-7,Urease inhibitor
25992,m18,BRD-K74141488-003-03-9,Fungal squalene epoxidase inhibitor
25992,m20,BRD-K74195153-050-03-0,Phosphodiesterase inhibitor
25992,m21,BRD-K74212935-001-03-1,Dopamine agonist
25992,m23,BRD-K74305673-001-01-3,IKK inhibitor|NFkB pathway inhibitor|protein kinase inhibitor
25992,m24,BRD-K74430258-001-01-2,hepatotoxicant
25992,n02,BRD-K74765201-001-01-9,Leukotriene receptor antagonist
25992,n03,BRD-K74913225-001-03-3,Carbonic anhydrase inhibitor
25992,n05,BRD-K75089421-001-02-5,sodium channel blocker
25992,n06,BRD-K75181824-001-02-3,inhibitor of methyl esterification of geranylgeranylated proteins
25992,n11,BRD-K75478907-001-01-5,GABA receptor modulator|GABA receptor positive allosteric modulator
25992,n16,BRD-K75615183-001-01-7,Adrenergic receptor agonist
25992,n17,BRD-K75641298-001-01-5,Dopamine receptor antagonist
25992,n21,BRD-K75958195-001-01-7,serotonin receptor antagonist
25992,n24,BRD-K76064317-001-04-0,FLT3 inhibitor
25992,o01,BRD-K76133116-001-01-2,Membrane integrity inhibitor
25992,o03,BRD-K76274772-001-02-7,Ceramidase inhibitor
25992,o05,BRD-K76304753-003-04-7,local anesthetic
25992,o07,BRD-K76568384-001-01-4,estrogen receptor antagonist
25992,o08,BRD-K76587808-001-02-0,Antioxidant
25992,o09,BRD-K76617868-001-02-2,rho associated kinase inhibitor
25992,o10,BRD-K76634210-001-02-2,DNA directed DNA polymerase inhibitor
25992,o13,BRD-K76674262-001-01-7,apoptosis stimulant|protein synthesis inhibitor
25992,o15,BRD-K76723084-001-05-9,retinoid receptor agonist
25992,o16,BRD-K76775527-001-06-2,Cyclooxygenase inhibitor
25992,o17,BRD-K76805682-001-05-0,glycogen synthase kinase inhibitor
25992,o18,BRD-K76810206-001-05-7,adrenergic receptor antagonist
25992,o20,BRD-K76840893-003-01-7,adrenergic receptor antagonist
25992,o22,BRD-K76872913-001-02-8,Aromatic hydrocarbon derivative
25992,o23,BRD-K76927775-001-04-3,DNA inhibitor
25992,o24,BRD-K77133231-001-01-1,p38 MAPK inhibitor
25992,p01,BRD-K77171813-050-01-4,histamine receptor modulator
25992,p03,BRD-K77554836-001-03-3,glucocorticoid receptor agonist
25992,p07,BRD-K77641333-003-04-0,adrenergic receptor agonist
25992,p08,BRD-K77677632-003-01-8,serotonin receptor antagonist
25992,p09,BRD-K77695569-001-04-5,angiogenesis inhibitor
25992,p10,BRD-K77771411-003-03-2,imidazoline receptor agonist
25992,p13,BRD-K77793136-003-01-4,rho associated kinase inhibitor
25992,p15,BRD-K77925998-001-01-3,serotonin receptor agonist
25992,p16,BRD-K77947974-001-04-9,dopamine receptor antagonist
25992,p17,BRD-K77987382-001-05-8,acetylcholinesterase inhibitor|microtubule inhibitor|tubulin inhibitor
25992,p18,BRD-K78010432-001-04-1,diuretic
25992,p20,BRD-K78084463-003-01-0,calmodulin antagonist
25992,p21,BRD-K78113049-001-04-8,topoisomerase inhibitor
25992,p22,BRD-K78122587-300-01-9,T-type calcium channel blocker
25992,p23,BRD-K78280988-001-02-2,cannabinoid receptor agonist|potassium channel blocker|TRPV agonist
25938,a01,BRD-A00100033-001-04-8,DNA inhibitor
25938,a02,BRD-A00267231-001-01-1,Adenosine receptor agonist
25938,a04,BRD-A00520476-001-03-3,Acetylcholine receptor antagonist
25938,a06,BRD-A00993607-003-04-8,Adrenergic receptor antagonist
25938,a07,BRD-A01078468-001-04-9,synthetic estrogen
25938,a08,BRD-A01295252-001-01-5,Dopamine receptor ligand
25938,a09,BRD-A01320529-001-05-9,adrenergic receptor agonist
25938,a11,BRD-A01593789-001-01-5,5 alpha reductase inhibitor
25938,a12,BRD-A01636364-003-04-5,sodium channel blocker
25938,a15,BRD-A01787639-003-08-6,adrenergic receptor antagonist
25938,a16,BRD-A02006392-001-06-5,calcium channel blocker
25938,a17,BRD-A02176148-001-02-2,Mitochondrial complex I inhibitor
25938,a19,BRD-A02710418-003-03-5,opioid receptor agonist
25938,a20,BRD-A02713983-001-02-0,growth factor receptor activator
25938,a21,BRD-A02759312-003-11-2,Adrenergic receptor antagonist
25938,a23,BRD-A03216249-003-02-9,Potassium channel blocker
25938,a24,BRD-A03359064-001-01-5,Adrenergic receptor antagonist
25938,b02,BRD-A03623303-045-02-0,Adrenergic receptor antagonist
25938,b03,BRD-A03816571-001-01-0,cannabinoid receptor agonist|CC chemokine receptor antagonist
25938,b09,BRD-A04322457-003-03-9,adrenergic receptor agonist
25938,b10,BRD-A04438777-001-01-4,dopamine receptor agonist
25938,b11,BRD-A04553218-050-03-0,histamine receptor antagonist
25938,b15,BRD-A04668240-001-01-5,GABA receptor antagonist
25938,b16,BRD-A04706586-236-01-7,Adenosine receptor agonist
25938,b18,BRD-A05186015-003-04-0,dopamine uptake inhibitor
25938,b24,BRD-A06352418-001-03-6,Histamine receptor antagonist
25938,c01,BRD-A06352508-001-02-9,CHK inhibitor
25938,c02,BRD-A06390036-001-02-0,Antiarrhythmic
25938,c03,BRD-A06726973-001-02-0,cGMP analog
25938,c04,BRD-A06935312-001-02-7,bacterial 30S ribosomal subunit inhibitor
25938,c06,BRD-A07207424-001-04-1,phosphodiesterase inhibitor
25938,c08,BRD-A07440155-003-04-9,Adrenergic receptor antagonist
25938,c09,BRD-A07780951-001-02-2,Adrenergic receptor agonist
25938,c10,BRD-A07824748-001-02-6,11-beta hydroxysteroid dehydrogenase inhibitor
25938,c14,BRD-A07875874-001-01-6,calcium channel blocker
25938,c17,BRD-A07932845-001-01-1,anti-HCVE2
25938,c18,BRD-A07952294-001-02-3,farnesyltransferase inhibitors
25938,c19,BRD-A08187463-001-03-8,enkephalinase inhibitor
25938,c22,BRD-A08709697-001-02-9,pyrrolizidine alkaloid
25938,c23,BRD-A08877921-001-02-2,Protein synthesis inhibitor
25938,c24,BRD-A09056319-003-03-6,Adrenergic receptor antagonist
25938,d01,BRD-A09062839-003-03-5,Local anesthetic
25938,d02,BRD-A09094913-001-02-3,acetylcholine receptor antagonist
25938,d03,BRD-A09161221-001-01-9,HSP inhibitor
25938,d04,BRD-A09349126-001-02-4,progesterone receptor agonist
25938,d05,BRD-A09467419-003-04-2,acetylcholine receptor antagonist
25938,d06,BRD-A09472452-001-02-8,Sodium channel blocker
25938,d07,BRD-A09533288-001-02-7,calcium channel blocker
25938,d08,BRD-A09539288-004-02-8,Acetylcholine receptor antagonist
25938,d09,BRD-A09828896-004-04-5,Dopamine receptor agonist
25938,d10,BRD-A09925278-003-03-1,Adrenergic receptor agonist
25938,d14,BRD-A10070317-003-05-1,adrenergic receptor antagonist
25938,d17,BRD-A10355991-003-01-8,Glutamate receptor antagonist
25938,d18,BRD-A10715913-001-02-0,Dopamine receptor antagonist
25938,d19,BRD-A10739734-003-01-5,adrenergic receptor antagonist
25938,d20,BRD-A10903566-003-02-8,Adrenergic receptor antagonist
25938,d21,BRD-A10969569-001-02-0,Plant alkaloid
25938,d22,BRD-A10977446-001-04-8,Adrenergic receptor antagonist
25938,e03,BRD-A11605036-001-03-2,GABA receptor antagonist
25938,e04,BRD-A11609859-303-01-2,opioid receptor agonist
25938,e05,BRD-A11678676-001-02-6,PI3K inhibitor
25938,e07,BRD-A11813248-001-02-8,Potassium channel blocker
25938,e08,BRD-A12016240-001-01-7,Serotonin receptor antagonist
25938,e14,BRD-A13188892-066-03-3,Adrenergic receptor antagonist
25938,e15,BRD-A13650332-236-03-9,Bacterial cell wall synthesis inhibitor
25938,e16,BRD-A13946108-001-03-1,Cyclooxygenase inhibitor
25938,e23,BRD-A14395271-001-01-5,Dopamine receptor antagonist
25938,e24,BRD-A14566392-004-03-5,acetylcholine receptor antagonist
25938,f03,BRD-A14574269-051-01-4,Acetylcholine receptor agonist
25938,f04,BRD-A15034104-002-03-6,interleukin inhibitor
25938,f05,BRD-A15070535-323-02-1,adenosine receptor agonist|cAMP stimulant
25938,f06,BRD-A15415227-003-01-1,PPAR receptor agonist
25938,f07,BRD-A15435692-003-01-5,sigma receptor antagonist|glutamate receptor antagonist|serotonin receptor agonist
25938,f11,BRD-A15530910-001-01-3,adrenergic receptor antagonist|serotonin receptor antagonist
25938,f14,BRD-A15914070-001-01-5,cytotoxic lipid peroxidation product
25938,f15,BRD-A16332958-001-02-4,Adrenergic receptor agonist
25938,f16,BRD-A16665823-008-03-3,Bacterial cell wall synthesis inhibitor
25938,f19,BRD-A16694057-001-02-7,PPAR receptor antagonist
25938,f21,BRD-A17065207-001-06-9,protein synthesis inhibitor
25938,f23,BRD-A17428743-001-01-1,Serotonin receptor agonist
25938,f24,BRD-A17453586-001-01-9,Serotonin receptor agonist
25938,g02,BRD-A17535965-001-02-2,Acetylcholine receptor antagonist
25938,g05,BRD-A17655518-001-02-0,Cyclooxygenase inhibitor
25938,g08,BRD-A18043272-001-03-2,succinimide antiepileptic
25938,g09,BRD-A18202423-001-01-6,Glutamate receptor antagonist
25938,g10,BRD-A18497530-001-04-6,adenosine kinase inhibitor|nucleoside transporter inhibitor
25938,g11,BRD-A18579359-001-03-1,Neural Wiskott-Aldrich syndrome protein inhibitor
25938,g12,BRD-A18696154-003-11-9,adrenergic receptor antagonist
25938,g13,BRD-A18763547-019-01-0,Cytochrome C release inhibitor
25938,g15,BRD-A19053259-003-03-3,Anthelmintic
25938,g17,BRD-A19195498-050-04-2,Norepinephrine reuptake inhibitor
25938,g18,BRD-A19736161-310-01-3,Serotonin receptor antagonist
25938,g23,BRD-A20239487-001-02-5,Adrenergic receptor antagonist
25938,h01,BRD-A20348246-001-04-2,GABA receptor modulator
25938,h06,BRD-A20968261-001-01-3,glutamate transporter inhibitor
25938,h08,BRD-A21723284-066-01-7,Opioid receptor antagonist
25938,h09,BRD-A21858158-001-04-5,Anthelmintic
25938,h14,BRD-A22305049-003-04-5,gluconeogenesis inhibitor
25938,h15,BRD-A22380646-001-01-5,ATPase inhibitor
25938,h16,BRD-A22684332-003-02-3,adrenergic receptor agonist
25938,h17,BRD-A22707317-001-02-5,GABA receptor modulator
25938,h21,BRD-A22769835-300-03-2,Antihistamine
25938,h22,BRD-A22783572-065-01-3,microtubule formation inhibitor|tubulin inhibitor|tubulin polymerisation inhibitor
25938,h23,BRD-A22844106-001-04-7,Cyclooxygenase inhibitor
25938,h24,BRD-A23034328-003-03-4,protein synthesis inhibitor
25938,i01,BRD-A23072235-050-04-5,Histamine receptor antagonist
25938,i02,BRD-A23226398-001-02-7,estrogen receptor agonist
25938,i03,BRD-A23683907-334-01-0,serotonin receptor antagonist
25938,i04,BRD-A23723433-001-01-2,tubulin inhibitor|microtubule stabilizing agent|microtubule stimulant|P glycoprotein inhibitor|taxane
25938,i08,BRD-A24122750-001-01-1,GABA receptor antagonist
25938,i09,BRD-A24191444-045-03-1,Adrenergic receptor antagonist
25938,i10,BRD-A24228527-001-04-2,Bacterial DNA gyrase inhibitor
25938,i13,BRD-A24514565-236-01-6,Vitamin K antagonist
25938,i15,BRD-A24587114-066-03-5,adrenergic receptor agonist
25938,i16,BRD-A24817035-001-04-7,central nervous system agent
25938,i17,BRD-A25234499-001-04-3,glucocorticoid receptor antagonist
25938,i20,BRD-A25775766-001-03-3,GABA receptor antagonist|TP53 activator
25938,i23,BRD-A26032986-050-01-3,Calmodulin antagonist
25938,i24,BRD-A26222320-001-02-6,protein synthesis inhibitor
25938,j01,BRD-A26334849-001-02-1,Antiarrhythmic
25938,j02,BRD-A26384407-001-04-6,Carbonic anhydrase inhibitor
25938,j03,BRD-A26711594-001-02-7,calcium channel blocker
25938,j07,BRD-A26845397-001-01-4,Adrenergic receptor antagonist
25938,j09,BRD-A27143604-001-01-2,Estrogen receptor agonist
25938,j14,BRD-A28318179-003-03-6,Nitric oxide synthase inhibitor
25938,j15,BRD-A28856712-003-04-7,adrenergic receptor agonist
25938,j18,BRD-A29260609-003-04-7,adrenergic receptor antagonist
25938,j19,BRD-A29289453-001-02-1,platelet activating factor receptor antagonist
25938,j20,BRD-A29322418-237-02-4,mineralocorticoid receptor antagonist
25938,k01,BRD-A29426959-050-04-1,Histamine receptor antagonist
25938,k02,BRD-A29437505-001-01-6,TLR agonist
25938,k04,BRD-A29644307-050-04-8,Dopamine uptake inhibitor
25938,k05,BRD-A29734509-011-02-9,Sodium channel blocker
25938,k10,BRD-A30590053-003-01-1,Acetylcholine release enhancer
25938,k11,BRD-A30655177-001-04-1,BTK inhibitor
25938,k13,BRD-A30717181-001-02-7,glucocorticoid receptor agonist
25938,k14,BRD-A30815329-001-03-0,Calcium channel blocker
25938,k17,BRD-A31007383-001-01-0,Adenosine receptor agonist
25938,k18,BRD-A31159102-001-01-9,Selective serotonin reuptake inhibitor (SSRI)
25938,k19,BRD-A31195449-004-01-9,Serotonin receptor agonist
25938,k20,BRD-A31521121-001-04-1,Muscle relaxant
25938,k21,BRD-A31575449-300-01-4,Adrenergic receptor antagonist
25938,l02,BRD-A31800922-003-04-6,acetylcholine receptor antagonist
25938,l05,BRD-A32164164-048-01-4,Acetylcholine receptor antagonist
25938,l06,BRD-A32505112-001-02-8,angiotensin converting enzyme inhibitor
25938,l09,BRD-A32673558-003-02-1,acetylcholine receptor agonist
25938,l10,BRD-A32949107-001-01-7,calcium channel blocker
25938,l12,BRD-A33168282-003-06-5,Adrenergic receptor antagonist
25938,l13,BRD-A33447119-001-02-5,Anthelmintic
25938,l14,BRD-A33711280-311-02-0,Acetylcholine receptor antagonist
25938,l19,BRD-A34255068-001-04-8,phosphodiesterase inhibitor
25938,l20,BRD-A34309505-001-08-5,benzodiazepine receptor agonist
25938,l22,BRD-A34706053-003-01-9,Adrenergic receptor agonist
25938,m01,BRD-A34751532-001-03-6,HSP inducer
25938,m03,BRD-A34788695-003-04-5,bacterial 30S ribosomal subunit inhibitor
25938,m04,BRD-A34806832-001-02-7,ATPase inhibitor
25938,m07,BRD-A35033682-001-01-0,cytochrome P450 inhibitor
25938,m08,BRD-A35338386-001-04-6,adenosine receptor agonist
25938,m11,BRD-A35511923-019-01-6,Somatostatin receptor agonist
25938,m12,BRD-A35623999-001-03-2,mitochondrial Na+/Ca2+ exchanger antagonist|sodium/calcium exchange inhibitor
25938,m16,BRD-A35931254-003-02-7,dopamine receptor agonist
25938,m18,BRD-A36066264-001-02-3,Estrogen receptor agonist
25938,m19,BRD-A36074203-003-03-5,Glutamate receptor antagonist
25938,m20,BRD-A36217750-001-04-9,Uricosuric blocker
25938,m21,BRD-A36267905-003-02-8,Adrenergic receptor agonist
25938,m22,BRD-A36318220-001-01-3,RIPK inhibitor
25938,m23,BRD-A36471396-003-02-2,Acetylcholine receptor antagonist
25938,n01,BRD-A37347161-003-01-8,opioid receptor agonist
25938,n02,BRD-A37432947-004-02-5,acetylcholine receptor antagonist
25938,n03,BRD-A37441042-003-02-2,adrenergic receptor agonist
25938,n04,BRD-A37492983-001-03-8,radiopaque medium
25938,n06,BRD-A37704979-001-02-4,p38 MAPK inhibitor
25938,n07,BRD-A37776212-003-02-5,opioid receptor agonist
25938,n17,BRD-A38747044-001-01-5,Imidazoline receptor ligand
25938,n18,BRD-A38898897-003-01-0,Leukocyte elastase inhibitor
25938,n19,BRD-A38913120-001-01-0,BCL inhibitor
25938,n21,BRD-A39230911-001-03-7,Muscle relaxant
25938,n22,BRD-A39255369-001-01-5,Chloride channel blocker
25938,n23,BRD-A39268308-001-02-0,Acetylcholine receptor agonist
25938,o01,BRD-A39522003-001-01-0,FAAH inhibitor|FAAH reuptake inhibitor
25938,o03,BRD-A39747742-001-02-7,estrogen receptor agonist
25938,o05,BRD-A39969961-001-01-3,Cytochrome P450 inhibitor
25938,o06,BRD-A40022950-001-02-9,ATPase inhibitor
25938,o08,BRD-A40639672-234-04-0,Cyclooxygenase inhibitor
25938,o10,BRD-A41112154-001-02-1,G protein-coupled receptor agonist
25938,o13,BRD-A41145729-001-02-7,Retinoid receptor agonist
25938,o14,BRD-A41250306-001-03-4,Thiazide diuretic
25938,o15,BRD-A41301928-001-02-5,"Mitochondrial ADP, ATP translocase inhibitor"
25938,o16,BRD-A41304429-001-04-9,Adrenergic receptor antagonist
25938,o17,BRD-A41451487-001-01-3,Benzodiazepine receptor antagonist
25938,o18,BRD-A41519720-001-02-2,Niemann-Pick C1-like 1 protein antagonist
25938,o19,BRD-A41722204-003-01-5,adenosine receptor antagonist
25938,o20,BRD-A41833852-001-01-9,Opioid receptor antagonist
25938,o22,BRD-A41941932-001-03-0,Antioxidant
25938,o23,BRD-A42167015-003-03-7,Adrenergic receptor antagonist
25938,o24,BRD-A42335949-300-04-9,phosphatidylglycerophosphatase inhibitor
25938,p01,BRD-A42346008-003-03-6,epinephrine metabolite
25938,p02,BRD-A42553870-001-05-1,neuropeptide receptor antagonist
25938,p03,BRD-A42571354-300-01-3,histamine receptor antagonist
25938,p04,BRD-A42628519-001-04-1,radiopaque medium
25938,p05,BRD-A42759514-001-03-1,Antiprotozoal
25938,p06,BRD-A42831637-001-02-2,anti-inflammatory|Cannabinoid metabolite
25938,p07,BRD-A43076080-001-03-3,protein phosphatase inhibitor
25938,p09,BRD-A43150328-001-02-0,other antibiotic
25938,p13,BRD-A43671941-003-03-6,Adrenergic receptor antagonist
25938,p14,BRD-A43849199-001-02-3,Phytotoxin
25938,p15,BRD-A43930669-003-01-0,oxytocin receptor antagonist
25938,p16,BRD-A43940795-001-02-8,serotonin release inhibitor
25938,p17,BRD-A43974499-066-01-1,Adrenergic receptor antagonist
25938,p19,BRD-A44008656-036-04-3,Histamine receptor antagonist
25938,p20,BRD-A44090213-001-04-1,Cyclooxygenase inhibitor
25938,p21,BRD-A44133049-001-01-5,Serotonin receptor antagonist
25938,p22,BRD-A44448661-001-02-2,Barbiturate antiepileptic
25938,p23,BRD-A44551378-001-01-9,EGFR inhibitor
25938,p24,BRD-A44863528-001-04-1,CCK receptor antagonist
24357,a01,BRD-K90382497-001-01-6,PLK inhibitor
24357,a02,BRD-K92723993-066-02-9,PDGFR tyrosine kinase receptor inhibitor|Bcr-Abl kinase inhibitor|KIT inhibitor|Abl kinase inhibitor|apoptosis stimulant|breast cancer resistance protein inhibitor|colony stimulating factor receptor inhibitor
24357,a03,BRD-K07762753-001-03-6,CDK inhibitor|tyrosine kinase inhibitor
24357,a04,BRD-K09991945-001-02-0,glycogen synthase kinase inhibitor|PKC inhibitor|superoxide dismutase expression inhibitor
24357,a05,BRD-K37312348-001-05-1,CDK inhibitor|glycogen synthase kinase inhibitor
24357,a06,BRD-K46678324-001-03-7,rho associated kinase inhibitor
24357,a07,BRD-K67860401-001-02-3,glycogen synthase kinase inhibitor
24357,a08,BRD-K52620403-001-01-8,calcium/calmodulin dependent protein kinase inhibitor|calmodulin inhibitor
24357,a09,BRD-K68336408-001-03-4,EGFR inhibitor
24357,a10,BRD-K72703948-001-01-0,Aurora kinase inhibitor
24357,a11,BRD-K93201660-001-05-7,myosin light chain kinase inhibitor
24357,a15,BRD-A47633927-001-01-8,ICAM1 antagonist
24357,a16,BRD-A68039575-001-02-5,Aromatase inhibitor
24357,a17,BRD-A75455249-001-02-0,calcium channel modulator|mTOR inhibitor|sodium channel blocker
24357,a18,BRD-K01555864-001-02-8,antineoplastic
24357,a19,BRD-K09497549-001-03-6,calcium channel modulator|mTOR inhibitor|sodium channel blocker
24357,a20,BRD-K14536225-001-02-7,Glucosidase inhibitor
24357,a21,BRD-K15086322-103-01-0,histamine receptor antagonist|histamine receptor silent antagonist
24357,a23,BRD-K23623876-001-01-6,ultrasound contrast agent
24357,a24,BRD-K36377456-001-02-0,angiogenesis inhibitor
24357,b01,BRD-K36395411-003-01-4,serotonin receptor antagonist|serotonin receptor partial agonist
24357,b03,BRD-K41160163-001-01-9,Glutamate receptor antagonist
24357,b04,BRD-K42095107-001-02-3,estrogen receptor agonist
24357,b05,BRD-K43797669-001-02-3,tyrosine kinase inhibitor
24357,b06,BRD-K45988865-001-01-0,organosilicon compound used as an internal standard in NMR spectroscopy
24357,b07,BRD-K49061529-001-01-0,GABA benzodiazepine site receptor inverse agonist
24357,b09,BRD-K59331372-001-01-2,TRPV antagonist
24357,b11,BRD-K60690191-003-02-1,glutamate receptor antagonist
24357,b12,BRD-K61177364-003-01-1,CRF receptor antagonist
24357,b17,BRD-K61250553-001-02-9,opioid receptor agonist
24357,b18,BRD-K61269089-001-01-4,Protein kinase inhibitor
24357,b19,BRD-K61271364-001-02-4,GABA receptor antagonist
24357,b20,BRD-K61323504-001-02-4,CC chemokine receptor antagonist
24357,b22,BRD-K61496577-001-03-8,glucocorticoid receptor agonist
24357,b23,BRD-K61590534-001-01-4,EGFR inhibitor
24357,c01,BRD-K61737877-001-01-6,VEGFR inhibitor
24357,c03,BRD-K61951118-001-01-2,GABA benzodiazepine site receptor inverse agonist
24357,c04,BRD-K62008436-001-03-1,tubulin polymerization inhibitor
24357,c05,BRD-K62056274-001-01-9,Serotonin receptor agonist
24357,c07,BRD-K62206109-303-01-1,histamine receptor antagonist
24357,c08,BRD-K62221994-001-01-8,gonadotropin releasing factor hormone receptor antagonist
24357,c10,BRD-K62289640-003-01-9,Cannabinoid receptor agonist
24357,c13,BRD-K62310379-001-03-0,glucocorticoid receptor agonist
24357,c17,BRD-K62353524-001-01-8,estrogen receptor agonist
24357,c18,BRD-K62363391-001-04-1,bacterial antifolate
24357,c23,BRD-K62607865-001-03-0,bacterial cell wall synthesis inhibitor
24357,c24,BRD-K62609077-001-02-2,adrenergic receptor antagonist|GABA receptor antagonist|serotonin receptor antagonist
24357,d01,BRD-K62810658-001-05-6,MEK inhibitor
24357,d02,BRD-K62929068-001-01-7,Purinergic receptor activator
24357,d04,BRD-K62996583-001-03-8,calcium channel blocker
24357,d05,BRD-K63089472-001-02-7,Inhibitor of methyl esterification of farnesylated proteins
24357,d06,BRD-K63150726-001-01-3,cannabinoid receptor inverse agonist
24357,d07,BRD-K63151507-001-01-6,Lymphocyte inhibitor
24357,d08,BRD-K63165456-001-03-3,Adrenergic receptor agonist
24357,d09,BRD-K63430059-001-03-2,DNA synthesis inhibitor
24357,d10,BRD-K63504947-001-05-5,VEGFR inhibitor
24357,d13,BRD-K63516691-001-01-6,Phosphodiesterase inhibitor
24357,d14,BRD-K63533170-001-01-1,cannabinoid receptor antagonist|cannabinoid receptor inverse agonist
24357,d17,BRD-K63606607-001-01-8,ATPase inhibitor|chloride channel activator
24357,d18,BRD-K63630713-001-04-3,sodium/potassium/chloride transporter inhibitor
24357,d19,BRD-K63750851-001-03-3,dehydrogenase inhibitor|inositol monophosphatase inhibitor
24357,d21,BRD-K63784565-001-02-1,Topoisomerase inhibitor
24357,d22,BRD-K63792901-075-01-3,acetylcholine receptor agonist
24357,d23,BRD-K63828191-003-07-3,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)
24357,e03,BRD-K63874012-103-01-5,histamine receptor antagonist|histamine receptor inverse agonist
24357,e04,BRD-K63913457-001-02-7,vasodilator
24357,e06,BRD-K63945320-001-02-4,Phospholipase inhibitor
24357,e07,BRD-K63979671-001-03-6,Compound used in hepatobiliary scans of the liver
24357,e08,BRD-K64044582-001-02-8,ACAT inhibitor
24357,e11,BRD-K64157027-003-01-9,Adrenergic receptor agonist
24357,e14,BRD-K64245000-001-01-7,FXR agonist
24357,e16,BRD-K64341947-003-01-6,guanylate cyclase activator
24357,e20,BRD-K64402243-001-01-1,Caspase inhibitor
24357,e22,BRD-K64670467-001-01-2,glutamate receptor antagonist
24357,f03,BRD-K64755930-003-01-6,phosphodiesterase inhibitor
24357,f04,BRD-K64862097-001-03-9,glucocorticoid receptor agonist
24357,f06,BRD-K64994968-001-03-6,Progesterone receptor agonist
24357,f07,BRD-K65146499-001-04-8,Cyclooxygenase inhibitor
24357,f11,BRD-K65285700-001-01-5,cannabinoid receptor agonist
24357,f12,BRD-K65417056-003-03-6,Local anesthetic
24357,f13,BRD-K65503129-001-01-4,HSP inhibitor|HSP antagonist
24357,f15,BRD-K65639003-001-02-5,phosphodiesterase inhibitor
24357,f16,BRD-K65667145-001-04-1,cell division inducer
24357,f19,BRD-K65786282-001-02-6,GABA receptor modulator
24357,f20,BRD-K65814004-001-02-3,nitric oxide synthase inhibitor|aldehyde dehydrogenase inhibitor|cytochrome P450 inhibitor|NADPH oxidase inhibitor|xanthine oxidase inhibitor
24357,f23,BRD-K66093087-001-01-5,Benzodiazepine receptor agonist
24357,f24,BRD-K66206289-003-03-1,Acetylcholine receptor antagonist
24357,g02,BRD-K66353228-001-05-4,myorelaxant
24357,g05,BRD-K66404838-003-03-8,opioid receptor agonist|opioid receptor antagonist
24357,g08,BRD-K66707493-001-02-6,Coloring agent
24357,g09,BRD-K66715657-001-01-3,dopamine receptor antagonist
24357,g10,BRD-K66782112-001-01-2,Histamine receptor antagonist
24357,g11,BRD-K66874953-001-02-7,TP53 inhibitor
24357,g12,BRD-K66898851-001-03-7,apoptosis stimulant
24357,g13,BRD-K66944906-001-02-6,Carbonic anhydrase inhibitor
24357,g14,BRD-K67013324-001-01-5,melatonin receptor antagonist
24357,g16,BRD-K67017579-001-13-3,Phosphodiesterase inhibitor
24357,g17,BRD-K67043667-001-04-1,DNA synthesis inhibitor
24357,g18,BRD-K67080878-001-05-5,phosphodiesterase inhibitor
24357,g21,BRD-K67102207-236-01-0,HDAC inhibitor
24357,g23,BRD-K67261995-001-03-4,Contrast agent
24357,g24,BRD-K67277431-002-03-0,thromboxane receptor antagonist|thromboxane synthase inhibitor
24357,h01,BRD-K67298865-001-02-5,TGF beta receptor inhibitor
24357,h02,BRD-K67352070-364-01-5,Acetylcholine receptor agonist
24357,h05,BRD-K67439147-001-01-7,glutamate receptor antagonist
24357,h06,BRD-K67445247-001-01-3,Urease inhibitor
24357,h08,BRD-K67537649-001-01-1,insulin growth factor receptor inhibitor
24357,h12,BRD-K67680372-003-01-8,GAT inhibitor
24357,h13,BRD-K67783091-001-05-5,Dopamine receptor antagonist
24357,h14,BRD-K67831364-003-01-7,vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor|VEGFR inhibitor
24357,h17,BRD-K68095457-001-04-4,Cannabinoid receptor agonist
24357,h18,BRD-K68103045-001-01-1,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist
24357,h24,BRD-K68190965-001-01-4,Serotonin receptor agonist
24357,i01,BRD-K68246049-001-01-4,Retinoid receptor agonist
24357,i02,BRD-K68264559-001-07-6,Adrenergic receptor agonist
24357,i03,BRD-K68332390-001-03-3,aldose reductase inhibitor|reductase inhibitor
24357,i04,BRD-K68341547-003-01-6,calmodulin antagonist
24357,i07,BRD-K68392338-003-01-2,Benzodiazepine receptor antagonist
24357,i08,BRD-K68402494-001-04-7,myosin light chain kinase inhibitor
24357,i10,BRD-K68507560-003-04-8,acetylcholine receptor antagonist
24357,i12,BRD-K68552125-001-03-8,PKC activator|CD antagonist
24357,i13,BRD-K68553471-003-04-0,antihypertensive agent
24357,i14,BRD-K68558722-001-02-4,Cyclooxygenase inhibitor
24357,i15,BRD-K68620903-001-03-1,progesterone receptor agonist
24357,i17,BRD-K68873215-001-01-3,phosphodiesterase inhibitor
24357,i18,BRD-K69023402-001-02-5,ATPase inhibitor|calcium channel blocker|PKC activator
24357,i19,BRD-K69032158-001-02-2,Dipeptidyl peptidase inhibitor
24357,i20,BRD-K69195780-001-01-5,Serotonin receptor agonist
24357,i23,BRD-K69556541-001-02-6,Calcium channel blocker
24357,j01,BRD-K69763916-001-01-7,Glutamate receptor antagonist
24357,j02,BRD-K69837166-003-01-2,Nociceptin/orphanin FQ (NOP) receptor antagonist
24357,j03,BRD-K70241288-001-01-1,Growth hormone releasing peptide ligand agonist
24357,j04,BRD-K70246307-001-02-5,vitamin B2
24357,j07,BRD-K70281171-001-01-7,Dopamine receptor antagonist
24357,j08,BRD-K70330367-001-02-4,Glutamate receptor antagonist
24357,j10,BRD-K70487031-001-01-0,dopamine receptor antagonist
24357,j12,BRD-K70778732-003-04-4,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor
24357,j13,BRD-K70792160-003-01-2,AKT inhibitor
24357,j15,BRD-K70881766-001-02-3,Acetylcholinesterase inhibitor
24357,j16,BRD-K70914287-300-01-0,EGFR inhibitor|tyrosine kinase inhibitor
24357,j17,BRD-K70976396-236-04-7,Bacterial cell wall synthesis inhibitor
24357,j18,BRD-K71003802-001-02-9,Plant alkaloid
24357,j19,BRD-K13356952-001-11-1,carbonic anhydrase inhibitor
24357,k03,BRD-K71266197-236-01-9,NTPDase inhibitor
24357,k04,BRD-K71430621-303-01-5,histamine receptor antagonist|histamine receptor inverse agonist
24357,k06,BRD-K71499074-001-03-8,Carbonic anhydrase inhibitor
24357,k09,BRD-K71534238-001-03-5,Free fatty acid receptor agonist
24357,k11,BRD-K71726959-001-05-9,CDK inhibitor
24357,k12,BRD-K71731651-001-01-9,Acetylcholine receptor agonist
24357,k13,BRD-K71799778-001-02-2,CDK inhibitor
24357,k14,BRD-K71799949-001-04-2,Carboxamide antiepileptic
24357,k17,BRD-K71860425-001-01-1,CDK inhibitor
24357,k18,BRD-K72024482-001-01-3,adenosine receptor antagonist
24357,k19,BRD-K72034655-001-02-1,apoptosis inducer|antileukemic
24357,k22,BRD-K72222507-003-02-8,ACE inhibitor
24357,l04,BRD-K72676686-103-01-8,selective serotonin reuptake inhibitor (SSRI)|serotonin reuptake inhibitor|serotonin uptake inhibitor
24357,l05,BRD-K72726508-001-01-3,CDK inhibitor
24357,l06,BRD-K72783841-001-01-0,CDK inhibitor|epidermal growth factor receptor (EGFR) inhibitor|tyrosine kinase inhibitor|EGFR inhibitor
24357,l09,BRD-K72895815-001-01-4,leukocyte elastase inhibitor
24357,l10,BRD-K72903603-001-03-8,Reverse transcriptase inhibitor
24357,l13,BRD-K73109821-001-05-2,Potassium channel activator
24357,l18,BRD-K73196317-003-06-4,adrenergic receptor antagonist
24357,l21,BRD-K73290745-003-01-8,opioid receptor agonist
24357,l22,BRD-K73323637-003-03-4,adrenergic receptor antagonist
24357,m02,BRD-K73391359-003-03-7,Local anesthetic
24357,m05,BRD-K73397362-001-01-7,smoothened receptor agonist
24357,m06,BRD-K73589401-001-03-8,mineralocorticoid receptor agonist
24357,m12,BRD-K73789395-001-04-0,RAF inhibitor
24357,m15,BRD-K73991644-001-01-7,aldose reductase inhibitor|falcipain inhibitor
24357,m17,BRD-K74112339-001-02-7,Urease inhibitor
24357,m18,BRD-K74141488-003-03-9,Fungal squalene epoxidase inhibitor
24357,m20,BRD-K74195153-050-03-0,Phosphodiesterase inhibitor
24357,m21,BRD-K74212935-001-03-1,Dopamine agonist
24357,m23,BRD-K74305673-001-01-3,IKK inhibitor|NFkB pathway inhibitor|protein kinase inhibitor
24357,m24,BRD-K74430258-001-01-2,hepatotoxicant
24357,n02,BRD-K74765201-001-01-9,Leukotriene receptor antagonist
24357,n03,BRD-K74913225-001-03-3,Carbonic anhydrase inhibitor
24357,n05,BRD-K75089421-001-02-5,sodium channel blocker
24357,n06,BRD-K75181824-001-02-3,inhibitor of methyl esterification of geranylgeranylated proteins
24357,n11,BRD-K75478907-001-01-5,GABA receptor modulator|GABA receptor positive allosteric modulator
24357,n16,BRD-K75615183-001-01-7,Adrenergic receptor agonist
24357,n17,BRD-K75641298-001-01-5,Dopamine receptor antagonist
24357,n21,BRD-K75958195-001-01-7,serotonin receptor antagonist
24357,n24,BRD-K76064317-001-04-0,FLT3 inhibitor
24357,o01,BRD-K76133116-001-01-2,Membrane integrity inhibitor
24357,o03,BRD-K76274772-001-02-7,Ceramidase inhibitor
24357,o05,BRD-K76304753-003-04-7,local anesthetic
24357,o07,BRD-K76568384-001-01-4,estrogen receptor antagonist
24357,o08,BRD-K76587808-001-02-0,Antioxidant
24357,o09,BRD-K76617868-001-02-2,rho associated kinase inhibitor
24357,o10,BRD-K76634210-001-02-2,DNA directed DNA polymerase inhibitor
24357,o13,BRD-K76674262-001-01-7,apoptosis stimulant|protein synthesis inhibitor
24357,o15,BRD-K76723084-001-05-9,retinoid receptor agonist
24357,o16,BRD-K76775527-001-06-2,Cyclooxygenase inhibitor
24357,o17,BRD-K76805682-001-05-0,glycogen synthase kinase inhibitor
24357,o18,BRD-K76810206-001-05-7,adrenergic receptor antagonist
24357,o22,BRD-K76872913-001-02-8,Aromatic hydrocarbon derivative
24357,o23,BRD-K76927775-001-04-3,DNA inhibitor
24357,o24,BRD-K77133231-001-01-1,p38 MAPK inhibitor
24357,p01,BRD-K77171813-050-01-4,histamine receptor modulator
24357,p03,BRD-K77554836-001-03-3,glucocorticoid receptor agonist
24357,p07,BRD-K77641333-003-04-0,adrenergic receptor agonist
24357,p08,BRD-K77677632-003-01-8,serotonin receptor antagonist
24357,p09,BRD-K77695569-001-04-5,angiogenesis inhibitor
24357,p10,BRD-K77771411-003-03-2,imidazoline receptor agonist
24357,p13,BRD-K77793136-003-01-4,rho associated kinase inhibitor
24357,p15,BRD-K77925998-001-01-3,serotonin receptor agonist
24357,p16,BRD-K77947974-001-04-9,dopamine receptor antagonist
24357,p17,BRD-K77987382-001-05-8,acetylcholinesterase inhibitor|microtubule inhibitor|tubulin inhibitor
24357,p18,BRD-K78010432-001-04-1,diuretic
24357,p20,BRD-K78084463-003-01-0,calmodulin antagonist
24357,p21,BRD-K78113049-001-04-8,topoisomerase inhibitor
24357,p22,BRD-K78122587-300-01-9,T-type calcium channel blocker
24357,p23,BRD-K78280988-001-02-2,cannabinoid receptor agonist|potassium channel blocker|TRPV agonist
25968,a01,BRD-K18250272-003-03-7,local anesthetic
25968,a02,BRD-K18316707-001-01-9,cannabinoid receptor antagonist
25968,a04,BRD-K18550767-001-02-8,interleukin inhibitor
25968,a05,BRD-K18574842-323-03-3,bacterial cell wall synthesis inhibitor
25968,a06,BRD-K18619710-001-03-7,steroid
25968,a07,BRD-K18742343-001-03-2,PKA inhibitor
25968,a08,BRD-K18757346-001-02-9,thromboxane receptor agonist
25968,a09,BRD-K18779551-003-03-7,acetylcholine release stimulant|adrenergic transmitter uptake inhibitor|reducing agent
25968,a10,BRD-K18787491-001-05-2,MEK inhibitor
25968,a11,BRD-K18799075-001-01-0,cannabinoid receptor partial agonist
25968,a12,BRD-K18816859-001-01-4,Serotonin receptor agonist
25968,a15,BRD-K18909381-001-01-4,serotonin receptor agonist
25968,a16,BRD-K18910433-001-04-4,estrogen receptor agonist
25968,a19,BRD-K19111024-001-04-3,PPAR receptor agonist
25968,a20,BRD-K19295594-001-04-4,BCL inhibitor|MCL1 inhibitor
25968,a21,BRD-K19309090-300-03-0,acetylcholine receptor agonist
25968,a22,BRD-K19352500-332-03-7,dopamine receptor antagonist
25968,a23,BRD-K19360254-001-01-3,Dopamine receptor agonist
25968,b01,BRD-K19462402-003-03-0,adrenergic receptor antagonist|calcium channel blocker
25968,b03,BRD-K19533706-001-01-9,Angiogenesis inhibitor
25968,b04,BRD-K19554809-001-01-1,serotonin receptor agonist
25968,b05,BRD-K19605405-001-01-9,adenosine receptor antagonist
25968,b07,BRD-K20141153-003-03-8,norepinephrine transporter inhibitor|adrenergic transmitter uptake inhibitor
25968,b08,BRD-K20152659-001-02-0,Cholesterol inhibitor
25968,b10,BRD-K20620780-001-01-0,dopamine receptor antagonist
25968,b11,BRD-K20655524-003-04-7,psychoactive drug
25968,b15,BRD-K20714604-001-01-5,Serotonin receptor partial agonist
25968,b16,BRD-K20742498-001-01-5,serotonin receptor antagonist
25968,b17,BRD-K20755323-001-01-8,sphingosine kinase inhibitor
25968,b18,BRD-K20995441-001-01-7,Opioid receptor agonist
25968,b19,BRD-K21283037-001-02-5,glutamate inhibitor
25968,b20,BRD-K21350491-001-02-1,acid sensing ion channel blocker|sodium channel blockers|TRPP3 channel inhibitor|TRPV modulator
25968,b21,BRD-K21450440-001-04-7,carbonic anhydrase inhibitor
25968,b22,BRD-K21520694-001-02-4,PABA antagonist
25968,b23,BRD-K21548250-001-01-3,sodium channel blocker
25968,b24,BRD-K21565985-001-04-3,adrenergic receptor agonist
25968,c01,BRD-K21667562-001-01-4,FAAH transport inhibitor|anandamide transport inhibitor|nucelar factor of activated T-cells inhibitor|TRPV agonist
25968,c02,BRD-K21680192-300-05-2,topoisomerase inhibitor
25968,c03,BRD-K21733600-001-02-6,cyclooxygenase inhibitor
25968,c04,BRD-K21853356-001-04-4,EGFR inhibitor
25968,c07,BRD-K22031190-001-04-6,Prostanoid receptor antagonist
25968,c08,BRD-K22134346-001-04-1,HMGCR inhibitor
25968,c09,BRD-K22193694-001-04-5,Topical sunscreen agent
25968,c10,BRD-K22385716-001-01-7,casein kinase inhibitor|mTOR inhibitor|PI3K inhibitor
25968,c17,BRD-K22861715-001-03-4,breast cancer resistance protein inhibitor
25968,c19,BRD-K22969690-001-02-6,bacterial 50S ribosomal subunit inhibitor
25968,c21,BRD-K23301018-001-02-6,antiprotozoal agent
25968,c23,BRD-K23335153-300-01-7,glutamate receptor positive allosteric modulator
25968,c24,BRD-K23383398-001-01-6,LXR agonist|ABC transporter expression enhancer|ROR inverse agonist
25968,d02,BRD-K23478508-001-03-7,ATPase inhibitor
25968,d03,BRD-K23541596-300-04-9,histamine receptor agonist
25968,d04,BRD-K23566484-001-04-5,androgen receptor antagonist
25968,d05,BRD-K23583188-001-05-6,EGFR inhibitor|tyrosine kinase inhibitor
25968,d06,BRD-K23704908-001-03-2,serine protease inhibitor
25968,d07,BRD-K23913458-001-02-5,Vitamin K antagonist
25968,d08,BRD-K23922020-075-01-1,acetylcholine receptor agonist
25968,d10,BRD-K24084088-001-02-2,adenosine receptor antagonist
25968,d13,BRD-K24132293-001-02-0,glutathione transferase inhibitor
25968,d14,BRD-K24201553-003-02-4,Serotonin receptor antagonist
25968,d17,BRD-K24240364-003-02-1,Glutamate receptor antagonist
25968,d18,BRD-K24396733-001-01-1,dopamine receptor agonist
25968,d20,BRD-K24526313-001-08-6,Potassium channel activator
25968,e05,BRD-K25224017-001-04-5,serotonin receptor antagonist
25968,e07,BRD-K25394294-001-04-0,Cyclooxygenase inhibitor
25968,e11,BRD-K25433859-003-11-4,norepinephrine reputake inhibitor|tricyclic antidepressant
25968,e13,BRD-K25741894-001-03-8,acetylcholinesterase inhibitor
25968,e15,BRD-K25875056-001-01-2,Protein tyrosine kinase activator
25968,e16,BRD-K25906698-303-01-9,histamine receptor agonist
25968,e21,BRD-K26160755-003-01-8,Imidazoline receptor agonist
25968,e22,BRD-K26373640-001-02-8,IKK inhibitor
25968,f03,BRD-K26429091-051-01-9,acetylcholine receptor antagonist
25968,f04,BRD-K26521938-001-04-9,prostanoid receptor agonist
25968,f05,BRD-K26548821-001-01-8,Dopamine receptor agonist
25968,f06,BRD-K26573499-300-01-3,Adrenergic receptor agonist
25968,f12,BRD-K26979635-001-01-1,Glutamate receptor antagonist
25968,f13,BRD-K26997899-001-01-4,microtubule inhibitor|tubulin inhibitor
25968,f15,BRD-K27141178-001-01-0,Serotonin receptor antagonist
25968,f20,BRD-K27305650-001-04-2,mTOR inhibitor|PI3K inhibitor|DNA dependent protein kinase inhibitor|phosphodiesterase inhibitor|PLK inhibitor
25968,f21,BRD-K27316855-001-02-6,vitamin D receptor agonist
25968,f23,BRD-K27351809-001-02-0,progesterone receptor agonist
25968,g01,BRD-K27450477-001-03-9,Adenosine deaminase inhibitor
25968,g02,BRD-K27499107-001-02-6,IP receptor activator
25968,g06,BRD-K27710560-001-02-6,SIRT inhibitor
25968,g07,BRD-K27737647-001-03-4,PKA inhibitor
25968,g09,BRD-K27871032-001-02-6,Ergoline alkaloid
25968,g11,BRD-K28115081-001-01-9,Platelet activating factor receptor antagonist
25968,g12,BRD-K28137194-003-01-3,GABA receptor agonist
25968,g13,BRD-K28143534-001-01-4,histamine receptor antagonist
25968,g15,BRD-K28183345-003-05-6,Dihydrofolate reductase inhibitor
25968,g17,BRD-K28307902-001-04-3,androgen receptor antagonist
25968,g18,BRD-K28453807-003-05-4,Cholinergic receptor antagonist
25968,g23,BRD-K28578425-001-01-3,phosphodiesterase inhibitor
25968,g24,BRD-K28667196-001-02-9,Increases arterial blood pressure
25968,h01,BRD-K28680267-001-01-8,CCK receptor antagonist
25968,h02,BRD-K28761384-003-03-6,dopamine receptor antagonist
25968,h05,BRD-K28761891-001-01-0,melatonin receptor agonist
25968,h06,BRD-K28806945-001-01-9,dopamine receptor antagonist
25968,h07,BRD-K28863208-001-01-2,Cholinergic receptor agonist
25968,h08,BRD-K28907958-001-01-9,retinoid receptor agonist
25968,h09,BRD-K28936863-051-04-1,histamine receptor agonist|leukotriene receptor antagonist|phosphodiesterase inhibitor
25968,h10,BRD-K29113274-001-03-6,Sterol demethylase inhibitor
25968,h12,BRD-K29178788-001-02-0,Furoquinoline alkaloid
25968,h13,BRD-K29359156-001-04-6,H+/K+-ATPase inhibitor
25968,h16,BRD-K29555132-001-02-2,Cannabinoid receptor agonist
25968,h17,BRD-K29582677-001-02-7,Calcium channel blocker
25968,h18,BRD-K29668683-300-01-4,sigma receptor antagonist
25968,h21,BRD-K29673530-001-03-9,tyrosine kinase inhibitor
25968,h22,BRD-K29950728-048-02-6,estrogen receptor antagonist
25968,h23,BRD-K30197592-001-01-5,Serotonin receptor agonist
25968,i01,BRD-K30240666-051-05-0,histamine receptor antagonist
25968,i02,BRD-K30421593-050-02-3,adrenergic receptor antagonist
25968,i03,BRD-K30480208-001-04-5,Electrolyte reabsorption inhibitor
25968,i08,BRD-K30685142-001-04-8,thyroid hormone stimulant
25968,i09,BRD-K30867024-001-01-1,serotonin receptor antagonist
25968,i11,BRD-K30990140-003-01-6,Cyclooxygenase inhibitor
25968,i12,BRD-K31054881-300-01-3,Adrenergic receptor antagonist
25968,i13,BRD-K31238592-001-01-6,CCK receptor antagonist|gastrin inhibitor
25968,i16,BRD-K31342827-001-05-4,PKC inhibitor
25968,i18,BRD-K31491153-001-01-2,serotonin receptor agonist
25968,i19,BRD-K31542390-001-01-5,dehydrogenase inhibitor|inositol monophosphatase inhibitor
25968,i20,BRD-K31611373-001-02-7,Prostanoid receptor agonist
25968,i23,BRD-K31627533-001-03-8,glucocorticoid receptor agonist
25968,i24,BRD-K31633810-003-01-0,Acetylcholine receptor antagonist
25968,j03,BRD-K31699485-001-01-9,glutamate receptor modulator
25968,j04,BRD-K31792052-004-01-9,interleukin receptor antagonist
25968,j09,BRD-K31843556-001-01-7,PPAR receptor anatagonist|PPAR receptor antagonist
25968,j10,BRD-K31912990-003-01-0,neuropeptide receptor antagonist
25968,j12,BRD-K31987754-001-01-2,Cannabinoid receptor agonist
25968,j15,BRD-K32164935-001-06-8,ATP channel blocker
25968,j16,BRD-K32247306-001-04-7,GABA receptor antagonist
25968,j19,BRD-K32292990-001-01-0,EGFR inhibitor
25968,j20,BRD-K32412559-001-01-7,Adrenergic receptor antagonist
25968,j23,BRD-K32501161-001-01-7,dopamine uptake inhibitor
25968,j24,BRD-K32526544-001-01-2,Potassium channel activator
25968,k02,BRD-K32584078-001-02-3,AKT inhibitor|HCV NS5B RdRp inhibitor
25968,k04,BRD-K32645441-001-01-4,serotonin receptor agonist
25968,k05,BRD-K32696739-001-02-6,Monoamine oxidase inhibitor
25968,k06,BRD-K32744045-001-04-9,aldehyde dehydrogenase inhibitor|DNA methyltransferase inhibitor|TRPV agonist
25968,k09,BRD-K32755366-003-03-4,Norepinephrine transporter inhibitor
25968,k10,BRD-K32821942-001-04-9,dehydrogenase inhibitor
25968,k11,BRD-K32828673-001-01-5,tubulin polymerization inhibitor
25968,k12,BRD-K32830106-003-11-3,adrenergic receptor agonist
25968,k14,BRD-K33204703-001-04-6,PDGFR receptor inhibitor
25968,k17,BRD-K33211335-337-03-7,glutamate receptor antagonist|sigma receptor agonist
25968,k19,BRD-K33308633-001-01-6,calcineurin inhibitor
25968,k20,BRD-K33396764-001-02-0,Omega 3 fatty acid stimulant
25968,k22,BRD-K33453211-003-03-2,Histamine receptor antagonist
25968,l01,BRD-K33459542-001-02-5,sigma receptor agonist
25968,l02,BRD-K33583600-001-03-9,guanylate cyclase activator
25968,l03,BRD-K33710385-001-05-4,mycolic synthesis inhibitor
25968,l04,BRD-K33818169-003-01-2,LXR agonist|ABC transporter expression enhancer
25968,l05,BRD-K33864865-001-01-7,CCK receptor antagonist
25968,l06,BRD-K33882852-003-01-0,benzodiazepine receptor agonist
25968,l10,BRD-K34014345-001-02-6,Anti-inflammatory
25968,l11,BRD-K34034388-300-01-0,dopamine uptake inhibitor
25968,l12,BRD-K34092021-001-02-3,TRPV agonist|cannabinoid receptor agonist
25968,l13,BRD-K34154330-003-04-9,GABA receptor modulator
25968,l17,BRD-K34170797-001-01-1,FXR agonist
25968,l20,BRD-K34415467-003-04-9,histamine receptor antagonist
25968,l21,BRD-K34568562-001-02-7,interferon inducer
25968,l22,BRD-K34608650-001-01-6,Cannabinoid receptor agonist
25968,m02,BRD-K34685430-001-01-1,dopamine receptor antagonist|serotonin receptor antagonist
25968,m03,BRD-K34995470-001-02-3,receptor tyrosine protein kinase inhibitor|vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor|VEGFR inhibitor
25968,m06,BRD-K35240538-001-03-1,glucocorticoid receptor agonist
25968,m07,BRD-K35430135-003-01-5,Adrenergic receptor antagonist
25968,m08,BRD-K35458079-001-04-2,Nootropic agent
25968,m11,BRD-K35498378-001-03-8,Aldose reductase inhibitor
25968,m15,BRD-K35629949-001-01-2,CCK receptor antagonist
25968,m16,BRD-K35708212-331-03-1,ATPase inhibitor
25968,m17,BRD-K35941380-001-01-7,Serotonin receptor antagonist
25968,m18,BRD-K35960502-001-04-4,DNA replication inhibitor|STAT inhibitor
25968,m20,BRD-K36007650-300-02-3,protein synthesis inhibitor
25968,m21,BRD-K36009368-001-01-8,Opioid receptor agonist
25968,m22,BRD-K36021395-300-01-6,adenosine kinase inhibitor
25968,m23,BRD-K36055864-001-04-4,protein synthesis inhibitor
25968,m24,BRD-K36116267-001-05-4,psychoactive drug
25968,n01,BRD-K36198571-001-01-2,metalloproteinase inhibitor
25968,n02,BRD-K36258877-001-01-5,caspase inhibitor
25968,n05,BRD-K36638830-001-02-2,acetylcholine receptor agonist
25968,n06,BRD-K36756879-003-04-6,calcium channel blocker
25968,n11,BRD-K36862742-001-04-1,sodium/potassium/chloride transporter inhibitor
25968,n12,BRD-K36864847-303-01-7,Adrenergic receptor antagonist
25968,n15,BRD-K36927236-001-06-0,Sulfonylurea
25968,n16,BRD-K36965586-001-01-7,serotonin receptor agonist
25968,n18,BRD-K37249724-001-04-2,histamine receptor antagonist
25968,n19,BRD-K37270826-001-03-7,glucocorticoid receptor antagonist|progesterone receptor antagonist
25968,n21,BRD-K37289225-001-07-5,Dopamine receptor antagonist
25968,n22,BRD-K37392901-003-01-7,ubiquitin hydrolase inhibitor|ubiquitin isopeptidase inhibitor
25968,n23,BRD-K37447567-001-01-8,Opioid receptor antagonist
25968,n24,BRD-K37561857-001-04-9,phosphodiesterase inhibitor
25968,o02,BRD-K37618799-001-01-4,adenosine receptor antagonist
25968,o03,BRD-K37682401-001-05-1,bacterial DNA gyrase inhibitor
25968,o04,BRD-K37688416-003-04-0,psychoactive drug
25968,o05,BRD-K37691127-001-02-2,tyrosinase inhibitor
25968,o07,BRD-K37792168-001-01-0,Phosphodiesterase inhibitor
25968,o08,BRD-K37798499-001-02-5,topoisomerase inhibitor
25968,o09,BRD-K37848908-001-03-1,penicillin binding protein inhibitor
25968,o10,BRD-K37865504-001-01-7,FAAH inhibitor|FAAH reuptake inhibitor
25968,o14,BRD-K37991163-050-05-1,selective serotonin reuptake inhibitor (SSRI)
25968,o15,BRD-K38003476-001-03-4,steroid
25968,o16,BRD-K38055836-001-03-9,respiratory stimulant
25968,o17,BRD-K38197229-001-06-7,solute carrier family member inhibitor
25968,o18,BRD-K38251852-001-02-5,ABC transporter expression enhancer|high conductance calcium activated potassium blocker|LXR agonist|potassium channel blocker
25968,o19,BRD-K38305202-001-01-8,dopamine receptor antagonist
25968,o20,BRD-K38323065-001-05-8,cyclooxygenase inhibitor
25968,o21,BRD-K38347298-001-02-3,adenosine receptor antagonist
25968,o22,BRD-K38436528-003-04-8,norepinephrine reputake inhibitor|serotonin reuptake inhibitor
25968,o23,BRD-K38449220-001-03-8,cytochrome P450 inhibitor
25968,o24,BRD-K38477985-001-01-8,protein tyrosine kinase inhibitor|tyrosine kinase inhibitor
25968,p01,BRD-K38684403-001-02-1,bacterial 50S ribosomal subunit inhibitor
25968,p03,BRD-K38775274-001-02-3,glucocorticoid receptor agonist
25968,p04,BRD-K38903228-001-02-8,flavanone glycoside
25968,p05,BRD-K39120595-304-02-1,autotaxin inhibitor
25968,p07,BRD-K39187410-001-01-7,antiamyloidogenic agent
25968,p08,BRD-K39188321-001-03-9,glucocorticoid receptor agonist
25968,p09,BRD-K39339537-001-03-8,cyclooxygenase inhibitor
25968,p10,BRD-K39356024-001-02-4,acetylcholine release enhancer|dopamine release enhancer|GABA receptor negative allosteric modulator|glutamate receptor modulator|progesterone receptor agonist|steroid hormone inhibitor of CYP17A1 and SULT2B1
25968,p13,BRD-K39484304-001-02-5,RNA polymerase inhibitor
25968,p14,BRD-K39670393-303-01-3,histamine receptor agonist
25968,p15,BRD-K39733634-001-01-8,prostanoid receptor antagonist|angiotensin receptor antagonist
25968,p16,BRD-K39746403-084-02-3,NFkB pathway inhibitor|50S ribosomal subunit inhibitor|motilin receptor agonist|RPLV inhibitor
25968,p17,BRD-K39915878-036-04-6,dopamine receptor antagonist|serotonin receptor antagonist
25968,p18,BRD-K39965020-001-02-6,PPAR receptor agonist
25968,p19,BRD-K39987650-001-04-3,laxative
25968,p20,BRD-K40255344-001-05-1,protein tyrosine kinase inhibitor|tyrosine kinase inhibitor
25968,p21,BRD-K40530731-001-02-5,acetylcholine receptor inhibitor
25968,p22,BRD-K40578143-001-01-8,adenosine receptor agonist
25968,p23,BRD-K40656405-001-01-5,PPAR receptor agonist
25968,p24,BRD-K40742111-001-02-6,lipoxygenase inhibitor
25991,a01,BRD-K90382497-001-01-6,PLK inhibitor
25991,a02,BRD-K92723993-066-02-9,PDGFR tyrosine kinase receptor inhibitor|Bcr-Abl kinase inhibitor|KIT inhibitor|Abl kinase inhibitor|apoptosis stimulant|breast cancer resistance protein inhibitor|colony stimulating factor receptor inhibitor
25991,a03,BRD-K07762753-001-03-6,CDK inhibitor|tyrosine kinase inhibitor
25991,a04,BRD-K09991945-001-02-0,glycogen synthase kinase inhibitor|PKC inhibitor|superoxide dismutase expression inhibitor
25991,a05,BRD-K37312348-001-05-1,CDK inhibitor|glycogen synthase kinase inhibitor
25991,a06,BRD-K46678324-001-03-7,rho associated kinase inhibitor
25991,a07,BRD-K67860401-001-02-3,glycogen synthase kinase inhibitor
25991,a08,BRD-K52620403-001-01-8,calcium/calmodulin dependent protein kinase inhibitor|calmodulin inhibitor
25991,a09,BRD-K68336408-001-03-4,EGFR inhibitor
25991,a10,BRD-K72703948-001-01-0,Aurora kinase inhibitor
25991,a11,BRD-K93201660-001-05-7,myosin light chain kinase inhibitor
25991,a15,BRD-A47633927-001-01-8,ICAM1 antagonist
25991,a16,BRD-A68039575-001-02-5,Aromatase inhibitor
25991,a17,BRD-A75455249-001-02-0,calcium channel modulator|mTOR inhibitor|sodium channel blocker
25991,a18,BRD-K01555864-001-02-8,antineoplastic
25991,a19,BRD-K09497549-001-03-6,calcium channel modulator|mTOR inhibitor|sodium channel blocker
25991,a20,BRD-K14536225-001-02-7,Glucosidase inhibitor
25991,a21,BRD-K15086322-103-01-0,histamine receptor antagonist|histamine receptor silent antagonist
25991,a23,BRD-K23623876-001-01-6,ultrasound contrast agent
25991,a24,BRD-K36377456-001-02-0,angiogenesis inhibitor
25991,b01,BRD-K36395411-003-01-4,serotonin receptor antagonist|serotonin receptor partial agonist
25991,b03,BRD-K41160163-001-01-9,Glutamate receptor antagonist
25991,b04,BRD-K42095107-001-02-3,estrogen receptor agonist
25991,b05,BRD-K43797669-001-02-3,tyrosine kinase inhibitor
25991,b06,BRD-K45988865-001-01-0,organosilicon compound used as an internal standard in NMR spectroscopy
25991,b07,BRD-K49061529-001-01-0,GABA benzodiazepine site receptor inverse agonist
25991,b09,BRD-K59331372-001-01-2,TRPV antagonist
25991,b11,BRD-K60690191-003-02-1,glutamate receptor antagonist
25991,b12,BRD-K61177364-003-01-1,CRF receptor antagonist
25991,b17,BRD-K61250553-001-02-9,opioid receptor agonist
25991,b18,BRD-K61269089-001-01-4,Protein kinase inhibitor
25991,b19,BRD-K61271364-001-02-4,GABA receptor antagonist
25991,b20,BRD-K61323504-001-02-4,CC chemokine receptor antagonist
25991,b22,BRD-K61496577-001-03-8,glucocorticoid receptor agonist
25991,b23,BRD-K61590534-001-01-4,EGFR inhibitor
25991,c01,BRD-K61737877-001-01-6,VEGFR inhibitor
25991,c03,BRD-K61951118-001-01-2,GABA benzodiazepine site receptor inverse agonist
25991,c04,BRD-K62008436-001-03-1,tubulin polymerization inhibitor
25991,c05,BRD-K62056274-001-01-9,Serotonin receptor agonist
25991,c07,BRD-K62206109-303-01-1,histamine receptor antagonist
25991,c08,BRD-K62221994-001-01-8,gonadotropin releasing factor hormone receptor antagonist
25991,c10,BRD-K62289640-003-01-9,Cannabinoid receptor agonist
25991,c13,BRD-K62310379-001-03-0,glucocorticoid receptor agonist
25991,c17,BRD-K62353524-001-01-8,estrogen receptor agonist
25991,c18,BRD-K62363391-001-04-1,bacterial antifolate
25991,c23,BRD-K62607865-001-03-0,bacterial cell wall synthesis inhibitor
25991,c24,BRD-K62609077-001-02-2,adrenergic receptor antagonist|GABA receptor antagonist|serotonin receptor antagonist
25991,d01,BRD-K62810658-001-05-6,MEK inhibitor
25991,d02,BRD-K62929068-001-01-7,Purinergic receptor activator
25991,d04,BRD-K62996583-001-03-8,calcium channel blocker
25991,d05,BRD-K63089472-001-02-7,Inhibitor of methyl esterification of farnesylated proteins
25991,d06,BRD-K63150726-001-01-3,cannabinoid receptor inverse agonist
25991,d07,BRD-K63151507-001-01-6,Lymphocyte inhibitor
25991,d08,BRD-K63165456-001-03-3,Adrenergic receptor agonist
25991,d09,BRD-K63430059-001-03-2,DNA synthesis inhibitor
25991,d10,BRD-K63504947-001-05-5,VEGFR inhibitor
25991,d13,BRD-K63516691-001-01-6,Phosphodiesterase inhibitor
25991,d14,BRD-K63533170-001-01-1,cannabinoid receptor antagonist|cannabinoid receptor inverse agonist
25991,d17,BRD-K63606607-001-01-8,ATPase inhibitor|chloride channel activator
25991,d18,BRD-K63630713-001-04-3,sodium/potassium/chloride transporter inhibitor
25991,d19,BRD-K63750851-001-03-3,dehydrogenase inhibitor|inositol monophosphatase inhibitor
25991,d21,BRD-K63784565-001-02-1,Topoisomerase inhibitor
25991,d22,BRD-K63792901-075-01-3,acetylcholine receptor agonist
25991,d23,BRD-K63828191-003-07-3,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)
25991,e03,BRD-K63874012-103-01-5,histamine receptor antagonist|histamine receptor inverse agonist
25991,e04,BRD-K63913457-001-02-7,vasodilator
25991,e06,BRD-K63945320-001-02-4,Phospholipase inhibitor
25991,e07,BRD-K63979671-001-03-6,Compound used in hepatobiliary scans of the liver
25991,e08,BRD-K64044582-001-02-8,ACAT inhibitor
25991,e11,BRD-K64157027-003-01-9,Adrenergic receptor agonist
25991,e14,BRD-K64245000-001-01-7,FXR agonist
25991,e16,BRD-K64341947-003-01-6,guanylate cyclase activator
25991,e20,BRD-K64402243-001-01-1,Caspase inhibitor
25991,e22,BRD-K64670467-001-01-2,glutamate receptor antagonist
25991,f03,BRD-K64755930-003-01-6,phosphodiesterase inhibitor
25991,f04,BRD-K64862097-001-03-9,glucocorticoid receptor agonist
25991,f06,BRD-K64994968-001-03-6,Progesterone receptor agonist
25991,f07,BRD-K65146499-001-04-8,Cyclooxygenase inhibitor
25991,f11,BRD-K65285700-001-01-5,cannabinoid receptor agonist
25991,f12,BRD-K65417056-003-03-6,Local anesthetic
25991,f13,BRD-K65503129-001-01-4,HSP inhibitor|HSP antagonist
25991,f15,BRD-K65639003-001-02-5,phosphodiesterase inhibitor
25991,f16,BRD-K65667145-001-04-1,cell division inducer
25991,f19,BRD-K65786282-001-02-6,GABA receptor modulator
25991,f20,BRD-K65814004-001-02-3,nitric oxide synthase inhibitor|aldehyde dehydrogenase inhibitor|cytochrome P450 inhibitor|NADPH oxidase inhibitor|xanthine oxidase inhibitor
25991,f23,BRD-K66093087-001-01-5,Benzodiazepine receptor agonist
25991,f24,BRD-K66206289-003-03-1,Acetylcholine receptor antagonist
25991,g02,BRD-K66353228-001-05-4,myorelaxant
25991,g05,BRD-K66404838-003-03-8,opioid receptor agonist|opioid receptor antagonist
25991,g08,BRD-K66707493-001-02-6,Coloring agent
25991,g09,BRD-K66715657-001-01-3,dopamine receptor antagonist
25991,g10,BRD-K66782112-001-01-2,Histamine receptor antagonist
25991,g11,BRD-K66874953-001-02-7,TP53 inhibitor
25991,g12,BRD-K66898851-001-03-7,apoptosis stimulant
25991,g13,BRD-K66944906-001-02-6,Carbonic anhydrase inhibitor
25991,g14,BRD-K67013324-001-01-5,melatonin receptor antagonist
25991,g16,BRD-K67017579-001-13-3,Phosphodiesterase inhibitor
25991,g17,BRD-K67043667-001-04-1,DNA synthesis inhibitor
25991,g18,BRD-K67080878-001-05-5,phosphodiesterase inhibitor
25991,g21,BRD-K67102207-236-01-0,HDAC inhibitor
25991,g23,BRD-K67261995-001-03-4,Contrast agent
25991,g24,BRD-K67277431-002-03-0,thromboxane receptor antagonist|thromboxane synthase inhibitor
25991,h01,BRD-K67298865-001-02-5,TGF beta receptor inhibitor
25991,h02,BRD-K67352070-364-01-5,Acetylcholine receptor agonist
25991,h05,BRD-K67439147-001-01-7,glutamate receptor antagonist
25991,h06,BRD-K67445247-001-01-3,Urease inhibitor
25991,h08,BRD-K67537649-001-01-1,insulin growth factor receptor inhibitor
25991,h12,BRD-K67680372-003-01-8,GAT inhibitor
25991,h13,BRD-K67783091-001-05-5,Dopamine receptor antagonist
25991,h14,BRD-K67831364-003-01-7,vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor|VEGFR inhibitor
25991,h17,BRD-K68095457-001-04-4,Cannabinoid receptor agonist
25991,h18,BRD-K68103045-001-01-1,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist
25991,h21,BRD-K68143200-001-04-2,CDC inhibitor
25991,h24,BRD-K68190965-001-01-4,Serotonin receptor agonist
25991,i01,BRD-K68246049-001-01-4,Retinoid receptor agonist
25991,i02,BRD-K68264559-001-07-6,Adrenergic receptor agonist
25991,i03,BRD-K68332390-001-03-3,aldose reductase inhibitor|reductase inhibitor
25991,i04,BRD-K68341547-003-01-6,calmodulin antagonist
25991,i07,BRD-K68392338-003-01-2,Benzodiazepine receptor antagonist
25991,i08,BRD-K68402494-001-04-7,myosin light chain kinase inhibitor
25991,i10,BRD-K68507560-003-04-8,acetylcholine receptor antagonist
25991,i12,BRD-K68552125-001-03-8,PKC activator|CD antagonist
25991,i13,BRD-K68553471-003-04-0,antihypertensive agent
25991,i14,BRD-K68558722-001-02-4,Cyclooxygenase inhibitor
25991,i15,BRD-K68620903-001-03-1,progesterone receptor agonist
25991,i17,BRD-K68873215-001-01-3,phosphodiesterase inhibitor
25991,i18,BRD-K69023402-001-02-5,ATPase inhibitor|calcium channel blocker|PKC activator
25991,i19,BRD-K69032158-001-02-2,Dipeptidyl peptidase inhibitor
25991,i20,BRD-K69195780-001-01-5,Serotonin receptor agonist
25991,i23,BRD-K69556541-001-02-6,Calcium channel blocker
25991,j01,BRD-K69763916-001-01-7,Glutamate receptor antagonist
25991,j02,BRD-K69837166-003-01-2,Nociceptin/orphanin FQ (NOP) receptor antagonist
25991,j03,BRD-K70241288-001-01-1,Growth hormone releasing peptide ligand agonist
25991,j04,BRD-K70246307-001-02-5,vitamin B2
25991,j07,BRD-K70281171-001-01-7,Dopamine receptor antagonist
25991,j08,BRD-K70330367-001-02-4,Glutamate receptor antagonist
25991,j10,BRD-K70487031-001-01-0,dopamine receptor antagonist
25991,j12,BRD-K70778732-003-04-4,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor
25991,j13,BRD-K70792160-003-01-2,AKT inhibitor
25991,j15,BRD-K70881766-001-02-3,Acetylcholinesterase inhibitor
25991,j16,BRD-K70914287-300-01-0,EGFR inhibitor|tyrosine kinase inhibitor
25991,j17,BRD-K70976396-236-04-7,Bacterial cell wall synthesis inhibitor
25991,j18,BRD-K71003802-001-02-9,Plant alkaloid
25991,j19,BRD-K13356952-001-11-1,carbonic anhydrase inhibitor
25991,k03,BRD-K71266197-236-01-9,NTPDase inhibitor
25991,k04,BRD-K71430621-303-01-5,histamine receptor antagonist|histamine receptor inverse agonist
25991,k06,BRD-K71499074-001-03-8,Carbonic anhydrase inhibitor
25991,k09,BRD-K71534238-001-03-5,Free fatty acid receptor agonist
25991,k11,BRD-K71726959-001-05-9,CDK inhibitor
25991,k12,BRD-K71731651-001-01-9,Acetylcholine receptor agonist
25991,k13,BRD-K71799778-001-02-2,CDK inhibitor
25991,k14,BRD-K71799949-001-04-2,Carboxamide antiepileptic
25991,k17,BRD-K71860425-001-01-1,CDK inhibitor
25991,k18,BRD-K72024482-001-01-3,adenosine receptor antagonist
25991,k19,BRD-K72034655-001-02-1,apoptosis inducer|antileukemic
25991,k22,BRD-K72222507-003-02-8,ACE inhibitor
25991,l04,BRD-K72676686-103-01-8,selective serotonin reuptake inhibitor (SSRI)|serotonin reuptake inhibitor|serotonin uptake inhibitor
25991,l05,BRD-K72726508-001-01-3,CDK inhibitor
25991,l06,BRD-K72783841-001-01-0,CDK inhibitor|epidermal growth factor receptor (EGFR) inhibitor|tyrosine kinase inhibitor|EGFR inhibitor
25991,l09,BRD-K72895815-001-01-4,leukocyte elastase inhibitor
25991,l10,BRD-K72903603-001-03-8,Reverse transcriptase inhibitor
25991,l13,BRD-K73109821-001-05-2,Potassium channel activator
25991,l18,BRD-K73196317-003-06-4,adrenergic receptor antagonist
25991,l21,BRD-K73290745-003-01-8,opioid receptor agonist
25991,l22,BRD-K73323637-003-03-4,adrenergic receptor antagonist
25991,m02,BRD-K73391359-003-03-7,Local anesthetic
25991,m05,BRD-K73397362-001-01-7,smoothened receptor agonist
25991,m06,BRD-K73589401-001-03-8,mineralocorticoid receptor agonist
25991,m12,BRD-K73789395-001-04-0,RAF inhibitor
25991,m15,BRD-K73991644-001-01-7,aldose reductase inhibitor|falcipain inhibitor
25991,m17,BRD-K74112339-001-02-7,Urease inhibitor
25991,m18,BRD-K74141488-003-03-9,Fungal squalene epoxidase inhibitor
25991,m20,BRD-K74195153-050-03-0,Phosphodiesterase inhibitor
25991,m21,BRD-K74212935-001-03-1,Dopamine agonist
25991,m23,BRD-K74305673-001-01-3,IKK inhibitor|NFkB pathway inhibitor|protein kinase inhibitor
25991,m24,BRD-K74430258-001-01-2,hepatotoxicant
25991,n02,BRD-K74765201-001-01-9,Leukotriene receptor antagonist
25991,n03,BRD-K74913225-001-03-3,Carbonic anhydrase inhibitor
25991,n05,BRD-K75089421-001-02-5,sodium channel blocker
25991,n06,BRD-K75181824-001-02-3,inhibitor of methyl esterification of geranylgeranylated proteins
25991,n11,BRD-K75478907-001-01-5,GABA receptor modulator|GABA receptor positive allosteric modulator
25991,n16,BRD-K75615183-001-01-7,Adrenergic receptor agonist
25991,n17,BRD-K75641298-001-01-5,Dopamine receptor antagonist
25991,n21,BRD-K75958195-001-01-7,serotonin receptor antagonist
25991,n24,BRD-K76064317-001-04-0,FLT3 inhibitor
25991,o01,BRD-K76133116-001-01-2,Membrane integrity inhibitor
25991,o03,BRD-K76274772-001-02-7,Ceramidase inhibitor
25991,o05,BRD-K76304753-003-04-7,local anesthetic
25991,o07,BRD-K76568384-001-01-4,estrogen receptor antagonist
25991,o08,BRD-K76587808-001-02-0,Antioxidant
25991,o09,BRD-K76617868-001-02-2,rho associated kinase inhibitor
25991,o10,BRD-K76634210-001-02-2,DNA directed DNA polymerase inhibitor
25991,o13,BRD-K76674262-001-01-7,apoptosis stimulant|protein synthesis inhibitor
25991,o15,BRD-K76723084-001-05-9,retinoid receptor agonist
25991,o16,BRD-K76775527-001-06-2,Cyclooxygenase inhibitor
25991,o17,BRD-K76805682-001-05-0,glycogen synthase kinase inhibitor
25991,o18,BRD-K76810206-001-05-7,adrenergic receptor antagonist
25991,o20,BRD-K76840893-003-01-7,adrenergic receptor antagonist
25991,o22,BRD-K76872913-001-02-8,Aromatic hydrocarbon derivative
25991,o23,BRD-K76927775-001-04-3,DNA inhibitor
25991,o24,BRD-K77133231-001-01-1,p38 MAPK inhibitor
25991,p01,BRD-K77171813-050-01-4,histamine receptor modulator
25991,p03,BRD-K77554836-001-03-3,glucocorticoid receptor agonist
25991,p07,BRD-K77641333-003-04-0,adrenergic receptor agonist
25991,p08,BRD-K77677632-003-01-8,serotonin receptor antagonist
25991,p09,BRD-K77695569-001-04-5,angiogenesis inhibitor
25991,p10,BRD-K77771411-003-03-2,imidazoline receptor agonist
25991,p13,BRD-K77793136-003-01-4,rho associated kinase inhibitor
25991,p15,BRD-K77925998-001-01-3,serotonin receptor agonist
25991,p16,BRD-K77947974-001-04-9,dopamine receptor antagonist
25991,p17,BRD-K77987382-001-05-8,acetylcholinesterase inhibitor|microtubule inhibitor|tubulin inhibitor
25991,p18,BRD-K78010432-001-04-1,diuretic
25991,p20,BRD-K78084463-003-01-0,calmodulin antagonist
25991,p21,BRD-K78113049-001-04-8,topoisomerase inhibitor
25991,p22,BRD-K78122587-300-01-9,T-type calcium channel blocker
25991,p23,BRD-K78280988-001-02-2,cannabinoid receptor agonist|potassium channel blocker|TRPV agonist
24278,a01,BRD-K78364995-236-03-5,bacterial cell wall synthesis inhibitor
24278,a03,BRD-K78485176-001-02-9,angiotensin receptor antagonist
24278,a05,BRD-K78599730-001-02-6,farnesyltransferase inhibitor|NFkB pathway inhibitor|ras farnesyltransferase inhibitor
24278,a07,BRD-K78633253-001-01-2,ARF inhibitor
24278,a08,BRD-K78637815-001-01-4,cannabinoid receptor antagonist
24278,a09,BRD-K78643075-001-03-3,dopamine receptor antagonist
24278,a10,BRD-K78692225-001-11-2,dihydroorotate dehydrogenase inhibitor|PDGFR tyrosine kinase receptor inhibitor
24278,a11,BRD-K78815826-001-04-7,cyclooxygenase inhibitor
24278,a12,BRD-K78838262-001-02-4,hypolipidemic
24278,a16,BRD-K78959463-001-02-5,calcium channel activator
24278,a18,BRD-K79092138-001-04-5,POXB inhibitor|bacterial DNA inhibitor
24278,a19,BRD-K79116891-003-03-7,sodium channel blocker
24278,a20,BRD-K79124250-001-03-0,radiopaque medium
24278,a21,BRD-K79131256-001-03-9,tubulin polymerization inhibitor
24278,a22,BRD-K79145749-001-01-8,norepinephrine reputake inhibitor
24278,a24,BRD-K79366068-236-01-5,NTPDase inhibitor
24278,b01,BRD-K79425933-001-03-6,dopamine receptor antagonist
24278,b02,BRD-K79437791-001-02-4,Inhibitor of methylation of endogenous isoprenylated proteins
24278,b03,BRD-K79501723-003-03-4,histamine receptor modulator
24278,b04,BRD-K79684402-300-01-0,dopamine receptor partial agonist
24278,b05,BRD-K79711234-001-04-3,bacterial 50S ribosomal subunit inhibitor
24278,b06,BRD-K79759585-001-02-1,phosphodiesterase inhibitor
24278,b07,BRD-K79930101-300-01-1,EGFR inhibitor|epidermal growth factor receptor (EGFR) inhibitor|ErbB2 tyrosine kinase inhibitor|receptor tyrosine protein kinase inhibitor
24278,b09,BRD-K80315159-051-01-2,histamine receptor antagonist
24278,b12,BRD-K80334323-001-03-5,progestogen hormone
24278,b15,BRD-K80353807-001-03-0,vasodilator
24278,b16,BRD-K80396088-001-03-9,Sulfonylurea
24278,b17,BRD-K80451230-051-01-8,acetylcholine receptor antagonist
24278,b19,BRD-K80639402-003-01-1,serotonin receptor antagonist
24278,b20,BRD-K80725821-300-01-1,serotonin receptor antagonist
24278,b21,BRD-K80738081-001-06-2,cytochrome P450 inhibitor|SIRT activator
24278,b22,BRD-K80778372-001-01-7,GABA benzodiazepine site receptor inverse agonist
24278,b24,BRD-K80946661-001-02-8,p53 activator
24278,c01,BRD-K80970344-201-02-9,NFkB pathway inhibitor
24278,c02,BRD-K81029756-001-02-8,L-type calcium channel blocker|calcium channel antagonist|calcium channel blocker
24278,c04,BRD-K81209159-001-02-9,Acetylcholinesterase inhibitor
24278,c05,BRD-K81209512-001-01-3,EGFR inhibitor|epidermal growth factor receptor (EGFR) inhibitor|tyrosine kinase inhibitor
24278,c06,BRD-K81225797-001-01-5,adenosine receptor antagonist
24278,c07,BRD-K81272440-001-02-6,calcium channel blocker
24278,c09,BRD-K81376179-001-01-4,FLT3 inhibitor
24278,c14,BRD-K81709173-001-03-8,glucocorticoid receptor agonist
24278,c17,BRD-K81729199-001-01-0,acetylcholine receptor antagonist
24278,c20,BRD-K81839095-001-02-0,Estrogen receptor agonist
24278,c21,BRD-K81876028-300-01-2,Serotonin receptor agonist
24278,c23,BRD-K82103381-003-03-7,vasodilator
24278,d03,BRD-K82255054-001-04-3,GABA receptor agonist
24278,d04,BRD-K82484965-003-02-7,dopamine receptor agonist
24278,d05,BRD-K82561139-001-01-9,casein kinase inhibitor
24278,d06,BRD-K82562631-236-02-0,Cyclooxygenase inhibitor
24278,d07,BRD-K82577285-001-01-7,Dopamine receptor agonist
24278,d08,BRD-K82731415-001-04-7,CDK inhibitor
24278,d09,BRD-K82795137-001-02-3,Histamine receptor antagonist
24278,d10,BRD-K82823076-001-01-8,GABA benzodiazepine site receptor inverse agonist
24278,d13,BRD-K82846253-001-03-0,Insulin secretagogue
24278,d14,BRD-K82865713-001-02-6,cAMP inhibitor
24278,d17,BRD-K83023055-001-01-9,Melatonin receptor agonist
24278,d19,BRD-K83063356-003-01-7,CC chemokine receptor antagonist|CCR antagonist
24278,d23,BRD-K83302049-001-01-6,Histamine receptor antagonist
24278,d24,BRD-K83322645-103-01-6,sigma receptor antagonist|sigma receptor ligand
24278,e04,BRD-K83459933-001-02-1,angiogenesis inhibitor
24278,e05,BRD-K83508485-001-01-9,tachykinin antagonist
24278,e06,BRD-K83597974-003-05-7,Monoamine oxidase inhibitor
24278,e07,BRD-K83637872-001-01-7,Smoothened receptor antagonist
24278,e08,BRD-K84175871-003-02-2,Adrenergic receptor agonist
24278,e12,BRD-K84266862-001-01-6,phosphodiesterase inhibitor
24278,e13,BRD-K84421793-001-01-1,dopamine receptor agonist
24278,e14,BRD-K84595254-001-03-0,ATPase inhibitor
24278,e15,BRD-K84663978-001-02-3,phosphodiesterase inhibitor|platelet aggregation inhibitor|potassium channel blocker
24278,e16,BRD-K84709232-001-02-6,lipoxygenase inhibitor|HIV integrase inhibitor|NFkB pathway inhibitor|nitric oxide production inhibitor|PPAR receptor modulator|tumor necrosis factor production inhibitor
24278,e19,BRD-K85015012-003-01-1,GABA uptake inhibitor|GAT inhibitor
24278,e20,BRD-K85090592-003-08-7,Acetylcholine receptor agonist
24278,e22,BRD-K85119730-001-06-5,ATP channel blocker
24278,e23,BRD-K85242180-001-01-1,"indoleamine 2,3-dioxygenase inhibitor"
24278,e24,BRD-K85266041-304-01-7,glutamate receptor antagonist
24278,f04,BRD-K85383046-001-02-5,chloride channel blocker
24278,f06,BRD-K85871428-001-01-9,p38 MAPK inhibitor
24278,f11,BRD-K85883481-001-02-6,glucocorticoid receptor agonist
24278,f12,BRD-K86204871-001-02-2,sterol demethylase inhibitor
24278,f13,BRD-K86301799-001-14-0,phosphodiesterase inhibitor
24278,f14,BRD-K86434416-001-02-7,Monoamine oxidase inhibitor
24278,f15,BRD-K84663978-001-03-1,phosphodiesterase inhibitor|platelet aggregation inhibitor|potassium channel blocker
24278,f16,BRD-K86509404-001-02-0,CDK inhibitor
24278,f19,BRD-K86600316-003-01-2,Adrenergic receptor antagonist
24278,f20,BRD-K86727142-001-06-6,HCV inhibitor|XIAP inhibitor
24278,f21,BRD-K86873305-236-03-0,Bacterial cell wall synthesis inhibitor
24278,f22,BRD-K86882815-001-01-6,dopamine receptor agonist|prolactin inhibitor|prolactin secretion inhibitor
24278,f23,BRD-K86958018-001-01-9,TRPV agonist
24278,f24,BRD-K87048468-003-01-9,Serotonin receptor antagonist
24278,g01,BRD-K87049188-001-03-6,chelating agent|dopamine beta hydroxylase inhibitor
24278,g08,BRD-K87510569-001-01-0,CC chemokine receptor antagonist
24278,g09,BRD-K87696786-003-01-0,glutamate receptor antagonist
24278,g14,BRD-K87990216-001-03-7,Glucocorticoid receptor agonist
24278,g15,BRD-K87991767-001-02-0,carbonic anhydrase inhibitor|cyclooxygenase inhibitor
24278,g16,BRD-K88090157-050-03-3,antihistamine
24278,g21,BRD-K88282786-066-04-9,cannabinoid receptor agonist
24278,g22,BRD-K88358234-003-01-4,serotonin receptor agonist|nerve growth factor agonist|neurotrophic factor enhancer
24278,g23,BRD-K88366685-300-03-7,3-ketoacyl CoA thiolase inhibitor
24278,g24,BRD-K88405679-003-01-5,antihistamine
24278,h01,BRD-K88429204-001-04-7,dihydrofolate reductase inhibitor
24278,h02,BRD-K88544581-001-01-2,ACAT inhibitor
24278,h05,BRD-K88568253-065-02-1,monoamine oxidase inhibitor
24278,h06,BRD-K88611939-001-01-8,Glutamate receptor agonist
24278,h08,BRD-K88677950-001-01-3,MAP kinase inhibitor|MEK inhibitor
24278,h10,BRD-K88741031-001-01-0,EGFR inhibitor|tyrosine kinase inhibitor
24278,h11,BRD-K88743730-001-01-0,serotonin receptor partial agonist
24278,h12,BRD-K88759641-003-01-0,Angiotensin receptor antagonist
24278,h13,BRD-K88789588-001-03-2,aromatase inhibitor
24278,h14,BRD-K88809146-003-02-1,monoamine oxidase inhibitor
24278,h15,BRD-K88849294-001-02-1,Tyrosine phosphatase inhibitor
24278,h16,BRD-K88871508-001-01-9,Dopamine receptor agonist
24278,h18,BRD-K89046952-001-03-4,bacterial cell wall synthesis inhibitor
24278,h21,BRD-K89055274-048-03-7,muscle relaxant
24278,h22,BRD-K89085489-001-02-6,apoptosis stimulant|retinoid receptor agonist
24278,h23,BRD-K89125793-001-05-4,antiprotozoal agent
24278,h24,BRD-K89152108-001-03-3,thyroid hormone stimulant
24278,i01,BRD-K89210380-001-03-8,vitamin B
24278,i04,BRD-K89272762-001-04-4,chloride channel blocker
24278,i07,BRD-K89274813-001-01-5,acetylcholine release enhancer
24278,i08,BRD-K89375097-300-04-7,Acetylcholine receptor antagonist
24278,i09,BRD-K89402695-001-01-5,Thromboxane receptor antagonist
24278,i13,BRD-K89732114-001-02-6,dopamine receptor antagonist
24278,i14,BRD-K89923877-003-02-4,acetylcholine receptor antagonist
24278,i15,BRD-K89930444-001-01-9,tyrosine kinase inhibitor
24278,i16,BRD-K89997465-001-02-0,dopamine receptor antagonist
24278,i17,BRD-K90027355-001-03-4,mineralocorticoid receptor antagonist
24278,i23,BRD-K90259198-003-04-8,calmodulin antagonist|potassium channel blocker|squalene monooxygenase channel blocker
24278,i24,BRD-K90333595-001-02-8,adrenergic receptor antagonist
24278,j01,BRD-K90524085-001-05-2,phosphodiesterase inhibitor|platelet aggregation inhibitor
24278,j04,BRD-K90574421-001-01-9,Serotonin receptor agonist
24278,j08,BRD-K90789829-003-03-3,Adrenergic inhibitor
24278,j09,BRD-K90976994-001-02-1,Bile acid
24278,j10,BRD-K91243525-001-01-5,Neurotensin receptor antagonist
24278,j11,BRD-K91263825-001-02-8,tricyclic antidepressant
24278,j13,BRD-K91315211-334-02-3,Histamine receptor agonist
24278,j15,BRD-K91336023-001-01-4,Dopamine receptor agonist
24278,j16,BRD-K91370081-001-04-6,DNA synthesis inhibitor
24278,j19,BRD-K91904471-001-01-6,p38 MAPK inhibitor
24278,j20,BRD-K92000912-001-06-8,cannabinoid receptor antagonist
24278,j24,BRD-K92015269-001-01-6,dopamine uptake inhibitor
24278,k02,BRD-K92049597-001-04-2,sodium channel blocker
24278,k04,BRD-K92093830-003-05-0,topoisomerase inhibitor
24278,k05,BRD-K92138166-001-01-0,other antibiotic
24278,k09,BRD-K92492521-001-01-1,Leukotriene receptor antagonist
24278,k12,BRD-K92678294-001-01-0,Isoflavone
24278,k14,BRD-K92726801-003-02-7,Haemostatic agent
24278,k17,BRD-K92731339-227-02-3,ACE inhibitor
24278,k18,BRD-K92758126-001-06-3,NFkB pathway inhibitor
24278,k19,BRD-K92778217-001-04-6,Cyclooxygenase inhibitor
24278,k20,BRD-K92830582-003-04-8,adrenergic receptor antagonist
24278,k22,BRD-K92984783-003-02-4,Serotonin receptor antagonist
24278,l01,BRD-K93080877-001-02-1,tripeptidyl peptidase inhibitor
24278,l02,BRD-K93176058-001-01-0,retinoid receptor agonist
24278,l03,BRD-K93188295-300-01-4,adrenergic receptor antagonist
24278,l05,BRD-K93258693-001-02-5,PPAR receptor antagonist
24278,l06,BRD-K93280214-004-02-3,GABA receptor antagonist
24278,l09,BRD-K93325701-001-03-0,SRC inhibitor
24278,l10,BRD-K93332168-001-03-2,Monoamine oxidase inhibitor
24278,l11,BRD-K93441486-067-03-7,Acetylcholine receptor antagonist
24278,l12,BRD-K93460210-001-01-3,Serotonin receptor antagonist
24278,l13,BRD-K93461745-001-01-5,Serotonin receptor agonist
24278,l14,BRD-K93480852-001-02-2,calcium/calmodulin dependent protein kinase inhibitor
24278,l19,BRD-K93568044-001-03-1,glucocorticoid receptor agonist
24278,l20,BRD-K93658967-001-01-7,CDK inhibitor|CFTR channel activator|glycogen synthase kinase inhibitor|JNK inhibitor
24278,l21,BRD-K93754473-001-02-9,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)
24278,l22,BRD-K94144010-001-05-5,nicotine metabolite
24278,m04,BRD-K94270326-004-01-0,dopamine receptor antagonist
24278,m06,BRD-K94379058-001-03-5,cannabinoid receptor inverse agonist
24278,m07,BRD-K94441233-001-03-1,HMGCR inhibitor
24278,m08,BRD-K94512704-001-01-3,dopamine receptor antagonist
24278,m12,BRD-K94689771-001-02-5,CYP1B1 inhibitor
24278,m17,BRD-K94832621-001-01-5,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)
24278,m19,BRD-K94841585-001-02-8,laxative|free radical generator
24278,m21,BRD-K94887716-001-01-5,Serotonin receptor agonist
24278,m22,BRD-K94920105-001-01-3,PARP inhibitor
24278,m24,BRD-K95202259-001-01-9,p38 MAPK inhibitor
24278,n01,BRD-K95237249-001-04-2,Uricosuric blocker
24278,n02,BRD-K95309561-001-04-9,estrogen receptor agonist
24278,n04,BRD-K95435023-001-01-0,c-Met inhibitor|hepatocyte growth factor receptor inhibitor
24278,n07,BRD-K95603879-001-03-4,ATPase inhibitor
24278,n08,BRD-K95609758-001-01-1,potassium channel activator
24278,n11,BRD-K95655893-001-01-0,VEGFR kinase inhibitor
24278,n12,BRD-K95676198-001-02-6,JAK inhibitor
24278,n15,BRD-K95739795-001-01-1,Vesicular monoamine transporter inhibitor
24278,n16,BRD-K95763993-001-03-7,PDGFR receptor inhibitor
24278,n17,BRD-K95785537-001-04-1,src inhibitor
24278,n20,BRD-K95851186-001-02-9,GABA receptor modulator
24278,n21,BRD-K95899059-003-01-0,Serotonin receptor agonist
24278,n22,BRD-K95992530-001-02-4,integrin antagonist
24278,n23,BRD-K96119599-001-04-7,Melanin inhibitor
24278,n24,BRD-K96144918-001-02-3,KPL-1 tumor suppressor
24278,o04,BRD-K96263742-001-02-3,PPAR receptor agonist
24278,o05,BRD-K96271548-001-02-2,antioxidant
24278,o07,BRD-K96402602-001-01-8,PPMTase inhibitor
24278,o08,BRD-K96527333-001-03-4,GABA receptor modulator
24278,o10,BRD-K96670504-001-01-9,Glucokinase inhibitor
24278,o13,BRD-K96720755-001-01-8,Vasopressin receptor antagonist
24278,o14,BRD-K96799727-001-01-7,HSP inhibitor
24278,o15,BRD-K96809896-001-01-9,p38 MAPK inhibitor
24278,o16,BRD-K96862998-001-03-1,TGF beta receptor inhibitor
24278,o17,BRD-K97061094-001-03-2,Histamine receptor antagonist
24278,o18,BRD-K97118047-001-01-2,Casein kinase inhibitor
24278,o19,BRD-K97158071-001-04-1,Dopamine receptor antagonist
24278,o20,BRD-K97181089-001-02-7,sodium channel blocker
24278,o22,BRD-K97330509-001-01-4,src inhibitor
24278,o23,BRD-K97354755-001-01-5,src inhibitor
24278,o24,BRD-K97365803-001-01-3,PI3K inhibitor
24278,p01,BRD-K97399794-001-07-0,polar auxin transport inhibitor
24278,p02,BRD-K97440753-066-03-3,adrenergic receptor antagonist|prolactin inhibitor
24278,p04,BRD-K97509413-001-01-8,AGE inhibitor|estrogen receptor agonist|estrogen receptor ligand
24278,p05,BRD-K97521363-001-03-9,glycolysis inhibitor
24278,p06,BRD-K97530723-001-04-3,melatonin receptor agonist|nitric oxide synthase inhibitor
24278,p07,BRD-K97564742-103-01-9,histamine receptor antagonist
24278,p10,BRD-K97688263-001-02-9,sodium channel blocker
24278,p13,BRD-K97746869-001-04-9,ATP channel blocker
24278,p14,BRD-K97752965-001-01-6,ATP channel activator|nitric oxide donor|potassium channel agonist
24278,p15,BRD-K97799481-002-03-6,Adenosine receptor antagonist
24278,p16,BRD-K97810537-001-03-7,glucocorticoid receptor agonist
24278,p17,BRD-K98039984-001-03-0,glucocorticoid receptor agonist
24278,p18,BRD-K98143437-001-01-7,p38 MAPK inhibitor|interleukin inhibitor|tumor necrosis factor production inhibitor
24278,p20,BRD-K98157055-001-04-2,glutamate receptor antagonist
24278,p21,BRD-K98174813-001-05-7,bacterial 30S ribosomal subunit inhibitor
24278,p23,BRD-K98297262-001-01-1,"1,3-beta-glucan synthase inhibitor"
24278,p24,BRD-K98521173-001-03-8,mineralocorticoid receptor agonist
24301,a01,BRD-A44966919-001-03-1,acetylcholine receptor antagonist
24301,a02,BRD-A45140972-060-02-4,bacterial 50S ribosomal subunit inhibitor
24301,a03,BRD-A45499626-001-01-0,Glutamate receptor antagonist
24301,a04,BRD-A45543382-001-02-7,radiopaque medium
24301,a05,BRD-A46066006-004-04-4,muscarinic antagonist
24301,a10,BRD-A47144777-001-02-5,HSP90 inhibitor
24301,a11,BRD-A47494775-003-03-0,Adrenergic receptor agonist
24301,a12,BRD-A47513740-001-02-5,protein phosphatase inhibitor
24301,a15,BRD-A47598013-004-02-0,selective serotonin reuptake inhibitor (SSRI)
24301,a17,BRD-A48257147-001-01-9,glutamate receptor agonist
24301,a18,BRD-A48300215-001-01-4,sodium channel blocker
24301,a21,BRD-A48809242-001-02-9,adenosine receptor agonist
24301,a23,BRD-A49046702-001-01-2,GABA uptake inhibitor
24301,a24,BRD-A49172652-001-13-1,ATPase inhibitor
24301,b01,BRD-A49225603-045-02-7,histamine receptor agonist
24301,b02,BRD-A49358627-001-03-9,PPAR receptor agonist
24301,b03,BRD-A49370193-051-01-7,serotonin receptor agonist
24301,b05,BRD-A49680073-001-01-9,JAK inhibitor|Lipocortin synthesis stimulant|STAT inhibitor
24301,b06,BRD-A49734948-001-03-3,Plant alkaloid
24301,b07,BRD-A49906757-004-03-1,Acetylcholine receptor antagonist
24301,b09,BRD-A50157456-065-02-4,adrenergic receptor agonist
24301,b10,BRD-A50311610-300-04-7,CAR agonist
24301,b11,BRD-A50675702-001-03-0,chloride channel blocker|GABA gated chloride channel blocker
24301,b12,BRD-A50684349-001-01-5,dopamine receptor agonist
24301,b15,BRD-A50737080-001-01-4,ATR kinase inhibitor
24301,b16,BRD-A50764878-001-01-4,serotonin receptor antagonist
24301,b19,BRD-A51410489-001-01-4,adrenergic receptor antagonist
24301,b21,BRD-A51714012-001-02-3,Adrenergic inhibitor
24301,b22,BRD-A51820102-008-04-0,Bacterial cell wall synthesis inhibitor
24301,b23,BRD-A51829654-001-01-4,Serotonin receptor antagonist
24301,c01,BRD-A52588987-004-04-1,Dopamine receptor antagonist
24301,c02,BRD-A52660433-066-01-3,Monoamine oxidase inhibitor
24301,c04,BRD-A52922642-001-02-9,L-type calcium channel blocker
24301,c05,BRD-A53077924-236-01-4,Selective serotonin reuptake enhancer (SSRE)
24301,c07,BRD-A53416814-001-01-5,nitric oxide production inhibitor|phosphoenolpyruvate carboxylase activator|serine/threonine protein phosphatase activator
24301,c09,BRD-A53576514-003-03-1,Acetylcholine receptor antagonist
24301,c10,BRD-A53952395-003-04-6,local anesthetic
24301,c13,BRD-A54029483-001-01-5,endothelin receptor antagonist
24301,c14,BRD-A54236247-003-02-7,Adrenergic receptor agonist
24301,c17,BRD-A54490543-066-04-4,monoamine oxidase inhibitor
24301,c18,BRD-A54845972-066-01-5,serotonin receptor agonist|adrenergic receptor partial agonist|dopamine receptor agonist
24301,c19,BRD-A54927599-001-07-8,P-selectin inhibitor
24301,c22,BRD-A55272860-001-03-9,dopamine receptor antagonist
24301,c23,BRD-A55369275-001-01-6,GABA receptor antagonist
24301,c24,BRD-A55393291-001-02-4,Androgen receptor agonist
24301,d01,BRD-A55424491-001-04-1,dihydrofolate reductase inhibitor
24301,d04,BRD-A55756846-001-05-5,PKA inhibitor
24301,d05,BRD-A55913614-316-04-7,antimalarial agent|DNA inhibitor
24301,d07,BRD-A56020723-001-02-0,cathepsin inhibitor|antiamyloidogenic agent
24301,d08,BRD-A56675431-001-04-0,Thiazide diuretic
24301,d13,BRD-A56987319-001-03-8,Adenylyl cyclase inhibitor
24301,d14,BRD-A57133233-003-03-7,histamine receptor antagonist
24301,d17,BRD-A57382968-001-06-8,Cyclooxygenase inhibitor
24301,d20,BRD-A58048407-001-06-3,Calcium channel blocker
24301,d24,BRD-A59215453-003-03-3,Acetylcholine receptor antagonist
24301,e03,BRD-A59303141-001-03-9,Thiazide diuretic
24301,e06,BRD-A60197193-001-05-4,Dopamine receptor antagonist
24301,e12,BRD-A61154809-001-03-5,ATP channel blocker|insulin secretagogue
24301,e14,BRD-A61392169-001-01-9,glutamate receptor antagonist
24301,e15,BRD-A61470182-001-02-4,macrophage activator
24301,e16,BRD-A61793559-001-04-0,Carbonic anhydrase inhibitor
24301,e19,BRD-A61856038-001-01-2,Lipoxygenase inhibitor
24301,e22,BRD-A62021152-003-01-8,serotonin receptor agonist
24301,e23,BRD-A62057054-001-01-5,Serotonin receptor antagonist
24301,f04,BRD-A62428732-096-02-6,antihistamine
24301,f05,BRD-A62505706-001-02-3,DNA directed DNA polymerase inhibitor
24301,f06,BRD-A62525898-001-02-9,Glucocorticoid receptor agonist
24301,f08,BRD-A63346720-300-01-1,sigma receptor antagonist|dopamine reuptake inhibitor
24301,f11,BRD-A63546914-003-01-2,Glutamate receptor antagonist
24301,f12,BRD-A63667919-103-01-9,dopamine receptor antagonist|partial serotonin receptor agonist
24301,f14,BRD-A63836183-362-01-1,angiotensin receptor antagonist
24301,f15,BRD-A63894585-001-03-4,glucocorticoid receptor agonist
24301,f16,BRD-A64092382-003-03-5,Sodium channel blocker
24301,f19,BRD-A64125466-236-02-0,choleretic agent
24301,f20,BRD-A64227845-004-02-8,Dopamine receptor agonist
24301,f21,BRD-A64228451-001-03-5,BTK inhibitor
24301,f23,BRD-A64485570-001-02-9,DNA directed DNA polymerase inhibitor|thymidylate synthase inhibitor
24301,g02,BRD-A64933752-001-01-0,adenosine receptor agonist
24301,g06,BRD-A64977602-001-01-9,Adrenergic receptor antagonist
24301,g07,BRD-A65013509-003-03-8,Acetylcholine receptor antagonist
24301,g08,BRD-A65051990-001-03-8,vitamin K antagonist
24301,g09,BRD-A65076780-001-01-3,adrenergic receptor antagonist|prolactin inhibitor
24301,g10,BRD-A65145453-001-02-0,glutamate receptor agonist
24301,g11,BRD-A65280694-003-03-8,Dopamine receptor antagonist
24301,g12,BRD-A65440446-001-02-5,Adrenergic receptor agonist
24301,g13,BRD-A65597028-003-02-4,Adrenergic receptor antagonist
24301,g14,BRD-A65615053-003-01-4,Serotonin receptor antagonist
24301,g15,BRD-A65671304-001-02-6,angiotensin receptor antagonist
24301,g17,BRD-A66025870-237-05-1,bacterial cell wall synthesis inhibitor
24301,g18,BRD-A66199457-001-02-2,antineoplastic
24301,g22,BRD-A66435872-313-01-8,Histamine receptor agonist
24301,g23,BRD-A66563878-003-01-8,Adrenergic receptor agonist
24301,h01,BRD-A66927094-001-01-7,Dopamine receptor antagonist
24301,h07,BRD-A67552019-001-02-2,ATPase inhibitor
24301,h09,BRD-A67862938-034-04-0,Adrenergic receptor antagonist
24301,h10,BRD-A68281735-001-02-0,Leukotriene receptor antagonist
24301,h12,BRD-A68723818-050-04-4,Histamine receptor antagonist
24301,h13,BRD-A68888262-003-02-9,histamine receptor antagonist
24301,h14,BRD-A68929948-001-01-9,antiamyloidogenic agent|gamma secretase inhibitor
24301,h15,BRD-A69636825-003-02-1,Calcium channel blocker
24301,h17,BRD-A69777949-001-04-4,topoisomerase inhibitor
24301,h18,BRD-A69786436-003-02-5,acetylcholine receptor antagonist
24301,h23,BRD-A70083328-001-02-9,Acetylcholinesterase inhibitor
24301,h24,BRD-A70268693-103-01-9,Acetylcholine receptor agonist
24301,i01,BRD-A70407468-001-01-2,adenosine receptor antagonist
24301,i02,BRD-A70514680-003-03-9,Local anesthetic
24301,i03,BRD-A70649075-008-04-3,sterol demethylase inhibitor
24301,i08,BRD-A71157293-003-03-5,Vitamin B
24301,i09,BRD-A71203467-001-01-5,Dopamine receptor antagonist
24301,i10,BRD-A71774530-001-01-8,chitin inhibitor
24301,i12,BRD-A71816415-236-02-7,HMGCR inhibitor
24301,i13,BRD-A72066420-001-01-1,PPAR receptor antagonist
24301,i14,BRD-A72483914-001-01-1,Serotonin receptor antagonist
24301,i15,BRD-A72596465-001-01-3,PPAR receptor antagonist
24301,i16,BRD-A72703248-001-02-7,calcium channel blocker|cytochrome P450 inhibitor
24301,i17,BRD-A72711497-236-02-0,bacterial permeability inducer
24301,i18,BRD-A72988804-001-03-8,Cyclooxygenase inhibitor
24301,i19,BRD-A73368467-003-02-8,Histamine receptor antagonist
24301,i23,BRD-A73859745-236-01-8,Apoptosis stimulant
24301,j02,BRD-A74667430-001-04-6,Cyclooxygenase inhibitor
24301,j03,BRD-A74904029-001-04-0,Casein kinase inhibitor
24301,j07,BRD-A74980173-001-02-8,Bacterial DNA gyrase inhibitor
24301,j09,BRD-A75478957-001-01-6,collagenase inhibitor|metalloproteinase inhibitor|stromelysin inhibitor
24301,j10,BRD-A75552914-001-04-4,Cyclooxygenase inhibitor
24301,j12,BRD-A75769826-003-01-3,opioid receptor antagonist
24301,j13,BRD-A75817871-001-02-6,ATPase inhibitor
24301,j14,BRD-A75850590-003-04-9,bacterial DNA gyrase inhibitor
24301,j16,BRD-A76093993-001-01-8,Potassium channel activator
24301,j24,BRD-A77291778-003-04-8,acetylcholine receptor antagonist
24301,k01,BRD-A77299732-001-01-6,Eukaryotic translation initiation factor inhibitor
24301,k02,BRD-A77349281-001-02-2,heparanase inhibitor|tyrosine phosphatase inhibitor
24301,k06,BRD-A78295502-337-03-5,anti-arrhythmia agent
24301,k10,BRD-A78377521-001-02-2,Kinesin-like spindle protein inhibitor
24301,k11,BRD-A78877355-003-03-6,Cyclooxygenase inhibitor
24301,k12,BRD-A78942461-003-01-3,Adrenergic receptor antagonist
24301,k13,BRD-A79226577-003-01-1,serotonin receptor antagonist|polarization inhibitor|sodium channel blocker
24301,k17,BRD-A79672927-001-04-1,Acetylcholine receptor antagonist
24301,k18,BRD-A79981887-003-04-0,adrenergic receptor agonist
24301,k19,BRD-A80017228-001-04-2,Sodium/potassium/chloride transporter inhibitor
24301,k21,BRD-A80213327-305-01-8,Ras GTPase inhibitor
24301,k22,BRD-A80594172-001-02-0,glucocorticoid receptor agonist
24301,l01,BRD-A80641450-001-01-4,Endothelin receptor antagonist
24301,l05,BRD-A81177136-001-03-6,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist
24301,l10,BRD-A81615860-001-02-9,tryptophan hydroxylase inhibitor
24301,l11,BRD-A81795050-003-01-7,oxidosqualene cyclase inhibitor
24301,l12,BRD-A81866333-003-01-5,Adenosine receptor agonist
24301,l13,BRD-A82238138-001-01-7,glucocorticoid receptor agonist
24301,l17,BRD-A82371568-001-01-5,ribonucleoside reductase inhibitor|DNA polymerase inhibitor|DNA repair enzyme inhibitor|DNA synthesis inhibitor|ribonucleotide reductase inhibitor
24301,l19,BRD-A82590476-001-01-1,tachykinin antagonist
24301,l20,BRD-A82656074-003-01-2,opioid receptor antagonist
24301,l22,BRD-A83326220-001-02-6,Nitric oxide production inhibitor
24301,m02,BRD-A83431637-001-01-3,Cytochrome P450 inhibitor
24301,m04,BRD-A83695761-001-01-1,Potassium channel blocker
24301,m05,BRD-A83855350-003-01-4,Opioid receptor antagonist
24301,m07,BRD-A83937277-001-03-0,Hydantoin antiepileptic
24301,m08,BRD-A84174393-001-02-0,Cyclooxygenase inhibitor
24301,m11,BRD-A84174873-001-06-0,benzodiazepine receptor agonist
24301,m12,BRD-A84389091-001-01-1,GABA receptor inverse agonist
24301,m15,BRD-A84389633-001-01-6,serotonin receptor antagonist
24301,m19,BRD-A85137183-001-01-2,bacterial cell wall synthesis inhibitor
24301,m21,BRD-A85234536-001-04-5,Adenosine receptor agonist
24301,m22,BRD-A85280935-003-01-7,Dopamine receptor agonist
24301,m23,BRD-A85472596-001-01-4,Prostanoid receptor antagonist
24301,m24,BRD-A85587465-001-01-7,Serotonin receptor antagonist
24301,n01,BRD-A86044036-001-04-2,cyclooxygenase inhibitor
24301,n06,BRD-A87479750-001-01-9,Cyclooxygenase inhibitor
24301,n08,BRD-A87719232-001-02-4,Cyclooxygenase inhibitor
24301,n11,BRD-A88254928-001-04-6,adrenergic receptor agonist
24301,n12,BRD-A88282067-001-02-2,Antiarrhythmic
24301,n15,BRD-A88548664-001-01-5,dopamine receptor agonist
24301,n18,BRD-A89434049-001-02-1,ATPase inhibitor
24301,n19,BRD-A89585551-003-03-4,adenosine receptor antagonist|hemoglobin antagonist
24301,n20,BRD-A89672324-001-02-2,GABA receptor antagonist
24301,n22,BRD-A89947015-001-01-4,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor
24301,n24,BRD-A90311807-236-01-4,Dehydropeptidase inhibitor
24301,o01,BRD-A90462498-003-02-1,antineoplastic
24301,o02,BRD-A90490067-001-01-9,estrogen receptor antagonist|DNA directed DNA polymerase inhibitor|soluble epoxide hydrolase inhibitor
24301,o03,BRD-A90515964-001-05-8,expectorant
24301,o04,BRD-A90799790-001-04-1,calcium channel blocker
24301,o06,BRD-A91008255-001-02-8,calcium channel blocker
24301,o08,BRD-A91699651-316-04-2,Antimalarial
24301,o09,BRD-A91866971-001-02-2,Thromboxane receptor antagonist
24301,o13,BRD-A92161634-001-02-6,Acetylcholine receptor antagonist
24301,o14,BRD-A92585442-237-01-0,Cytochrome P450 inhibitor
24301,o15,BRD-A92670106-003-03-9,Sodium channel blocker
24301,o16,BRD-A92826379-009-02-6,Sodium channel blocker
24301,o18,BRD-A93000692-001-03-2,PPAR receptor agonist
24301,o19,BRD-A93206962-001-01-2,adrenergic receptor agonist|adrenergic receptor partial agonist
24301,o20,BRD-A93255169-001-06-9,TNF production inhibitor
24301,o24,BRD-A93477898-001-01-8,caspase activator
24301,p01,BRD-A93659613-051-03-6,Opioid receptor agonist
24301,p02,BRD-A93739713-065-02-7,muscarinic antagonist
24301,p05,BRD-A94413429-003-01-6,neuropeptide receptor antagonist
24301,p06,BRD-A94543220-001-02-3,Sterol demethylase inhibitor
24301,p07,BRD-A94624445-236-02-2,adenosine receptor agonist|cAMP stimulant
24301,p08,BRD-A94669766-001-02-6,Aromatase inhibitor
24301,p10,BRD-A94709349-001-02-6,Muscle relaxant
24301,p13,BRD-A95096829-300-01-4,dopamine receptor antagonist
24301,p14,BRD-A95207036-001-02-8,androgen receptor antagonist
24301,p15,BRD-A95445494-001-02-9,interleukin synthesis inhibitor|sodium/glucose cotransporter inhibitor
24301,p16,BRD-A95513702-001-02-2,aromatase inhibitor
24301,p17,BRD-A95696066-003-06-2,Norepinephrine reuptake inhibitor
24301,p18,BRD-A95869247-001-03-8,thiazide diuretic
24301,p19,BRD-A95939040-008-03-3,sterol demethylase inhibitor
24301,p20,BRD-A96456596-001-01-4,Leukotriene receptor antagonist
24301,p21,BRD-A96485169-001-02-8,Aldose reductase inhibitor
24301,p23,BRD-A96882008-001-01-3,Tachykinin antagonist
24301,p24,BRD-A96897502-001-02-0,lipid peroxidase inhibitor
24311,a01,BRD-K40782193-003-01-1,sodium channel blocker
24311,a02,BRD-K40887525-001-02-9,serotonin receptor antagonist
24311,a03,BRD-K40901640-001-01-0,serotonin receptor antagonist
24311,a04,BRD-K40905133-001-02-3,sodium channel blocker
24311,a05,BRD-K40965114-001-01-2,Adrenergic receptor antagonist
24311,a06,BRD-K40990712-001-02-4,gonadotropin releasing factor hormone receptor antagonist|sodium/hydrogen antiport inhibitor|sodium/hydrogen exchanger inhibitor|urokinase inhibitor
24311,a07,BRD-K41143549-003-01-6,glutamate receptor antagonist
24311,a08,BRD-K41337261-001-01-4,Src and Abl inhibitor|vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor
24311,a09,BRD-K41406082-001-04-8,PABA antagonist
24311,a11,BRD-K41445866-001-03-0,Chloride channel agonist
24311,a12,BRD-K41524689-001-05-2,cyclooxygenase inhibitor
24311,a15,BRD-K41564320-001-01-2,tyrosine kinase inhibitor
24311,a16,BRD-K41567364-001-01-2,orexin receptor antagonist
24311,a19,BRD-K41707108-001-02-3,Phosphoenolpyruvate carboxylase activator
24311,a20,BRD-K41713976-001-02-0,potassium channel blocker
24311,a23,BRD-K41868777-003-02-9,calmodulin antagonist
24311,b01,BRD-K41876534-001-02-0,carbonic anhydrase inhibitor
24311,b02,BRD-K41996876-001-05-5,EGFR inhibitor
24311,b03,BRD-K42098891-003-03-1,tricyclic antidepressant
24311,b04,BRD-K42221274-001-01-4,GAT inhibitor
24311,b05,BRD-K42348709-003-04-0,adrenergic receptor agonist|serotonin receptor agonist
24311,b07,BRD-K42452249-001-01-7,p38 MAPK inhibitor
24311,b08,BRD-K42500029-001-01-9,"MAP kinase inhibitor|MAPK-interacting kinase inhibitor,"
24311,b10,BRD-K42635745-001-02-4,adrenergic receptor antagonist
24311,b12,BRD-K42679050-001-01-3,potassium channel activator|potassium channel agonist
24311,b16,BRD-K42748308-300-01-2,acetylcholine release enhancer|potassium channel blocker|voltage-gated potassium channel blocker
24311,b18,BRD-K43068349-001-01-9,TRPV antagonist
24311,b19,BRD-K43149758-001-04-5,Androgen receptor agonist
24311,b21,BRD-K43245338-001-02-4,calpain inhibitor|cathepsin inhibitor
24311,b22,BRD-K43290182-001-01-9,Serotonin receptor antagonist
24311,b23,BRD-K43330982-001-01-5,lysophospholipid receptor antagonist
24311,b24,BRD-K43389675-003-02-7,RNA synthesis inhibitor|topoisomerase inhibitor
24311,c01,BRD-K43405658-001-01-8,protein tyrosine kinase inhibitor
24311,c02,BRD-K43457670-001-04-7,carbonic anhydrase inhibitor
24311,c03,BRD-K43468059-001-02-9,Mycotoxin
24311,c05,BRD-K43736954-001-03-3,glucocorticoid receptor agonist
24311,c06,BRD-K43744935-048-01-6,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)|estrogen receptor agonist|estrogen receptor modulator|PKC inhibitor
24311,c07,BRD-K43796186-001-01-1,EGFR inhibitor
24311,c08,BRD-K43860855-065-03-6,antineoplastic agent
24311,c09,BRD-K44067360-001-06-3,chloride channel blocker
24311,c10,BRD-K44084986-001-03-9,rho associated kinase inhibitor
24311,c18,BRD-K44849676-001-03-0,TRPV agonist
24311,c19,BRD-K44876623-001-01-1,Benzodiazepine receptor agonist
24311,c20,BRD-K44899736-003-02-1,Monoamine oxidase inhibitor
24311,c22,BRD-K45033733-001-02-3,DNA polymerase inhibitor
24311,c24,BRD-K45068323-003-01-3,Calmodulin antagonist
24311,d02,BRD-K45117373-001-01-1,potassium channel activator|potassium channel agonist
24311,d03,BRD-K45158365-001-02-3,angiotensin receptor antagonist
24311,d04,BRD-K45296539-003-01-0,Adrenergic receptor agonist
24311,d05,BRD-K45330754-001-04-3,estrogen receptor agonist
24311,d06,BRD-K45401373-001-05-0,Apoptosis stimulant
24311,d07,BRD-K45435259-001-01-6,Dopamine receptor antagonist
24311,d09,BRD-K45479396-001-01-8,Serotonin receptor agonist
24311,d13,BRD-K45542189-048-04-9,Lipoxygenase inhibitor
24311,d14,BRD-K45662124-001-01-8,dopamine receptor ligand
24311,d17,BRD-K45861246-001-04-3,Dopamine receptor antagonist
24311,d19,BRD-K46018455-001-06-0,PPAR receptor agonist
24311,d20,BRD-K46137903-001-03-3,phospholipase activator
24311,d21,BRD-K46142322-003-01-6,serotonin receptor partial agonist
24311,d22,BRD-K46211610-003-05-1,Adrenergic receptor antagonist
24311,d23,BRD-K46317332-003-04-6,Nitric oxide synthase inhibitor
24311,d24,BRD-K46384212-001-01-1,phospholipase activator
24311,e03,BRD-K46424862-001-04-2,Monoamine oxidase inhibitor
24311,e04,BRD-K46435977-003-01-2,DNA polymerase inhibitor
24311,e05,BRD-K46441700-001-01-8,serotonin receptor antagonist
24311,e06,BRD-K46469693-001-01-8,adenosine receptor antagonist
24311,e08,BRD-K46556543-237-03-0,Mineralocorticoid receptor antagonist
24311,e13,BRD-K46766488-003-01-2,Serotonin receptor agonist
24311,e14,BRD-K46862739-001-03-6,cytochrome P450 inhibitor
24311,e15,BRD-K46937689-001-05-1,Cyclooxygenase inhibitor
24311,e16,BRD-K47105409-001-05-3,JAK inhibitor
24311,e20,BRD-K47150025-001-01-2,PDGFR alpha and c-Kit inhibitor|vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor|VEGFR inhibitor
24311,e21,BRD-K47192521-001-02-1,Platelet aggregation inhibitor
24311,e22,BRD-K47207162-312-02-2,Serotonin reuptake inhibitor
24311,e23,BRD-K47278471-003-04-0,Histamine receptor antagonist
24311,e24,BRD-K47323024-003-04-6,Histamine receptor antagonist
24311,f03,BRD-K47328134-001-02-0,heparin activation inhibitor
24311,f07,BRD-K47598052-001-04-2,src inhibitor
24311,f08,BRD-K47608922-001-02-1,chelating agent
24311,f11,BRD-K47631482-003-02-1,Mucolytic agent
24311,f12,BRD-K47635719-001-03-9,glucocorticoid receptor agonist
24311,f13,BRD-K47639036-003-03-3,Acetylcholine receptor antagonist
24311,f14,BRD-K47659338-003-01-0,serotonin receptor agonist
24311,f15,BRD-K47693913-001-02-4,Furoquinoline alkaloid
24311,f16,BRD-K47717570-304-01-5,Glutamate receptor antagonist
24311,f21,BRD-K47869605-001-04-9,microtubule inhibitor|tubulin polymerization inhibitor
24311,f23,BRD-K47936004-001-01-9,dopamine receptor agonist
24311,f24,BRD-K47943470-001-02-8,EGFR inhibitor
24311,g05,BRD-K48168960-001-05-1,Thyroid peroxidase inhibitor
24311,g07,BRD-K48300629-001-03-8,Sodium channel blocker
24311,g11,BRD-K48692744-001-01-2,PARP inhibitor
24311,g12,BRD-K48722258-300-04-5,adenosine reuptake inhibitor
24311,g13,BRD-K48735772-001-01-4,EGFR inhibitor|epidermal growth factor receptor (EGFR) inhibitor
24311,g15,BRD-K49027941-237-01-1,Adenosine receptor antagonist
24311,g16,BRD-K49049886-001-03-8,adenosine receptor antagonist
24311,g17,BRD-K49111258-001-02-8,Adrenergic receptor antagonist
24311,g23,BRD-K49294207-300-01-2,EGFR inhibitor
24311,g24,BRD-K49448285-001-01-3,CDK inhibitor
24311,h01,BRD-K49481516-004-03-5,Acetylcholinesterase inhibitor
24311,h02,BRD-K49519092-303-01-4,Histamine receptor agonist
24311,h05,BRD-K49577446-001-03-1,cytochrome P450 inhibitor
24311,h06,BRD-K49657628-001-02-3,EGFR inhibitor|tyrosine kinase inhibitor
24311,h07,BRD-K49671696-001-02-1,Serotonin receptor antagonist
24311,h11,BRD-K49890030-236-01-6,Glutamate receptor antagonist
24311,h12,BRD-K49945136-001-03-5,Serotonin receptor antagonist
24311,h13,BRD-K50018155-003-01-3,Serotonin receptor partial agonist
24311,h15,BRD-K50135270-001-01-9,dopamine uptake inhibitor
24311,h17,BRD-K50214219-001-02-4,PARP inhibitor
24311,h21,BRD-K50325075-001-01-3,potassium channel blocker|slow afterhyperpolarization channel blocker
24311,h22,BRD-K50388907-001-04-9,PPAR receptor agonist
24311,h23,BRD-K50398167-236-02-9,Cyclooxygenase inhibitor
24311,i01,BRD-K50417881-003-05-9,Dopamine receptor antagonist
24311,i02,BRD-K50422030-001-01-2,GABA receptor antagonist
24311,i03,BRD-K50464341-001-02-6,calmodulin antagonist
24311,i04,BRD-K50495309-001-01-2,src inhibitor
24311,i07,BRD-K50660797-001-02-8,Bacterial DNA gyrase inhibitor
24311,i08,BRD-K50836978-001-01-7,CDK inhibitor
24311,i09,BRD-K50841342-001-01-6,caspase activator
24311,i10,BRD-K50859149-001-04-7,bacterial antifolate
24311,i11,BRD-K50891186-001-01-0,dopamine receptor antagonist
24311,i14,BRD-K51276371-001-01-8,CDK inhibitor|CFTR channel activator|glycogen synthase kinase inhibitor|JNK inhibitor
24311,i15,BRD-K51318897-001-04-7,tubulin polymerization inhibitor
24311,i17,BRD-K51465424-003-03-6,adrenergic receptor agonist
24311,i18,BRD-K51476772-001-01-9,tyrosine kinase inhibitor
24311,i19,BRD-K51541829-001-01-3,Ionotropic glutamate receptor antagonist
24311,i23,BRD-K51575138-001-01-7,IKK inhibitor
24311,i24,BRD-K51671335-001-01-5,Dopamine receptor antagonist
24311,j01,BRD-K51751936-001-03-4,benzodiazepine receptor agonist
24311,j03,BRD-K51918615-303-01-1,histamine receptor antagonist|histamine receptor inhibitor|ionotropic glutamate receptor antagonist
24311,j07,BRD-K52020312-001-04-5,DNA inhibitor
24311,j08,BRD-K52075040-001-02-2,fatty acid synthase inhibitor
24311,j10,BRD-K52219182-001-01-6,Phosphodiesterase inhibitor
24311,j11,BRD-K52313696-001-01-6,HDAC inhibitor
24311,j13,BRD-K52394958-001-01-9,tachykinin antagonist
24311,j14,BRD-K52397688-001-01-9,dopamine receptor antagonist|FAAH inhibitor|serotonin receptor antagonist
24311,j15,BRD-K52459643-001-10-2,Prostanoid receptor agonist
24311,j16,BRD-K52512893-001-03-0,Prostanoid receptor antagonist
24311,j18,BRD-K52662033-001-02-6,histamine receptor agonist
24311,j19,BRD-K52721684-001-02-2,potassium channel activator
24311,j20,BRD-K52850071-001-01-2,JAK inhibitor
24311,j23,BRD-K52930707-001-04-8,ACE inhibitor
24311,k01,BRD-K52989797-001-01-1,serotonin transporter (SERT) inhibitor
24311,k03,BRD-K53123955-001-03-0,Phosphofructokinase inhibitor
24311,k05,BRD-K53263234-001-02-9,constitutive androstane receptor (CAR) agonist
24311,k06,BRD-K53318339-001-04-1,Phosphodiesterase inhibitor
24311,k09,BRD-K53523901-001-01-0,adiponectin receptor agonist|AP inhibitor|aryl hydrocarbon receptor antagonist|HIV integrase inhibitor|MEK inhibitor|NFkB pathway inhibitor|topoisomerase inhibitor
24311,k11,BRD-K53545112-304-01-6,Glutamate receptor antagonist
24311,k13,BRD-K53737926-003-04-7,Norepinephrine inhibitor
24311,k14,BRD-K53857191-001-04-5,Dopamine receptor antagonist
24311,k17,BRD-K53878242-001-02-4,phosphodiesterase inhibitor
24311,k19,BRD-K53979406-003-01-0,glycine transporter inhibitor|GlyT-1 inhibitor
24311,k20,BRD-K54094468-001-01-6,dopamine receptor antagonist
24311,k21,BRD-K54095730-001-01-5,p38 MAPK inhibitor
24311,k22,BRD-K54142781-001-02-1,Adrenergic receptor agonist
24311,l01,BRD-K54210043-001-02-0,calcium channel activator|large conductance potassium channel activator
24311,l02,BRD-K54233340-300-01-0,AMPK inhibitor|DNA damaging|TGF beta receptor inhibitor
24311,l03,BRD-K54330070-001-05-5,p38 MAPK inhibitor
24311,l04,BRD-K54411430-001-02-5,cAMP inhibitor
24311,l06,BRD-K54529596-001-04-0,ACE inhibitor
24311,l10,BRD-K54665485-001-01-2,Diacylglycerol kinase inhibitor
24311,l11,BRD-K54704028-001-01-3,glutamate receptor antagonist
24311,l12,BRD-K54708045-001-01-3,PPAR receptor agonist
24311,l13,BRD-K54759182-003-02-3,Norepinephrine reuptake inhibitor
24311,l14,BRD-K54771420-001-03-2,Cholesterol inhibitor
24311,l17,BRD-K54790157-001-03-1,DNA synthesis inhibitor
24311,l19,BRD-K55034111-066-02-3,bacterial DNA gyrase inhibitor
24311,l21,BRD-K55191674-236-03-7,Penicillin binding protein inhibitor
24311,m01,BRD-K55344148-003-01-8,Imidazoline receptor ligand
24311,m02,BRD-K55424922-001-01-4,Serotonin receptor agonist
24311,m03,BRD-K55430733-003-01-6,Serotonin receptor agonist
24311,m04,BRD-K55454768-001-01-8,voltage-independent calcium influx blocker
24311,m05,BRD-K55468218-001-04-8,dopamine receptor antagonist
24311,m06,BRD-K55529781-236-02-0,thromboxane synthase inhibitor
24311,m07,BRD-K55567017-001-02-4,alcohol dehydrogenase inhibitor
24311,m08,BRD-K55677650-003-01-1,ionotropic glutamate receptor antagonist
24311,m11,BRD-K55748775-001-01-4,ATPase inhibitor|potassium-competitive acid antagonist
24311,m16,BRD-K55930204-001-02-7,Hydantoin antiepileptic
24311,m17,BRD-K56047318-001-02-2,Triacylglycerol lipase inhibitor
24311,m18,BRD-K56064827-001-04-7,PKC inhibitor
24311,m20,BRD-K56115039-003-01-3,Imidazoline receptor ligand
24311,m22,BRD-K56403959-300-01-9,CC chemokine receptor ligand
24311,m23,BRD-K56429665-001-03-9,vitamin D receptor agonist
24311,m24,BRD-K56509348-003-01-3,Endothelin receptor antagonist
24311,n02,BRD-K56558538-003-02-8,Sodium channel blocker
24311,n03,BRD-K56596464-004-02-4,Sodium channel blocker
24311,n04,BRD-K56699285-001-03-7,dopamine receptor agonist|serotonin receptor antagonist
24311,n08,BRD-K57033106-048-02-8,Histamine receptor antagonist
24311,n11,BRD-K57179821-001-04-8,Antipruritic
24311,n12,BRD-K57222227-001-06-1,cyclooxygenase inhibitor
24311,n16,BRD-K57304726-003-03-6,Sigma receptor agonist
24311,n18,BRD-K57545991-050-03-3,angiotensin converting enzyme inhibitor
24311,n19,BRD-K57569181-001-04-4,Phosphodiesterase inhibitor
24311,n21,BRD-K57718010-001-06-9,GABA receptor antagonist
24311,n22,BRD-K57886322-001-03-4,glucocorticoid receptor agonist
24311,n23,BRD-K57926513-001-02-9,PDGFR receptor inhibitor
24311,o01,BRD-K58220566-001-02-2,PKC inhibitor|sodium channel blocker|calcium channel blocker
24311,o02,BRD-K58265391-001-03-6,diuretic
24311,o03,BRD-K58299615-001-02-7,amyloid precursor protein inhibitor|beta amyloid aggregation inhibitor
24311,o05,BRD-K58466253-003-04-1,serotonin release inhibitor
24311,o06,BRD-K58685305-001-02-2,11-beta hydroxysteroid dehydrogenase inhibitor
24311,o08,BRD-K58930050-001-01-1,glutamate receptor antagonist
24311,o09,BRD-K58938839-001-03-8,smoothened receptor antagonist|hedgehog pathway inhibitor
24311,o10,BRD-K59037100-001-04-8,lipase inhibitor
24311,o13,BRD-K59058766-003-03-7,dopamine receptor antagonist
24311,o15,BRD-K59184148-001-04-2,glycogen synthase kinase inhibitor
24311,o18,BRD-K59273480-001-01-5,adenosine reuptake inhibitor|phosphodiesterase inhibitor
24311,o20,BRD-K59332007-300-01-9,acetylcholine release enhancer|acetylcholine release stimulant|neurotransmitter agonist|voltage-gated potassium channel blocker
24311,o22,BRD-K59419204-001-01-9,cannabinoid receptor antagonist|cannabinoid receptor inhibitor
24311,o23,BRD-K59469039-001-04-9,Angiogenesis inhibitor
24311,o24,BRD-K59522102-001-04-7,monoamine oxidase inhibitor
24311,p01,BRD-K59574735-001-02-7,leukotriene synthesis inhibitor
24311,p02,BRD-K59637651-001-01-4,protein synthesis inhibitor|botulin neurotoxin inhibitor|mur synthetase inhibitor
24311,p03,BRD-K59650319-003-01-7,glutamate receptor antagonist
24311,p04,BRD-K59753853-001-01-5,glutamate receptor antagonist
24311,p06,BRD-K59851896-001-02-4,GABA release inhibitor
24311,p07,BRD-K59983611-001-05-2,bacterial antifolate
24311,p09,BRD-K60060639-005-01-4,antiarrhythmic medication
24311,p10,BRD-K60174629-001-02-2,prolyl endopeptidase inhibitor
24311,p13,BRD-K60184833-001-02-3,tyrosine kinase inhibitor
24311,p14,BRD-K60230970-001-04-3,proteasome inhibitor
24311,p15,BRD-K60274257-001-01-1,tyrosine phosphatase inhibitor
24311,p17,BRD-K60298136-001-01-7,aryl hydrocarbon receptor agonist|aryl hydrocarbon receptor ligand
24311,p18,BRD-K60476892-001-02-1,activator of soluble guanylyl cyclase|guanylate cyclase activator|hypoxia inducible factor inhibitor
24311,p19,BRD-K60511616-236-01-4,HMGCR inhibitor
24311,p20,BRD-K60640630-001-03-7,glucocorticoid receptor agonist
24311,p22,BRD-K60923938-001-02-8,sodium channel activator
24311,p23,BRD-K60932973-001-01-7,dopamine receptor agonist
24311,p24,BRD-K61097567-001-03-6,tachykinin antagonist
24305,a01,BRD-A97104540-004-04-4,adrenergic receptor agonist
24305,a04,BRD-A97479839-003-04-2,Acetylcholine receptor antagonist
24305,a05,BRD-A97701745-001-04-6,adrenergic receptor antagonist|serotonin receptor antagonist
24305,a06,BRD-A97730597-003-03-2,sodium channel blocker
24305,a07,BRD-A97739905-001-04-2,cyclooxygenase inhibitor
24305,a08,BRD-A98299281-050-03-9,calcium channel activator
24305,a09,BRD-A98378129-001-01-4,cyclooxygenase inhibitor|calcium channel blocker|calcium-activated chloride channel blocker|mucin production inhibitor
24305,a10,BRD-A98702003-304-02-2,11-beta-HSD1 inhibitor
24305,a11,BRD-A98725278-103-01-9,serotonin receptor antagonist
24305,a15,BRD-A99177642-001-02-5,acetylcholine receptor antagonist
24305,a16,BRD-A99402294-236-02-0,bacterial cell wall synthesis inhibitor
24305,a17,BRD-A99411506-002-01-3,antioxidant
24305,a18,BRD-A99449986-001-01-4,adenine nucleotide translocase inhibitor|caspase activator|neurotrophic agent
24305,a19,BRD-A99571536-001-01-0,anti-epileptic
24305,a20,BRD-K00141480-001-03-0,anti-inflammatory agent|interleukin inhibitor
24305,a21,BRD-K00184207-001-02-4,aryl hydrocarbon receptor ligand
24305,a22,BRD-K00206590-001-01-2,ATP channel activator
24305,a23,BRD-K00259736-001-03-2,microtubule inhibitor
24305,a24,BRD-K00312224-001-03-8,estrogen receptor agonist
24305,b03,BRD-K00603606-003-03-4,purinergic receptor antagonist|platelet aggregation inhibitor
24305,b04,BRD-K00610438-003-01-7,serotonin receptor antagonist|collagen stimulant
24305,b05,BRD-K00662280-001-01-1,GABA receptor agonist
24305,b06,BRD-K00673382-001-04-9,histamine receptor antagonist
24305,b07,BRD-K00675675-003-01-2,metalloproteinase inhibitor
24305,b09,BRD-K00824317-001-03-0,glucocorticoid receptor agonist
24305,b11,BRD-K01095011-001-03-5,5 alpha reductase inhibitor
24305,b15,BRD-K01244426-236-04-8,bacterial cell wall synthesis inhibitor
24305,b16,BRD-K01292756-001-06-0,dopamine receptor antagonist
24305,b19,BRD-K01567962-001-06-5,JNK inhibitor
24305,b20,BRD-K01624546-001-02-8,LTB4 inhibitor
24305,b21,BRD-K01648091-001-04-2,Dopamine receptor antagonist
24305,b22,BRD-K01663662-003-03-8,muscarinic antagonist
24305,b23,BRD-K01815685-001-02-3,aryl hydrocarbon receptor agonist
24305,c01,BRD-K01868942-001-01-3,serotonin receptor antagonist
24305,c02,BRD-K01902415-001-03-4,PPAR receptor agonist
24305,c05,BRD-K02265150-001-04-2,norepinephrine reputake inhibitor
24305,c06,BRD-K02275692-003-03-4,bacterial cell wall synthesis inhibitor
24305,c07,BRD-K02283807-003-01-4,thromboxane receptor antagonist
24305,c09,BRD-K02404261-001-02-7,Adenosine receptor antagonist
24305,c10,BRD-K02407574-001-03-0,tubulin polymerization inhibitor
24305,c14,BRD-K02581333-001-01-8,Tyrosine phosphatase inhibitor
24305,c17,BRD-K02590140-001-01-2,cannabinoid receptor antagonist
24305,c18,BRD-K02607075-333-03-6,Acetylcholine receptor antagonist
24305,c19,BRD-K02637541-001-02-4,Cyclooxygenase inhibitor
24305,c22,BRD-K02764365-001-03-7,anthelmintic agent
24305,c23,BRD-K02867583-300-04-8,serotonin reuptake inhibitor
24305,c24,BRD-K02900412-001-02-2,protein synthesis inhibitor
24305,d01,BRD-K02953697-001-01-9,cytochrome P450 inhibitor
24305,d03,BRD-K03015355-003-01-5,adenylyl cyclase activator|Adenylate cyclase stimulant|growth hormone receptor agonist|phosphokinase stimulant
24305,d04,BRD-K03067624-300-02-9,protein synthesis inhibitor
24305,d06,BRD-K03109492-001-01-4,CDC inhibitor
24305,d07,BRD-K03384561-001-01-9,Angiogenesis inhibitor
24305,d08,BRD-K03440695-001-02-6,Acetylcholine receptor antagonist
24305,d13,BRD-K03600606-001-02-3,Beta secretase inhibitor
24305,d14,BRD-K03602135-236-02-1,HMGCR inhibitor
24305,d17,BRD-K03642198-300-01-7,hedgehog pathway inhibitor
24305,d18,BRD-K03670461-001-02-0,EGFR inhibitor
24305,d19,BRD-K03842655-001-02-1,potassium channel blocker
24305,d20,BRD-K03981224-001-02-9,Progestogen hormone
24305,d21,BRD-K04010869-001-02-6,HSP inducer|NFKB pathway inhibitor
24305,d22,BRD-K04046242-001-03-6,Estrogen receptor agonist
24305,d23,BRD-K04111260-001-01-9,Dopamine receptor antagonist
24305,d24,BRD-K04170657-001-02-4,Ras GTPase inhibitor
24305,e03,BRD-K04185004-003-03-6,Local anesthetic
24305,e04,BRD-K04414442-001-03-4,tachykinin antagonist
24305,e05,BRD-K04430056-001-02-9,nitric oxide synthase inhibitor
24305,e06,BRD-K04704168-003-03-6,HCV inhibitor
24305,e08,BRD-K04976539-001-01-0,PKC inhibitor|src inhibitor
24305,e11,BRD-K05151076-001-01-8,estrogen receptor antagonist
24305,e12,BRD-K05181084-003-02-9,dopamine receptor antagonist
24305,e13,BRD-K05181463-001-01-6,Dopamine receptor antagonist
24305,e16,BRD-K05434375-001-04-0,calcium channel blocker
24305,e19,BRD-K05464208-001-01-6,p38 MAPK inhibitor
24305,e21,BRD-K05653692-001-02-5,Glucosyltransferase inhibitor
24305,e22,BRD-K05673000-323-02-8,Bacterial cell wall synthesis inhibitor
24305,e23,BRD-K05901394-001-01-1,Dopamine receptor agonist
24305,e24,BRD-K05906022-001-02-8,HIV protease inhibitor
24305,f03,BRD-K05977355-001-02-6,sterol demethylase inhibitor
24305,f05,BRD-K06014311-001-01-2,Melatonin receptor antagonist
24305,f06,BRD-K06024458-001-01-4,cannabinoid receptor agonist
24305,f07,BRD-K06147391-003-01-9,Acetylcholine receptor antagonist
24305,f08,BRD-K06159959-001-01-2,Inhibitor of the binding of homoquinolinic acid to non-NMDA sensitive sites
24305,f12,BRD-K06208435-001-02-9,Calcium channel blocker
24305,f13,BRD-K06221026-001-03-5,Cyclooxygenase inhibitor
24305,f14,BRD-K06234293-001-01-8,TGF beta receptor inhibitor|p38 MAPK inhibitor
24305,f15,BRD-K06426971-001-01-9,histone lyinse methyltransferase inhibitor
24305,f19,BRD-K06467078-001-01-5,Adrenergic receptor antagonist
24305,f20,BRD-K06543683-001-03-6,PKC inhibitor|glycogen synthase kinase inhibitor|leucine rich repeat kinase inhibitor|SIRT inhibitor
24305,f21,BRD-K06593056-001-01-4,retinoid receptor agonist
24305,f22,BRD-K06753942-001-02-0,MEK inhibitor
24305,f23,BRD-K06854232-001-03-3,retinoid receptor agonist
24305,f24,BRD-K06980535-003-04-4,Dopamine receptor antagonist
24305,g02,BRD-K07117950-001-02-6,CDK inhibitor
24305,g06,BRD-K07212038-001-02-1,Mast cell stabilizer
24305,g07,BRD-K07220430-001-03-6,Calcium channel blocker
24305,g08,BRD-K07325606-001-02-3,PKC inhibitor
24305,g10,BRD-K07507905-236-01-8,adrenergic receptor agonist
24305,g13,BRD-K07691486-001-05-6,CDK inhibitor
24305,g14,BRD-K07888196-001-01-8,IGF-1 inhibitor
24305,g15,BRD-K08078237-001-04-0,calcium channel blocker
24305,g16,BRD-K08109516-001-01-1,glutamate receptor antagonist
24305,g17,BRD-K08115555-001-02-8,catechol O methyltransferase inhibitor|tumor necrosis factor inhibitor
24305,g18,BRD-K08132273-001-01-6,EGFR inhibitor
24305,g22,BRD-K08219523-001-01-9,Serotonin receptor agonist
24305,g23,BRD-K08252256-236-04-9,Cyclooxygenase inhibitor
24305,g24,BRD-K08287586-001-03-6,DNA synthesis inhibitor
24305,h01,BRD-K08316444-001-02-7,inhibitor of mitochondrial electron transport
24305,h05,BRD-K08438429-001-01-0,glucosylceramidase inhibitor|somatostatin receptor agonist
24305,h07,BRD-K08554278-001-02-4,DNA binding agent
24305,h09,BRD-K08619574-334-03-9,Dopamine receptor antagonist
24305,h10,BRD-K08619838-300-03-2,Acetylcholine receptor agonist
24305,h11,BRD-K08640512-003-01-5,Adrenergic receptor antagonist
24305,h13,BRD-K08806317-050-03-6,Adrenergic receptor antagonist
24305,h14,BRD-K08890269-001-01-5,Sodium channel blocker
24305,h16,BRD-K08973992-001-01-3,Oxidative stress inducer
24305,h17,BRD-K08996725-313-01-7,histamine receptor antagonist
24305,h18,BRD-K08998509-001-01-6,dopamine receptor antagonist|serotonin receptor antagonist
24305,h23,BRD-K09132007-001-01-8,casein kinase inhibitor|TGF beta receptor inhibitor
24305,i01,BRD-K09255212-001-03-4,chelating agent
24305,i02,BRD-K09397065-001-01-6,Serotonin receptor agonist
24305,i03,BRD-K09416995-001-16-7,HMGCR inhibitor
24305,i04,BRD-K09471561-001-02-6,bacterial DNA gyrase inhibitor
24305,i07,BRD-K09537769-001-01-6,DNA dependent protein kinase inhibitor|mTOR inhibitor|PI3K inhibitor
24305,i08,BRD-K09549677-300-01-8,T-type calcium channel blocker|angiogenesis inhibitor|calcium channel blocker|calcium channel inhibitor|L-type calcium channel blocker|sodium channel blocker
24305,i09,BRD-K09598619-065-01-5,tubulin polymerization inhibitor
24305,i10,BRD-K09631521-001-02-4,cytochrome P450 inhibitor
24305,i11,BRD-K09635134-001-02-4,negative control for D-erythro-MAPP
24305,i12,BRD-K09635314-001-01-8,phospholipase activator
24305,i13,BRD-K09668667-001-02-0,Carcinogen
24305,i14,BRD-K09764130-001-02-6,Cannabinoid receptor agonist
24305,i15,BRD-K09778810-001-01-5,inositol monophosphatase inhibitor
24305,i17,BRD-K09963420-066-03-4,HIV protease inhibitor
24305,i18,BRD-K10042277-001-02-7,cetylcholine receptor agonist|dopamine receptor agonist|dopamine receptor antagonist|dopamine receptor partial agonist|serotonin receptor antagonist|serotonin receptor inverse agonist
24305,i19,BRD-K10065684-001-02-5,laxative
24305,i23,BRD-K10176267-001-01-7,glutamate receptor antagonist
24305,i24,BRD-K10177585-003-01-6,Adenosine receptor antagonist
24305,j01,BRD-K10207760-236-03-0,bacterial permeability inducer
24305,j02,BRD-K10314788-003-04-4,nootropic agent
24305,j07,BRD-K10670311-001-04-9,Antirheumatic
24305,j10,BRD-K10705233-001-01-4,Cannabinoid receptor agonist
24305,j11,BRD-K10843433-001-02-9,Cyclooxygenase inhibitor
24305,j12,BRD-K10870738-001-02-4,lipoxygenase inhibitor
24305,j13,BRD-K10974103-001-03-9,Protein synthesis inhibitor
24305,j15,BRD-K10995081-001-05-5,Dopamine receptor antagonist
24305,j16,BRD-K11107424-001-01-1,histamine receptor antagonist
24305,j17,BRD-K11129031-001-04-4,Lipoprotein lipase activator
24305,j18,BRD-K11158509-001-02-0,EGFR inhibitor
24305,j19,BRD-K11163873-001-02-8,PARP inhibitor
24305,j24,BRD-K11298197-001-03-9,protein synthesis inhibitor
24305,k01,BRD-K11373525-003-01-3,Angiotensin receptor antagonist
24305,k02,BRD-K11399644-003-03-0,AMPK activator
24305,k04,BRD-K11634954-300-01-8,dopamine uptake inhibitor
24305,k06,BRD-K11696279-003-01-5,Imidazoline receptor agonist
24305,k09,BRD-K11717138-001-03-0,chloride channel blocker
24305,k10,BRD-K11742128-003-04-4,histamine receptor antagonist
24305,k13,BRD-K11911061-003-02-8,serotonin receptor antagonist
24305,k14,BRD-K11927976-050-01-1,mediator release inhibitor|syk inhibitor
24305,k17,BRD-K12102668-001-04-0,Monoamine oxidase inhibitor
24305,k18,BRD-K12120659-305-01-4,Integrin antagonist
24305,k20,BRD-K12184470-300-01-8,calcium channel blocker|T-type calcium channel blocker
24305,k21,BRD-K12219985-001-04-8,Sulfonylurea
24305,k22,BRD-K12244279-001-01-7,MEK inhibitor
24305,l03,BRD-K12357156-001-01-5,EGFR inhibitor|ErbB2 inhibitor|JAK2 inhibitor
24305,l04,BRD-K12513978-001-04-3,cyclooxygenase inhibitor
24305,l05,BRD-K12539581-001-06-2,tubulin polymerization inhibitor
24305,l12,BRD-K12932420-001-01-5,Phosphodiesterase inhibitor
24305,l14,BRD-K12994359-001-02-8,Cyclooxygenase inhibitor
24305,l19,BRD-K13169950-001-04-5,HDAC inhibitor
24305,l20,BRD-K13211965-001-01-4,dopamine receptor antagonist
24305,l21,BRD-K13261168-001-01-4,Dopamine receptor agonist
24305,m01,BRD-K13533483-001-03-0,calcineurin inhibitor|cyclophilin inhibitor|immunosuppressant|insulin expression inhibitor|T cell inhibitor
24305,m02,BRD-K13544237-001-01-0,dopamine receptor agonist|antiamyloidogenic agent
24305,m03,BRD-K13571841-001-03-7,Aspartic protease inhibitor
24305,m04,BRD-K13642330-001-02-6,cytochrome P450 inhibitor
24305,m05,BRD-K13819402-003-02-9,Acetylcholinesterase inhibitor
24305,m07,BRD-K13994703-001-02-0,adrenergic receptor antagonist
24305,m11,BRD-K14200658-001-02-6,Vesicular monoamine transporter inhibitor
24305,m12,BRD-K14221570-236-01-1,HIV entry inhibitor
24305,m16,BRD-K14282469-001-01-5,serotonin receptor antagonist
24305,m18,BRD-K14441456-001-01-2,EGFR inhibitor
24305,m19,BRD-K14496212-001-01-1,dopamine receptor agonist
24305,m21,BRD-K14618467-003-01-8,IKK inhibitor
24305,n01,BRD-K14765469-003-02-3,acetylcholinesterase inhibitor
24305,n02,BRD-K14767410-001-01-5,cyclooxygenase inhibitor
24305,n03,BRD-K14807180-001-01-7,serotonin receptor antagonist
24305,n04,BRD-K14821540-001-02-1,mitochondrial oxidative phosphorylation uncoupler
24305,n06,BRD-K14888893-001-02-3,KATP activator
24305,n07,BRD-K14965640-001-03-3,Cyclooxygenase inhibitor
24305,n08,BRD-K14993104-001-03-4,Chemoreceptor agonist
24305,n11,BRD-K15025317-001-04-5,NFkB pathway inhibitor
24305,n12,BRD-K15164005-001-01-5,carboxylesterase inhibitor
24305,n15,BRD-K15196155-001-01-5,Hydroxycarboxylic acid receptor agonist
24305,n17,BRD-K15519488-001-01-6,dopamine receptor agonist
24305,n19,BRD-K15567136-001-01-1,phosphodiesterase inhibitor
24305,n21,BRD-K15588452-003-01-9,serotonin receptor antagonist
24305,n22,BRD-K15601958-001-01-3,Lysophospholipid receptor agonist
24305,n23,BRD-K15616905-001-01-5,mitochondrial oxidative phosphorylation uncoupler
24305,n24,BRD-K15715913-001-01-5,dopamine receptor antagonist|serotonin receptor antagonist
24305,o01,BRD-K15766189-001-02-3,bacterial cell wall synthesis inhibitor
24305,o02,BRD-K15791587-003-01-7,tachykinin antagonist
24305,o04,BRD-K15868788-001-01-4,Serotonin receptor antagonist
24305,o05,BRD-K15916496-001-04-8,cytochrome P450 inhibitor|imidazoline receptor ligand
24305,o06,BRD-K15933101-003-01-2,dopamine receptor agonist|dopamine receptor modulator
24305,o07,BRD-K15935639-001-02-0,PGPH inhibitor|proteasome inhibitor
24305,o08,BRD-K15957397-001-02-6,CDC inhibitor
24305,o09,BRD-K16195444-001-01-7,Adrenergic receptor agonist
24305,o10,BRD-K16444452-001-03-4,phosphodiesterase inhibitor|leukotriene receptor antagonist|toll-like receptor antagonist|macrophage migration inhibiting factor inhibitor|macrophage migration inhibiting factor modulator|mediator release inhibitor|nitric oxide synthase inhibitor
24305,o14,BRD-K16485616-001-01-4,HDAC inhibitor|cell cycle inhibitor
24305,o15,BRD-K16508793-001-01-8,benzodiazepine receptor agonist
24305,o16,BRD-K16542329-001-05-1,phosphodiesterase inhibitor
24305,o17,BRD-K16551401-003-01-8,serotonin receptor agonist
24305,o19,BRD-K16604360-001-01-8,antiamyloidogenic agent|dopamine receptor agonist
24305,o20,BRD-K16664969-001-01-7,FLT3 inhibitor|tyrosine kinase inhibitor
24305,o22,BRD-K16977723-001-01-0,EGFR inhibitor
24305,o23,BRD-K17016787-001-03-5,estrogen receptor agonist
24305,p01,BRD-K17140735-300-01-6,Proteasome inhibitor
24305,p03,BRD-K17294426-050-04-0,dopamine receptor antagonist
24305,p04,BRD-K17368287-001-03-5,11-beta hydroxysteroid dehydrogenase inhibitor
24305,p05,BRD-K17378184-300-03-4,Dopamine receptor agonist
24305,p06,BRD-K17415526-001-02-7,protein tyrosine kinase inhibitor
24305,p07,BRD-K17497770-001-01-0,EGFR inhibitor|src inhibitor
24305,p08,BRD-K17565903-066-04-1,muscle relaxant
24305,p09,BRD-K17674993-001-03-1,Corticosteroid agonist
24305,p10,BRD-K17693482-001-03-9,potassium channel activator
24305,p14,BRD-K17743125-001-01-9,HDAC inhibitor|cell cycle inhibitor
24305,p15,BRD-K17743697-066-01-0,sodium/calcium exchange inhibitor
24305,p16,BRD-K17796732-001-02-0,cannabinoid receptor agonist
24305,p19,BRD-K17894950-001-04-4,CDK inhibitor|glycogen synthase kinase inhibitor
24305,p20,BRD-K17896185-001-01-2,opioid receptor agonist
24305,p21,BRD-K18059238-001-02-1,cyclooxygenase inhibitor|prostanoid receptor stimulant|thromboxane synthase stimulant
24305,p24,BRD-K18194590-065-02-3,adrenergic receptor agonist
25945,a01,BRD-A44966919-001-03-1,acetylcholine receptor antagonist
25945,a02,BRD-A45140972-060-02-4,bacterial 50S ribosomal subunit inhibitor
25945,a03,BRD-A45499626-001-01-0,Glutamate receptor antagonist
25945,a04,BRD-A45543382-001-02-7,radiopaque medium
25945,a05,BRD-A46066006-004-04-4,muscarinic antagonist
25945,a10,BRD-A47144777-001-02-5,HSP90 inhibitor
25945,a11,BRD-A47494775-003-03-0,Adrenergic receptor agonist
25945,a12,BRD-A47513740-001-02-5,protein phosphatase inhibitor
25945,a15,BRD-A47598013-004-02-0,selective serotonin reuptake inhibitor (SSRI)
25945,a17,BRD-A48257147-001-01-9,glutamate receptor agonist
25945,a18,BRD-A48300215-001-01-4,sodium channel blocker
25945,a21,BRD-A48809242-001-02-9,adenosine receptor agonist
25945,a23,BRD-A49046702-001-01-2,GABA uptake inhibitor
25945,a24,BRD-A49172652-001-13-1,ATPase inhibitor
25945,b01,BRD-A49225603-045-02-7,histamine receptor agonist
25945,b02,BRD-A49358627-001-03-9,PPAR receptor agonist
25945,b03,BRD-A49370193-051-01-7,serotonin receptor agonist
25945,b05,BRD-A49680073-001-01-9,JAK inhibitor|Lipocortin synthesis stimulant|STAT inhibitor
25945,b06,BRD-A49734948-001-03-3,Plant alkaloid
25945,b07,BRD-A49906757-004-03-1,Acetylcholine receptor antagonist
25945,b09,BRD-A50157456-065-02-4,adrenergic receptor agonist
25945,b10,BRD-A50311610-300-04-7,CAR agonist
25945,b11,BRD-A50675702-001-03-0,chloride channel blocker|GABA gated chloride channel blocker
25945,b12,BRD-A50684349-001-01-5,dopamine receptor agonist
25945,b15,BRD-A50737080-001-01-4,ATR kinase inhibitor
25945,b16,BRD-A50764878-001-01-4,serotonin receptor antagonist
25945,b19,BRD-A51410489-001-01-4,adrenergic receptor antagonist
25945,b21,BRD-A51714012-001-02-3,Adrenergic inhibitor
25945,b22,BRD-A51820102-008-04-0,Bacterial cell wall synthesis inhibitor
25945,b23,BRD-A51829654-001-01-4,Serotonin receptor antagonist
25945,c01,BRD-A52588987-004-04-1,Dopamine receptor antagonist
25945,c02,BRD-A52660433-066-01-3,Monoamine oxidase inhibitor
25945,c04,BRD-A52922642-001-02-9,L-type calcium channel blocker
25945,c05,BRD-A53077924-236-01-4,Selective serotonin reuptake enhancer (SSRE)
25945,c07,BRD-A53416814-001-01-5,nitric oxide production inhibitor|phosphoenolpyruvate carboxylase activator|serine/threonine protein phosphatase activator
25945,c09,BRD-A53576514-003-03-1,Acetylcholine receptor antagonist
25945,c10,BRD-A53952395-003-04-6,local anesthetic
25945,c13,BRD-A54029483-001-01-5,endothelin receptor antagonist
25945,c14,BRD-A54236247-003-02-7,Adrenergic receptor agonist
25945,c17,BRD-A54490543-066-04-4,monoamine oxidase inhibitor
25945,c18,BRD-A54845972-066-01-5,serotonin receptor agonist|adrenergic receptor partial agonist|dopamine receptor agonist
25945,c19,BRD-A54927599-001-07-8,P-selectin inhibitor
25945,c22,BRD-A55272860-001-03-9,dopamine receptor antagonist
25945,c23,BRD-A55369275-001-01-6,GABA receptor antagonist
25945,c24,BRD-A55393291-001-02-4,Androgen receptor agonist
25945,d01,BRD-A55424491-001-04-1,dihydrofolate reductase inhibitor
25945,d04,BRD-A55756846-001-05-5,PKA inhibitor
25945,d05,BRD-A55913614-316-04-7,antimalarial agent|DNA inhibitor
25945,d07,BRD-A56020723-001-02-0,cathepsin inhibitor|antiamyloidogenic agent
25945,d08,BRD-A56675431-001-04-0,Thiazide diuretic
25945,d13,BRD-A56987319-001-03-8,Adenylyl cyclase inhibitor
25945,d14,BRD-A57133233-003-03-7,histamine receptor antagonist
25945,d17,BRD-A57382968-001-06-8,Cyclooxygenase inhibitor
25945,d20,BRD-A58048407-001-06-3,Calcium channel blocker
25945,d24,BRD-A59215453-003-03-3,Acetylcholine receptor antagonist
25945,e03,BRD-A59303141-001-03-9,Thiazide diuretic
25945,e06,BRD-A60197193-001-05-4,Dopamine receptor antagonist
25945,e12,BRD-A61154809-001-03-5,ATP channel blocker|insulin secretagogue
25945,e14,BRD-A61392169-001-01-9,glutamate receptor antagonist
25945,e15,BRD-A61470182-001-02-4,macrophage activator
25945,e16,BRD-A61793559-001-04-0,Carbonic anhydrase inhibitor
25945,e19,BRD-A61856038-001-01-2,Lipoxygenase inhibitor
25945,e22,BRD-A62021152-003-01-8,serotonin receptor agonist
25945,e23,BRD-A62057054-001-01-5,Serotonin receptor antagonist
25945,f04,BRD-A62428732-096-02-6,antihistamine
25945,f05,BRD-A62505706-001-02-3,DNA directed DNA polymerase inhibitor
25945,f06,BRD-A62525898-001-02-9,Glucocorticoid receptor agonist
25945,f08,BRD-A63346720-300-01-1,sigma receptor antagonist|dopamine reuptake inhibitor
25945,f11,BRD-A63546914-003-01-2,Glutamate receptor antagonist
25945,f12,BRD-A63667919-103-01-9,dopamine receptor antagonist|partial serotonin receptor agonist
25945,f14,BRD-A63836183-362-01-1,angiotensin receptor antagonist
25945,f15,BRD-A63894585-001-03-4,glucocorticoid receptor agonist
25945,f16,BRD-A64092382-003-03-5,Sodium channel blocker
25945,f19,BRD-A64125466-236-02-0,choleretic agent
25945,f20,BRD-A64227845-004-02-8,Dopamine receptor agonist
25945,f21,BRD-A64228451-001-03-5,BTK inhibitor
25945,f23,BRD-A64485570-001-02-9,DNA directed DNA polymerase inhibitor|thymidylate synthase inhibitor
25945,g02,BRD-A64933752-001-01-0,adenosine receptor agonist
25945,g06,BRD-A64977602-001-01-9,Adrenergic receptor antagonist
25945,g07,BRD-A65013509-003-03-8,Acetylcholine receptor antagonist
25945,g08,BRD-A65051990-001-03-8,vitamin K antagonist
25945,g09,BRD-A65076780-001-01-3,adrenergic receptor antagonist|prolactin inhibitor
25945,g10,BRD-A65145453-001-02-0,glutamate receptor agonist
25945,g11,BRD-A65280694-003-03-8,Dopamine receptor antagonist
25945,g12,BRD-A65440446-001-02-5,Adrenergic receptor agonist
25945,g13,BRD-A65597028-003-02-4,Adrenergic receptor antagonist
25945,g14,BRD-A65615053-003-01-4,Serotonin receptor antagonist
25945,g15,BRD-A65671304-001-02-6,angiotensin receptor antagonist
25945,g17,BRD-A66025870-237-05-1,bacterial cell wall synthesis inhibitor
25945,g18,BRD-A66199457-001-02-2,antineoplastic
25945,g22,BRD-A66435872-313-01-8,Histamine receptor agonist
25945,g23,BRD-A66563878-003-01-8,Adrenergic receptor agonist
25945,h01,BRD-A66927094-001-01-7,Dopamine receptor antagonist
25945,h07,BRD-A67552019-001-02-2,ATPase inhibitor
25945,h09,BRD-A67862938-034-04-0,Adrenergic receptor antagonist
25945,h10,BRD-A68281735-001-02-0,Leukotriene receptor antagonist
25945,h12,BRD-A68723818-050-04-4,Histamine receptor antagonist
25945,h13,BRD-A68888262-003-02-9,histamine receptor antagonist
25945,h14,BRD-A68929948-001-01-9,antiamyloidogenic agent|gamma secretase inhibitor
25945,h15,BRD-A69636825-003-02-1,Calcium channel blocker
25945,h17,BRD-A69777949-001-04-4,topoisomerase inhibitor
25945,h18,BRD-A69786436-003-02-5,acetylcholine receptor antagonist
25945,h23,BRD-A70083328-001-02-9,Acetylcholinesterase inhibitor
25945,h24,BRD-A70268693-103-01-9,Acetylcholine receptor agonist
25945,i01,BRD-A70407468-001-01-2,adenosine receptor antagonist
25945,i02,BRD-A70514680-003-03-9,Local anesthetic
25945,i03,BRD-A70649075-008-04-3,sterol demethylase inhibitor
25945,i08,BRD-A71157293-003-03-5,Vitamin B
25945,i09,BRD-A71203467-001-01-5,Dopamine receptor antagonist
25945,i10,BRD-A71774530-001-01-8,chitin inhibitor
25945,i12,BRD-A71816415-236-02-7,HMGCR inhibitor
25945,i13,BRD-A72066420-001-01-1,PPAR receptor antagonist
25945,i14,BRD-A72483914-001-01-1,Serotonin receptor antagonist
25945,i15,BRD-A72596465-001-01-3,PPAR receptor antagonist
25945,i16,BRD-A72703248-001-02-7,calcium channel blocker|cytochrome P450 inhibitor
25945,i17,BRD-A72711497-236-02-0,bacterial permeability inducer
25945,i18,BRD-A72988804-001-03-8,Cyclooxygenase inhibitor
25945,i19,BRD-A73368467-003-02-8,Histamine receptor antagonist
25945,i23,BRD-A73859745-236-01-8,Apoptosis stimulant
25945,j02,BRD-A74667430-001-04-6,Cyclooxygenase inhibitor
25945,j03,BRD-A74904029-001-04-0,Casein kinase inhibitor
25945,j07,BRD-A74980173-001-02-8,Bacterial DNA gyrase inhibitor
25945,j09,BRD-A75478957-001-01-6,collagenase inhibitor|metalloproteinase inhibitor|stromelysin inhibitor
25945,j10,BRD-A75552914-001-04-4,Cyclooxygenase inhibitor
25945,j12,BRD-A75769826-003-01-3,opioid receptor antagonist
25945,j13,BRD-A75817871-001-02-6,ATPase inhibitor
25945,j14,BRD-A75850590-003-04-9,bacterial DNA gyrase inhibitor
25945,j16,BRD-A76093993-001-01-8,Potassium channel activator
25945,j24,BRD-A77291778-003-04-8,acetylcholine receptor antagonist
25945,k01,BRD-A77299732-001-01-6,Eukaryotic translation initiation factor inhibitor
25945,k02,BRD-A77349281-001-02-2,heparanase inhibitor|tyrosine phosphatase inhibitor
25945,k06,BRD-A78295502-337-03-5,anti-arrhythmia agent
25945,k10,BRD-A78377521-001-02-2,Kinesin-like spindle protein inhibitor
25945,k11,BRD-A78877355-003-03-6,Cyclooxygenase inhibitor
25945,k12,BRD-A78942461-003-01-3,Adrenergic receptor antagonist
25945,k13,BRD-A79226577-003-01-1,serotonin receptor antagonist|polarization inhibitor|sodium channel blocker
25945,k17,BRD-A79672927-001-04-1,Acetylcholine receptor antagonist
25945,k18,BRD-A79981887-003-04-0,adrenergic receptor agonist
25945,k19,BRD-A80017228-001-04-2,Sodium/potassium/chloride transporter inhibitor
25945,k21,BRD-A80213327-305-01-8,Ras GTPase inhibitor
25945,k22,BRD-A80594172-001-02-0,glucocorticoid receptor agonist
25945,l01,BRD-A80641450-001-01-4,Endothelin receptor antagonist
25945,l05,BRD-A81177136-001-03-6,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist
25945,l10,BRD-A81615860-001-02-9,tryptophan hydroxylase inhibitor
25945,l11,BRD-A81795050-003-01-7,oxidosqualene cyclase inhibitor
25945,l12,BRD-A81866333-003-01-5,Adenosine receptor agonist
25945,l13,BRD-A82238138-001-01-7,glucocorticoid receptor agonist
25945,l17,BRD-A82371568-001-01-5,ribonucleoside reductase inhibitor|DNA polymerase inhibitor|DNA repair enzyme inhibitor|DNA synthesis inhibitor|ribonucleotide reductase inhibitor
25945,l19,BRD-A82590476-001-01-1,tachykinin antagonist
25945,l20,BRD-A82656074-003-01-2,opioid receptor antagonist
25945,l22,BRD-A83326220-001-02-6,Nitric oxide production inhibitor
25945,m02,BRD-A83431637-001-01-3,Cytochrome P450 inhibitor
25945,m04,BRD-A83695761-001-01-1,Potassium channel blocker
25945,m05,BRD-A83855350-003-01-4,Opioid receptor antagonist
25945,m07,BRD-A83937277-001-03-0,Hydantoin antiepileptic
25945,m08,BRD-A84174393-001-02-0,Cyclooxygenase inhibitor
25945,m11,BRD-A84174873-001-06-0,benzodiazepine receptor agonist
25945,m12,BRD-A84389091-001-01-1,GABA receptor inverse agonist
25945,m15,BRD-A84389633-001-01-6,serotonin receptor antagonist
25945,m19,BRD-A85137183-001-01-2,bacterial cell wall synthesis inhibitor
25945,m21,BRD-A85234536-001-04-5,Adenosine receptor agonist
25945,m22,BRD-A85280935-003-01-7,Dopamine receptor agonist
25945,m23,BRD-A85472596-001-01-4,Prostanoid receptor antagonist
25945,m24,BRD-A85587465-001-01-7,Serotonin receptor antagonist
25945,n01,BRD-A86044036-001-04-2,cyclooxygenase inhibitor
25945,n06,BRD-A87479750-001-01-9,Cyclooxygenase inhibitor
25945,n08,BRD-A87719232-001-02-4,Cyclooxygenase inhibitor
25945,n11,BRD-A88254928-001-04-6,adrenergic receptor agonist
25945,n12,BRD-A88282067-001-02-2,Antiarrhythmic
25945,n15,BRD-A88548664-001-01-5,dopamine receptor agonist
25945,n18,BRD-A89434049-001-02-1,ATPase inhibitor
25945,n19,BRD-A89585551-003-03-4,adenosine receptor antagonist|hemoglobin antagonist
25945,n20,BRD-A89672324-001-02-2,GABA receptor antagonist
25945,n22,BRD-A89947015-001-01-4,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor
25945,n24,BRD-A90311807-236-01-4,Dehydropeptidase inhibitor
25945,o01,BRD-A90462498-003-02-1,antineoplastic
25945,o02,BRD-A90490067-001-01-9,estrogen receptor antagonist|DNA directed DNA polymerase inhibitor|soluble epoxide hydrolase inhibitor
25945,o03,BRD-A90515964-001-05-8,expectorant
25945,o04,BRD-A90799790-001-04-1,calcium channel blocker
25945,o06,BRD-A91008255-001-02-8,calcium channel blocker
25945,o08,BRD-A91699651-316-04-2,Antimalarial
25945,o09,BRD-A91866971-001-02-2,Thromboxane receptor antagonist
25945,o13,BRD-A92161634-001-02-6,Acetylcholine receptor antagonist
25945,o14,BRD-A92585442-237-01-0,Cytochrome P450 inhibitor
25945,o15,BRD-A92670106-003-03-9,Sodium channel blocker
25945,o16,BRD-A92826379-009-02-6,Sodium channel blocker
25945,o18,BRD-A93000692-001-03-2,PPAR receptor agonist
25945,o19,BRD-A93206962-001-01-2,adrenergic receptor agonist|adrenergic receptor partial agonist
25945,o20,BRD-A93255169-001-06-9,TNF production inhibitor
25945,o24,BRD-A93477898-001-01-8,caspase activator
25945,p01,BRD-A93659613-051-03-6,Opioid receptor agonist
25945,p02,BRD-A93739713-065-02-7,muscarinic antagonist
25945,p05,BRD-A94413429-003-01-6,neuropeptide receptor antagonist
25945,p06,BRD-A94543220-001-02-3,Sterol demethylase inhibitor
25945,p07,BRD-A94624445-236-02-2,adenosine receptor agonist|cAMP stimulant
25945,p08,BRD-A94669766-001-02-6,Aromatase inhibitor
25945,p10,BRD-A94709349-001-02-6,Muscle relaxant
25945,p13,BRD-A95096829-300-01-4,dopamine receptor antagonist
25945,p14,BRD-A95207036-001-02-8,androgen receptor antagonist
25945,p15,BRD-A95445494-001-02-9,interleukin synthesis inhibitor|sodium/glucose cotransporter inhibitor
25945,p16,BRD-A95513702-001-02-2,aromatase inhibitor
25945,p17,BRD-A95696066-003-06-2,Norepinephrine reuptake inhibitor
25945,p18,BRD-A95869247-001-03-8,thiazide diuretic
25945,p19,BRD-A95939040-008-03-3,sterol demethylase inhibitor
25945,p20,BRD-A96456596-001-01-4,Leukotriene receptor antagonist
25945,p21,BRD-A96485169-001-02-8,Aldose reductase inhibitor
25945,p23,BRD-A96882008-001-01-3,Tachykinin antagonist
25945,p24,BRD-A96897502-001-02-0,lipid peroxidase inhibitor
24319,a01,BRD-K90382497-001-01-6,PLK inhibitor
24319,a02,BRD-K92723993-066-02-9,PDGFR tyrosine kinase receptor inhibitor|Bcr-Abl kinase inhibitor|KIT inhibitor|Abl kinase inhibitor|apoptosis stimulant|breast cancer resistance protein inhibitor|colony stimulating factor receptor inhibitor
24319,a03,BRD-K07762753-001-03-6,CDK inhibitor|tyrosine kinase inhibitor
24319,a04,BRD-K09991945-001-02-0,glycogen synthase kinase inhibitor|PKC inhibitor|superoxide dismutase expression inhibitor
24319,a05,BRD-K37312348-001-05-1,CDK inhibitor|glycogen synthase kinase inhibitor
24319,a06,BRD-K46678324-001-03-7,rho associated kinase inhibitor
24319,a07,BRD-K67860401-001-02-3,glycogen synthase kinase inhibitor
24319,a08,BRD-K52620403-001-01-8,calcium/calmodulin dependent protein kinase inhibitor|calmodulin inhibitor
24319,a09,BRD-K68336408-001-03-4,EGFR inhibitor
24319,a10,BRD-K72703948-001-01-0,Aurora kinase inhibitor
24319,a11,BRD-K93201660-001-05-7,myosin light chain kinase inhibitor
24319,a15,BRD-A47633927-001-01-8,ICAM1 antagonist
24319,a16,BRD-A68039575-001-02-5,Aromatase inhibitor
24319,a17,BRD-A75455249-001-02-0,calcium channel modulator|mTOR inhibitor|sodium channel blocker
24319,a18,BRD-K01555864-001-02-8,antineoplastic
24319,a19,BRD-K09497549-001-03-6,calcium channel modulator|mTOR inhibitor|sodium channel blocker
24319,a20,BRD-K14536225-001-02-7,Glucosidase inhibitor
24319,a21,BRD-K15086322-103-01-0,histamine receptor antagonist|histamine receptor silent antagonist
24319,a23,BRD-K23623876-001-01-6,ultrasound contrast agent
24319,a24,BRD-K36377456-001-02-0,angiogenesis inhibitor
24319,b01,BRD-K36395411-003-01-4,serotonin receptor antagonist|serotonin receptor partial agonist
24319,b03,BRD-K41160163-001-01-9,Glutamate receptor antagonist
24319,b04,BRD-K42095107-001-02-3,estrogen receptor agonist
24319,b05,BRD-K43797669-001-02-3,tyrosine kinase inhibitor
24319,b06,BRD-K45988865-001-01-0,organosilicon compound used as an internal standard in NMR spectroscopy
24319,b07,BRD-K49061529-001-01-0,GABA benzodiazepine site receptor inverse agonist
24319,b09,BRD-K59331372-001-01-2,TRPV antagonist
24319,b11,BRD-K60690191-003-02-1,glutamate receptor antagonist
24319,b12,BRD-K61177364-003-01-1,CRF receptor antagonist
24319,b17,BRD-K61250553-001-02-9,opioid receptor agonist
24319,b18,BRD-K61269089-001-01-4,Protein kinase inhibitor
24319,b19,BRD-K61271364-001-02-4,GABA receptor antagonist
24319,b20,BRD-K61323504-001-02-4,CC chemokine receptor antagonist
24319,b22,BRD-K61496577-001-03-8,glucocorticoid receptor agonist
24319,b23,BRD-K61590534-001-01-4,EGFR inhibitor
24319,c01,BRD-K61737877-001-01-6,VEGFR inhibitor
24319,c03,BRD-K61951118-001-01-2,GABA benzodiazepine site receptor inverse agonist
24319,c04,BRD-K62008436-001-03-1,tubulin polymerization inhibitor
24319,c05,BRD-K62056274-001-01-9,Serotonin receptor agonist
24319,c07,BRD-K62206109-303-01-1,histamine receptor antagonist
24319,c08,BRD-K62221994-001-01-8,gonadotropin releasing factor hormone receptor antagonist
24319,c10,BRD-K62289640-003-01-9,Cannabinoid receptor agonist
24319,c13,BRD-K62310379-001-03-0,glucocorticoid receptor agonist
24319,c17,BRD-K62353524-001-01-8,estrogen receptor agonist
24319,c18,BRD-K62363391-001-04-1,bacterial antifolate
24319,c23,BRD-K62607865-001-03-0,bacterial cell wall synthesis inhibitor
24319,c24,BRD-K62609077-001-02-2,adrenergic receptor antagonist|GABA receptor antagonist|serotonin receptor antagonist
24319,d01,BRD-K62810658-001-05-6,MEK inhibitor
24319,d02,BRD-K62929068-001-01-7,Purinergic receptor activator
24319,d04,BRD-K62996583-001-03-8,calcium channel blocker
24319,d05,BRD-K63089472-001-02-7,Inhibitor of methyl esterification of farnesylated proteins
24319,d06,BRD-K63150726-001-01-3,cannabinoid receptor inverse agonist
24319,d07,BRD-K63151507-001-01-6,Lymphocyte inhibitor
24319,d08,BRD-K63165456-001-03-3,Adrenergic receptor agonist
24319,d09,BRD-K63430059-001-03-2,DNA synthesis inhibitor
24319,d10,BRD-K63504947-001-05-5,VEGFR inhibitor
24319,d13,BRD-K63516691-001-01-6,Phosphodiesterase inhibitor
24319,d14,BRD-K63533170-001-01-1,cannabinoid receptor antagonist|cannabinoid receptor inverse agonist
24319,d17,BRD-K63606607-001-01-8,ATPase inhibitor|chloride channel activator
24319,d18,BRD-K63630713-001-04-3,sodium/potassium/chloride transporter inhibitor
24319,d19,BRD-K63750851-001-03-3,dehydrogenase inhibitor|inositol monophosphatase inhibitor
24319,d21,BRD-K63784565-001-02-1,Topoisomerase inhibitor
24319,d22,BRD-K63792901-075-01-3,acetylcholine receptor agonist
24319,d23,BRD-K63828191-003-07-3,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)
24319,e03,BRD-K63874012-103-01-5,histamine receptor antagonist|histamine receptor inverse agonist
24319,e04,BRD-K63913457-001-02-7,vasodilator
24319,e06,BRD-K63945320-001-02-4,Phospholipase inhibitor
24319,e07,BRD-K63979671-001-03-6,Compound used in hepatobiliary scans of the liver
24319,e08,BRD-K64044582-001-02-8,ACAT inhibitor
24319,e11,BRD-K64157027-003-01-9,Adrenergic receptor agonist
24319,e14,BRD-K64245000-001-01-7,FXR agonist
24319,e16,BRD-K64341947-003-01-6,guanylate cyclase activator
24319,e20,BRD-K64402243-001-01-1,Caspase inhibitor
24319,e22,BRD-K64670467-001-01-2,glutamate receptor antagonist
24319,f03,BRD-K64755930-003-01-6,phosphodiesterase inhibitor
24319,f04,BRD-K64862097-001-03-9,glucocorticoid receptor agonist
24319,f06,BRD-K64994968-001-03-6,Progesterone receptor agonist
24319,f07,BRD-K65146499-001-04-8,Cyclooxygenase inhibitor
24319,f11,BRD-K65285700-001-01-5,cannabinoid receptor agonist
24319,f12,BRD-K65417056-003-03-6,Local anesthetic
24319,f13,BRD-K65503129-001-01-4,HSP inhibitor|HSP antagonist
24319,f15,BRD-K65639003-001-02-5,phosphodiesterase inhibitor
24319,f16,BRD-K65667145-001-04-1,cell division inducer
24319,f19,BRD-K65786282-001-02-6,GABA receptor modulator
24319,f20,BRD-K65814004-001-02-3,nitric oxide synthase inhibitor|aldehyde dehydrogenase inhibitor|cytochrome P450 inhibitor|NADPH oxidase inhibitor|xanthine oxidase inhibitor
24319,f23,BRD-K66093087-001-01-5,Benzodiazepine receptor agonist
24319,f24,BRD-K66206289-003-03-1,Acetylcholine receptor antagonist
24319,g02,BRD-K66353228-001-05-4,myorelaxant
24319,g05,BRD-K66404838-003-03-8,opioid receptor agonist|opioid receptor antagonist
24319,g08,BRD-K66707493-001-02-6,Coloring agent
24319,g09,BRD-K66715657-001-01-3,dopamine receptor antagonist
24319,g10,BRD-K66782112-001-01-2,Histamine receptor antagonist
24319,g11,BRD-K66874953-001-02-7,TP53 inhibitor
24319,g12,BRD-K66898851-001-03-7,apoptosis stimulant
24319,g13,BRD-K66944906-001-02-6,Carbonic anhydrase inhibitor
24319,g14,BRD-K67013324-001-01-5,melatonin receptor antagonist
24319,g16,BRD-K67017579-001-13-3,Phosphodiesterase inhibitor
24319,g17,BRD-K67043667-001-04-1,DNA synthesis inhibitor
24319,g18,BRD-K67080878-001-05-5,phosphodiesterase inhibitor
24319,g21,BRD-K67102207-236-01-0,HDAC inhibitor
24319,g23,BRD-K67261995-001-03-4,Contrast agent
24319,g24,BRD-K67277431-002-03-0,thromboxane receptor antagonist|thromboxane synthase inhibitor
24319,h01,BRD-K67298865-001-02-5,TGF beta receptor inhibitor
24319,h02,BRD-K67352070-364-01-5,Acetylcholine receptor agonist
24319,h05,BRD-K67439147-001-01-7,glutamate receptor antagonist
24319,h06,BRD-K67445247-001-01-3,Urease inhibitor
24319,h08,BRD-K67537649-001-01-1,insulin growth factor receptor inhibitor
24319,h12,BRD-K67680372-003-01-8,GAT inhibitor
24319,h13,BRD-K67783091-001-05-5,Dopamine receptor antagonist
24319,h14,BRD-K67831364-003-01-7,vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor|VEGFR inhibitor
24319,h17,BRD-K68095457-001-04-4,Cannabinoid receptor agonist
24319,h18,BRD-K68103045-001-01-1,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist
24319,h24,BRD-K68190965-001-01-4,Serotonin receptor agonist
24319,i01,BRD-K68246049-001-01-4,Retinoid receptor agonist
24319,i02,BRD-K68264559-001-07-6,Adrenergic receptor agonist
24319,i03,BRD-K68332390-001-03-3,aldose reductase inhibitor|reductase inhibitor
24319,i04,BRD-K68341547-003-01-6,calmodulin antagonist
24319,i07,BRD-K68392338-003-01-2,Benzodiazepine receptor antagonist
24319,i08,BRD-K68402494-001-04-7,myosin light chain kinase inhibitor
24319,i10,BRD-K68507560-003-04-8,acetylcholine receptor antagonist
24319,i12,BRD-K68552125-001-03-8,PKC activator|CD antagonist
24319,i13,BRD-K68553471-003-04-0,antihypertensive agent
24319,i14,BRD-K68558722-001-02-4,Cyclooxygenase inhibitor
24319,i15,BRD-K68620903-001-03-1,progesterone receptor agonist
24319,i17,BRD-K68873215-001-01-3,phosphodiesterase inhibitor
24319,i18,BRD-K69023402-001-02-5,ATPase inhibitor|calcium channel blocker|PKC activator
24319,i19,BRD-K69032158-001-02-2,Dipeptidyl peptidase inhibitor
24319,i20,BRD-K69195780-001-01-5,Serotonin receptor agonist
24319,i23,BRD-K69556541-001-02-6,Calcium channel blocker
24319,j01,BRD-K69763916-001-01-7,Glutamate receptor antagonist
24319,j02,BRD-K69837166-003-01-2,Nociceptin/orphanin FQ (NOP) receptor antagonist
24319,j03,BRD-K70241288-001-01-1,Growth hormone releasing peptide ligand agonist
24319,j04,BRD-K70246307-001-02-5,vitamin B2
24319,j07,BRD-K70281171-001-01-7,Dopamine receptor antagonist
24319,j08,BRD-K70330367-001-02-4,Glutamate receptor antagonist
24319,j10,BRD-K70487031-001-01-0,dopamine receptor antagonist
24319,j12,BRD-K70778732-003-04-4,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor
24319,j13,BRD-K70792160-003-01-2,AKT inhibitor
24319,j15,BRD-K70881766-001-02-3,Acetylcholinesterase inhibitor
24319,j16,BRD-K70914287-300-01-0,EGFR inhibitor|tyrosine kinase inhibitor
24319,j17,BRD-K70976396-236-04-7,Bacterial cell wall synthesis inhibitor
24319,j18,BRD-K71003802-001-02-9,Plant alkaloid
24319,j19,BRD-K13356952-001-11-1,carbonic anhydrase inhibitor
24319,k03,BRD-K71266197-236-01-9,NTPDase inhibitor
24319,k04,BRD-K71430621-303-01-5,histamine receptor antagonist|histamine receptor inverse agonist
24319,k06,BRD-K71499074-001-03-8,Carbonic anhydrase inhibitor
24319,k09,BRD-K71534238-001-03-5,Free fatty acid receptor agonist
24319,k11,BRD-K71726959-001-05-9,CDK inhibitor
24319,k12,BRD-K71731651-001-01-9,Acetylcholine receptor agonist
24319,k13,BRD-K71799778-001-02-2,CDK inhibitor
24319,k14,BRD-K71799949-001-04-2,Carboxamide antiepileptic
24319,k17,BRD-K71860425-001-01-1,CDK inhibitor
24319,k18,BRD-K72024482-001-01-3,adenosine receptor antagonist
24319,k19,BRD-K72034655-001-02-1,apoptosis inducer|antileukemic
24319,k22,BRD-K72222507-003-02-8,ACE inhibitor
24319,l04,BRD-K72676686-103-01-8,selective serotonin reuptake inhibitor (SSRI)|serotonin reuptake inhibitor|serotonin uptake inhibitor
24319,l05,BRD-K72726508-001-01-3,CDK inhibitor
24319,l06,BRD-K72783841-001-01-0,CDK inhibitor|epidermal growth factor receptor (EGFR) inhibitor|tyrosine kinase inhibitor|EGFR inhibitor
24319,l09,BRD-K72895815-001-01-4,leukocyte elastase inhibitor
24319,l10,BRD-K72903603-001-03-8,Reverse transcriptase inhibitor
24319,l13,BRD-K73109821-001-05-2,Potassium channel activator
24319,l18,BRD-K73196317-003-06-4,adrenergic receptor antagonist
24319,l21,BRD-K73290745-003-01-8,opioid receptor agonist
24319,l22,BRD-K73323637-003-03-4,adrenergic receptor antagonist
24319,m02,BRD-K73391359-003-03-7,Local anesthetic
24319,m05,BRD-K73397362-001-01-7,smoothened receptor agonist
24319,m06,BRD-K73589401-001-03-8,mineralocorticoid receptor agonist
24319,m12,BRD-K73789395-001-04-0,RAF inhibitor
24319,m15,BRD-K73991644-001-01-7,aldose reductase inhibitor|falcipain inhibitor
24319,m17,BRD-K74112339-001-02-7,Urease inhibitor
24319,m18,BRD-K74141488-003-03-9,Fungal squalene epoxidase inhibitor
24319,m20,BRD-K74195153-050-03-0,Phosphodiesterase inhibitor
24319,m21,BRD-K74212935-001-03-1,Dopamine agonist
24319,m23,BRD-K74305673-001-01-3,IKK inhibitor|NFkB pathway inhibitor|protein kinase inhibitor
24319,m24,BRD-K74430258-001-01-2,hepatotoxicant
24319,n02,BRD-K74765201-001-01-9,Leukotriene receptor antagonist
24319,n03,BRD-K74913225-001-03-3,Carbonic anhydrase inhibitor
24319,n05,BRD-K75089421-001-02-5,sodium channel blocker
24319,n06,BRD-K75181824-001-02-3,inhibitor of methyl esterification of geranylgeranylated proteins
24319,n11,BRD-K75478907-001-01-5,GABA receptor modulator|GABA receptor positive allosteric modulator
24319,n16,BRD-K75615183-001-01-7,Adrenergic receptor agonist
24319,n17,BRD-K75641298-001-01-5,Dopamine receptor antagonist
24319,n21,BRD-K75958195-001-01-7,serotonin receptor antagonist
24319,n24,BRD-K76064317-001-04-0,FLT3 inhibitor
24319,o01,BRD-K76133116-001-01-2,Membrane integrity inhibitor
24319,o03,BRD-K76274772-001-02-7,Ceramidase inhibitor
24319,o05,BRD-K76304753-003-04-7,local anesthetic
24319,o07,BRD-K76568384-001-01-4,estrogen receptor antagonist
24319,o08,BRD-K76587808-001-02-0,Antioxidant
24319,o09,BRD-K76617868-001-02-2,rho associated kinase inhibitor
24319,o10,BRD-K76634210-001-02-2,DNA directed DNA polymerase inhibitor
24319,o13,BRD-K76674262-001-01-7,apoptosis stimulant|protein synthesis inhibitor
24319,o15,BRD-K76723084-001-05-9,retinoid receptor agonist
24319,o16,BRD-K76775527-001-06-2,Cyclooxygenase inhibitor
24319,o17,BRD-K76805682-001-05-0,glycogen synthase kinase inhibitor
24319,o18,BRD-K76810206-001-05-7,adrenergic receptor antagonist
24319,o20,BRD-K76840893-003-01-7,adrenergic receptor antagonist
24319,o22,BRD-K76872913-001-02-8,Aromatic hydrocarbon derivative
24319,o23,BRD-K76927775-001-04-3,DNA inhibitor
24319,o24,BRD-K77133231-001-01-1,p38 MAPK inhibitor
24319,p01,BRD-K77171813-050-01-4,histamine receptor modulator
24319,p03,BRD-K77554836-001-03-3,glucocorticoid receptor agonist
24319,p07,BRD-K77641333-003-04-0,adrenergic receptor agonist
24319,p08,BRD-K77677632-003-01-8,serotonin receptor antagonist
24319,p09,BRD-K77695569-001-04-5,angiogenesis inhibitor
24319,p10,BRD-K77771411-003-03-2,imidazoline receptor agonist
24319,p13,BRD-K77793136-003-01-4,rho associated kinase inhibitor
24319,p15,BRD-K77925998-001-01-3,serotonin receptor agonist
24319,p16,BRD-K77947974-001-04-9,dopamine receptor antagonist
24319,p17,BRD-K77987382-001-05-8,acetylcholinesterase inhibitor|microtubule inhibitor|tubulin inhibitor
24319,p18,BRD-K78010432-001-04-1,diuretic
24319,p20,BRD-K78084463-003-01-0,calmodulin antagonist
24319,p21,BRD-K78113049-001-04-8,topoisomerase inhibitor
24319,p22,BRD-K78122587-300-01-9,T-type calcium channel blocker
24319,p23,BRD-K78280988-001-02-2,cannabinoid receptor agonist|potassium channel blocker|TRPV agonist
24313,a01,BRD-K40782193-003-01-1,sodium channel blocker
24313,a02,BRD-K40887525-001-02-9,serotonin receptor antagonist
24313,a03,BRD-K40901640-001-01-0,serotonin receptor antagonist
24313,a04,BRD-K40905133-001-02-3,sodium channel blocker
24313,a05,BRD-K40965114-001-01-2,Adrenergic receptor antagonist
24313,a06,BRD-K40990712-001-02-4,gonadotropin releasing factor hormone receptor antagonist|sodium/hydrogen antiport inhibitor|sodium/hydrogen exchanger inhibitor|urokinase inhibitor
24313,a07,BRD-K41143549-003-01-6,glutamate receptor antagonist
24313,a08,BRD-K41337261-001-01-4,Src and Abl inhibitor|vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor
24313,a09,BRD-K41406082-001-04-8,PABA antagonist
24313,a11,BRD-K41445866-001-03-0,Chloride channel agonist
24313,a12,BRD-K41524689-001-05-2,cyclooxygenase inhibitor
24313,a15,BRD-K41564320-001-01-2,tyrosine kinase inhibitor
24313,a16,BRD-K41567364-001-01-2,orexin receptor antagonist
24313,a19,BRD-K41707108-001-02-3,Phosphoenolpyruvate carboxylase activator
24313,a20,BRD-K41713976-001-02-0,potassium channel blocker
24313,a23,BRD-K41868777-003-02-9,calmodulin antagonist
24313,b01,BRD-K41876534-001-02-0,carbonic anhydrase inhibitor
24313,b02,BRD-K41996876-001-05-5,EGFR inhibitor
24313,b03,BRD-K42098891-003-03-1,tricyclic antidepressant
24313,b04,BRD-K42221274-001-01-4,GAT inhibitor
24313,b05,BRD-K42348709-003-04-0,adrenergic receptor agonist|serotonin receptor agonist
24313,b07,BRD-K42452249-001-01-7,p38 MAPK inhibitor
24313,b08,BRD-K42500029-001-01-9,"MAP kinase inhibitor|MAPK-interacting kinase inhibitor,"
24313,b10,BRD-K42635745-001-02-4,adrenergic receptor antagonist
24313,b12,BRD-K42679050-001-01-3,potassium channel activator|potassium channel agonist
24313,b16,BRD-K42748308-300-01-2,acetylcholine release enhancer|potassium channel blocker|voltage-gated potassium channel blocker
24313,b18,BRD-K43068349-001-01-9,TRPV antagonist
24313,b19,BRD-K43149758-001-04-5,Androgen receptor agonist
24313,b21,BRD-K43245338-001-02-4,calpain inhibitor|cathepsin inhibitor
24313,b22,BRD-K43290182-001-01-9,Serotonin receptor antagonist
24313,b23,BRD-K43330982-001-01-5,lysophospholipid receptor antagonist
24313,b24,BRD-K43389675-003-02-7,RNA synthesis inhibitor|topoisomerase inhibitor
24313,c01,BRD-K43405658-001-01-8,protein tyrosine kinase inhibitor
24313,c02,BRD-K43457670-001-04-7,carbonic anhydrase inhibitor
24313,c03,BRD-K43468059-001-02-9,Mycotoxin
24313,c05,BRD-K43736954-001-03-3,glucocorticoid receptor agonist
24313,c06,BRD-K43744935-048-01-6,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)|estrogen receptor agonist|estrogen receptor modulator|PKC inhibitor
24313,c07,BRD-K43796186-001-01-1,EGFR inhibitor
24313,c08,BRD-K43860855-065-03-6,antineoplastic agent
24313,c09,BRD-K44067360-001-06-3,chloride channel blocker
24313,c10,BRD-K44084986-001-03-9,rho associated kinase inhibitor
24313,c18,BRD-K44849676-001-03-0,TRPV agonist
24313,c19,BRD-K44876623-001-01-1,Benzodiazepine receptor agonist
24313,c20,BRD-K44899736-003-02-1,Monoamine oxidase inhibitor
24313,c22,BRD-K45033733-001-02-3,DNA polymerase inhibitor
24313,c24,BRD-K45068323-003-01-3,Calmodulin antagonist
24313,d02,BRD-K45117373-001-01-1,potassium channel activator|potassium channel agonist
24313,d03,BRD-K45158365-001-02-3,angiotensin receptor antagonist
24313,d04,BRD-K45296539-003-01-0,Adrenergic receptor agonist
24313,d05,BRD-K45330754-001-04-3,estrogen receptor agonist
24313,d06,BRD-K45401373-001-05-0,Apoptosis stimulant
24313,d07,BRD-K45435259-001-01-6,Dopamine receptor antagonist
24313,d09,BRD-K45479396-001-01-8,Serotonin receptor agonist
24313,d13,BRD-K45542189-048-04-9,Lipoxygenase inhibitor
24313,d14,BRD-K45662124-001-01-8,dopamine receptor ligand
24313,d17,BRD-K45861246-001-04-3,Dopamine receptor antagonist
24313,d19,BRD-K46018455-001-06-0,PPAR receptor agonist
24313,d20,BRD-K46137903-001-03-3,phospholipase activator
24313,d21,BRD-K46142322-003-01-6,serotonin receptor partial agonist
24313,d22,BRD-K46211610-003-05-1,Adrenergic receptor antagonist
24313,d23,BRD-K46317332-003-04-6,Nitric oxide synthase inhibitor
24313,d24,BRD-K46384212-001-01-1,phospholipase activator
24313,e03,BRD-K46424862-001-04-2,Monoamine oxidase inhibitor
24313,e04,BRD-K46435977-003-01-2,DNA polymerase inhibitor
24313,e05,BRD-K46441700-001-01-8,serotonin receptor antagonist
24313,e06,BRD-K46469693-001-01-8,adenosine receptor antagonist
24313,e08,BRD-K46556543-237-03-0,Mineralocorticoid receptor antagonist
24313,e13,BRD-K46766488-003-01-2,Serotonin receptor agonist
24313,e14,BRD-K46862739-001-03-6,cytochrome P450 inhibitor
24313,e15,BRD-K46937689-001-05-1,Cyclooxygenase inhibitor
24313,e16,BRD-K47105409-001-05-3,JAK inhibitor
24313,e20,BRD-K47150025-001-01-2,PDGFR alpha and c-Kit inhibitor|vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor|VEGFR inhibitor
24313,e21,BRD-K47192521-001-02-1,Platelet aggregation inhibitor
24313,e22,BRD-K47207162-312-02-2,Serotonin reuptake inhibitor
24313,e23,BRD-K47278471-003-04-0,Histamine receptor antagonist
24313,e24,BRD-K47323024-003-04-6,Histamine receptor antagonist
24313,f03,BRD-K47328134-001-02-0,heparin activation inhibitor
24313,f07,BRD-K47598052-001-04-2,src inhibitor
24313,f08,BRD-K47608922-001-02-1,chelating agent
24313,f11,BRD-K47631482-003-02-1,Mucolytic agent
24313,f12,BRD-K47635719-001-03-9,glucocorticoid receptor agonist
24313,f13,BRD-K47639036-003-03-3,Acetylcholine receptor antagonist
24313,f14,BRD-K47659338-003-01-0,serotonin receptor agonist
24313,f15,BRD-K47693913-001-02-4,Furoquinoline alkaloid
24313,f16,BRD-K47717570-304-01-5,Glutamate receptor antagonist
24313,f21,BRD-K47869605-001-04-9,microtubule inhibitor|tubulin polymerization inhibitor
24313,f23,BRD-K47936004-001-01-9,dopamine receptor agonist
24313,f24,BRD-K47943470-001-02-8,EGFR inhibitor
24313,g05,BRD-K48168960-001-05-1,Thyroid peroxidase inhibitor
24313,g07,BRD-K48300629-001-03-8,Sodium channel blocker
24313,g11,BRD-K48692744-001-01-2,PARP inhibitor
24313,g12,BRD-K48722258-300-04-5,adenosine reuptake inhibitor
24313,g13,BRD-K48735772-001-01-4,EGFR inhibitor|epidermal growth factor receptor (EGFR) inhibitor
24313,g15,BRD-K49027941-237-01-1,Adenosine receptor antagonist
24313,g16,BRD-K49049886-001-03-8,adenosine receptor antagonist
24313,g17,BRD-K49111258-001-02-8,Adrenergic receptor antagonist
24313,g23,BRD-K49294207-300-01-2,EGFR inhibitor
24313,g24,BRD-K49448285-001-01-3,CDK inhibitor
24313,h01,BRD-K49481516-004-03-5,Acetylcholinesterase inhibitor
24313,h02,BRD-K49519092-303-01-4,Histamine receptor agonist
24313,h05,BRD-K49577446-001-03-1,cytochrome P450 inhibitor
24313,h06,BRD-K49657628-001-02-3,EGFR inhibitor|tyrosine kinase inhibitor
24313,h07,BRD-K49671696-001-02-1,Serotonin receptor antagonist
24313,h11,BRD-K49890030-236-01-6,Glutamate receptor antagonist
24313,h12,BRD-K49945136-001-03-5,Serotonin receptor antagonist
24313,h13,BRD-K50018155-003-01-3,Serotonin receptor partial agonist
24313,h15,BRD-K50135270-001-01-9,dopamine uptake inhibitor
24313,h17,BRD-K50214219-001-02-4,PARP inhibitor
24313,h21,BRD-K50325075-001-01-3,potassium channel blocker|slow afterhyperpolarization channel blocker
24313,h22,BRD-K50388907-001-04-9,PPAR receptor agonist
24313,h23,BRD-K50398167-236-02-9,Cyclooxygenase inhibitor
24313,i01,BRD-K50417881-003-05-9,Dopamine receptor antagonist
24313,i02,BRD-K50422030-001-01-2,GABA receptor antagonist
24313,i03,BRD-K50464341-001-02-6,calmodulin antagonist
24313,i04,BRD-K50495309-001-01-2,src inhibitor
24313,i07,BRD-K50660797-001-02-8,Bacterial DNA gyrase inhibitor
24313,i08,BRD-K50836978-001-01-7,CDK inhibitor
24313,i09,BRD-K50841342-001-01-6,caspase activator
24313,i10,BRD-K50859149-001-04-7,bacterial antifolate
24313,i11,BRD-K50891186-001-01-0,dopamine receptor antagonist
24313,i14,BRD-K51276371-001-01-8,CDK inhibitor|CFTR channel activator|glycogen synthase kinase inhibitor|JNK inhibitor
24313,i15,BRD-K51318897-001-04-7,tubulin polymerization inhibitor
24313,i17,BRD-K51465424-003-03-6,adrenergic receptor agonist
24313,i18,BRD-K51476772-001-01-9,tyrosine kinase inhibitor
24313,i19,BRD-K51541829-001-01-3,Ionotropic glutamate receptor antagonist
24313,i23,BRD-K51575138-001-01-7,IKK inhibitor
24313,i24,BRD-K51671335-001-01-5,Dopamine receptor antagonist
24313,j01,BRD-K51751936-001-03-4,benzodiazepine receptor agonist
24313,j03,BRD-K51918615-303-01-1,histamine receptor antagonist|histamine receptor inhibitor|ionotropic glutamate receptor antagonist
24313,j07,BRD-K52020312-001-04-5,DNA inhibitor
24313,j08,BRD-K52075040-001-02-2,fatty acid synthase inhibitor
24313,j10,BRD-K52219182-001-01-6,Phosphodiesterase inhibitor
24313,j11,BRD-K52313696-001-01-6,HDAC inhibitor
24313,j13,BRD-K52394958-001-01-9,tachykinin antagonist
24313,j14,BRD-K52397688-001-01-9,dopamine receptor antagonist|FAAH inhibitor|serotonin receptor antagonist
24313,j15,BRD-K52459643-001-10-2,Prostanoid receptor agonist
24313,j16,BRD-K52512893-001-03-0,Prostanoid receptor antagonist
24313,j18,BRD-K52662033-001-02-6,histamine receptor agonist
24313,j19,BRD-K52721684-001-02-2,potassium channel activator
24313,j20,BRD-K52850071-001-01-2,JAK inhibitor
24313,j23,BRD-K52930707-001-04-8,ACE inhibitor
24313,k01,BRD-K52989797-001-01-1,serotonin transporter (SERT) inhibitor
24313,k03,BRD-K53123955-001-03-0,Phosphofructokinase inhibitor
24313,k05,BRD-K53263234-001-02-9,constitutive androstane receptor (CAR) agonist
24313,k06,BRD-K53318339-001-04-1,Phosphodiesterase inhibitor
24313,k09,BRD-K53523901-001-01-0,adiponectin receptor agonist|AP inhibitor|aryl hydrocarbon receptor antagonist|HIV integrase inhibitor|MEK inhibitor|NFkB pathway inhibitor|topoisomerase inhibitor
24313,k11,BRD-K53545112-304-01-6,Glutamate receptor antagonist
24313,k13,BRD-K53737926-003-04-7,Norepinephrine inhibitor
24313,k14,BRD-K53857191-001-04-5,Dopamine receptor antagonist
24313,k17,BRD-K53878242-001-02-4,phosphodiesterase inhibitor
24313,k19,BRD-K53979406-003-01-0,glycine transporter inhibitor|GlyT-1 inhibitor
24313,k20,BRD-K54094468-001-01-6,dopamine receptor antagonist
24313,k21,BRD-K54095730-001-01-5,p38 MAPK inhibitor
24313,k22,BRD-K54142781-001-02-1,Adrenergic receptor agonist
24313,l01,BRD-K54210043-001-02-0,calcium channel activator|large conductance potassium channel activator
24313,l02,BRD-K54233340-300-01-0,AMPK inhibitor|DNA damaging|TGF beta receptor inhibitor
24313,l03,BRD-K54330070-001-05-5,p38 MAPK inhibitor
24313,l04,BRD-K54411430-001-02-5,cAMP inhibitor
24313,l06,BRD-K54529596-001-04-0,ACE inhibitor
24313,l10,BRD-K54665485-001-01-2,Diacylglycerol kinase inhibitor
24313,l11,BRD-K54704028-001-01-3,glutamate receptor antagonist
24313,l12,BRD-K54708045-001-01-3,PPAR receptor agonist
24313,l13,BRD-K54759182-003-02-3,Norepinephrine reuptake inhibitor
24313,l14,BRD-K54771420-001-03-2,Cholesterol inhibitor
24313,l17,BRD-K54790157-001-03-1,DNA synthesis inhibitor
24313,l19,BRD-K55034111-066-02-3,bacterial DNA gyrase inhibitor
24313,l21,BRD-K55191674-236-03-7,Penicillin binding protein inhibitor
24313,m01,BRD-K55344148-003-01-8,Imidazoline receptor ligand
24313,m02,BRD-K55424922-001-01-4,Serotonin receptor agonist
24313,m03,BRD-K55430733-003-01-6,Serotonin receptor agonist
24313,m04,BRD-K55454768-001-01-8,voltage-independent calcium influx blocker
24313,m05,BRD-K55468218-001-04-8,dopamine receptor antagonist
24313,m06,BRD-K55529781-236-02-0,thromboxane synthase inhibitor
24313,m07,BRD-K55567017-001-02-4,alcohol dehydrogenase inhibitor
24313,m08,BRD-K55677650-003-01-1,ionotropic glutamate receptor antagonist
24313,m11,BRD-K55748775-001-01-4,ATPase inhibitor|potassium-competitive acid antagonist
24313,m16,BRD-K55930204-001-02-7,Hydantoin antiepileptic
24313,m17,BRD-K56047318-001-02-2,Triacylglycerol lipase inhibitor
24313,m18,BRD-K56064827-001-04-7,PKC inhibitor
24313,m20,BRD-K56115039-003-01-3,Imidazoline receptor ligand
24313,m22,BRD-K56403959-300-01-9,CC chemokine receptor ligand
24313,m23,BRD-K56429665-001-03-9,vitamin D receptor agonist
24313,m24,BRD-K56509348-003-01-3,Endothelin receptor antagonist
24313,n02,BRD-K56558538-003-02-8,Sodium channel blocker
24313,n03,BRD-K56596464-004-02-4,Sodium channel blocker
24313,n04,BRD-K56699285-001-03-7,dopamine receptor agonist|serotonin receptor antagonist
24313,n08,BRD-K57033106-048-02-8,Histamine receptor antagonist
24313,n11,BRD-K57179821-001-04-8,Antipruritic
24313,n12,BRD-K57222227-001-06-1,cyclooxygenase inhibitor
24313,n16,BRD-K57304726-003-03-6,Sigma receptor agonist
24313,n18,BRD-K57545991-050-03-3,angiotensin converting enzyme inhibitor
24313,n19,BRD-K57569181-001-04-4,Phosphodiesterase inhibitor
24313,n21,BRD-K57718010-001-06-9,GABA receptor antagonist
24313,n22,BRD-K57886322-001-03-4,glucocorticoid receptor agonist
24313,n23,BRD-K57926513-001-02-9,PDGFR receptor inhibitor
24313,o01,BRD-K58220566-001-02-2,PKC inhibitor|sodium channel blocker|calcium channel blocker
24313,o02,BRD-K58265391-001-03-6,diuretic
24313,o03,BRD-K58299615-001-02-7,amyloid precursor protein inhibitor|beta amyloid aggregation inhibitor
24313,o05,BRD-K58466253-003-04-1,serotonin release inhibitor
24313,o06,BRD-K58685305-001-02-2,11-beta hydroxysteroid dehydrogenase inhibitor
24313,o08,BRD-K58930050-001-01-1,glutamate receptor antagonist
24313,o09,BRD-K58938839-001-03-8,smoothened receptor antagonist|hedgehog pathway inhibitor
24313,o10,BRD-K59037100-001-04-8,lipase inhibitor
24313,o13,BRD-K59058766-003-03-7,dopamine receptor antagonist
24313,o15,BRD-K59184148-001-04-2,glycogen synthase kinase inhibitor
24313,o18,BRD-K59273480-001-01-5,adenosine reuptake inhibitor|phosphodiesterase inhibitor
24313,o20,BRD-K59332007-300-01-9,acetylcholine release enhancer|acetylcholine release stimulant|neurotransmitter agonist|voltage-gated potassium channel blocker
24313,o22,BRD-K59419204-001-01-9,cannabinoid receptor antagonist|cannabinoid receptor inhibitor
24313,o23,BRD-K59469039-001-04-9,Angiogenesis inhibitor
24313,o24,BRD-K59522102-001-04-7,monoamine oxidase inhibitor
24313,p01,BRD-K59574735-001-02-7,leukotriene synthesis inhibitor
24313,p02,BRD-K59637651-001-01-4,protein synthesis inhibitor|botulin neurotoxin inhibitor|mur synthetase inhibitor
24313,p03,BRD-K59650319-003-01-7,glutamate receptor antagonist
24313,p04,BRD-K59753853-001-01-5,glutamate receptor antagonist
24313,p06,BRD-K59851896-001-02-4,GABA release inhibitor
24313,p07,BRD-K59983611-001-05-2,bacterial antifolate
24313,p09,BRD-K60060639-005-01-4,antiarrhythmic medication
24313,p10,BRD-K60174629-001-02-2,prolyl endopeptidase inhibitor
24313,p13,BRD-K60184833-001-02-3,tyrosine kinase inhibitor
24313,p14,BRD-K60230970-001-04-3,proteasome inhibitor
24313,p15,BRD-K60274257-001-01-1,tyrosine phosphatase inhibitor
24313,p17,BRD-K60298136-001-01-7,aryl hydrocarbon receptor agonist|aryl hydrocarbon receptor ligand
24313,p18,BRD-K60476892-001-02-1,activator of soluble guanylyl cyclase|guanylate cyclase activator|hypoxia inducible factor inhibitor
24313,p19,BRD-K60511616-236-01-4,HMGCR inhibitor
24313,p20,BRD-K60640630-001-03-7,glucocorticoid receptor agonist
24313,p22,BRD-K60923938-001-02-8,sodium channel activator
24313,p23,BRD-K60932973-001-01-7,dopamine receptor agonist
24313,p24,BRD-K61097567-001-03-6,tachykinin antagonist
